Citrus Sinensis ID: 008378
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 568 | 2.2.26 [Sep-21-2011] | |||||||
| Q944Q0 | 563 | Serine/threonine-protein | yes | no | 0.853 | 0.861 | 0.532 | 1e-149 | |
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.934 | 0.867 | 0.500 | 1e-143 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.637 | 0.638 | 0.613 | 1e-130 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.635 | 0.648 | 0.621 | 1e-129 | |
| Q8RXE5 | 524 | Probable serine/threonine | no | no | 0.633 | 0.687 | 0.659 | 1e-127 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.683 | 0.551 | 0.547 | 1e-118 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.683 | 0.551 | 0.547 | 1e-118 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.649 | 0.527 | 0.518 | 1e-115 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.630 | 0.576 | 0.546 | 1e-112 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.688 | 0.688 | 0.491 | 1e-111 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 527 bits (1357), Expect = e-149, Method: Compositional matrix adjust.
Identities = 307/577 (53%), Positives = 374/577 (64%), Gaps = 92/577 (15%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
MQ P QLERLYSEVHLLK+LKHENIIK + SWVD+ N+TINMITELFTSGSLR YRKKH+
Sbjct: 66 MQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHR 125
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
VD KAIKNWARQIL+GL+YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA V+QQ
Sbjct: 126 KVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQ 185
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPYNEC+N AQIYKKVTS
Sbjct: 186 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTS 245
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP------- 233
IKP SL KV DPQV+QFIEKC++PAS R ALEL KDPFL D KD
Sbjct: 246 NIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSALLASSSTSSK 305
Query: 234 -LRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFT 292
+R P L E PMD+D N K S + + W T+ELQR+ EN EF
Sbjct: 306 YVRPPQL----------EHLPMDVDHNENK----SVSSNEDYPWSQTIELQRIAENKEFR 351
Query: 293 LRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIA 352
LRGE++DD T S+ LRI D SG +HF FYL +DTA +IAEEMVE+L L+ ++VV IA
Sbjct: 352 LRGERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQEVVVIA 411
Query: 353 ELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQ 412
++ID+ IM+L+ T+S N P + EA +Q
Sbjct: 412 DMIDDFIMQLLSD------RTSSHHN------------------QNSPRLTHEDHEAANQ 447
Query: 413 QGVLS--ELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGH 470
Q V S E A+G +S SDISA++ P + DG +A A D
Sbjct: 448 QTVNSKDEEAAG------QSMKSDISADYYFPYSAN---------DGNAAMEAGRD---- 488
Query: 471 EVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLEL 530
ES+ +S++DSCS M S+I +LS++D ++ + LK EL
Sbjct: 489 ---------AESM----------SSYLDSCSMM------STIYNLSISDNDYPEDLKTEL 523
Query: 531 DAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSV 567
+ I S++ Q FQ+LL+ +ED +ENA+++W+ +V
Sbjct: 524 NLIESQFNQSFQDLLKLKEDAIENAKRKWITKKQKAV 560
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 510 bits (1313), Expect = e-143, Method: Compositional matrix adjust.
Identities = 289/577 (50%), Positives = 375/577 (64%), Gaps = 46/577 (7%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
MQSPD LERLYSEVHLLKSLKHEN++KFYN WVDD +TIN+ITELFTSGSLRQYR+KH
Sbjct: 62 MQSPDNLERLYSEVHLLKSLKHENVMKFYNYWVDDQKKTINVITELFTSGSLRQYRQKHP 121
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
VD+KAIKNWARQ+LRGL YLH+H PPIIHRDLKCDNIFVNGN+GEVKIGDLGLA VM
Sbjct: 122 RVDLKAIKNWARQVLRGLDYLHTHQPPIIHRDLKCDNIFVNGNHGEVKIGDLGLATVMLT 181
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
P A+SVIGTPEFMAPELY+E Y+ELVDIYSFGMC+LEM T EYPY+EC N AQI+KKV+
Sbjct: 182 PRAKSVIGTPEFMAPELYDENYDELVDIYSFGMCMLEMFTLEYPYSECTNAAQIFKKVSK 241
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
G+KPA+L+K+T+ Q KQFI+KC+VPAS RL A ELL+DPFL +DN LV + P+ +
Sbjct: 242 GVKPAALAKITNIQAKQFIDKCLVPASERLSAKELLQDPFLCSDNSSVLV--GTKFPSSL 299
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLT-LELQRLTENNEFTLRGEKND 299
P+ ++++ H MD+D N ++ +C +++ G + LE R +N E L GEK D
Sbjct: 300 PKSVDVSLEALH-MDVDTNESMCTS-TCKRNDLGGPHRSVLEFTRTNKNTELKLTGEKLD 357
Query: 300 DDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLI 359
D++VSL LRI D GH NIHF+FYL++DTA+S+A EMVEQL+L+ DV IA+ ID LI
Sbjct: 358 DNSVSLVLRIADLCGHARNIHFLFYLDSDTAMSVAAEMVEQLELADCDVTFIADFIDLLI 417
Query: 360 MKLVPS---WNPSLGSTASQQNGLLKGSPVSQGNSI--SLKCPGEPGSNNAFAEAVSQQG 414
+ LVP N ++ ST+S+ S + + + S + P E + E +
Sbjct: 418 VNLVPGQQLMNDAVMSTSSE-------SKMGESEHVITSQQHPSELTHDYVLVEGMMHSK 470
Query: 415 ---------VLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVY 465
+ S L + S SDIS + D KSL + Y V
Sbjct: 471 EANASPSDYIDSLLNATNLGGPNSSEGSDISVQLDGS-------SKSL------SEYGVD 517
Query: 466 DHGGHEVKADEVS--LGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHS 523
++ E A + + LG + + N +D S S+ + +S+S E+
Sbjct: 518 EYRTLECGAYKGTDKLGCRHPLSNGSSNFAIFQMDQASHHSELVIGASVSI-----TENR 572
Query: 524 DGLKLELDAINSKYQQCFQELLRQREDEMENARKRWL 560
D L EL I ++Y+Q F+EL R RE+ +E ARK+WL
Sbjct: 573 DVLNGELGLIEAQYEQWFRELTRMREEALEGARKKWL 609
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1195), Expect = e-130, Method: Compositional matrix adjust.
Identities = 232/378 (61%), Positives = 287/378 (75%), Gaps = 16/378 (4%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSP+ LERLYSEV LLKSLKH NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+
Sbjct: 65 LQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHR 124
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V+MKA+KNWARQIL GL YLH PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q
Sbjct: 125 KVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQ 184
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+S
Sbjct: 185 ANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSS 244
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPASLS+V DP+VKQFIEKC++PAS RL A ELL DPFL + + +PL LP++V
Sbjct: 245 GIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIV 302
Query: 241 -PE--------VMNLAHSEPHP---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTEN 288
P+ +M+ P + IDL+ N+G+ +E++R
Sbjct: 303 MPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGS--RCIEVRRAKRG 360
Query: 289 NEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDV 348
N F L+GE+ND+ +VSL LRI D++G V NIHF+FY DTA ++ EMVEQL+L+ ++V
Sbjct: 361 NFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNV 420
Query: 349 VSIAELIDNLIMKLVPSW 366
IAELID L++ ++P+W
Sbjct: 421 TFIAELIDILLVNMIPTW 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1193), Expect = e-129, Method: Compositional matrix adjust.
Identities = 235/378 (62%), Positives = 293/378 (77%), Gaps = 17/378 (4%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSPD LERLYSEV LLKSLKH+NII+FYNSW+DD N+T+N+ITELFTSGSLRQYRKKH+
Sbjct: 65 LQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHR 124
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V+MKA+K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q
Sbjct: 125 KVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQ 184
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+S
Sbjct: 185 ANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSS 244
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVC-DPLRLPNL 239
GIKPASLSKV DP+V +FIEKC++PAS RL A ELL D FL N LV +PL LP++
Sbjct: 245 GIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDI 301
Query: 240 V-PEVMNLAH----SEPHP------MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTEN 288
V P+ + SE P M ++L+ + +N+GT +E++R
Sbjct: 302 VMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGTN--CIEVRRAKRG 359
Query: 289 NEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDV 348
N F L+GE+ND+++VSL LRI D++G V NIHF+F+ DTA +++ EMVEQL+L+ ++V
Sbjct: 360 NFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNV 419
Query: 349 VSIAELIDNLIMKLVPSW 366
IAELID L++ L+P+W
Sbjct: 420 KFIAELIDVLLVNLIPNW 437
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1174), Expect = e-127, Method: Compositional matrix adjust.
Identities = 240/364 (65%), Positives = 271/364 (74%), Gaps = 4/364 (1%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+Q P QL+RLYSEVHLL SLKH+NIIK + SWVDD N++INMITELFTSGSL YRKKH+
Sbjct: 53 LQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHR 112
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
VD KAI NWARQIL+GLHYLHS PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQ
Sbjct: 113 KVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQ 172
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTS
Sbjct: 173 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTS 232
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKP SLSKV DPQVKQFIEKC++PA R ALELLKD L D KD
Sbjct: 233 GIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFK 292
Query: 241 PEVMNLAHSEPHPMDIDL-NHKKVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKN 298
P + E PMD++ + VS S AKS+ L T+E+QR+ E+ EF L GE+
Sbjct: 293 PAMP--PQCEYRPMDVEYKKNTSVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERR 350
Query: 299 DDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNL 358
DD S+ LRI SG + F F L DTA ++ EMVE+LDLS +V IAE+ID L
Sbjct: 351 DDVAASMALRIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDEL 410
Query: 359 IMKL 362
IMKL
Sbjct: 411 IMKL 414
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1097), Expect = e-118, Method: Compositional matrix adjust.
Identities = 224/409 (54%), Positives = 275/409 (67%), Gaps = 21/409 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSP+ LERLY E+HLLK+LKH NI+KFY SWVD + R IN ITE+FTSG+LRQYR+KH
Sbjct: 64 LQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHM 123
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V++ A+K+W RQIL GL YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++
Sbjct: 124 RVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 183
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV S
Sbjct: 184 SHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVIS 243
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP------- 233
G KP +L KV DP V+QF+EKC+ AS RL A ELLKDPFL D DLV P
Sbjct: 244 GTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSL 300
Query: 234 ---LRLPNLVPEVMNLAH-----SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRL 285
LR P L N++ SE D + D K++ F E + L
Sbjct: 301 MNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPL 360
Query: 286 TENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSH 345
N + T++G K++D ++ L LRI D GHV NI+F F + ADTA+S+A EMV +LD++
Sbjct: 361 G-NVDITIKGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITD 419
Query: 346 EDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLK--GSPVSQGNSI 392
+V IAE+ID + LVP W P G SQ GS VS S+
Sbjct: 420 HEVTRIAEMIDGEVSALVPDWRPGPGIEESQDTTYCHNCGSNVSSCGSL 468
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 427 bits (1097), Expect = e-118, Method: Compositional matrix adjust.
Identities = 224/409 (54%), Positives = 275/409 (67%), Gaps = 21/409 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSP+ LERLY E+HLLK+LKH NI+KFY SWVD + R IN ITE+FTSG+LRQYR+KH
Sbjct: 64 LQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHM 123
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V++ A+K+W RQIL GL YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++
Sbjct: 124 RVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 183
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV S
Sbjct: 184 SHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVIS 243
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP------- 233
G KP +L KV DP V+QF+EKC+ AS RL A ELLKDPFL D DLV P
Sbjct: 244 GTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSL 300
Query: 234 ---LRLPNLVPEVMNLAH-----SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRL 285
LR P L N++ SE D + D K++ F E + L
Sbjct: 301 MNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPL 360
Query: 286 TENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSH 345
N + T++G K++D ++ L LRI D GHV NI+F F + ADTA+S+A EMV +LD++
Sbjct: 361 G-NVDITIKGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITD 419
Query: 346 EDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLK--GSPVSQGNSI 392
+V IAE+ID + LVP W P G SQ GS VS S+
Sbjct: 420 HEVTRIAEMIDGEVSALVPDWRPGPGIEESQDTTYCHNCGSNVSSCGSL 468
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1066), Expect = e-115, Method: Compositional matrix adjust.
Identities = 212/409 (51%), Positives = 269/409 (65%), Gaps = 40/409 (9%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSP+ LERLY E+HLLK+LKH+NI+KFY SWVD NR IN +TELFTSG+LRQYR +HK
Sbjct: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHK 120
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V+++A+K+W RQILRGLHYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++
Sbjct: 121 RVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A +GTPEFMAPE+YEE YNELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV S
Sbjct: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMS 240
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNP---------KDLVC 231
G KP +L KV DP+VK FIEKC+ SLR+ A ELL DPFL D+ +D V
Sbjct: 241 GKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVG 300
Query: 232 DPLRLPNLVPEVMNLAHSEP----------HPMD-IDLNHKKVSADSCAKSNTGTWFLT- 279
R P+ +P+ N + +P + LN + + + W
Sbjct: 301 PLYRQPHHLPDYYNYPSNSSSLNRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWAYNP 360
Query: 280 --------LEL-----------QRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIH 320
+EL ++ + N + T++G++ DD + L LRI DK G V NI+
Sbjct: 361 AETEETHGIELFESRNNDDQEEEKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVRNIY 420
Query: 321 FVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPS 369
F F + DTA+S+A EMV +LD+ V IA +ID I LVPSW P
Sbjct: 421 FPFDIETDTALSVATEMVAELDMDDHGVTKIANMIDGEISSLVPSWRPG 469
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 405 bits (1040), Expect = e-112, Method: Compositional matrix adjust.
Identities = 206/377 (54%), Positives = 263/377 (69%), Gaps = 19/377 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+++ D LERL SEV LLK+LKH+NIIKFYNSW+D N IN ITE+FTSG+LRQYR KHK
Sbjct: 65 LRNNDDLERLRSEVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHK 124
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
VD++A+K W+RQIL GL YLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++
Sbjct: 125 KVDVRALKKWSRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDN 184
Query: 121 P-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
+A S+IGTPEFMAPELY+EEYNELVDIY+FGMC+LE+VT EYPY EC N AQIYKKV+
Sbjct: 185 ARSAHSIIGTPEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVS 244
Query: 180 SGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 239
G KP+SL+K+ DP+V+ FIEKCI AS RL A ELL DPFL D K + PL+
Sbjct: 245 DGEKPSSLAKIEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRDDGEK--IFYPLQSNTK 302
Query: 240 VPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTW----------FLTLELQRLTENN 289
+ ++S + + + ++ + +TG++ T++ Q
Sbjct: 303 ASDGAGSSNSS-----MGYKYDRDASSMAIREHTGSFAEEHPSDRYIHSTMDPQ-AAAGR 356
Query: 290 EFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVV 349
T+ + D +T+ L LRI D +GH NIHF F + ADT+IS+A EMV QLDL+ +DV
Sbjct: 357 IITVESQMKDLNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVT 416
Query: 350 SIAELIDNLIMKLVPSW 366
+IAE+ID I +P W
Sbjct: 417 AIAEMIDAEIRAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 402 bits (1034), Expect = e-111, Method: Compositional matrix adjust.
Identities = 202/411 (49%), Positives = 272/411 (66%), Gaps = 20/411 (4%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++P++LE+ + E+HLLK+L H+NI+KFY SWVD N +IN +TELFTSG+LRQYR +H+
Sbjct: 62 RNPEELEKFFREIHLLKTLNHQNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHRR 121
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
V+++A+K W +QIL+GL YLHS +PPIIHRDLKCDNIF+NGN GEVKIGDLGLA ++++
Sbjct: 122 VNIRAVKQWCKQILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKS 181
Query: 122 TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 181
A +GTPEFMAPE+Y+EEYNELVD+Y+FGMC+LEMVT +YPY+EC +PAQIYKKVTSG
Sbjct: 182 HAVRCVGTPEFMAPEVYDEEYNELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTSG 241
Query: 182 IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 241
KP + V DP+V++F+EKC+ + RL ALELL+DPFL DN V P+ N
Sbjct: 242 KKPEAFYLVKDPEVREFVEKCLANVTCRLTALELLQDPFLQDDNMDGFVMRPIDYYNGYD 301
Query: 242 EVMNLAHSEPHPM-DIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDD 300
E HP+ D L H + + + + L ++ + +++G++N D
Sbjct: 302 ETGVFLR---HPLIDDPLYHDQFESSQICE-------IDLFANDDEDHVDISIKGKRNGD 351
Query: 301 DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIM 360
D + L LRI D G + NI+F F DTA S+A EMV +LD++++DV IAE+ID I
Sbjct: 352 DGIFLRLRISDAEGRIRNIYFPFETAIDTAWSVAVEMVSELDITNQDVAKIAEMIDAEIA 411
Query: 361 KLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVS 411
LVP W T S QN + + G GE SN E VS
Sbjct: 412 ALVPDWK---NDTESSQNVNNNKNNNTAGFC------GECASNGYIQETVS 453
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 568 | ||||||
| 224072272 | 596 | predicted protein [Populus trichocarpa] | 0.931 | 0.887 | 0.644 | 0.0 | |
| 359474135 | 645 | PREDICTED: serine/threonine-protein kina | 0.989 | 0.871 | 0.628 | 0.0 | |
| 255555709 | 585 | kinase, putative [Ricinus communis] gi|2 | 0.922 | 0.895 | 0.628 | 0.0 | |
| 224058021 | 571 | predicted protein [Populus trichocarpa] | 0.887 | 0.882 | 0.628 | 0.0 | |
| 357462359 | 614 | Serine/threonine protein kinase WNK8 [Me | 0.978 | 0.905 | 0.6 | 1e-175 | |
| 449452398 | 679 | PREDICTED: serine/threonine-protein kina | 0.968 | 0.810 | 0.576 | 1e-169 | |
| 351724041 | 618 | with no lysine kinase 8 [Glycine max] gi | 0.971 | 0.893 | 0.581 | 1e-166 | |
| 356547519 | 618 | PREDICTED: serine/threonine-protein kina | 0.975 | 0.896 | 0.579 | 1e-165 | |
| 225470964 | 625 | PREDICTED: probable serine/threonine-pro | 0.970 | 0.881 | 0.551 | 1e-155 | |
| 449478217 | 713 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.982 | 0.782 | 0.546 | 1e-154 |
| >gi|224072272|ref|XP_002303683.1| predicted protein [Populus trichocarpa] gi|222841115|gb|EEE78662.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/562 (64%), Positives = 420/562 (74%), Gaps = 33/562 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QS QLERLYSEVHLLKSLKHENIIKFY+SWVDD N+TIN+ITELFTSGS+RQYRKKHK
Sbjct: 61 LQSSQQLERLYSEVHLLKSLKHENIIKFYSSWVDDKNKTINIITELFTSGSMRQYRKKHK 120
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
VDMKAIKNWARQILRGLHYLH+H+PPIIHRDLKCDNIFVNGN GEVKIGDLGLAIVMQQ
Sbjct: 121 TVDMKAIKNWARQILRGLHYLHTHSPPIIHRDLKCDNIFVNGNTGEVKIGDLGLAIVMQQ 180
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
P ARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKKV+S
Sbjct: 181 PIARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKKVSS 240
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPASL KV+D QVK FIEKC+VPAS RLPA+ELLKDPFL T+N K+LV L+LPNL+
Sbjct: 241 GIKPASLGKVSDHQVKVFIEKCLVPASTRLPAIELLKDPFLATENSKELVSSSLQLPNLI 300
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKND 299
++L SE H MDID KK+S SC KS N F TLEL R TENNEF LRG KN+
Sbjct: 301 SRQVHLLQSESHLMDIDC--KKLSVGSCTKSINESPQFSTLELSRFTENNEFRLRGAKNN 358
Query: 300 DDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLI 359
D+TVSLTLRI D G NIHF FYL++DTA+ IAEEMVEQLDL EDV IAELIDNLI
Sbjct: 359 DNTVSLTLRIADPCGRARNIHFTFYLDSDTAVLIAEEMVEQLDLLTEDVAVIAELIDNLI 418
Query: 360 MKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSEL 419
KLVPSWN SP + S L+ N++ +EAV + L L
Sbjct: 419 AKLVPSWNT---------------SPSVRNGSSELE-------NHSTSEAVKKPDFLP-L 455
Query: 420 ASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSL 479
+ ++S +SDISAE+++ + D+ +KSL +YD E E +
Sbjct: 456 TNMTDLETKQSVNSDISAEYNMAIASDSGTNKSLGSSDCCLQSNMYD---LEFGMLEDGI 512
Query: 480 GESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQ 539
+ N+ST+NS S+I S SGMS+N S SSI SLSLADK+ S+ LK ELD+I+S Y Q
Sbjct: 513 SK---HNKSTRNSNDSYIGSFSGMSRNASMSSICSLSLADKDGSE-LKQELDSIDSHYNQ 568
Query: 540 CFQELLRQREDEMENARKRWLA 561
C QEL++ RE+ +ENA+KR +
Sbjct: 569 CLQELMKMREEAIENAKKRGIT 590
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/581 (62%), Positives = 434/581 (74%), Gaps = 19/581 (3%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSP QLERLYSEVHLLKSLKH+NIIKFYNSWVDDTN+TIN+ITELFTSGSLRQYRKKHK
Sbjct: 60 LQSPQQLERLYSEVHLLKSLKHDNIIKFYNSWVDDTNKTINLITELFTSGSLRQYRKKHK 119
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
NVD+KAIKNWA+QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ
Sbjct: 120 NVDLKAIKNWAKQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 179
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE+VTCEYPYNECKNPAQIYKKV+S
Sbjct: 180 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILELVTCEYPYNECKNPAQIYKKVSS 239
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVC------DPL 234
GIKPASL KV+DPQVKQFIEKC+VPASLRL A ELLKD F T+N K+ V D L
Sbjct: 240 GIKPASLGKVSDPQVKQFIEKCLVPASLRLSAQELLKDAFFATENSKEPVYNHMHVDDSL 299
Query: 235 RLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGT-WFLTLELQRLTENNEFTL 293
+ N +P +MNL E PMD+D N+KK+S + KS +GT F L+ +R +NN F L
Sbjct: 300 QSSNFMPNLMNLPKPELQPMDMDPNYKKLSVSTHMKSISGTPHFRALQFERFNKNNLFKL 359
Query: 294 RGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAE 353
RGEK DD+++S+TL I D G NIHF FYL++DTA+SIA EMVEQLDL +EDV IAE
Sbjct: 360 RGEKIDDNSISMTLHIADPCGRAKNIHFAFYLDSDTALSIAGEMVEQLDLYNEDVAVIAE 419
Query: 354 LIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQ 413
LID +I +LVP+W P+ S N + S V SL+ P + GS ++AV++
Sbjct: 420 LIDVMISELVPTWKPAFESMLCGANSSCEDSLVLHNGGTSLRHPSDSGSAKGTSDAVTEH 479
Query: 414 GVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSL-VPDG----------YSAHY 462
++S A+G+ Q ES+ S +S + D V DA+ KSL PD ++
Sbjct: 480 -LISLSANGEEQSTVESALSGMSTKDDATVASDANDIKSLECPDDECYEASDRCCFNGDR 538
Query: 463 AVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEH 522
V DH H+ ++GE + N T++ E S I+SCSGMS +LS SSI SLSLADK+
Sbjct: 539 QVLDHERHKEGRYNGNIGEPVAMNGFTKDWEISCIESCSGMSNSLSLSSICSLSLADKDP 598
Query: 523 SDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGS 563
SD LKLE+D I+++Y QCFQELLR RE+ +E A+ RW+ S
Sbjct: 599 SDELKLEVDTIDTQYHQCFQELLRMREEAIEKAKNRWITKS 639
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555709|ref|XP_002518890.1| kinase, putative [Ricinus communis] gi|223541877|gb|EEF43423.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/570 (62%), Positives = 413/570 (72%), Gaps = 46/570 (8%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSPDQLERLYSEVHLLKSLKHENI+KFYNSWVDD N+TINMITELFTSGSLR+YRKKHK
Sbjct: 60 LQSPDQLERLYSEVHLLKSLKHENIMKFYNSWVDDNNKTINMITELFTSGSLRKYRKKHK 119
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
NVD+KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN+FVNGNNGEVKIGDLGLA VMQQ
Sbjct: 120 NVDIKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNVFVNGNNGEVKIGDLGLATVMQQ 179
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTS
Sbjct: 180 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTS 239
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPASL KV DP VK+FIEKCIVPAS+RLPALELLKDPFL T+NPK+LV L LP+L+
Sbjct: 240 GIKPASLCKVNDPLVKRFIEKCIVPASMRLPALELLKDPFLATENPKELVFASLHLPDLM 299
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKND 299
+ ++ SE +PMDID NHKK+S SC KS + F T E QRLT NEF LRGEKND
Sbjct: 300 LKQVSRGQSESYPMDIDSNHKKLSVGSCTKSMDESLHFSTSEFQRLTVKNEFRLRGEKND 359
Query: 300 DDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLI 359
D+T+SLTLRI D+ G V NIHF FYL++DT +SIAEEMVEQLDLS+EDV IAELID LI
Sbjct: 360 DNTISLTLRIVDRCGGVKNIHFTFYLDSDTTLSIAEEMVEQLDLSNEDVAIIAELIDALI 419
Query: 360 MKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSEL 419
+KLVP + S GST+S NG N+A + S+ L L
Sbjct: 420 LKLVPHLSQS-GSTSSMPNGF------------------SELHNDATFKVASKHDFLP-L 459
Query: 420 ASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSL 479
A K Q Q+S S++S E + V DA +K L Y+ + Y+ G +D +
Sbjct: 460 ADLKGQETQDSLLSELSTELPLTVASDASTNKPLGSSDYTIDFNTYEFG-----SDFMMH 514
Query: 480 GESIL-FNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQ 538
G+ + + T++SE L A E D LKLELDAI+ +Y
Sbjct: 515 GDGTFKYGKYTKHSE-------------------KHLPSAKGEVQDDLKLELDAIDMQYN 555
Query: 539 QCFQELLRQREDEMENARKRWLAGSNVSVI 568
QCF+EL RE+ +ENA+K+W+ V I
Sbjct: 556 QCFRELSMMREEAIENAKKKWITRKKVPAI 585
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224058021|ref|XP_002299436.1| predicted protein [Populus trichocarpa] gi|222846694|gb|EEE84241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1656), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/563 (62%), Positives = 409/563 (72%), Gaps = 59/563 (10%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QS QLERLYSEVHLLKSLKHENIIKFYNSWVDD N+TINMITEL TSG+LRQYRKKHK
Sbjct: 61 LQSSQQLERLYSEVHLLKSLKHENIIKFYNSWVDDKNKTINMITELLTSGNLRQYRKKHK 120
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
VDMKAIKNWARQILRGL YLH+ +P IIHRDLKCDNI VNGNNGEVKIGDLGLAIVMQQ
Sbjct: 121 TVDMKAIKNWARQILRGLQYLHTRSPRIIHRDLKCDNILVNGNNGEVKIGDLGLAIVMQQ 180
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
P ARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKKVTS
Sbjct: 181 PIARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKKVTS 240
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPASL KV D QVK+FIEKC+VPAS+RL A++LLKDPFL T+N K++V +LPN++
Sbjct: 241 GIKPASLVKVNDLQVKEFIEKCLVPASVRLSAIDLLKDPFLATENSKEVVSSLSQLPNVI 300
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKND 299
+ ++L SE H MDID K +S SC KS N FLTLEL+R TENNEF LR EKND
Sbjct: 301 CKQVHLPQSESHHMDIDC--KMLSLGSCPKSINESPQFLTLELRRFTENNEFRLRAEKND 358
Query: 300 DDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLI 359
D+TVSLTLRI D G NIHF FYLN+DTA+SIAEEMVEQLDLS EDV IAELID+LI
Sbjct: 359 DNTVSLTLRIADPCGRARNIHFTFYLNSDTAVSIAEEMVEQLDLSSEDVAVIAELIDSLI 418
Query: 360 MKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPG-EPGSNNAFAEAVSQQGVLSE 418
+KLVP WN S +S +NG + S + K P P +N EA+
Sbjct: 419 VKLVPCWNTS----SSVRNG--SSELENHATSETGKTPDFSPLTNITDHEAL-------- 464
Query: 419 LASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVS 478
+S +SDISAE+++ + DA +KSL S V+
Sbjct: 465 ----------QSVNSDISAEYNMAIASDASTNKSLGSSSCSLQSNVF------------- 501
Query: 479 LGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQ 538
IDSCSGMS+N S S I SL LADK+ S+ LKLELD+I+S Y
Sbjct: 502 -----------------HIDSCSGMSRNASLSIICSLFLADKDGSE-LKLELDSIDSHYN 543
Query: 539 QCFQELLRQREDEMENARKRWLA 561
QCFQEL++ RE+ +ENA++RW++
Sbjct: 544 QCFQELMKTREEAIENAKRRWIS 566
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357462359|ref|XP_003601461.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] gi|355490509|gb|AES71712.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1603), Expect = e-175, Method: Compositional matrix adjust.
Identities = 342/570 (60%), Positives = 412/570 (72%), Gaps = 14/570 (2%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
MQSP LE+LYSEVHLLKSLKHENIIK Y+SWVD+ + INMITELFTSGSLRQYRKKHK
Sbjct: 57 MQSPQNLEKLYSEVHLLKSLKHENIIKMYSSWVDEKSSNINMITELFTSGSLRQYRKKHK 116
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
NVDMKAIKNWARQILRGL +LHSHNPP+IHRDLKCDNIFVNGNNG+VKIGDLGLAIVMQQ
Sbjct: 117 NVDMKAIKNWARQILRGLCFLHSHNPPVIHRDLKCDNIFVNGNNGQVKIGDLGLAIVMQQ 176
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVD+YSFGMCILEM+TCEYPY+ECKNPAQIYKKVTS
Sbjct: 177 PTARSVIGTPEFMAPELYEEEYNELVDVYSFGMCILEMITCEYPYSECKNPAQIYKKVTS 236
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPASL++V DP+VKQFIEKC+VPAS+RLPA ELLKDPFL T N K++ D L LPN
Sbjct: 237 GIKPASLARVNDPEVKQFIEKCLVPASMRLPASELLKDPFLATGNTKEIYHDNLLLPNPP 296
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTL--ELQRLTENNEFTLRGEKN 298
+ +N EPHPM+ID N K S S + + T ++ ++ R TENNEF LRGEKN
Sbjct: 297 SKSLNPPTCEPHPMEIDSNVKHTSPASTVERDKETSQVSSNHDILRKTENNEFRLRGEKN 356
Query: 299 DDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNL 358
D T+SLTLRI D +G NIHF FY+++DT ISIAEEMVE L+L EDV IAELI N+
Sbjct: 357 ADRTISLTLRIADANGGARNIHFPFYIDSDTTISIAEEMVEHLELKDEDVAVIAELIHNM 416
Query: 359 IMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSE 418
I KLVP W P L +S + L + P+ N L C GSNN +++ + S+
Sbjct: 417 IFKLVPDWKP-LCENSSGTDNLYR--PLEPQNE-QLNCHWTLGSNNFDMKSMYEDLGHSQ 472
Query: 419 LASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVS 478
L G+ Q QES SDISAE+ + DA K + + + H G D
Sbjct: 473 L-DGEDQDKQESVSSDISAEYGTVIATDA---KGVEQNCFILHECCKGSNGLNTNPDVRI 528
Query: 479 LGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQ 538
G+ + ++ SE S + SC S+NL S SL+ D++H D L+LE++AI +YQ
Sbjct: 529 CGQE---DGNSNQSENSVV-SCCSPSENLDRLSKCSLTALDQDHLDELQLEIEAIEIQYQ 584
Query: 539 QCFQELLRQREDEMENARKRWLAGSNVSVI 568
Q F+EL++ RE+ +EN +KRW + N+SV+
Sbjct: 585 QSFRELMKMREEAIENVKKRWTSKKNISVM 614
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452398|ref|XP_004143946.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] gi|449529646|ref|XP_004171809.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 603 bits (1554), Expect = e-169, Method: Compositional matrix adjust.
Identities = 337/585 (57%), Positives = 408/585 (69%), Gaps = 35/585 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSP+QL+RLYSEVHLLKSLKHENIIKFY+ WVDD ++TINMITELFTSGSLRQYRKKH+
Sbjct: 113 LQSPEQLQRLYSEVHLLKSLKHENIIKFYSYWVDDKHKTINMITELFTSGSLRQYRKKHR 172
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
VD+KA KNWARQILRGL YLH HNPPIIHRDLKCDNIFVNGN GEVKIGDLGLAIVMQQ
Sbjct: 173 KVDLKAFKNWARQILRGLTYLHGHNPPIIHRDLKCDNIFVNGNTGEVKIGDLGLAIVMQQ 232
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELY+E+YNELVDIYSFGMC+LE+VTCEYPYNECKN AQI+KKVTS
Sbjct: 233 PTARSVIGTPEFMAPELYDEDYNELVDIYSFGMCMLEIVTCEYPYNECKNSAQIFKKVTS 292
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPASL KV DPQVKQFIEKC+VPAS RLPA ELLKDPFL ++PKD + R N
Sbjct: 293 GIKPASLEKVLDPQVKQFIEKCLVPASTRLPASELLKDPFLAAESPKDNSSELSRSLNEH 352
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVSAD--SCAKSNTG-TWFLTLELQRLTENNEFTLRGEK 297
+ +N HPM+ D N K+S S KSN G + F T ELQRLTENNE TL+G+
Sbjct: 353 FKSVNPPLLGSHPMETDHNCTKLSGSVASSVKSNNGISHFSTQELQRLTENNELTLKGDM 412
Query: 298 NDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDN 357
D +T+S LRI + G NIHF FYL++DT+++IA EMVEQL+LS+ED IA+LID
Sbjct: 413 TDHNTMSFHLRIAELYGKSRNIHFAFYLDSDTSLAIALEMVEQLELSNEDATIIAKLIDE 472
Query: 358 LIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAV------- 410
LI K VPSW P QQ SP +Q + + + F+E V
Sbjct: 473 LIAKFVPSWKPCPNYCEEQQQN-TPHSPEAQEDKTFI--------SPFFSELVLSSPMVA 523
Query: 411 SQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLV------PDGYSAHYAV 464
+ + L+ LA + Q NQ+S S S E+ + D I K PD A+ +
Sbjct: 524 AARNNLTGLAKVEDQENQQSIISCASVEYIYSTVSDYSIGKGSECGEFGHPDCEKAYIS- 582
Query: 465 YDHGGHEVKADEV-SLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHS 523
G ++ A+ V SL +I F ++ S I SCS MSK LS SS S+LS+ +++H
Sbjct: 583 --SGTIDLDAEAVGSLSTTIDF------AKPSLISSCSEMSKELSLSSFSTLSMEERDHQ 634
Query: 524 DGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSVI 568
D LK+E+DAI+ +Y QC EL R RE+ +E+A+KRW++ + I
Sbjct: 635 DELKMEIDAIDLQYHQCLCELSRMREEAIESAKKRWMSKKKATGI 679
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351724041|ref|NP_001236020.1| with no lysine kinase 8 [Glycine max] gi|225348645|gb|ACN87284.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 591 bits (1524), Expect = e-166, Method: Compositional matrix adjust.
Identities = 325/559 (58%), Positives = 406/559 (72%), Gaps = 7/559 (1%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+Q+P QL +LYSEVHLLKSLKH+N+IK YNSWVDDT TINMITELFTSGSLRQYRKKHK
Sbjct: 53 VQTPQQLGKLYSEVHLLKSLKHDNVIKLYNSWVDDTAGTINMITELFTSGSLRQYRKKHK 112
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
NVDMKAIKNWARQILRGL +LHS +PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQ
Sbjct: 113 NVDMKAIKNWARQILRGLCFLHSQSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQ 172
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTS
Sbjct: 173 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTS 232
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPA+L+KV DP+VKQFIEKC+VPAS+RL A ELLKDPFL T+N K++ D L+LPN
Sbjct: 233 GIKPAALAKVNDPEVKQFIEKCLVPASMRLSASELLKDPFLATENTKEINHDTLQLPNPH 292
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKND 299
+++NL EPHPM+ID ++ S S + + +L R+T+NN+ LRGEKN
Sbjct: 293 IKLVNLPKCEPHPMEIDSYSRRTSPGSSMGRIEETSQVSFFDLVRMTDNNKLMLRGEKNA 352
Query: 300 DDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLI 359
+ T+SLTLRI D G NIHF FY+++DTAISIAEEMVE L+L++EDV IAELI+++I
Sbjct: 353 ESTISLTLRIPDACGGARNIHFPFYMDSDTAISIAEEMVEHLELTNEDVSVIAELINDMI 412
Query: 360 MKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSEL 419
KLVP+ P +S+ N L + S Q N C S++ +A+ + V S
Sbjct: 413 AKLVPNSKPLCEKLSSETNLLYRPSSEVQ-NGEQFNCHWPLQSSDYDMKAMYKDLVHSRP 471
Query: 420 ASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSL 479
G Q QES SDISA + + D+ K + PD + + + G +D
Sbjct: 472 VDGDDQEKQESVMSDISAACGITIASDS---KVVEPDIFI--FDEFWEGFFNSTSDIRFC 526
Query: 480 GESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQ 539
G+ ++NS S I+SC KN SSI SL+LADK+ S+GL+L+++AI++ + +
Sbjct: 527 GQEDGHKNQSENSVGSLINSCCCPFKNFDMSSICSLTLADKDPSEGLRLDIEAIDTYFDR 586
Query: 540 CFQELLRQREDEMENARKR 558
F EL R++ +++A++R
Sbjct: 587 RFLELEMMRQEAIKSAKRR 605
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547519|ref|XP_003542159.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1513), Expect = e-165, Method: Compositional matrix adjust.
Identities = 324/559 (57%), Positives = 397/559 (71%), Gaps = 5/559 (0%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+Q+P QLE+LYSE+HLLKSLKH+N+IK YNSWVDDT TINMITELFTSGSLRQYR KHK
Sbjct: 53 VQTPQQLEKLYSEIHLLKSLKHDNVIKLYNSWVDDTTGTINMITELFTSGSLRQYRNKHK 112
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
NVDMKAIKNWARQILRGL +LH H+PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQ
Sbjct: 113 NVDMKAIKNWARQILRGLCFLHCHSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQ 172
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY+EC NPAQIYKKVTS
Sbjct: 173 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECNNPAQIYKKVTS 232
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPA+L+KV DP+VKQFIEKC+VPAS+RL A ELLKDPFL T+N K++ D L LPN
Sbjct: 233 GIKPAALAKVNDPEVKQFIEKCLVPASMRLSASELLKDPFLATENTKEINHDILELPNPH 292
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKND 299
+++N EPHPM+ID ++ S S + + +L R+TENN+F LRGEKN
Sbjct: 293 TKLVNPPTCEPHPMEIDSKSRRTSPGSSMGRIEETSQVSFFDLVRMTENNKFMLRGEKNA 352
Query: 300 DDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLI 359
+ T+SLTLRI + G NIHF FY+N+DTAISIAEEMVE L+L++EDV IAELI+++I
Sbjct: 353 ESTISLTLRIANACGGARNIHFPFYINSDTAISIAEEMVEHLELTNEDVSVIAELINDMI 412
Query: 360 MKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSEL 419
KLVP+ P +S + L + S Q N C S++ + V + V S
Sbjct: 413 AKLVPNLKPLSEKLSSGTDQLYRPSSEVQ-NGEQFNCHWPLQSSDYDMKPVFKDLVHSWP 471
Query: 420 ASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSL 479
G QES SDIS E + V D+ K + PD + +D
Sbjct: 472 VDGDDLEKQESVMSDISVECGITVASDS---KVVEPDIFIFDEFWEGFDAFNSTSDVRFC 528
Query: 480 GESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQ 539
G+ ++NS S I+SC KN SSI SL+LADK+ S+GL+LE++AI++ ++Q
Sbjct: 529 GQEDGHKNQSENSSGSLINSCCCPFKNFDISSICSLTLADKDPSEGLRLEIEAIDTYFEQ 588
Query: 540 CFQELLRQREDEMENARKR 558
F+EL R +E+ ++R
Sbjct: 589 RFRELEMMRVAAIESLKRR 607
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1433), Expect = e-155, Method: Compositional matrix adjust.
Identities = 321/582 (55%), Positives = 394/582 (67%), Gaps = 31/582 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++SP+ LE+LYSEVHLLKSLKHENIIKFYNSWVDD +T+NMITELFTSGSLRQYRKKHK
Sbjct: 59 LRSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYRKKHK 118
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
NVDMKAIKNWARQ+LRGL YLHSHNPPIIHRDLKCDNIFVNGN+GEVKIGDLGLAIVMQQ
Sbjct: 119 NVDMKAIKNWARQVLRGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIVMQQ 178
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVT EYPYNECKNPAQIYKKVTS
Sbjct: 179 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTFEYPYNECKNPAQIYKKVTS 238
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPASL KVTD Q+K+FI KC+ PAS RLPA ELLKDPF ++NPK+ + PL+LP+
Sbjct: 239 GIKPASLCKVTDLQIKEFIVKCLAPASERLPAKELLKDPFFQSENPKEPIRVPLQLPSRS 298
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDD 300
P+ + L+ S P MDID +H ++S+ + ++N F LE QR+ +++EF LR +K +D
Sbjct: 299 PKSIILSKSGPFSMDIDPDHPQLSSSTSTENNGSPDFPVLEFQRMYKSSEFRLRAKKIND 358
Query: 301 DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIM 360
+++SLTLR D G V NIHF F L+ DT S+ EMVEQL+L+ +V IA+ ID +IM
Sbjct: 359 NSISLTLRTVDSYGPVKNIHFPFSLDTDTVHSVVGEMVEQLELAEHEVAFIADFIDYVIM 418
Query: 361 KLVPSWNP----SLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNA---FAEAVSQQ 413
+L+P W P LG S P GN + C G N+ A A Q
Sbjct: 419 RLLPGWKPPRDDPLGGARSPN-----AEPPVLGNGNNHDCTISHGDGNSSPNLANAEDQD 473
Query: 414 GV-------LSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYD 466
+ L+ AS K D +I + H + D Y
Sbjct: 474 SLASAGLVTLTVDASKKNDKTVGFGDYNIGGNYKGSN--GGHASEQESRDPY-------- 523
Query: 467 HGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSK-NLSFSSISSLSLADKEHSDG 525
H ++++ + S+ E N+ +++ SF D SG+S S SSLSLAD + G
Sbjct: 524 HEDYKLQRNNSSIEEFTPMNKFQKSTVLSF-DDLSGLSNVRSLTCSCSSLSLADIDQDPG 582
Query: 526 LKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSV 567
LK ELDAI+ +YQ FQEL R R + +E +KRW+ ++V
Sbjct: 583 LKQELDAIDLQYQHWFQELSRMRVEALEATKKRWMTKKKLAV 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449478217|ref|XP_004155253.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1419), Expect = e-154, Method: Compositional matrix adjust.
Identities = 323/591 (54%), Positives = 400/591 (67%), Gaps = 33/591 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSP+ LE+LYSEVHLLKSLKHENIIKFYNSWVDD +T+NMITELFTSGSLRQYRKKHK
Sbjct: 120 LQSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYRKKHK 179
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+VDMKAIKNWARQILRGL YLHSH+PPIIHRDLK DNIF+NGN+GEVKIGDLGLAIVMQQ
Sbjct: 180 HVDMKAIKNWARQILRGLVYLHSHDPPIIHRDLKGDNIFINGNHGEVKIGDLGLAIVMQQ 239
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVD+YSFGMC+LEMVT EYPY+ECKNPAQI++KVTS
Sbjct: 240 PTARSVIGTPEFMAPELYEEEYNELVDVYSFGMCMLEMVTFEYPYSECKNPAQIFRKVTS 299
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPASL+KV+DP+ +FI KC+VP RL A ELLKD FL +NPK+ +PL+L N V
Sbjct: 300 GIKPASLAKVSDPRTMEFINKCLVPVHERLSAKELLKDSFLQVENPKESARNPLQLSNQV 359
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGT-WFLTLELQRLTENNEFTLRGEKND 299
+ +NL S P MDID++ K S + A+SN+G+ F +E Q + +NNEF LRG KND
Sbjct: 360 SKSINLPKSGPISMDIDIDQKIHSLSTYAESNSGSPRFPVVEFQTMNKNNEFRLRGNKND 419
Query: 300 DDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLI 359
D++V+LTLRI D +G V NIHF YL++DTA+S+A EM EQL+L + DV IAE ID LI
Sbjct: 420 DNSVALTLRIADSNGRVRNIHFTXYLDSDTALSVAAEMAEQLELINHDVDFIAEFIDFLI 479
Query: 360 MKLVPSWNP-----SLGSTASQQNGLLKGSP---VSQGNSISLKCPGEP----GSNNAFA 407
KL+P W P S G S +L GS V+Q S L C + + +
Sbjct: 480 TKLIPEWKPLSVYSSNGELRSAWGSILTGSHDGLVAQDISSGLGCGTQKDCLQSEEDGWT 539
Query: 408 EAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILD------------AHIDKSLVP 455
+S + S N E D + A F + +++D ++ID S
Sbjct: 540 TDISAGHIFDTCPSSPSLANFE--DLNSHASFALELLVDDCSTKSAKVFDCSNIDGSSKG 597
Query: 456 DGYSAHYAVYDHGGHEVKADEV--SLGESILFNES---TQNSETSFIDSCSGMSKNLSFS 510
+S + HG V D+ ++G+ +F +NS S + S
Sbjct: 598 SSWSI-AELEHHGSSYVVEDKFQRNVGDVGIFTPMDYFAKNSVVSMPAPSEASNVMSLTS 656
Query: 511 SISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLA 561
S SSLSL DK+ LK+E+DAI + Y+Q F EL R RE+ +E R+RW+A
Sbjct: 657 SCSSLSLTDKDLDAELKMEIDAIETHYRQLFDELSRMREEALEATRRRWIA 707
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 568 | ||||||
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.628 | 0.634 | 0.685 | 5.6e-143 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.637 | 0.638 | 0.613 | 6.5e-123 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.764 | 0.828 | 0.575 | 2.2e-121 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.635 | 0.648 | 0.621 | 6.9e-118 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.403 | 0.327 | 0.708 | 9.2e-111 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.385 | 0.424 | 0.731 | 5.8e-105 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.651 | 0.752 | 0.516 | 2.7e-100 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.427 | 0.442 | 0.641 | 8.7e-98 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.394 | 0.392 | 0.635 | 4.4e-90 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.396 | 0.716 | 0.606 | 2.2e-73 |
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1268 (451.4 bits), Expect = 5.6e-143, Sum P(3) = 5.6e-143
Identities = 249/363 (68%), Positives = 286/363 (78%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
MQ P QLERLYSEVHLLK+LKHENIIK + SWVD+ N+TINMITELFTSGSLR YRKKH+
Sbjct: 66 MQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHR 125
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
VD KAIKNWARQIL+GL+YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA V+QQ
Sbjct: 126 KVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQ 185
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPYNEC+N AQIYKKVTS
Sbjct: 186 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTS 245
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
IKP SL KV DPQV+QFIEKC++PAS R ALEL KDPFL D KD L +
Sbjct: 246 NIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSAL--LASSSTS 303
Query: 241 PEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDD 300
+ + E PMD+D N K S + + W T+ELQR+ EN EF LRGE++DD
Sbjct: 304 SKYVRPPQLEHLPMDVDHNENK----SVSSNEDYPWSQTIELQRIAENKEFRLRGERSDD 359
Query: 301 DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIM 360
T S+ LRI D SG +HF FYL +DTA +IAEEMVE+L L+ ++VV IA++ID+ IM
Sbjct: 360 VTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQEVVVIADMIDDFIM 419
Query: 361 KLV 363
+L+
Sbjct: 420 QLL 422
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1163 (414.5 bits), Expect = 6.5e-123, Sum P(2) = 6.5e-123
Identities = 232/378 (61%), Positives = 287/378 (75%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSP+ LERLYSEV LLKSLKH NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+
Sbjct: 65 LQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHR 124
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V+MKA+KNWARQIL GL YLH PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q
Sbjct: 125 KVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQ 184
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+S
Sbjct: 185 ANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSS 244
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKPASLS+V DP+VKQFIEKC++PAS RL A ELL DPFL + + +PL LP++V
Sbjct: 245 GIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIV 302
Query: 241 -PE--------VMNLAHSEPHP---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTEN 288
P+ +M+ P + IDL+ N+G+ +E++R
Sbjct: 303 MPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGS--RCIEVRRAKRG 360
Query: 289 NEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDV 348
N F L+GE+ND+ +VSL LRI D++G V NIHF+FY DTA ++ EMVEQL+L+ ++V
Sbjct: 361 NFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNV 420
Query: 349 VSIAELIDNLIMKLVPSW 366
IAELID L++ ++P+W
Sbjct: 421 TFIAELIDILLVNMIPTW 438
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1194 (425.4 bits), Expect = 2.2e-121, P = 2.2e-121
Identities = 258/448 (57%), Positives = 301/448 (67%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+Q P QL+RLYSEVHLL SLKH+NIIK + SWVDD N++INMITELFTSGSL YRKKH+
Sbjct: 53 LQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHR 112
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
VD KAI NWARQIL+GLHYLHS PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQ
Sbjct: 113 KVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQ 172
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTS
Sbjct: 173 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTS 232
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 240
GIKP SLSKV DPQVKQFIEKC++PA R ALELLKD L D KD
Sbjct: 233 GIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFK 292
Query: 241 PEVMNLAHSEPHPMDIDLN-HKKVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKN 298
P + E PMD++ + VS S AKS+ L T+E+QR+ E+ EF L GE+
Sbjct: 293 PAMP--PQCEYRPMDVEYKKNTSVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERR 350
Query: 299 DDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNL 358
DD S+ LRI SG + F F L DTA ++ EMVE+LDLS +V IAE+ID L
Sbjct: 351 DDVAASMALRIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDEL 410
Query: 359 IMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISL----KCPGEPGSN-NAFAEAVSQQ 413
IMKL N SL + S + + S + IS + GS EAV +
Sbjct: 411 IMKLKA--NRSLPNANSVYQSKDEEAGESMKSEISADYYHRVSSNEGSRLGCCCEAV--E 466
Query: 414 GVLSELASGKYQYNQESSDSDISAEFDV 441
+LS + + S+ D+ E +V
Sbjct: 467 SLLSSFLDSCSMVSNKQSE-DLKTELNV 493
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1161 (413.8 bits), Expect = 6.9e-118, P = 6.9e-118
Identities = 235/378 (62%), Positives = 293/378 (77%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSPD LERLYSEV LLKSLKH+NII+FYNSW+DD N+T+N+ITELFTSGSLRQYRKKH+
Sbjct: 65 LQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHR 124
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V+MKA+K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q
Sbjct: 125 KVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQ 184
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+S
Sbjct: 185 ANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSS 244
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD-PLRLPNL 239
GIKPASLSKV DP+V +FIEKC++PAS RL A ELL D FL N LV + PL LP++
Sbjct: 245 GIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDI 301
Query: 240 V-PEVMNLAH----SEPHP------MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTEN 288
V P+ + SE P M ++L+ + +N+GT +E++R
Sbjct: 302 VMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGT--NCIEVRRAKRG 359
Query: 289 NEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDV 348
N F L+GE+ND+++VSL LRI D++G V NIHF+F+ DTA +++ EMVEQL+L+ ++V
Sbjct: 360 NFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNV 419
Query: 349 VSIAELIDNLIMKLVPSW 366
IAELID L++ L+P+W
Sbjct: 420 KFIAELIDVLLVNLIPNW 437
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 887 (317.3 bits), Expect = 9.2e-111, Sum P(3) = 9.2e-111
Identities = 163/230 (70%), Positives = 193/230 (83%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSP+ LERLY E+HLLK+LKH+NI+KFY SWVD NR IN +TELFTSG+LRQYR +HK
Sbjct: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHK 120
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V+++A+K+W RQILRGLHYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++
Sbjct: 121 RVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A +GTPEFMAPE+YEE YNELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV S
Sbjct: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMS 240
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL-VTDNPKDL 229
G KP +L KV DP+VK FIEKC+ SLR+ A ELL DPFL + D DL
Sbjct: 241 GKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDL 290
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 871 (311.7 bits), Expect = 5.8e-105, Sum P(2) = 5.8e-105
Identities = 161/220 (73%), Positives = 190/220 (86%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
S + L+RLYSEVHLLK+LKH++IIKFY SW+D + TIN+ITE+FTSG+LRQYRKKHK V
Sbjct: 61 SSEDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCV 120
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 121
D++A+K W+RQIL GL YLHSH+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ +
Sbjct: 121 DLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRAR 180
Query: 122 TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 181
+A SVIGTPEFMAPELYEE+YN LVDIY+FGMC+LE+VT EYPY+EC N AQIY+KVTSG
Sbjct: 181 SAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSG 240
Query: 182 IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 221
IKPA+L VTDPQV+ FIEKCI S RL A ELL DPFL
Sbjct: 241 IKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFL 280
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 995 (355.3 bits), Expect = 2.7e-100, P = 2.7e-100
Identities = 206/399 (51%), Positives = 269/399 (67%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+QSP +LERLY E+HLLK+LKH++I+KFY SWVD NR IN +TE+FTSG+LRQYR KHK
Sbjct: 62 LQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHK 121
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V+++A+KNW RQILRGL+YLH+H+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA +Q
Sbjct: 122 RVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQH 181
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A +GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEMVT +YPY+EC +PAQIYK+V S
Sbjct: 182 SHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVIS 241
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTD--------NPKDLVCD 232
G KP L KV DP+V+ FIEKC+ SLRL A ELL D FL D + K L+ +
Sbjct: 242 GKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCIDESDMRRVESEKGLIDE 301
Query: 233 ---PLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENN 289
PLR +P N +S + D N D +S+ LE Q +
Sbjct: 302 AGTPLRHSYHIPHYSNGYYSLYNQNQWDYN-----GDETVESHE---IDLLEFQNDDDEE 353
Query: 290 E---------FTLRGEKNDD-DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVE 339
E +++G++ D+ D + L L+ +K G V NI+F F + DTAIS+A EMVE
Sbjct: 354 EEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVE 413
Query: 340 QLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQN 378
+L++ DV IA +ID I LVP+W+ S +++ +
Sbjct: 414 ELEMDDRDVTKIANMIDGEIASLVPNWSIFCSSESNRSS 452
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 833 (298.3 bits), Expect = 8.7e-98, Sum P(2) = 8.7e-98
Identities = 159/248 (64%), Positives = 196/248 (79%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+SP+ L+RLYSEVHLLK+L HE+II++ SW+D RT N ITELFTSG+LR+YR+K++
Sbjct: 63 RSPEPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQK 122
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-Q 120
VD++AIK+WARQIL GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++
Sbjct: 123 VDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 182
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A SVIGTPEFMAPELYEE+YNELVDIYSFGMC+LEM+T EYPY+EC NPAQIYKKVTS
Sbjct: 183 QNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTS 242
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNL 239
G P S + + ++F+ KC+ S RLPA ELL DPFL + +DL PL RLP
Sbjct: 243 GKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLA--PLFRLPQQ 300
Query: 240 VPEVMNLA 247
+ + NLA
Sbjct: 301 LA-IQNLA 307
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 787 (282.1 bits), Expect = 4.4e-90, Sum P(2) = 4.4e-90
Identities = 143/225 (63%), Positives = 183/225 (81%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++S L+RLYSEVHLL +L H++II+FY SW+D N T+N ITELFTSG+LRQY+ K+
Sbjct: 56 LRSSVDLQRLYSEVHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYL 115
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+D++AIK+WARQIL GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++
Sbjct: 116 RIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRD 175
Query: 121 -PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
+A S+IGTPEFMAPELYEE YNEL+D+YSFGMC LEM+T E+PY+EC +PAQIYKKV
Sbjct: 176 CHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVV 235
Query: 180 SGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTD 224
G P + +V D + ++FI KC+V AS R+ A ELL+DPFL +D
Sbjct: 236 GGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQDPFLASD 280
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
Identities = 139/229 (60%), Positives = 177/229 (77%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
P ERLYSEV LLK+LK+ NII Y W D+ N T+N ITE+ TSG+LR+YRKKH++V
Sbjct: 71 PAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHVS 130
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPT 122
M+A+K W++QIL+GL YLH+H+P IIHRDL C NIFVNGN G+VKIGDLGLA IV +
Sbjct: 131 MRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNHL 190
Query: 123 ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 182
A S++GTPEFMAPELYEE Y E+VDIYS+GMC+LE+V+ E PY+EC + A+IYK+V+ G+
Sbjct: 191 AHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKGL 250
Query: 183 KPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPF---LVTDNPKD 228
KP +L+KV DP+ K FIEKCI R A ELL DPF ++ D+ +D
Sbjct: 251 KPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPFFDGILDDDDED 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6EU49 | WNK4_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5008 | 0.9348 | 0.8676 | yes | no |
| Q944Q0 | WNK8_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5320 | 0.8538 | 0.8614 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00031177 | hypothetical protein (596 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 568 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-48 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-44 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-35 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-33 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-31 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-31 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-30 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-24 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-23 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 2e-62
Identities = 76/222 (34%), Positives = 115/222 (51%), Gaps = 11/222 (4%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
ER+ E+ +LK LKH NI++ Y+ + D+ + ++ E G L KK +
Sbjct: 39 KDRERILREIKILKKLKHPNIVRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSE 96
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A 123
+ + RQIL L YLHS I+HRDLK +NI ++ +G VK+ D GLA +
Sbjct: 97 DEARFYLRQILSALEYLHSKG--IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKL 153
Query: 124 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSG 181
+ +GTPE+MAPE L + Y + VDI+S G IL E++T + P+ +++KK+
Sbjct: 154 TTFVGTPEYMAPEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKP 212
Query: 182 IKPASLSKVT-DPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
P + P+ K I K +V RL A E L+ PF
Sbjct: 213 KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 6e-62
Identities = 85/226 (37%), Positives = 123/226 (54%), Gaps = 9/226 (3%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
S ++LE L E+ +L SL+H NI+++Y S D+ T+N+ E + GSL KK
Sbjct: 38 DSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK 97
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ I+ + RQIL GL YLHS+ I+HRD+K NI V ++G VK+ D G A +
Sbjct: 98 LPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILV-DSDGVVKLADFGCAKRLGDI 154
Query: 122 TA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
SV GTP +MAPE+ EEY DI+S G ++EM T + P++E NP
Sbjct: 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
K+ S +P + + + K F+ KC+ R A ELL+ PFL
Sbjct: 215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 6e-54
Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 14/228 (6%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
+ + E+ +L+ L H NI++ +++ D + + ++ E G L Y + +
Sbjct: 38 KSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH--LYLVMEYCEGGDLFDYLSRGGPL 95
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--Q 120
K A QILRGL YLHS+ IIHRDLK +NI ++ NG VKI D GLA +
Sbjct: 96 SEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSS 152
Query: 121 PTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK-- 176
+ + +GTP +MAPE L Y VD++S G+ + E++T + P++ Q+
Sbjct: 153 SSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
Query: 177 KVTSGIKPASLSKVTD--PQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
++ K + + K I+KC+ S R A E+L+ P+
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 4e-48
Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 60
S LE L E+ +LK L H NI+K Y + D+ + + ++ E GSL+ ++
Sbjct: 30 DSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENH--LYLVMEYCEGGSLKDLLKENEG 87
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ I QIL GL YLHS+ IIHRDLK +NI ++ +NG+VK+ D GL+ ++
Sbjct: 88 KLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145
Query: 121 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
++++GTP +MAPE+ Y+E DI+S G+ + E+
Sbjct: 146 DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------ 187
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDP 219
P++K I K + R A E+L+
Sbjct: 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 7e-47
Identities = 82/223 (36%), Positives = 123/223 (55%), Gaps = 19/223 (8%)
Query: 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 65
QLE+ E+ LL L+H NI+++ + ++ N + + EL GSL + KK+ +
Sbjct: 48 QLEQ---EIALLSKLQHPNIVQYLGTEREEDN--LYIFLELVPGGSLAKLLKKYGSFPEP 102
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTAR 124
I+ + RQIL GL YLH N +HRD+K NI V+ NG VK+ D G+A V++ A+
Sbjct: 103 VIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAK 159
Query: 125 SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 182
S G+P +MAPE+ + Y DI+S G +LEM T + P+++ + A ++K S
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 183 KPA---SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFL 221
P LS + K FI KC+ SLR A ELL+ PF+
Sbjct: 220 LPPIPDHLS----DEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 70/228 (30%), Positives = 119/228 (52%), Gaps = 15/228 (6%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
S + E +EV +LK L H NIIK+Y S+ + + ++ E G L Q KK K
Sbjct: 38 MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK--LCIVMEYADGGDLSQKIKKQKK 95
Query: 62 VDM----KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
+ I +W Q+ L YLHS I+HRD+K NIF+ +NG VK+GD G++ V
Sbjct: 96 EGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKV 152
Query: 118 MQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 174
+ A++V+GTP +++PEL + + YN DI+S G + E+ T ++P+ E +N ++
Sbjct: 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLEL 211
Query: 175 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
K+ G + + +++ + + R ++L+ PF+
Sbjct: 212 ALKILKG-QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-44
Identities = 78/232 (33%), Positives = 124/232 (53%), Gaps = 18/232 (7%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHK 60
E + +E+ ++K KH NI+ +Y+S++ + ++ E GSL Q +
Sbjct: 57 QNKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMN 114
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVM 118
+ + R++L+GL YLHS N +IHRD+K DNI ++ +G VK+ D G A +
Sbjct: 115 EPQIAYV---CREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTK 168
Query: 119 QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYK 176
++ SV+GTP +MAPE+ + ++Y VDI+S G+ +EM E PY + P + ++
Sbjct: 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFL 227
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
T GI P + P+ K F+ KC+V R A ELL+ PFL PK
Sbjct: 228 ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-42
Identities = 75/224 (33%), Positives = 127/224 (56%), Gaps = 11/224 (4%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHK 60
+S ++ E++ +E+ +LK KH NI+K+Y S++ I M E + GSL+ + ++
Sbjct: 36 ESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM--EFCSGGSLKDLLKSTNQ 93
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ I +++L+GL YLHS+ IIHRD+K NI + ++GEVK+ D GL+ +
Sbjct: 94 TLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSD 150
Query: 121 PTAR-SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
AR +++GTP +MAPE + + Y+ DI+S G+ +E+ + PY+E ++K
Sbjct: 151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA 210
Query: 179 TSGIKP-ASLSKVTDPQVKQFIEKCIVPA-SLRLPALELLKDPF 220
T+G + K +D K F++KC+ R A +LLK PF
Sbjct: 211 TNGPPGLRNPEKWSDE-FKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 82/237 (34%), Positives = 127/237 (53%), Gaps = 25/237 (10%)
Query: 2 QSPDQ--LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 59
Q D ++ + E+ +L+ LKH N++K+Y V I M E + G+L + +
Sbjct: 36 QDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM--EYCSGGTLEELLEHG 93
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+ +D I+ + Q+L GL YLHSH I+HRD+K NIF+ +NG +K+GD G A+ ++
Sbjct: 94 RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFL-DHNGVIKLGDFGCAVKLK 150
Query: 120 QPTAR------SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECK 169
T S+ GTP +MAPE+ + + DI+S G +LEM T + P++E
Sbjct: 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210
Query: 170 NPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFL 221
N QI V +G KP SL P+ K F+++C+ P R A ELL+ PF+
Sbjct: 211 NEFQIMFHVGAGHKPPIPDSLQL--SPEGKDFLDRCLESDP-KKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 70/225 (31%), Positives = 124/225 (55%), Gaps = 14/225 (6%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVD 63
++L SEV++L+ LKH NI+++Y+ +D +N+T+ ++ E G L ++ +K+ K ++
Sbjct: 44 QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE 103
Query: 64 MKAIKNWARQILRGLHYLHSHNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ I Q+L L+ H+ + P ++HRDLK NIF++ NN VK+GD GLA ++
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGH 162
Query: 121 PT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
+ A++ +GTP +M+PE L Y+E DI+S G I E+ P+ +N Q+ K
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASK 221
Query: 178 VTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFL 221
+ G + ++ + I+ + V R ELL+ P +
Sbjct: 222 IKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 75/223 (33%), Positives = 120/223 (53%), Gaps = 11/223 (4%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
+ L+ + E+ LLK+LKH NI+K+ S +T+ ++ +I E +GSLRQ KK
Sbjct: 39 KEEALKSIMQEIDLLKNLKHPNIVKYIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPF 96
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--Q 120
+ + Q+L+GL YLH +IHRD+K NI +G VK+ D G+A +
Sbjct: 97 PESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTK-DGVVKLADFGVATKLNDVS 153
Query: 121 PTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
SV+GTP +MAPE+ E + DI+S G ++E++T PY + A +++ V
Sbjct: 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213
Query: 180 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
P L + P++K F+ +C +LR A +LLK P++
Sbjct: 214 DDHPP--LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 66/225 (29%), Positives = 117/225 (52%), Gaps = 12/225 (5%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
+ ++L E+ L+S + ++K Y ++ I+++ E GSL KK +
Sbjct: 40 EEFRKQLLRELKTLRSCESPYVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIP 97
Query: 64 MKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 122
+ ARQIL+GL YLH+ + IIHRD+K N+ +N + GEVKI D G++ V++
Sbjct: 98 EPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTL 154
Query: 123 A--RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKK 177
+ +GT +M+PE + E Y+ DI+S G+ +LE ++P+ + ++ +
Sbjct: 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA 214
Query: 178 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
+ G P+ ++ P+ + FI C+ R A ELL+ PF+
Sbjct: 215 ICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 75/218 (34%), Positives = 115/218 (52%), Gaps = 13/218 (5%)
Query: 10 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN 69
L E+ LLK+L+HE I+++Y DD +I M E GS++ K + + +
Sbjct: 51 LECEIQLLKNLQHERIVQYYGCLRDDETLSIFM--EYMPGGSVKDQLKAYGALTETVTRK 108
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTAR 124
+ RQIL G+ YLHS+ I+HRD+K NI + + G VK+GD G + I +
Sbjct: 109 YTRQILEGVEYLHSNM--IVHRDIKGANI-LRDSAGNVKLGDFGASKRLQTICSSGTGMK 165
Query: 125 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 183
SV GTP +M+PE+ E Y D++S G ++EM+T + P+ E + A I+K T
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 225
Query: 184 PASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPF 220
P S V P + F+ + V + + P A ELL+ F
Sbjct: 226 PQLPSHV-SPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 4e-33
Identities = 76/226 (33%), Positives = 122/226 (53%), Gaps = 10/226 (4%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ ++ L E+ LLK+L HE I+++Y D RT+++ E GS++ K +
Sbjct: 43 ETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA 102
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----I 116
+ + + RQIL G+ YLHS+ I+HRD+K NI + + G VK+GD G + I
Sbjct: 103 LTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTI 159
Query: 117 VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
+ +SV GTP +M+PE+ E Y DI+S G ++EM+T + P+ E + A I+
Sbjct: 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF 219
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 221
K T P V+D + F+++ V A LR A ELL+ F+
Sbjct: 220 KIATQPTNPVLPPHVSD-HCRDFLKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 5e-33
Identities = 75/225 (33%), Positives = 120/225 (53%), Gaps = 10/225 (4%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ ++ L E+ LLK+L+HE I+++Y D +T+ + E GS++ K +
Sbjct: 43 ETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA 102
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----I 116
+ + + RQIL G+ YLHS+ I+HRD+K NI + + G VK+GD G + I
Sbjct: 103 LTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTI 159
Query: 117 VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
M RSV GTP +M+PE+ E Y D++S G ++EM+T + P+ E + A I+
Sbjct: 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPF 220
K T P S +++ + F+ V A R A ELL+ PF
Sbjct: 220 KIATQPTNPQLPSHISE-HARDFLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 2e-32
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 13/206 (6%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
S Q+E E +++ L H N++K ++ + ++ E G L Y RK
Sbjct: 41 SEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPK 98
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ + + ++A QI RG+ YL S N IHRDL N V G N VKI D GL+ +
Sbjct: 99 LSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDD 155
Query: 122 TARSVIGTPE---FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 176
G +MAPE L E ++ D++SFG+ + E+ T E PY N ++ +
Sbjct: 156 DYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLE 214
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKC 202
+ +G + + + +C
Sbjct: 215 YLKNGYRLPQPPNCPPE-LYDLMLQC 239
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ----YR 56
M + E+ LLK L H N+IK+ S+++ N +N++ EL +G L + ++
Sbjct: 40 MMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNIVLELADAGDLSRMIKHFK 97
Query: 57 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
K+ + + + I + Q+ L ++HS I+HRD+K N+F+ G VK+GDLGL
Sbjct: 98 KQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITA-TGVVKLGDLGLGR 154
Query: 117 VMQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPA 172
T A S++GTP +M+PE ++E YN DI+S G + EM + P Y + N
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214
Query: 173 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 205
+ KK+ P + +++ + +CI P
Sbjct: 215 SLCKKIEKCDYPPLPADHYSEELRDLVSRCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
S Q+E E +++ L H NI+K ++ + ++ E G L Y +K++
Sbjct: 41 SEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPK 98
Query: 63 DMKAIK--NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
++ ++A QI RG+ YL S N IHRDL N V G N VKI D GL+ +
Sbjct: 99 ELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYD 155
Query: 121 PTARSVIGTPE---FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 175
V G +MAPE L E ++ D++SFG+ + E+ T E PY N A++
Sbjct: 156 DDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVL 214
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKC 202
+ + G + + + + +C
Sbjct: 215 EYLKKGYRLPKPPNCPPE-LYKLMLQC 240
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 1e-31
Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 15/187 (8%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
S ++ E E ++K L H NI++ + ++TE G L + +KH
Sbjct: 41 SEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEK 98
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ +K + A QI +G+ YL S N +HRDL N V N VKI D GL+ +
Sbjct: 99 LTLKDLLQMALQIAKGMEYLESKN--FVHRDLAARNCLV-TENLVVKISDFGLSRDI-YE 154
Query: 122 TARSVIGTPEF-----MAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 174
MAPE ++ ++ D++SFG+ + E+ T E PY N ++
Sbjct: 155 DDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEV 213
Query: 175 YKKVTSG 181
+ + G
Sbjct: 214 LELLEDG 220
|
Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 76/234 (32%), Positives = 127/234 (54%), Gaps = 20/234 (8%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSW-VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA 66
E L++EV +++ +H NI++ Y+S+ V D + ++ E G+L H ++ +
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDE---LWVVMEFLEGGALTDI-VTHTRMNEEQ 116
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 124
I +L+ L +LH+ +IHRD+K D+I + ++G VK+ D G + + P +
Sbjct: 117 IATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRK 173
Query: 125 SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGI 182
S++GTP +MAPE+ Y VDI+S G+ ++EMV E PY NE P Q K++ +
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--PPLQAMKRIRDNL 231
Query: 183 KPAS--LSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 232
P L KV+ P+++ F+++ +V PA R A ELL PFL P +
Sbjct: 232 PPKLKNLHKVS-PRLRSFLDRMLVRDPAQ-RATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 14/225 (6%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
+ +E L E+ L+ L H +II+ + +D++ N+ E GS+ K+
Sbjct: 45 EVVEALRKEIRLMARLNHPHIIRMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKE 102
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
I N+ Q+LRGL YLH + IIHRD+K N+ ++ ++I D G A +
Sbjct: 103 AVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160
Query: 125 S------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN--ECKNPAQIY 175
+ ++GT FMAPE L E+Y D++S G I+EM T + P+N + N +
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDP 219
K+ S S+ + P ++ +C+ + R P+ ELLK P
Sbjct: 221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-31
Identities = 70/227 (30%), Positives = 127/227 (55%), Gaps = 14/227 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
M ++ E + E +L L II++Y S++D +N++ E +G L + K +
Sbjct: 38 MNRREREEAI-DEARVLAKLDSSYIIRYYESFLDK--GKLNIVMEYAENGDLHKLLKMQR 94
Query: 61 NVDMKAIKNWAR--QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
+ + W QIL GL +LHS I+HRD+K N+F++ + VKIGDLG+A ++
Sbjct: 95 GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL 151
Query: 119 QQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
T A +++GTP +++PEL E++ YNE D+++ G+ + E T ++P+ + N +
Sbjct: 152 SDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF-DANNQGALI 210
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 221
K+ G+ P +S++ Q+ Q I++C+ + P +LL++P L
Sbjct: 211 LKIIRGVFP-PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 70/237 (29%), Positives = 112/237 (47%), Gaps = 26/237 (10%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR---QYRKK 58
+ ++ L EV + H N++K+Y S+V + M + GSL +
Sbjct: 38 KCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM--PYLSGGSLLDIMKSSYP 95
Query: 59 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
+D I +++L+GL YLHS+ IHRD+K NI + G +G VKI D G++ +
Sbjct: 96 RGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILL-GEDGSVKIADFGVSASL 152
Query: 119 QQPTARS------VIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKN 170
R+ +GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T PY++
Sbjct: 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP- 211
Query: 171 PAQIYKKVTSGIKPASLSKVTDPQV-----KQFIEKCIV--PASLRLPALELLKDPF 220
P ++ P SL D + ++ I C+ P+ R A ELLK F
Sbjct: 212 PMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSK-RPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-31
Identities = 71/225 (31%), Positives = 120/225 (53%), Gaps = 10/225 (4%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ ++ L E+ LLK+L+H+ I+++Y D + +++ E GS++ K +
Sbjct: 43 ETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA 102
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----I 116
+ + + RQIL+G+ YLHS+ I+HRD+K NI + + G VK+GD G + I
Sbjct: 103 LTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTI 159
Query: 117 VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
M +SV GTP +M+PE+ E Y D++S ++EM+T + P+ E + A I+
Sbjct: 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF 219
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPF 220
K T KP V+D + F+++ V R A LL+ PF
Sbjct: 220 KIATQPTKPMLPDGVSD-ACRDFLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 76/225 (33%), Positives = 123/225 (54%), Gaps = 17/225 (7%)
Query: 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA 66
L+ L E+ LLK L+HENI+++ S +D + +N+ E GS+ + +
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETL 107
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQ 119
++N+ RQIL+GL+YLH+ IIHRD+K NI V+ N G +KI D G++ + +
Sbjct: 108 VRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTK 164
Query: 120 QPTAR-SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
AR S+ G+ +MAPE+ ++ Y DI+S G ++EM+T ++P+ +C I+ K
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-K 223
Query: 178 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
+ P S ++ + F+EK + R A ELLK PFL
Sbjct: 224 IGENASPEIPSNISS-EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-31
Identities = 74/229 (32%), Positives = 116/229 (50%), Gaps = 15/229 (6%)
Query: 1 MQSPDQLERLYS--EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--- 55
+ S Q ER + E+ +L S+ H NII + +++D I M E G L +
Sbjct: 35 LGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM--EYAPFGDLSKAISK 92
Query: 56 RKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 114
RKK + + + I Q+LRGL LH I+HRDLK NI + N VKIGDLG+
Sbjct: 93 RKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGI 149
Query: 115 AIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 173
+ V+++ A++ IGTP +MAPE+++ Y+ DI+S G + EM T P+ E ++
Sbjct: 150 SKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQD 208
Query: 174 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
+ KV G P + + ++ FI + LR ++L P +
Sbjct: 209 LRYKVQRGKYPP-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 9e-31
Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 11/203 (5%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
++E +E ++L + H I+K + ++ + + ++ E G L + K
Sbjct: 35 KEVEHTLTERNILSRINHPFIVKLHYAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSE 92
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPT 122
+ + +A +I+ L YLHS II+RDLK +NI ++ +G +K+ D GLA + +
Sbjct: 93 ERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSR 149
Query: 123 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 181
+ GTPE++APE L + Y + VD +S G+ + EM+T + P+ ++ +IY+K+
Sbjct: 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK- 207
Query: 182 IKPASLSKVTDPQVKQFIEKCIV 204
P + P+ + I +
Sbjct: 208 -DPLRFPEFLSPEARDLISGLLQ 229
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 74/225 (32%), Positives = 118/225 (52%), Gaps = 20/225 (8%)
Query: 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMK 65
L+ + E+ +LK I+K+Y S+ +T+ I M E +GS+ K +K + +
Sbjct: 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM--EYCGAGSVSDIMKITNKTLTEE 99
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR- 124
I Q L+GL YLHS+ IHRD+K NI +N G+ K+ D G++ + A+
Sbjct: 100 EIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKR 156
Query: 125 -SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 182
+VIGTP +MAPE+ +E YN DI+S G+ +EM + PY++ I+ I
Sbjct: 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----I 211
Query: 183 K---PASLSKVTD--PQVKQFIEKCIV-PASLRLPALELLKDPFL 221
P +LS P+ F++KC+V R A++LL+ PF+
Sbjct: 212 PNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 82/228 (35%), Positives = 115/228 (50%), Gaps = 27/228 (11%)
Query: 10 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMK--A 66
L+ E+ L LKH NI+++ S D N + E GSL R K +
Sbjct: 52 LHEEIALHSYLKHRNIVQYLGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQT 109
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG----LAIVMQQPT 122
I + +QIL GL YLH + I+HRD+K DN+ VN +G VKI D G LA + P
Sbjct: 110 IIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPC 165
Query: 123 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYK-- 176
+ GT ++MAPE+ ++ Y DI+S G I+EM T + P+ E P A ++K
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 177 --KVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 221
K+ I P SLS + K FI +C P + A +LL+DPFL
Sbjct: 226 MFKIHPEI-PESLSA----EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 81/246 (32%), Positives = 111/246 (45%), Gaps = 48/246 (19%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWA 71
E+ LLK LKH NI+K + V T R + ++ E + L++Y K+ + IK+
Sbjct: 48 EISLLKELKHPNIVKLLD--VIHTERKLYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIM 104
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVI 127
Q+LRGL Y HSH I+HRDLK NI +N +G +K+ D GLA I ++ T V
Sbjct: 105 YQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVV- 160
Query: 128 GTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT--------CE------------YPY 165
T + APE+ + Y+ VDI+S G EM+T E P
Sbjct: 161 -TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT 219
Query: 166 NE-----CKNPAQIYKKVTSGIKPASLSKVT---DPQVKQFIEK--CIVPASLRLPALEL 215
E K P YK P L KV DP+ + K PA R+ A E
Sbjct: 220 EESWPGVTKLPD--YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RISAKEA 276
Query: 216 LKDPFL 221
LK P+
Sbjct: 277 LKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 73/243 (30%), Positives = 117/243 (48%), Gaps = 27/243 (11%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ D++E + E+ L + I K+Y S++ + I M E GS K K
Sbjct: 38 EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM--EYCGGGSCLDLLKPGK- 94
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+D I R++L GL YLH IHRD+K NI ++ G+VK+ D G++ +
Sbjct: 95 LDETYIAFILREVLLGLEYLHEEGK--IHRDIKAANILLS-EEGDVKLADFGVSGQLTST 151
Query: 122 TAR--SVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
++ + +GTP +MAPE+ + Y+E DI+S G+ +E+ E P ++ +P +V
Sbjct: 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-LHPM----RV 206
Query: 179 TSGI---KPASL--SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFL----VTDNPK 227
I P SL +K + P K F+ C+ P R A ELLK F+ T
Sbjct: 207 LFLIPKNNPPSLEGNKFSKP-FKDFVSLCLNKDPKE-RPSAKELLKHKFIKKAKKTSYLT 264
Query: 228 DLV 230
L+
Sbjct: 265 LLI 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 74/227 (32%), Positives = 109/227 (48%), Gaps = 19/227 (8%)
Query: 5 DQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
D + + EV LL L+ NI K+Y S++ I M E GS+R K
Sbjct: 41 DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM--EYAEGGSVRTLMKAGP- 97
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ K I R++L L Y+H +IHRD+K NI V N G VK+ D G+A ++ Q
Sbjct: 98 IAEKYISVIIREVLVALKYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQN 154
Query: 122 TAR--SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
+++ + +GTP +MAPE+ E Y+ DI+S G+ I EM T PY A
Sbjct: 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY--SDVDAFRAMM 212
Query: 178 VTSGIKPASLS-KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFL 221
+ KP L +++F+ C+ P RL A ELLK ++
Sbjct: 213 LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKE-RLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 22/215 (10%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
S ++ + E ++K L H N+++ V + ++ E G L Y +K + V
Sbjct: 36 SEEERKDFLKEARVMKKLGHPNVVRLLG--VCTEEEPLYLVLEYMEGGDLLDYLRKSRPV 93
Query: 63 DMKAIKN---------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 113
K+ +A QI +G+ YL S +HRDL N V G + VKI D G
Sbjct: 94 FPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLV-GEDLVVKISDFG 150
Query: 114 LAIVMQQPT-ARSVIGTPE---FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNE 167
L+ + R G +MAPE L + + D++SFG+ + E+ T PY
Sbjct: 151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210
Query: 168 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 202
N ++ + + G + D ++ + + C
Sbjct: 211 LSN-EEVLEYLRKGYRLPKPEYCPD-ELYELMLSC 243
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 74/336 (22%), Positives = 122/336 (36%), Gaps = 34/336 (10%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 59
++ER E+ +L SL H NI+K Y+ + D+ + + M E GSL KK
Sbjct: 35 ESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM--EYVDGGSLEDLLKKI 92
Query: 60 ---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
+ QIL L YLHS IIHRD+K +NI ++ + VK+ D GLA
Sbjct: 93 GRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAK 150
Query: 117 VM--------QQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYP 164
++ + +GTP +MAPE+ + DI+S G+ + E++T P
Sbjct: 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
Query: 165 Y---NECKNPAQIYKKVTSGIKPASLSKV-------TDPQVKQFIEKCIVP-ASLRLPAL 213
+ +Q K + P+ S + ++K + RL +
Sbjct: 211 FEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270
Query: 214 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNT 273
L L L L + L S P ++ ++ A S +
Sbjct: 271 SDLSHDLL---AHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKL 327
Query: 274 GTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRI 309
+ EL ++ S +
Sbjct: 328 DDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSL 363
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 16 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 75
L + H IIK Y ++ D+ N + + E +G L QY +K+ ++D K + +A +IL
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112
Query: 76 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------------- 118
L YLHS IIHRDLK +NI ++ + +KI D G A V+
Sbjct: 113 LALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 119 -----QQPTARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCIL-EMVTCEYPYNECKNP 171
+ S +GT E+++PEL E+ + D+++ G CI+ +M+T + P+ N
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNE 227
Query: 172 AQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIV 204
++K I S P K IEK +V
Sbjct: 228 YLTFQK----ILKLEYSFPPNFPPDAKDLIEKLLV 258
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 75/247 (30%), Positives = 125/247 (50%), Gaps = 23/247 (9%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HK 60
+S ++LE E+ +L KH NI+ Y ++ + ++ E G+L + +
Sbjct: 41 ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW--ILIEFCDGGALDSIMLELER 98
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ I+ RQ+L L++LHSH +IHRDLK NI + +G+VK+ D G++ +
Sbjct: 99 GLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKS 155
Query: 121 PTAR--SVIGTPEFMAPELYEEE------YNELVDIYSFGMCILEMVTCEYPYNECKNPA 172
+ + IGTP +MAPE+ E Y+ DI+S G+ ++E+ E P++E NP
Sbjct: 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPM 214
Query: 173 QIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL--VTDNP- 226
++ K+ P SK + F++ C+V R A ELLK PF+ +DN
Sbjct: 215 RVLLKILKSEPPTLDQPSKWSS-SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKA 273
Query: 227 -KDLVCD 232
KDL+ +
Sbjct: 274 IKDLLAE 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 69/213 (32%), Positives = 118/213 (55%), Gaps = 11/213 (5%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKN 69
+E +LK L H NII++Y ++++D I M E G+L +Y +K N +D I +
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVM--EYAPGGTLAEYIQKRCNSLLDEDTILH 105
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIG 128
+ QIL LH++H+ I+HRDLK NI ++ + VKIGD G++ I+ + A +V+G
Sbjct: 106 FFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVG 163
Query: 129 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 187
TP +++PEL E + YN+ DI++ G + E+ + + + PA + K+ SG A +
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSG-TFAPI 221
Query: 188 SKVTDPQVKQFIEKCI-VPASLRLPALELLKDP 219
S P ++Q I + + S R +++ P
Sbjct: 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 17/227 (7%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVD 63
D E + E+ +LK +H NI+ ++ S++ I M E GSL+ Y+ +
Sbjct: 42 DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM--EYCGGGSLQDIYQVTRGPLS 99
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
I R+ L+GL YLH IHRD+K NI + +G+VK+ D G++ + A
Sbjct: 100 ELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIA 156
Query: 124 R--SVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYK 176
+ S IGTP +MAPE+ E Y+ DI++ G+ +E+ + P + +P + ++
Sbjct: 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFL 215
Query: 177 KVTSGIKPASLSKVT--DPQVKQFIEKCIVPASLRLP-ALELLKDPF 220
S P L P FI+KC+ + P A +LL+ PF
Sbjct: 216 ISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
Q E ++SE +L+ H I+K Y ++ D + I M+ E G L + D
Sbjct: 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDE 92
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A 123
+ + ++ YLH+ II+RDLK +N+ ++ +NG VK+ D G A ++
Sbjct: 93 YTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKT 149
Query: 124 RSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSG 181
+ GTPE++APE+ + Y+ VD +S G+ + E++T P+ E +P +IY + G
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG 209
Query: 182 IKPASLSKVTDPQVKQFIEK 201
D K I++
Sbjct: 210 NGKLEFPNYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 59/221 (26%), Positives = 111/221 (50%), Gaps = 11/221 (4%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAI 67
++ E+ +L I+ FY ++ ++ + I++ E GSL + K+ + + +
Sbjct: 45 QILRELDILHKCNSPYIVGFYGAFYNNGD--ISICMEYMDGGSLDKILKEVQGRIPERIL 102
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 127
A +L+GL YLH IIHRD+K NI VN + G++K+ D G++ + A++ +
Sbjct: 103 GKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFV 160
Query: 128 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGI 182
GT +MAPE + +Y+ DI+S G+ ++E+ T +PY ++ + + +
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP 220
Query: 183 KPASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLV 222
P S P + F+ C++ P+ ELL+ PF+
Sbjct: 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 78/236 (33%), Positives = 128/236 (54%), Gaps = 18/236 (7%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
E L++EV +++ +HEN+++ YNS++ + ++ E G+L H ++ + I
Sbjct: 62 ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 118
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS 125
+L+ L LH+ +IHRD+K D+I + ++G VK+ D G + + P +S
Sbjct: 119 AAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKS 175
Query: 126 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 183
++GTP +MAPEL Y VDI+S G+ ++EMV E PY NE P + K + +
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLP 233
Query: 184 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 235
P +L KV+ P +K F+++ +V PA R A ELLK PFL P + +R
Sbjct: 234 PKLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPSCIVPLMR 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 13/214 (6%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIK 68
E+ LLK L H N+IK+Y S+++D +N++ EL +G L + ++K+ + + K +
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109
Query: 69 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSV 126
+ Q+ L ++HS ++HRD+K N+F+ G VK+GDLGL T A S+
Sbjct: 110 KYFVQLCSALEHMHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSL 166
Query: 127 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKP 184
+GTP +M+PE ++E YN DI+S G + EM + P Y + N + KK+ P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 226
Query: 185 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 218
S +++Q + CI P + P + + D
Sbjct: 227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 53/158 (33%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT---SGSLRQYRKKHKNVDMKAIKN 69
E+ LL+ L+H NI++ +I M+ E +G L K IK
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKC 104
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---- 125
+ +Q+L GL YLHS+ I+HRD+K NI +N N+G +K+ D GLA + +
Sbjct: 105 YMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 126 VIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 160
VI T + PEL Y VD++S G CIL E+
Sbjct: 162 VI-TLWYRPPELLLGATRYGPEVDMWSVG-CILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 60/236 (25%), Positives = 112/236 (47%), Gaps = 21/236 (8%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
M +Q++++ +E +L + ++K Y S+ N + ++ E G L +
Sbjct: 31 MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKN--LYLVMEYLPGGDLASLLENVG 88
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL------ 114
++D + + +I+ L YLHS+ IIHRDLK DNI ++ +NG +K+ D GL
Sbjct: 89 SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLV 145
Query: 115 --AIVMQQPTARS--VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 169
I + ++GTP+++APE + + +++ VD +S G + E + P++ +
Sbjct: 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-E 204
Query: 170 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL-RLPAL---ELLKDPFL 221
P +I++ + +G + I K +VP RL A E+ PF
Sbjct: 205 TPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 17/227 (7%)
Query: 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 65
+ E+L EV LLKSLKH NI+++ + +DD TI++ E GS+ + +
Sbjct: 45 EYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--TISIFMEFVPGGSISSILNRFGPLPEP 102
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--------V 117
+ +QIL G+ YLH++ ++HRD+K +N+ + NG +K+ D G A
Sbjct: 103 VFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHG 159
Query: 118 MQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-Y 175
+S+ GTP +MAPE+ E Y DI+S G + EM T + P A + Y
Sbjct: 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY 219
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 221
G+ P L F+ C+ P AL+LL+ FL
Sbjct: 220 IGAHRGLMP-RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 65/237 (27%), Positives = 120/237 (50%), Gaps = 18/237 (7%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYR 56
+PD +++ E+ + KS K I+K+Y +++D+++ +I + E GSL ++ +
Sbjct: 37 DPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVK 96
Query: 57 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
K+ + K + A +L+GL YLHS IIHRD+K NI + G+VK+ D G++
Sbjct: 97 KRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSG 153
Query: 117 VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
+ A + GT +MAPE + + Y+ D++S G+ +LE+ +P+ P
Sbjct: 154 ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213
Query: 176 KKVTSGIKPASLSKVTD-PQV--------KQFIEKCIVPASLRLPA-LELLKDPFLV 222
++ S I ++ D P K FI++C+ R P ++L+ P++
Sbjct: 214 IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 25/215 (11%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
Q+E + +E +L+S++H ++ Y S+ DD+N + ++ E G L + +K
Sbjct: 43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPE 100
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
+ +A Q++ L YLHS + I++RDLK +N+ + ++G +KI D G A ++ T
Sbjct: 101 PVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRT-Y 156
Query: 125 SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSG 181
++ GTPE++APE+ + Y + VD ++ G+ I EM+ YP +++ NP QIY+K+ G
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEML-AGYPPFFDD--NPIQIYEKILEG 213
Query: 182 IKPASLSKVT-----DPQVKQFIEK-CIVPASLRL 210
KV P K I V + RL
Sbjct: 214 -------KVRFPSFFSPDAKDLIRNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-25
Identities = 72/235 (30%), Positives = 123/235 (52%), Gaps = 16/235 (6%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
E L++EV +++ HEN++ YNS++ + ++ E G+L H ++ + I
Sbjct: 64 ELLFNEVVIMRDYHHENVVDMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 120
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS 125
+LR L YLH+ +IHRD+K D+I + ++G +K+ D G + + P +S
Sbjct: 121 ATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKS 177
Query: 126 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 183
++GTP +MAPE+ Y VDI+S G+ ++EM+ E PY NE P Q +++ +
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDNLP 235
Query: 184 P--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLR 235
P KV+ ++ F++ +V S R A ELL+ PFL P + +R
Sbjct: 236 PRVKDSHKVSS-VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLMR 289
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 63/225 (28%), Positives = 113/225 (50%), Gaps = 13/225 (5%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHK 60
S + +E+ +L L+H NII +YN ++DD I M E G+L R+K +
Sbjct: 39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQ 96
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ + + + QI+ + Y+H I+HRD+K NIF+ G +K+GD G++ ++
Sbjct: 97 LFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGS 153
Query: 121 PT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
A +V+GTP +M+PEL + +YN DI++ G + E++T + + + NP + K
Sbjct: 154 EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVK 212
Query: 178 VTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFL 221
+ G +S + ++ + + R A E+L P L
Sbjct: 213 IVQGNYTPVVSVYSS-ELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 62/207 (29%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ----YRKKHKNVDMKAIK 68
E+ LLK L H N+IK+ +S+++D +N++ EL +G L Q ++K+ + + + +
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109
Query: 69 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSV 126
+ Q+ + ++HS ++HRD+K N+F+ G VK+GDLGL T A S+
Sbjct: 110 KYFVQLCSAVEHMHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSL 166
Query: 127 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKP 184
+GTP +M+PE ++E YN DI+S G + EM + P Y + N + +K+ P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP 226
Query: 185 ASLSKVTDPQVKQFIEKCIVPASLRLP 211
++ ++++ + CI P + P
Sbjct: 227 PLPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 64/215 (29%), Positives = 113/215 (52%), Gaps = 12/215 (5%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNW 70
E LL LKH NI+ + SW + + + ++ G L K+ K + + W
Sbjct: 49 EAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIG 128
QI L YLH + I+HRDLK N+F+ N +K+GDLG+A V+ Q A ++IG
Sbjct: 108 FVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIG 164
Query: 129 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 187
TP +M+PEL+ + YN D+++ G C+ EM T ++ +N + +Y+ + + P +
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--M 222
Query: 188 SKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFL 221
K P++ + I + + P+++ +L+ P++
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 58/168 (34%), Positives = 83/168 (49%), Gaps = 26/168 (15%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMK 65
R+ E+ LL+ L+HENII + + + ++TEL + L + K + +
Sbjct: 45 RILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDD 103
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
I+ + QILRGL YLHS N +IHRDLK NI VN N ++KI D GLA +
Sbjct: 104 HIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED-- 158
Query: 126 VIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 160
F+ APE L Y + +DI+S G CI E++T
Sbjct: 159 ---EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
D ++ L SE+ LK L H NI+++ + T +++ E GS+ + + +
Sbjct: 50 DMVKALRSEIETLKDLDHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE 107
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVMQQ 120
+ ++ + Q+L GL YLHS I+HRDLK DN+ V+ +G KI D G+ +
Sbjct: 108 QLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDN 164
Query: 121 PTARSVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK- 176
S+ G+ +MAPE Y + Y+ VDI+S G +LEM P+++ + A ++K
Sbjct: 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL 224
Query: 177 ---KVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPF 220
+ I P ++ P F+ C P A ELL+ PF
Sbjct: 225 GNKRSAPPIPPDVSMNLS-PVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 7/156 (4%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 72
E +L+ L H ++ + S+ D+ N + ++ +L G LR + + + +K W
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC 107
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 131
+I+ L YLHS IIHRD+K DNI ++ G V I D +A V S GTP
Sbjct: 108 EIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPG 164
Query: 132 FMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 166
+MAPE+ + Y+ VD +S G+ E + + PY
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/150 (36%), Positives = 79/150 (52%), Gaps = 14/150 (9%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-IKNWA 71
E+ LL+ LKH NII + + +N IN++ E F L + K V A IK++
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSN--INLVFE-FMETDLEKVIKDKSIVLTPADIKSYM 108
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIG 128
LRGL YLHS+ I+HRDLK +N+ + ++G +K+ D GLA P + V+
Sbjct: 109 LMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVV- 164
Query: 129 TPEFMAPELY--EEEYNELVDIYSFGMCIL 156
T + APEL Y VD++S G CI
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 71/229 (31%), Positives = 120/229 (52%), Gaps = 13/229 (5%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
E L++EV +++ +H+N+++ Y S++ + ++ E G+L + + ++ + I
Sbjct: 63 ELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVLMEFLQGGALTDIVSQTR-LNEEQI 119
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS 125
+L+ L YLHS +IHRD+K D+I + +G VK+ D G I P +S
Sbjct: 120 ATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKS 176
Query: 126 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 184
++GTP +MAPE+ Y VDI+S G+ ++EMV E PY +P Q K++ P
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPP 235
Query: 185 -ASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 230
+ P ++ F+E+ + R A ELL PFL+ T P+ LV
Sbjct: 236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 74/231 (32%), Positives = 120/231 (51%), Gaps = 15/231 (6%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
Q P + E + +E+ +++ KH NI+ + +S++ + ++ E GSL +
Sbjct: 56 QQPKK-ELIINEILVMRENKHPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TC 111
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
+D I R+ L+ L +LHS+ +IHRD+K DNI + G +G VK+ D G I +
Sbjct: 112 MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPE 168
Query: 120 QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYK 176
Q +++GTP +MAPE+ + Y VDI+S G+ +EMV E PY NE NP + +Y
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYL 226
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 226
T+G + + F+ +C+ + R A ELL+ PFL P
Sbjct: 227 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 65
Q + +++E +LK + H II+ + + D + M+ E G L Y +
Sbjct: 44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF--LYMLMEYVPGGELFSYLRNSGRFSNS 101
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
+A +I+ L YLHS I++RDLK +NI ++ G +K+ D G A ++ T +
Sbjct: 102 TGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTW-T 157
Query: 126 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK 183
+ GTPE++APE+ + + +N+ VD ++ G+ I EM+ P+ + NP IY+K+ +G ++
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLE 216
Query: 184 -PASLSKVTDPQVKQFIEKCIV 204
P L D K I+K +V
Sbjct: 217 FPRHL----DLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 10/163 (6%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VD 63
+ + L E+ +L++L HENI+K+ +D I +I E SGSL++Y ++KN ++
Sbjct: 48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN 107
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 121
+K +A QI +G+ YL S +HRDL N+ V + +VKIGD GL ++
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKE 164
Query: 122 --TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 160
T + + +P F APE L + ++ D++SFG+ + E++T
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 69/228 (30%), Positives = 115/228 (50%), Gaps = 18/228 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG-----SLRQYRK 57
+P++ + E LL L H I+KF+ S+++ I ITE + G L + +
Sbjct: 42 NPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI--ITE-YCEGRDLDCKLEELKH 98
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
K + + W Q+L G+HY+H I+HRDLK NIF+ N +KIGD G++ +
Sbjct: 99 TGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNN--LLKIGDFGVSRL 154
Query: 118 MQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 174
+ A + GTP +M+PE L + Y+ DI+S G + EM + + E +N +
Sbjct: 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSV 213
Query: 175 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
++ G P SL + Q+ ++ + SLR A E+L++PF+
Sbjct: 214 VLRIVEGPTP-SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 73/253 (28%), Positives = 125/253 (49%), Gaps = 18/253 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT-SGSLRQYRKKHK 60
QS ++ + + EV L+ L+H N I++ ++ + + M L + S L ++K +
Sbjct: 54 QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQ 113
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V++ AI L+GL YLHSH IHRD+K NI + G VK+ D G A ++
Sbjct: 114 EVEIAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVS- 166
Query: 121 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + +Y
Sbjct: 167 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 177 KVTSGIKPASLSKVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPL 234
+ +LS + F++ C+ R + ELLK F++ + P ++ D +
Sbjct: 226 IAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLI 283
Query: 235 -RLPNLVPEVMNL 246
R + V E+ NL
Sbjct: 284 QRTKDAVRELDNL 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 8e-23
Identities = 74/232 (31%), Positives = 122/232 (52%), Gaps = 14/232 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+Q + E + +E+ ++K LK+ NI+ F +S++ + ++ E GSL +
Sbjct: 54 LQKQPKKELIINEILVMKELKNPNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVVTE-T 110
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVM 118
+D I R+ L+ L +LH++ +IHRD+K DN+ + G +G VK+ D G I
Sbjct: 111 CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITP 167
Query: 119 QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IY 175
+Q +++GTP +MAPE+ + Y VDI+S G+ +EMV E PY NE NP + +Y
Sbjct: 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALY 225
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 226
T+G + P + F+ +C+ + R A ELL+ PFL P
Sbjct: 226 LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 12/215 (5%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNW 70
EV LL +KH NI+ F+ S+ ++ I M E G L + + + V I +W
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVM--EYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIG 128
QI GL H H+ I+HRD+K NIF++ N K+GD G+A + A + +G
Sbjct: 107 FVQISLGLK--HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164
Query: 129 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 187
TP +++PE+ + YN DI+S G + E+ T ++P+ E N Q+ K+ G A +
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQG-YFAPI 222
Query: 188 SKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFL 221
S ++ I + + P++ +LK PFL
Sbjct: 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 72/230 (31%), Positives = 118/230 (51%), Gaps = 12/230 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ D++E + E+ +L + K+Y S++ DT I I E GS +
Sbjct: 41 EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI--IMEYLGGGSALDLLEPGP- 97
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
+D I R+IL+GL YLHS IHRD+K N+ ++ +GEVK+ D G+A +
Sbjct: 98 LDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDT 154
Query: 120 QPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
Q + +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P++E +P ++ +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLI 213
Query: 179 TSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 227
P + P +K+F+E C+ S R A ELLK F+V K
Sbjct: 214 PKNNPPTLEGNYSKP-LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 13 EVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKN 69
EV L+ L H NI+K + + N + + E + G+L Q K K I++
Sbjct: 47 EVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRS 103
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 128
QIL+GL ++H H HRDLK +N+ V+G VKI D GLA + +P +
Sbjct: 104 IIYQILQGLAHIHKHG--FFHRDLKPENLLVSG-PEVVKIADFGLAREIRSRPPYTDYVS 160
Query: 129 TPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCE 162
T + APE L Y+ VDI++ G CI+ E+ T
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALG-CIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 56/166 (33%), Positives = 89/166 (53%), Gaps = 20/166 (12%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-----YRKKHKNVDMKAI 67
E+ LL+ LKHEN++ +++ ++++ ++ + + L Q + K ++ +
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP--- 121
K+ QIL G+HYLHS+ ++HRDLK NI V G G VKIGDLGLA + P
Sbjct: 111 KSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 122 --TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE 162
V+ T + APEL Y + +DI++ G CI E++T E
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWV--DDTNR--TINMITELFTSGSLRQYRKK 58
D+ E + E ++L+ H NI FY +++ + + ++ EL GS+ K
Sbjct: 43 EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG 102
Query: 59 HKNVDMKAIKNW----ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 114
+ + + W R+ LRGL YLH + +IHRD+K NI + N EVK+ D G+
Sbjct: 103 LRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGV 159
Query: 115 AIVMQQPTAR--SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYN 166
+ + R + IGTP +MAPE+ + Y+ D++S G+ +E+ + P
Sbjct: 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL- 218
Query: 167 ECKNPA-----QIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDP 219
C +I + +K P + SK + FI +C++ + P ELL+ P
Sbjct: 219 -CDMHPMRALFKIPRNPPPTLKSPENWSK----KFNDFISECLIKNYEQRPFMEELLEHP 273
Query: 220 FL 221
F+
Sbjct: 274 FI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 68/240 (28%), Positives = 124/240 (51%), Gaps = 19/240 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYR-KKHK 60
+S ++LE E+ +L S H NI+K +++ + N I + E G++ + +
Sbjct: 41 KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI--LIEFCAGGAVDAVMLELER 98
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ I+ +Q L L+YLH + IIHRDLK NI +G++K+ D G++ +
Sbjct: 99 PLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTR 155
Query: 121 PTAR--SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 172
R S IGTP +MAPE+ + Y+ D++S G+ ++EM E P++E NP
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPM 214
Query: 173 QIYKKVTSGIKPASLSKVT--DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 229
++ K+ +P +L++ + + K F++KC+ R +LL+ PF+ ++ K +
Sbjct: 215 RVLLKIAKS-EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-21
Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 16/254 (6%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-K 60
Q+ ++ + + EV L+ LKH N I++ ++ + + M L ++ L + KK +
Sbjct: 60 QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ 119
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V++ AI + A L+GL YLHSHN +IHRD+K NI + G+VK+ D G A
Sbjct: 120 EVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS- 172
Query: 121 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + +Y
Sbjct: 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY- 230
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPL- 234
+ P S + F++ C+ PA ELL+ F+ D P ++ D +
Sbjct: 231 HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQ 290
Query: 235 RLPNLVPEVMNLAH 248
R + V E+ NL +
Sbjct: 291 RTKDAVRELDNLQY 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 1e-20
Identities = 76/236 (32%), Positives = 123/236 (52%), Gaps = 22/236 (9%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+Q + E + +E+ +++ K+ NI+ + +S++ + ++ E GSL +
Sbjct: 54 LQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-T 110
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVM 118
+D I R+ L+ L +LHS+ +IHRD+K DNI + G +G VK+ D G I
Sbjct: 111 CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITP 167
Query: 119 QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IY 175
+Q +++GTP +MAPE+ + Y VDI+S G+ +EMV E PY NE NP + +Y
Sbjct: 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALY 225
Query: 176 KKVTSGI----KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 226
T+G P LS V + F+ +C+ + R A ELL+ PFL P
Sbjct: 226 LIATNGTPELQNPERLSAV----FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 56/165 (33%), Positives = 87/165 (52%), Gaps = 10/165 (6%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 61
+ + L E+ +LKSL+H+NI+K+ R + ++ E GSLR Y +KH+
Sbjct: 45 TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER 104
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+D + + +A QI +G+ YL S +HRDL NI V N VKIGD GL V+ Q
Sbjct: 105 LDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESEN-RVKIGDFGLTKVLPQD 161
Query: 122 TARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 160
+ P + APE L E +++ D++SFG+ + E+ T
Sbjct: 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 20/233 (8%)
Query: 5 DQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKH 59
D+ E + E+++LK H NI +Y +++ + + ++ E +GS+ K
Sbjct: 44 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 103
Query: 60 KNVDMKA--IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
K +K I R+ILRGL +LH H +IHRD+K N+ + N EVK+ D G++
Sbjct: 104 KGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQ 160
Query: 118 MQQPTAR--SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECK 169
+ + R + IGTP +MAPE+ + Y+ D++S G+ +EM P +
Sbjct: 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-M 219
Query: 170 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFL 221
+P + + P SK + + FIE C+V + P E L+K PF+
Sbjct: 220 HPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 71/235 (30%), Positives = 117/235 (49%), Gaps = 20/235 (8%)
Query: 3 SPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRK 57
+ D+ E + E+++LK H NI +Y +++ + + + ++ E +GS+ K
Sbjct: 52 TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK 111
Query: 58 KHKNVDMKA--IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115
K +K I R+ILRGL +LH+H +IHRD+K N+ + N EVK+ D G++
Sbjct: 112 NTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVS 168
Query: 116 IVMQQPTAR--SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNE 167
+ + R + IGTP +MAPE+ + Y+ DI+S G+ +EM P +
Sbjct: 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
Query: 168 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFL 221
+P + + P SK + FIE C+V L P+ E LLK PF+
Sbjct: 229 -MHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 64/169 (37%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRK 57
QS +R Y E+ LLK + HEN+I + + ++ + + ++T L + L K
Sbjct: 53 QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK 111
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
K D I+ QILRGL Y+HS IIHRDLK NI VN + E+KI D GLA
Sbjct: 112 CQKLSDDH-IQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA-- 165
Query: 118 MQQPTARSVIG---TPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 160
+ T + G T + APE L YN+ VDI+S G CI+ E++T
Sbjct: 166 --RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 69/231 (29%), Positives = 115/231 (49%), Gaps = 17/231 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
+ + +++ SE+ +L II FY ++ + NR I++ TE GSL YRK ++V
Sbjct: 39 TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NR-ISICTEFMDGGSLDVYRKIPEHV 96
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 122
+ A +++GL YL S I+HRD+K N+ VN G+VK+ D G++ +
Sbjct: 97 ----LGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSI 149
Query: 123 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY-----NECK-NPAQIY 175
A++ +GT +MAPE + E+Y D++S G+ +E+ +PY N+ P Q+
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD-PFLVTDN 225
+ + P + FI +C+ PA E L D PF+V N
Sbjct: 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 76/254 (29%), Positives = 130/254 (51%), Gaps = 16/254 (6%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-K 60
QS ++ + + EV L+ L+H N I++ ++ + + M L ++ L + KK +
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ 113
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V++ A+ + A L+GL YLHSHN +IHRD+K NI ++ G VK+GD G A +M
Sbjct: 114 EVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA- 166
Query: 121 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
A +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + +Y
Sbjct: 167 -PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY- 224
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL- 234
+ PA S + F++ C+ P E LLK F++ + P ++ D +
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284
Query: 235 RLPNLVPEVMNLAH 248
R + V E+ NL +
Sbjct: 285 RTKDAVRELDNLQY 298
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 76/255 (29%), Positives = 132/255 (51%), Gaps = 18/255 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-K 60
QS ++ + + EV L+ +KH N I++ ++ + + M L ++ L + KK +
Sbjct: 64 QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ 123
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V++ AI + A L+GL YLHSHN +IHRD+K NI + G+VK+ D G A +
Sbjct: 124 EVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIAS- 176
Query: 121 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + +Y
Sbjct: 177 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY- 234
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPL 234
+ P S + F++ C+ +P R + ELLK F++ + P+ ++ D +
Sbjct: 235 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQD-RPTSEELLKHMFVLRERPETVLIDLI 293
Query: 235 -RLPNLVPEVMNLAH 248
R + V E+ NL +
Sbjct: 294 QRTKDAVRELDNLQY 308
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-20
Identities = 57/154 (37%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
+R Y E+ LLK L+HENII + ++ I +TEL + R + ++ + I
Sbjct: 54 KRTYRELKLLKHLRHENIISLSDIFISPLE-DIYFVTELLGTDLHRLL--TSRPLEKQFI 110
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 127
+ + QILRGL Y+HS ++HRDLK NI +N N ++KI D GLA + Q P +
Sbjct: 111 QYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARI-QDPQMTGYV 166
Query: 128 GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMV 159
T + APE L ++Y+ VDI+S G EM+
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 8e-20
Identities = 61/187 (32%), Positives = 97/187 (51%), Gaps = 11/187 (5%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
SP + E EV +L ++KH NI+++ S+ ++ N I M + G L + + V
Sbjct: 39 SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM--DYCEGGDLYKKINAQRGV 96
Query: 63 --DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
I +W QI L H H+ I+HRD+K NIF+ +G +K+GD G+A V+
Sbjct: 97 LFPEDQILDWFVQICLALK--HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNS 153
Query: 121 PT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
AR+ IGTP +++PE+ E YN DI++ G + EM T ++ + E N + K
Sbjct: 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLK 212
Query: 178 VTSGIKP 184
+ G P
Sbjct: 213 IIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 57/157 (36%), Positives = 82/157 (52%), Gaps = 16/157 (10%)
Query: 13 EVHLLKSLK---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDM 64
E+ LLK L+ H NI++ + D + ++ E L Y K +
Sbjct: 48 EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPP 106
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
+ IK+ RQ+LRG+ +LHSH I+HRDLK NI V ++G+VKI D GLA + A
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMAL 163
Query: 125 -SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EM 158
SV+ T + APE L + Y VD++S G CI E+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVG-CIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 54/168 (32%), Positives = 87/168 (51%), Gaps = 12/168 (7%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-RTINMITELFTSGSLRQYRKKH 59
E+ +L++L HENI+K Y + R++ +I E SGSLR Y ++H
Sbjct: 44 SGEEQHRSDFEREIEILRTLDHENIVK-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH 102
Query: 60 K-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
+ +++K + ++ QI +G+ YL S IHRDL NI V + VKI D GLA V+
Sbjct: 103 RDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVL 159
Query: 119 QQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 160
+ + +P F APE L +++ D++SFG+ + E+ T
Sbjct: 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 68/230 (29%), Positives = 113/230 (49%), Gaps = 12/230 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ D++E + E+ +L + K+Y S++ T I I E GS +
Sbjct: 41 EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI--IMEYLGGGSALDLLRAGP- 97
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
D I ++IL+GL YLHS IHRD+K N+ ++ G+VK+ D G+A +
Sbjct: 98 FDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDT 154
Query: 120 QPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
Q + +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P N +P ++ +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLI 213
Query: 179 TSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 227
P + + K+FI+ C+ S R A ELLK F+V + K
Sbjct: 214 PKNNPPTLTGEFSK-PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 12/225 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ D++E + E+ +L I ++Y S++ T I I E GS K
Sbjct: 41 EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI--IMEYLGGGSALDLLKPGP- 97
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
++ I R+IL+GL YLHS IHRD+K N+ ++ G+VK+ D G+A +
Sbjct: 98 LEETYIATILREILKGLDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDT 154
Query: 120 QPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
Q + +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P ++ +P ++ +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLI 213
Query: 179 TSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 222
P + + P K+F+E C+ R A ELLK F+
Sbjct: 214 PKNSPPTLEGQYSKP-FKEFVEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 5e-19
Identities = 73/236 (30%), Positives = 122/236 (51%), Gaps = 22/236 (9%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+Q + E + +E+ +++ K+ NI+ + +S++ + ++ E GSL +
Sbjct: 55 LQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-T 111
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVM 118
+D I R+ L+ L +LHS+ +IHRD+K DNI + G +G VK+ D G I
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITP 168
Query: 119 QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IY 175
+Q +++GTP +MAPE+ + Y VDI+S G+ +EM+ E PY NE NP + +Y
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALY 226
Query: 176 KKVTSGI----KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 226
T+G P LS + + F+ +C+ + R A ELL+ FL P
Sbjct: 227 LIATNGTPELQNPEKLSAI----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 11/157 (7%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK 68
E+ LLK L H NIIK + V + ++ E + + + + + + IK
Sbjct: 44 TALREIKLLKELNHPNIIKLLD--VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIK 101
Query: 69 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSV 126
++ Q+L+GL + HSH I+HRDLK +N+ +N G +K+ D GLA
Sbjct: 102 SYLYQLLQGLAFCHSHG--ILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHY 158
Query: 127 IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 160
+ T + APEL ++ Y+ VDI+S G CI E+++
Sbjct: 159 VVTRWYRAPELLLGDKGYSTPVDIWSVG-CIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 9/177 (5%)
Query: 53 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 112
++ K + + A I++ L YLHS +IHRD+K N+ +N NG+VK+ D
Sbjct: 91 KKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLIN-RNGQVKLCDF 148
Query: 113 GLAIVMQQPTARSV-IGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYN 166
G++ + A+++ G +MAPE E Y+ D++S G+ ++E+ T +PY+
Sbjct: 149 GISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
Query: 167 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLV 222
K P Q K+V P ++ P+ + F+ KC+ P ELL+ PF
Sbjct: 209 SWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 59/177 (33%), Positives = 86/177 (48%), Gaps = 10/177 (5%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNW 70
E LL +KH NI+ F S+ D + I M E G L Q K + I W
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVM--EYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IG 128
Q+ G+ H H ++HRD+K NIF+ NG+VK+GD G A ++ P A + +G
Sbjct: 106 FVQMCLGVQ--HIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVG 162
Query: 129 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 184
TP ++ PE++E YN DI+S G + E+ T ++P+ I K KP
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 57/236 (24%), Positives = 110/236 (46%), Gaps = 21/236 (8%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK 68
++ E+ ++ + I+ FY +++++ N I M E GSL + KK + ++ +
Sbjct: 49 QILRELQIMHECRSPYIVSFYGAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILG 106
Query: 69 NWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 127
A ++ GL YL++ H I+HRD+K NI VN G++K+ D G++ + A + +
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFV 163
Query: 128 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---- 182
GT +M+PE + +Y D++S G+ I+E+ ++P+ N + GI
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLL 222
Query: 183 ------KPASLSKVTDPQV-KQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDL 229
P L P+ + F++ C++ P P PF+ ++
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 16/218 (7%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 72
E+ ++K KH NI+ ++ S++ I M E GSL+ + I +R
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSR 113
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTP 130
+ L+GL+YLHS +HRD+K NI + +NG VK+ D G++ + A+ S IGTP
Sbjct: 114 ETLQGLYYLHSKGK--MHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 131 EFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 186
+MAPE+ E YN+L DI++ G+ +E+ + P + ++ S +P
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK 230
Query: 187 LS---KVTDPQVKQFIEKCIVPASLRLPALE-LLKDPF 220
L K ++ F++ + + P E LL+ PF
Sbjct: 231 LKDKMKWSN-SFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 7 LERLYSEVHLLK-SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKN 61
+ + SEV ++K L+H NI+++Y ++++ N + ++ +L L ++ ++K +
Sbjct: 52 IGDIVSEVTIIKEQLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQR 109
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ I N Q++ L YLH I+HRDL +NI + G + +V I D GLA +QP
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKR-IVHRDLTPNNIML-GEDDKVTITDFGLA-KQKQP 166
Query: 122 TAR--SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
++ SV+GT + PE+ + E Y E D+++FG + +M T + P+ N + K+
Sbjct: 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKI 225
Query: 179 TSGIKPASLSKVTDPQVKQFIEKCIVP 205
+ + V I C+ P
Sbjct: 226 VEAVYEPLPEGMYSEDVTDVITSCLTP 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 55/166 (33%), Positives = 88/166 (53%), Gaps = 14/166 (8%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
E+++LK+L HENI+K+ + + + +I E GSLR Y KH +
Sbjct: 46 GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KL 104
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 122
++ + +A+QI G+ YLHS + IHRDL N+ ++ N+ VKIGD GLA + P
Sbjct: 105 NLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV--PE 159
Query: 123 A------RSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 160
R +P F A E L E +++ D++SFG+ + E++T
Sbjct: 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 68/232 (29%), Positives = 118/232 (50%), Gaps = 19/232 (8%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HK 60
+S ++LE E+ +L + H I+K ++ D I MI E G++ + +
Sbjct: 48 KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI-MI-EFCPGGAVDAIMLELDR 105
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ I+ RQ+L L YLHS IIHRDLK N+ + +G++K+ D G++ +
Sbjct: 106 GLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVK 162
Query: 121 PTAR--SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 172
R S IGTP +MAPE + + Y+ DI+S G+ ++EM E P++E NP
Sbjct: 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPM 221
Query: 173 QIYKKVTSGIKPASLSKVT--DPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
++ K+ +P +LS+ + + + F++ + R A +LL+ PF+
Sbjct: 222 RVLLKIAKS-EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 36/197 (18%)
Query: 3 SPDQLERLYS----EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK 58
D+L + E ++ SL HEN+I+ Y + + M+TEL GSL +K
Sbjct: 32 KSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH---PLMMVTELAPLGSLLDRLRK 88
Query: 59 HKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA- 115
+ + ++A QI G+ YL S IHRDL NI + ++ +VKIGD GL
Sbjct: 89 DALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDD-KVKIGDFGLMR 145
Query: 116 --------IVMQQ----PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C 161
VM++ P A + APE L ++ D++ FG+ + EM T
Sbjct: 146 ALPQNEDHYVMEEHLKVPFA--------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYG 197
Query: 162 EYPYNECKNPAQIYKKV 178
E P+ + +QI KK+
Sbjct: 198 EEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 13/224 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++ D + E+ ++K KH NI+ ++ S++ I M E GSL+
Sbjct: 44 LEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM--EYCGGGSLQDIYHVTG 101
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ I R+ L+GL YLHS +HRD+K NI + +NG+VK+ D G+A +
Sbjct: 102 PLSELQIAYVCRETLQGLAYLHSKGK--MHRDIKGANILLT-DNGDVKLADFGVAAKITA 158
Query: 121 PTAR--SVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 174
A+ S IGTP +MAPE+ E YN+L DI++ G+ +E+ + P + +
Sbjct: 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
Query: 175 YKKVTSGIKPASLSKVT--DPQVKQFIEKCIVPASLRLPALELL 216
+ S +P L T F++ + + P E L
Sbjct: 219 FLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 50/141 (35%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 25 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84
I+ FY ++ D +I M E GSL Q KK + + + +LRGL YL
Sbjct: 61 IVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE- 117
Query: 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYN 143
I+HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y
Sbjct: 118 KHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYT 176
Query: 144 ELVDIYSFGMCILEMVTCEYP 164
DI+S G+ ++EM YP
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 41/99 (41%), Positives = 63/99 (63%), Gaps = 6/99 (6%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 127
+ QI+ GL +LH II+RDLK +N+ ++ N+G V+I DLGLA+ ++ Q +
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 128 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY 165
GTP FMAPEL + EEY+ VD ++ G+ + EM+ P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-18
Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 72
E+ +L+ + H N++K ++ + D N I ++ E GSL + + + + AR
Sbjct: 122 EIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADE----QFLADVAR 175
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---PTARSVIGT 129
QIL G+ YLH + I+HRD+K N+ +N VKI D G++ ++ Q P SV GT
Sbjct: 176 QILSGIAYLHRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV-GT 231
Query: 130 PEFMAPELYEEEYNELV------DIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSG 181
+M+PE + N DI+S G+ ILE +P+ + A + +
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS 291
Query: 182 IKPASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLV 222
P + + + + + FI C+ PA R A++LL+ PF++
Sbjct: 292 QPPEAPATAS-REFRHFISCCLQREPAK-RWSAMQLLQHPFIL 332
|
Length = 353 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNW 70
E ++K L+H +I+ Y V I ++TEL GSL +Y + + + + +
Sbjct: 51 EAQIMKKLRHPKLIQLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM 108
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIG 128
A Q+ G+ YL + N IHRDL N+ V G N K+ D GLA V+++ AR
Sbjct: 109 AAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAK 165
Query: 129 TP-EFMAPELYEEEYNELV---DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 183
P ++ APE YN D++SFG+ + E+VT PY N A++ ++V G +
Sbjct: 166 FPIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQGYR 222
Query: 184 ---PASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 217
P ++ + C P E L+
Sbjct: 223 MPCPPG----CPKELYDIMLDCWKEDPDDRPTFETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 43/164 (26%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
P+Q R E+ L++ +H ++K + + + ++ E S R + + +
Sbjct: 43 PNQALR---EIKALQACQHPYVVKLLDVFPHGSG--FVLVMEYMPSDLSEVLRDEERPLP 97
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
+K++ R +L+G+ Y+H++ I+HRDLK N+ + +G +KI D GLA + +
Sbjct: 98 EAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEP 154
Query: 124 RSV---IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTC 161
R + T + APEL +Y+ VD+++ G CI E++
Sbjct: 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVG-CIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 72
EV +L+ L+HENI+ ++ + ++ E L + A++++
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW 107
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGT 129
Q+L+ + Y HSHN IIHRD+K +NI V+ +G +K+ D G A ++ A + T
Sbjct: 108 QLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVAT 164
Query: 130 PEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 160
+ APEL + Y + VD+++ G CI+ E++
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIG-CIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 55/218 (25%), Positives = 106/218 (48%), Gaps = 13/218 (5%)
Query: 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDM 64
+ EV LK L+H+++I + V + +ITEL GSL + + + + + +
Sbjct: 46 QQDFQKEVQALKRLRHKHLISLFA--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV 103
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 122
++ + A Q+ G+ YL N IHRDL NI V G + K+ D GLA ++++
Sbjct: 104 ASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYL 160
Query: 123 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 180
+ ++ APE ++ D++SFG+ + EM T + PY N ++Y ++T+
Sbjct: 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITA 219
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 218
G + +K ++ + + +C P+ + L++
Sbjct: 220 GYRMPCPAKCP-QEIYKIMLECWAAEPEDRPSFKALRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 51/156 (32%), Positives = 87/156 (55%), Gaps = 15/156 (9%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKN 69
E+ L+K LKHENI++ ++ V T + ++ E + L++Y H +D +K+
Sbjct: 48 EISLMKELKHENIVRLHD--VIHTENKLMLVFE-YMDKDLKKYMDTHGVRGALDPNTVKS 104
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 127
+ Q+L+G+ + H + ++HRDLK N+ +N GE+K+ D GLA P T + +
Sbjct: 105 FTYQLLKGIAFCHENR--VLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEV 161
Query: 128 GTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 160
T + AP+ L Y+ +DI+S G CI+ EM+T
Sbjct: 162 VTLWYRAPDVLLGSRTYSTSIDIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 25 IIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYL 81
I+ FY ++ + + M E +GSL + + + ++ +++GL +L
Sbjct: 61 IVDFYGAFFIEG--AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 82 -HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE 140
HN IIHRD+K N+ VNGN G+VK+ D G++ + A++ IG +MAPE +
Sbjct: 119 KEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKS 175
Query: 141 E-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------PASL 187
Y D++S G+ ILEM YPY P + Y + + + P +L
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIVDGDPPTL 230
Query: 188 SKVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKD 228
+ F+ KC+ +P + R +LL+ P+LV D
Sbjct: 231 PSGYSDDAQDFVAKCLNKIP-NRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 40/99 (40%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VI 127
+A ++ GL YLH + I++RDLK DN+ ++ G VKI D GL R+
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFC 162
Query: 128 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 165
GTPEF+APE L E Y VD + G+ I EM+ E P+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 42/136 (30%), Positives = 75/136 (55%), Gaps = 6/136 (4%)
Query: 36 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 95
T + + E G L + + D + +A +I+ GL +LH II+RDLK
Sbjct: 67 TKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKL 124
Query: 96 DNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFG 152
DN+ ++ +G +KI D G+ + + A + GTP+++APE+ + ++YNE VD +SFG
Sbjct: 125 DNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFG 183
Query: 153 MCILEMVTCEYPYNEC 168
+ + EM+ + P++
Sbjct: 184 VLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 46/209 (22%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 24 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83
+ K Y + + + ++ E G K + K + +++ G+ LH
Sbjct: 58 YVAKLY--YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEY 142
IIHRD+K +N+ ++ G +K+ D GL+ + + +GTP+++APE
Sbjct: 116 RG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETILGVGD 170
Query: 143 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIE 200
+++ D +S G I E + YP + P ++ + S P + + P+ I
Sbjct: 171 DKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229
Query: 201 KCIVP-ASLRLPA---LELLKDPFLVTDN 225
+ + + RL A E+ PF + N
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-16
Identities = 58/202 (28%), Positives = 108/202 (53%), Gaps = 29/202 (14%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHK---NVDM 64
+L EV++++ LKH+NI+++ + +++ N+ + ++ E +G L R +K +K ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 65 KAIKNWARQILRGLHYLHS-----HNPPIIHRDLKCDNIFV--------------NGNNG 105
AI + RQ+L L Y H+ + ++HRDLK NIF+ N NG
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 106 E--VKIGDLGLAI-VMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMV 159
KIGD GL+ + + A S +GTP + +PEL E Y++ D+++ G I E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 160 TCEYPYNECKNPAQIYKKVTSG 181
+ + P+++ N +Q+ ++ G
Sbjct: 238 SGKTPFHKANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 18/157 (11%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNW 70
E+ LLK L H NI++ + + + ++ E F L++Y +D IK++
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENK--LYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSY 104
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSV 126
Q+L+G+ Y HSH ++HRDLK N+ ++ G +K+ D GLA + ++ T V
Sbjct: 105 LYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVV 161
Query: 127 IGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 160
T + APE L +Y+ VDI+S G CI EMV
Sbjct: 162 --TLWYRAPEILLGSRQYSTPVDIWSIG-CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 53/154 (34%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNW 70
E+ LLK L H NI+K + V T + ++ E F L+++ + + IK++
Sbjct: 49 EISLLKELNHPNIVKLLD--VIHTENKLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSY 105
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIG 128
Q+L+GL + HSH ++HRDLK N+ +N G +K+ D GLA P T +
Sbjct: 106 LFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVV 162
Query: 129 TPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
T + APE L + Y+ VDI+S G EMVT
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 54/165 (32%), Positives = 86/165 (52%), Gaps = 17/165 (10%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMK 65
R E+ +L+ KHENII + + + N ++ EL + + + +H + D
Sbjct: 49 RTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH- 107
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
I+ + QILRGL Y+HS N ++HRDLK N+ +N N ++KI D GLA + +
Sbjct: 108 -IQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHT 163
Query: 126 -----VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCE 162
+ T + APE L + Y + +DI+S G CIL EM++
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 51/154 (33%), Positives = 92/154 (59%), Gaps = 17/154 (11%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWA 71
E+ LLK LKH+NI++ Y+ V +++ + ++ E + L++Y + ++D + +K++
Sbjct: 49 EICLLKELKHKNIVRLYD--VLHSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFM 105
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVI 127
Q+L+GL + HSHN ++HRDLK N+ +N NGE+K+ D GLA I ++ +A V
Sbjct: 106 FQLLKGLAFCHSHN--VLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVV- 161
Query: 128 GTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EM 158
T + P+ + Y+ +D++S G CI E+
Sbjct: 162 -TLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 32/173 (18%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT---------SGSLRQYRKKHKNVD 63
E+ +LK LKH N++ + V+ +++ ++ SG L K +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LT 113
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----Q 119
IK + Q+L G++YLH ++ I+HRD+K NI ++ N G +KI D GLA
Sbjct: 114 ESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPP 170
Query: 120 QPTARSVIGTPEFM---------APELY--EEEYNELVDIYSFGMCIL-EMVT 160
P GT ++ PEL E Y VDI+ G C+ EM T
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 47/289 (16%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMK 65
R E+ LL+ L HEN+I + N ++ EL + L Q + + +
Sbjct: 50 RTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDD 108
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
+ + Q+LRGL Y+HS N ++HRDLK N+ +N N ++KI D GL AR+
Sbjct: 109 HCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANC-DLKICDFGL--------ART 157
Query: 126 VIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKN 170
+FM APEL EY +D++S G CI E++ + +P + +
Sbjct: 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVH 216
Query: 171 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-----------ALELLKDP 219
++ ++ L + + + +++I +P + R A++LL +
Sbjct: 217 QLKLITELLGSPSEEDLGFIRNEKARRYIRS--LPYTPRQSFARLFPHANPLAIDLL-EK 273
Query: 220 FLVTDNPKDL-VCDPLRLPNLVP-EVMNLAHSEPHPMDIDLNHKKVSAD 266
LV D K + V + L P L + P D ++ +
Sbjct: 274 MLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEE 322
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 52/162 (32%), Positives = 84/162 (51%), Gaps = 5/162 (3%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
P ++ E+ +L I+ FY ++ D +I M E GSL Q K+ K +
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRIP 101
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
+ + + +LRGL YL + I+HRD+K NI VN + GE+K+ D G++ + A
Sbjct: 102 EEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 124 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 164
S +GT +M+PE L Y+ DI+S G+ ++E+ YP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 9/154 (5%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 72
E LL+++ H ++I+ ++ V + M+ ++S K+ + + + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 131
QIL GL YLH+ IIHRD+K +NIF+N + +V IGDLG A + P + GT E
Sbjct: 165 QILEGLRYLHAQR--IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 132 FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 164
APE L ++YN DI+S G+ + EM+ YP
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YP 253
|
Length = 357 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 9/154 (5%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 72
E+ +LK L+HEN++ V + + ++ E L K +D ++ +
Sbjct: 50 EIRMLKQLRHENLVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF 107
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP 130
QILRG+ + HSHN IIHRD+K +NI V+ +G VK+ D G A + P + T
Sbjct: 108 QILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 131 EFMAPELY--EEEYNELVDIYSFGMCILEMVTCE 162
+ APEL + +Y VDI++ G + EM+T E
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 66/301 (21%), Positives = 126/301 (41%), Gaps = 52/301 (17%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---DTNRTINMITELFTSGSLRQYRK 57
+ P ++ E+ +++ L H+NI+K Y D + +TEL + +++Y +
Sbjct: 40 LTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME 99
Query: 58 -------KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 110
+ + + + + Q+LRGL Y+HS N ++HRDLK N+F+N + +KIG
Sbjct: 100 TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIG 157
Query: 111 DLGLAIVMQQPTARS-----VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTC- 161
D GLA ++ + + T + +P L Y + +D+++ G CI EM+T
Sbjct: 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGK 216
Query: 162 -----------------------EYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQV 195
E NE N + + G L + +P+
Sbjct: 217 PLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEA 276
Query: 196 KQFIEKCIVPASL-RLPALELLKDPFL-VTDNPKD--LVCDPLRLPNLVPEVMNLAHSEP 251
F+E+ + + RL A E L P++ P D + P + + + +++ +
Sbjct: 277 LDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHS 336
Query: 252 H 252
Sbjct: 337 I 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 54/153 (35%), Positives = 81/153 (52%), Gaps = 11/153 (7%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 71
EV LLK+LKH NI+ ++ + T R + ++ E S L+QY N+ M +K +
Sbjct: 53 EVSLLKNLKHANIVTLHD--IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGT 129
Q+LRGL Y H I+HRDLK N+ +N GE+K+ D GLA PT + + T
Sbjct: 110 FQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVT 166
Query: 130 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
+ P+ L EY+ +D++ G + EM T
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 72
E+ +LK LKH N++ V R ++++ E L + K + V IK
Sbjct: 50 EIRMLKQLKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTP 130
Q L+ +++ H HN IHRD+K +NI + G++K+ D G A ++ P + T
Sbjct: 108 QTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 131 EFMAPELY--EEEYNELVDIYSFGMCILEMVT 160
+ APEL + +Y VD+++ G E++T
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 127
+A +I+ GL +LH II+RDLK DN+ ++ G +KI D G+ ++ T +
Sbjct: 101 YAAEIVLGLQFLHERG--IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFC 157
Query: 128 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 165
GTP+++APE L + Y VD ++ G+ + EM+ + P+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 35/166 (21%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA------ 66
E+++L L+H NI+ V I M+ E +H D+K+
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV----------EH---DLKSLMETMK 100
Query: 67 -------IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+K Q+L G+ +LH + I+HRDLK N+ +N N G +KI D GLA
Sbjct: 101 QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYG 157
Query: 120 QPTAR--SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 160
P ++ T + APEL +EY+ +D++S G CI E++T
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 74 ILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPE 131
I++ LHYL H +IHRD+K NI ++ +G VK+ D G++ + A++ G
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 132 FMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA- 185
+MAPE + +Y+ D++S G+ ++E+ T ++PY CK ++ K+ P+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 186 SLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKD 228
++ P F++ C+ + P ELL+ PF+ +
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRK 57
QS +R Y E+ LLK +KHEN+I + + + + ++T L L K
Sbjct: 55 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK 113
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
K D ++ QILRGL Y+HS + IIHRDLK N+ VN + E+KI D GLA
Sbjct: 114 CQKLTD-DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA-- 167
Query: 118 MQQPTARSVIG---TPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCE--YPYNECKN 170
+ T + G T + APE+ YN+ VDI+S G + E++T +P + +
Sbjct: 168 --RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225
Query: 171 PAQIYKKVTSGIKPASLSKVTDPQVKQFIE 200
++ ++ L K++ + +I+
Sbjct: 226 QLKLILRLVGTPGAELLKKISSESARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 38/103 (36%), Positives = 61/103 (59%), Gaps = 7/103 (6%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVI 127
+A QI+ GL +LH I++RDLK +N+ ++ ++G V+I DLGLA+ + +
Sbjct: 100 YAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRA- 155
Query: 128 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 169
GTP +MAPE L E Y+ VD ++ G + EM+ P+ + K
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 13/165 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+S +Q+ L E+ L+ L H NI++ D + ++ EL +L + K K
Sbjct: 37 KSLEQVNNL-REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRK 94
Query: 61 N-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IV 117
+ K +K++ Q+L+ L ++H + I HRD+K +NI + + +K+ D G I
Sbjct: 95 RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKDDI--LKLADFGSCRGIY 150
Query: 118 MQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
+ P I T + APE L + Y +DI++ G E+++
Sbjct: 151 SKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 48/153 (31%), Positives = 78/153 (50%), Gaps = 11/153 (7%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWA 71
E LLK LKH NI+ ++ + T +T+ ++ E + L+QY + M ++ +
Sbjct: 53 EASLLKDLKHANIVTLHD--IIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFL 109
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGT 129
Q+LRGL Y H ++HRDLK N+ ++ GE+K+ D GLA P T + + T
Sbjct: 110 FQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVT 166
Query: 130 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
+ P+ L EY+ +D++ G EM T
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 49/177 (27%), Positives = 92/177 (51%), Gaps = 8/177 (4%)
Query: 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 65
Q++ + E +L L H I+ S+ D+ + + E G L + +K
Sbjct: 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPND 118
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
K + +++ YLHS + II+RDLK +N+ ++ N G VK+ D G A + T +
Sbjct: 119 VAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTF-T 174
Query: 126 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 181
+ GTPE++APE+ + + + + VD ++ G+ + E + P+ + P +IY+K+ +G
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG 230
|
Length = 329 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
SP + + E +++ S+ H ++++ + + + +IT+L G L Y + HK N
Sbjct: 49 SPKANKEILDEAYVMASVDHPHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDN 105
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ + + NW QI +G+ YL ++HRDL N+ V VKI D GLA +
Sbjct: 106 IGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQ-HVKITDFGLA-KLLDV 161
Query: 122 TARSVIGT----P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 160
+ P ++MA E + Y D++S+G+ + E++T
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 54/167 (32%), Positives = 83/167 (49%), Gaps = 26/167 (15%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRT-------INMITELFTSGSLRQYRKKHKN 61
R E+ +L+ KH+NII + D R + ++ +L S L +
Sbjct: 50 RTLRELKILRHFKHDNIIA-----IRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQP 103
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQ 120
+ + I+ + Q+LRGL Y+HS N +IHRDLK N+ VN + E++IGD G+A +
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNE-DCELRIGDFGMARGLSSS 160
Query: 121 PTARSV-----IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMV 159
PT + T + APEL EY +D++S G CI EM+
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 5/162 (3%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
P ++ E+ +L I+ FY ++ D +I M E GSL Q KK +
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIP 101
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
+ + + +++GL YL + I+HRD+K NI VN + GE+K+ D G++ + A
Sbjct: 102 EQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 124 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 164
S +GT +M+PE L Y+ DI+S G+ ++EM YP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 71
E ++ L H N+++ Y V R I ++TE +G L Y ++ K + + +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 129
+ + YL S+ IHRDL N V G + VK+ D GLA ++ Q T+
Sbjct: 107 SDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163
Query: 130 P-EFMAPELYE-EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGI---K 183
P ++ PE+++ ++ D++SFG+ + E+ + + PY N +++ + V++G +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYRLYR 222
Query: 184 PASLSKVTDPQVKQFIEKCIVPASLRLPALELL 216
P K+ +V + C PA + L
Sbjct: 223 P----KLAPTEVYTIMYSCWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 11/153 (7%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWA 71
EV LLK LKH NI+ ++ + T +++ ++ E + L+QY N ++M +K +
Sbjct: 54 EVSLLKDLKHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFL 110
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGT 129
Q+LRGL+Y H ++HRDLK N+ +N GE+K+ D GLA PT + + T
Sbjct: 111 FQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVT 167
Query: 130 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
+ P+ L +Y+ +D++ G EM T
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 55/162 (33%), Positives = 82/162 (50%), Gaps = 16/162 (9%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNW 70
E ++K L+H+ +++ Y V I ++TE + GSL + K K + + + +
Sbjct: 51 EAQIMKKLRHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIG 128
A QI G+ YL S N IHRDL NI V G N KI D GLA +++ TAR
Sbjct: 109 AAQIAEGMAYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAK 165
Query: 129 TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT---CEYP 164
P ++ APE Y + D++SFG+ + E+VT YP
Sbjct: 166 FPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT----SGSLRQYRKKHKNVD 63
+R Y E+ LLK +KHEN+I + + D + ++ + + G+ KH+ +
Sbjct: 59 KRAYRELRLLKHMKHENVIGLLDVFTPDLS--LDRFHDFYLVMPFMGTDLGKLMKHEKLS 116
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
I+ Q+L+GL Y+H+ IIHRDLK N+ VN + E+KI D GLA
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMT 173
Query: 124 RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
V+ T + APE L Y + VDI+S G + EM+T
Sbjct: 174 GYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 14/187 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+ E ++ L H I++ + + ++ EL G L +Y KK +
Sbjct: 35 HIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP---LMLVMELAPLGPLLKYLKKRRE 91
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--- 118
+ + +K A Q+ G+ YL S + +HRDL N+ + N + KI D G++ +
Sbjct: 92 IPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAG 148
Query: 119 -QQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 174
A + P ++ APE + +++ D++S+G+ + E + PY E K ++
Sbjct: 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EV 207
Query: 175 YKKVTSG 181
+ SG
Sbjct: 208 IAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 65
Q++ ++SE +L + H + Y S+ D++ + ++ E G + +++K
Sbjct: 74 QVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRFPND 131
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
+A QI+ YL S N I++RDLK +N+ ++ +G +K+ D G A V+ T +
Sbjct: 132 VGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDTRT-YT 187
Query: 126 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 184
+ GTPE++APE L + + D ++ G+ I E++ P+ P IY+K+ GI
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF-YANEPLLIYQKILEGI-- 244
Query: 185 ASLSKVTDPQVKQFIEKCI 203
K D K ++K +
Sbjct: 245 IYFPKFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 21/159 (13%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVD-------DTNRTINMITELFTSGSLRQYRKKHKN 61
R++ E+ +L KH+N++ S +D D I ++TEL S L + +
Sbjct: 45 RVFRELKMLCFFKHDNVL----SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQP 99
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ +K + QILRGL YLHS I+HRD+K N+ VN +N +KI D GLA V +
Sbjct: 100 LSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPD 156
Query: 122 TARSV---IGTPEFMAPELY--EEEYNELVDIYSFGMCI 155
++ + + T + APE+ Y VDI+S G CI
Sbjct: 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVG-CI 194
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 51/158 (32%), Positives = 78/158 (49%), Gaps = 19/158 (12%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV------DMKA 66
E+ LLK ++H NI++ + V + + + ++ E L KKH + + +
Sbjct: 51 EISLLKEMQHGNIVRLQD--VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRL 103
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 124
IK + QILRG+ Y HSH ++HRDLK N+ ++ +K+ D GLA P T
Sbjct: 104 IKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161
Query: 125 SVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
+ T + APE L Y+ VDI+S G EMV
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 36/171 (21%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTN--------RTINMITE--------LFTSGSLRQYR 56
E+ +L+ L H NI+ D + ++ E L SG L +
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFS 114
Query: 57 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
+ H IK++ +Q+L GL+Y H N +HRD+KC NI +N N G++K+ D GLA
Sbjct: 115 EDH-------IKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLAR 164
Query: 117 VM----QQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 160
+ +P VI T + PEL EE Y +D++S G CIL E+ T
Sbjct: 165 LYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 21/166 (12%)
Query: 9 RLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 65
R + E+ L+ L H NI+K N + ++ I ++ E + L + + ++V +
Sbjct: 52 RTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKR 110
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVM 118
I Q+L+ L Y+HS N +IHRDLK NI +N ++ VK+ D GLA
Sbjct: 111 YI---MYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENP 164
Query: 119 QQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTC 161
+ P + T + APE L Y + VD++S G CIL EM+
Sbjct: 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG-CILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 11/153 (7%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 71
EV LLK LKH NI+ ++ + T++++ ++ E + L+QY N+ M +K +
Sbjct: 54 EVSLLKDLKHANIVTLHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFL 110
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGT 129
QILRGL Y H ++HRDLK N+ +N GE+K+ D GLA PT + + T
Sbjct: 111 YQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVT 167
Query: 130 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
+ P+ L EY+ +D++ G EM +
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 71/243 (29%), Positives = 120/243 (49%), Gaps = 30/243 (12%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRT---INMITELFTSGSLRQYRKKHKNVDMK 65
R+ E+ LL+ L+H +I++ + + + R I ++ EL S L Q K + ++ +
Sbjct: 45 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPE 103
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
+ + Q+LR L Y+H+ N + HRDLK NI N + ++KI D GLA V T +
Sbjct: 104 HHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTA 160
Query: 126 V-----IGTPEFMAPEL---YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
+ + T + APEL + +Y +DI+S G CI V P KN
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKNVVHQLDL 219
Query: 178 VTSGI---KPASLSKVTDPQVKQFI----EKCIVPASLRLP-----ALELLKDPFLVTDN 225
+T + P ++S+V + + ++++ +K VP S + P AL LL+ L+ +
Sbjct: 220 ITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER--LLAFD 277
Query: 226 PKD 228
PKD
Sbjct: 278 PKD 280
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 54/157 (34%), Positives = 84/157 (53%), Gaps = 17/157 (10%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYR---KKHKNVDMKAIKN 69
E+ LLK L+H NI+ + + + +R + +I E F S L++Y K + +D + +K+
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQE-SR-LYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKS 105
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARS 125
+ QIL+G+ + HS ++HRDLK N+ ++ N G +K+ D GLA P T
Sbjct: 106 YLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 126 VIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
V T + APE L Y+ VDI+S G EM T
Sbjct: 163 V--TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 22/161 (13%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT---SGSLRQYRKKHKNV---DMK 65
+E H+L+++ H +II+ ++ T N T L L Y +N+ D+
Sbjct: 132 TEAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYCYLAAKRNIAICDIL 185
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPT 122
AI+ R +LR + YLH IIHRD+K +NIF+N + G+V +GD G A + +
Sbjct: 186 AIE---RSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANK 239
Query: 123 ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCE 162
GT APEL + Y VDI+S G+ + EM TC
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRK 57
QS R Y E+ LLK +KHEN+I + + T+ + ++T L L K
Sbjct: 53 QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK 111
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
K D + ++ Q+LRGL Y+HS IIHRDLK N+ VN + E++I D GLA
Sbjct: 112 CQKLSD-EHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQ 167
Query: 118 MQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQ 173
+ T + APE L YN+ VDI+S G + E++ + +P N+ + +
Sbjct: 168 ADDEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK 226
Query: 174 IYKKVTSGIKPASLSKVTDPQVKQFIE 200
+V P L K++ +++I+
Sbjct: 227 RIMEVVGTPSPEVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
S + L+ L E+ + L+H NI+ + S++ D+ + +++ L GS K H
Sbjct: 38 CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAYGSCEDLLKTHFP 95
Query: 62 VDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM- 118
+ AI + +L L Y+HS IHR +K +I ++G +G+V + L ++ M
Sbjct: 96 EGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSG-DGKVVLSGLRYSVSMI 152
Query: 119 -QQPTARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNE 167
R V P+ ++PE+ ++ YNE DIYS G+ E+ P+ +
Sbjct: 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
Query: 168 CKNPAQIYKKVTSGIKPASLSKVTDPQV 195
Q+ + G P L K T P
Sbjct: 213 MP-ATQMLLEKVRGTVPCLLDKSTYPLY 239
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 51/158 (32%), Positives = 72/158 (45%), Gaps = 28/158 (17%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS--GSLRQYRKKHKNVDMKA---- 66
E+ LL +L+H NI++ V +I ++ E SL +M
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLD--------NMPTPFSE 107
Query: 67 --IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 121
+K Q+LRGL YLH + IIHRDLK N+ + G +KI D GLA P
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKP 164
Query: 122 -TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL 156
T + V T + APEL Y +D+++ G CIL
Sbjct: 165 MTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 44/138 (31%), Positives = 77/138 (55%), Gaps = 11/138 (7%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 127
+A +I GL +LHS II+RDLK DN+ ++ G +KI D G+ + T R+
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFC 162
Query: 128 GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIK 183
GTP+++APE Y + Y + VD ++FG+ + EM+ + P+ + ++ ++++ + +
Sbjct: 163 GTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSY 220
Query: 184 PASLSKVTDPQVKQFIEK 201
P SLSK K + K
Sbjct: 221 PKSLSKEAVSICKGLLTK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 23/198 (11%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMK 65
E E ++K L+H+ +++ Y + I ++TE + GSL + K + + + +
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLP 102
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTA 123
+ + A Q+ G+ Y+ N IHRDL+ NI V G+ KI D GLA +++ + TA
Sbjct: 103 NLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTA 159
Query: 124 RSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 179
R P ++ APE LY + D++SFG+ + E+VT PY N ++ ++V
Sbjct: 160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVE 217
Query: 180 SGIK-------PASLSKV 190
G + P SL ++
Sbjct: 218 RGYRMPCPQDCPISLHEL 235
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 42/134 (31%), Positives = 73/134 (54%), Gaps = 6/134 (4%)
Query: 36 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 95
T + + E G L + + D+ +A +I+ GL +LHS I++RDLK
Sbjct: 67 TKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKL 124
Query: 96 DNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFG 152
DNI ++ +G +KI D G+ ++ + GTP+++APE L ++YN VD +SFG
Sbjct: 125 DNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFG 183
Query: 153 MCILEMVTCEYPYN 166
+ + EM+ + P++
Sbjct: 184 VLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 65/239 (27%), Positives = 112/239 (46%), Gaps = 30/239 (12%)
Query: 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT---INMITELFTSGSLRQYRK--- 57
D E + +E ++L+SL H N++KFY + + ++ EL GS+ + K
Sbjct: 60 DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL 119
Query: 58 -KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
+ +D I L GL +LH N IIHRD+K +NI + G VK+ D G++
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGG-VKLVDFGVSA 176
Query: 117 VMQQPTAR--SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNEC 168
+ R + +GTP +MAPE+ Y+ Y+ D++S G+ +E+ + P +
Sbjct: 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD- 235
Query: 169 KNPAQIYKKVTSGIKPASLSKVTDPQ-----VKQFIEKCIVPASLRLPAL-ELLKDPFL 221
+P + K+ P L P+ FI +C++ P++ LL+ PF+
Sbjct: 236 MHPVKTLFKIPRNPPPTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDM 64
E+ LL+ LKH N+I ++ ++R + ++ + + + KK +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP 121
+K+ QIL G+HYLH++ ++HRDLK NI V G G VKI D+G A + P
Sbjct: 108 SMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 122 TA-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 169
V+ T + APEL Y + +DI++ G E++T E P C+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 47/182 (25%), Positives = 88/182 (48%), Gaps = 12/182 (6%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKA 66
+ E ++ L HE +++ Y V R I ++TE ++G L Y ++H K
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ 101
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 126
+ + + G+ YL S IHRDL N V+ + G VK+ D GL+ + S
Sbjct: 102 LLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSS 158
Query: 127 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
+G+ + PE L +++ D+++FG+ + E+ + + PY N ++ +KV+ G
Sbjct: 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQG 217
Query: 182 IK 183
++
Sbjct: 218 LR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 42/161 (26%), Positives = 82/161 (50%), Gaps = 11/161 (6%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 61
SP E+ E ++++ H +I+K ++ + ++ EL G LR Y + +K
Sbjct: 47 SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PVWIVMELAPLGELRSYLQVNKYS 103
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+D+ ++ ++ Q+ L YL S +HRD+ N+ V+ + VK+GD GL+ ++
Sbjct: 104 LDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDE 160
Query: 122 T--ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEM 158
+ S P ++MAPE + + D++ FG+C+ E+
Sbjct: 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 53/149 (35%), Positives = 80/149 (53%), Gaps = 11/149 (7%)
Query: 17 LKSLKHENIIKFYN-SWVDDTNRTINMITELF--TSGSLRQYRKK--HKNVDMKAIKNWA 71
L++ +H N+++ ++ V T+R + T +F L Y K V + IK+
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTP 130
Q+LRGL +LHSH ++HRDLK NI V ++G++K+ D GLA I Q SV+ T
Sbjct: 117 FQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 131 EFMAPE-LYEEEYNELVDIYSFGMCILEM 158
+ APE L + Y VD++S G EM
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 84/294 (28%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWV-----DDTNRTINMITELFTSGSLRQYR 56
QS +R Y E+ LLK ++HEN+I + + D+ ++ + T L++
Sbjct: 53 QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIM 110
Query: 57 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
+ D ++ Q+L GL Y+HS IIHRDLK N+ VN + E+KI D GLA
Sbjct: 111 GHPLSED--KVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR 165
Query: 117 VMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 174
V+ T + APE L YN+ VDI+S G + EM+T + + Q+
Sbjct: 166 HADAEMTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 224
Query: 175 YK--KVTSGIKPASLSKVTDPQVKQFIEKCIVPA------SLRLP-----ALELLKDPFL 221
+ KVT P + K+ D K +I+ +P S P A++LL + L
Sbjct: 225 TQILKVTGVPGPEFVQKLEDKAAKSYIKS--LPKYPRKDFSTLFPKASPQAVDLL-EKML 281
Query: 222 VTDNPKDLVC---------DPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD 266
D K L D R + E P D L ++K+S D
Sbjct: 282 ELDVDKRLTATEALEHPYFDSFRDADEET--------EQQPYDDSLENEKLSVD 327
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 41/127 (32%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 43 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 102
+ E G L + + D+ +A +I+ GL +LHS II+RDLK DN+ ++
Sbjct: 74 VMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDR 131
Query: 103 NNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159
+G +KI D G+ V A + GTP+++APE+ + +Y VD +SFG+ + EM+
Sbjct: 132 -DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
Query: 160 TCEYPYN 166
+ P++
Sbjct: 191 IGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 13/174 (7%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
E +E +L+K L+H +++ Y T I +ITE +GSL + K + + +
Sbjct: 46 EAFLAEANLMKQLQHPRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPEGIKLTIN 102
Query: 68 K--NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTA 123
K + A QI G+ ++ N IHRDL+ NI V+ KI D GLA I + TA
Sbjct: 103 KLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTA 159
Query: 124 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 174
R P ++ APE + + D++SFG+ + E+VT PY NP I
Sbjct: 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 25/161 (15%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 72
E+ ++ +KHENI+ + +V+ IN++ ++ + L++ + + +K
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGD--FINLVMDIM-ASDLKKVVDRKIRLTESQVKCILL 126
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----------IVMQQP 121
QIL GL+ LH +HRDL NIF+N + G KI D GLA + +
Sbjct: 127 QILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 122 TARSVIGTPE-----FMAPELY--EEEYNELVDIYSFGMCI 155
R T + + APEL E+Y+ VD++S G CI
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 6e-13
Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 23/197 (11%)
Query: 14 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 73
VH L + N IK Y S T + +I + G L KK + +K RQ
Sbjct: 61 VHQLMK-DNPNFIKLYYSV--TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117
Query: 74 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 133
++ L+ LH HN IIH D+K +N+ + + + D GL ++ P+ GT ++
Sbjct: 118 LVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--GTLDYF 173
Query: 134 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPY----NECKNPAQ----IYKKVTSGIKP 184
+PE + Y+ D ++ G+ E++T ++P+ +E + KK+
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP----- 228
Query: 185 ASLSKVTDPQVKQFIEK 201
K F++
Sbjct: 229 --FIKNVSKNANDFVQS 243
|
Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 14/160 (8%)
Query: 13 EVHLLKSLKHEN-IIKFYN-SWVDDTNRTINM-ITELFTSGSLRQY-----RKKHKNVDM 64
E+ LL+ L I++ + V++ N ++ + + L+++ R + +
Sbjct: 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPA 109
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
K IK++ Q+L+G+ + H H ++HRDLK N+ V+ G +KI DLGL P
Sbjct: 110 KTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 125 SV--IGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
I T + APE L Y+ VDI+S G EM
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 52/175 (29%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDM 64
E+ LL+ LKH N+I ++ +R + ++ + + + KK +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP 121
+K+ QIL G+HYLH++ ++HRDLK NI V G G VKI D+G A + P
Sbjct: 108 GMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 122 TA-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 169
V+ T + APEL Y + +DI++ G E++T E P C+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 40/164 (24%), Positives = 84/164 (51%), Gaps = 8/164 (4%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
D++ +E +L++ +H + + T+ + + E G L + + +
Sbjct: 37 DEVAHTVTESRVLQNTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE 94
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPT 122
+ + + +I+ L YLHS + +++RD+K +N+ ++ +G +KI D GL + T
Sbjct: 95 ERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGAT 151
Query: 123 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 165
++ GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 41/140 (29%), Positives = 78/140 (55%), Gaps = 9/140 (6%)
Query: 35 DTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 92
++ + ++ L G L+ Y + ++M+ + +++ QI G+ LH H+ I++RD
Sbjct: 63 ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI--LHLHSMDIVYRD 120
Query: 93 LKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE-LYEEEYNELVDIY 149
+K +N+ ++ + G ++ DLGLA+ ++ + + GT +MAPE L EE Y+ VD +
Sbjct: 121 MKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILKEEPYSYPVDWF 178
Query: 150 SFGMCILEMVTCEYPYNECK 169
+ G I EMV P+ + K
Sbjct: 179 AMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 18 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-----RQYRKKHKNVDMKAIKNWAR 72
+S I+KFY + + + I M EL SL Y + + + A
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICM--ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAV 114
Query: 73 QILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTP 130
++ L+YL IIHRD+K NI ++ NG +K+ D G++ + A++ G
Sbjct: 115 ATVKALNYLKEELK--IIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCR 171
Query: 131 EFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IK 183
+MAPE + Y+ D++S G+ + E+ T ++PY + + +V G I
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231
Query: 184 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPF 220
S + P FI C++ S R ELL+ PF
Sbjct: 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 51/190 (26%), Positives = 91/190 (47%), Gaps = 40/190 (21%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWV--DDTN----RTINMITELFTSGSLRQYR 56
S R +EV L + +I+K + + D N I ++ + +G LRQ
Sbjct: 71 SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ-- 128
Query: 57 KKHKNVDMKAIKNWAR---------------QILRGLHYLHSHNPPIIHRDLKCDNIFVN 101
IK+ A+ Q+L +H++HS + +IHRD+K NI +
Sbjct: 129 ---------EIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL- 176
Query: 102 GNNGEVKIGDLGL----AIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCIL 156
+NG VK+GD G A + R+ GTP ++APE++ + Y++ D++S G+ +
Sbjct: 177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLY 236
Query: 157 EMVTCEYPYN 166
E++T + P++
Sbjct: 237 ELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 46/169 (27%), Positives = 85/169 (50%), Gaps = 9/169 (5%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
+ D++ +E +LK+ +H + S+ T + + E G L + + +
Sbjct: 35 AKDEVAHTLTESRVLKNTRHPFLTSLKYSF--QTKDRLCFVMEYVNGGELFFHLSRERVF 92
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQ 120
+ + +I+ L YLHS I++RDLK +N+ ++ +G +KI D GL +
Sbjct: 93 SEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDA 149
Query: 121 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNE 167
T ++ GTPE++APE+ E+ +Y VD + G+ + EM+ P YN+
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 60/157 (38%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 13 EVHLLKSLK---HENIIKFYNSWVDDTNRTIN--MITELF--TSGSLRQYRKK--HKNVD 63
EV LLK L+ H NI++ + V T+RT +T +F LR Y K +
Sbjct: 49 EVALLKRLEAFDHPNIVRLMD--VCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLP 106
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPT 122
+ IK+ RQ LRGL +LH++ I+HRDLK +NI V + G+VK+ D GLA I Q
Sbjct: 107 AETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMA 163
Query: 123 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 158
V+ T + APE L + Y VD++S G EM
Sbjct: 164 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 56/181 (30%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAI 67
SE+H L + H I+K ++ + D + +I E + G L +Q K+H +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----A 123
QI+ L +HS ++HRDLK NIF+ G +K+GD G + A
Sbjct: 172 GLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 124 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--IYKKVTS 180
S GTP ++APEL+E + Y++ D++S G+ + E++T P+ K P+Q I ++V
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLY 285
Query: 181 G 181
G
Sbjct: 286 G 286
|
Length = 478 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 70/247 (28%)
Query: 13 EVHLLKSLKHENIIKFY---NSWVDDTNR---TINMITELFT---SGSLRQYRKKHKNVD 63
E+ +L+ LKHEN++ + NR + ++ E +G L KNV
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN-----KNVK 115
Query: 64 MK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
IK + +L GL+Y+H + I+HRD+K NI + +G +K+ D GLA
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARAFSLS 172
Query: 122 --------TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT---------- 160
T R V T + PEL E +Y +D++ G CI+ EM T
Sbjct: 173 KNSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWTRSPIMQGNTE 229
Query: 161 ----------C------------EYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 197
C + + + + P +KV +KP V DP
Sbjct: 230 QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDPHALD 285
Query: 198 FIEKCIV 204
I+K +V
Sbjct: 286 LIDKLLV 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 48/166 (28%), Positives = 89/166 (53%), Gaps = 9/166 (5%)
Query: 16 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 75
LLK++KH ++ + S+ T + + + G L + ++ ++ + +A +I
Sbjct: 49 LLKNVKHPFLVGLHYSF--QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 76 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFM 133
L YLHS N I++RDLK +NI ++ + G V + D GL + Q T + GTPE++
Sbjct: 107 SALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYL 163
Query: 134 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
APE + ++ Y+ VD + G + EM+ P+ C++ A++Y +
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 51/188 (27%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 16 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 75
LLK++KH ++ + S+ T + + + G L + ++ + + +A +I
Sbjct: 49 LLKNVKHPFLVGLHFSF--QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 106
Query: 76 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFM 133
L YLHS N I++RDLK +NI ++ + G + + D GL + T + GTPE++
Sbjct: 107 SALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYL 163
Query: 134 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 192
APE L+++ Y+ VD + G + EM+ P+ +N A++Y + + KP L
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILN--KPLQLKPNIT 220
Query: 193 PQVKQFIE 200
+ +E
Sbjct: 221 NSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 11/152 (7%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWA 71
E LLK LKH NI+ ++ + T T+ ++ E + L QY KH + + +K +
Sbjct: 53 EASLLKGLKHANIVLLHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFL 109
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGT 129
Q+LRGL Y+H I+HRDLK N+ ++ + GE+K+ D GLA P T + + T
Sbjct: 110 FQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVT 166
Query: 130 PEFMAPE--LYEEEYNELVDIYSFGMCILEMV 159
+ P+ L EY+ +D++ G +EM+
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 50/160 (31%), Positives = 83/160 (51%), Gaps = 14/160 (8%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 65
E E ++K L+HE +++ Y ++ I ++TE + GSL + K K + +
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLP 102
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTA 123
+ + A QI G+ Y+ N +HRDL+ NI V G N K+ D GLA +++ + TA
Sbjct: 103 QLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTA 159
Query: 124 RSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
R P ++ APE LY + D++SFG+ + E+ T
Sbjct: 160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 34/187 (18%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
S +L L SE +LLK + H ++IK Y + D + +I E GSLR + ++ + V
Sbjct: 43 SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKV 100
Query: 63 D------------------------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 98
M + ++A QI RG+ YL ++HRDL N+
Sbjct: 101 GPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNV 158
Query: 99 FVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGM 153
V ++KI D GL+ + + + RS P ++MA E L++ Y D++SFG+
Sbjct: 159 LV-AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 154 CILEMVT 160
+ E+VT
Sbjct: 218 LLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 39/129 (30%), Positives = 69/129 (53%), Gaps = 5/129 (3%)
Query: 43 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 102
I +L G L + +H K ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 103 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 160
+G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 161 CEYPYNECK 169
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 9/168 (5%)
Query: 16 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 75
LLK+LKH ++ + S+ T + + + G L + ++ + + +A ++
Sbjct: 49 LLKNLKHPFLVGLHYSF--QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106
Query: 76 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFM 133
+ YLHS N II+RDLK +NI ++ + G V + D GL +P T + GTPE++
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYL 163
Query: 134 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
APE L +E Y+ VD + G + EM+ P+ ++ +Q+Y +
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 5/102 (4%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 128
+A +I GL LH I++RDLK +NI ++ + G ++I DLGLA+ + + T R +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVG 163
Query: 129 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK 169
T +MAPE+ + E Y D + G I EM+ + P+ + K
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 11/188 (5%)
Query: 19 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78
+ KH + + + T + + E G L ++ + D + +A ++ L
Sbjct: 52 AAKHPFLTALHCCF--QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL 109
Query: 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE 136
+LH H +I+RDLK DNI ++ G K+ D G+ ++ T + GTP+++APE
Sbjct: 110 MFLHRHG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 137 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDP 193
L E EY VD ++ G+ + EM+ + P+ E N +++ + + P LSK
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVS 225
Query: 194 QVKQFIEK 201
+K F+ K
Sbjct: 226 ILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 52/160 (32%), Positives = 84/160 (52%), Gaps = 14/160 (8%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 65
E E ++K L+H+ ++ Y ++ I ++TE GSL + K+ K + +
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLP 102
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTA 123
+ + A QI G+ Y+ N IHRDL+ NI V G+N KI D GLA +++ + TA
Sbjct: 103 QLVDMAAQIADGMAYIERMN--YIHRDLRAANILV-GDNLVCKIADFGLARLIEDNEYTA 159
Query: 124 RSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
R P ++ APE LY + D++SFG+ + E+VT
Sbjct: 160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 59/236 (25%), Positives = 110/236 (46%), Gaps = 30/236 (12%)
Query: 8 ERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT---INMITELFTSGSL----RQYRKKH 59
E + +E ++LK+L H N++KFY + + + ++ EL GS+ + + K+
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG 118
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+ ++ I + L GL +LH IHRD+K +NI + G VK+ D G++ +
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQLT 175
Query: 120 QPTAR--SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 171
R + +GTP +MAPE+ + Y+ D++S G+ +E+ + P + +P
Sbjct: 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HP 234
Query: 172 AQIYKKVTSGIKPASLSKVTDPQV-----KQFIEKCIVPA-SLRLPALELLKDPFL 221
+ K+ P + P++ FI KC+ R +LL+ F+
Sbjct: 235 MRALFKIPRNPPP----TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM--------ITELFTSGSL 52
+ +++ + +E +L + K E ++K ++ DD + M T L G L
Sbjct: 39 LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVL 98
Query: 53 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 112
+ + +M + LH L IHRDLK +N F+ +G +K+ D
Sbjct: 99 SEDHARFYMAEMFEAVD-------ALHELG-----YIHRDLKPEN-FLIDASGHIKLTDF 145
Query: 113 GLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 164
GL+ IV A SV+G+P++MAPE L + Y+ VD +S G C+L C +P
Sbjct: 146 GLSKGIVTY---ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLG-CMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 12/178 (6%)
Query: 43 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 102
+ E G L + +K + D + +A +I L +LH II+RDLK DN+ ++
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD- 130
Query: 103 NNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 159
+ G K+ D G+ + T + GTP+++APE L E Y VD ++ G+ + EM+
Sbjct: 131 HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML 190
Query: 160 TCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEKCIVPASLRLPALEL 215
P+ E +N +++ + + + P LS+ +K F+ K ++RL +L L
Sbjct: 191 CGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK---NPTMRLGSLTL 244
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWA 71
E LLK LKH NI+ ++ + T T+ + E + L QY +H + ++ +
Sbjct: 53 EASLLKGLKHANIVLLHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFM 109
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGT 129
Q+LRGL Y+H + I+HRDLK N+ ++ GE+K+ D GLA P T S + T
Sbjct: 110 FQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVT 166
Query: 130 PEFMAPE--LYEEEYNELVDIYSFGMCILEMV 159
+ P+ L +Y+ +DI+ G +EM+
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 22/169 (13%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRK 57
Q+ +R Y E+ L+K + H+NII N + + + + ++ EL + +L Q
Sbjct: 54 QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQV-- 110
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
++D + + Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA
Sbjct: 111 IQMDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA-- 165
Query: 118 MQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCIL-EMV 159
+ S + TP + APE + Y E VDI+S G CI+ EM+
Sbjct: 166 --RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/177 (31%), Positives = 85/177 (48%), Gaps = 29/177 (16%)
Query: 7 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 65
L L SE+ ++K + KH+NII + D + +I E + G+LR+Y + + M+
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGME 121
Query: 66 AIKNWAR----------------QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 109
+ AR Q+ RG+ YL S IHRDL N+ V NN +KI
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKI 178
Query: 110 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 160
D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 13 EVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 70
E+ L+ + NI+K Y +D D +++I E T G LR+ K K++ K +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 71 ARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 129
A +GL+ L+ N P +++L + V N ++KI GL ++ P ++V
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVT-ENYKLKIICHGLEKILSSPPFKNV--- 181
Query: 130 PEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 183
FM Y+ EY DIYS G+ + E+ T + P+ +IY + +
Sbjct: 182 -NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNN 239
Query: 184 PASLSKVTDPQVKQFIEKCIVPASLRLPAL 213
L ++K +E C S++ P +
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
|
Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 43 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 102
I +L G L + +H ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 103 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 160
+G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 161 CEYPYNECK 169
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 69/247 (27%), Positives = 118/247 (47%), Gaps = 20/247 (8%)
Query: 16 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 75
LLK++KH ++ + S+ T + + + G L + ++ ++ + +A +I
Sbjct: 49 LLKNVKHPFLVGLHYSF--QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 76 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFM 133
L YLHS N II+RDLK +NI ++ + G V + D GL + T + GTPE++
Sbjct: 107 SALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYL 163
Query: 134 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 192
APE L ++ Y+ VD + G + EM+ P+ ++ A++Y + + KP L
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEMYDNILN--KPLRLKPNIS 220
Query: 193 PQVKQFIEKCIVP-ASLRLPA----LELLKDPFLVTDNPKDLVCDPLRLPNLVPEV---M 244
+ +E + + RL A LE+ F + N DLV + P P V M
Sbjct: 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPP-FNPNVSGPM 279
Query: 245 NLAHSEP 251
+L H +P
Sbjct: 280 DLKHFDP 286
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 27/178 (15%)
Query: 8 ERL--YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 65
ER+ +E ++K ++++ V T+ ++ EL G L+ Y + +
Sbjct: 52 ERIEFLNEASVMKEFNCHHVVRLLGV-VSTGQPTL-VVMELMAKGDLKSYLRSRRPEAEN 109
Query: 66 A----------IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115
A +I G+ YL + +HRDL N V + VKIGD G+
Sbjct: 110 NPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMT 166
Query: 116 --IVMQ---QPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPY 165
I + + ++ P +MAPE L + + D++SFG+ + EM T E PY
Sbjct: 167 RDIYETDYYRKGGKGLL--PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 49/235 (20%)
Query: 25 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84
I+K Y S+ D+ + + ++ E G L + + + + +++ L +H
Sbjct: 63 IVKLYYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------------------------- 118
IHRD+K DNI + +G +K+ D GL M
Sbjct: 121 G--FIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 119 ---QQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKN 170
+Q A S +GTP+++APE L Y D +S G+ + EM+ +P Y++
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFPPFYSD--T 234
Query: 171 PAQIYKKVTSGIKPASLSKVTDPQV----KQFIEKCIVPASLRL-PALELLKDPF 220
+ Y K+ + + SL DP V I + + RL E+ PF
Sbjct: 235 LQETYNKIINWKE--SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 36 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 95
T + + E G L + ++ + + + + ++ +I L+YLH II+RDLK
Sbjct: 67 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKL 124
Query: 96 DNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFG 152
DN+ ++ + G +K+ D G+ +P T + GTP ++APE+ E+Y VD ++ G
Sbjct: 125 DNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 183
Query: 153 MCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASL 208
+ + EM+ P++ NP Q D + +EK I +P SL
Sbjct: 184 VLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYLFQVILEKQIRIPRSL 228
Query: 209 RLPALELLKDPFLVTDNPKDLVCDP 233
+ A +LK FL D + L C P
Sbjct: 229 SVKAASVLKS-FLNKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 44/167 (26%), Positives = 85/167 (50%), Gaps = 8/167 (4%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
D++ +E +L++ +H + S+ T+ + + E G L + + +
Sbjct: 37 DEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSE 94
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPT 122
+ + +I+ L YLHS +++RDLK +N+ ++ +G +KI D GL + T
Sbjct: 95 DRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGAT 152
Query: 123 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNE 167
++ GTPE++APE+ E+ +Y VD + G+ + EM+ P YN+
Sbjct: 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 51/180 (28%), Positives = 93/180 (51%), Gaps = 17/180 (9%)
Query: 10 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT-----ELFTSGSLRQYRKKHKNVDM 64
L +E+ L L HENI+K + N MIT +L++ + K + + +
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTY--MITQKYDFDLYSFMYDEAFDWKDRPL-L 266
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TA 123
K + +Q+L + Y+H +IHRD+K +NIF+N +G++ +GD G A+ ++ A
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC-DGKIVLGDFGTAMPFEKEREA 323
Query: 124 RSV--IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY-PYNE-CKNPAQIYKKV 178
+GT +PE L + Y E+ DI+S G+ +L+M++ ++ P + P + K+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------IVMQQ 120
+++ QIL GL Y+HS N ++HRDLK N+ VN + E+KI D GLA
Sbjct: 107 FQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNA-DCELKICDFGLARGFSENPGENA 163
Query: 121 PTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL 156
+ T + APE L + Y + +D++S G CIL
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 44/154 (28%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWA 71
E ++ S+ H ++++ + + TI ++T+L G L Y +HK N+ + + NW
Sbjct: 59 EALIMASMDHPHLVRLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC 115
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVI 127
QI +G+ YL ++HRDL N+ V N VKI D GLA +++ + A
Sbjct: 116 VQIAKGMMYLEERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGK 172
Query: 128 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 160
++MA E ++ ++ D++S+G+ I E++T
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 11/160 (6%)
Query: 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDM 64
++ E +L+K+L+H+ +++ Y V I +ITE GSL + K + V +
Sbjct: 45 VQAFLEEANLMKTLQHDKLVRLYA--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL 102
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 122
+ +++ QI G+ Y+ N IHRDL+ N+ V+ + KI D GLA V++ + T
Sbjct: 103 PKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYT 159
Query: 123 ARSVIGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVT 160
AR P ++ APE + D++SFG+ + E+VT
Sbjct: 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 22/197 (11%)
Query: 42 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 101
+ E + G L + ++ + + + + ++ +I L++LH II+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 102 GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 158
G +K+ D G+ +P T + GTP ++APE L E+Y VD ++ G+ + EM
Sbjct: 131 A-EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLK 217
+ P++ G+ D + +EK I +P SL + A +LK
Sbjct: 190 MAGRSPFD------------IVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 218 DPFLVTDNPKD-LVCDP 233
FL +PK+ L C P
Sbjct: 238 G-FL-NKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 42/164 (25%), Positives = 84/164 (51%), Gaps = 8/164 (4%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
D++ +E +L++ +H + S+ T+ + + E G L + + +
Sbjct: 37 DEVAHTLTESRVLQNTRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSE 94
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPT 122
+ + +I+ L YLHS + +++RDLK +N+ ++ +G +KI D GL + T
Sbjct: 95 DRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGAT 151
Query: 123 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 165
++ GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 34/100 (34%), Positives = 62/100 (62%), Gaps = 6/100 (6%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 127
+A +I GL +LH II+RDLK DN+ ++ + G +KI D G+ ++ T R+
Sbjct: 106 YAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFC 162
Query: 128 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 166
GTP+++APE+ + Y + VD +++G+ + EM+ + P++
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 36 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 95
T+ + ++T+ + G L + +K K + +++ L +LH ++ I++RDLK
Sbjct: 67 TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKP 124
Query: 96 DNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSF 151
+NI ++ G + + D GL A + T + GT E++APE+ +E Y + VD +S
Sbjct: 125 ENILLDA-TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183
Query: 152 GMCILEMVTCEYPYNECKNPAQIYKKVTSG 181
G+ + EM P+ ++ Q+Y+ + G
Sbjct: 184 GVLVFEMCCGWSPF-YAEDTQQMYRNIAFG 212
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 40/125 (32%), Positives = 74/125 (59%), Gaps = 9/125 (7%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 127
+A +I GL +LHS II+RDLK DN+ ++ + G +KI D G+ + T ++
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFC 162
Query: 128 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP 184
GTP+++APE+ + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYP 221
Query: 185 ASLSK 189
S+SK
Sbjct: 222 KSMSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 52/192 (27%), Positives = 94/192 (48%), Gaps = 16/192 (8%)
Query: 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKN 61
+ E L SE+ ++ L HENI+ + I +ITE G L + RK+
Sbjct: 80 SEREALMSELKIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESF 137
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV-KIGDLGLAIVMQQ 120
+ ++ + +++ Q+ +G+ +L S N IHRDL N+ + +G++ KI D GLA +
Sbjct: 138 LTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLL--THGKIVKICDFGLARDIMN 193
Query: 121 PTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 174
+ V G ++MAPE ++ Y D++S+G+ + E+ + PY ++
Sbjct: 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253
Query: 175 YKKVTSGIKPAS 186
YK + G + A
Sbjct: 254 YKLIKEGYRMAQ 265
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 13/175 (7%)
Query: 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDM 64
+E +E +++K+L+H+ ++K ++ V T I +ITE GSL + K + +
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKL-HAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 101
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 122
+ +++ QI G+ ++ N IHRDL+ NI V+ + KI D GLA V++ + T
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158
Query: 123 ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 174
AR P ++ APE + + D++SFG+ ++E+VT PY NP I
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 16/152 (10%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 128
+A +I GL LH I++RDLK +NI ++ ++G ++I DLGLA+ V + T + +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 129 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 187
T +MAPE+ + E Y D ++ G + EM+ + P+ + K KK IK +
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK------KK----IKREEV 213
Query: 188 SKVTDPQVKQFIEKCIVPASLRLPALELLKDP 219
++ +++ EK P + L + L KDP
Sbjct: 214 ERLVKEVQEEYSEK-FSPDARSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 22/190 (11%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN------- 61
E HL+ + H NI+K + N +I EL G L Y + +
Sbjct: 45 EFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPL 102
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIV 117
+ +K + + + +G YL + IHRDL N V+ + VKIGD GLA
Sbjct: 103 LTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160
Query: 118 MQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNP 171
+ + G +MAPE L + ++ D++SFG+ + E++T + PY N
Sbjct: 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN- 219
Query: 172 AQIYKKVTSG 181
++ + VT+G
Sbjct: 220 QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 36 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 95
T + ++ E G L + ++ + + + + +A +I L++LH II+RDLK
Sbjct: 67 TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKL 124
Query: 96 DNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFG 152
DN+ ++ +G +K+ D G+ P T + GTP ++APE+ EEY VD ++ G
Sbjct: 125 DNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALG 183
Query: 153 MCILEMVTCEYPYN-ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRL 210
+ + EM+ P++ NP D + +EK I +P L +
Sbjct: 184 VLMFEMMAGRSPFDIITDNPDM---------------NTEDYLFQVILEKPIRIPRFLSV 228
Query: 211 PALELLKDPFLVTDNPKDLVCDP 233
A +LK FL D + L C P
Sbjct: 229 KASHVLKG-FLNKDPKERLGCQP 250
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 29/181 (16%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK- 60
+ L L SE+ ++K + KH+NII + D + +I E + G+LR+Y + +
Sbjct: 63 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRP 120
Query: 61 ---------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 105
+ K + + A Q+ RG+ YL S IHRDL N+ V +N
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN- 177
Query: 106 EVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 159
+KI D GLA I + T + ++MAPE L++ Y D++SFG+ + E+
Sbjct: 178 VMKIADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 160 T 160
T
Sbjct: 237 T 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 17/187 (9%)
Query: 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVD 63
++E E ++K +KH N+++ V +ITE T G+L Y + V+
Sbjct: 45 EVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 102
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
+ A QI + YL N IHRDL N V G N VK+ D GL+ +M T
Sbjct: 103 AVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTY 159
Query: 124 RSVIGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVT---CEYPYNECKNPAQIYK 176
+ G ++ APE L +++ D+++FG+ + E+ T YP + +Q+Y+
Sbjct: 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE 216
Query: 177 KVTSGIK 183
+ G +
Sbjct: 217 LLEKGYR 223
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 36/98 (36%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 128
+A +IL GL LH N ++RDLK +NI ++ + G ++I DLGLA+ + + + R +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 129 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 165
T +MAPE L + Y D + G I EM+ + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 44/164 (26%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
SP + + E +++ S+ + ++ + + T+ +IT+L G L Y ++HK N
Sbjct: 49 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDN 105
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--- 118
+ + + NW QI +G++YL ++HRDL N+ V VKI D GLA ++
Sbjct: 106 IGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAD 162
Query: 119 -QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 160
++ A ++MA E + Y D++S+G+ + E++T
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 29/177 (16%)
Query: 7 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---------- 55
L L SE+ L+K + KH+NII + + +I E G+LR++
Sbjct: 61 LADLISEMELMKLIGKHKNIINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 56 ------RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 109
+ + + K + + A Q+ RG+ YL S IHRDL N+ V +N +KI
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKI 175
Query: 110 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 160
D GLA I + T+ + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 176 ADFGLARGVHDIDYYKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 45 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 104
ELFT R++ + ++ + +I+ L +LH II+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTES------EVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDS-E 141
Query: 105 GEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 158
G V + D GL+ A S GT E+MAPE+ +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 159 VTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 201
+T P+ E + ++I +++ P K + + FI+K
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQK 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 7 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM- 64
L L SE+ ++K + KH+NII V + ++ E G+LR + + +
Sbjct: 59 LSDLVSEMEMMKMIGKHKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEY 116
Query: 65 ---------------KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 109
K + ++A Q+ RG+ +L S IHRDL N+ V ++ +KI
Sbjct: 117 ASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMKI 173
Query: 110 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 160
D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 24/114 (21%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------PT 122
+I + Y+HS ++HRDLK DNI + G GEV I D G AI +
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 123 ARS----------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 165
++GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 37/128 (28%), Positives = 74/128 (57%), Gaps = 9/128 (7%)
Query: 39 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 97
++ ++T+L GSL + ++H+ ++D + + NW QI +G++YL H ++HR+L N
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARN 139
Query: 98 IFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTP-EFMAPE-LYEEEYNELVDIYSFG 152
I + ++ V+I D G+A ++ + S TP ++MA E + Y D++S+G
Sbjct: 140 ILLK-SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 153 MCILEMVT 160
+ + EM++
Sbjct: 199 VTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 38/132 (28%), Positives = 72/132 (54%), Gaps = 7/132 (5%)
Query: 50 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 109
G L + ++ D+ + + ++L L LH N +I+RDLK +NI ++ G + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 110 GDLGLAIVMQQPTARS--VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 166
D GL + + ++ GTPE++APEL Y + VD ++ G+ + EM+T P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 167 ECKNPAQIYKKV 178
+ +N ++Y+K+
Sbjct: 195 D-ENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSV 126
ARQ+L + Y+H IIHRD+K +N+ VNG ++ +GD G A + P +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322
Query: 127 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 157
GT + APE L + Y VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRK 57
Q+ +R Y E+ LLK + H+NII N + + + + ++ EL + +
Sbjct: 59 QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-- 116
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
H +D + + Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA
Sbjct: 117 -HMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLART 172
Query: 118 -----MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 171
M P + T + APE + Y E VDI+S G + E+V + +
Sbjct: 173 ACTNFMMTP----YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
Query: 172 AQIYKKVTS-GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 228
Q K + G A P V+ ++E P + EL D +++ +D
Sbjct: 229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN--RPQYPGISFEELFPDWIFPSESERD 284
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 4 PDQLE-RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
P +L+ + SE +LK H NI+K V + I ++ EL G + RKK
Sbjct: 32 PQELKIKFLSEARILKQYDHPNIVKLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDE 89
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ K + +A G+ YL S N IHRDL N V G N +KI D G++ +
Sbjct: 90 LKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLV-GENNVLKISDFGMS-RQEDD 145
Query: 122 TARSVIGTPE----FMAPE-LYEEEYNELVDIYSFGMCILEMVT---CEYPYNECKNPAQ 173
S G + + APE L Y+ D++S+G+ + E + C YP Q
Sbjct: 146 GIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP---GMTNQQ 202
Query: 174 IYKKVTSGIKPASLSKVTDPQVKQFIEKC 202
++V G + + K D V + +++C
Sbjct: 203 AREQVEKGYRMSCPQKCPD-DVYKVMQRC 230
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 29/177 (16%)
Query: 7 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM- 64
L L SE+ ++K + KH+NII + D + ++ E + G+LR+Y + + M
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 65 ---------------KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 109
K + + A Q+ RG+ YL S IHRDL N+ V +N +KI
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMKI 175
Query: 110 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 160
D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 17/192 (8%)
Query: 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 65
Q + SE ++ H NII+ V + +ITE +G+L +Y + H +
Sbjct: 49 QRQDFLSEASIMGQFSHHNIIRLEG--VVTKFKPAMIITEYMENGALDKYLRDHDG-EFS 105
Query: 66 AIK--NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
+ + R I G+ YL N +HRDL NI VN +N E K+ D GL+ V++
Sbjct: 106 SYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPE 162
Query: 124 RSVIGTP-----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 176
+ + + APE + ++ D++SFG+ + E+++ E PY + N ++ K
Sbjct: 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMK 221
Query: 177 KVTSGIK-PASL 187
+ G + PA +
Sbjct: 222 AINDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 45 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 104
ELFT S R+ K+ + ++ ++ +I+ L +LH II+RD+K +NI ++ +N
Sbjct: 91 ELFTHLSQRERFKEQE------VQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SN 141
Query: 105 GEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 158
G V + D GL+ + A S GT E+MAP++ + +++ VD +S G+ + E+
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
Query: 159 VTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL---- 210
+T P+ E + A+I +++ P + K I++ ++ RL
Sbjct: 202 LTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLGCGP 259
Query: 211 -PALELLKDPFLVTDNPKDLVCDPLRLP 237
A E+ K PF N DL + P
Sbjct: 260 SDADEIKKHPFFQKINWDDLAAKKVPAP 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 26/169 (15%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------- 59
E LL +L+HE+I+KFY D + M+ E G L ++ + H
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 114
Query: 60 ---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
+ + + + A QI G+ YL S + +HRDL N V G N VKIGD G++
Sbjct: 115 QAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSR 171
Query: 117 VMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 160
+ V G +M PE + ++ D++SFG+ + E+ T
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 49/215 (22%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV-DMKAIKN 69
+E ++ L+H N+++ V++ + ++TE GSL Y R + ++V +
Sbjct: 48 AEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVI 127
++ + + YL ++N +HRDL N+ V+ +N K+ D GL Q T + +
Sbjct: 107 FSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPV 163
Query: 128 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 186
++ APE L E++++ D++SFG+ + E+ Y + P K V ++
Sbjct: 164 ---KWTAPEALREKKFSTKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVPRVEKGY 216
Query: 187 LSKVTD---PQVKQFIEKCIVPASLRLPALELLKD 218
D P V +++C + P+ L++
Sbjct: 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 28/203 (13%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
S D + E LL + +HENI+KFY + M+ E G L ++ + H
Sbjct: 46 TASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHG 103
Query: 61 NVDMKAIKN--------------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 106
A QI G+ YL S + +HRDL N V G +
Sbjct: 104 PDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLV 160
Query: 107 VKIGDLGLAIVMQQPTARSVIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
VKIGD G++ + V G +M PE +Y + E D++SFG+ + E+ T
Sbjct: 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFT 219
Query: 161 C-EYPYNECKNPAQIYKKVTSGI 182
+ P+ N ++ + +T G
Sbjct: 220 YGKQPWYGLSN-EEVIECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 4/87 (4%)
Query: 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE 139
H H+ II+RDLK +NI ++ G +K+ D GL+ + + A S GT E+MAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 140 EE-YNELVDIYSFGMCILEMVTCEYPY 165
+ + D +SFG+ + EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 77/308 (25%), Positives = 129/308 (41%), Gaps = 56/308 (18%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENII----KFYNSWV--DDTNRTINMITELF---TSGS 51
+Q P R E+ ++K+L H NII +Y ++ N +N++ E
Sbjct: 100 LQDPQYKNR---ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKY 156
Query: 52 LRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 111
++ Y + + + + +K ++ Q+ R L Y+HS I HRDLK N+ ++ N +K+ D
Sbjct: 157 MKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD 214
Query: 112 LGLAI-VMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNEC 168
G A ++ + S I + + APEL Y +D++S G I EM+ YP
Sbjct: 215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSG 273
Query: 169 KN--------------PAQIYKKVTS---------GIKPASLSKV----TDPQVKQFIEK 201
++ P + K + +KP L KV T FI +
Sbjct: 274 QSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQ 333
Query: 202 CIVPASL-RLPALELLKDPFLVTDNPKDLVCDP-LRLPNLV---PEVMNLAHSEPHPMDI 256
+ L RL +E L DPF D + DP ++LP + P++ N +E M
Sbjct: 334 FLKYEPLKRLNPIEALADPFF------DDLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSD 387
Query: 257 DLNHKKVS 264
K +
Sbjct: 388 ACRRKIIP 395
|
Length = 440 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 50/170 (29%), Positives = 74/170 (43%), Gaps = 14/170 (8%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV 62
PD + E +LK H NI+K V + I ++ EL GSL + RKK +
Sbjct: 33 PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKNRL 90
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 122
+K + + G+ YL S N IHRDL N V G N +KI D G++ +
Sbjct: 91 TVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLV-GENNVLKISDFGMSREEEGGI 147
Query: 123 ARSVIGTPE----FMAPE-LYEEEYNELVDIYSFGMCILEMVT---CEYP 164
G + + APE L Y D++S+G+ + E + YP
Sbjct: 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 71
E+ +LK++ H II +++ T+ M+ + L Y + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVI 127
R++L L YLH IIHRD+K +NIF++ +GD G A + P
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 128 GTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158
GT E +PEL + Y DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 128
+A ++ GL L I++RDLK +NI ++ + G ++I DLGLA+ + + T R +G
Sbjct: 107 YAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVG 163
Query: 129 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 169
T +MAPE + E+Y D + G I EM+ + P+ + K
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 44/216 (20%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
M +Q+ + +E +L ++K + S+ D R + +I E G + K
Sbjct: 39 MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKD 96
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ +A + + + + + +H IHRD+K DN+ ++ G VK+ D GL +++
Sbjct: 97 TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKK 153
Query: 121 --------------PT-----------------------ARSVIGTPEFMAPELYEEE-Y 142
P+ A S +GTP+++APE++ + Y
Sbjct: 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY 213
Query: 143 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
N+L D +S G+ + EM+ YP + P + Y+KV
Sbjct: 214 NKLCDWWSLGVIMYEMLI-GYPPFCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 44/216 (20%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
M +Q+ + +E +L ++K + S+ D N + +I E G + K
Sbjct: 39 MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKD 96
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ + + + + + + +H IHRD+K DN+ ++ + G VK+ D GL +++
Sbjct: 97 TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKK 153
Query: 121 --------------PT-----------------------ARSVIGTPEFMAPELYEEE-Y 142
P+ A S +GTP+++APE++ + Y
Sbjct: 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY 213
Query: 143 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
N+L D +S G+ + EM+ YP + P + YKKV
Sbjct: 214 NKLCDWWSLGVIMYEMLI-GYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 48/184 (26%), Positives = 72/184 (39%), Gaps = 16/184 (8%)
Query: 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 65
Q R E L L H NI+ +S + E +LR+ +
Sbjct: 21 QRARFRRETALCARLYHPNIVALLDSGEAPPGLLF-AVFEYVPGRTLREVLAADGALPAG 79
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGL--------- 114
Q+L L +HN I+HRDLK NI V+ K+ D G+
Sbjct: 80 ETGRLMLQVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137
Query: 115 AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 173
A V V+GTP + APE L E D+Y++G+ LE +T + + + A+
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RVVQGASVAE 196
Query: 174 IYKK 177
I +
Sbjct: 197 ILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 41/146 (28%), Positives = 77/146 (52%), Gaps = 21/146 (14%)
Query: 78 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 134
+H LH +HRD+K DNI ++ NG +++ D G + +M+ T +S +GTP++++
Sbjct: 118 VHQLH-----YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 135 PELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----P 184
PE+ + +Y D +S G+C+ EM+ E P+ ++ + Y K+ + + P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFP 230
Query: 185 ASLSKVTDPQVKQFIEKCIVPASLRL 210
A ++ V++ K I + I RL
Sbjct: 231 AQVTDVSE-DAKDLIRRLICSREHRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 45/196 (22%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
+Q+++++ E +L ++ ++ + S+ +T R + M+ E G K + +
Sbjct: 43 NQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLKNIGALPV 100
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV------- 117
+ + + + L YLH++ I+HRDLK DN+ + + G +K+ D GL+ +
Sbjct: 101 DMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTT 157
Query: 118 ----------MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPY 165
++ + V GTPE++APE + + Y + VD ++ G+ + E +V C +
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217
Query: 166 NECKNPAQIYKKVTSG 181
+ P +++ +V S
Sbjct: 218 GD--TPEELFGQVISD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 23/179 (12%)
Query: 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------- 59
E EV +L L NI + D + MI E +G L Q+ +KH
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 60 ----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115
K++ + A QI G+ YL S N +HRDL N V G N +KI D G++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLV-GKNYTIKIADFGMS 177
Query: 116 IVMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 167
+ V G +MA E + ++ D+++FG+ + E++T C E PY
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 21/224 (9%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYR 56
Q+ +R Y E+ L+K + H+NII N + + + + ++ EL + + +
Sbjct: 54 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ 113
Query: 57 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
+ +D + + Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA
Sbjct: 114 ME---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA- 166
Query: 117 VMQQPTARSVIGTP-----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 170
+ S + TP + APE + Y E VDI+S G + EMV + +
Sbjct: 167 ---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 171 PAQIYKKVTS-GIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 213
Q K + G K P V+ ++E A L P L
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 25/191 (13%)
Query: 10 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------- 59
+ E LL +L+HE+I+KFY V+ + M+ E G L ++ + H
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 60 ---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
+ + + A+QI G+ YL S + +HRDL N V G N VKIGD G++
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSR 168
Query: 117 VMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN 170
+ V G +M PE + ++ D++S G+ + E+ T + P+ + N
Sbjct: 169 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
Query: 171 PAQIYKKVTSG 181
++ + +T G
Sbjct: 229 -NEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 40/144 (27%), Positives = 78/144 (54%), Gaps = 17/144 (11%)
Query: 81 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPE 136
+HS H +HRD+K DN+ ++ NG +++ D G + M Q T +S +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 137 LYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----PAS 186
+ + +Y D +S G+C+ EM+ E P+ ++ + Y K+ + + P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHEERFQFPSH 232
Query: 187 LSKVTDPQVKQFIEKCIVPASLRL 210
++ V++ + K I++ I RL
Sbjct: 233 ITDVSE-EAKDLIQRLICSRERRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 39/128 (30%), Positives = 68/128 (53%), Gaps = 9/128 (7%)
Query: 39 TINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 97
T+ ++T+L G L Y +++K+ + + + NW QI +G+ YL ++HRDL N
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARN 139
Query: 98 IFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIG--TP-EFMAPE-LYEEEYNELVDIYSFG 152
+ V N VKI D GLA ++ T G P ++MA E + + D++S+G
Sbjct: 140 VLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198
Query: 153 MCILEMVT 160
+ + E++T
Sbjct: 199 VTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 43/195 (22%), Positives = 87/195 (44%), Gaps = 43/195 (22%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG----SLRQYR 56
M ++++R+ +E +L +L H + Y T + ++ + + G L Q R
Sbjct: 39 MIKRNKVKRVLTEQEILATLDHPFLPTLY--ASFQTETYLCLVMD-YCPGGELFRLLQ-R 94
Query: 57 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA- 115
+ K + + + +A ++L L YLH I++RDLK +NI ++ +G + + D L+
Sbjct: 95 QPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHE-SGHIMLSDFDLSK 151
Query: 116 ----------------------------IVMQQPTAR--SVIGTPEFMAPELYEEE-YNE 144
++P+ R S +GT E++APE+ + +
Sbjct: 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS 211
Query: 145 LVDIYSFGMCILEMV 159
VD ++ G+ + EM+
Sbjct: 212 AVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 35/135 (25%), Positives = 72/135 (53%), Gaps = 8/135 (5%)
Query: 36 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 95
T +++I + + G + + + N ++ ++ +I+ L +LH I++RD+K
Sbjct: 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKL 133
Query: 96 DNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYS 150
+NI ++ + G V + D GL+ + ++ S GT E+MAPE+ + + + VD +S
Sbjct: 134 ENILLD-SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS 192
Query: 151 FGMCILEMVTCEYPY 165
G+ I E++T P+
Sbjct: 193 LGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 43/180 (23%), Positives = 90/180 (50%), Gaps = 12/180 (6%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA 66
E E ++ L H +++ Y V + + ++TE +G L Y R++ +
Sbjct: 44 EDFIEEAKVMMKLSHPKLVQLYG--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM 101
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 124
+ + + + G+ YL ++ IHRDL N V+ + G VK+ D G+ ++ + T+
Sbjct: 102 LLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSS 158
Query: 125 SVIGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 181
S P ++ PE++ +Y+ D++SFG+ + E+ T + P+ E K+ ++ + ++ G
Sbjct: 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 20/168 (11%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRK 57
Q+ +R Y E+ L+K + H+NII N + + + + ++ EL + + +
Sbjct: 62 QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 121
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
+ +D + + Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA
Sbjct: 122 E---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA-- 173
Query: 118 MQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMV 159
+ S + TP + APE + Y E VDI+S G + EM+
Sbjct: 174 --RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 36/149 (24%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 25 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84
+++ + ++ DD + + M+ E G L + +V K K + +++ L +HS
Sbjct: 105 VVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM 161
Query: 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE 141
+IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 142 -----YNELVDIYSFGMCILEMVTCEYPY 165
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 47/219 (21%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
M +Q+ + +E +L + ++K Y S+ D+ + +I E G + K
Sbjct: 39 MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY--LYLIMEYLPGGDMMTLLMKKD 96
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL------ 114
+ + + + + + +H IHRD+K DN+ ++ G +K+ D GL
Sbjct: 97 TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKK 153
Query: 115 ------------------AIVMQQPT----------------ARSVIGTPEFMAPELYEE 140
+ +P A S +GTP+++APE++ +
Sbjct: 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213
Query: 141 E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
YN+ D +S G+ + EM+ YP NP + Y+K+
Sbjct: 214 TGYNKECDWWSLGVIMYEMLV-GYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 23/173 (13%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------N 61
E+ ++ LK NII+ + + MITE +G L Q+ +H+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ + A QI G+ YL S N +HRDL N V G N +KI D G++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSG 183
Query: 122 -----TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 167
R+V+ + ++ D+++FG+ + E++T C E PY++
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL---AIVMQQPTARSVIGT 129
+I L +LH II+RDLK +NI ++ G VK+ D GL +I T + GT
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVT-HTFCGT 163
Query: 130 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS 186
E+MAPE L + + VD +S G + +M+T P+ +N + K+ G P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPY 222
Query: 187 LSKVTDPQVKQFIEK 201
L+ P+ + ++K
Sbjct: 223 LT----PEARDLLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------- 59
E LL L+H++I++FY + R + M+ E G L ++ + H
Sbjct: 57 EAELLTVLQHQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV 114
Query: 60 --KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
+ + + A QI G+ YL S + +HRDL N V G VKIGD G++
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRD 171
Query: 118 MQQPTARSVIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 160
+ V G +M PE LY + E DI+SFG+ + E+ T
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDM 64
Q SE ++ H NII V +R + +ITE +G+L + R+ +
Sbjct: 48 QRRDFLSEASIMGQFDHPNIIHLEG--VVTKSRPVMIITEFMENGALDSFLRQNDGQFTV 105
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---- 120
+ R I G+ YL N +HRDL NI VN +N K+ D GL+ ++
Sbjct: 106 IQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSD 162
Query: 121 PTARSVIGTP---EFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 170
PT S +G + APE + ++ D++S+G+ + E M E PY + N
Sbjct: 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---------RKKHKNVD 63
E+ + + L H+N+++ + MI E G L+Q+ + K +
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQP- 121
K QI G+ +L + +HRDL N V+ EVK+ L L+ V
Sbjct: 116 TKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEY 172
Query: 122 -TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN 170
R+ + ++APE + E++++ D++SFG+ + E+ T E P+ +
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 64/273 (23%), Positives = 94/273 (34%), Gaps = 79/273 (28%)
Query: 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------------------------- 118
H IHRD+K DNI ++ +G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 119 --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 157
Q+ A S++GTP ++APE+ Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 158 MVTCEYPYNECKNPAQIYKKV-----TSGIKP-ASLSKVTDPQVKQFIEKCIVPASLRL- 210
M+ + P+ PA+ KV T I A LS + I + A RL
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS----REASDLILRLCCGAEDRLG 291
Query: 211 --PALELLKDPFLVTDNPKDLVCDPLRLP-NLVPEVMNLAHSEPHPMDIDLNHKKVSADS 267
A E+ PF D R +P++ HP D N V +
Sbjct: 292 KNGADEIKAHPFFKG---IDFASLIRRQKAPYIPKIT-------HPTDTS-NFDPVDPEK 340
Query: 268 CAKSNTG---TWFLTLELQR-LTENN--EFTLR 294
++G R TE+ EFT R
Sbjct: 341 LRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFR 373
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 16/169 (9%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA 66
E E ++ L H +++ Y V I ++ E G L Y R + +
Sbjct: 44 EDFIEEAQVMMKLSHPKLVQLYG--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQET 101
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 126
+ + G+ YL S N +IHRDL N V G N VK+ D G+ + S
Sbjct: 102 LLGMCLDVCEGMAYLESSN--VIHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSS 158
Query: 127 IGTP---EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP 171
GT ++ +PE++ +Y+ D++SFG+ + E+ ++E K P
Sbjct: 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 36/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 25 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84
+++ + ++ DD R + M+ E G L + +V K + + +++ L +HS
Sbjct: 105 VVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM 161
Query: 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE 141
IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 142 -----YNELVDIYSFGMCILEMVTCEYPY 165
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMK 65
+ +E ++ +L+H N+++ + + ++TE GSL Y R + + V
Sbjct: 44 AQAFLAEASVMTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITL 101
Query: 66 A-IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPT 122
A +A + G+ YL N +HRDL N+ V+ + K+ D GLA Q +
Sbjct: 102 AQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDS 158
Query: 123 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 158
+ + ++ APE L E++++ D++SFG+ + E+
Sbjct: 159 GKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 24/173 (13%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------NVD 63
E+ ++ LK+ NII+ V D + MITE +G L Q+ + + N+
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 64 MKAIKN---WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+I N A QI G+ YL S N +HRDL N V GN+ +KI D G++ +
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV-GNHYTIKIADFGMSRNLYS 181
Query: 121 PTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYN 166
+ G +MA E + ++ D+++FG+ + EM T C E PY+
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 13/177 (7%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNW 70
+E ++ H NII+ V +R + +ITE +GSL ++ R+ + +
Sbjct: 54 TEASIMGQFDHPNIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM 111
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSV 126
R I G+ YL N +HRDL NI VN +N K+ D GL+ ++ T +
Sbjct: 112 LRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGG 168
Query: 127 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKNPAQIYKKVTSG 181
+ APE + ++ D++SFG+ + E M E PY + N + K V G
Sbjct: 169 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 33/182 (18%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD--------- 63
EV +L LK NII+ VD+ + MITE +G L Q+ H D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 64 ----------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 113
++ + A QI G+ YL S N +HRDL N V G N +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLV-GENLTIKIADFG 183
Query: 114 LAIVM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE--MVTCEYPY 165
++ + + R+V+ +MA E + ++ D+++FG+ + E M+ E PY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 166 NE 167
E
Sbjct: 243 GE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 22/181 (12%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS-GSLRQYRKKHKN 61
S Q+ L E LL L H+NI+ + ++D + + + G+L+ + ++ +
Sbjct: 48 SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP--FVLYPYMNWGNLKLFLQQCRL 105
Query: 62 VDM---KAIK-----NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 113
+ +A+ + A QI G+ YLH +IH+D+ N ++ +VKI D
Sbjct: 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNA 162
Query: 114 LAIVMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYN 166
L+ + P +G E +MA E L +EY+ D++SFG+ + E++T + PY
Sbjct: 163 LSRDLF-PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221
Query: 167 E 167
E
Sbjct: 222 E 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 19/179 (10%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
+ + L+ L +EV L +H NI+ + V T + +I+ GS K +
Sbjct: 39 TEEHLKALQNEVVLSHFFRHPNIMTSWT--VFTTGSWLWVISPFMAYGSANSLLKTYFPE 96
Query: 63 DMKA--IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG--LAIVM 118
M I N LRGL+YLH + IHR++K +I ++G+ G V + L ++V
Sbjct: 97 GMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVR 153
Query: 119 QQPTARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNE 167
A+ V P+F ++PEL ++ YN DIYS G+ E+ T P+ +
Sbjct: 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNW 70
SE ++ H NII V ++ + ++TE +GSL + +KH + +
Sbjct: 54 SEASIMGQFDHPNIIHLEG--VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARS 125
R I G+ YL +HRDL NI VN +N K+ D GL+ V++ T R
Sbjct: 112 LRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRG 168
Query: 126 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 170
+ APE + ++ D++S+G+ + E M E PY E N
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 15/108 (13%)
Query: 70 WAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ---QPT 122
WAR +++ L +HS IHRD+K DN+ ++ +G +K+ D G + M
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVR 199
Query: 123 ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPY 165
+ +GTP++++PE+ + Y D +S G+ + EM+ + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 81 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAPE 136
+HS H +HRD+K +N+ ++ G +K+ D G A + + ++ +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 137 LYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 189
+ Y D +S G+ EM+ P++E A+ Y + + L
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQRFLKF 230
Query: 190 VTDPQV----KQFIEKCIVPASLRLPALELLKDPF 220
DP+V I+ + RL L PF
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGT-- 129
Q+ G+ +L S N +HRDL N+ + VKI D GLA +M+ S T
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 130 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 186
P ++MAPE ++ Y L D++SFG+ + E+ T PY E Q Y + G + A
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK 363
Query: 187 LSKVTDPQVKQFIEKC 202
+ +D ++ + ++KC
Sbjct: 364 PAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 21/146 (14%)
Query: 78 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 134
+H L +HRD+K DN+ ++ NG +++ D G + ++ T +S +GTP++++
Sbjct: 118 VHQLG-----YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 135 PELYEE------EYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASL 187
PE+ + Y D +S G+C+ EM+ E P Y E + + Y K+ + +
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQF 229
Query: 188 -SKVTD--PQVKQFIEKCIVPASLRL 210
VTD + K I + I RL
Sbjct: 230 PPDVTDVSEEAKDLIRRLICSPETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 49/178 (27%), Positives = 70/178 (39%), Gaps = 28/178 (15%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKH 59
P + E L+ L+H NI+ V + M+ E G L ++ H
Sbjct: 48 EPKVQQEFRQEAELMSDLQHPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPH 105
Query: 60 KNV-------------DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 106
+V D + A QI G+ YL SH+ +HRDL N V G
Sbjct: 106 SDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLT 162
Query: 107 VKIGDLGLAIVMQQPTARSVIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEM 158
VKI D GL+ + V +M PE LY + E DI+SFG+ + E+
Sbjct: 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 44/192 (22%), Positives = 81/192 (42%), Gaps = 36/192 (18%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-------VDMK 65
E ++ H+NI++ + R I + EL G L+ + ++++ + MK
Sbjct: 59 EALIMSKFNHQNIVRLIGVSFERLPRFI--LLELMAGGDLKSFLRENRPRPERPSSLTMK 116
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTA 123
+ AR + +G YL ++ IHRD+ N + G KI D G+A
Sbjct: 117 DLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMA-------- 166
Query: 124 RSVIGTP------------EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY-PYNECK 169
R + ++M PE + + + D++SFG+ + E+ + Y PY
Sbjct: 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
Query: 170 NPAQIYKKVTSG 181
N ++ + VT G
Sbjct: 227 N-QEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 40/175 (22%), Positives = 83/175 (47%), Gaps = 14/175 (8%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKN 69
E ++ L H+N+++ + + + ++ EL + G+L + + V + +
Sbjct: 48 EETAVMTKLHHKNLVRLLGVIL---HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 129
++ + G+ YL S ++HRDL NI V+ +G K+ D GLA V S +
Sbjct: 105 FSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPV 161
Query: 130 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 183
++ APE L ++++ D++S+G+ + E+ + Y P K+V ++
Sbjct: 162 -KWTAPEALKHKKFSSKSDVWSYGVLLWEV----FSYGRAPYPKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 48/187 (25%), Positives = 78/187 (41%), Gaps = 13/187 (6%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV 62
PD + E +LK H NI++ V + I ++ EL G + R + +
Sbjct: 34 PDLKAKFLQEARILKQYSHPNIVRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGPRL 91
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 122
+K + G+ YL S + IHRDL N V N +KI D G++ +
Sbjct: 92 KVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNV-LKISDFGMSREEEDGV 148
Query: 123 ARSVIGTPE----FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 176
S G + + APE L Y+ D++SFG+ + E + PY N Q +
Sbjct: 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-QQTRE 207
Query: 177 KVTSGIK 183
+ G++
Sbjct: 208 AIEQGVR 214
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 132
Q+ RG+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229
Query: 133 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 160
MAPE ++++ Y D++SFG+ + E+ +
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 37/153 (24%), Positives = 80/153 (52%), Gaps = 10/153 (6%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
E E+ +L++LK ENI++ ++ + ++ E L + V + +
Sbjct: 45 ETTLRELKMLRTLKQENIVELKEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV 102
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-- 125
+++ Q+++ +H+ H ++ I+HRD+K +N+ ++ N+ +K+ D G A + + + +
Sbjct: 103 RSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYT 159
Query: 126 -VIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 156
+ T + +PE L Y + VD++S G CIL
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 130
Q+ RG+ +L S N +HRDL N+ + VKI D GLA + + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 131 --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 186
++MAPE +++ Y L D++S+G+ + E+ + PY + Y K+ SG + A
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361
Query: 187 LSKVTDPQVKQFIEKCIVPASLRLPALELLKD 218
T +V + KC + P+ L D
Sbjct: 362 PDHATQ-EVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 132
Q+ RG+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230
Query: 133 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 160
MAPE ++++ Y D++SFG+ + E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 39/173 (22%), Positives = 62/173 (35%), Gaps = 22/173 (12%)
Query: 70 WA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 127
WA Q L L LH L + + +G V + +S
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLK-LDGSV----------AFKTPEQS-R 65
Query: 128 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 186
P FMAPE+ + Y E DIYS G+ + E + E PYNE + + I + + +G +
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG--MPA 123
Query: 187 LSKVTDPQVKQFIEKCIVPASLRLPALELLK---DPFLVTDNPKDLVCDPLRL 236
++ +RL A L + + + L + L L
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 26/144 (18%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 132
Q+ +G+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235
Query: 133 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 178
MAPE +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295
Query: 179 TSGIKPASLSKVTDPQVKQFIEKC 202
G + + T P++ Q + C
Sbjct: 296 KEGTRMRA-PDYTTPEMYQTMLDC 318
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 24/194 (12%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
+PD+ EV + L H N+++ ++ ++ E G L+ Y R
Sbjct: 35 TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLLVLEFCPLGDLKNYLRSNRGM 92
Query: 62 VDMKA----IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
V A ++ A ++ GL +LH + IH DL N + + VKIGD GLA+
Sbjct: 93 VAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALE 149
Query: 118 MQQP----TARSVIGTPEFMAPELYEEEYNELV--------DIYSFGMCILEMVT-CEYP 164
T ++APEL E +L+ +I+S G+ + E+ T + P
Sbjct: 150 QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
Query: 165 YNECKNPAQIYKKV 178
Y + + Q+ K+V
Sbjct: 210 YPDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 17/143 (11%)
Query: 71 ARQILR-------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
++Q+L+ G+ YL IHRDL N+ V G N KI D GL+ +
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVK 174
Query: 124 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVT 179
+++ P +MA E L Y D++SFG+ + E+V+ PY C A++Y+K+
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY--CGMTCAELYEKLP 232
Query: 180 SGIKPASLSKVTDPQVKQFIEKC 202
G + + D +V + + +C
Sbjct: 233 QGYR-MEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
D+ IK RQ+L GL LH I+HRD+K +N+ V +G+VKI D G A+ M
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 22/173 (12%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
S + + E +SL+H N+++ + T + M E G L+ Y + +
Sbjct: 35 SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVM--EFCPLGDLKGYLRSCRKA 92
Query: 63 -----DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
D ++ A +I GL +LH +N IH DL N + + VKIGD GL+
Sbjct: 93 ELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADL-TVKIGDYGLSHN 149
Query: 118 MQQP----TARSVIGTPEFMAPELYEEEYNELV--------DIYSFGMCILEM 158
+ T + ++APEL +E + L+ +++S G+ I E+
Sbjct: 150 KYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 9/122 (7%)
Query: 42 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 101
++ EL G L ++ +K+K+V K I Q+ G+ YL N +HRDL N+ +
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV 129
Query: 102 GNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 155
+ KI D GL+ + A++ P ++ APE + +++ D++SFG+ +
Sbjct: 130 TQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
Query: 156 LE 157
E
Sbjct: 189 WE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 32/123 (26%)
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----- 119
K I+ RQIL L LHS I+HRD+K NI + +G KI DLG A ++
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312
Query: 120 QPTARSVIGTPEFMAPE-----------------------LYEEEYNELVDIYSFGMCIL 156
P + + P + APE L++ + DIYS G+ L
Sbjct: 313 IP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 157 EMV 159
+M
Sbjct: 371 QMA 373
|
Length = 566 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 17/143 (11%)
Query: 71 ARQILR-------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
++Q+L G+ YL IHRDL NI V G N KI D GL+ +
Sbjct: 111 SQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVK 167
Query: 124 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVT 179
+++ P +MA E L Y D++S+G+ + E+V+ PY C A++Y+K+
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLP 225
Query: 180 SGIKPASLSKVTDPQVKQFIEKC 202
G + D +V + +C
Sbjct: 226 QGYR-LEKPLNCDDEVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 33/132 (25%), Positives = 51/132 (38%), Gaps = 51/132 (38%)
Query: 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----------------------------- 114
H IHRD+K DNI ++ +G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 115 --------------------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 153
A Q+ A S++GTP ++APE L Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 154 CILEMVTCEYPY 165
+ EM+ + P+
Sbjct: 237 ILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 78 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
L YLH H IIHRDLK DN+ ++ N G +K+ D GL+ V
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 76/353 (21%), Positives = 134/353 (37%), Gaps = 80/353 (22%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
+Q+ + +E +L +E ++K Y S+ D N + + + G + + +
Sbjct: 43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMEVFPE 100
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----- 119
+ + ++ + +H IHRD+K DNI ++ +G +K+ D GL +
Sbjct: 101 VLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNS 157
Query: 120 --------------QPT------------------------------ARSVIGTPEFMAP 135
+P+ A S++GTP ++AP
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP 217
Query: 136 E-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT---SGIKPASLSKVT 191
E L + Y +L D +S G+ + EM+ + P+ P + KV + + K++
Sbjct: 218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPPF-LAPTPTETQLKVINWENTLHIPPQVKLS 276
Query: 192 DPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAH 248
P+ I K A RL A ++ PF + D D P P V ++
Sbjct: 277 -PEAVDLITKLCCSAEERLGRNGADDIKAHPFF---SEVDFSSDIRTQP--APYVPKIS- 329
Query: 249 SEPHPMDIDLNHKKVSADS----CAKSNTGTW-FLTLELQRLTENN--EFTLR 294
HPMD N V +S + +T TW L + E+ EFT R
Sbjct: 330 ---HPMDTS-NFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFR 378
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 16/140 (11%)
Query: 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 129
+A + RG+ YL IHRDL NI V G N KI D GL+ + +++
Sbjct: 129 FAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGRL 185
Query: 130 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGI--- 182
P +MA E L Y D++S+G+ + E+V+ PY C A++Y+K+ G
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYRLE 243
Query: 183 KPASLSKVTDPQVKQFIEKC 202
KP + D +V + +C
Sbjct: 244 KPLN----CDDEVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 43/170 (25%), Positives = 78/170 (45%), Gaps = 23/170 (13%)
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-- 118
+ ++ + + I G+ YL S N IHRDL N +N N V + D GL+ +
Sbjct: 109 TLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADFGLSKKIYS 165
Query: 119 ----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPA 172
+Q A + +++A E L + Y D+++FG+ + E++T + PY +N +
Sbjct: 166 GDYYRQGCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-S 222
Query: 173 QIYKKVTSGIK----PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 218
+IY + G + P L V + + +C P P+ + L+D
Sbjct: 223 EIYNYLIKGNRLKQPPDCLEDVYE-----LMCQCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 37/168 (22%), Positives = 72/168 (42%), Gaps = 22/168 (13%)
Query: 20 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQIL 75
L+H NI++ V+ ++ E G L+ Y + +N + ++ A +I
Sbjct: 52 LQHPNILQCLGQCVEAI--PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109
Query: 76 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPE 131
G+ ++H HN +H DL N F+ + VK+GD G+ + T
Sbjct: 110 AGVTHMHKHN--FLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 132 FMAPELYEEEYNELV--------DIYSFGMCILEMVTC-EYPYNECKN 170
++APEL E + L+ ++++ G+ + E+ PY+ +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
+ + + L E+H+ K H NI+ + +++ D + ++T GS + H
Sbjct: 39 TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMD 96
Query: 63 DMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL--GLAIVM 118
M AI + +L+ L Y+H +HR +K +I ++ +G+V + L L+++
Sbjct: 97 GMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISV-DGKVYLSGLRSNLSMIN 153
Query: 119 QQPTARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNEC 168
R V P++ ++PE+ ++ Y+ DIYS G+ E+ P+ +
Sbjct: 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213
Query: 169 KNPA-QIYKKVTSGIKPASLSKVTDP 193
PA Q+ + +G P L T P
Sbjct: 214 --PATQMLLEKLNGTVPCLLDTTTIP 237
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 45/228 (19%), Positives = 88/228 (38%), Gaps = 56/228 (24%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
M DQL + +E +L ++ Y S+ D + + +I E G L K+
Sbjct: 39 MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYD 96
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI---- 116
+ + + + + +H IHRD+K DNI ++ G +K+ D GL+
Sbjct: 97 TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHK 153
Query: 117 ---------VMQQPTAR------------------------------------SVIGTPE 131
++Q + + S +GTP+
Sbjct: 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213
Query: 132 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
++APE++ ++ Y + D +S G + E + +P +N + Y+K+
Sbjct: 214 YIAPEIFLQQGYGQECDWWSLGAIMFECL-IGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 568 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.66 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.64 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.62 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.6 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.56 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.54 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.53 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.49 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.49 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.36 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.33 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.33 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.31 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.29 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.06 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.06 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.78 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.77 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.68 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.63 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.58 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.55 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.55 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.51 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.35 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.32 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.25 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.68 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.61 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.56 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.41 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.3 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.97 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.84 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.69 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.63 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.6 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.45 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.27 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.15 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 95.69 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 94.66 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 92.58 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.47 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 91.31 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 91.3 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 91.07 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 90.14 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 89.48 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 89.44 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 88.74 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 86.57 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 86.08 | |
| PLN02236 | 344 | choline kinase | 85.34 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 84.74 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 84.63 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 83.95 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 83.59 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 83.54 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 83.2 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 82.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 81.34 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 81.23 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 80.2 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-83 Score=685.74 Aligned_cols=370 Identities=59% Similarity=0.960 Sum_probs=315.3
Q ss_pred CCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 1 lqs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+|+|+++++|+.|+++|+.|+|||||+||++|++..+++++||+|++++|+|+.|++++++++.++++.|++||+.||.|
T Consensus 79 ~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~y 158 (632)
T KOG0584|consen 79 TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVY 158 (632)
T ss_pred hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhh
Confidence 48899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHHHHHHhh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmlt 160 (568)
||++.||||||||||+||||+|..|.|||||+|||+.++...+++++|||+|||||+|+..|++.+||||||||++||+|
T Consensus 159 LHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 159 LHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred hhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhcCCCCCCCCCCC-------cccCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD-------LVCDP 233 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~~p~~Rpsa~ElL~hpff~~~~~~~-------l~~~~ 233 (568)
+++||++|.++++||+++++|++|..+.++.+|++++||++||...+.|+|+.|||+||||..+..-. .....
T Consensus 239 ~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~ 318 (632)
T KOG0584|consen 239 SEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPA 318 (632)
T ss_pred ccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccccccchhhccccc
Confidence 99999999999999999999999999999999999999999999899999999999999999864310 00000
Q ss_pred --CCCCCCchhhhccCCCCCCCCCcccccccccc--ccccCCCCCccchhHHHhhhccCCceeeccccCCCC-ceEEEEE
Q 008378 234 --LRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSA--DSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDD-TVSLTLR 308 (568)
Q Consensus 234 --l~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~e~~~~~~~~~~~~~g~~~~~~-~i~L~Lr 308 (568)
+.+..........+......++.+.+...... +.-.....-.+-...++.|..+++.+.++|+++++. .++|.||
T Consensus 319 ~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~ 398 (632)
T KOG0584|consen 319 LSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELR 398 (632)
T ss_pred ccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEee
Confidence 01111111111111111112222221111000 000011111222346677888899999999999766 9999999
Q ss_pred ecCCCCCcceeeeecccCCCCHhHHHHHHHHccCCCCcCHHHHHHHHHHHHHHhCCCCCCCC
Q 008378 309 IGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSL 370 (568)
Q Consensus 309 i~d~~g~~r~I~F~F~~~~Dta~~vA~EmV~~~~~~~~d~~~iA~~i~~~i~~l~~~~~~~~ 370 (568)
|++++|+.|||+|||++..|||.+||.|||+++.+++++|..||+|||.+|.+|+|.|+...
T Consensus 399 i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~~ 460 (632)
T KOG0584|consen 399 IADEDGLVRNIHFPFDLEGDTAPSVAHEMVEELEITDQPVVNIAEMIDGEISALVPNWKAST 460 (632)
T ss_pred ccCCCCCcccccCCCcCCCcchhHHHHHHHhhcCCcccchhhHHHHHhchhhhcCCccCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=387.57 Aligned_cols=220 Identities=29% Similarity=0.531 Sum_probs=201.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++...+++.+|+++++.++|||||+||++|+.... .++++||||++|+|.+++++.++++|..+.+++.+|++||.|||
T Consensus 117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh 195 (364)
T KOG0581|consen 117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLH 195 (364)
T ss_pred CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 46677899999999999999999999999998765 79999999999999999999999999999999999999999999
Q ss_pred h-CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccccc-CCCccceehhhHHHHHHHhh
Q 008378 83 S-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 83 s-~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~-~ys~ksDIWSLGiilyEmlt 160 (568)
. ++ ||||||||.|||+| ..|.|||||||.+..+.+..+.+++||..|||||.+.+ .|+.++||||||+.++||++
T Consensus 196 ~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~ 272 (364)
T KOG0581|consen 196 EERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI 272 (364)
T ss_pred hccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhh
Confidence 5 77 99999999999998 78999999999999998888899999999999998854 69999999999999999999
Q ss_pred cCCCCCCC----CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 161 CEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 161 G~~Pf~~~----~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
|++||... .+..+++..|..+.+|......+++++++||.+||+ +|++|+++.||+.|||+++...
T Consensus 273 GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 273 GRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 99999763 467788888888877765555699999999999996 6999999999999999986543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=390.55 Aligned_cols=221 Identities=28% Similarity=0.494 Sum_probs=193.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
..++.+.+|++.|+.++||||+++|.+|+.+. .+|+||.|+.+|++.++++.. ..++|..|+.+++++++||.|||
T Consensus 66 ~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH 143 (516)
T KOG0582|consen 66 NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH 143 (516)
T ss_pred hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH
Confidence 45889999999999999999999999998765 799999999999999999875 35999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----Cc-ccccCCCCccCcccc---ccCCCccceehhhHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TA-RSVIGTPEFMAPELY---EEEYNELVDIYSFGM 153 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----~~-~s~~GTp~YmAPEvl---~~~ys~ksDIWSLGi 153 (568)
.+| .||||||+.||||+ .+|.|||+|||.+..+-.. .. ++++|||+|||||++ -.+|+.|+|||||||
T Consensus 144 ~~G--~IHRdvKAgnILi~-~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGI 220 (516)
T KOG0582|consen 144 QNG--HIHRDVKAGNILID-SDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGI 220 (516)
T ss_pred hcC--ceecccccccEEEc-CCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhH
Confidence 999 99999999999997 8999999999987654221 12 677999999999995 356999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIK-------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~-------p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
++.||++|..||........+..+++...+ +....+..+..++++|..||+ +|.+||||.++|+|+||+...
T Consensus 221 TA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 221 TACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 999999999999998888888888776544 222334567789999999996 699999999999999999988
Q ss_pred CCCcc
Q 008378 226 PKDLV 230 (568)
Q Consensus 226 ~~~l~ 230 (568)
.+...
T Consensus 301 ~~~~~ 305 (516)
T KOG0582|consen 301 SKEYL 305 (516)
T ss_pred chhhc
Confidence 76643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=373.92 Aligned_cols=214 Identities=26% Similarity=0.392 Sum_probs=187.9
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
..+.+|+++|++|+|||||+++++|..++ ..||||||++||+|.+.+-.++.+.+..-+-+++|++.|+.|||+.|
T Consensus 221 ~~v~~EieILkkL~HP~IV~~~d~f~~~d--s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G-- 296 (475)
T KOG0615|consen 221 RDVQNEIEILKKLSHPNIVRIKDFFEVPD--SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG-- 296 (475)
T ss_pred hhhHHHHHHHHhcCCCCEEEEeeeeecCC--ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--
Confidence 34679999999999999999999987664 67999999999999999999999999999999999999999999999
Q ss_pred eEeeeccCCcEEEeCC--CCcEEEeecChhhhccC-CCcccccCCCCccCcccccc----CCCccceehhhHHHHHHHhh
Q 008378 88 IIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 88 IiHRDLKp~NILl~~~--~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl~~----~ys~ksDIWSLGiilyEmlt 160 (568)
|+||||||+|||++.+ +-.+||+|||+|+..+. ...++.||||.|.|||++.. .|..++||||+||++|-+++
T Consensus 297 I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs 376 (475)
T KOG0615|consen 297 IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS 376 (475)
T ss_pred cccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec
Confidence 9999999999999722 25799999999998854 45678999999999999843 24569999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~el~~lI~kcL-~~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|.+||++......+.+.|..|..+. ..+..++.++++||..|| ++|.+||++.|+|+||||+...
T Consensus 377 G~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 377 GYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred cCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 9999998766666888888885532 345567899999999999 5999999999999999998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=363.43 Aligned_cols=227 Identities=26% Similarity=0.462 Sum_probs=202.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+....|..+|.+++||+||+++.+|++.+ .+|||+||+.||.|+.++++.+.|++..++.|+.+|+.||.|||++
T Consensus 67 ~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~--kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~ 144 (357)
T KOG0598|consen 67 KEVRHTKAERNILSKIKHPFIVKLIYSFQTEE--KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK 144 (357)
T ss_pred hhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC
Confidence 46788999999999999999999999998765 6999999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
| ||||||||+|||++ .+|+++|+||||++.-- .....+++||++|||||++ ..+|+.++|+||||+++|||++|
T Consensus 145 g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G 221 (357)
T KOG0598|consen 145 G--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTG 221 (357)
T ss_pred C--eeeccCCHHHeeec-CCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhC
Confidence 9 99999999999998 89999999999998543 2345678999999999977 67899999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC----CHHHHhcCCCCCCCCCCCcccCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL----PALELLKDPFLVTDNPKDLVCDPLRL 236 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp----sa~ElL~hpff~~~~~~~l~~~~l~~ 236 (568)
..||.+ .+...++++|..+.. ...+...+++++++|.++|. +|.+|. .+.++-.||||...+|+.+....+..
T Consensus 222 ~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~P 299 (357)
T KOG0598|consen 222 KPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSP 299 (357)
T ss_pred CCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCC
Confidence 999987 567888888887752 33556689999999999996 799995 68899999999999999887766654
Q ss_pred CC
Q 008378 237 PN 238 (568)
Q Consensus 237 p~ 238 (568)
|.
T Consensus 300 pF 301 (357)
T KOG0598|consen 300 PF 301 (357)
T ss_pred Ce
Confidence 43
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=380.57 Aligned_cols=216 Identities=34% Similarity=0.582 Sum_probs=195.4
Q ss_pred CCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 1 lqs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
|+.+.+.+++.+||++.++|+|||||+||++|.|.. ++|||.|+|..|+|..++++.+.++|.+++.+++||+.||.|
T Consensus 56 l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~--nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkY 133 (592)
T KOG0575|consen 56 LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN--NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKY 133 (592)
T ss_pred hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC--ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHH
Confidence 467888999999999999999999999999997665 799999999999999999999999999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
||+++ |||||||..|+|++ .+-+|||||||||+.+... ...+.||||-|+|||++ ..+++..+||||+||+||-
T Consensus 134 LH~~~--IiHRDLKLGNlfL~-~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYt 210 (592)
T KOG0575|consen 134 LHSLG--IIHRDLKLGNLFLN-ENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYT 210 (592)
T ss_pred HHhcC--ceecccchhheeec-CcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHh
Confidence 99999 99999999999998 6779999999999988644 45678999999999988 5679999999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|++|++||.. .+..+.+.+|..... .++...++++++||.++|. +|.+|||++++|.|+||...
T Consensus 211 LL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 211 LLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred hhhCCCCccc-chHHHHHHHHHhcCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 9999999975 567888888876532 3455789999999999996 69999999999999999543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=348.85 Aligned_cols=227 Identities=28% Similarity=0.502 Sum_probs=204.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
++.+...+|.++|+.+.||+++++++.|.+.. .+||||||.+||.|+.|+++.++|++..++.++.||+.||+|||++
T Consensus 86 KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~--~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~ 163 (355)
T KOG0616|consen 86 KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS--NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL 163 (355)
T ss_pred HHHHHHhhHHHHHhhccCceeEEEEEeeccCC--eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc
Confidence 57788999999999999999999999887654 7999999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCC
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
+ |++|||||+|||++ .+|.+||.|||+|+..... ..+.||||.|+|||++ ..+|+.++|+|+||+++|||+.|..
T Consensus 164 ~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r-T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~p 239 (355)
T KOG0616|consen 164 D--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR-TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYP 239 (355)
T ss_pred C--eeeccCChHHeeec-cCCcEEEEeccceEEecCc-EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 9 99999999999998 8999999999999887655 6678999999999977 6779999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCC-----CCHHHHhcCCCCCCCCCCCcccCCCCCC
Q 008378 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR-----LPALELLKDPFLVTDNPKDLVCDPLRLP 237 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~R-----psa~ElL~hpff~~~~~~~l~~~~l~~p 237 (568)
||.. .++.++|.+|..+.- .++...++++++||+++|+ +-++| ....++..||||+...|..+....+..|
T Consensus 240 PF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P 316 (355)
T KOG0616|consen 240 PFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPP 316 (355)
T ss_pred CCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCC
Confidence 9987 567899999988743 4677889999999999995 66777 3577999999999999998877777777
Q ss_pred CCc
Q 008378 238 NLV 240 (568)
Q Consensus 238 ~~~ 240 (568)
..+
T Consensus 317 ~~p 319 (355)
T KOG0616|consen 317 FEP 319 (355)
T ss_pred CCC
Confidence 654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=368.99 Aligned_cols=216 Identities=33% Similarity=0.612 Sum_probs=193.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+-+.+|+.+|+.++|+|||+|+++|... ..+|+||||++||+|.+.+.+.. ++|.+|+.++++++.||+|||.+
T Consensus 312 ~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVVMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~ 388 (550)
T KOG0578|consen 312 PKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVVMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHAR 388 (550)
T ss_pred CchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEEEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhc
Confidence 3456789999999999999999999988766 46999999999999999888755 99999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
| |||||||.+|||+. .+|.+||+|||++..+.. ....+.+|||.|||||++ +..|++++||||||++++||+-|
T Consensus 389 g--IiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG 465 (550)
T KOG0578|consen 389 G--IIHRDIKSDNILLT-MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG 465 (550)
T ss_pred c--eeeeccccceeEec-cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC
Confidence 9 99999999999996 889999999999987643 356788999999999988 55799999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
++||...+....++..-+.|.+....+...++++++|+.+||+ ++.+|++|.|||.||||+.+.+
T Consensus 466 EPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 466 EPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred CCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 9999876666777877788877777788899999999999995 8999999999999999965543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=353.33 Aligned_cols=217 Identities=33% Similarity=0.547 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+.+.+|+++|++|+|||||++++.........++++|||+++|+|.+++.+.+ .|++..++.+++||+.||+|||++|
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g 137 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG 137 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 677999999999999999999999633222246899999999999999999988 7999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-----CCcccccCCCCccCccccccCCCc--cceehhhHHHHHHH
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-----PTARSVIGTPEFMAPELYEEEYNE--LVDIYSFGMCILEM 158 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-----~~~~s~~GTp~YmAPEvl~~~ys~--ksDIWSLGiilyEm 158 (568)
++||||||+|||++..+|.+||+|||++..... .....+.|||.|||||++..++.. ++|||||||++.||
T Consensus 138 --~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM 215 (313)
T KOG0198|consen 138 --IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEM 215 (313)
T ss_pred --EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEec
Confidence 999999999999984368999999999987652 224467999999999998755444 99999999999999
Q ss_pred hhcCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 159 VTCEYPYNE-CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 159 ltG~~Pf~~-~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
+||..||.+ ......++........| .++...++++++||.+|++ +|..||||.+||.|||.+....
T Consensus 216 ~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 216 LTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred cCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999987 34444455555555334 6778899999999999996 7999999999999999987543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=341.81 Aligned_cols=208 Identities=32% Similarity=0.518 Sum_probs=185.3
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL 78 (568)
+.+..+.+.+|+.+|++|+|||||+||+.-+.+++..+++|||||.+|+|.+.++. ++.++++.+++++.|++.||
T Consensus 58 d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL 137 (375)
T KOG0591|consen 58 DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRAL 137 (375)
T ss_pred cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHH
Confidence 45677889999999999999999999994445566679999999999999998874 45799999999999999999
Q ss_pred HhhhhCCCC--eEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc-ccCCCccceehhhHH
Q 008378 79 HYLHSHNPP--IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEEYNELVDIYSFGM 153 (568)
Q Consensus 79 ~yLHs~g~~--IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGi 153 (568)
..+|+.-+. |+||||||.|||++ .+|.|||+||||++.+... .+++++|||.||+||++ +.+|+.++||||+||
T Consensus 138 ~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGC 216 (375)
T KOG0591|consen 138 YHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGC 216 (375)
T ss_pred HHHhccccccceeeccCcchheEEc-CCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHH
Confidence 999994444 99999999999998 7899999999999998654 46789999999999977 678999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
++|||+.-+.||.+. +-.++.++|.++..|+-+...++..++.+|..|+. ++..||+.
T Consensus 217 llyEMcaL~~PF~g~-n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 217 LLYEMCALQSPFYGD-NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHhcCCCcccc-cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 999999999999885 88999999999977765667889999999999995 79999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=346.84 Aligned_cols=218 Identities=27% Similarity=0.517 Sum_probs=190.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+++..+.+.+|+.+|+.++|||||.+++...+.+ ++|||||||+||+|.+|+++++.+++..++.++.||+.||++||
T Consensus 49 ~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~--~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~ 126 (429)
T KOG0595|consen 49 NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD--FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH 126 (429)
T ss_pred CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC--eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5678899999999999999999999999876554 89999999999999999999999999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCC--C---CcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGN--N---GEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~--~---g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
+++ ||||||||+|||++.. . -.+||+|||+|+.+... .+.+.+|+|-|||||++ .++|+.|+|+||+|+|+
T Consensus 127 ~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Il 204 (429)
T KOG0595|consen 127 ENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTIL 204 (429)
T ss_pred HCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHH
Confidence 999 9999999999999743 1 46899999999998754 46688999999999988 78899999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|+|++|+.||... ++.++...+..+.. ...++...++..++++-..|+ ++..|.+..+-+.|+|+....
T Consensus 205 yq~l~g~~Pf~a~-t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 205 YQCLTGKPPFDAE-TPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHHHhCCCCcccc-CHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 9999999999874 56667767766543 334555566777788877775 799999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=357.72 Aligned_cols=219 Identities=27% Similarity=0.482 Sum_probs=194.8
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+.+.+|-.+|.+| .||.||++|..|.|+. .+|||+||+++|+|.+||++.+.|++..++.++.||+.||+|||+
T Consensus 115 ~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~--sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~ 192 (604)
T KOG0592|consen 115 KKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE--SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS 192 (604)
T ss_pred cccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh
Confidence 4556778899999999 8999999999998876 699999999999999999999999999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-------------C--cccccCCCCccCccccccC-CCccce
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------------T--ARSVIGTPEFMAPELYEEE-YNELVD 147 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-------------~--~~s~~GTp~YmAPEvl~~~-ys~ksD 147 (568)
+| ||||||||+|||++ .+|++||.|||-|+.+... . ..+++||..|.+||++..+ .+..+|
T Consensus 193 ~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sD 269 (604)
T KOG0592|consen 193 NG--IIHRDLKPENILLD-KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSD 269 (604)
T ss_pred cC--ceeccCChhheeEc-CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccc
Confidence 99 99999999999998 7899999999999876321 1 2468999999999999654 688999
Q ss_pred ehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 148 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 148 IWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
||+||||+|+|+.|.+||.+ .+.-.++++|..- .-.++...++.+++||+++|+ +|+.|+++.+|..||||...+|
T Consensus 270 iWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 270 LWALGCILYQMLAGQPPFRA-ANEYLIFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred hHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 99999999999999999987 5677788887754 334667778999999999996 7999999999999999999999
Q ss_pred CCccc
Q 008378 227 KDLVC 231 (568)
Q Consensus 227 ~~l~~ 231 (568)
+.+.+
T Consensus 347 ~nlw~ 351 (604)
T KOG0592|consen 347 ENLWQ 351 (604)
T ss_pred hhhhh
Confidence 88643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.60 Aligned_cols=212 Identities=28% Similarity=0.589 Sum_probs=186.9
Q ss_pred HHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+.+|+.++ ||||+++++++.... .+|+|||||.||+|.+++.+.+++.+..++++++||+.|++|||++
T Consensus 62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~--~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~ 139 (370)
T KOG0583|consen 62 LDELIKREISILRRLRSHPNIIRLLEVFATPT--KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR 139 (370)
T ss_pred cchhhHHHHHHHHHhccCCCEeEEEEEEecCC--eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC
Confidence 3456778999999999 999999999887665 4999999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccccc-C-C-CccceehhhHHHHHHHh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYEE-E-Y-NELVDIYSFGMCILEMV 159 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~~-~-y-s~ksDIWSLGiilyEml 159 (568)
| |+||||||+|||++...+.+||+|||++.... ....++.+|||.|+|||++.+ . | +.++||||+|+++|.|+
T Consensus 140 g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml 217 (370)
T KOG0583|consen 140 G--IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL 217 (370)
T ss_pred C--EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence 9 99999999999998443999999999999883 456778999999999999854 4 6 47899999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC-cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~-s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+|.+||.. .+...++.++..+... ++... +++++.+|.+||+ +|.+|+++.+++.||||+..
T Consensus 218 ~G~~PF~d-~~~~~l~~ki~~~~~~--~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 218 CGRLPFDD-SNVPNLYRKIRKGEFK--IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred hCCCCCCC-ccHHHHHHHHhcCCcc--CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 99999987 5566667777766332 44445 9999999999996 69999999999999999974
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.19 Aligned_cols=213 Identities=26% Similarity=0.537 Sum_probs=192.4
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
+...+.+||-+|+.+.||||+++|++|... ..+|+|.||++||.|++|+.++|++++..++++++||+.|+.|||..+
T Consensus 55 ~~~~IerEIviMkLi~HpnVl~LydVwe~~--~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~ 132 (786)
T KOG0588|consen 55 QPAGIEREIVIMKLIEHPNVLRLYDVWENK--QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN 132 (786)
T ss_pred cccchhhhhHHHHHhcCCCeeeeeeeeccC--ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 456789999999999999999999999654 579999999999999999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc-CCCcccccCCCCccCccccc-cCC-CccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYE-EEY-NELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~-~~~~~s~~GTp~YmAPEvl~-~~y-s~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|+|++ ..+.+||+|||.|.... .....+.||+|.|.|||++. +.| +.++||||.|+|+|.|+||.
T Consensus 133 --icHRDLKpENlLLd-~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~ 209 (786)
T KOG0588|consen 133 --ICHRDLKPENLLLD-VKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGK 209 (786)
T ss_pred --ceeccCCchhhhhh-cccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCC
Confidence 99999999999998 56679999999997654 44567889999999999874 445 67999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL-~~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
.||.+ .|...+..++.+|... ++..+++++++||.+|| ++|..|.|..|+++|||+.....
T Consensus 210 LPFdD-dNir~LLlKV~~G~f~--MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 210 LPFDD-DNIRVLLLKVQRGVFE--MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred CCCCC-ccHHHHHHHHHcCccc--CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 99985 7899999999998653 56788999999999999 69999999999999999987543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.64 Aligned_cols=225 Identities=24% Similarity=0.447 Sum_probs=194.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
..++++.++.|..+|...++|+||++|.+|++.. ++||||||++||++..++.+.+.|++..++.|+.+++.|++.||
T Consensus 181 ~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~--~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH 258 (550)
T KOG0605|consen 181 KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE--YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH 258 (550)
T ss_pred hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC--eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH
Confidence 4578899999999999999999999999998765 79999999999999999999999999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-------------------------C----------------
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-------------------------P---------------- 121 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-------------------------~---------------- 121 (568)
++| +|||||||+|+||+ ..|++||.||||++-+.. +
T Consensus 259 ~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (550)
T KOG0605|consen 259 QLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQ 335 (550)
T ss_pred HcC--cccccCChhheeec-CCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHH
Confidence 999 99999999999998 899999999999852200 0
Q ss_pred --------CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CC
Q 008378 122 --------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KV 190 (568)
Q Consensus 122 --------~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~ 190 (568)
.+.+++|||.|||||++ ..+|+..+|+||||||+|||+.|.+||.. .++.+.+++|......-.++ ..
T Consensus 336 ~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~ 414 (550)
T KOG0605|consen 336 TWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVD 414 (550)
T ss_pred HHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCc
Confidence 01246899999999987 56799999999999999999999999987 56888888877643222222 23
Q ss_pred CcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCCCcccCC
Q 008378 191 TDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDLVCDP 233 (568)
Q Consensus 191 ~s~el~~lI~kcL~~p~~Rps---a~ElL~hpff~~~~~~~l~~~~ 233 (568)
.++++++||.+||.+|.+|.. +.|+.+||||+..+|..+...+
T Consensus 415 ~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~ 460 (550)
T KOG0605|consen 415 LSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLREMP 460 (550)
T ss_pred ccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhhcCC
Confidence 469999999999999999985 8899999999999998865433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=338.53 Aligned_cols=209 Identities=35% Similarity=0.592 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k--~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+..+.|.+|+.+|++|+|||||+|++++..... .+.+||||+++|+|.+++.+ .+.++...+..|+.||+.|+.|||
T Consensus 81 ~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH 159 (362)
T KOG0192|consen 81 ESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH 159 (362)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 337799999999999999999999998865542 68899999999999999988 578999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCC-cEEEeecChhhhccC--CCcccccCCCCccCccccccC---CCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g-~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl~~~---ys~ksDIWSLGiily 156 (568)
++++ ||||||||+|||++ ..+ ++||+|||+++.... .......||+.|||||++.+. |+.++|||||||++|
T Consensus 160 ~~~~-iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlW 237 (362)
T KOG0192|consen 160 SEGP-IIHRDLKSDNILVD-LKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLW 237 (362)
T ss_pred cCCC-eeecccChhhEEEc-CCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHH
Confidence 9986 99999999999998 565 999999999987765 334457899999999999754 999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
||+||+.||.+... .++...+..+.....++...++.+..+|..||. +|..||+..+++.
T Consensus 238 El~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 238 ELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999998766 555555543334444566689999999999995 7999999988764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.86 Aligned_cols=222 Identities=23% Similarity=0.448 Sum_probs=189.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.....++.+|+.+|+.++||||++++++|... ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+
T Consensus 36 ~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~ 113 (323)
T cd05571 36 KDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS 113 (323)
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45567788999999999999999999988654 4799999999999999999998899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++ .+|.+||+|||+++.... ......+||+.|+|||++ ...|+.++|||||||++|||+|
T Consensus 114 ~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 190 (323)
T cd05571 114 CD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190 (323)
T ss_pred CC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhc
Confidence 99 99999999999997 788999999999875422 223456899999999988 4568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcccCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDP 233 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~~~~ 233 (568)
|..||.. .+...+...+..+. ..++...++++++||.+||. +|.+|| ++.++++||||...++..+....
T Consensus 191 g~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~ 266 (323)
T cd05571 191 GRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKK 266 (323)
T ss_pred CCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence 9999976 44555666665442 23556678999999999996 799999 89999999999987776554333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=329.00 Aligned_cols=218 Identities=25% Similarity=0.460 Sum_probs=189.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+++.+|+.+|++++||||++++++|.+. ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 60 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 137 (329)
T PTZ00263 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137 (329)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567889999999999999999999998765 47999999999999999999988999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCC
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
| |+||||||+|||++ .+|.+||+|||++...... .....||+.|+|||++. ..++.++|||||||++|+|++|..
T Consensus 138 ~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 213 (329)
T PTZ00263 138 D--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDR-TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213 (329)
T ss_pred C--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCCC-cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCC
Confidence 9 99999999999997 7899999999999765432 23567999999999874 558999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCccc
Q 008378 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVC 231 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~ 231 (568)
||.+ .++..++..+..+.. .++...++.+++||.+||. +|.+|++ +.+++.||||...++..+..
T Consensus 214 pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~ 284 (329)
T PTZ00263 214 PFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYA 284 (329)
T ss_pred CCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence 9976 456667777766543 2455678999999999996 7999987 79999999999877665443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=341.46 Aligned_cols=214 Identities=29% Similarity=0.509 Sum_probs=190.5
Q ss_pred CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+++++++.+.+|+++++.|+|||||.++++|... ..+|+|+|||.| +|+.++...+.++|+.++.++.|++.||.||
T Consensus 40 r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~--~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yL 116 (808)
T KOG0597|consen 40 RNEKELKNLRQEVRILRSLKHPNIVEMLESFETS--AHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYL 116 (808)
T ss_pred CchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc--ceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHH
Confidence 3567899999999999999999999999988544 579999999986 9999999999999999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
|+++ |+|||+||.|||+. ..|.+|+||||+|+.+... ..+++.|||.|||||+++ +.|+..+|+||+|||+|||
T Consensus 117 hs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~ 193 (808)
T KOG0597|consen 117 HSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYEL 193 (808)
T ss_pred HhcC--cccccCCcceeeec-CCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHH
Confidence 9999 99999999999996 7899999999999988643 346778999999999885 5699999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
.+|++||.. ....++.+.|... |..++...+..++.|+..+|. +|.+|.++.+++.|||.+..
T Consensus 194 ~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 194 YVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 999999976 4566677777654 444566889999999999995 79999999999999999763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=322.24 Aligned_cols=215 Identities=29% Similarity=0.485 Sum_probs=186.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+..+.+.+|+.+|+.++||||+++++++.+. ..+|+||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||++
T Consensus 43 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 120 (291)
T cd05612 43 KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120 (291)
T ss_pred HHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--CeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567789999999999999999999987654 47999999999999999999988999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCC
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
| ++||||||+|||++ .+|.+||+|||++...... ....+||+.|+|||++. ..++.++|||||||++|+|++|..
T Consensus 121 ~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~ 196 (291)
T cd05612 121 E--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR-TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196 (291)
T ss_pred C--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC-cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9 99999999999997 7899999999999776432 33467999999999874 558999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCC
Q 008378 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKD 228 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~ 228 (568)
||.. .+...++..+..+.. .++...++.++++|.+||+ +|.+|++ +.+++.||||...++..
T Consensus 197 pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 264 (291)
T cd05612 197 PFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264 (291)
T ss_pred CCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence 9976 456667777666532 3455668999999999996 7999995 99999999998766544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=320.49 Aligned_cols=215 Identities=27% Similarity=0.505 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
|...+-..|||++|++|+|||+|.+.++|.. +..+++|+|||+..-|..+-.-...++...++.+++|++.|+.|||+
T Consensus 42 ~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk 119 (396)
T KOG0593|consen 42 PVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK 119 (396)
T ss_pred HHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh
Confidence 4455667999999999999999999998854 45799999999875555554444579999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccc--ccCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGiilyEml 159 (568)
++ +|||||||+|||++ .+|.+||||||+|+.+..+. -+.++.|.||+|||++ ..+|+..+|||++||++.||+
T Consensus 120 ~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~ 196 (396)
T KOG0593|consen 120 NN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELL 196 (396)
T ss_pred cC--eecccCChhheEEe-cCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHh
Confidence 99 99999999999997 89999999999999886432 3457899999999977 467999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHc-------------------CCC---CC---CC---CCCCcHHHHHHHHHhcC-CCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTS-------------------GIK---PA---SL---SKVTDPQVKQFIEKCIV-PASLRL 210 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~-------------------~~~---p~---~~---~~~~s~el~~lI~kcL~-~p~~Rp 210 (568)
+|++.|.+..+.++++..... |.. |. .+ ....+..+.+|+++||. +|.+|+
T Consensus 197 ~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~ 276 (396)
T KOG0593|consen 197 TGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL 276 (396)
T ss_pred cCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc
Confidence 999999999999998866542 111 11 11 12235678899999995 899999
Q ss_pred CHHHHhcCCCCCC
Q 008378 211 PALELLKDPFLVT 223 (568)
Q Consensus 211 sa~ElL~hpff~~ 223 (568)
+.+++|.||||..
T Consensus 277 sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 277 SCEQLLHHPYFDG 289 (396)
T ss_pred cHHHHhcChHHHH
Confidence 9999999999943
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=323.17 Aligned_cols=218 Identities=24% Similarity=0.430 Sum_probs=186.8
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+.....++.+|+.+|++++||||+++++++... ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||
T Consensus 33 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH 110 (312)
T cd05585 33 SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH 110 (312)
T ss_pred hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345667889999999999999999999988654 479999999999999999998889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++ .+|.+||+|||+++.... ......+||+.|+|||++ ...|+.++|||||||++|+|+
T Consensus 111 ~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 187 (312)
T cd05585 111 KFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187 (312)
T ss_pred hCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHH
Confidence 999 99999999999997 789999999999875422 223456799999999987 456899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC---CHHHHhcCCCCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL---PALELLKDPFLVTDNPKD 228 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp---sa~ElL~hpff~~~~~~~ 228 (568)
||..||... +...+++.+..+ +..++...++++++||.+||. +|.+|| ++.++|.||||....+..
T Consensus 188 tg~~pf~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~ 257 (312)
T cd05585 188 TGLPPFYDE-NVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKK 257 (312)
T ss_pred hCCCCcCCC-CHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHH
Confidence 999999764 455666666554 334566788999999999996 699997 589999999999865544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=329.41 Aligned_cols=222 Identities=25% Similarity=0.459 Sum_probs=190.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+.+|+.++||||++++++|.+. ..+|+||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+
T Consensus 72 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~ 149 (340)
T PTZ00426 72 QKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149 (340)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567788999999999999999999998765 4799999999999999999998999999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
+| |+||||||+|||++ .+|.+||+|||++..... ...+..||+.|||||++. ..++.++|||||||++|+|++|.
T Consensus 150 ~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~ 225 (340)
T PTZ00426 150 LN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDT-RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225 (340)
T ss_pred CC--eEccCCCHHHEEEC-CCCCEEEecCCCCeecCC-CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCC
Confidence 99 99999999999997 789999999999976543 234568999999999874 55899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcccCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~~~~l 234 (568)
.||.. .++..+++.+..+.. .++...++.++++|++||+ +|.+|+ ++.++++||||...++..+....+
T Consensus 226 ~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~ 300 (340)
T PTZ00426 226 PPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNV 300 (340)
T ss_pred CCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 99986 456667777776543 3456678999999999996 688885 899999999999877655443333
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=329.83 Aligned_cols=224 Identities=23% Similarity=0.423 Sum_probs=185.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+..+.+.+|+.+|++++||||+++++.|.+. ..+|+|||||++|+|.+++.+.+.+++..++.++.||+.||.|||+
T Consensus 42 ~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~ 119 (363)
T cd05628 42 KEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119 (363)
T ss_pred hhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567788999999999999999999988754 4799999999999999999998999999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-------------------------------------Ccccc
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------------------------------------TARSV 126 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-------------------------------------~~~s~ 126 (568)
+| |+||||||+|||++ .+|.+||+|||+++.+... .....
T Consensus 120 ~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (363)
T cd05628 120 LG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFST 196 (363)
T ss_pred CC--eEecCCCHHHeEEC-CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccc
Confidence 99 99999999999997 7899999999998654211 01245
Q ss_pred cCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhc
Q 008378 127 IGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCI 203 (568)
Q Consensus 127 ~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~el~~lI~kcL 203 (568)
+||+.|+|||++ ...|+.++|||||||++|||++|..||.+ .+....+..+........++ ...+++++++|.+++
T Consensus 197 ~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~ 275 (363)
T cd05628 197 VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFC 275 (363)
T ss_pred cCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHc
Confidence 899999999987 55689999999999999999999999976 44566666666533222222 235789999999976
Q ss_pred CC---CCCCCCHHHHhcCCCCCCCCCCCcccCC
Q 008378 204 VP---ASLRLPALELLKDPFLVTDNPKDLVCDP 233 (568)
Q Consensus 204 ~~---p~~Rpsa~ElL~hpff~~~~~~~l~~~~ 233 (568)
.. +..||++.|+++||||+..++..+...+
T Consensus 276 ~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~ 308 (363)
T cd05628 276 CEWEHRIGAPGVEEIKTNPFFEGVDWEHIRERP 308 (363)
T ss_pred CChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCC
Confidence 53 4467899999999999988876654433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.05 Aligned_cols=211 Identities=29% Similarity=0.432 Sum_probs=182.0
Q ss_pred HHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 11 YSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 11 ~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
+|||+.|++|+ |||||++++++.+.++ .+||||||++ .+|.++++.. +.|++..|+.|+.||++||+|+|.+| +
T Consensus 56 LREvksL~kln~hpniikL~Evi~d~~~-~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--f 131 (538)
T KOG0661|consen 56 LREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--F 131 (538)
T ss_pred HHHHHHHHhcCCCCcchhhHHHhhccCc-eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--c
Confidence 68999999998 9999999999887765 8999999997 5899988754 56999999999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccc--ccCCCccceehhhHHHHHHHhhcCCCC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 165 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGiilyEmltG~~Pf 165 (568)
.||||||+|||+.+ ...|||+|||+|+...... -+.++.|.||+|||++ ...|+.++|||++|||++|+.+-++.|
T Consensus 132 FHRDlKPENiLi~~-~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF 210 (538)
T KOG0661|consen 132 FHRDLKPENILISG-NDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF 210 (538)
T ss_pred ccccCChhheEecc-cceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence 99999999999974 5689999999999886544 4567999999999977 456999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCC------------------------CCCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 166 NECKNPAQIYKKVTSGI------------------------KPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 166 ~~~~~~~~i~~~i~~~~------------------------~p~~---~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
.+....+++++...--- .+.. +-...++++.++|.+|+. +|.+||||.|+|+
T Consensus 211 PG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 211 PGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred CCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 99888999987754110 0111 112357899999999998 7999999999999
Q ss_pred CCCCCCCCC
Q 008378 218 DPFLVTDNP 226 (568)
Q Consensus 218 hpff~~~~~ 226 (568)
||||+....
T Consensus 291 ~pffq~~~~ 299 (538)
T KOG0661|consen 291 HPFFQVGRA 299 (538)
T ss_pred Ccccccccc
Confidence 999997554
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=308.08 Aligned_cols=214 Identities=26% Similarity=0.500 Sum_probs=187.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.-+++.+|++|-+.|+|||||++.+..... .+.|||+|+++||+|..-|.+...+++..+..+++||+.+|.|+|.+|
T Consensus 53 ~~e~l~rEarIC~~LqHP~IvrL~~ti~~~--~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~ 130 (355)
T KOG0033|consen 53 DFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG 130 (355)
T ss_pred cHHHHHHHHHHHHhcCCCcEeehhhhhccc--ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC
Confidence 457899999999999999999999976543 489999999999999877766677999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 86 PPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
|+|||+||.|+++.+ ...-||++|||+|..+... .....+|||.|||||++ ...|+..+|||+.|+|+|-|+.|
T Consensus 131 --IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G 208 (355)
T KOG0033|consen 131 --IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 208 (355)
T ss_pred --ceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhC
Confidence 999999999999963 2346999999999888643 34577999999999988 56799999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL-~~p~~Rpsa~ElL~hpff~~~ 224 (568)
..||++ .+...+|+.|..+.- |...+...++++++||.+|| .+|++|.|+.|.|+|||+++.
T Consensus 209 ~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 209 YPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred CCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999987 467889999988743 44456678899999999999 589999999999999999863
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=343.77 Aligned_cols=227 Identities=24% Similarity=0.472 Sum_probs=197.8
Q ss_pred HHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.++++.++.|.+++...+ ||.++.+|..|+.++ .+|+||||+.||++. ++++.+.|++..++.|+..|+.||.|||
T Consensus 409 ~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~--~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH 485 (694)
T KOG0694|consen 409 RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE--HLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLH 485 (694)
T ss_pred cccHHHHHHHHHHHHHhccCCeEeecccccccCC--eEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHH
Confidence 467788999999999985 999999999997654 799999999999944 3445578999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhc--cCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~--~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
++| |||||||.+|||+| ..|++||+|||+++.. ......+++|||.|||||++ +..|+.++|+|+||++||||+
T Consensus 486 ~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML 562 (694)
T KOG0694|consen 486 ENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEML 562 (694)
T ss_pred hcC--ceeeecchhheEEc-ccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHH
Confidence 999 99999999999998 8899999999999864 34456789999999999988 567999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDP 233 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~ 233 (568)
+|+.||.+ .+.++++..|... ...++..++.++..+++++|. +|.+|+. +.++.+||||+..+|..|....
T Consensus 563 ~Gq~PF~g-ddEee~FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~ 639 (694)
T KOG0694|consen 563 VGESPFPG-DDEEEVFDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRR 639 (694)
T ss_pred cCCCCCCC-CCHHHHHHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhcc
Confidence 99999987 5788888888764 334677789999999999995 6999986 5789999999999998887777
Q ss_pred CCCCCC
Q 008378 234 LRLPNL 239 (568)
Q Consensus 234 l~~p~~ 239 (568)
++.|..
T Consensus 640 i~PPf~ 645 (694)
T KOG0694|consen 640 IKPPFV 645 (694)
T ss_pred CCCCCC
Confidence 665543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=313.05 Aligned_cols=213 Identities=26% Similarity=0.478 Sum_probs=184.5
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+-++...+|+.+|+++ -||||+++.+++..+ .++++|+|+|+.|.|++|+...-.++++..+++++|++.|++|||.
T Consensus 64 ~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~--sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa 141 (411)
T KOG0599|consen 64 EMREATRQEISILRQVMGHPYIIDLQDVYESD--AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA 141 (411)
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc--chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH
Confidence 3456778899999999 699999999988544 4799999999999999999999899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-------cCCCccceehhhHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCI 155 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-------~~ys~ksDIWSLGiil 155 (568)
++ |+||||||+|||++ ++-++||.|||+++.+... ..+..||||+|+|||.+. .+|+..+|+|++|+||
T Consensus 142 ~~--IVHRDLKpENILld-dn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm 218 (411)
T KOG0599|consen 142 RN--IVHRDLKPENILLD-DNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIM 218 (411)
T ss_pred hh--hhhcccChhheeec-cccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHH
Confidence 99 99999999999998 7789999999999988655 456789999999999773 4689999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|-|+.|.+||.... .-.+.+.|..|.. ....+...+..++++|.+||+ +|.+|.|++|.|.||||..
T Consensus 219 yTLLaGcpPFwHRk-QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 219 YTLLAGCPPFWHRK-QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHcCCCchhHHH-HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 99999999997632 2334456666643 233455678899999999995 8999999999999999964
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=321.45 Aligned_cols=220 Identities=30% Similarity=0.447 Sum_probs=186.7
Q ss_pred CCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---CCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHH
Q 008378 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 77 (568)
Q Consensus 1 lqs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~---~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~g 77 (568)
++++-..++.+||+++|+.++|+|||.+++.+.. .....+|+|+|+++ -+|.+.++..+.++...+..++.||+.|
T Consensus 59 F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrg 137 (359)
T KOG0660|consen 59 FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRG 137 (359)
T ss_pred hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHh
Confidence 3567788999999999999999999999998865 23457999999994 6999999998889999999999999999
Q ss_pred HHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc----CCCcccccCCCCccCcccc--ccCCCccceehhh
Q 008378 78 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPELY--EEEYNELVDIYSF 151 (568)
Q Consensus 78 L~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~----~~~~~s~~GTp~YmAPEvl--~~~ys~ksDIWSL 151 (568)
|+|+|+.| |+||||||.|+|++ .+..+||+|||+|+... ....+.++-|.||.|||++ ...|+.++||||.
T Consensus 138 LKyiHSAn--ViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSv 214 (359)
T KOG0660|consen 138 LKYIHSAN--VIHRDLKPSNLLLN-ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSV 214 (359)
T ss_pred cchhhccc--ccccccchhheeec-cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhh
Confidence 99999999 99999999999998 77899999999999874 3445678899999999977 4679999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHHc------------------------CCC-CCC---CCCCCcHHHHHHHHHhc
Q 008378 152 GMCILEMVTCEYPYNECKNPAQIYKKVTS------------------------GIK-PAS---LSKVTDPQVKQFIEKCI 203 (568)
Q Consensus 152 GiilyEmltG~~Pf~~~~~~~~i~~~i~~------------------------~~~-p~~---~~~~~s~el~~lI~kcL 203 (568)
|||+.||++|+..|.+.....|+...+.. ... +.. .-+..+|.+.+|+++||
T Consensus 215 GCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL 294 (359)
T KOG0660|consen 215 GCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKML 294 (359)
T ss_pred hHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHh
Confidence 99999999999999886666555322211 111 111 22456899999999999
Q ss_pred C-CCCCCCCHHHHhcCCCCCCC
Q 008378 204 V-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 204 ~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+ +|.+|+|++|+|.||||..-
T Consensus 295 ~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 295 VFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred ccCccccCCHHHHhcChhhhhh
Confidence 7 89999999999999999753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=332.09 Aligned_cols=216 Identities=32% Similarity=0.600 Sum_probs=190.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~y 80 (568)
++...+...+|+.++++++|||||.|++.|+.++ ..+++||+||+||+|.+.+++.+ .|+++.+..|+.|++.|+.|
T Consensus 43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~y 121 (426)
T KOG0589|consen 43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNY 121 (426)
T ss_pred CchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 3445567889999999999999999999998765 35999999999999999988654 69999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
||+++ |+|||||+.|||++ .++.|||+|||+|+.+... .+.+++|||.||.||++. ..|+.++||||||||+||
T Consensus 122 lH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yE 198 (426)
T KOG0589|consen 122 LHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYE 198 (426)
T ss_pred HHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHH
Confidence 99988 99999999999998 7788899999999999765 577899999999999995 569999999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|++-+.+|.+ .+...+..++..+. -..++...+.+++.+|+.||. +|..||++.+||.+|.++..
T Consensus 199 m~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 199 MCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 9999999987 56677777777665 233667788999999999996 69999999999999988753
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.04 Aligned_cols=218 Identities=24% Similarity=0.471 Sum_probs=183.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+|+.++||||++++++|.+. ..+|+|||||.+|+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 120 (364)
T cd05599 43 EQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120 (364)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4566788999999999999999999988764 47999999999999999999888999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----------------------------------------Ccc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----------------------------------------TAR 124 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----------------------------------------~~~ 124 (568)
| |+||||||+|||++ .+|.+||+|||++..+... ...
T Consensus 121 ~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (364)
T cd05599 121 G--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAY 197 (364)
T ss_pred C--eEeccCCHHHeEEC-CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccc
Confidence 9 99999999999997 7899999999998654211 111
Q ss_pred cccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHH
Q 008378 125 SVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEK 201 (568)
Q Consensus 125 s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~el~~lI~k 201 (568)
+.+||+.|+|||++ ...|+.++|||||||++|+|++|..||... +....+..+.........+ ...++++++||.+
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 276 (364)
T cd05599 198 STVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD-NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKR 276 (364)
T ss_pred ccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHH
Confidence 35799999999987 556899999999999999999999999764 4555555555433322222 2458899999999
Q ss_pred hcCCCCCCCC---HHHHhcCCCCCCCCCCC
Q 008378 202 CIVPASLRLP---ALELLKDPFLVTDNPKD 228 (568)
Q Consensus 202 cL~~p~~Rps---a~ElL~hpff~~~~~~~ 228 (568)
|+.+|.+|++ +.+++.||||+...+..
T Consensus 277 ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~ 306 (364)
T cd05599 277 LCCEAERRLGNNGVNEIKSHPFFKGVDWEH 306 (364)
T ss_pred HccCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 9988999997 99999999998866543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.84 Aligned_cols=225 Identities=24% Similarity=0.454 Sum_probs=186.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+..+++.+|+.+|..++||||++++++|.+. ..+|+||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||+
T Consensus 42 ~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~ 119 (360)
T cd05627 42 KEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119 (360)
T ss_pred hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999988754 4799999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-------------------------------------Ccccc
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------------------------------------TARSV 126 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-------------------------------------~~~s~ 126 (568)
+| |+||||||+|||++ .+|.+||+|||++..+... ...+.
T Consensus 120 ~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (360)
T cd05627 120 LG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYST 196 (360)
T ss_pred CC--eEccCCCHHHEEEC-CCCCEEEeeccCCcccccccccccccccccCCccccccccccccccccccccccccccccc
Confidence 99 99999999999997 7899999999998644211 01245
Q ss_pred cCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhc
Q 008378 127 IGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCI 203 (568)
Q Consensus 127 ~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~el~~lI~kcL 203 (568)
+||+.|+|||++ ...|+.++|||||||++|||+||..||.. .++...+..+........++ ...+++++++|.+++
T Consensus 197 ~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~ 275 (360)
T cd05627 197 VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC 275 (360)
T ss_pred CCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc
Confidence 799999999987 55699999999999999999999999976 44556666665432222222 236789999999988
Q ss_pred CCCCCCC---CHHHHhcCCCCCCCCCCCcccCCC
Q 008378 204 VPASLRL---PALELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 204 ~~p~~Rp---sa~ElL~hpff~~~~~~~l~~~~l 234 (568)
.+|.+|+ ++.+++.||||+..++..+...+.
T Consensus 276 ~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~ 309 (360)
T cd05627 276 TDSENRIGSNGVEEIKSHPFFEGVDWGHIRERPA 309 (360)
T ss_pred cChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCC
Confidence 8888887 489999999999988766544433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.94 Aligned_cols=219 Identities=24% Similarity=0.416 Sum_probs=181.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+.++++.+|+++|++++|||||+++++|.+. ..+|+||||+.+|+|.+++.+.+.+++..++.|+.||+.||+|||+
T Consensus 42 ~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~ 119 (377)
T cd05629 42 KDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119 (377)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567889999999999999999999998754 4799999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------------------------------------------
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------------------------------------------ 121 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------------------------------------------ 121 (568)
+| |+||||||+|||++ .+|.+||+|||+++.+...
T Consensus 120 ~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (377)
T cd05629 120 LG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIAT 196 (377)
T ss_pred CC--eeccCCCHHHEEEC-CCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 99 99999999999997 7899999999998632110
Q ss_pred -------CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CC
Q 008378 122 -------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VT 191 (568)
Q Consensus 122 -------~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~ 191 (568)
...+.+||+.|+|||++ ...|+.++|||||||++|||+||..||... +....+..+........++. ..
T Consensus 197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~ 275 (377)
T cd05629 197 WKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSE-NSHETYRKIINWRETLYFPDDIHL 275 (377)
T ss_pred hhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCC-CHHHHHHHHHccCCccCCCCCCCC
Confidence 00135799999999987 456999999999999999999999999764 44555555554322222222 46
Q ss_pred cHHHHHHHHHhcCCCCC---CCCHHHHhcCCCCCCCCCCC
Q 008378 192 DPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 192 s~el~~lI~kcL~~p~~---Rpsa~ElL~hpff~~~~~~~ 228 (568)
++++++||.+||.+|.+ |+++.+++.||||...++..
T Consensus 276 s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 315 (377)
T cd05629 276 SVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDT 315 (377)
T ss_pred CHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 78999999999976554 56999999999998765533
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.84 Aligned_cols=214 Identities=26% Similarity=0.351 Sum_probs=182.3
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...-..|||.||++|+|||||++.+..++.....+|||+|||+. +|.-++.. .-+|++.+|+.+++||+.||+|||++
T Consensus 159 ~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~ 237 (560)
T KOG0600|consen 159 FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR 237 (560)
T ss_pred chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc
Confidence 34556899999999999999999998887766799999999985 77777665 34799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc--ccCCCccceehhhHHHHHHHh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGiilyEml 159 (568)
| |+|||||+.||||| ++|.+||+|||||+.+.... .+..+.|.||+|||++ ...|+.++|+||.|||+.||+
T Consensus 238 g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~ 314 (560)
T KOG0600|consen 238 G--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF 314 (560)
T ss_pred C--eeeccccccceEEc-CCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH
Confidence 9 99999999999998 89999999999999775432 4456889999999977 567999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCC-C-C------------------------CCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPA-S-L------------------------SKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~-~-~------------------------~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
+|++.|.+.+..+|+.+.+.-.--|. . | .+..++.+.+|+..+|. +|.+|.||
T Consensus 315 ~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA 394 (560)
T KOG0600|consen 315 LGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA 394 (560)
T ss_pred cCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH
Confidence 99999999888888876665321111 0 1 13456788899999995 89999999
Q ss_pred HHHhcCCCCCC
Q 008378 213 LELLKDPFLVT 223 (568)
Q Consensus 213 ~ElL~hpff~~ 223 (568)
.+.|.++||..
T Consensus 395 ~~aL~seyF~t 405 (560)
T KOG0600|consen 395 SSALQSEYFTT 405 (560)
T ss_pred HHHhcCccccc
Confidence 99999999944
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=320.47 Aligned_cols=218 Identities=23% Similarity=0.454 Sum_probs=186.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+...++.+|+++|+.++||||+++++++... ..+++||||+++|+|..++...+.+++..++.++.||+.||.|||+
T Consensus 36 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~ 113 (328)
T cd05593 36 KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS 113 (328)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45667889999999999999999999988654 4799999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++ .+|.+||+|||+++.... ......+||+.|+|||++ ...++.++|||||||++|+|++
T Consensus 114 ~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 190 (328)
T cd05593 114 GK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190 (328)
T ss_pred CC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhh
Confidence 99 99999999999997 789999999999875422 223456799999999988 4568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l 229 (568)
|..||... +...+.+.+..+. ..++...++++++||.+||+ +|.+|+ ++.++++||||...++..+
T Consensus 191 G~~Pf~~~-~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~ 262 (328)
T cd05593 191 GRLPFYNQ-DHEKLFELILMED--IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV 262 (328)
T ss_pred CCCCCCCC-CHHHHHHHhccCC--ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 99999764 4455555554432 23556778999999999996 699997 8999999999988766543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=319.20 Aligned_cols=219 Identities=22% Similarity=0.454 Sum_probs=186.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+....+.+|+++|+.++||||++++++|... ..+|+||||+++|+|..++.+.+.+++..++.++.||+.||.|||+
T Consensus 36 ~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~ 113 (323)
T cd05595 36 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 113 (323)
T ss_pred hHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45567788999999999999999999988755 4799999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++ .+|.+||+|||++..... .......||+.|+|||++ ...++.++|||||||++|+|++
T Consensus 114 ~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~ 190 (323)
T cd05595 114 RD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190 (323)
T ss_pred CC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHh
Confidence 99 99999999999997 788999999999875322 223456799999999987 4568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLV 230 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~ 230 (568)
|..||... +...+...+.... ..++...+++++++|.+||. +|.+|+ ++.+++.||||....+..+.
T Consensus 191 g~~Pf~~~-~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 191 GRLPFYNQ-DHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 263 (323)
T ss_pred CCCCCCCC-CHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 99999764 4455555554432 23456678999999999996 699998 89999999999987765543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=318.35 Aligned_cols=220 Identities=29% Similarity=0.457 Sum_probs=191.0
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~y 80 (568)
+.+++.|+..|-+||+.++||.++.+|..|..+ .++++|||||.||+|..+++++ +.|++..++.|+.+|+.||+|
T Consensus 117 ~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~--~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEY 194 (459)
T KOG0610|consen 117 SRKKLKRAQTEREILSLLDHPFLPTLYASFETD--KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEY 194 (459)
T ss_pred hhhHHHHHHHHHHHHHhcCCCccchhhheeecc--ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHH
Confidence 356788899999999999999999999998654 5899999999999999998876 579999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhc-------c---------------------------C-C----
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------Q---------------------------Q-P---- 121 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~-------~---------------------------~-~---- 121 (568)
||..| ||+|||||+||||. ++|+|-|.||.|+... . . .
T Consensus 195 LHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k 271 (459)
T KOG0610|consen 195 LHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKK 271 (459)
T ss_pred HHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccc
Confidence 99999 99999999999997 8999999999986421 0 0 0
Q ss_pred -------------------CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 008378 122 -------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 181 (568)
Q Consensus 122 -------------------~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~ 181 (568)
...+++||-+|+|||++. .+.+.++|+|+|||++|||+.|..||.+.++.+.+++.+.+.
T Consensus 272 ~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~ 351 (459)
T KOG0610|consen 272 KDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP 351 (459)
T ss_pred ccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC
Confidence 012468999999999995 569999999999999999999999999988888888888776
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC----HHHHhcCCCCCCCCCCC
Q 008378 182 IKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALELLKDPFLVTDNPKD 228 (568)
Q Consensus 182 ~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps----a~ElL~hpff~~~~~~~ 228 (568)
..-+..+ ..+..+++||+++|+ +|.+|.. |.|+..||||+..+|.-
T Consensus 352 l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaL 402 (459)
T KOG0610|consen 352 LKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWAL 402 (459)
T ss_pred CcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhh
Confidence 5433332 557899999999996 6999998 99999999999999973
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=318.79 Aligned_cols=217 Identities=22% Similarity=0.395 Sum_probs=183.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+..+.+.+|+.+|+.++||||+++++++.+. ..+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 43 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 120 (333)
T cd05600 43 NEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120 (333)
T ss_pred hHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567789999999999999999999988654 47999999999999999999888999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCC
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
| |+||||||+|||++ .+|.+||+|||++..... .....+||+.|+|||++ ...|+.++|||||||++|||++|..
T Consensus 121 ~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 196 (333)
T cd05600 121 G--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196 (333)
T ss_pred C--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCC
Confidence 9 99999999999997 789999999999976543 34556899999999987 4568999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCC---C---CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCCC
Q 008378 164 PYNECKNPAQIYKKVTSGIKPAS---L---SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~---~---~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~~ 228 (568)
||.. .+....+..+........ . ....++++++||.+||. +|.+||++.++++||||....+..
T Consensus 197 pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~ 267 (333)
T cd05600 197 PFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE 267 (333)
T ss_pred CCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence 9976 445555555543221111 1 12457899999999996 588999999999999998765543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.16 Aligned_cols=217 Identities=27% Similarity=0.498 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+...+++.+|+++|++++||||+++++++.... .+++||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~ 121 (331)
T cd06649 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 121 (331)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 455678999999999999999999999987654 799999999999999999988889999999999999999999998
Q ss_pred C-CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 84 H-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 ~-g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
. + |+||||||+|||++ .+|.+||+|||++............||+.|+|||++. ..++.++|||||||++|+|+||
T Consensus 122 ~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 198 (331)
T cd06649 122 KHQ--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198 (331)
T ss_pred cCC--EEcCCCChhhEEEc-CCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 5 5 99999999999997 7889999999999876555556678999999999874 5589999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH----------------------------------------------HcCCCCCCCCCCCcHHH
Q 008378 162 EYPYNECKNPAQIYKKV----------------------------------------------TSGIKPASLSKVTDPQV 195 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i----------------------------------------------~~~~~p~~~~~~~s~el 195 (568)
+.||.... ...+...+ .....+.......++++
T Consensus 199 ~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (331)
T cd06649 199 RYPIPPPD-AKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDF 277 (331)
T ss_pred CCCCCCCC-HHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHH
Confidence 99996532 22222211 11112222223467899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 196 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 196 ~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
++||.+||+ +|.+||++.++++||||+....
T Consensus 278 ~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 278 QEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred HHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 999999996 7999999999999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=324.34 Aligned_cols=217 Identities=24% Similarity=0.406 Sum_probs=180.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+++|++++|||||+++++|.+. ..+|+|||||.+|+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 43 ~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~ 120 (382)
T cd05625 43 NQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120 (382)
T ss_pred HHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4567889999999999999999999998765 47999999999999999999888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--------------------------------------------
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-------------------------------------------- 120 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-------------------------------------------- 120 (568)
| |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 121 ~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (382)
T cd05625 121 G--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAA 197 (382)
T ss_pred C--eecCCCCHHHEEEC-CCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhc
Confidence 9 99999999999997 789999999999753210
Q ss_pred -----CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCc
Q 008378 121 -----PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTD 192 (568)
Q Consensus 121 -----~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s 192 (568)
....+.+||+.|+|||++ ...|+.++|||||||++|||++|+.||.... +......+......... ....+
T Consensus 198 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~s 276 (382)
T cd05625 198 RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT-PLETQMKVINWQTSLHIPPQAKLS 276 (382)
T ss_pred cccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCC-HHHHHHHHHccCCCcCCCCcccCC
Confidence 001245799999999987 5569999999999999999999999998744 44444444332222112 23468
Q ss_pred HHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCC
Q 008378 193 PQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPK 227 (568)
Q Consensus 193 ~el~~lI~kcL~~p~~Rps---a~ElL~hpff~~~~~~ 227 (568)
++++++|.+++.+|.+|++ +.+++.||||+...+.
T Consensus 277 ~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 277 PEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999999998888888887 9999999999876553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.60 Aligned_cols=217 Identities=26% Similarity=0.388 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.....+.+|+.+|+.++||||++++++|... ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 42 ~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (323)
T cd05584 42 KDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119 (323)
T ss_pred hhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3456678899999999999999999988754 47999999999999999999988999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
| |+||||||+|||++ .+|.+||+|||+++... ........||+.|+|||++. ..++.++||||||+++|||++|
T Consensus 120 ~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 196 (323)
T cd05584 120 G--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196 (323)
T ss_pred C--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcC
Confidence 9 99999999999997 78999999999986432 22234567999999999874 4588999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCc
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l 229 (568)
..||... +.......+..+.. .++...++.+++||.+||+ +|.+|| ++.+++.||||....+..+
T Consensus 197 ~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~ 267 (323)
T cd05584 197 APPFTAE-NRKKTIDKILKGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL 267 (323)
T ss_pred CCCCCCC-CHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 9999874 44455555555432 3455678999999999996 699999 8999999999987665443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.50 Aligned_cols=214 Identities=23% Similarity=0.470 Sum_probs=179.4
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
++++++||.+|++|+|||||+++++.-+.....+|||+|||..|.+...-.....+++.+++.|++.++.||+|||.+|
T Consensus 152 ~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg- 230 (576)
T KOG0585|consen 152 IEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG- 230 (576)
T ss_pred HHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 5789999999999999999999998888888899999999999998653332223999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-------CcccccCCCCccCccccccC-----CCccceehhhHHH
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMC 154 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-------~~~s~~GTp~YmAPEvl~~~-----ys~ksDIWSLGii 154 (568)
||||||||.|+|++ .+|+|||+|||.+...... .....+|||.|||||++..+ -+.+.||||+|++
T Consensus 231 -iiHRDIKPsNLLl~-~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 231 -IIHRDIKPSNLLLS-SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred -eeccccchhheEEc-CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 99999999999997 7799999999999766322 12346899999999988442 3678999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
||.|+.|++||.+ ...-.++.+|.....-..........++++|.++|. +|.+|.+..++..|||....
T Consensus 309 LYCllfG~~PF~~-~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 309 LYCLLFGQLPFFD-DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHhhhccCCccc-chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999999999987 456667777776432211222457899999999995 69999999999999998764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.38 Aligned_cols=217 Identities=24% Similarity=0.387 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+|+.++||||+++++.|.+. ..+|+|||||++|+|.+++.+.+.+++..++.|+.||+.||+|||++|
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (376)
T cd05598 44 QAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121 (376)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 456788999999999999999999988754 479999999999999999999889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC---------------------------------------------
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------------------------------------- 120 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--------------------------------------------- 120 (568)
|+||||||+|||++ .+|.+||+|||++..+..
T Consensus 122 --ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (376)
T cd05598 122 --FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQR 198 (376)
T ss_pred --eEeCCCCHHHEEEC-CCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccc
Confidence 99999999999997 789999999999743210
Q ss_pred CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHH
Q 008378 121 PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQ 197 (568)
Q Consensus 121 ~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~el~~ 197 (568)
......+||+.|||||++ ...++.++|||||||++|+|++|+.||.... +......+....... ......++++++
T Consensus 199 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 277 (376)
T cd05598 199 CLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT-PAETQLKVINWETTLHIPSQAKLSREASD 277 (376)
T ss_pred ccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCC-HHHHHHHHhccCccccCCCCCCCCHHHHH
Confidence 001235799999999987 4568999999999999999999999998744 344444443322211 122356889999
Q ss_pred HHHHhcCCCCCCC---CHHHHhcCCCCCCCCCCC
Q 008378 198 FIEKCIVPASLRL---PALELLKDPFLVTDNPKD 228 (568)
Q Consensus 198 lI~kcL~~p~~Rp---sa~ElL~hpff~~~~~~~ 228 (568)
+|.+|+.+|.+|+ ++.++++||||+......
T Consensus 278 li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~ 311 (376)
T cd05598 278 LILRLCCGAEDRLGKNGADEIKAHPFFKGIDFAS 311 (376)
T ss_pred HHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence 9999888999999 999999999998765433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=333.45 Aligned_cols=216 Identities=31% Similarity=0.542 Sum_probs=189.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
..++++.+.+|+.+|.+++++||.++|++++... .+|++||||.||++.+.++....+++..+..++++++.||.|||
T Consensus 51 ~~deIediqqei~~Ls~~~~~~it~yygsyl~g~--~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH 128 (467)
T KOG0201|consen 51 AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT--KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH 128 (467)
T ss_pred cchhhHHHHHHHHHHHhcCcchHHhhhhheeecc--cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhh
Confidence 4567889999999999999999999999998765 69999999999999999998887899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
.++ .+|||||+.|||+. ..|.||++|||++..++.. ...+++|||.|||||++. .+|+.++||||||+++|||+
T Consensus 129 ~~~--kiHrDIKaanil~s-~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla 205 (467)
T KOG0201|consen 129 SEK--KIHRDIKAANILLS-ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELA 205 (467)
T ss_pred hcc--eecccccccceeEe-ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHh
Confidence 999 99999999999997 6699999999999887543 347889999999999885 47999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|++|+..+..+..++- .....|+.+...+++.+++||..||. +|..||+|.+||+|+|++...
T Consensus 206 ~GePP~s~~hPmrvlfl--Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 206 KGEPPHSKLHPMRVLFL--IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred cCCCCCcccCcceEEEe--ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 99999988654332222 22334566667889999999999996 699999999999999998743
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=318.03 Aligned_cols=217 Identities=23% Similarity=0.443 Sum_probs=184.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.....++.+|+++++.++||||++++++|... ..+|+||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+
T Consensus 36 ~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~ 113 (325)
T cd05594 36 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 113 (325)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 44567788999999999999999999988654 4799999999999999999988899999999999999999999997
Q ss_pred -CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 84 -HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 -~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
+| |+||||||+|||++ .+|.+||+|||++.... ........||+.|+|||++ ...|+.++|||||||++|+|+
T Consensus 114 ~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (325)
T cd05594 114 EKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 190 (325)
T ss_pred cCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeec
Confidence 68 99999999999997 78999999999986532 2223456799999999988 456899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKD 228 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~ 228 (568)
||..||... +...+...+... ...++...++++++||.+||+ +|.+|+ ++.++++||||....+..
T Consensus 191 tG~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~ 262 (325)
T cd05594 191 CGRLPFYNQ-DHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQD 262 (325)
T ss_pred cCCCCCCCC-CHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999999764 455555555443 223456678999999999996 799997 899999999998765544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.28 Aligned_cols=217 Identities=23% Similarity=0.430 Sum_probs=185.2
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+..+.+.+|+.+++.+ +||||+++++++... ..+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+
T Consensus 37 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~ 114 (320)
T cd05590 37 DDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114 (320)
T ss_pred cHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567788899999877 799999999988654 4799999999999999999998899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
++ ++||||||+|||++ .+|.+||+|||++.... ........||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 115 ~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (320)
T cd05590 115 KG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191 (320)
T ss_pred CC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh
Confidence 99 99999999999997 78999999999987542 22334567999999999884 568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH------HHHhcCCCCCCCCCCCc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDL 229 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa------~ElL~hpff~~~~~~~l 229 (568)
|+.||.. .+...++..+..+.. .++...+++++++|.+||. +|.+|+++ .+++.||||....+..+
T Consensus 192 g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~ 264 (320)
T cd05590 192 GHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264 (320)
T ss_pred CCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 9999976 456666666665432 2445678999999999996 79999998 89999999988766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=318.89 Aligned_cols=218 Identities=23% Similarity=0.425 Sum_probs=184.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+|+.++||||++++++|.+. ..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 120 (350)
T cd05573 43 NQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120 (350)
T ss_pred cHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567789999999999999999999988754 47999999999999999999888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-------------------------------cccccCCCCcc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-------------------------------ARSVIGTPEFM 133 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-------------------------------~~s~~GTp~Ym 133 (568)
| |+||||||+|||++ .+|.+||+|||++....... .....||+.|+
T Consensus 121 g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 197 (350)
T cd05573 121 G--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYI 197 (350)
T ss_pred C--eeccCCCHHHeEEC-CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCcccc
Confidence 9 99999999999997 78999999999997654322 23457999999
Q ss_pred Ccccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCC
Q 008378 134 APELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRL 210 (568)
Q Consensus 134 APEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~el~~lI~kcL~~p~~Rp 210 (568)
|||++ ...++.++|||||||++|+|++|..||.... ....+..+........++ ...++++++||.+||.+|.+|+
T Consensus 198 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~ 276 (350)
T cd05573 198 APEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRL 276 (350)
T ss_pred CHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcC
Confidence 99987 4568999999999999999999999998754 455555555422211222 2358999999999999999999
Q ss_pred C-HHHHhcCCCCCCCCCCC
Q 008378 211 P-ALELLKDPFLVTDNPKD 228 (568)
Q Consensus 211 s-a~ElL~hpff~~~~~~~ 228 (568)
+ +.++++||||+...+..
T Consensus 277 ~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 277 GSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred CCHHHHhcCCCcCCCCHHH
Confidence 9 99999999998765543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.68 Aligned_cols=223 Identities=23% Similarity=0.375 Sum_probs=183.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+|+++|++++|+||++++++|.+. ..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+
T Consensus 43 ~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 120 (285)
T cd05631 43 GEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120 (285)
T ss_pred hHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345678899999999999999999988654 3799999999999999887643 368999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
++ |+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++ ...|+.++|||||||++|+|++|
T Consensus 121 ~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 197 (285)
T cd05631 121 ER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197 (285)
T ss_pred CC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhC
Confidence 99 99999999999997 7889999999999765432 23456799999999988 45689999999999999999999
Q ss_pred CCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccC
Q 008378 162 EYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCD 232 (568)
Q Consensus 162 ~~Pf~~~~~~---~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~ 232 (568)
+.||...... ..+...+... +..++...++++++||.+||. +|.+|++ +.++++||||...+++.+...
T Consensus 198 ~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05631 198 QSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN 275 (285)
T ss_pred CCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence 9999764332 2233333222 233555678999999999996 7999997 899999999999887766554
Q ss_pred CCC
Q 008378 233 PLR 235 (568)
Q Consensus 233 ~l~ 235 (568)
.+.
T Consensus 276 ~~~ 278 (285)
T cd05631 276 MLE 278 (285)
T ss_pred cCC
Confidence 433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.48 Aligned_cols=219 Identities=22% Similarity=0.382 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+..+.+.+|+.+|+.++||||++++++|.+. ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+
T Consensus 42 ~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~ 119 (381)
T cd05626 42 RNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK 119 (381)
T ss_pred hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567889999999999999999999998764 4799999999999999999998899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------------------------------------------
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------------------------------------------ 121 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------------------------------------------ 121 (568)
+| |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 120 ~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (381)
T cd05626 120 MG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRA 196 (381)
T ss_pred CC--eeecCCcHHHEEEC-CCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccc
Confidence 99 99999999999997 7899999999997532100
Q ss_pred -------CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCC
Q 008378 122 -------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVT 191 (568)
Q Consensus 122 -------~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~ 191 (568)
...+.+||+.|+|||++ ...|+.++|||||||++|||+||..||..... ......+......... ....
T Consensus 197 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 275 (381)
T cd05626 197 TKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP-TETQLKVINWENTLHIPPQVKL 275 (381)
T ss_pred cccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCH-HHHHHHHHccccccCCCCCCCC
Confidence 11345799999999987 45689999999999999999999999987543 3333333322111112 2246
Q ss_pred cHHHHHHHHHhcC---CCCCCCCHHHHhcCCCCCCCCCCC
Q 008378 192 DPQVKQFIEKCIV---PASLRLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 192 s~el~~lI~kcL~---~p~~Rpsa~ElL~hpff~~~~~~~ 228 (568)
++++++||.+++. ++..|+++.+++.||||....+..
T Consensus 276 s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 276 SPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS 315 (381)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence 8999999999653 355699999999999998876544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.40 Aligned_cols=222 Identities=28% Similarity=0.489 Sum_probs=189.9
Q ss_pred CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHh
Q 008378 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~y 80 (568)
++.+.++.+.-||.||..|+||+||++++.|+.++ .+||+.|||.||-...++-. ...|.+..|.-+++|++.||.|
T Consensus 68 kseEELEDylVEIeILa~CdHP~ivkLl~ayy~en--kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~ 145 (1187)
T KOG0579|consen 68 KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNW 145 (1187)
T ss_pred cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHH
Confidence 67899999999999999999999999999887665 58999999999999887665 4579999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccc------ccCCCccceehhhH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY------EEEYNELVDIYSFG 152 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl------~~~ys~ksDIWSLG 152 (568)
||+++ |||||||..|||++ -+|.|+|+|||.+.... .....+++|||+|||||++ ...|+.++||||||
T Consensus 146 LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlG 222 (1187)
T KOG0579|consen 146 LHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLG 222 (1187)
T ss_pred Hhhcc--hhhhhccccceEEE-ecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhh
Confidence 99999 99999999999998 78999999999986543 2345689999999999976 34699999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCCC
Q 008378 153 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~~ 228 (568)
|+|+||+-+++|.++.+....+.+.-.+..+.-..+..++..+++|+.+||. +|..||++.+||+||||+.....+
T Consensus 223 ITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 223 ITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred hHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence 9999999999999886555555554444433333456678899999999996 699999999999999999765543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.32 Aligned_cols=212 Identities=29% Similarity=0.467 Sum_probs=180.8
Q ss_pred HHHHHHHHhCCCCCeeeeeeEEEcCCCC---eEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 11 YSEVHLLKSLKHENIIKFYNSWVDDTNR---TINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 11 ~~Ei~iLk~L~HpNIV~l~~~~~~~~~~---~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+|+++|+.++|||||++..+|...... ++++||||++ .+|.++++. ..+++.-.++-+..||++||.|||+
T Consensus 65 nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~ 143 (364)
T KOG0658|consen 65 NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS 143 (364)
T ss_pred cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh
Confidence 4699999999999999998888655443 6789999998 688888874 4679999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc--ccCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||.|+|+|...|.+||||||.|+.+... ...++..|..|+|||++ ...|+.+.||||.||++.||+-
T Consensus 144 ~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 144 HG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred cC--cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhc
Confidence 99 9999999999999988999999999999988544 45678899999999977 5679999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHc----------------------CCCCCC----CCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 161 CEYPYNECKNPAQIYKKVTS----------------------GIKPAS----LSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~----------------------~~~p~~----~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
|++.|.+....+|+...+.- ..++.. +.+..++++.+|+.++|+ .|.+|.++.
T Consensus 222 g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~ 301 (364)
T KOG0658|consen 222 GQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL 301 (364)
T ss_pred CCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence 99999987777776555431 011111 334568999999999998 799999999
Q ss_pred HHhcCCCCCCCC
Q 008378 214 ELLKDPFLVTDN 225 (568)
Q Consensus 214 ElL~hpff~~~~ 225 (568)
|+|.||||....
T Consensus 302 ~~l~h~fFdelr 313 (364)
T KOG0658|consen 302 EALAHPFFDELR 313 (364)
T ss_pred HHhcchhhHHhh
Confidence 999999998654
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.59 Aligned_cols=219 Identities=19% Similarity=0.354 Sum_probs=184.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+.+|+.+++.++||||+++++++.+. ..+++||||+++|+|.+++++. +.+++..++.++.||+.||.|||
T Consensus 42 ~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH 119 (330)
T cd05601 42 QETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119 (330)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567788999999999999999999988654 4799999999999999999887 67999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-------cCCCccceehhhH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-------EEYNELVDIYSFG 152 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-------~~ys~ksDIWSLG 152 (568)
+++ |+||||||+|||++ .+|.+||+|||++..+.... .....||+.|+|||++. ..|+.++||||||
T Consensus 120 ~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 196 (330)
T cd05601 120 QMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196 (330)
T ss_pred HCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeeccc
Confidence 999 99999999999997 78999999999997654322 23347999999999874 3478899999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCCCHHHHhcCCCCCCCCCCC
Q 008378 153 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~el~~lI~kcL~~p~~Rpsa~ElL~hpff~~~~~~~ 228 (568)
|++|+|++|..||.... ....+..+........++ ...++.+++||.+||.+|.+||++.+++.||||...++..
T Consensus 197 ~il~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 197 VIAYEMIYGRSPFHEGT-SAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred ceeeeeccCCCCCCCCC-HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHH
Confidence 99999999999998744 444555555443322222 2467899999999999999999999999999999866544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.23 Aligned_cols=218 Identities=19% Similarity=0.398 Sum_probs=182.2
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+.+|+.+++.+ +||||++++++|.+. ..+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||
T Consensus 36 ~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 113 (329)
T cd05588 36 DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH 113 (329)
T ss_pred hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44567788999999999 799999999988655 479999999999999999998889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| ++||||||+||+++ .+|.+||+|||+++... .......+||+.|+|||++. ..|+.++|||||||++|+|+
T Consensus 114 ~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 190 (329)
T cd05588 114 ERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190 (329)
T ss_pred HCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHH
Confidence 999 99999999999997 78999999999986532 22334568999999999884 56899999999999999999
Q ss_pred hcCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC------HHHHhcCCCCCCC
Q 008378 160 TCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP------ALELLKDPFLVTD 224 (568)
Q Consensus 160 tG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps------a~ElL~hpff~~~ 224 (568)
||+.||... .....+.+.+.... ..++...++.++++|.+||+ +|.+|++ +.++++||||...
T Consensus 191 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 191 AGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999531 12233444454432 23556678999999999996 7999987 7899999999876
Q ss_pred CCCC
Q 008378 225 NPKD 228 (568)
Q Consensus 225 ~~~~ 228 (568)
.+..
T Consensus 269 ~~~~ 272 (329)
T cd05588 269 DWDL 272 (329)
T ss_pred CHHH
Confidence 5533
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.57 Aligned_cols=218 Identities=22% Similarity=0.369 Sum_probs=185.4
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+..|+++++.+ +||||++++++|... ..+|+||||+++|+|..++.+.+.+++..++.++.||+.||.|||
T Consensus 36 ~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH 113 (321)
T cd05591 36 DDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113 (321)
T ss_pred hhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34566788899999876 899999999998755 479999999999999999999899999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++ .+|.+||+|||++.... ........||+.|+|||++. ..|+.++|||||||++|+|+
T Consensus 114 ~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 190 (321)
T cd05591 114 RHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMM 190 (321)
T ss_pred HCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHh
Confidence 999 99999999999997 78999999999987542 22334567999999999874 56899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-------CHHHHhcCCCCCCCCCCCc
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-------PALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-------sa~ElL~hpff~~~~~~~l 229 (568)
+|+.||... +...++..+..+.. .++...+++++++|.+||. +|.+|+ ++.++++||||....+..+
T Consensus 191 tg~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~ 265 (321)
T cd05591 191 AGQPPFEAD-NEDDLFESILHDDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265 (321)
T ss_pred cCCCCCCCC-CHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 999999764 45666666665432 2344578999999999996 699999 8999999999987766544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.63 Aligned_cols=217 Identities=21% Similarity=0.388 Sum_probs=181.8
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+++.+|+.+|+.+ +||||++++++|... ..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+
T Consensus 46 ~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~ 123 (332)
T cd05614 46 KTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK 123 (332)
T ss_pred hHHHHHHHHHHHHHhccCCCCcccEEEEEecC--CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999 599999999988654 4789999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCcccccc--CCCccceehhhHHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEM 158 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEm 158 (568)
+| |+||||||+|||++ .+|.+||+|||+++..... .....+||+.|||||++.+ .++.++|||||||++|+|
T Consensus 124 ~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 200 (332)
T cd05614 124 LG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200 (332)
T ss_pred CC--cEecCCCHHHeEEC-CCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhh
Confidence 99 99999999999997 7889999999999765322 2234679999999998853 478899999999999999
Q ss_pred hhcCCCCCCC---CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCC
Q 008378 159 VTCEYPYNEC---KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKD 228 (568)
Q Consensus 159 ltG~~Pf~~~---~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~ 228 (568)
+||..||... .....+...+.... ..++...++.++++|.+||. +|.+|| ++.++++||||+...+..
T Consensus 201 ltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 277 (332)
T cd05614 201 LTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA 277 (332)
T ss_pred hcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 9999999642 23344555554432 23455678999999999996 699999 889999999998765544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=317.90 Aligned_cols=214 Identities=21% Similarity=0.420 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+++.++||||++++++|.+. ..+|+||||+.+|+|.+++... .+++..++.++.||+.||+|||+++
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~ 162 (370)
T cd05621 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG 162 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 455678999999999999999999988754 4799999999999999999765 5899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccccc-----CCCccceehhhHHHHHH
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILE 157 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~~-----~ys~ksDIWSLGiilyE 157 (568)
|+||||||+|||++ .+|.+||+|||++....... ..+.+||+.|||||++.. .++.++|||||||++|+
T Consensus 163 --IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilye 239 (370)
T cd05621 163 --LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFE 239 (370)
T ss_pred --eEecCCCHHHEEEC-CCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHH
Confidence 99999999999997 78999999999997654322 245689999999998743 27889999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcCCC---CCCCCHHHHhcCCCCCCCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVPA---SLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~s~el~~lI~kcL~~p---~~Rpsa~ElL~hpff~~~~~ 226 (568)
|++|..||... +....+..+........++. ..++.++++|.+||.++ ..|+++.++++||||+...+
T Consensus 240 ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 240 MLVGDTPFYAD-SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHhCCCCCCCC-CHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 99999999764 44555566654433222332 45889999999999743 34889999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=317.03 Aligned_cols=214 Identities=22% Similarity=0.415 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+|+.++||||++++++|.+. ..+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++|
T Consensus 86 ~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ 162 (370)
T cd05596 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG 162 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecC--CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345678899999999999999999988654 4799999999999999998764 5899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCcccccc-----CCCccceehhhHHHHHH
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILE 157 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~~-----~ys~ksDIWSLGiilyE 157 (568)
|+||||||+|||++ .+|.+||+|||++...... .....+||+.|+|||++.. .++.++|||||||++||
T Consensus 163 --ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilye 239 (370)
T cd05596 163 --FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239 (370)
T ss_pred --eeccCCCHHHEEEc-CCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHH
Confidence 99999999999997 7899999999999765432 2235679999999998742 37899999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcCC-CCC--CCCHHHHhcCCCCCCCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVP-ASL--RLPALELLKDPFLVTDNP 226 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~s~el~~lI~kcL~~-p~~--Rpsa~ElL~hpff~~~~~ 226 (568)
|++|..||... +....+..+........++. ..+.++++||.+||.+ |.+ |+++.+++.||||+...+
T Consensus 240 lltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 240 MLVGDTPFYAD-SLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred HHhCCCCcCCC-CHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 99999999864 45556666665443333333 4689999999999974 555 999999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.12 Aligned_cols=218 Identities=26% Similarity=0.445 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
..+.+..|+++|+.++||||++++++|... ..+++||||+++|+|.+++.. ...+++..++.++.||+.||.||
T Consensus 36 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l 113 (280)
T cd05608 36 GYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113 (280)
T ss_pred HHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 446778899999999999999999987654 469999999999999988743 35699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
|+++ |+||||||+||+++ .++.+||+|||++....... .....||+.|+|||++ ...++.++||||||+++|+|
T Consensus 114 H~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el 190 (280)
T cd05608 114 HQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEM 190 (280)
T ss_pred HHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHH
Confidence 9999 99999999999997 68899999999997654322 3345799999999987 45689999999999999999
Q ss_pred hhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCc
Q 008378 159 VTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 159 ltG~~Pf~~~~~~---~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l 229 (568)
++|+.||...... ..+...+.. .+..++...++.+++++.+||. +|.+|+ +++++++||||+...+..+
T Consensus 191 ~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 268 (280)
T cd05608 191 IAARGPFRARGEKVENKELKQRILN--DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268 (280)
T ss_pred HhCCCCCCCCCcchhHHHHHHhhcc--cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence 9999999764322 222333222 2334455678999999999996 799999 8899999999998766554
Q ss_pred c
Q 008378 230 V 230 (568)
Q Consensus 230 ~ 230 (568)
.
T Consensus 269 ~ 269 (280)
T cd05608 269 E 269 (280)
T ss_pred h
Confidence 3
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=311.65 Aligned_cols=217 Identities=28% Similarity=0.417 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~---~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
....++.+|+.+|+.++||||+++++++..... ..+|+|||||. ++|.+++...+.+++..++.++.||+.||.||
T Consensus 41 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L 119 (338)
T cd07859 41 SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119 (338)
T ss_pred hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999998865432 35899999995 79999999888899999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc---cCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE---EEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~---~~ys~ksDIWSLGi 153 (568)
|++| |+||||||+|||++ .+|.+||+|||+++...... ....+||+.|+|||++. ..|+.++|||||||
T Consensus 120 H~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGv 196 (338)
T cd07859 120 HTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 196 (338)
T ss_pred HHCC--eecCCCCHHHeEEC-CCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHH
Confidence 9999 99999999999997 78999999999997543211 13457999999999874 46899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHH--------------HHHH-----------cCCCCCC---CCCCCcHHHHHHHHHhcC-
Q 008378 154 CILEMVTCEYPYNECKNPAQIY--------------KKVT-----------SGIKPAS---LSKVTDPQVKQFIEKCIV- 204 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~--------------~~i~-----------~~~~p~~---~~~~~s~el~~lI~kcL~- 204 (568)
++|+|+||+.||.+.....++. ..+. ....+.. .....++.++++|.+||.
T Consensus 197 vl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 276 (338)
T cd07859 197 IFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAF 276 (338)
T ss_pred HHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCc
Confidence 9999999999997644322211 0100 0001111 112357889999999996
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 008378 205 PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 205 ~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|.+||++.|+|.||||+...
T Consensus 277 ~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 277 DPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred CcccCCCHHHHhcCchhhhcC
Confidence 799999999999999997644
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.09 Aligned_cols=212 Identities=19% Similarity=0.367 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+++.++||||++++++|... ..+++||||+.++.+..+......+++..++.++.||+.||.|||++
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 119 (287)
T cd07848 42 EVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119 (287)
T ss_pred cchhhHHHHHHHHHhCCCccccchhhhEecC--CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4457788999999999999999999988654 47999999999888877766667799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+ ++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++
T Consensus 120 ~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~ 196 (287)
T cd07848 120 D--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSD 196 (287)
T ss_pred C--eecCCCCHHHEEEc-CCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHh
Confidence 9 99999999999997 78899999999997764322 2345799999999987 4568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHc--CC------------------CCC---------CCCCCCcHHHHHHHHHhcC-CCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTS--GI------------------KPA---------SLSKVTDPQVKQFIEKCIV-PASLRL 210 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~--~~------------------~p~---------~~~~~~s~el~~lI~kcL~-~p~~Rp 210 (568)
|+.||............... .. .+. ......++++++||.+||. +|.+||
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~ 276 (287)
T cd07848 197 GQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY 276 (287)
T ss_pred CCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC
Confidence 99999875443333221110 00 000 0112357889999999996 699999
Q ss_pred CHHHHhcCCCC
Q 008378 211 PALELLKDPFL 221 (568)
Q Consensus 211 sa~ElL~hpff 221 (568)
++.++|+||||
T Consensus 277 s~~~~l~hp~f 287 (287)
T cd07848 277 LTEQCLNHPAF 287 (287)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.06 Aligned_cols=216 Identities=25% Similarity=0.386 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
...++.+|+++|++++||||++++++|.+. ..+|+||||+.+|+|.+++.+...+++..++.|+.||+.||.|||++|
T Consensus 41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 118 (318)
T cd05582 41 DRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118 (318)
T ss_pred hHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345678899999999999999999988754 479999999999999999998888999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+
T Consensus 119 --i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 119 --IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred --EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCC
Confidence 99999999999997 7889999999998765433 234568999999999874 56889999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCc
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l 229 (568)
.||... +.......+..... .++...++.++++|.+||+ +|.+||+ ..+++.||||....+..+
T Consensus 196 ~p~~~~-~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T cd05582 196 LPFQGK-DRKETMTMILKAKL--GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL 265 (318)
T ss_pred CCCCCC-CHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHH
Confidence 999764 44555555544322 2455678999999999996 7999999 677999999988665443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.13 Aligned_cols=221 Identities=27% Similarity=0.441 Sum_probs=183.5
Q ss_pred HHHHHHHHHH-HHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~-iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+++.+|.. +++.++||||++++++|.+. ..+|+||||+.+|+|..++.+.+.+++..++.++.||+.||.|||++
T Consensus 38 ~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 115 (323)
T cd05575 38 EQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115 (323)
T ss_pred HHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3445556655 56889999999999988654 47999999999999999999888999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
| |+||||||+|||++ .+|.+||+|||++.... .......+||+.|+|||++ ...|+.++|||||||++|+|++|
T Consensus 116 g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g 192 (323)
T cd05575 116 N--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192 (323)
T ss_pred C--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcC
Confidence 9 99999999999997 78999999999987532 2233456799999999987 45689999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH----HHHhcCCCCCCCCCCCcccCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa----~ElL~hpff~~~~~~~l~~~~l 234 (568)
..||.. .+..+++..+..+. ..+....++.++++|.+||+ +|.+||++ .+++.||||....+..+.....
T Consensus 193 ~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~ 267 (323)
T cd05575 193 LPPFYS-RDTAEMYDNILNKP--LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKI 267 (323)
T ss_pred CCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccC
Confidence 999976 45666676666543 23444568999999999996 69999987 6999999998877655544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=330.15 Aligned_cols=220 Identities=32% Similarity=0.549 Sum_probs=193.4
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHH-hCCCC--CHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNV--DMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~-k~~~l--~e~~i~~i~~QIl~gL~ 79 (568)
+.+..+-+..||.+.++|+|.|||+|.+++- .+.++-+.||-++||+|..+++ +++++ ++.++..+.+||++||.
T Consensus 612 dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLk 689 (1226)
T KOG4279|consen 612 DSREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLK 689 (1226)
T ss_pred cchhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhh
Confidence 4456677899999999999999999999863 3458889999999999999776 67888 89999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc---cCCCccceehhhHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMC 154 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~---~~ys~ksDIWSLGii 154 (568)
|||.+. |+|||||-+|+|++.-.|.+||.|||-++.+. ++...++.||..|||||++. ++|+.++|||||||+
T Consensus 690 YLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT 767 (1226)
T KOG4279|consen 690 YLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCT 767 (1226)
T ss_pred hhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccce
Confidence 999999 99999999999999889999999999998774 45667889999999999994 569999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
+.||+||++||.+..++..-+-++---..-+.++...+.+++.||.+|+. +|..||+|.+||.+||++..+.
T Consensus 768 ~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 768 MVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred eEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCC
Confidence 99999999999998887766666554444455777788999999999997 5999999999999999987643
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=318.77 Aligned_cols=214 Identities=27% Similarity=0.479 Sum_probs=186.9
Q ss_pred HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+.+.+.+|+++|++|. |||||.++++|.+.. .+++|||+|.||.|.+.+.+. .+++..+..+++||+.++.|||+
T Consensus 77 ~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~ 153 (382)
T KOG0032|consen 77 EDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHS 153 (382)
T ss_pred ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHh
Confidence 35678999999999998 999999999997665 799999999999999998877 59999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCC---CCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~---~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
.| |+||||||+|+|+... ++.+|++|||++...... .....+|||.|+|||++. ..|+..+||||+|+++|.|
T Consensus 154 ~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiL 231 (382)
T KOG0032|consen 154 LG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYIL 231 (382)
T ss_pred CC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHH
Confidence 99 9999999999999643 358999999999887653 456789999999999996 7899999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
++|..||.+.. .......+..+.. +...+...+..+++||.++|. +|..|+||.++|+|||++..
T Consensus 232 L~G~~PF~~~~-~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 232 LSGVPPFWGET-EFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred hhCCCCCcCCC-hhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999998754 4445556666533 334555668999999999995 79999999999999999865
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=310.16 Aligned_cols=216 Identities=25% Similarity=0.448 Sum_probs=182.5
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+..+.+..|..+++.+ +||||++++++|.+. ..+|+||||+.+|+|..++.+.+.+++..+..++.||+.||+|||+
T Consensus 37 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~ 114 (316)
T cd05620 37 DDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114 (316)
T ss_pred chHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456677888888765 899999999988754 4799999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++ .+|.+||+|||++.... .......+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 115 ~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~ 191 (316)
T cd05620 115 KG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191 (316)
T ss_pred CC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh
Confidence 99 99999999999997 78899999999986432 23344568999999999884 568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH-HHHhcCCCCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-LELLKDPFLVTDNPKD 228 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa-~ElL~hpff~~~~~~~ 228 (568)
|..||.. .+...+.+.+..+. ..++...+++++++|.+||. +|.+|+++ .+++.||||....+..
T Consensus 192 g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~ 258 (316)
T cd05620 192 GQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA 258 (316)
T ss_pred CCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHHH
Confidence 9999976 44566666665442 23455678999999999996 69999997 5888999998866543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.72 Aligned_cols=207 Identities=24% Similarity=0.345 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEc--CCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~--~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+.+|++++|||||++++++.+ .....+++||||+++|+|.+++.+.+.+++.....++.|++.||.|||+
T Consensus 61 ~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~ 140 (283)
T PHA02988 61 LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYK 140 (283)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHh
Confidence 35788899999999999999999999877 4455789999999999999999988889999999999999999999998
Q ss_pred C-CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc---cCCCccceehhhHHHHHHHh
Q 008378 84 H-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~-g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~---~~ys~ksDIWSLGiilyEml 159 (568)
. + ++||||||+||+++ .+|.+||+|||+++.+... ....+||+.|+|||++. ..|+.++|||||||++|||+
T Consensus 141 ~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~ 216 (283)
T PHA02988 141 YTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSP-PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216 (283)
T ss_pred cCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhccc-cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 4 7 88999999999997 7899999999999876433 23457899999999884 46899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|..||... +...++..+.........+...++++++||.+||+ +|.+||++.+++.
T Consensus 217 ~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 217 TGKIPFENL-TTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HCCCCCCCC-CHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 999999864 45566666654433334555678999999999996 7999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.59 Aligned_cols=215 Identities=27% Similarity=0.498 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+...+.+.+|+++|++++||||++++++|.+. ..+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~ 121 (333)
T cd06650 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121 (333)
T ss_pred HHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567799999999999999999999998765 4799999999999999999988889999999999999999999997
Q ss_pred C-CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 84 H-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 ~-g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
. + ++||||||+|||++ .+|.+||+|||++............||+.|+|||++. ..++.++|||||||++|+|++|
T Consensus 122 ~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g 198 (333)
T cd06650 122 KHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198 (333)
T ss_pred cCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 4 6 99999999999997 7889999999999776555455668999999999884 4589999999999999999999
Q ss_pred CCCCCCCCCHHHHH--------------------------------------------HHHHcCCCCCCCCCCCcHHHHH
Q 008378 162 EYPYNECKNPAQIY--------------------------------------------KKVTSGIKPASLSKVTDPQVKQ 197 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~--------------------------------------------~~i~~~~~p~~~~~~~s~el~~ 197 (568)
+.||.... ...+. ..+.....+.......++++++
T Consensus 199 ~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T cd06650 199 RYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQD 277 (333)
T ss_pred CCCCCCcc-hhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHH
Confidence 99996532 22211 1111222222222345789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 198 FIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 198 lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
||.+||+ +|.+||++.|++.||||+..
T Consensus 278 li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 278 FVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 9999996 79999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=304.53 Aligned_cols=211 Identities=26% Similarity=0.357 Sum_probs=182.6
Q ss_pred HHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 10 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
-+|||.+|.+++|||||.+.++.+..+.+.+|||||||+ -+|..++..-+ +|...+++.++.|++.||+|||.++ |
T Consensus 122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--i 198 (419)
T KOG0663|consen 122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--I 198 (419)
T ss_pred hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--e
Confidence 368999999999999999999999888889999999998 58999888765 8999999999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccc--ccCCCccceehhhHHHHHHHhhcCCC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGiilyEmltG~~P 164 (568)
+||||||+|+|++ +.|.+||+|||+|+.+..+. .+..+.|.||+|||++ ...|++++|+||+|||+.||+++++.
T Consensus 199 lHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl 277 (419)
T KOG0663|consen 199 LHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL 277 (419)
T ss_pred Eecccchhheeec-cCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence 9999999999997 89999999999999987653 4556889999999976 56799999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCC----------------------------CCCC-CcHHHHHHHHHhcC-CCCCCCCHHH
Q 008378 165 YNECKNPAQIYKKVTSGIKPAS----------------------------LSKV-TDPQVKQFIEKCIV-PASLRLPALE 214 (568)
Q Consensus 165 f~~~~~~~~i~~~i~~~~~p~~----------------------------~~~~-~s~el~~lI~kcL~-~p~~Rpsa~E 214 (568)
|.+....+|+.+.+..--.|.. +... .+....+|+..+|. +|.+|.||.|
T Consensus 278 f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 278 FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 9998888888777653111110 0011 34677889999996 8999999999
Q ss_pred HhcCCCCCCC
Q 008378 215 LLKDPFLVTD 224 (568)
Q Consensus 215 lL~hpff~~~ 224 (568)
.|+|.||.+.
T Consensus 358 ~L~h~~F~e~ 367 (419)
T KOG0663|consen 358 GLKHEYFRET 367 (419)
T ss_pred hhcccccccC
Confidence 9999999863
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=309.41 Aligned_cols=217 Identities=22% Similarity=0.426 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+.+|+.+++.+ +||||+++++++.+. ..+|+||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||
T Consensus 36 ~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH 113 (318)
T cd05570 36 DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113 (318)
T ss_pred hhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567788999999988 799999999988654 479999999999999999998889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
+++ ++||||||+||+++ .+|.+||+|||++.... .......+||+.|+|||++. ..++.++|||||||++|+|+
T Consensus 114 ~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~ 190 (318)
T cd05570 114 ERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190 (318)
T ss_pred hCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHh
Confidence 999 99999999999997 78999999999986532 22334567999999999874 56899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH-----HHHhcCCCCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKD 228 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa-----~ElL~hpff~~~~~~~ 228 (568)
+|+.||.. .+...+...+..... .++...++.+++||.+||. +|.+||++ .+++.||||+...+..
T Consensus 191 ~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~ 262 (318)
T cd05570 191 AGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDK 262 (318)
T ss_pred hCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 99999976 445666666655432 3455678999999999996 79999999 9999999998866543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.04 Aligned_cols=217 Identities=19% Similarity=0.411 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+.+|+.++.++ +||||+++++++... ..+++||||+.+|+|..++.+.+.+++..++.++.||+.||.|||
T Consensus 36 ~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH 113 (329)
T cd05618 36 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 113 (329)
T ss_pred hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45567788999998877 899999999988765 479999999999999999998889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+||+++ .+|.+||+|||+++... ........||+.|+|||++. ..++.++|||||||++|+|+
T Consensus 114 ~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (329)
T cd05618 114 ERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190 (329)
T ss_pred HCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHh
Confidence 999 99999999999997 78999999999987532 22234568999999999874 56899999999999999999
Q ss_pred hcCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC------HHHHhcCCCCCCC
Q 008378 160 TCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP------ALELLKDPFLVTD 224 (568)
Q Consensus 160 tG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps------a~ElL~hpff~~~ 224 (568)
+|..||... .....+.+.+... ...++...++.++++|.+||+ +|.+|++ +.+++.||||+..
T Consensus 191 ~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 191 AGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred hCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999521 1123344444443 223556678999999999996 6999998 4799999999876
Q ss_pred CCC
Q 008378 225 NPK 227 (568)
Q Consensus 225 ~~~ 227 (568)
++.
T Consensus 269 ~~~ 271 (329)
T cd05618 269 DWD 271 (329)
T ss_pred CHH
Confidence 653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.27 Aligned_cols=218 Identities=22% Similarity=0.390 Sum_probs=184.6
Q ss_pred HHHHHHHHHHHHHHHhCCCC-CeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~Hp-NIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+..|+++++.++|+ +|++++++|.+. ..+|+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||
T Consensus 41 ~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 118 (324)
T cd05587 41 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118 (324)
T ss_pred hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 35567888999999999765 588888887654 479999999999999999998889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++ .+|.+||+|||++.... .......+||+.|+|||++. ..|+.++|||||||++|+|+
T Consensus 119 ~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell 195 (324)
T cd05587 119 SKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195 (324)
T ss_pred HCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHH
Confidence 999 99999999999997 78899999999986432 22334567999999999874 45899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH-----HHHhcCCCCCCCCCCCc
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDL 229 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa-----~ElL~hpff~~~~~~~l 229 (568)
||+.||.+ .+...++..+.... ..++...+++++++|.+||. +|.+|+++ .+++.||||...++..+
T Consensus 196 tG~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~ 268 (324)
T cd05587 196 AGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268 (324)
T ss_pred hCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 99999976 45666666666543 23556678999999999996 79999976 89999999998776544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.12 Aligned_cols=219 Identities=20% Similarity=0.395 Sum_probs=184.0
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+.+|+.+++++ +||||+++++++.+. ..+|+||||+++|+|..++.+.+.+++..++.++.||+.||.|||
T Consensus 36 ~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH 113 (327)
T cd05617 36 DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH 113 (327)
T ss_pred hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45667789999999998 699999999988654 479999999999999999998889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++ .+|.+||+|||++.... .......+||+.|+|||++ ...|+.++||||||+++|+|+
T Consensus 114 ~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell 190 (327)
T cd05617 114 ERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 190 (327)
T ss_pred HCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHH
Confidence 999 99999999999997 78899999999987532 2233456899999999987 456899999999999999999
Q ss_pred hcCCCCCCC------CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC------HHHHhcCCCCCCCCC
Q 008378 160 TCEYPYNEC------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP------ALELLKDPFLVTDNP 226 (568)
Q Consensus 160 tG~~Pf~~~------~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps------a~ElL~hpff~~~~~ 226 (568)
||..||... .....+.+.+... +..++...++.++++|.+||. +|.+|++ ..+++.||||...++
T Consensus 191 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 191 AGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred hCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 999999532 2233445555443 334566788999999999996 6999998 469999999998765
Q ss_pred CCc
Q 008378 227 KDL 229 (568)
Q Consensus 227 ~~l 229 (568)
..+
T Consensus 269 ~~~ 271 (327)
T cd05617 269 DLL 271 (327)
T ss_pred HHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=325.82 Aligned_cols=218 Identities=31% Similarity=0.543 Sum_probs=191.2
Q ss_pred CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHh
Q 008378 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~y 80 (568)
|+.++-+.+.+||..|++|+|||+|.|.++|..+. +.|+|||||- |+-.+++.-+ +++.+-.|..|+.+.+.||.|
T Consensus 65 Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaY 141 (948)
T KOG0577|consen 65 QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAY 141 (948)
T ss_pred ccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--hHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHH
Confidence 56788899999999999999999999999887654 7899999996 7888887755 579999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc----ccCCCccceehhhHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl----~~~ys~ksDIWSLGiily 156 (568)
||+++ .||||||..|||++ +.|.|||+|||.|... ..+.+++|||.||||||+ ++.|+.++|||||||+.+
T Consensus 142 LHS~~--~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~--~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCI 216 (948)
T KOG0577|consen 142 LHSHN--RIHRDIKAGNILLS-EPGLVKLADFGSASIM--APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 216 (948)
T ss_pred HHHhh--HHhhhccccceEec-CCCeeeeccccchhhc--CchhcccCCccccchhHheeccccccCCccceeeccchhh
Confidence 99999 99999999999997 8999999999999775 346789999999999976 578999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcCC-CCCCCCHHHHhcCCCCCCCCCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~~-p~~Rpsa~ElL~hpff~~~~~~~ 228 (568)
||+-.++|+...+....+|..-. ...|......++..++.||..||++ |..|||+.++|+|+|.....+..
T Consensus 217 ELAERkPPlFnMNAMSALYHIAQ-NesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t 288 (948)
T KOG0577|consen 217 ELAERKPPLFNMNAMSALYHIAQ-NESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPT 288 (948)
T ss_pred hhhhcCCCccCchHHHHHHHHHh-cCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence 99999999988777777776544 3344444556789999999999985 89999999999999998776544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=305.63 Aligned_cols=213 Identities=27% Similarity=0.413 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
..+.+|+.+|+.++||||+++++++.+. ..+++||||+. ++|.+++.++ +.+++..++.++.||+.||.|||+++
T Consensus 48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~- 123 (303)
T cd07869 48 FTAIREASLLKGLKHANIVLLHDIIHTK--ETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY- 123 (303)
T ss_pred hhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4577899999999999999999988755 47999999996 6777777654 57999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus 124 -ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 201 (303)
T cd07869 124 -ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV 201 (303)
T ss_pred -eecCCCCHHHEEEC-CCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999997 7899999999998654322 233457899999999874 35889999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcC--C---------------CCCCCC-------------CCCcHHHHHHHHHhcC-CCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSG--I---------------KPASLS-------------KVTDPQVKQFIEKCIV-PASLRLP 211 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~--~---------------~p~~~~-------------~~~s~el~~lI~kcL~-~p~~Rps 211 (568)
.||.+..+.......+... . .+..+. ...++.+++||.+||+ +|.+|||
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s 281 (303)
T cd07869 202 AAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS 281 (303)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC
Confidence 9998765544333322110 0 000000 0134678999999997 6999999
Q ss_pred HHHHhcCCCCCCCCC
Q 008378 212 ALELLKDPFLVTDNP 226 (568)
Q Consensus 212 a~ElL~hpff~~~~~ 226 (568)
+.|+|.||||+...+
T Consensus 282 ~~~~l~h~~f~~~~~ 296 (303)
T cd07869 282 AQAALSHEYFSDLPP 296 (303)
T ss_pred HHHHhcCcccccCCh
Confidence 999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.29 Aligned_cols=216 Identities=26% Similarity=0.454 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHHH---HhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 5 DQLERLYSEVHLL---KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 5 ~~~e~l~~Ei~iL---k~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+..+.+.+|++++ +.++||||++++++|... ..+|+||||+.+|+|..++.+ +.+++..+..++.||+.||.||
T Consensus 41 ~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~l 117 (324)
T cd05589 41 DEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYL 117 (324)
T ss_pred hHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 4556777777765 566899999999988654 479999999999999988865 5699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
|++| ++||||||+||+++ .+|.+||+|||++..... ......+||+.|||||++ ...++.++|||||||++|+|
T Consensus 118 H~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el 194 (324)
T cd05589 118 HENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194 (324)
T ss_pred HhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHH
Confidence 9999 99999999999997 789999999999865322 223456899999999987 45689999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCc
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l 229 (568)
++|..||... +...+...+..+.. .++...++.+.++|.+||. +|.+|| ++.++++||||....+..+
T Consensus 195 ~~G~~pf~~~-~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~ 268 (324)
T cd05589 195 LVGESPFPGD-DEEEVFDSIVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268 (324)
T ss_pred HhCCCCCCCC-CHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence 9999999764 45555555555432 2455678999999999996 799999 6999999999987665443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.37 Aligned_cols=216 Identities=24% Similarity=0.455 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+.+..|..++..+ +||||+++++++... ..+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||+
T Consensus 37 ~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~ 114 (316)
T cd05592 37 DDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114 (316)
T ss_pred hhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456667788877755 899999999988654 4799999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
++ |+||||||+|||++ .+|.+||+|||++..... ......+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 115 ~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 191 (316)
T cd05592 115 KG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191 (316)
T ss_pred CC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh
Confidence 99 99999999999997 789999999999975432 2334568999999999874 558999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH-HHHhcCCCCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-LELLKDPFLVTDNPKD 228 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa-~ElL~hpff~~~~~~~ 228 (568)
|..||.+. +..+++..+..... .++...+++++++|.+||. +|.+|+++ .+++.||||....+..
T Consensus 192 G~~Pf~~~-~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~ 258 (316)
T cd05592 192 GQSPFHGE-DEDELFDSILNDRP--HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWER 258 (316)
T ss_pred CCCCCCCC-CHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHH
Confidence 99999864 45666666655422 3456678999999999996 69999986 5899999998876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=308.18 Aligned_cols=213 Identities=23% Similarity=0.481 Sum_probs=189.0
Q ss_pred CCCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 1 lqs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+++++++-++.+||+||..|+|||||.+|++|...+ .+.+||||..+|.|.+|+...+.|++..++.+++||+.|+.|
T Consensus 91 IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd--KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhY 168 (668)
T KOG0611|consen 91 IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD--KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHY 168 (668)
T ss_pred cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc--eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999999999986554 699999999999999999999999999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccccC-C-CccceehhhHHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILE 157 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~-y-s~ksDIWSLGiilyE 157 (568)
||.++ ++|||||.+|||++ .++.+||+||||+..+... ...++||+|-|.+||++.+. | ++.+|-||||+++|-
T Consensus 169 CHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYt 245 (668)
T KOG0611|consen 169 CHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYT 245 (668)
T ss_pred Hhhcc--ceecccchhheeec-CCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHH
Confidence 99999 99999999999998 8899999999999888654 46789999999999988654 5 689999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 222 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL-~~p~~Rpsa~ElL~hpff~ 222 (568)
|+.|..||.+ .+-..+++.|.+|.... ...+..+.-||+-|| ++|.+|.|..++-.|=|+.
T Consensus 246 LVyGtMPFDG-~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 246 LVYGTMPFDG-RDHKRLVRQISRGAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HhhcccccCC-chHHHHHHHhhcccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 9999999987 45677778888774322 122457888999998 6899999999999998764
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.83 Aligned_cols=219 Identities=28% Similarity=0.546 Sum_probs=187.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~-k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+++++.+|+.+|++|+.|+||+||++++... .+|+|||||..|+..++++ +.+.+.+..+..+++..+.||+|||-
T Consensus 70 sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~ 147 (502)
T KOG0574|consen 70 TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD 147 (502)
T ss_pred chHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH
Confidence 46889999999999999999999999887544 5999999999999999877 45789999999999999999999998
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
.. -||||||..|||++ ..|..||+|||.|-.+... ...+++|||.|||||+++ -+|+.++||||||++..||+-
T Consensus 148 ~~--KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAE 224 (502)
T KOG0574|consen 148 LK--KIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAE 224 (502)
T ss_pred HH--HHHhhcccccEEEc-ccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhc
Confidence 87 79999999999998 7899999999999888654 356789999999999995 579999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCCCcc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 230 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~~l~ 230 (568)
|++||...-....++..-+. +|+.+ +...+.++.+||++||. +|.+|-+|.+|+.|||.+.+....++
T Consensus 225 G~PPYsDIHPMRAIFMIPT~--PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~ 295 (502)
T KOG0574|consen 225 GRPPYSDIHPMRAIFMIPTK--PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIM 295 (502)
T ss_pred CCCCcccccccceeEeccCC--CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHH
Confidence 99999875444444332222 23333 34568899999999996 69999999999999999987765543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.52 Aligned_cols=209 Identities=26% Similarity=0.403 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
...+.+|+++|+.++||||+++++++... ..+++||||+. |+|.+++...+ .+++..++.++.||+.||.|||++|
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 123 (288)
T cd07871 47 PCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123 (288)
T ss_pred chhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45678999999999999999999988654 47999999997 59999887654 5799999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhc
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG 161 (568)
|+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+||
T Consensus 124 --ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g 200 (288)
T cd07871 124 --ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200 (288)
T ss_pred --cccCCCCHHHEEEC-CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhC
Confidence 99999999999997 7899999999998754322 233457899999999874 4589999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCC-CCC--------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 162 EYPYNECKNPAQIYKKVTSGI-KPA--------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~-~p~--------------------------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
+.||.+....+.+...+.... ++. ......++++++||.+||+ +|.+|||+.
T Consensus 201 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~ 280 (288)
T cd07871 201 RPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAE 280 (288)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHH
Confidence 999977544333322221100 000 0012357889999999997 799999999
Q ss_pred HHhcCCCC
Q 008378 214 ELLKDPFL 221 (568)
Q Consensus 214 ElL~hpff 221 (568)
|+|+||||
T Consensus 281 ~~l~hp~f 288 (288)
T cd07871 281 AALRHSYF 288 (288)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.19 Aligned_cols=216 Identities=25% Similarity=0.461 Sum_probs=182.6
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+....|..+++.+ +||||+++++++.+. ..+++||||+++|+|.+++.+...+++..+..++.||+.||.|||+
T Consensus 37 ~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~ 114 (316)
T cd05619 37 DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114 (316)
T ss_pred chHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456677788888864 999999999988755 4799999999999999999988889999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
++ |+||||||+|||++ .++.+||+|||++.... ........||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 115 ~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 191 (316)
T cd05619 115 KG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191 (316)
T ss_pred CC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 99 99999999999997 78899999999986532 22344567999999999874 568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH-HHhcCCCCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL-ELLKDPFLVTDNPKD 228 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~-ElL~hpff~~~~~~~ 228 (568)
|..||... +...+...+..... .++...+.+++++|.+||. +|.+|+++. +++.||||....+..
T Consensus 192 G~~pf~~~-~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~ 258 (316)
T cd05619 192 GQSPFHGH-DEEELFQSIRMDNP--CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSA 258 (316)
T ss_pred CCCCCCCC-CHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHH
Confidence 99999764 45666666654432 2445678899999999996 799999996 899999999876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.55 Aligned_cols=214 Identities=21% Similarity=0.412 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+++.++||||+++++.|.+. ..+|+||||+.+|+|.++++.. .+++..++.++.||+.||.|||++|
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ 162 (371)
T cd05622 86 DSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG 162 (371)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445678899999999999999999988754 4799999999999999998764 5899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCcccccc-----CCCccceehhhHHHHHH
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILE 157 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~~-----~ys~ksDIWSLGiilyE 157 (568)
|+||||||+|||++ .+|.+||+|||++...... .....+||+.|||||++.. .|+.++|||||||++||
T Consensus 163 --ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilye 239 (371)
T cd05622 163 --FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239 (371)
T ss_pred --EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHH
Confidence 99999999999997 7899999999999765432 2235679999999998843 27899999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCC---CCCCHHHHhcCCCCCCCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPAS---LRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~el~~lI~kcL~~p~---~Rpsa~ElL~hpff~~~~~ 226 (568)
|++|..||.. .+....+..+........++ ...+++++++|.+||.+|. .|+++.++++||||+...+
T Consensus 240 ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 240 MLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 9999999976 45566667776544322222 3568999999999997544 3789999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.19 Aligned_cols=221 Identities=22% Similarity=0.373 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+.+..|..++..+ +||+|+++++++.+. ..+|+||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 119 (323)
T cd05616 42 DDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119 (323)
T ss_pred hHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4456677888888888 589999999988654 4799999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++ .+|.+||+|||+++... .......+||+.|+|||++. ..|+.++|||||||++|+|+|
T Consensus 120 ~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 196 (323)
T cd05616 120 KG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196 (323)
T ss_pred CC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHh
Confidence 99 99999999999997 78999999999987542 22334568999999999874 568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDP 233 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~ 233 (568)
|..||.+ .+...+...+..... .++...+++++++|.+||+ +|.+|++ ..+++.||||+..++..+....
T Consensus 197 g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~ 272 (323)
T cd05616 197 GQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 272 (323)
T ss_pred CCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCC
Confidence 9999976 455666666665432 3456678999999999996 7999997 4899999999987766544333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.98 Aligned_cols=217 Identities=27% Similarity=0.423 Sum_probs=181.3
Q ss_pred HHHHHHHHHH-HHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~-iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...++.+|+. +++.++||||++++++|.+. ..+|+||||+.+|+|..++.+.+.+++..++.++.||+.||.|||++
T Consensus 38 ~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 115 (321)
T cd05603 38 EQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115 (321)
T ss_pred HHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3445666654 68899999999999988654 47999999999999999998888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
+ |+||||||+||+++ .+|.+||+|||++..... ......+||+.|+|||++. ..|+.++|||||||++|+|++|
T Consensus 116 ~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (321)
T cd05603 116 N--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192 (321)
T ss_pred C--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcC
Confidence 9 99999999999997 789999999999875322 2234567999999999874 5689999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH----HHHhcCCCCCCCCCCCcc
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELLKDPFLVTDNPKDLV 230 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa----~ElL~hpff~~~~~~~l~ 230 (568)
..||.. .+..+++..+... +..++...+..+.++|.+||+ +|.+|+++ .+++.|+||...++..+.
T Consensus 193 ~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 193 LPPFYS-RDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLY 263 (321)
T ss_pred CCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHh
Confidence 999976 4556666666654 334555678899999999996 69999875 599999999877665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.88 Aligned_cols=215 Identities=27% Similarity=0.448 Sum_probs=179.6
Q ss_pred HHHHHHHH-HHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~-iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.++.+|.. +++.++||||++++++|... ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 40 ~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g- 116 (325)
T cd05602 40 KHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN- 116 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 34455544 57889999999999988655 479999999999999999998888999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
|+||||||+|||++ .+|.+||+|||+++... .......+||+.|+|||++. ..|+.++|||||||++|+|++|..
T Consensus 117 -iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (325)
T cd05602 117 -IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194 (325)
T ss_pred -eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCC
Confidence 99999999999997 78899999999987542 22334568999999999874 558999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH----HHhcCCCCCCCCCCCcc
Q 008378 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL----ELLKDPFLVTDNPKDLV 230 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~----ElL~hpff~~~~~~~l~ 230 (568)
||.. .+....+..+... +..+....++.++++|.+||+ +|.+|+++. ++++|+||...++..+.
T Consensus 195 pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 195 PFYS-RNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred CCCC-CCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHH
Confidence 9986 4455566665543 223445678999999999996 699999876 89999999887765544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.53 Aligned_cols=216 Identities=24% Similarity=0.397 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHHHhC---CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 6 QLERLYSEVHLLKSL---KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L---~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
...++.+|..++..+ +||||++++++|... ..+|+||||+.+|+|..++.+.+.+++..++.++.||+.||.|||
T Consensus 36 ~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH 113 (330)
T cd05586 36 EVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH 113 (330)
T ss_pred HHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 445566777777766 699999999988655 479999999999999999999889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc--cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEm 158 (568)
++| |+||||||+|||++ .+|.+||+|||++.... .......+||+.|+|||++. ..|+.++|||||||++|+|
T Consensus 114 ~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~el 190 (330)
T cd05586 114 KYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190 (330)
T ss_pred HCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEe
Confidence 999 99999999999997 78899999999986532 22334568999999999874 3489999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC----CHHHHhcCCCCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL----PALELLKDPFLVTDNPKD 228 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp----sa~ElL~hpff~~~~~~~ 228 (568)
+||..||.. .+..++++.+..+.... .....++++++||.+||. +|.+|| ++.+++.||||....+..
T Consensus 191 ltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~ 263 (330)
T cd05586 191 CCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDL 263 (330)
T ss_pred ccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence 999999976 45666677766553321 123468899999999996 699998 689999999998765433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.23 Aligned_cols=217 Identities=26% Similarity=0.429 Sum_probs=180.0
Q ss_pred HHHHHHHHHHH-HHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~-iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+++.+|.. +++.++||||++++++|... ..+|+||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+
T Consensus 37 ~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~ 114 (325)
T cd05604 37 KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114 (325)
T ss_pred hHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34456666665 57889999999999988654 4799999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++ .+|.+||+|||++.... .......+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 115 ~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 191 (325)
T cd05604 115 IN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY 191 (325)
T ss_pred CC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc
Confidence 99 99999999999997 78999999999987532 22334567999999999874 568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH----HHHhcCCCCCCCCCCCc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELLKDPFLVTDNPKDL 229 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa----~ElL~hpff~~~~~~~l 229 (568)
|..||.. .+...++..+.... .......+..+.++|.+||. +|.+||++ .+++.||||....+..+
T Consensus 192 G~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~ 262 (325)
T cd05604 192 GLPPFYC-RDVAEMYDNILHKP--LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262 (325)
T ss_pred CCCCCCC-CCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 9999976 44556666665542 22334567899999999996 68888876 58999999988665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=289.76 Aligned_cols=210 Identities=34% Similarity=0.607 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|++++++++||||+++++++.+.. .+++|+||+++++|.+++.+.+.+++..++.++.||+.||.|||..|
T Consensus 47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 124 (263)
T cd06625 47 EVNALECEIQLLKNLQHERIVQYYGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM 124 (263)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--eEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4567899999999999999999999987654 89999999999999999998888999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++||||+|+||+++ .++.+||+|||++....... .....|++.|+|||++. ..++.++||||||+++|+|+
T Consensus 125 --i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 201 (263)
T cd06625 125 --IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201 (263)
T ss_pred --eecCCCCHHHEEEc-CCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHH
Confidence 99999999999997 78999999999987553221 13456889999999884 45889999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
+|+.||..........+ +........++...+..++++|.+||. +|.+||++.++++||||
T Consensus 202 ~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 202 TEKPPWAEFEAMAAIFK-IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred hCCCCccccchHHHHHH-HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99999977544444443 333333344666788999999999996 69999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=291.66 Aligned_cols=209 Identities=26% Similarity=0.423 Sum_probs=177.3
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
...|||+.|+.++|+|||.+.++|...+ .+.+|+||++ .+|...++.. ..+....++.|+.++++||+|||+++
T Consensus 47 talREIK~Lqel~h~nIi~LiD~F~~~~--~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~-- 121 (318)
T KOG0659|consen 47 TALREIKLLQELKHPNIIELIDVFPHKS--NLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW-- 121 (318)
T ss_pred HHHHHHHHHHHccCcchhhhhhhccCCC--ceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--
Confidence 4689999999999999999999986554 6889999997 5888887754 46999999999999999999999999
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc--ccccCCCCccCcccc--ccCCCccceehhhHHHHHHHhhcCC
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~--~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
|+||||||.|+|++ .+|.+||+|||+|+.+..+.. ...+-|.||+|||++ .+.|+..+||||.|||+.||+-|.+
T Consensus 122 IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P 200 (318)
T KOG0659|consen 122 ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP 200 (318)
T ss_pred hhcccCCccceEEc-CCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC
Confidence 99999999999997 899999999999998865432 334789999999977 5779999999999999999999998
Q ss_pred CCCCCCCHHHHHHHHHcCCC--CCCCC-----------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 164 PYNECKNPAQIYKKVTSGIK--PASLS-----------------------KVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~--p~~~~-----------------------~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
-|.+.++.+|+...+..--. +..|+ ...+.++.+|+.+++. +|.+|+++.|+|+
T Consensus 201 ~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 201 FFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred CCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 88888888888666542111 11111 1235677999999997 7999999999999
Q ss_pred CCCCCC
Q 008378 218 DPFLVT 223 (568)
Q Consensus 218 hpff~~ 223 (568)
|+||++
T Consensus 281 ~~yf~~ 286 (318)
T KOG0659|consen 281 HPYFKS 286 (318)
T ss_pred chhhhc
Confidence 999986
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=298.68 Aligned_cols=220 Identities=25% Similarity=0.407 Sum_probs=180.8
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+|+.+|+.++||||+++++.+... ..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35578899999999999999999988654 4799999999999999887653 4699999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcC
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~ 162 (568)
+ ++||||||+||+++ +++.++|+|||++...... .....+|++.|+|||++ ...++.++||||||+++|+|++|+
T Consensus 122 ~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~ 198 (285)
T cd05605 122 R--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198 (285)
T ss_pred C--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence 9 99999999999997 7789999999998765432 22445799999999987 456899999999999999999999
Q ss_pred CCCCCCCCHH---HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcccCC
Q 008378 163 YPYNECKNPA---QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDP 233 (568)
Q Consensus 163 ~Pf~~~~~~~---~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~~~~ 233 (568)
.||.+..... .+...+... +..++...++.+++||.+||. +|.+|| ++.+++.||||...+++.+...+
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05605 199 SPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM 276 (285)
T ss_pred CCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCC
Confidence 9998643322 222222221 233445678899999999996 799999 89999999999987776654333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=321.69 Aligned_cols=214 Identities=28% Similarity=0.460 Sum_probs=181.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL 78 (568)
.......+.+|+++|+.++|||||+++++|... ..+|+||||+++|+|.+++.. ...+++..+..++.||+.||
T Consensus 105 ~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 182 (478)
T PTZ00267 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182 (478)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHH
Confidence 345566788899999999999999999998765 479999999999999987753 35689999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccc-cCCCccceehhhHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 153 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGi 153 (568)
.|||+++ |+||||||+|||++ .+|.+||+|||++..+... ...+.+||+.|+|||++. ..|+.++|||||||
T Consensus 183 ~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 259 (478)
T PTZ00267 183 DEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259 (478)
T ss_pred HHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHH
Confidence 9999999 99999999999997 7899999999999866432 234567999999999884 56899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
++|+|++|..||... +...+...+..+..+ .++...+++++++|.+||. +|.+||++.+++.|||++.
T Consensus 260 ~l~el~tg~~Pf~~~-~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 260 ILYELLTLHRPFKGP-SQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHhCCCCCCCC-CHHHHHHHHHhCCCC-CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999764 455555555544332 2345568899999999996 6999999999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.77 Aligned_cols=213 Identities=27% Similarity=0.394 Sum_probs=171.8
Q ss_pred HHHHHHHHHhCCCCCeeeeeeEEEcC------CCCeEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHH
Q 008378 10 LYSEVHLLKSLKHENIIKFYNSWVDD------TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNIV~l~~~~~~~------~~~~l~lV~Ey~~gGsL~~~i~----k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
..+|+.+|+.++|||||+++++|... ...++++||||+. ++|.+++. ....+++..++.++.||+.||.
T Consensus 106 ~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~ 184 (440)
T PTZ00036 106 KNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184 (440)
T ss_pred HHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Confidence 45799999999999999999877542 2236789999997 46766654 3467999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc--cCCCccceehhhHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiily 156 (568)
|||+++ |+||||||+|||++..++.+||+|||+++.+... .....+||+.|+|||++. ..|+.++|||||||++|
T Consensus 185 yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 262 (440)
T PTZ00036 185 YIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIA 262 (440)
T ss_pred HHHHCC--EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHH
Confidence 999999 9999999999999855568999999999876432 334568999999999873 35899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCC----------------------C----CCCCCCcHHHHHHHHHhcC-CCCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKP----------------------A----SLSKVTDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p----------------------~----~~~~~~s~el~~lI~kcL~-~p~~R 209 (568)
||+||..||.+.....++.+.+.....| . .++...++++++||.+||+ +|.+|
T Consensus 263 elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R 342 (440)
T PTZ00036 263 EMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342 (440)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHC
Confidence 9999999998866665555444311100 0 1223356899999999996 79999
Q ss_pred CCHHHHhcCCCCCCCC
Q 008378 210 LPALELLKDPFLVTDN 225 (568)
Q Consensus 210 psa~ElL~hpff~~~~ 225 (568)
+++.|+|.||||....
T Consensus 343 ~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 343 LNPIEALADPFFDDLR 358 (440)
T ss_pred cCHHHHhCChhHHhhh
Confidence 9999999999997643
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.31 Aligned_cols=213 Identities=25% Similarity=0.458 Sum_probs=184.9
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
--.+++||+.|+.++|||||++|++. +....+|+|.|+-++|+|.+||-+| ..+.+..+++|++||+.|+.|||+..
T Consensus 61 t~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH 138 (864)
T KOG4717|consen 61 TGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH 138 (864)
T ss_pred hhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh
Confidence 35689999999999999999999965 4445799999999999999999887 47999999999999999999999998
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-CCcccccCCCCccCcccc-ccCCC-ccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELY-EEEYN-ELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl-~~~ys-~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+|+.+-...|-|||.|||++..+.. ....+.+|+..|-|||++ ...|+ +++||||||+|+|.|++|+
T Consensus 139 --VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq 216 (864)
T KOG4717|consen 139 --VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQ 216 (864)
T ss_pred --hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCC
Confidence 999999999998766899999999999976654 456788999999999966 56675 7899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
.||.+.++.+.+...+... ...+...+.++++||..||+ +|.+|.+.+++..++|++....
T Consensus 217 ~PFqeANDSETLTmImDCK---YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 217 PPFQEANDSETLTMIMDCK---YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred Cccccccchhhhhhhhccc---ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 9999877766665544322 23456778999999999996 7999999999999999997654
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.95 Aligned_cols=214 Identities=34% Similarity=0.583 Sum_probs=180.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+..+.+.+|+.+++.++||||+++++++.+.....+++++||+.+++|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 46 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 125 (266)
T cd06651 46 KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125 (266)
T ss_pred HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45678899999999999999999999887665568999999999999999999888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----CcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
+ ++||||||+||+++ .++.+||+|||++...... ......++..|+|||.+. ..++.++|||||||++|+|
T Consensus 126 ~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el 202 (266)
T cd06651 126 M--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEM 202 (266)
T ss_pred C--eeeCCCCHHHEEEC-CCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHH
Confidence 8 99999999999997 7889999999998755321 122356889999999874 4588999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhcCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLV 222 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~~p~~Rpsa~ElL~hpff~ 222 (568)
++|+.||........+.+..... ....++...++.++++|..|+.+|.+||++.|++.||||+
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 203 LTEKPPWAEYEAMAAIFKIATQP-TNPQLPSHISEHARDFLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHCCCCccccchHHHHHHHhcCC-CCCCCchhcCHHHHHHHHHhcCChhhCcCHHHHhcCcccc
Confidence 99999998765555555443333 2334556678999999955556899999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.32 Aligned_cols=219 Identities=22% Similarity=0.380 Sum_probs=183.9
Q ss_pred HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+.+..|+.+++.+. |++|++++++|.+. ..+|+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||+
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~ 119 (323)
T cd05615 42 DDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119 (323)
T ss_pred hHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45567888999999886 57788898887654 3799999999999999999998899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++ .+|.+||+|||++..... .......||+.|+|||++. ..++.++|||||||++|+|+|
T Consensus 120 ~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 196 (323)
T cd05615 120 RG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA 196 (323)
T ss_pred CC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHh
Confidence 99 99999999999997 789999999999875432 2234567999999999874 558999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCccc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVC 231 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~ 231 (568)
|..||.. .+...+.+.+.... ..++...++++++++.+||. +|.+|++ ..+++.||||...++..+..
T Consensus 197 G~~pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~ 270 (323)
T cd05615 197 GQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN 270 (323)
T ss_pred CCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhc
Confidence 9999976 45566666665543 23456678999999999996 6999997 57899999999877655433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=288.01 Aligned_cols=218 Identities=27% Similarity=0.470 Sum_probs=186.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+++++.++||||+++++++.+. ..+++|+||+++++|.+++.+.+.+++..+..++.||+.||.|||+
T Consensus 34 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~ 111 (262)
T cd05572 34 TGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111 (262)
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 34567899999999999999999999988654 4689999999999999999988889999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
++ ++|+||+|+||+++ .++.+||+|||++...... ......|++.|+|||.+ ...++.++|+||||+++|+|++|
T Consensus 112 ~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g 188 (262)
T cd05572 112 RG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188 (262)
T ss_pred CC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC
Confidence 99 99999999999997 6889999999999876543 23345789999999987 45689999999999999999999
Q ss_pred CCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCC
Q 008378 162 EYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNP 226 (568)
Q Consensus 162 ~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~ 226 (568)
..||.... ++..++..+..+......+...+++++++|.+||. +|.+|++ +.|++.||||+..++
T Consensus 189 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 189 RPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred CCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 99997654 35556666664444444555558999999999996 7999999 999999999987554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.73 Aligned_cols=222 Identities=27% Similarity=0.503 Sum_probs=188.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+..+++.+|+++|++++||||+++++++.+. ..+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+
T Consensus 42 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~ 119 (290)
T cd05580 42 LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119 (290)
T ss_pred hhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999988654 4799999999999999999998999999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcC
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~ 162 (568)
+| ++||||+|.|||++ .+|.+||+|||++...... .....|++.|+|||.+ ...++.++||||||+++|+|++|.
T Consensus 120 ~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 195 (290)
T cd05580 120 LD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR-TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGY 195 (290)
T ss_pred CC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC-CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 99 99999999999997 7889999999999776444 3445789999999977 455788999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcccCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~~~~l 234 (568)
.||.... .....+.+..+.. .++...++.++++|.+||. +|.+|+ ++.+++.||||....+..+....+
T Consensus 196 ~p~~~~~-~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 270 (290)
T cd05580 196 PPFFDDN-PIQIYEKILEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKI 270 (290)
T ss_pred CCCCCCC-HHHHHHHHhcCCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccC
Confidence 9997644 5555555554432 3455668999999999996 699998 899999999998877655544333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.45 Aligned_cols=210 Identities=29% Similarity=0.462 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHhC---CCCCeeeeeeEEEc---CCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHH
Q 008378 8 ERLYSEVHLLKSL---KHENIIKFYNSWVD---DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 8 e~l~~Ei~iLk~L---~HpNIV~l~~~~~~---~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~ 79 (568)
..+.+|+.+++.+ +||||+++++++.. .....+++||||+. ++|.+++... ..+++..++.++.||+.||.
T Consensus 46 ~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 124 (290)
T cd07862 46 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124 (290)
T ss_pred HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Confidence 4556777777766 69999999998753 23346899999997 6999998764 45899999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
|||++| |+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++ ...++.++|||||||++||
T Consensus 125 ~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e 201 (290)
T cd07862 125 FLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 201 (290)
T ss_pred HHHHCC--eeeCCCCHHHEEEc-CCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHH
Confidence 999999 99999999999997 7889999999999765433 23455799999999987 5568999999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCC--CCC----------------------CCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIK--PAS----------------------LSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~--p~~----------------------~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
|++|..||.+......+.+.+..... +.. +....++.++++|.+||+ +|.+||++
T Consensus 202 l~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~ 281 (290)
T cd07862 202 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 281 (290)
T ss_pred HHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH
Confidence 99999999876554444333321100 000 112357789999999996 69999999
Q ss_pred HHHhcCCCC
Q 008378 213 LELLKDPFL 221 (568)
Q Consensus 213 ~ElL~hpff 221 (568)
.++|+||||
T Consensus 282 ~~~l~hp~f 290 (290)
T cd07862 282 YSALSHPYF 290 (290)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.62 Aligned_cols=218 Identities=18% Similarity=0.374 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+.+.+|+.+++.++||||++++++|.+. ..+|+||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 120 (331)
T cd05597 43 AETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120 (331)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456688999999999999999999988654 479999999999999999987 4579999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc------cCCCccceehhhHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMC 154 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~------~~ys~ksDIWSLGii 154 (568)
++ |+||||||+|||++ .+|.+||+|||++....... ....+||+.|||||++. ..++.++|||||||+
T Consensus 121 ~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~ 197 (331)
T cd05597 121 LG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVC 197 (331)
T ss_pred CC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhH
Confidence 99 99999999999997 78999999999986553322 12346999999999884 347889999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCcHHHHHHHHHhcCC---CCCCCCHHHHhcCCCCCCCCCCC
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s~el~~lI~kcL~~---p~~Rpsa~ElL~hpff~~~~~~~ 228 (568)
+|+|++|+.||... +..+.+..+....... ......++.+++||.+||.. +..|+++.+++.||||....+..
T Consensus 198 l~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 198 MYEMLYGETPFYAE-SLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred HHHHhhCCCCCCCC-CHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 99999999999763 4455555554432211 11234688999999998853 44578999999999998766544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.92 Aligned_cols=211 Identities=27% Similarity=0.441 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHH
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~---------~~l~e~~i~~i~~QIl~gL 78 (568)
..+.+|+.+|++++||||++++++|.......+++||||+. ++|.+++... ..+++..++.++.||+.||
T Consensus 43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 121 (317)
T cd07868 43 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121 (317)
T ss_pred HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHH
Confidence 45778999999999999999999998776678999999996 5888887632 2589999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEe---CCCCcEEEeecChhhhccCC-----CcccccCCCCccCccccc--cCCCcccee
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDI 148 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~---~~~g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl~--~~ys~ksDI 148 (568)
.|||++| |+||||||+|||+. ...+.+||+|||++...... ......||+.|+|||++. ..|+.++||
T Consensus 122 ~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 199 (317)
T cd07868 122 HYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI 199 (317)
T ss_pred HHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhH
Confidence 9999999 99999999999994 24578999999999765432 123567899999999874 348999999
Q ss_pred hhhHHHHHHHhhcCCCCCCCCC---------HHHHHHHHHcCCCCC----------------------------------
Q 008378 149 YSFGMCILEMVTCEYPYNECKN---------PAQIYKKVTSGIKPA---------------------------------- 185 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~~~---------~~~i~~~i~~~~~p~---------------------------------- 185 (568)
|||||++|+|++|+.||..... ..++...+.....|.
T Consensus 200 wslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (317)
T cd07868 200 WAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM 279 (317)
T ss_pred HHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchH
Confidence 9999999999999999964321 111111111000000
Q ss_pred -CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 186 -SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 186 -~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
......++.+.+||.+||+ +|.+|||++|+|+||||
T Consensus 280 ~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 280 EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0011235678999999996 79999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=293.12 Aligned_cols=215 Identities=23% Similarity=0.373 Sum_probs=174.9
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+..|+++|++++||||+++++++... ..+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++|
T Consensus 38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 115 (277)
T cd05607 38 KMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115 (277)
T ss_pred HHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456799999999999999999988654 47999999999999998886543 5899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|++|..
T Consensus 116 --ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~ 192 (277)
T cd05607 116 --IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRT 192 (277)
T ss_pred --EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCC
Confidence 99999999999997 78899999999987654332 2345789999999987 4558999999999999999999999
Q ss_pred CCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH----HHHhcCCCCCCCCCCC
Q 008378 164 PYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELLKDPFLVTDNPKD 228 (568)
Q Consensus 164 Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa----~ElL~hpff~~~~~~~ 228 (568)
||..... ...+.........+ ......+++++++|.+||+ +|.+||++ .+++.||||+..++..
T Consensus 193 p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~ 264 (277)
T cd05607 193 PFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264 (277)
T ss_pred CCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence 9975432 23333333332221 1223568899999999996 69999999 6788999998765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=287.59 Aligned_cols=214 Identities=34% Similarity=0.582 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+.++.+.+|+++++.++||||++++++|.+.....+++||||+++++|.+++.+.+.+++..+..++.|++.||.|||++
T Consensus 46 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (265)
T cd06652 46 KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125 (265)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45778999999999999999999999887765568899999999999999999888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
+ ++|+||||+||+++ .++.+||+|||++...... ......|+..|+|||++ ...++.++||||||+++|+|
T Consensus 126 ~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 126 M--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred C--EecCCCCHHHEEec-CCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHH
Confidence 9 99999999999997 7889999999998765321 22345689999999987 45588999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhcCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLV 222 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~~p~~Rpsa~ElL~hpff~ 222 (568)
++|+.||........+.+ ..........+...+..+.++|.+|+.+|.+||++.+++.|||+.
T Consensus 203 ~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 203 LTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHCRDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHHHHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 999999987544444443 333322233455567889999999999999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.30 Aligned_cols=218 Identities=18% Similarity=0.389 Sum_probs=178.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+.+++.++|+||+++++++.+. ..+|+||||+.+|+|.+++.+ .+.+++..++.|+.||+.||.|||++
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~ 121 (332)
T cd05623 44 ETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121 (332)
T ss_pred HHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345578899999999999999999988655 479999999999999999987 46799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc------cCCCccceehhhHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCI 155 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~------~~ys~ksDIWSLGiil 155 (568)
+ |+||||||+|||++ .++.+||+|||++....... ....+||+.|+|||++. ..|+.++|||||||++
T Consensus 122 ~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil 198 (332)
T cd05623 122 H--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCM 198 (332)
T ss_pred C--eEecCCCHHHEEEC-CCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHH
Confidence 9 99999999999997 78899999999986543221 22357999999999874 3488999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCcHHHHHHHHHhcCC---CCCCCCHHHHhcCCCCCCCCCCCc
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASL---SKVTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~---~~~~s~el~~lI~kcL~~---p~~Rpsa~ElL~hpff~~~~~~~l 229 (568)
|||++|+.||... +....+..+........+ ....++++++||.+||.. +..|+++.++++||||....+..+
T Consensus 199 ~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~ 277 (332)
T cd05623 199 YEMLYGETPFYAE-SLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI 277 (332)
T ss_pred HHHhcCCCCCCCC-CHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence 9999999999864 455556666544322222 234689999999999953 344689999999999998765443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.66 Aligned_cols=215 Identities=29% Similarity=0.506 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
++..+++.+|+++|++++||||++++++|.+. ..+++||||+++++|.+++.+.+.+++..+..++.||+.||.|||+
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~ 117 (308)
T cd06615 40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117 (308)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567789999999999999999999998765 4799999999999999999988899999999999999999999997
Q ss_pred -CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 84 -HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 -~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
++ ++||||||+|||++ .++.+||+|||++............|++.|+|||++. ..++.++|+||||+++|+|++|
T Consensus 118 ~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 194 (308)
T cd06615 118 KHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194 (308)
T ss_pred hCC--EEECCCChHHEEEe-cCCcEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhC
Confidence 57 99999999999997 6889999999998766555556678999999999874 4588999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHH------------------------------------cCCCCCCCCCCCcHHHHHHHHHhcC-
Q 008378 162 EYPYNECKNPAQIYKKVT------------------------------------SGIKPASLSKVTDPQVKQFIEKCIV- 204 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~------------------------------------~~~~p~~~~~~~s~el~~lI~kcL~- 204 (568)
..||.... .......+. ....|.......++++++||.+||.
T Consensus 195 ~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 273 (308)
T cd06615 195 RYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKK 273 (308)
T ss_pred CCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccC
Confidence 99996432 222222221 1111221222367889999999996
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 008378 205 PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 205 ~p~~Rpsa~ElL~hpff~~~ 224 (568)
+|.+||++.+++.||||...
T Consensus 274 ~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 274 NPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ChhhCcCHHHHhcChhhhhc
Confidence 79999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=291.58 Aligned_cols=210 Identities=24% Similarity=0.474 Sum_probs=188.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~--k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.-..+.+|+++-..|+||||+++|++|.+.. .+|+++||...|+|...++ +.+++++.....+++|++.||.|+|.
T Consensus 65 v~~qlrREiEIqs~L~hpnilrlY~~fhd~~--riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~ 142 (281)
T KOG0580|consen 65 VEHQLRREIEIQSHLRHPNILRLYGYFHDSK--RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL 142 (281)
T ss_pred chhhhhheeEeecccCCccHHhhhhheeccc--eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc
Confidence 3467889999999999999999999998765 6999999999999999999 67789999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
.+ ||||||||+|+|+. ..|.+||+|||.+.........+.+||..|.+||+.+ ..++..+|+|++|++.||++.|.
T Consensus 143 k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ 219 (281)
T KOG0580|consen 143 KR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGL 219 (281)
T ss_pred CC--cccCCCCHHHhccC-CCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcC
Confidence 99 99999999999995 8899999999999888777788899999999999885 56999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
.||.... ..+.|++|..-. ..++..++..++++|.+||+ +|.+|++..|++.|||...
T Consensus 220 ppFes~~-~~etYkrI~k~~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 220 PPFESQS-HSETYKRIRKVD--LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred Cchhhhh-hHHHHHHHHHcc--ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 9997644 778888887542 22446788999999999996 6999999999999999864
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=288.80 Aligned_cols=217 Identities=28% Similarity=0.533 Sum_probs=179.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+....+.+.+|+++++.++||||+++++++... ...++|+||+.+++|..++.+ .+.+++..+..++.||+.||.||
T Consensus 42 ~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~L 119 (282)
T cd06643 42 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119 (282)
T ss_pred CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 456778899999999999999999999988765 478999999999999988764 46799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc------cCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~------~~ys~ksDIWSLGi 153 (568)
|+.| ++||||||+||+++ .++.+||+|||++...... ......|++.|+|||++. ..++.++|||||||
T Consensus 120 H~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv 196 (282)
T cd06643 120 HENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 196 (282)
T ss_pred HHCC--eeecCCCcccEEEc-cCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHH
Confidence 9999 99999999999997 7889999999998655322 223457899999999872 23778999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
++|+|++|..||.... .......+..... ....+...+.++++||.+||. +|.+||++.++++||||....
T Consensus 197 il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 197 TLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 9999999999997644 3333333333322 223345567899999999996 699999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.75 Aligned_cols=213 Identities=28% Similarity=0.451 Sum_probs=179.5
Q ss_pred HHHHHHHHHHhCCCCC-eeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHH
Q 008378 9 RLYSEVHLLKSLKHEN-IIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpN-IV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~~----~l~e~~i~~i~~QIl~gL~ 79 (568)
...+|+-+|+.|+|+| ||++++++...+ ...+++|+||++ -+|.+|+.... .++...++.+++||+.||+
T Consensus 56 taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~ 134 (323)
T KOG0594|consen 56 TAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLA 134 (323)
T ss_pred hhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHH
Confidence 3579999999999999 999999887654 237899999997 69999998765 5888999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc--ccCCCccceehhhHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGiil 155 (568)
|||+++ |+||||||+||+++ ..|.+||+|||+|+...-+ ...+.++|.+|.|||++ ...|+..+||||+|||+
T Consensus 135 ~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIf 211 (323)
T KOG0594|consen 135 FLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIF 211 (323)
T ss_pred HHHhCC--eecccCCcceEEEC-CCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHH
Confidence 999999 99999999999998 6999999999999977533 34566899999999977 34699999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCC-------------------------CCCcHHHHHHHHHhcC-CCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLS-------------------------KVTDPQVKQFIEKCIV-PAS 207 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~-------------------------~~~s~el~~lI~kcL~-~p~ 207 (568)
+||++++..|.+..+.+++.+.+..--.| ..|+ +..++...+++.+||+ +|.
T Consensus 212 aEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~ 291 (323)
T KOG0594|consen 212 AEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPA 291 (323)
T ss_pred HHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcc
Confidence 99999999999988888877666521111 0110 1223588999999997 699
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 008378 208 LRLPALELLKDPFLVTDN 225 (568)
Q Consensus 208 ~Rpsa~ElL~hpff~~~~ 225 (568)
+|.||..+|.||||....
T Consensus 292 ~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 292 KRISAKGALTHPYFSELP 309 (323)
T ss_pred cCcCHHHHhcChhhcccc
Confidence 999999999999998754
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=286.26 Aligned_cols=212 Identities=31% Similarity=0.514 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+..+.+.+|+++|++++|+||+++++++.+. ..+++|+||+.+++|.+++.+.+.+++..+..++.||+.||.|||+.
T Consensus 44 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (265)
T cd06631 44 KEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121 (265)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4557789999999999999999999988755 57999999999999999999888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--------CCcccccCCCCccCccccc-cCCCccceehhhHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 155 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--------~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiil 155 (568)
+ ++|+||+|+||+++ .++.+||+|||++..... .......|++.|+|||++. ..++.++|+||||+++
T Consensus 122 ~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~ 198 (265)
T cd06631 122 C--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTV 198 (265)
T ss_pred C--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHH
Confidence 9 99999999999997 789999999999876421 1123456899999999874 4588999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|+|++|..||......................+...+.++++||.+||. +|.+||++.+++.||||
T Consensus 199 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 199 FEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999765544444333322122233455678999999999996 69999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.88 Aligned_cols=212 Identities=27% Similarity=0.522 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+++|+.++|+||++++++|... ..+++||||+.+|+|... ...++..+..++.||+.||.|||+
T Consensus 113 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~ 186 (353)
T PLN00034 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHR 186 (353)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999988654 478999999999998653 346788899999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc-----C-CCccceehhhHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-----E-YNELVDIYSFGMCI 155 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~-----~-ys~ksDIWSLGiil 155 (568)
+| |+||||||+|||++ .++.+||+|||++..+... .....+||+.|+|||++.. . ++.++|||||||++
T Consensus 187 ~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil 263 (353)
T PLN00034 187 RH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263 (353)
T ss_pred CC--EeecCCCHHHEEEc-CCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHH
Confidence 99 99999999999997 7889999999999766432 2345689999999998732 2 35689999999999
Q ss_pred HHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 156 LEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 156 yEmltG~~Pf~~~~--~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|||++|+.||.... ....+...+.... +.......++++++||.+||. +|.+||++.|+|+||||....
T Consensus 264 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 264 LEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 99999999997432 2223333333222 233445678899999999996 799999999999999998754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=286.75 Aligned_cols=211 Identities=28% Similarity=0.515 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.....+.+|+.+++.++||||+++++++... ..+++||||+++++|.+++...+.+++..+..++.||+.||.|||++
T Consensus 48 ~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 125 (267)
T cd06645 48 EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125 (267)
T ss_pred hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4456688999999999999999999988765 47899999999999999999888999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc----ccCCCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl----~~~ys~ksDIWSLGiilyEm 158 (568)
| ++||||||+||+++ .++.+||+|||++...... ......|++.|+|||++ ...++.++|+|||||++|+|
T Consensus 126 ~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l 202 (267)
T cd06645 126 G--KMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred C--eecCCCCHHHEEEC-CCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHH
Confidence 9 99999999999997 7889999999998655332 22345799999999986 34588999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 220 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpf 220 (568)
++|..||........+.........+.... ...+..++++|.+||. +|.+||++.+++.|||
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 203 AELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred hcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999976544444433333332232222 1356789999999996 6999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.46 Aligned_cols=209 Identities=23% Similarity=0.424 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-----------------------
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------------- 59 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------------- 59 (568)
.+..+.+.+|+.+|+.+ +|||||++++++.... ..+++||||+++|+|.+++...
T Consensus 51 ~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 129 (338)
T cd05102 51 ASEHKALMSELKILIHIGNHLNVVNLLGACTKPN-GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVE 129 (338)
T ss_pred hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhh
Confidence 34567799999999999 8999999999886543 4689999999999999998753
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEE
Q 008378 60 ---------------------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 100 (568)
Q Consensus 60 ---------------------------------------~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl 100 (568)
..+++..+..++.||+.||.|||++| |+||||||+|||+
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~ 207 (338)
T cd05102 130 QSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILL 207 (338)
T ss_pred hhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEE
Confidence 23778889999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHH
Q 008378 101 NGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 174 (568)
Q Consensus 101 ~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i 174 (568)
+ .++.+||+|||+++...... .....+++.|+|||++ ...|+.++||||||+++|||++ |..||........+
T Consensus 208 ~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~ 286 (338)
T cd05102 208 S-ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286 (338)
T ss_pred c-CCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence 7 68899999999997653221 2234567889999977 5568999999999999999997 99999875555555
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 175 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 175 ~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
...+..+..+ ..+...++.++++|.+||. +|.+||++.++++
T Consensus 287 ~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 287 CQRLKDGTRM-RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHHhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 5666555433 2455678899999999996 6999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.04 Aligned_cols=214 Identities=29% Similarity=0.426 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
....+++.+|+.+|+.++||||++++++|..... ..+|+||||+.+ +|.+++. ..+++..+..++.||+.||.
T Consensus 61 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~ 137 (359)
T cd07876 61 QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIK 137 (359)
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHH
Confidence 4556788999999999999999999998865432 357999999975 6666654 35899999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
|||++| |+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..|+.++|||||||++|+
T Consensus 138 ~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e 214 (359)
T cd07876 138 HLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214 (359)
T ss_pred HHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHH
Confidence 999999 99999999999997 7899999999999765332 234567999999999874 568999999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCC--------------------CC-------------------CCCCCCCcHHHHHH
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGI--------------------KP-------------------ASLSKVTDPQVKQF 198 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~--------------------~p-------------------~~~~~~~s~el~~l 198 (568)
|+||..||.+......+...+.... .+ .......++++++|
T Consensus 215 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 294 (359)
T cd07876 215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL 294 (359)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHH
Confidence 9999999986543332221111000 00 00112346789999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 199 IEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 199 I~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|.+||. +|.+|||+.|+|.||||..
T Consensus 295 i~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 295 LSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHhccCcccCCCHHHHhcCchhhh
Confidence 999996 7999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=299.32 Aligned_cols=218 Identities=19% Similarity=0.400 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+.+++.++|+||+++++++.+. ..+|+||||+.+|+|.+++.+ .+.+++..++.|+.||+.||+|||++
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~ 121 (331)
T cd05624 44 ETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121 (331)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 455678899999999999999999988654 479999999999999999987 46799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc------cCCCccceehhhHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCI 155 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~------~~ys~ksDIWSLGiil 155 (568)
| |+||||||+|||++ .+|.+||+|||++....... .....||+.|+|||++. +.++.++||||||+++
T Consensus 122 ~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil 198 (331)
T cd05624 122 H--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCM 198 (331)
T ss_pred C--eeeccCchHHEEEc-CCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhh
Confidence 9 99999999999997 78899999999987654322 12357999999999874 3578899999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---CCCcHHHHHHHHHhcCCCCC---CCCHHHHhcCCCCCCCCCCCc
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS---KVTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~---~~~s~el~~lI~kcL~~p~~---Rpsa~ElL~hpff~~~~~~~l 229 (568)
|+|++|+.||... +....+..+........++ ...+++++++|.+||..+.+ |+++.++++||||+..++..+
T Consensus 199 ~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~ 277 (331)
T cd05624 199 YEMLYGETPFYAE-SLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI 277 (331)
T ss_pred hhhhhCCCCccCC-CHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence 9999999999764 4455555555432211122 23578999999999964333 568999999999998766543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.54 Aligned_cols=212 Identities=29% Similarity=0.429 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+.+|+++|++|+|||||+++++|... ...++|+|++. ++|..++...+.+++..++.++.||+.||.|||++|
T Consensus 127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~- 202 (391)
T PHA03212 127 RGGTATEAHILRAINHPSIIQLKGTFTYN--KFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR- 202 (391)
T ss_pred hhhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 35678999999999999999999988654 46889999995 789999988888999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccC---CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~---~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ ..|.+||+|||++..... ......+||+.|+|||++ ...|+.++|||||||++|||+||.
T Consensus 203 -IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~ 280 (391)
T PHA03212 203 -IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280 (391)
T ss_pred -cccCCCChHhEEEc-CCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99999999999997 788999999999965422 223356899999999987 456899999999999999999999
Q ss_pred CCCCCCC-------CHHHHHHHHHc-CCCC--------------------------CCCC-----CCCcHHHHHHHHHhc
Q 008378 163 YPYNECK-------NPAQIYKKVTS-GIKP--------------------------ASLS-----KVTDPQVKQFIEKCI 203 (568)
Q Consensus 163 ~Pf~~~~-------~~~~i~~~i~~-~~~p--------------------------~~~~-----~~~s~el~~lI~kcL 203 (568)
.||.+.. ...++...+.. +..| ...+ ...+.++++||.+||
T Consensus 281 ~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL 360 (391)
T PHA03212 281 DSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKML 360 (391)
T ss_pred CCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHh
Confidence 8875421 11111111110 0000 0000 123568999999999
Q ss_pred C-CCCCCCCHHHHhcCCCCCCC
Q 008378 204 V-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 204 ~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
. +|.+|||+.|+|.||||+..
T Consensus 361 ~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 361 AFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred cCChhhCCCHHHHhcChhhccC
Confidence 6 79999999999999999763
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=286.51 Aligned_cols=215 Identities=28% Similarity=0.537 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++..+++.+|+++++.++||||+++++.+... ..+++|+||+.+++|.+++... ..+++..+..++.||+.||.|||
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 117 (265)
T cd06605 40 EAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117 (265)
T ss_pred hHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc
Confidence 35567889999999999999999999988765 4799999999999999999876 78999999999999999999999
Q ss_pred h-CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 83 S-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 83 s-~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+ .+ ++||||||+||+++ .+|.+||+|||++............|++.|+|||.+ ...++.++||||||+++|+|++
T Consensus 118 ~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 194 (265)
T cd06605 118 EKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT 194 (265)
T ss_pred CCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 9 88 99999999999997 688999999999876644433347789999999977 4568999999999999999999
Q ss_pred cCCCCCCC----CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 161 CEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 161 G~~Pf~~~----~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|..||... .......+.+..+..+.......+++++++|.+||. +|.+||++.+++.||||+.
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 195 GRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred CCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999764 233444455555444443333378899999999996 7999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=288.03 Aligned_cols=214 Identities=28% Similarity=0.532 Sum_probs=178.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+..+++.+|+.+|++++||||+++++++.... ..++||||+++++|..+ ..+++..+..++.||+.||.|||+
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~ 113 (279)
T cd06619 40 VELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--RISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWS 113 (279)
T ss_pred hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--EEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHH
Confidence 455677899999999999999999999987653 68899999999999765 357899999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcC
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~ 162 (568)
++ ++|+||||+||+++ .+|.+||+|||++............||+.|+|||++ ...++.++|+||||+++|+|++|.
T Consensus 114 ~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 190 (279)
T cd06619 114 LK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190 (279)
T ss_pred CC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCC
Confidence 99 99999999999997 789999999999987655555667899999999987 456899999999999999999999
Q ss_pred CCCCCCCC------HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 163 YPYNECKN------PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 163 ~Pf~~~~~------~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
.||..... .....+.+.....+.......++++++||.+||. +|.+||++.+++.||||+..+.
T Consensus 191 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 191 FPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred CCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 99964221 2233344433333333334567899999999996 6999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=290.21 Aligned_cols=213 Identities=23% Similarity=0.396 Sum_probs=173.5
Q ss_pred HHHHHHH---HHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 10 LYSEVHL---LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 10 l~~Ei~i---Lk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
..+|..+ +...+||||+.+++++...+ ..++||||+.+|+|.+++..++.+++..+..++.||+.||.|||+++
T Consensus 41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~- 117 (279)
T cd05633 41 ALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF- 117 (279)
T ss_pred HHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3445443 34457999999999886543 68999999999999999998889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcCCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~~P 164 (568)
++||||||+||+++ .++.+||+|||++............||+.|+|||++. ..++.++||||||+++|+|++|..|
T Consensus 118 -ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 195 (279)
T cd05633 118 -VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195 (279)
T ss_pred -cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999997 7889999999998765444444567999999999874 3588999999999999999999999
Q ss_pred CCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCc
Q 008378 165 YNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 165 f~~~~~--~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l 229 (568)
|..... ...+.... . ..+..++...+++++++|.+||. +|.+|+ ++.++++||||+..+....
T Consensus 196 f~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 196 FRQHKTKDKHEIDRMT-L-TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred cCCCCCcCHHHHHHHh-h-cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 965332 22222221 1 12333555678999999999996 699999 6999999999998765553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=311.29 Aligned_cols=202 Identities=31% Similarity=0.499 Sum_probs=172.4
Q ss_pred HHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEe
Q 008378 11 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 90 (568)
Q Consensus 11 ~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiH 90 (568)
..+|+-|++|+|||||.|.++|.. .-++++|||||..|-|...++....+.......|.++|+.|+.|||.|. |||
T Consensus 160 ETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIH 235 (904)
T KOG4721|consen 160 ETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIH 235 (904)
T ss_pred hhhHHHHHhccCcceeeEeeeecC--CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--Hhh
Confidence 448999999999999999998754 3589999999999999999999999999999999999999999999999 999
Q ss_pred eeccCCcEEEeCCCCcEEEeecChhhhccC-CCcccccCCCCccCcccccc-CCCccceehhhHHHHHHHhhcCCCCCCC
Q 008378 91 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC 168 (568)
Q Consensus 91 RDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl~~-~ys~ksDIWSLGiilyEmltG~~Pf~~~ 168 (568)
||||.-||||. .+..|||+|||-++.... ...-+++||..|||||++.. ..++|+||||||++||||+||+.||.+-
T Consensus 236 RDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 236 RDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hccCCCceEee-ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 99999999997 677999999999987754 34557899999999999954 5799999999999999999999999764
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 169 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 169 ~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
...+ |+.-+-.....-..+...+.-++-||+.||. +|..||+..++|.|
T Consensus 315 dssA-IIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 315 DSSA-IIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred chhe-eEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 3333 2222222222223456677889999999995 89999999999998
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=281.15 Aligned_cols=211 Identities=32% Similarity=0.601 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yL 81 (568)
....+++.+|+++++.++||||+++++++... ..+++||||+.+++|.+++... ..+++..+..++.||+.||.||
T Consensus 40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~l 117 (256)
T cd08529 40 RREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117 (256)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45677899999999999999999999988754 4799999999999999999774 5789999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
|+.| ++||||||+||+++ .++.+||+|||++....... .....|++.|+|||++. ..++.++|+||||+++|+|
T Consensus 118 H~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 194 (256)
T cd08529 118 HSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYEC 194 (256)
T ss_pred HHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHH
Confidence 9998 99999999999997 67899999999987654322 23457899999999874 5588999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
++|..||... +.......+..+..+. .....++.++++|.+||+ +|.+||++.+++.|||+
T Consensus 195 ~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 195 CTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 9999999764 4555556665554433 344678899999999996 79999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=284.45 Aligned_cols=209 Identities=34% Similarity=0.614 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.++++++||||+++++++.... ..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ 126 (267)
T cd06628 49 MLDALAREIALLKELQHENIVQYLGSSLDAD--HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC
Confidence 4567889999999999999999999887653 78899999999999999999889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--------cccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--------~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
++||||+|+||+++ .++.+||+|||++....... .....|++.|+|||.+ ...++.++|+||||+++|
T Consensus 127 --ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~ 203 (267)
T cd06628 127 --IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVV 203 (267)
T ss_pred --cccccCCHHHEEEc-CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHH
Confidence 99999999999997 78899999999987664211 1234688999999987 456888999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
+|++|+.||........+.. +..... ...+...+..++++|.+||+ +|.+||++.+++.||||
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 204 EMLTGKHPFPDCTQLQAIFK-IGENAS-PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHhhCCCCCCCccHHHHHHH-HhccCC-CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999987655444333 333322 23455678899999999997 69999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=280.77 Aligned_cols=213 Identities=31% Similarity=0.536 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL~ 79 (568)
....+++..|+++|+.++||||+++++++.......++++|||+++++|.+++.. ...+++..+..++.||+.||.
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~ 119 (265)
T cd08217 40 EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119 (265)
T ss_pred HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999998887666789999999999999999876 357999999999999999999
Q ss_pred hhh-----hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-cCCCccceehhh
Q 008378 80 YLH-----SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSF 151 (568)
Q Consensus 80 yLH-----s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~~ys~ksDIWSL 151 (568)
||| +.+ ++||||||+||+++ .++.+||+|||++....... .....|++.|+|||++. ..++.++|+|||
T Consensus 120 ~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~sl 196 (265)
T cd08217 120 ECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSL 196 (265)
T ss_pred HHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHH
Confidence 999 777 99999999999998 78999999999998765433 34567999999999874 458899999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 152 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 152 GiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|+++|+|++|..||.... ...+.+.+..+..+ .++...++.+.+++.+||. +|.+||++.++++|||+
T Consensus 197 G~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 197 GCLIYELCALSPPFTARN-QLQLASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHCCCcccCcC-HHHHHHHHhcCCCC-CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999998643 56666666665443 3555678999999999996 79999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=296.00 Aligned_cols=215 Identities=21% Similarity=0.444 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+..+.+.+|+++++.++||||++++++|..+. ..++||||+++|+|.+++..+ +.+++..++.++.||+.||.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH 118 (327)
T cd08227 41 EMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118 (327)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44567788999999999999999999987654 789999999999999999764 45899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---------CcccccCCCCccCccccc---cCCCccceehh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE---EEYNELVDIYS 150 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl~---~~ys~ksDIWS 150 (568)
+++ |+||||||+|||++ .++.+++.||+........ ......++..|+|||++. ..|+.++||||
T Consensus 119 ~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws 195 (327)
T cd08227 119 HMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195 (327)
T ss_pred HCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHH
Confidence 999 99999999999997 7789999999865433211 112235778899999884 35899999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---------C----------------------------------CCC
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------P----------------------------------ASL 187 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~---------p----------------------------------~~~ 187 (568)
|||++|+|++|..||............+....+ + ...
T Consensus 196 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (327)
T cd08227 196 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPY 275 (327)
T ss_pred HHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccccc
Confidence 999999999999999764433333322221100 0 001
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 188 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 188 ~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
....++++++||.+||+ +|.+|||+.++++||||+..
T Consensus 276 ~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 276 NRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred ccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 12346789999999996 79999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.63 Aligned_cols=230 Identities=24% Similarity=0.430 Sum_probs=209.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+.++.+.++.|-++|.+++.|.||++|-.|.+. +++||+||-|-||.|...++..+.|++.+.+.++.-++.|++|||
T Consensus 460 dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~--kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH 537 (732)
T KOG0614|consen 460 DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS--KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH 537 (732)
T ss_pred chhHHHHHHhHHHHHHhcCchHHHHHHHHhccc--hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH
Confidence 356789999999999999999999999988654 589999999999999999999999999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
++| ||+|||||+|++++ .+|-+||.|||+|+.+... ...+++|||+|.|||++ ..+.+.++|.||||+++|||+|
T Consensus 538 ~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~ 614 (732)
T KOG0614|consen 538 RKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLT 614 (732)
T ss_pred hcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHc
Confidence 999 99999999999997 8999999999999988654 56789999999999955 8889999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~l 234 (568)
|.+||++ .++-..|..|..|+....+++.+...+.++|+++.. .|.+|+. ..++-+|.||..-+|..+....+
T Consensus 615 G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L 693 (732)
T KOG0614|consen 615 GSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTL 693 (732)
T ss_pred CCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccC
Confidence 9999987 678889999999999999999999999999998775 6999986 78999999999999988766665
Q ss_pred CCCC
Q 008378 235 RLPN 238 (568)
Q Consensus 235 ~~p~ 238 (568)
..|.
T Consensus 694 ~pPi 697 (732)
T KOG0614|consen 694 PPPI 697 (732)
T ss_pred CCCc
Confidence 5443
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=290.85 Aligned_cols=217 Identities=23% Similarity=0.387 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+.+|+.++|+||+++++.+.+. ..+++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 120 (285)
T cd05630 43 GESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120 (285)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345678899999999999999999988654 4799999999999999988654 359999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
++ ++||||||+||+++ .++.++|+|||++...... ......||+.|+|||++ ...++.++||||||+++|+|++|
T Consensus 121 ~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 197 (285)
T cd05630 121 ER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197 (285)
T ss_pred CC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhC
Confidence 99 99999999999997 7789999999998765332 22345799999999987 45689999999999999999999
Q ss_pred CCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCC
Q 008378 162 EYPYNECKNPA--QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKD 228 (568)
Q Consensus 162 ~~Pf~~~~~~~--~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~ 228 (568)
+.||....... .....+.... +..++...++++++||.+||+ +|.+||+ +.|+++||||+......
T Consensus 198 ~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05630 198 QSPFQQRKKKIKREEVERLVKEV-QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKR 271 (285)
T ss_pred CCCCCCCCccchHHHHHhhhhhh-hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHH
Confidence 99997643221 1122221111 223455678999999999997 7999999 99999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.18 Aligned_cols=214 Identities=31% Similarity=0.558 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+....+.+|++++++++||||+++++++.+.....+++|+||+.+++|.+++...+.+++..+..++.||+.||.|||+
T Consensus 45 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~ 124 (264)
T cd06653 45 SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124 (264)
T ss_pred hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45667899999999999999999999998776666789999999999999999888889999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----CcccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
++ ++||||||+||+++ .++.++|+|||++...... ......|++.|+|||++. ..++.++|+||||+++|+
T Consensus 125 ~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 201 (264)
T cd06653 125 NM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVE 201 (264)
T ss_pred CC--EecCCCCHHHEEEc-CCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHH
Confidence 99 99999999999997 6889999999999765321 123457899999999874 458899999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhcCCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 221 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~~p~~Rpsa~ElL~hpff 221 (568)
|++|+.||........+.+.. ....+..++...+++++++|.+|++.+..||++.+++.|||.
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 202 MLTEKPPWAEYEAMAAIFKIA-TQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHhCCCCCCccCHHHHHHHHH-cCCCCCCCCcccCHHHHHHHHHHhcCcccCccHHHHhcCCCC
Confidence 999999998765555554433 333334466778899999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=295.33 Aligned_cols=226 Identities=23% Similarity=0.436 Sum_probs=195.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+.+..-+.|-++|+.++||.+..+..+|+.. ..+++||||..||.|..++.+.+.|++...+.+..+|+.||.|||+
T Consensus 209 kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~--drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs 286 (516)
T KOG0690|consen 209 KDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ--DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS 286 (516)
T ss_pred hHHhhhhhhHHHHHHhccCcHHHHhhhhhccC--ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh
Confidence 45566778899999999999999998888654 4799999999999999999999999999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
++ |++||||.+|++++ .+|++||.||||.+.-- ....+++||||+|+|||+++ ..|+.++|+|.+|++||||++
T Consensus 287 ~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmC 363 (516)
T KOG0690|consen 287 RN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMC 363 (516)
T ss_pred CC--eeeeechhhhheec-cCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHh
Confidence 99 99999999999998 89999999999997542 34567899999999999995 569999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~l 234 (568)
|+.||... +-..++..|.-+ ...++...+++++.++..+|. +|.+|.. |.|+..|+||...+|.....+.+
T Consensus 364 GRLPFyn~-dh~kLFeLIl~e--d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki 440 (516)
T KOG0690|consen 364 GRLPFYNK-DHEKLFELILME--DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKI 440 (516)
T ss_pred ccCccccc-chhHHHHHHHhh--hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhcc
Confidence 99999874 444555555432 234677889999999999996 6999985 88999999999999987766655
Q ss_pred CCC
Q 008378 235 RLP 237 (568)
Q Consensus 235 ~~p 237 (568)
..|
T Consensus 441 ~PP 443 (516)
T KOG0690|consen 441 EPP 443 (516)
T ss_pred CCC
Confidence 444
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=279.50 Aligned_cols=212 Identities=29% Similarity=0.581 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yL 81 (568)
....+.+.+|+.++++++||||+++++.|... ...+++||||+++++|.+++... ..+++..++.++.|++.||.||
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~l 118 (257)
T cd08223 40 RRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118 (257)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34566789999999999999999999987543 34789999999999999998763 4589999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
|+.| ++||||||+||+++ .++.++|+|||++...... ......|++.|+|||++. ..++.++||||||+++|+|
T Consensus 119 H~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l 195 (257)
T cd08223 119 HEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195 (257)
T ss_pred HhCC--eeccCCCchhEEEe-cCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHH
Confidence 9999 99999999999997 7889999999998766432 233457899999999874 5588999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
++|+.||.... .......+..+..+ ..+...++++.+||.+|+. +|..||++.++++||||
T Consensus 196 ~~g~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 196 ATLKHAFNAKD-MNSLVYRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HcCCCCCCCCC-HHHHHHHHHhcCCC-CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999997643 44444445454433 2445678999999999996 69999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=302.26 Aligned_cols=217 Identities=28% Similarity=0.426 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~---~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
....+++.+|+.+|+.++||||+++++++..... ..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 118 (372)
T cd07853 40 LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118 (372)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999998865431 26899999996 6899988888889999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCcccccc--CCCccceehhhHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCI 155 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiil 155 (568)
||++| ++||||||+|||++ .++.+||+|||+++..... ......+|+.|+|||++.+ .|+.++|||||||++
T Consensus 119 LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 195 (372)
T cd07853 119 LHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIF 195 (372)
T ss_pred HHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHH
Confidence 99999 99999999999997 7899999999999765332 2234578999999998743 488999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHc------------------------CCCCC------CCCCCCcHHHHHHHHHhcC-
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTS------------------------GIKPA------SLSKVTDPQVKQFIEKCIV- 204 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~------------------------~~~p~------~~~~~~s~el~~lI~kcL~- 204 (568)
|||++|+.||.+.....++ ..+.. ...+. ......++++++||.+||.
T Consensus 196 ~el~~g~~pf~~~~~~~~~-~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 274 (372)
T cd07853 196 AELLGRRILFQAQSPIQQL-DLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVF 274 (372)
T ss_pred HHHHcCCCCCCCCCHHHHH-HHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCC
Confidence 9999999999765433322 22211 11111 1223457899999999996
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 008378 205 PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 205 ~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|.+||++.|+|.||||....
T Consensus 275 dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 275 DPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred ChhhCcCHHHHhcCHhhCCCc
Confidence 799999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=286.16 Aligned_cols=217 Identities=31% Similarity=0.574 Sum_probs=181.0
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+....+.+.+|+.++++++||||+++++++... ..+|+||||+++++|.+++.+. +.+++..++.++.|++.||.||
T Consensus 42 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l 119 (280)
T cd06611 42 SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119 (280)
T ss_pred CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 455678899999999999999999999988754 4789999999999999998774 5699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc------cCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~------~~ys~ksDIWSLGi 153 (568)
|+++ ++||||||+||+++ .++.+||+|||++...... ......|++.|+|||++. ..++.++|+||||+
T Consensus 120 h~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~ 196 (280)
T cd06611 120 HSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGI 196 (280)
T ss_pred HHCC--cccCCCChhhEEEC-CCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHH
Confidence 9999 99999999999997 7899999999998655332 223457899999999863 23677999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
++|+|++|..||... +.......+..+..+ ...+...+.++.++|.+||. +|.+||++.++++||||....
T Consensus 197 il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 197 TLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 999999999999764 344444445444332 22344567899999999996 699999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=286.16 Aligned_cols=219 Identities=28% Similarity=0.500 Sum_probs=180.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+++..+.+.+|+.+++.++||||+++++.+.... .+++||||+.+++|..++.+ ...+++..+..++.||+.||.||
T Consensus 49 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l 126 (292)
T cd06644 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126 (292)
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4667888999999999999999999999886543 78999999999999887754 45789999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc------cCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~------~~ys~ksDIWSLGi 153 (568)
|+++ ++||||||+||+++ .+|.+||+|||++...... ......+++.|+|||++. ..++.++||||||+
T Consensus 127 H~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ 203 (292)
T cd06644 127 HSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 203 (292)
T ss_pred hcCC--eeecCCCcceEEEc-CCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHH
Confidence 9999 99999999999997 6889999999988654322 223457899999999873 23678999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 227 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~ 227 (568)
++|+|++|..||.... .......+.....+ ...+...+.++.++|.+||. +|.+||++.++++||||....+.
T Consensus 204 il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 204 TLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred HHHHHhcCCCCCcccc-HHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 9999999999997643 44444444443332 22344567899999999996 79999999999999999876543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=283.20 Aligned_cols=214 Identities=31% Similarity=0.548 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+..+.+.+|+++|+.++||||+++++++.+. ..+++|+||+.+++|.+++.+.+.+++..+..|+.||+.||.|||++
T Consensus 45 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~ 122 (268)
T cd06630 45 EVVEALRKEIRLMARLNHPHIIRMLGATCED--SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN 122 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCceehhhceeccC--CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3567899999999999999999999988654 47899999999999999999888999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
| ++||||+|+||+++..+..+||+|||++....... .....||..|+|||++ ...++.++|+||||+++|+
T Consensus 123 ~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 200 (268)
T cd06630 123 Q--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE 200 (268)
T ss_pred C--eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHH
Confidence 9 99999999999997444579999999987664321 2234688999999987 4568899999999999999
Q ss_pred HhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 158 MVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 158 mltG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
|++|+.||..... .......+.........+...+++++++|.+||. +|.+||++.++++||||+
T Consensus 201 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 201 MATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999965332 2222223322333444556678999999999996 799999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=284.16 Aligned_cols=212 Identities=30% Similarity=0.539 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHH
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL 78 (568)
....+.+|+.+++.+ +||||++++++|.... ...+|+||||+.+|+|.+++... ..+++..+..++.||+.||
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l 124 (272)
T cd06637 45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124 (272)
T ss_pred cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 346788999999999 7999999999987543 24689999999999999998864 3689999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc------cCCCccceehh
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYS 150 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~------~~ys~ksDIWS 150 (568)
.|||+++ ++||||||+||+++ .++.+||+|||++...... ......|++.|+|||++. ..|+.++||||
T Consensus 125 ~~LH~~~--ivh~dl~~~nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 201 (272)
T cd06637 125 SHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 201 (272)
T ss_pred HHHHHCC--CccCCCCHHHEEEC-CCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence 9999999 99999999999997 7889999999998765322 234567999999999873 24888999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|||++|+|++|..||......... ..+.....+.......+..+++||.+||. +|.+||++.++++||||
T Consensus 202 lGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 202 LGITAIEMAEGAPPLCDMHPMRAL-FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHhCCCCccccCHHHHH-HHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 999999999999999764433322 23333323333344567899999999996 79999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=329.03 Aligned_cols=221 Identities=27% Similarity=0.490 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL~ 79 (568)
....+.+..|+.+|++|+|||||+++++|.+.....+||||||+.+|+|.+++.. .+.+++..++.|+.||+.||.
T Consensus 53 e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALa 132 (1021)
T PTZ00266 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132 (1021)
T ss_pred HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999999988777789999999999999999875 357999999999999999999
Q ss_pred hhhhCC-----CCeEeeeccCCcEEEeC----------------CCCcEEEeecChhhhccCC-CcccccCCCCccCccc
Q 008378 80 YLHSHN-----PPIIHRDLKCDNIFVNG----------------NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPEL 137 (568)
Q Consensus 80 yLHs~g-----~~IiHRDLKp~NILl~~----------------~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEv 137 (568)
|||+.+ .+||||||||+||||+. ..+.+||+|||++..+... .....+||+.|+|||+
T Consensus 133 YLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEv 212 (1021)
T PTZ00266 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPEL 212 (1021)
T ss_pred HHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHH
Confidence 999854 34999999999999952 1235899999999776433 2345689999999998
Q ss_pred cc---cCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 138 YE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 138 l~---~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
+. ..++.++||||||||+|+|+||..||.......++...+..+... .....++++.+||..||. +|.+||++.
T Consensus 213 L~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~ 290 (1021)
T PTZ00266 213 LLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSAL 290 (1021)
T ss_pred HhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHH
Confidence 73 348899999999999999999999998777777777776654322 223457899999999996 799999999
Q ss_pred HHhcCCCCCCCCC
Q 008378 214 ELLKDPFLVTDNP 226 (568)
Q Consensus 214 ElL~hpff~~~~~ 226 (568)
++|.|||++...+
T Consensus 291 QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 291 QCLGYQIIKNVGP 303 (1021)
T ss_pred HHhccHHHhhcCC
Confidence 9999999986543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=303.79 Aligned_cols=203 Identities=27% Similarity=0.447 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k--~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
-+.|.+|+++|++|+|+|||++|+++..+. .+||||||+..|+|.+|++. .+.++......++.||++|++||+++
T Consensus 245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~ 322 (468)
T KOG0197|consen 245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK 322 (468)
T ss_pred hhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC
Confidence 367889999999999999999999886544 79999999999999999997 46799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccccc---CCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI---GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~---GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+ +|||||-..||||+ +++.+||+|||||+......-.... -..-|.|||.+ ...|+.++||||||++||||+|
T Consensus 323 ~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT 399 (468)
T KOG0197|consen 323 N--YIHRDLAARNILVD-EDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFT 399 (468)
T ss_pred C--ccchhhhhhheeec-cCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhc
Confidence 9 99999999999997 8889999999999954332211111 23459999977 5779999999999999999999
Q ss_pred -cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 008378 161 -CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 216 (568)
Q Consensus 161 -G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL 216 (568)
|+.||.+. ...++.+.+.+|.+.+. +..+++++-+++..||. +|.+|||...+.
T Consensus 400 ~G~~py~~m-sn~ev~~~le~GyRlp~-P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 400 YGRVPYPGM-SNEEVLELLERGYRLPR-PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred cCCCCCCCC-CHHHHHHHHhccCcCCC-CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999875 45667788888876553 45578999999999996 799999988654
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=299.40 Aligned_cols=215 Identities=29% Similarity=0.415 Sum_probs=171.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
+....+++.+|+.+++.++||||+++++++.... ...+|+||||+. ++|.+++.. .+++..+..++.||+.||
T Consensus 63 ~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL 139 (364)
T cd07875 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGI 139 (364)
T ss_pred CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHH
Confidence 3455678899999999999999999999875432 236899999997 577777754 488999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
.|||++| |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||++ ...++.++|||||||++|
T Consensus 140 ~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 216 (364)
T cd07875 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216 (364)
T ss_pred HHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHH
Confidence 9999999 99999999999997 78999999999997664432 3456799999999987 456899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCC--------------------C-------------------CCCCCCCcHHHHH
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIK--------------------P-------------------ASLSKVTDPQVKQ 197 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~--------------------p-------------------~~~~~~~s~el~~ 197 (568)
+|++|+.||.+......+.+.+..... | .......+..+++
T Consensus 217 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 296 (364)
T cd07875 217 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296 (364)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHH
Confidence 999999999775443333222211000 0 0011123568899
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 198 FIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 198 lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
||.+||+ +|.+|||+.++|.||||..
T Consensus 297 ll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 297 LLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHhcCcCcccCCCHHHHhcCccccc
Confidence 9999996 7999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.06 Aligned_cols=209 Identities=23% Similarity=0.425 Sum_probs=173.8
Q ss_pred HHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeec
Q 008378 14 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 93 (568)
Q Consensus 14 i~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDL 93 (568)
+++++...||||+++++++... ..+++||||+.||+|.+++.+.+.+++..++.|+.|++.||.|||+++ ++||||
T Consensus 48 ~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di 123 (278)
T cd05606 48 LSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDL 123 (278)
T ss_pred HHHHHhCCCCcEeeeeeeeecC--CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCC
Confidence 3455556899999999988654 478999999999999999998888999999999999999999999999 999999
Q ss_pred cCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccccc--CCCccceehhhHHHHHHHhhcCCCCCCCCC-
Q 008378 94 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN- 170 (568)
Q Consensus 94 Kp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEmltG~~Pf~~~~~- 170 (568)
||+||+++ .++.+||+|||++..+.........|++.|+|||++.. .++.++||||||+++|+|++|..||.....
T Consensus 124 ~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~ 202 (278)
T cd05606 124 KPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202 (278)
T ss_pred CHHHEEEC-CCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc
Confidence 99999997 67899999999997665544556689999999998853 489999999999999999999999976422
Q ss_pred -HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCc
Q 008378 171 -PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 171 -~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l 229 (568)
...+...... .+..++...++.++++|.+||. +|.+|+ ++.++++||||+...+..+
T Consensus 203 ~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 203 DKHEIDRMTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred chHHHHHHhhc--cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 2222222222 2233555678999999999996 699999 9999999999998766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=299.37 Aligned_cols=215 Identities=29% Similarity=0.409 Sum_probs=171.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
+....+++.+|+.+|+.++||||++++++|.... ...+|+||||+.+ +|.+++.. .+++..++.++.||+.||
T Consensus 56 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL 132 (355)
T cd07874 56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGI 132 (355)
T ss_pred ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHH
Confidence 3456678899999999999999999999886443 2357999999974 67776653 589999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCccccc-cCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiily 156 (568)
.|||++| |+||||||+|||++ .+|.+||+|||+++...... .....||+.|+|||++. ..|+.++|||||||++|
T Consensus 133 ~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 209 (355)
T cd07874 133 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209 (355)
T ss_pred HHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHH
Confidence 9999999 99999999999997 78999999999997654332 34568999999999874 56899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCC----------------------------C-----------CCCCCCCcHHHHH
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIK----------------------------P-----------ASLSKVTDPQVKQ 197 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~----------------------------p-----------~~~~~~~s~el~~ 197 (568)
+|++|+.||.+......+...+..... + .......+.++++
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T cd07874 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289 (355)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHH
Confidence 999999999765433322221110000 0 0011223567899
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 198 FIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 198 lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
||.+||+ +|.+|||+.|+|+||||..
T Consensus 290 li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 290 LLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 9999996 7999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=282.07 Aligned_cols=214 Identities=32% Similarity=0.521 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNV--DMKAIKNWARQILRGLHY 80 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l--~e~~i~~i~~QIl~gL~y 80 (568)
....+.+.+|+.+++.++|+||+++++++... ..+++|+||+.+++|.+++... ..+ ++..+..++.||+.||.|
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~ 123 (268)
T cd06624 46 SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKY 123 (268)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHH
Confidence 45667899999999999999999999987654 4799999999999999998864 455 889999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc---CCCccceehhhHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCI 155 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~---~ys~ksDIWSLGiil 155 (568)
||+++ |+||||||+||+++...+.+||+|||++...... ......|++.|+|||++.. .++.++|+||||+++
T Consensus 124 lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl 201 (268)
T cd06624 124 LHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTI 201 (268)
T ss_pred HHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHH
Confidence 99998 9999999999999755789999999998765322 2234468999999998742 378999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|+|++|..||.....................++...++++++||.+||. +|.+||++.+++.||||
T Consensus 202 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 202 VEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999765443333222222122334556678999999999996 69999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.28 Aligned_cols=211 Identities=28% Similarity=0.449 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHH
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~---------~~l~e~~i~~i~~QIl~gL 78 (568)
..+.+|+.+|+.++||||+++++++.......+++||||+. ++|.+++..+ ..+++..++.++.||+.||
T Consensus 43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 121 (317)
T cd07867 43 MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121 (317)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHH
Confidence 45788999999999999999999998776778999999997 5787776532 2488999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEe---CCCCcEEEeecChhhhccCC-----CcccccCCCCccCccccc--cCCCcccee
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDI 148 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~---~~~g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl~--~~ys~ksDI 148 (568)
.|||+++ ++||||||+|||+. ..+|.+||+|||+++..... ......||+.|+|||++. ..++.++||
T Consensus 122 ~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 199 (317)
T cd07867 122 HYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI 199 (317)
T ss_pred HHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHH
Confidence 9999999 99999999999994 24678999999999765432 123457899999999874 348999999
Q ss_pred hhhHHHHHHHhhcCCCCCCCCC---------HHHHHHHHHcCCCC-----------------------------------
Q 008378 149 YSFGMCILEMVTCEYPYNECKN---------PAQIYKKVTSGIKP----------------------------------- 184 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~~~---------~~~i~~~i~~~~~p----------------------------------- 184 (568)
|||||++|||+||+.||..... ..++.+.+.....+
T Consensus 200 wSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (317)
T cd07867 200 WAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYM 279 (317)
T ss_pred HhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhh
Confidence 9999999999999999964321 11111111100000
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 185 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 185 ~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
.......+..++++|.+||+ +|.+|||+.|+|+||||
T Consensus 280 ~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 280 EKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00011235678899999996 79999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=338.86 Aligned_cols=213 Identities=31% Similarity=0.548 Sum_probs=190.0
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
...+.+|..+|..|+|||+|+||++-++.+ .+++.||||.+|+|.+.+...+..++...+.+..|++.|+.|||++|
T Consensus 1278 ~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--kv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g- 1354 (1509)
T KOG4645|consen 1278 FKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--KVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG- 1354 (1509)
T ss_pred CcchHHHHHHHHhccCccccccCceeecHH--HHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC-
Confidence 345778999999999999999999766554 57778899999999999998888999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------CcccccCCCCccCccccc----cCCCccceehhhHHHHH
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGiily 156 (568)
|+||||||.|||++ .+|.+|++|||.|...... .....+|||.|||||++. .+...++|||||||++.
T Consensus 1355 -IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVl 1432 (1509)
T KOG4645|consen 1355 -IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVL 1432 (1509)
T ss_pred -ceecCCCccceeee-cCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEE
Confidence 99999999999998 7889999999999766443 234678999999999983 45778999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||+||+.||.+..+..+|+-++.-|.+|... ...+++.++||+.||+ +|.+|.++.|||.|.|-+...
T Consensus 1433 EM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P-~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1433 EMATGKRPWAELDNEWAIMYHVAAGHKPQIP-ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred EeecCCCchhhccchhHHHhHHhccCCCCCc-hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 9999999999999999999999999888744 4489999999999995 899999999999999977544
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=304.93 Aligned_cols=214 Identities=24% Similarity=0.388 Sum_probs=172.2
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
.+.+|+++|++|+|||||+++++|... ..+++|||++. ++|.+++...+.+++..++.|+.||+.||.|||++| |
T Consensus 132 ~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--i 206 (392)
T PHA03207 132 TPGREIDILKTISHRAIINLIHAYRWK--STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--I 206 (392)
T ss_pred cHHHHHHHHHhcCCCCccceeeeEeeC--CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 456899999999999999999988654 47899999996 789999988888999999999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
+||||||+|||++ ..+.+||+|||++....... .....||+.|+|||++. ..|+.++|||||||++|||++|+.
T Consensus 207 vHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 285 (392)
T PHA03207 207 IHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285 (392)
T ss_pred cccCCCHHHEEEc-CCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999997 78899999999997654322 23467999999999884 568999999999999999999999
Q ss_pred CCCCCCC---HHHHHHHHHc-------------------------CCCC-CCCC-----CCCcHHHHHHHHHhcC-CCCC
Q 008378 164 PYNECKN---PAQIYKKVTS-------------------------GIKP-ASLS-----KVTDPQVKQFIEKCIV-PASL 208 (568)
Q Consensus 164 Pf~~~~~---~~~i~~~i~~-------------------------~~~p-~~~~-----~~~s~el~~lI~kcL~-~p~~ 208 (568)
||.+... ..++...+.. ...+ ...+ ...+.++++||.+||. +|.+
T Consensus 286 pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 365 (392)
T PHA03207 286 TLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEF 365 (392)
T ss_pred CCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhh
Confidence 9976432 1122111110 0000 0011 2346788999999996 7999
Q ss_pred CCCHHHHhcCCCCCCCCCCC
Q 008378 209 RLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 209 Rpsa~ElL~hpff~~~~~~~ 228 (568)
||++.|+|.||||++..+..
T Consensus 366 Rpsa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 366 RPSAQDILSLPLFTKEPINL 385 (392)
T ss_pred CCCHHHHhhCchhhccchhh
Confidence 99999999999998755433
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=285.44 Aligned_cols=219 Identities=28% Similarity=0.516 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL~y 80 (568)
....++.+|+++|+.++||||++++++|.+.....+++||||+++++|.+++.. ...+++..+..++.||+.||.|
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 120 (287)
T cd06621 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120 (287)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999887766789999999999999988653 3458999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
||+.+ ++|+||+|+||+++ .++.++|+|||++............++..|+|||.+ ...++.++||||||+++|+|+
T Consensus 121 lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 197 (287)
T cd06621 121 LHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA 197 (287)
T ss_pred HHHCC--cccCCCCHHHEEEe-cCCeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 99999 99999999999997 678999999999876654444455788999999977 456899999999999999999
Q ss_pred hcCCCCCCC----CCHHHHHHHHHcCCCCC---CCC--CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 160 TCEYPYNEC----KNPAQIYKKVTSGIKPA---SLS--KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 160 tG~~Pf~~~----~~~~~i~~~i~~~~~p~---~~~--~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
+|..||... .....+...+.....+. ... ...++.+++||.+||. +|.+||++.|++.||||+....
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred hCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 999999764 23344444444322211 111 2346789999999996 7999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=288.75 Aligned_cols=218 Identities=22% Similarity=0.416 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+++++.++||||+++++.+... ..+++||||++|++|.++++..+.+++..+..++.|++.||.|||++
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 120 (305)
T cd05609 43 NQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120 (305)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567788999999999999999999988654 47999999999999999999888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----------------CcccccCCCCccCcccc-ccCCCccc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------TARSVIGTPEFMAPELY-EEEYNELV 146 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----------------~~~s~~GTp~YmAPEvl-~~~ys~ks 146 (568)
+ ++||||||+||+++ .+|.+||+|||+++..... ......|++.|+|||.+ ...++.++
T Consensus 121 ~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 197 (305)
T cd05609 121 G--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV 197 (305)
T ss_pred C--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchh
Confidence 9 99999999999997 7899999999988632100 11234678899999976 55689999
Q ss_pred eehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHHHHHHHHHhcC-CCCCCCC---HHHHhcCCCC
Q 008378 147 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLP---ALELLKDPFL 221 (568)
Q Consensus 147 DIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~el~~lI~kcL~-~p~~Rps---a~ElL~hpff 221 (568)
|+||||+++|+|++|..||.+. ...++...+..+.. ........+++++++|.+||+ +|.+||+ +.++|.||||
T Consensus 198 Di~slG~vl~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 198 DWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred hHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 9999999999999999999764 45555555554422 222223568899999999996 6999998 7999999999
Q ss_pred CCCCCCC
Q 008378 222 VTDNPKD 228 (568)
Q Consensus 222 ~~~~~~~ 228 (568)
....+..
T Consensus 277 ~~~~~~~ 283 (305)
T cd05609 277 LGLDWNG 283 (305)
T ss_pred cCCCHHH
Confidence 8766544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=279.88 Aligned_cols=212 Identities=29% Similarity=0.541 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+.+|++++++++||||+++++++.+. ..++++|||+.+++|.+++... ..+++..+..++.|++.||.|||
T Consensus 41 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh 118 (262)
T cd06613 41 GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118 (262)
T ss_pred hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH
Confidence 34678899999999999999999999988765 4799999999999999999876 78999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-c---CCCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-E---EYNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~---~ys~ksDIWSLGiily 156 (568)
+++ ++||||||+||+++ .+|.+||+|||++...... ......++..|+|||++. . .++.++|+||||+++|
T Consensus 119 ~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~ 195 (262)
T cd06613 119 ETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAI 195 (262)
T ss_pred hCC--ceecCCChhhEEEC-CCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHH
Confidence 999 99999999999998 7899999999998765432 234457899999999874 3 5888999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 220 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpf 220 (568)
+|+||..||..................+.. .....+.++++||.+||. +|..||++.+++.|+|
T Consensus 196 ~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 196 ELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999876544444433333222222 122346789999999996 6999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=283.01 Aligned_cols=217 Identities=29% Similarity=0.505 Sum_probs=183.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+++++.++||||+++++++.+. ..+++|+||+.+++|.+++... ++++..++.++.||+.||.|||+
T Consensus 40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~ 116 (274)
T cd06609 40 EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE 116 (274)
T ss_pred chHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567789999999999999999999988765 4799999999999999999875 79999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
++ ++||||+|+||+++ .+|.++|+|||+++..... ......|++.|+|||++. ..++.++||||||+++|+|+|
T Consensus 117 ~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~t 193 (274)
T cd06609 117 EG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193 (274)
T ss_pred CC--cccCCCCHHHEEEC-CCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 99 99999999999997 7899999999999776543 234557899999999874 458999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 227 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~ 227 (568)
|..||.... +......+..+..+.......++.++++|.+||. +|.+||++.++++||||+.....
T Consensus 194 g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 194 GEPPLSDLH-PMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred CCCCcccCc-hHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999997643 4445555555444433223378899999999995 79999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=285.40 Aligned_cols=209 Identities=30% Similarity=0.451 Sum_probs=166.7
Q ss_pred HHHHHHHHHHhC---CCCCeeeeeeEEEcC---CCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHh
Q 008378 9 RLYSEVHLLKSL---KHENIIKFYNSWVDD---TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 9 ~l~~Ei~iLk~L---~HpNIV~l~~~~~~~---~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~y 80 (568)
.+.+|+.+++.+ +||||+++++++... ....+++||||+. ++|..++.+. ..+++..++.++.||+.||.|
T Consensus 45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 123 (288)
T cd07863 45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123 (288)
T ss_pred HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 455677777665 799999999987643 2346899999997 5898888764 348999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
||++| ++||||||+||+++ .+|.+||+|||++....... .....||+.|+|||++ ...++.++|||||||++|+|
T Consensus 124 lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 200 (288)
T cd07863 124 LHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200 (288)
T ss_pred HHhCC--eecCCCCHHHEEEC-CCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHH
Confidence 99999 99999999999997 78999999999998764332 3456789999999987 45689999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCC------C------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIK------P------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~------p------------------~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
++|..||........+.+.+..... + .......+..++++|.+||+ +|.+||++.
T Consensus 201 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 280 (288)
T cd07863 201 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAF 280 (288)
T ss_pred HhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHH
Confidence 9999999775544443333221000 0 00112356788999999996 799999999
Q ss_pred HHhcCCCC
Q 008378 214 ELLKDPFL 221 (568)
Q Consensus 214 ElL~hpff 221 (568)
+++.||||
T Consensus 281 ~~l~hp~f 288 (288)
T cd07863 281 RALQHPFF 288 (288)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=296.05 Aligned_cols=214 Identities=29% Similarity=0.465 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
...+++.+|+++|++++||||++++++|.... ...+|++++++ +++|.++++. +.+++..++.++.||+.||.|
T Consensus 56 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~ 133 (343)
T cd07878 56 IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKY 133 (343)
T ss_pred HHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999876432 13578999988 7899887764 569999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccccc--CCCccceehhhHHHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEM 158 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEm 158 (568)
||++| |+||||||+||+++ .++.+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|
T Consensus 134 LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 134 IHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred HHHCC--eecccCChhhEEEC-CCCCEEEcCCccceecCC-CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHH
Confidence 99999 99999999999997 789999999999976543 2345679999999998743 589999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHc-CCC------------------------CC---CCCCCCcHHHHHHHHHhcC-CCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTS-GIK------------------------PA---SLSKVTDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~-~~~------------------------p~---~~~~~~s~el~~lI~kcL~-~p~~R 209 (568)
++|..||........+...... +.. .. ......++.+.+||.+||. +|.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 9999999764433322221110 000 00 0112346778999999996 79999
Q ss_pred CCHHHHhcCCCCCCC
Q 008378 210 LPALELLKDPFLVTD 224 (568)
Q Consensus 210 psa~ElL~hpff~~~ 224 (568)
||+.|+|.||||...
T Consensus 290 ~s~~ell~hp~~~~~ 304 (343)
T cd07878 290 ISASEALAHPYFSQY 304 (343)
T ss_pred CCHHHHhcCcchhcc
Confidence 999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=283.96 Aligned_cols=218 Identities=24% Similarity=0.407 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+.+|+.++||||+++++++... ..+|+||||+++++|.+++.+.+ .+++..+..++.|++.||.|||+
T Consensus 36 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~ 113 (277)
T cd05577 36 GEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113 (277)
T ss_pred hhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345667899999999999999999988654 47899999999999999998765 79999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
+| ++||||+|+||+++ .++.+||+|||++...... ......+++.|+|||++ ...++.++||||||+++|+|++|
T Consensus 114 ~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g 190 (277)
T cd05577 114 RR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190 (277)
T ss_pred CC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC
Confidence 99 99999999999997 7889999999998765432 23345688999999987 44588999999999999999999
Q ss_pred CCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcc
Q 008378 162 EYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLV 230 (568)
Q Consensus 162 ~~Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~ 230 (568)
+.||..... ...+...+.. .+...+...++.++++|.+||+ +|.+|| ++.+++.||||...++..+.
T Consensus 191 ~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~ 266 (277)
T cd05577 191 RSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLE 266 (277)
T ss_pred CCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhh
Confidence 999966432 2233332221 2334555678999999999996 699999 89999999999887765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.73 Aligned_cols=216 Identities=29% Similarity=0.519 Sum_probs=180.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+++.++||||+++++.|... ...++||||+.+++|.+++.. ..+++..+..++.|++.||.|||+.
T Consensus 59 ~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~ 135 (296)
T cd06654 59 PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 135 (296)
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3457788999999999999999999988764 479999999999999999875 4589999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
| ++||||||+||+++ .++.+||+|||++....... .....|++.|+|||.+. ..++.++||||||+++|+|++|
T Consensus 136 g--i~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g 212 (296)
T cd06654 136 Q--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212 (296)
T ss_pred C--cccCCCCHHHEEEc-CCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC
Confidence 9 99999999999997 78899999999987653322 23457899999999874 4578999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
+.||........++.....+.++...+...++.++++|.+||. +|..||++.+++.||||....+
T Consensus 213 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 213 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred CCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 9999765444444444433333333445577899999999996 7999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=277.40 Aligned_cols=212 Identities=35% Similarity=0.589 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
++..+.+.+|+++++.++||||+++++++.+. ..+++|+||+++++|.+++.+.+.+++..+..++.||+.||.|||+
T Consensus 43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 120 (258)
T cd06632 43 QEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120 (258)
T ss_pred hHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999987654 4789999999999999999988889999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCccccc-cC-CCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EE-YNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl~-~~-ys~ksDIWSLGiilyEmlt 160 (568)
.+ ++|+||+|+||+++ .++.+||+|||++....... .....|++.|+|||.+. .. ++.++|+||||+++|+|++
T Consensus 121 ~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~ 197 (258)
T cd06632 121 RN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT 197 (258)
T ss_pred CC--cccCCCCHHHEEEC-CCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh
Confidence 99 99999999999997 78899999999987654332 34567899999999773 33 7899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|+.||..........+. .........+...++.+++||.+||. +|.+||++.+++.|||+
T Consensus 198 g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 198 GKPPWSQLEGVAAVFKI-GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CCCCcccCcHHHHHHHH-HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 99999775533434333 33223334555678999999999996 79999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=274.75 Aligned_cols=215 Identities=39% Similarity=0.648 Sum_probs=186.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+...+.+.+|+.++++++||||+++++.+.+.....+++|+||+.+++|.+++.+...+++..+..++.|++.||.|||+
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (260)
T cd06606 40 EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119 (260)
T ss_pred hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999999988766445899999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
++ ++|+||+|+||+++ .++.+||+|||.+....... .....++..|+|||.+. ..++.++||||||+++|+|
T Consensus 120 ~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l 196 (260)
T cd06606 120 NG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEM 196 (260)
T ss_pred CC--ccccCCCHHHEEEc-CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHH
Confidence 98 99999999999997 67899999999987765443 34557899999999874 4488999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
++|..||....+.......+..+.....++...++.+++||.+|+. +|.+||++.+++.||||
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 197 ATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999999876655555555554444445666678999999999996 69999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=281.25 Aligned_cols=212 Identities=29% Similarity=0.542 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHH
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILR 76 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~ 76 (568)
..+.+.+|+.+++++ +||||++++++|.... ...+++||||+.+++|.+++.. ...+++..++.++.|++.
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 124 (275)
T cd06608 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124 (275)
T ss_pred hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence 457789999999999 7999999999987643 3568999999999999998865 357999999999999999
Q ss_pred HHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc------cCCCcccee
Q 008378 77 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDI 148 (568)
Q Consensus 77 gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~------~~ys~ksDI 148 (568)
||.|||+++ ++||||+|+||+++ .++.+||+|||++...... ......|++.|+|||++. ..++.++||
T Consensus 125 al~~lH~~~--i~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 201 (275)
T cd06608 125 GLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV 201 (275)
T ss_pred HHHHHhcCC--cccCCCCHHHEEEc-cCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccH
Confidence 999999999 99999999999997 6789999999998654322 223457899999999873 236789999
Q ss_pred hhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 149 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
||||+++|+|++|..||........+.+ +..+..+. ......+..+++||.+||. +|.+||++.++++|||+
T Consensus 202 ~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 202 WSLGITAIELADGKPPLCDMHPMRALFK-IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHhHHHHHHHHhCCCCccccchHHHHHH-hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999976444444443 33332222 1222356799999999996 79999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=284.32 Aligned_cols=215 Identities=29% Similarity=0.544 Sum_probs=179.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~---~~l~e~~i~~i~~QIl~gL~y 80 (568)
+...+.+.+|+.+|++++||||+++++++... ..+++||||+++++|..++... ..+++..+..++.||+.||.|
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 117 (286)
T cd06622 40 ESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117 (286)
T ss_pred HHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHH
Confidence 45567899999999999999999999988654 4799999999999999998863 479999999999999999999
Q ss_pred hhh-CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccccc-------CCCccceehhhH
Q 008378 81 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-------EYNELVDIYSFG 152 (568)
Q Consensus 81 LHs-~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~-------~ys~ksDIWSLG 152 (568)
||. ++ ++||||||+||+++ .++.+||+|||++............|++.|+|||++.. .++.++||||||
T Consensus 118 LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 194 (286)
T cd06622 118 LKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG 194 (286)
T ss_pred HHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHH
Confidence 996 57 99999999999997 68899999999997765555556678999999998732 257899999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHH---HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 153 MCILEMVTCEYPYNECKNPAQIY---KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~---~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|++|+|++|..||..... .... ..+..+. +...+...++++++||.+||. +|.+||++.+++.||||....
T Consensus 195 ~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 195 LSILEMALGRYPYPPETY-ANIFAQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHHHhCCCCCCCcch-hhHHHHHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 999999999999965332 2222 2233333 333455578999999999996 699999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=278.93 Aligned_cols=215 Identities=27% Similarity=0.494 Sum_probs=180.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+++++.++||||+++++.+... ..+|+|+||+.+++|..++.+.+.+++..+..++.||+.||.|||.+
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~ 112 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN 112 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 5667899999999999999999999987543 47899999999999999999888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----------CcccccCCCCccCcccc-ccCCCccceehhhHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGM 153 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----------~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGi 153 (568)
+ ++||||+|+||+++ .++.+||+|||++...... ......+++.|+|||.. ...++.++|+||||+
T Consensus 113 ~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ 189 (265)
T cd05579 113 G--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGC 189 (265)
T ss_pred C--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHH
Confidence 9 99999999999997 7889999999998754322 22345688999999977 445888999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH---HHHhcCCCCCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA---LELLKDPFLVTDN 225 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa---~ElL~hpff~~~~ 225 (568)
++|+|++|..||... ....+...+..+..+.......++.+++||.+||. +|.+||++ .++|+||||...+
T Consensus 190 ~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 190 ILYEFLVGIPPFHGE-TPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHHHhCCCCCCCC-CHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 999999999999764 45555666655433221112248899999999996 69999999 9999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=282.98 Aligned_cols=213 Identities=31% Similarity=0.538 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcC----CCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDD----TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRG 77 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~----~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~g 77 (568)
.....+..|+.+++.+ +||||++++++|+.. ....++++|||+.+|+|.+++... ..+++..+..++.||+.|
T Consensus 54 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~a 133 (282)
T cd06636 54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133 (282)
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHH
Confidence 4456788999999999 799999999988643 245789999999999999998764 358899999999999999
Q ss_pred HHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCccccc------cCCCccceeh
Q 008378 78 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE------EEYNELVDIY 149 (568)
Q Consensus 78 L~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl~------~~ys~ksDIW 149 (568)
|.|||+++ ++||||||+||+++ .++.+||+|||++..... .......|++.|+|||++. ..++.++|+|
T Consensus 134 l~~LH~~~--ivH~dl~~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw 210 (282)
T cd06636 134 LAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW 210 (282)
T ss_pred HHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchh
Confidence 99999999 99999999999997 788999999999876532 2234567999999999773 3478899999
Q ss_pred hhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 150 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 150 SLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|||+++|+|++|..||........+. .+.....+.......++++.+||.+||. +|.+||++.|+|+||||
T Consensus 211 slG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 211 SLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHHhCCCCccccCHHhhhh-hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 99999999999999997654433333 2333333333345578899999999996 79999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=277.86 Aligned_cols=211 Identities=31% Similarity=0.565 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|++++++++||||+++++++.+. ..+|+++||+.+++|.+++.. ...+++..+..++.||+.||.|||+.
T Consensus 41 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~ 118 (256)
T cd06612 41 DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118 (256)
T ss_pred HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 367899999999999999999999988765 478999999999999999876 45689999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
+ ++||||+|+||+++ .++.+||+|||++....... .....|++.|+|||++. ..++.++||||||+++|+|++|
T Consensus 119 ~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g 195 (256)
T cd06612 119 K--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195 (256)
T ss_pred C--cccCCCCcceEEEC-CCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC
Confidence 9 99999999999997 68899999999998765432 23456899999999874 4588999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
..||......................+...+..+.++|.+||+ +|.+||++.++|.||||
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 196 KPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999764333322222111111222334567899999999996 79999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=287.26 Aligned_cols=216 Identities=31% Similarity=0.555 Sum_probs=180.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+++.++||||+++++++... ..+++|+||+.+++|..++.+. .+++..+..++.|++.||.|||++
T Consensus 58 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~ 134 (296)
T cd06655 58 PKKELIINEILVMKELKNPNIVNFLDSFLVG--DELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN 134 (296)
T ss_pred chHHHHHHHHHHHHhcCCCceeeeeeeEecC--ceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3457789999999999999999999988654 4799999999999999988764 589999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
| ++||||||+||+++ .+|.+||+|||++....... .....|++.|+|||.+. ..++.++||||||+++|+|++|
T Consensus 135 ~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg 211 (296)
T cd06655 135 Q--VIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (296)
T ss_pred C--cccCCCCHHHEEEC-CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 9 99999999999997 78999999999987654322 23457899999999874 5588999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
..||........+.........+...+...++.++++|.+||. +|.+||++.+++.||||+...+
T Consensus 212 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 212 EPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred CCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 9999775444444433333333333455678899999999996 7999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=287.61 Aligned_cols=218 Identities=23% Similarity=0.405 Sum_probs=179.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
...+.+.+|+++|+.++||||+++++.+.+. ..+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||
T Consensus 43 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 120 (316)
T cd05574 43 NKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120 (316)
T ss_pred HHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH
Confidence 3567899999999999999999999987654 4799999999999999998864 56999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-------------------------------CcccccCCCC
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------------------------------TARSVIGTPE 131 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-------------------------------~~~s~~GTp~ 131 (568)
+.| ++||||||+||+++ .+|.++|+|||++...... .....+||..
T Consensus 121 ~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 197 (316)
T cd05574 121 LLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEE 197 (316)
T ss_pred HCC--eeccCCChHHeEEc-CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccC
Confidence 999 99999999999997 6889999999998644211 1123478999
Q ss_pred ccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCC
Q 008378 132 FMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 132 YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~R 209 (568)
|+|||++ ...++.++||||||+++|+|++|..||.+.............. .........++.++++|.+||. +|.+|
T Consensus 198 y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (316)
T cd05574 198 YIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKR 276 (316)
T ss_pred CcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHC
Confidence 9999987 4458899999999999999999999998755444444433222 2211122268999999999996 79999
Q ss_pred CC----HHHHhcCCCCCCCCCCC
Q 008378 210 LP----ALELLKDPFLVTDNPKD 228 (568)
Q Consensus 210 ps----a~ElL~hpff~~~~~~~ 228 (568)
|+ +.++|.||||+...+..
T Consensus 277 ~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 277 LGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred CCchhhHHHHHcCchhhcCChhh
Confidence 99 99999999999866544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.04 Aligned_cols=214 Identities=27% Similarity=0.440 Sum_probs=177.8
Q ss_pred CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCH-HHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM-KAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e-~~i~~i~~QIl~gL~y 80 (568)
++..++-+..|+.+|.+| .|.+||.+|+|-+.+ .++||||||-+ .+|..++++.....+ -.++.|..|+|.++.+
T Consensus 399 D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~ 475 (677)
T KOG0596|consen 399 DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--GYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKT 475 (677)
T ss_pred CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--ceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHH
Confidence 567788899999999999 599999999987764 48999999875 699999998765433 5889999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc-cC-----------CCc
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EE-----------YNE 144 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~-~~-----------ys~ 144 (568)
+|.+| |||.||||.|+|+- .|.+||+|||+|....... ..+.+||+.||+||.+. .. .+.
T Consensus 476 IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r 551 (677)
T KOG0596|consen 476 IHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISR 551 (677)
T ss_pred HHHhc--eeecCCCcccEEEE--eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecC
Confidence 99999 99999999999986 6999999999998775543 34679999999999762 11 467
Q ss_pred cceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH-HHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 145 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 145 ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~e-l~~lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
++||||||||+|+|+.|+.||....+....+..|+...-...++...++. +.+++++||+ +|.+||+..+||+|||++
T Consensus 552 ~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 552 KSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred ccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence 89999999999999999999987665555555555543333455555444 9999999996 899999999999999997
Q ss_pred C
Q 008378 223 T 223 (568)
Q Consensus 223 ~ 223 (568)
.
T Consensus 632 ~ 632 (677)
T KOG0596|consen 632 I 632 (677)
T ss_pred c
Confidence 4
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=283.79 Aligned_cols=216 Identities=24% Similarity=0.489 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
++..+++.+|+++++.++||||+++++++... ..+++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 121 (284)
T cd06620 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121 (284)
T ss_pred chHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999998765 4789999999999999999988889999999999999999999997
Q ss_pred -CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 84 -HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 -~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
++ ++||||||+||+++ .++.++|+|||++............|+..|+|||++ ...++.++||||||+++|+|+||
T Consensus 122 ~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg 198 (284)
T cd06620 122 VHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198 (284)
T ss_pred hcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhC
Confidence 57 99999999999997 788999999999876544444556899999999977 55688999999999999999999
Q ss_pred CCCCCCCCCH----------HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 162 EYPYNECKNP----------AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 162 ~~Pf~~~~~~----------~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
..||...... ..+...+.....+.......++.+.+||.+||+ +|.+||++.|+++|+||...
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 199 KFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 9999754321 122333333322222222367889999999996 69999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=276.12 Aligned_cols=212 Identities=28% Similarity=0.519 Sum_probs=180.4
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~y 80 (568)
++...+++.+|+.+|++++|+||++++++|.+. ..+++||||+++|+|.+++.+. ..+++..+..++.|++.||.|
T Consensus 39 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 116 (256)
T cd08221 39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116 (256)
T ss_pred chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence 356677899999999999999999999998764 4799999999999999999875 468999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
||+.+ ++||||+|+||+++ .++.+||+|||++...... ......|++.|+|||++. ..++.++|+||||+++|+
T Consensus 117 lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~ 193 (256)
T cd08221 117 IHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYE 193 (256)
T ss_pred HHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHH
Confidence 99999 99999999999997 7889999999998765332 234567999999999774 457889999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|++|..||.. .+.......+..+..+. .....+.+++++|.+||. +|.+||++.++++|||+
T Consensus 194 l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 194 LLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 9999999976 44555555555543332 335668899999999996 69999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.66 Aligned_cols=212 Identities=26% Similarity=0.422 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
..+.+|+.+++.++||||+++++++... ...++||||+. ++|.+++...+ .+++..++.++.||+.||.|||++|
T Consensus 49 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~- 124 (309)
T cd07872 49 CTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124 (309)
T ss_pred hhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4577899999999999999999988754 36899999997 48888876654 5899999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+||+++ .++.+||+|||++...... ......+|+.|+|||++. ..++.++||||||+++|+|+||+
T Consensus 125 -ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~ 202 (309)
T cd07872 125 -VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202 (309)
T ss_pred -eecCCCCHHHEEEC-CCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999997 7889999999998754332 223457899999999874 35889999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHc--CCC------------------CC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 008378 163 YPYNECKNPAQIYKKVTS--GIK------------------PA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALE 214 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~--~~~------------------p~-------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~E 214 (568)
.||......+.+...... ... +. ......+++++++|.+||. +|.+|||+.|
T Consensus 203 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 282 (309)
T cd07872 203 PLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282 (309)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH
Confidence 999765433322211110 000 00 0112357899999999996 7999999999
Q ss_pred HhcCCCCCCCC
Q 008378 215 LLKDPFLVTDN 225 (568)
Q Consensus 215 lL~hpff~~~~ 225 (568)
+|.||||+...
T Consensus 283 ~l~h~~~~~~~ 293 (309)
T cd07872 283 AMKHAYFRSLG 293 (309)
T ss_pred HhcChhhhhcc
Confidence 99999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=310.22 Aligned_cols=216 Identities=25% Similarity=0.443 Sum_probs=182.3
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC------CeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN------RTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWAR 72 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~------~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~ 72 (568)
+++...++.+|+.+|..++|+||+++++.+..... ..+++||||+.+|+|.+++... ..+++..+..++.
T Consensus 71 ~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~ 150 (496)
T PTZ00283 71 SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150 (496)
T ss_pred CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHH
Confidence 45667889999999999999999999987754322 2478999999999999998653 4689999999999
Q ss_pred HHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccc-cCCCccce
Q 008378 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVD 147 (568)
Q Consensus 73 QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~-~~ys~ksD 147 (568)
||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+... .....+||+.|+|||++. ..|+.++|
T Consensus 151 qll~aL~~lH~~~--IiHrDLKP~NILl~-~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~D 227 (496)
T PTZ00283 151 QVLLAVHHVHSKH--MIHRDIKSANILLC-SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD 227 (496)
T ss_pred HHHHHHHHHHhCC--EecCCCCHHHEEEe-CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHH
Confidence 9999999999998 99999999999997 6889999999999765422 234568999999999884 55899999
Q ss_pred ehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 148 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 148 IWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
||||||++|||++|+.||.. .+...++..+..+..+ .++...+++++++|.+||. +|.+||++.+++.|||++.
T Consensus 228 VwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999976 4555666666555433 2456678999999999996 6999999999999999864
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=286.55 Aligned_cols=208 Identities=27% Similarity=0.500 Sum_probs=168.0
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
..+.+|++++++++||||+++++++.+.. .+++|+||+. ++|.+++.+ .+.+++..++.++.||+.||.|||+++
T Consensus 44 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~- 119 (284)
T cd07839 44 SSALREICLLKELKHKNIVRLYDVLHSDK--KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN- 119 (284)
T ss_pred cchhHHHHHHHhcCCCCeeeHHHHhccCC--ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 56788999999999999999999887554 7899999997 578877765 567999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc--CCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||+++ .++.+||+|||++...... ......+++.|+|||++.+ .++.++||||||+++|+|+||.
T Consensus 120 -i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 120 -VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred -EecCCCCHHHEEEc-CCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 99999999999997 7889999999999765432 2234568899999998743 4789999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCC-------------------C--------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 008378 163 YPYNECKNPAQIYKKVTSGIK-------------------P--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALE 214 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~-------------------p--------~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~E 214 (568)
.||....+.....+.+..... + .......++++++||.+||. +|.+|||+.+
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 277 (284)
T cd07839 198 RPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277 (284)
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence 997554444433333221100 0 00112357899999999996 7999999999
Q ss_pred HhcCCCC
Q 008378 215 LLKDPFL 221 (568)
Q Consensus 215 lL~hpff 221 (568)
++.||||
T Consensus 278 il~h~~f 284 (284)
T cd07839 278 ALQHPYF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=284.95 Aligned_cols=217 Identities=24% Similarity=0.399 Sum_probs=178.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+++|+.++|+||+++++.+... ..+++||||+.+++|.+++... ..+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~ 120 (285)
T cd05632 43 GESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120 (285)
T ss_pred HHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345678899999999999999999988654 4799999999999999888653 369999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
++ |+||||||+||+++ .++.+||+|||++...... ......|++.|+|||++ ...++.++|+||||+++|+|++|
T Consensus 121 ~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 197 (285)
T cd05632 121 EN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197 (285)
T ss_pred CC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 99 99999999999997 6789999999998655322 23455799999999987 45689999999999999999999
Q ss_pred CCCCCCCCCHH---HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCc
Q 008378 162 EYPYNECKNPA---QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 162 ~~Pf~~~~~~~---~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l 229 (568)
..||....... .+...+... ...+....++++.+|+.+||+ +|.+||+ +.+++.|+||+....+.+
T Consensus 198 ~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 272 (285)
T cd05632 198 QSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272 (285)
T ss_pred CCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHH
Confidence 99997643322 222222222 223445567899999999996 6999999 889999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=276.89 Aligned_cols=211 Identities=31% Similarity=0.547 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~---~~l~e~~i~~i~~QIl~gL~yL 81 (568)
...+.+.+|+.+|+.++|+||+++++.+... ...++||||+.+++|.+++... ..+++..++.++.||+.||.||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l 118 (267)
T cd06610 41 TSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118 (267)
T ss_pred hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3678899999999999999999999988764 4789999999999999999764 4589999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCcccccc--CCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGi 153 (568)
|++| ++||||||+||+++ .++.+||+|||++..+.... .....|++.|+|||++.. .++.++|+||||+
T Consensus 119 h~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~ 195 (267)
T cd06610 119 HSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGI 195 (267)
T ss_pred HhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhH
Confidence 9999 99999999999997 67899999999997664322 234578999999998743 5889999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC-C---CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-L---SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~-~---~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
++|+|++|+.||..........+.+.. ..+.. . ....++.++++|.+||. +|.+||++.+++.||||
T Consensus 196 i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 196 TAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999875444433333333 22211 1 12457899999999996 69999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=285.46 Aligned_cols=215 Identities=22% Similarity=0.362 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHhC-CCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHhhh
Q 008378 8 ERLYSEVHLLKSL-KHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 8 e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~~~--l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+.++||++.=.. .|||||.++++|... ...++.+|||.++||.|+..++.++. |+|+.+..+++||..|+.|||
T Consensus 99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH 178 (400)
T KOG0604|consen 99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH 178 (400)
T ss_pred HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH
Confidence 4567888877666 699999999987542 34689999999999999999998765 999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeC--CCCcEEEeecChhhhcc-CCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~-~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
+.+ |.||||||+|+|..+ .+..+||+|||+|+... .....+.+-||.|.|||++ .+.|+...|+||+|+++|-|
T Consensus 179 ~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIl 256 (400)
T KOG0604|consen 179 SMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256 (400)
T ss_pred hcc--hhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHh
Confidence 999 999999999999963 35579999999998775 3455677889999999998 45699999999999999999
Q ss_pred hhcCCCCCCCCC---HHHHHHHHHcCC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 159 VTCEYPYNECKN---PAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 159 ltG~~Pf~~~~~---~~~i~~~i~~~~--~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
++|.+||..... ......+|..|. .|..-+...+..++++|+++|. +|++|.|..+++.|||+...
T Consensus 257 LCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 257 LCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 999999965332 233455666553 3555566778999999999995 79999999999999999754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=322.44 Aligned_cols=216 Identities=22% Similarity=0.425 Sum_probs=189.3
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
.-|..|..+|..-+.+.|+.++.+|.|+. ++||||||++||+|..++.++++++++-++.|+.+|+.||.-||+.|
T Consensus 120 A~F~EERDimv~~ns~Wiv~LhyAFQD~~--~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg-- 195 (1317)
T KOG0612|consen 120 ACFREERDIMVFGNSEWIVQLHYAFQDER--YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG-- 195 (1317)
T ss_pred HHHHHHhHHHHcCCcHHHHHHHHHhcCcc--ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--
Confidence 45778999999999999999999998764 79999999999999999999999999999999999999999999999
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhcc-CCC--cccccCCCCccCccccc------cCCCccceehhhHHHHHHH
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPT--ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~-~~~--~~s~~GTp~YmAPEvl~------~~ys~ksDIWSLGiilyEm 158 (568)
+|||||||+|||++ ..|+|||+|||.+..+. .+. ....+|||-|++||++. +.|++.+|+||+||++|||
T Consensus 196 yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM 274 (1317)
T KOG0612|consen 196 YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM 274 (1317)
T ss_pred ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence 99999999999998 89999999999887665 333 23458999999999882 4599999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCCCc
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~el~~lI~kcL~~p~~Rps---a~ElL~hpff~~~~~~~l 229 (568)
+.|..||.. .....-|.+|..-...-.+| ..++.++++||.+++.+|..|.. +.++..||||....|..+
T Consensus 275 lyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 275 LYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred HcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhh
Confidence 999999987 45666777777654433344 34789999999999999999888 999999999999999654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=282.32 Aligned_cols=209 Identities=28% Similarity=0.455 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~---~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+.+.+|+.++++++||||+++++++.++ ..+++||||+. ++|.+++... +.+++..++.++.||+.||.|||+
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~ 119 (285)
T cd07861 43 PSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119 (285)
T ss_pred hHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh
Confidence 45688899999999999999999998764 47899999997 6898887653 468999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc--cCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEml 159 (568)
++ ++||||||+||+++ .+|.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|+
T Consensus 120 ~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~ 196 (285)
T cd07861 120 RR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196 (285)
T ss_pred CC--eeecCCCHHHEEEc-CCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHH
Confidence 99 99999999999997 78999999999987553322 23346789999999874 34789999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCC--------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKP--------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p--------------------------~~~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
||+.||.+..........+.....+ .......+++++++|.+||. +|.+||++
T Consensus 197 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 276 (285)
T cd07861 197 TKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA 276 (285)
T ss_pred HCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 9999998755444433322111000 01123467899999999996 79999999
Q ss_pred HHHhcCCCC
Q 008378 213 LELLKDPFL 221 (568)
Q Consensus 213 ~ElL~hpff 221 (568)
.+++.||||
T Consensus 277 ~~ll~~~~~ 285 (285)
T cd07861 277 KKALNHPYF 285 (285)
T ss_pred HHHhcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=281.88 Aligned_cols=212 Identities=27% Similarity=0.488 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHhC-CCCCeeeeeeEEEcCC---CCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSL-KHENIIKFYNSWVDDT---NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~---~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL 78 (568)
.+.+.+|+.+++.+ +||||++++++|...+ ...+++||||+.+|+|.++++. ...+++..++.++.|++.||
T Consensus 62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 141 (291)
T cd06639 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence 46678899999999 8999999999887543 2468999999999999998763 45789999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccccc------CCCccceehh
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE------EYNELVDIYS 150 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~~------~ys~ksDIWS 150 (568)
.|||+++ ++||||||+||+++ .++.+||+|||++....... .....|++.|+|||++.. .++.++||||
T Consensus 142 ~~lH~~~--ivH~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s 218 (291)
T cd06639 142 QHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS 218 (291)
T ss_pred HHHHhCC--eeccCCCHHHEEEc-CCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHH
Confidence 9999998 99999999999997 78899999999987654322 234578999999998732 2678999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
||+++|+|++|+.||........+.+ +.....+ ...+......++++|.+||+ +|.+||++.+++.||||+
T Consensus 219 lGvi~~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 219 LGITAIELGDGDPPLFDMHPVKTLFK-IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHhhCCCCCCCCcHHHHHHH-HhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 99999999999999987544344433 3333222 11223356789999999996 699999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=287.79 Aligned_cols=218 Identities=25% Similarity=0.469 Sum_probs=177.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~y 80 (568)
+.+..+++.+|+++|+.++||||++++++|.+.. ..+++|||+.+|+|.+++.+. ..+++..++.+++||+.||.|
T Consensus 39 ~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~ 116 (314)
T cd08216 39 SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDY 116 (314)
T ss_pred chhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999999987654 689999999999999999864 458999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---------CcccccCCCCccCcccccc---CCCcccee
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE---EYNELVDI 148 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl~~---~ys~ksDI 148 (568)
||+++ |+||||||+||+++ .+|.+||+|||.+...... ......++..|+|||++.. .|+.++|+
T Consensus 117 LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 193 (314)
T cd08216 117 IHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193 (314)
T ss_pred HHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhH
Confidence 99999 99999999999997 7799999999988644211 1223467889999998843 48899999
Q ss_pred hhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-------------------------------CCCCCCCcHHHHH
Q 008378 149 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------------------------ASLSKVTDPQVKQ 197 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p-------------------------------~~~~~~~s~el~~ 197 (568)
||||+++|+|++|..||...........++...... .......++++++
T Consensus 194 ws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (314)
T cd08216 194 YSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQ 273 (314)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHH
Confidence 999999999999999998755544444443221100 0011223467899
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 198 FIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 198 lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||.+||. +|.+||++.++|.||||+...
T Consensus 274 li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 274 FVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred HHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 9999996 799999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=279.37 Aligned_cols=210 Identities=27% Similarity=0.476 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+++.+|++++++++||||+++++.+.+. ..+++|+||+.+++|.+++.+...+++..+..|+.||+.||.|||.+
T Consensus 42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 119 (258)
T cd05578 42 GSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119 (258)
T ss_pred hHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 5678899999999999999999999987644 47999999999999999998888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
+ ++|+||+|+||+++ .++.++|+|||++...... ......|+..|+|||++. ..++.++|+||||+++|+|++|.
T Consensus 120 ~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~ 196 (258)
T cd05578 120 G--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196 (258)
T ss_pred C--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCC
Confidence 9 99999999999997 7899999999998765433 234457899999999874 45799999999999999999999
Q ss_pred CCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH--HHHhcCCCC
Q 008378 163 YPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA--LELLKDPFL 221 (568)
Q Consensus 163 ~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa--~ElL~hpff 221 (568)
.||..... ...+...... .....+...++.+.++|.+||. +|.+||++ .|++.||||
T Consensus 197 ~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 197 RPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 99987554 4444444332 2333455667899999999996 79999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=287.01 Aligned_cols=216 Identities=30% Similarity=0.532 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+++.++||||++++++|... ..+++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~ 134 (297)
T cd06656 58 PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN 134 (297)
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3457788999999999999999999988754 478999999999999999876 4589999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
+ ++||||||+||+++ .+|.+||+|||++...... ......|++.|+|||.+. ..++.++|+||||+++|+|++|
T Consensus 135 ~--i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg 211 (297)
T cd06656 135 Q--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (297)
T ss_pred C--cccCCCCHHHEEEC-CCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9 99999999999997 7899999999998765332 223457899999999874 5588999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
..||........+......+.++...+...++.+++||.+||. +|.+||++.+++.||||+...+
T Consensus 212 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 212 EPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred CCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 9999765443433333333333333455677899999999996 6999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=274.12 Aligned_cols=212 Identities=30% Similarity=0.539 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yL 81 (568)
.+..+.+.+|+++|+.++||||+++++.+... ..+++||||+++++|.+++.+. ..+++..+..++.|++.||.||
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 117 (256)
T cd08220 40 KDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117 (256)
T ss_pred cHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999988644 4789999999999999999864 3489999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
|++| ++||||||+||+++..++.+||+|||++....... .....|++.|+|||.+. ..++.++||||||+++|+|+
T Consensus 118 h~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~ 195 (256)
T cd08220 118 HTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195 (256)
T ss_pred HhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHH
Confidence 9999 99999999999997556678999999997664332 23457899999999884 45788999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
+|..||..... ......+..+..+ .++...++.++++|.+||. +|.+||++.+++.||||
T Consensus 196 ~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 196 SLKRAFEAANL-PALVLKIMSGTFA-PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred hCCCCcccCch-HHHHHHHHhcCCC-CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999977544 3444444443322 2444578899999999996 79999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=279.52 Aligned_cols=211 Identities=28% Similarity=0.497 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.++++++||||+++++++... ..+++||||+.+++|.+++.+.+.+++..+..++.|++.||.|||++
T Consensus 48 ~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 125 (267)
T cd06646 48 DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125 (267)
T ss_pred chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3455688999999999999999999998765 47899999999999999998888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc----cCCCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGiilyEm 158 (568)
+ |+||||||+||+++ .++.+||+|||++...... ......|++.|+|||.+. ..++.++|+||||+++|+|
T Consensus 126 ~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el 202 (267)
T cd06646 126 G--KMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred C--ccccCCCHHHEEEC-CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHH
Confidence 8 99999999999997 7889999999999765432 223457899999999762 3478899999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 220 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpf 220 (568)
++|+.||..................+..+ ....+..+++||.+||. +|.+||++.++|.|+|
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 203 AELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999996543322222222222222222 12357899999999996 7999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=275.76 Aligned_cols=214 Identities=31% Similarity=0.581 Sum_probs=184.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh-
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS- 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs- 83 (568)
...+.+.+|+..++.++||||+++++++... ..+++||||+.+++|.+++.....+++..+..++.||+.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~ 118 (264)
T cd06623 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118 (264)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcc
Confidence 4567899999999999999999999988765 4799999999999999999988889999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc--ccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~--~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
.+ ++||||+|+||+++ .++.++|+|||++........ ....++..|+|||.+ ...++.++|+||||+++|+|+|
T Consensus 119 ~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~t 195 (264)
T cd06623 119 RH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL 195 (264)
T ss_pred CC--CccCCCCHHHEEEC-CCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHh
Confidence 98 99999999999997 789999999999876644332 245789999999987 4457889999999999999999
Q ss_pred cCCCCCCCC--CHHHHHHHHHcCCCCCCCCCC-CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 161 CEYPYNECK--NPAQIYKKVTSGIKPASLSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 161 G~~Pf~~~~--~~~~i~~~i~~~~~p~~~~~~-~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|..||.... ...+..+.+.....+. .... .+..++++|.+||. +|.+||++.+++.|||++..
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 196 GKFPFLPPGQPSFFELMQAICDGPPPS-LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred CCCCCccccccCHHHHHHHHhcCCCCC-CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999997764 5556666666544443 3333 78899999999996 69999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=280.75 Aligned_cols=212 Identities=26% Similarity=0.471 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHhC-CCCCeeeeeeEEEcC---CCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSL-KHENIIKFYNSWVDD---TNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~---~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL 78 (568)
.+.+.+|+.+++.+ +||||+++++++... ....+++||||+++++|.+++.. ...+++..++.++.|++.||
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 137 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence 35678899999999 799999999987532 33578999999999999998753 35689999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc------cCCCccceehh
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYS 150 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~------~~ys~ksDIWS 150 (568)
.|||+++ ++||||||+||+++ .++.+||+|||++...... ......|++.|+|||++. ..|+.++||||
T Consensus 138 ~~lH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 214 (286)
T cd06638 138 QHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214 (286)
T ss_pred HHHHhCC--ccccCCCHHhEEEC-CCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence 9999998 99999999999997 6789999999998765432 233457999999999873 34788999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|||++|+|++|+.||........+.+...........+...+..++++|.+||. +|.+||++.|++.|+||
T Consensus 215 lGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 215 LGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 999999999999999775444443332222112222344567889999999996 79999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=285.49 Aligned_cols=215 Identities=30% Similarity=0.592 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+.+++.++||||+++++.+... ...++||||+++++|.+++.. +.+++..+..++.||+.||.|||+
T Consensus 60 ~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~ 136 (292)
T cd06658 60 QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN 136 (292)
T ss_pred HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45567789999999999999999999988654 478999999999999998864 568999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
++ ++||||||+||+++ .++.+||+|||++...... ......|++.|+|||++. ..++.++||||||+++|||++
T Consensus 137 ~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~ 213 (292)
T cd06658 137 QG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID 213 (292)
T ss_pred CC--EeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 99 99999999999997 7789999999998765322 223457899999999874 468899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|..||... ........+.....+. ......++.++++|.+||. +|.+||++.+++.||||....
T Consensus 214 g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 214 GEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred CCCCCCCC-CHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 99999764 3344444444333222 1223467899999999996 699999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=285.43 Aligned_cols=220 Identities=26% Similarity=0.447 Sum_probs=186.3
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....++++||+++.++ .|+||+.++++|.+++ .+|+|||-+.||+|..+|++++.|++..+..+.+.|..||.|||.
T Consensus 117 HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~ 194 (463)
T KOG0607|consen 117 HSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHT 194 (463)
T ss_pred hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh
Confidence 4568999999999999 5999999999997765 699999999999999999999999999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCC--CCcEEEeecChhhhccC---------CCcccccCCCCccCccccc------cCCCccc
Q 008378 84 HNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQ---------PTARSVIGTPEFMAPELYE------EEYNELV 146 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~--~g~vKI~DFGla~~~~~---------~~~~s~~GTp~YmAPEvl~------~~ys~ks 146 (568)
+| |.||||||+|||-... -.-||||||.|..-... +...+.+|+.+|||||+.. ..|+.+.
T Consensus 195 kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrC 272 (463)
T KOG0607|consen 195 KG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRC 272 (463)
T ss_pred cC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccc
Confidence 99 9999999999998622 23589999998754321 1234568999999999762 3499999
Q ss_pred eehhhHHHHHHHhhcCCCCCCCCC--------------HHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCC
Q 008378 147 DIYSFGMCILEMVTCEYPYNECKN--------------PAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 147 DIWSLGiilyEmltG~~Pf~~~~~--------------~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~R 209 (568)
|.||||+|+|-|+.|..||.+.-. ...++..|+.|.. |..-+..++.+++++|.++|+ ++.+|
T Consensus 273 DlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~r 352 (463)
T KOG0607|consen 273 DLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQR 352 (463)
T ss_pred cHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhh
Confidence 999999999999999999965211 2467888888854 555556678999999999996 79999
Q ss_pred CCHHHHhcCCCCCCCCCCC
Q 008378 210 LPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 210 psa~ElL~hpff~~~~~~~ 228 (568)
.+|.++++|||++...+.+
T Consensus 353 lsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 353 LSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred hhhhhccCCccccccchhc
Confidence 9999999999999876543
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=279.85 Aligned_cols=210 Identities=26% Similarity=0.467 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+.+|++++++++||||++++++|... ..+++||||+++++|..++.....+++..+..++.||+.||.|||+++
T Consensus 44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~- 120 (286)
T cd07847 44 KKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN- 120 (286)
T ss_pred cHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 35678999999999999999999988754 478999999999999988887778999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||+++ .+|.+||+|||++....... .....++..|+|||++. ..++.++||||||+++|+|++|+
T Consensus 121 -i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~ 198 (286)
T cd07847 121 -CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198 (286)
T ss_pred -ceecCCChhhEEEc-CCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence 99999999999997 78899999999997664432 23456889999999874 34789999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcC---------------------CC-CCC------CCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 163 YPYNECKNPAQIYKKVTSG---------------------IK-PAS------LSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~---------------------~~-p~~------~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
.||.+....+.+....... .+ +.. .....+..+.+||.+||. +|.+||++.
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 278 (286)
T cd07847 199 PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCE 278 (286)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHH
Confidence 9998765554443322110 00 000 012346789999999996 699999999
Q ss_pred HHhcCCCC
Q 008378 214 ELLKDPFL 221 (568)
Q Consensus 214 ElL~hpff 221 (568)
|++.||||
T Consensus 279 eil~~~~f 286 (286)
T cd07847 279 ELLEHPYF 286 (286)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=281.37 Aligned_cols=208 Identities=34% Similarity=0.617 Sum_probs=171.8
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
...+|+.++++++||||+++++++.+. ..+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ +
T Consensus 44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i 119 (260)
T PF00069_consen 44 ENIREIKILRRLRHPNIVQILDVFQDD--NYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--I 119 (260)
T ss_dssp HHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hhhhhhhcccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccc--c
Confidence 345699999999999999999998764 478899999999999999998889999999999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhc--cCCCcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcCCC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~--~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~~P 164 (568)
+||||||+||+++ .++.++|+|||++... .........+|+.|+|||++. ..++.++||||||+++|+|++|..|
T Consensus 120 ~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p 198 (260)
T PF00069_consen 120 VHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP 198 (260)
T ss_dssp EESSBSGGGEEES-TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999998 8899999999998753 223344567899999999886 5689999999999999999999999
Q ss_pred CCCCC--CHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 165 YNECK--NPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 165 f~~~~--~~~~i~~~i~~~~~p~~~--~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|.... +.............+... .....+.++++|.+||. +|.+||++.++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 199 FEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp STTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 98752 122222222221111111 11224899999999996 79999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=305.06 Aligned_cols=213 Identities=19% Similarity=0.317 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHhCCCC------CeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 7 LERLYSEVHLLKSLKHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~Hp------NIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
...+..|+++++.++|. +|++++++|.... ..+++||+++ +++|.+++.+++.+++..++.++.||+.||.|
T Consensus 169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~-~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~y 246 (467)
T PTZ00284 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET-GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDY 246 (467)
T ss_pred HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC-ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 44567788888888654 5888998886543 4789999998 68999999988899999999999999999999
Q ss_pred hhh-CCCCeEeeeccCCcEEEeCCCC----------------cEEEeecChhhhccCCCcccccCCCCccCcccc-ccCC
Q 008378 81 LHS-HNPPIIHRDLKCDNIFVNGNNG----------------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEY 142 (568)
Q Consensus 81 LHs-~g~~IiHRDLKp~NILl~~~~g----------------~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~y 142 (568)
||+ .| ||||||||+|||++ ..+ .+||+|||++.... ......+||+.|||||++ ...|
T Consensus 247 LH~~~g--IiHrDlKP~NILl~-~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~ 322 (467)
T PTZ00284 247 FHTELH--LMHTDLKPENILME-TSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGLGW 322 (467)
T ss_pred HHhcCC--eecCCCCHHHEEEe-cCCcccccccccccCCCCceEEECCCCccccCc-cccccccCCccccCcHHhhcCCC
Confidence 998 48 99999999999997 333 59999999875432 233457899999999987 4569
Q ss_pred CccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCCCC-----------------------------------
Q 008378 143 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPAS----------------------------------- 186 (568)
Q Consensus 143 s~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~-~~~p~~----------------------------------- 186 (568)
+.++|||||||++|||++|+.||.+..+...+...... +..|..
T Consensus 323 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (467)
T PTZ00284 323 MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARA 402 (467)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcc
Confidence 99999999999999999999999775543332211110 000000
Q ss_pred ---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 187 ---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 187 ---~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.....++.+.+||.+||+ +|.+||++.|+|+||||....
T Consensus 403 ~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 403 RPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred cchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 001125678899999997 799999999999999998643
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=278.89 Aligned_cols=208 Identities=23% Similarity=0.372 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAI 67 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------~~l~e~~i 67 (568)
....+++.+|+++|+.++||||+++++++.+. ..++++|||+.+|+|.+++.+. ..+++..+
T Consensus 49 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 126 (283)
T cd05048 49 PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126 (283)
T ss_pred HHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHH
Confidence 44567789999999999999999999988654 3688999999999999999865 45888999
Q ss_pred HHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCC
Q 008378 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEY 142 (568)
Q Consensus 68 ~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~y 142 (568)
..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||.+ ...+
T Consensus 127 ~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05048 127 LHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG-EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF 203 (283)
T ss_pred HHHHHHHHHHHHHHHhCC--eeccccccceEEEc-CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC
Confidence 999999999999999999 99999999999997 78899999999987543221 2234578899999976 4668
Q ss_pred CccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 143 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 143 s~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+.++|||||||++|||++ |..||.+. ....+...+..+..+. .+...++++.+++.+||. +|.+||++.+++++
T Consensus 204 ~~~sDv~slG~il~el~~~g~~p~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 204 TTESDIWSFGVVLWEIFSYGLQPYYGF-SNQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred chhhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999998 99999764 4566777776654443 445678999999999996 69999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=279.15 Aligned_cols=215 Identities=30% Similarity=0.604 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+.+++.++||||+++++++... ...++|+||+.+++|.+++.. +++++..+..++.||+.||.|||+
T Consensus 57 ~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~ 133 (285)
T cd06648 57 QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA 133 (285)
T ss_pred hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34556789999999999999999999988754 468999999999999999887 679999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
+| ++||||+|+||+++ .++.++|+|||++...... ......|++.|+|||++. ..++.++||||||+++|+|++
T Consensus 134 ~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~ 210 (285)
T cd06648 134 QG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD 210 (285)
T ss_pred CC--eecCCCChhhEEEc-CCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHh
Confidence 99 99999999999997 7899999999988655332 223457899999999874 458899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~-~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|+.||.. .++......+..+..+.. .....++.+.+||.+||. +|.+||++.+++.||||....
T Consensus 211 g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 211 GEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred CCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 9999976 345555555655533221 122367899999999996 699999999999999998755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=293.90 Aligned_cols=208 Identities=29% Similarity=0.471 Sum_probs=163.2
Q ss_pred HHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 10 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
...|+.+|++++||||++++++|.... ..++|+||+. ++|.+++.+ .+.+++..+..|+.||+.||.|||++| |
T Consensus 104 ~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i 178 (357)
T PHA03209 104 TLIEAMLLQNVNHPSVIRMKDTLVSGA--ITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--I 178 (357)
T ss_pred cHHHHHHHHhCCCCCCcChhheEEeCC--eeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence 457999999999999999999987654 6889999996 678777754 467999999999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccC-CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 166 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~ 166 (568)
+||||||+|||++ ..+.+||+|||++..... .......||+.|+|||++ ...|+.++|||||||++|||+++..|+.
T Consensus 179 vHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 179 IHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ecCCCCHHHEEEC-CCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 9999999999997 788999999999875432 233456799999999987 4568999999999999999998655543
Q ss_pred CCCC----------HHHHHHHHHc-CCCCCCCC------------------------------CCCcHHHHHHHHHhcC-
Q 008378 167 ECKN----------PAQIYKKVTS-GIKPASLS------------------------------KVTDPQVKQFIEKCIV- 204 (568)
Q Consensus 167 ~~~~----------~~~i~~~i~~-~~~p~~~~------------------------------~~~s~el~~lI~kcL~- 204 (568)
.... ...+.+.+.. +..|..++ ...+..+.+||.+||+
T Consensus 258 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 337 (357)
T PHA03209 258 EDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTF 337 (357)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcC
Confidence 3211 1112222211 11111111 1335677889999996
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q 008378 205 PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 205 ~p~~Rpsa~ElL~hpff~~ 223 (568)
+|.+|||+.|+|+||||+.
T Consensus 338 dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 338 DAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CcccCcCHHHHhcCchhcc
Confidence 7999999999999999975
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=272.59 Aligned_cols=212 Identities=36% Similarity=0.666 Sum_probs=178.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
++..+.+.+|+.+++.++|+||+++++.+... ..+++|+||+.+++|.+++.+.+.+++..+..++.|++.||.|||+
T Consensus 40 ~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 117 (264)
T cd06626 40 PKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117 (264)
T ss_pred hHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH
Confidence 35778899999999999999999999977544 4789999999999999999988889999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc------ccccCCCCccCcccccc-C---CCccceehhhHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPEFMAPELYEE-E---YNELVDIYSFGM 153 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~------~s~~GTp~YmAPEvl~~-~---ys~ksDIWSLGi 153 (568)
++ ++||||+|+||+++ .++.+||+|||++........ ....+++.|+|||++.. . ++.++||||||+
T Consensus 118 ~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~ 194 (264)
T cd06626 118 HG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC 194 (264)
T ss_pred CC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHH
Confidence 99 99999999999997 689999999999877643221 13467899999998743 2 788999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
++|+|++|..||....+.......+..+..+ .++. ..++.+++||.+||+ +|.+||++.+++.|||+
T Consensus 195 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 195 VVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHhCCCCccCCcchHHHHHHHhcCCCC-CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999997655555444444443322 2333 348899999999996 69999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=277.41 Aligned_cols=212 Identities=22% Similarity=0.418 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+.+.+|+.++++++||||+++++++.+. ..+++|+||+ +++|.+++.. .+.+++..++.++.||+.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 117 (286)
T cd07832 41 GIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117 (286)
T ss_pred hhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3457789999999999999999999998764 4789999999 9999998865 4569999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc--cCCCccceehhhHHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEm 158 (568)
++ ++|+||||+||+++ .++.++|+|||++....... .....|++.|+|||++. ..++.++||||||+++|+|
T Consensus 118 ~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l 194 (286)
T cd07832 118 NG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAEL 194 (286)
T ss_pred CC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHH
Confidence 99 99999999999997 68899999999997765432 23457899999999873 3478999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCC--------------------C-------CCCCCCcHHHHHHHHHhcC-CCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKP--------------------A-------SLSKVTDPQVKQFIEKCIV-PASLRL 210 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p--------------------~-------~~~~~~s~el~~lI~kcL~-~p~~Rp 210 (568)
+||..||....+...+...+.....+ . ......+..+.++|.+||. +|.+||
T Consensus 195 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 274 (286)
T cd07832 195 LNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL 274 (286)
T ss_pred HcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC
Confidence 99988887655444333322211000 0 0112346889999999996 699999
Q ss_pred CHHHHhcCCCCC
Q 008378 211 PALELLKDPFLV 222 (568)
Q Consensus 211 sa~ElL~hpff~ 222 (568)
++.++|.||||.
T Consensus 275 ~~~~~l~h~~~~ 286 (286)
T cd07832 275 SAAEALRHPYFT 286 (286)
T ss_pred CHHHHhhCcCcC
Confidence 999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=282.68 Aligned_cols=212 Identities=26% Similarity=0.443 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
...+.+|+++++.++||||+++++++... ..+++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++
T Consensus 48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ 124 (301)
T cd07873 48 PCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124 (301)
T ss_pred hhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34677899999999999999999998754 47999999997 6898888764 56899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhc
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG 161 (568)
++||||||+||+++ .++.+||+|||++...... ......+++.|+|||++. ..++.++||||||+++|+|+||
T Consensus 125 --i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg 201 (301)
T cd07873 125 --VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201 (301)
T ss_pred --eeCCCCCHHHEEEC-CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhC
Confidence 99999999999997 7889999999998765322 223446799999999874 3478899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCC---C------------------CC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 162 EYPYNECKNPAQIYKKVTSGI---K------------------PA-------SLSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~---~------------------p~-------~~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
+.||.......++. .+.... . +. ......++.+++||.+||. +|.+|||+
T Consensus 202 ~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~ 280 (301)
T cd07873 202 RPLFPGSTVEEQLH-FIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA 280 (301)
T ss_pred CCCCCCCCHHHHHH-HHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence 99998754333322 111100 0 00 0112457889999999997 69999999
Q ss_pred HHHhcCCCCCCCC
Q 008378 213 LELLKDPFLVTDN 225 (568)
Q Consensus 213 ~ElL~hpff~~~~ 225 (568)
.|+|.||||+...
T Consensus 281 ~eil~h~~f~~~~ 293 (301)
T cd07873 281 EEAMKHPYFHCLG 293 (301)
T ss_pred HHHhcCccccccc
Confidence 9999999997644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=279.57 Aligned_cols=210 Identities=27% Similarity=0.454 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+++|++++||||+++++++.+. ..+++||||+. ++|..++... ..+++..++.++.||+.||+|||.
T Consensus 42 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~ 118 (284)
T cd07860 42 VPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118 (284)
T ss_pred cchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999988654 47899999996 6899888653 568999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccccc--CCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEml 159 (568)
++ ++||||+|+||+++ .++.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|+
T Consensus 119 ~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~ 195 (284)
T cd07860 119 HR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195 (284)
T ss_pred CC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHH
Confidence 99 99999999999997 78899999999987654322 233467899999998743 3688999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCC--------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPA--------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~--------------------------~~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
||..||........+.+.+.....+. ......+++++++|.+||. +|.+||++
T Consensus 196 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 275 (284)
T cd07860 196 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA 275 (284)
T ss_pred HCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH
Confidence 99999987655544444332211110 0123457889999999996 79999999
Q ss_pred HHHhcCCCC
Q 008378 213 LELLKDPFL 221 (568)
Q Consensus 213 ~ElL~hpff 221 (568)
.++++||||
T Consensus 276 ~~~l~~~~f 284 (284)
T cd07860 276 KAALAHPFF 284 (284)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=274.00 Aligned_cols=211 Identities=22% Similarity=0.424 Sum_probs=173.9
Q ss_pred HHHHHHHHHH-HhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLL-KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iL-k~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
..+..|..++ +.++||||++++++|... ..+|+|+||+.+++|.++++..+.+++..+..++.||+.||.|||+++
T Consensus 41 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~- 117 (260)
T cd05611 41 TNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG- 117 (260)
T ss_pred HHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3455565544 455999999999988654 479999999999999999998889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccccc-CCCccceehhhHHHHHHHhhcCCCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 165 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~-~ys~ksDIWSLGiilyEmltG~~Pf 165 (568)
++||||+|+||+++ .++.+||+|||++..... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||
T Consensus 118 -i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 193 (260)
T cd05611 118 -IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF 193 (260)
T ss_pred -eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCC
Confidence 99999999999997 788999999999875433 334568999999998743 4789999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCH---HHHhcCCCCCCCCC
Q 008378 166 NECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPA---LELLKDPFLVTDNP 226 (568)
Q Consensus 166 ~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa---~ElL~hpff~~~~~ 226 (568)
... +...++..+..+.. +.......++.++++|.+||. +|.+||++ .|++.||||...+|
T Consensus 194 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 194 HAE-TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred CCC-CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 764 44555555544322 233344578999999999996 79999955 79999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=278.59 Aligned_cols=217 Identities=23% Similarity=0.488 Sum_probs=182.4
Q ss_pred CHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+.++.++++..+.++...+ .|+||+.|++|+.... +++.||.+. ..+..++++ .++++|..+-++..-++.||.|
T Consensus 130 Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~Y 206 (391)
T KOG0983|consen 130 NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYY 206 (391)
T ss_pred CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHH
Confidence 5788999999999887775 8999999999987664 667789884 455555544 4679999999999999999999
Q ss_pred hhh-CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccc-ccCCCCccCccccc----cCCCccceehhhHHH
Q 008378 81 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYE----EEYNELVDIYSFGMC 154 (568)
Q Consensus 81 LHs-~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s-~~GTp~YmAPEvl~----~~ys~ksDIWSLGii 154 (568)
|.. |+ |||||+||+|||++ ..|.+|+||||++-.+....+++ -.|-+.|||||.+. ..|+..+||||||++
T Consensus 207 LKeKH~--viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGIT 283 (391)
T KOG0983|consen 207 LKEKHG--VIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGIT 283 (391)
T ss_pred HHHhcc--eeecccCccceEEc-cCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccc
Confidence 965 55 99999999999998 88999999999998876665554 47999999999873 359999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~-~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
++||+||++||.+|...-+...++....+|.... ..+++.+++|+..||. ++.+||...+||+|||+..-.
T Consensus 284 lveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 284 LVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred hhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 9999999999999888777777777655543322 2379999999999996 699999999999999997543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.10 Aligned_cols=224 Identities=26% Similarity=0.441 Sum_probs=190.1
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
..+.|-++|.+++.+.||.+-.+|..+ ..+++|+..|+||+|..+|-.++ .|++..+..|+.+|+.||++||..+
T Consensus 231 maLnEk~iL~kV~s~FiVslaYAfeTk--d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~- 307 (591)
T KOG0986|consen 231 MALNEKQILEKVSSPFIVSLAYAFETK--DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR- 307 (591)
T ss_pred HhhHHHHHHHHhccCcEEEEeeeecCC--CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc-
Confidence 356799999999999999998777655 46999999999999999998887 8999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc-ccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~-~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~P 164 (568)
|++|||||+|||+| +.|+|+|+|+|||..+..... +.-+||.+|||||++ .+.|+..+|+|||||++|||+.|+.|
T Consensus 308 -iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sP 385 (591)
T KOG0986|consen 308 -IVYRDLKPENILLD-DHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSP 385 (591)
T ss_pred -eeeccCChhheeec-cCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCc
Confidence 99999999999998 899999999999988865443 444999999999988 45599999999999999999999999
Q ss_pred CCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCCCC
Q 008378 165 YNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLR 235 (568)
Q Consensus 165 f~~~~~~---~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~l~ 235 (568)
|...... +++-+++.. .+..++...+++++++.+.+|. +|++|+. +.++..||||+..+++.+-...+.
T Consensus 386 Fr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~ 463 (591)
T KOG0986|consen 386 FRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLE 463 (591)
T ss_pred hhhhhhhhhHHHHHHHHhc--chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCC
Confidence 9653321 233333332 3556778889999999999996 6888864 779999999999999988776666
Q ss_pred CCCC
Q 008378 236 LPNL 239 (568)
Q Consensus 236 ~p~~ 239 (568)
.|..
T Consensus 464 PPfi 467 (591)
T KOG0986|consen 464 PPFI 467 (591)
T ss_pred CCCC
Confidence 5554
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=274.10 Aligned_cols=210 Identities=30% Similarity=0.528 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+.+|+.+|+.++||||+++++++... ..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++
T Consensus 52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~- 128 (272)
T cd06629 52 VKALRSEIETLKDLDHLNIVQYLGFETTE--EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG- 128 (272)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeccC--CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 46788999999999999999999987654 478999999999999999998889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccccc---CCCccceehhhHHHHHHHh
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~~---~ys~ksDIWSLGiilyEml 159 (568)
++||||+|+||+++ .++.+||+|||++...... ......|+..|+|||++.. .++.++|+||||+++|+|+
T Consensus 129 -i~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~ 206 (272)
T cd06629 129 -ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF 206 (272)
T ss_pred -eeecCCChhhEEEc-CCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH
Confidence 99999999999997 7899999999998765322 1234468899999998742 3789999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~---p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
+|..||........+.+....... +.......+..++++|.+||. +|..||++.++|.|||+
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 207 AGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred hCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 999999765444434333222211 222334567899999999996 79999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=276.59 Aligned_cols=215 Identities=36% Similarity=0.642 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+++|+.++|+||+++++++... ...|+|+||+.+++|.+++..++ .++...+..++.||+.||.|||++
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~ 135 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 456789999999999999999999998766 47999999999999999999887 899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
| ++|+||+|+||+++ .+|.+||+|||++...... ......+++.|+|||++. ..++.++|+||||+++|+|++|
T Consensus 136 g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g 212 (286)
T cd06614 136 N--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212 (286)
T ss_pred C--eeeCCCChhhEEEc-CCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhC
Confidence 9 99999999999997 7889999999998765432 223456889999999774 4589999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTS-GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~-~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
..||.... +......+.. ...+.......+..+++||.+||. +|..||++.+++.||||....+
T Consensus 213 ~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 213 EPPYLREP-PLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred CCCCCCCC-HHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 99997643 3333333333 222222233467899999999996 6999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=282.14 Aligned_cols=213 Identities=31% Similarity=0.604 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+++.++||||+++++++... ..+++|+||+++++|..++.. ..+++..+..++.||+.||.|||++|
T Consensus 61 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ 137 (297)
T cd06659 61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG 137 (297)
T ss_pred hHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456788999999999999999999988654 478999999999999998765 56899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||+++ .++.+||+|||++...... ......|++.|+|||++. ..++.++||||||+++|+|++|+
T Consensus 138 --ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 214 (297)
T cd06659 138 --VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214 (297)
T ss_pred --eecCCCCHHHeEEc-cCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999997 7899999999998765432 233467999999999874 46899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||... ........+.....+ .......++.++++|.+||+ +|.+||++.+++.||||....
T Consensus 215 ~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 215 PPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 999764 334444444433222 12233467899999999996 799999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=278.02 Aligned_cols=210 Identities=26% Similarity=0.355 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
..+.+|+.+|++++||||+++++++.......+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+++
T Consensus 49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 126 (293)
T cd07843 49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW- 126 (293)
T ss_pred hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 45678999999999999999999998775568999999997 59999887654 5999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc--CCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||+++ .+|.+||+|||++...... ......+++.|+|||.+.+ .++.++||||||+++|+|++|.
T Consensus 127 -i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (293)
T cd07843 127 -ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204 (293)
T ss_pred -eeeccCCHHHEEEC-CCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence 99999999999997 7899999999998766443 2234568899999998743 3688999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCC-CcHHHHHHHHHhcC-CCCCCCCH
Q 008378 163 YPYNECKNPAQIYKKVTSGIK----------------------------PASLSKV-TDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~----------------------------p~~~~~~-~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
.||........+.+.+..-.. ...++.. .++.++++|.+||+ +|.+||++
T Consensus 205 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~ 284 (293)
T cd07843 205 PLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284 (293)
T ss_pred CCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH
Confidence 999875444333222111000 0112222 47889999999996 79999999
Q ss_pred HHHhcCCCC
Q 008378 213 LELLKDPFL 221 (568)
Q Consensus 213 ~ElL~hpff 221 (568)
.|+|.||||
T Consensus 285 ~ell~~~~f 293 (293)
T cd07843 285 EDALKHPYF 293 (293)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.55 Aligned_cols=210 Identities=24% Similarity=0.396 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
..+.+|+++|++|+|||||++++++.... ..++|||++. ++|..++... +.+++..++.|+.||+.||.|||++|
T Consensus 205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~--~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g- 280 (461)
T PHA03211 205 ASSVHEARLLRRLSHPAVLALLDVRVVGG--LTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG- 280 (461)
T ss_pred cCHHHHHHHHHHCCCCCCCcEEEEEEECC--EEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 34678999999999999999999887553 6889999995 7888887764 46999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
|+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||++ ...++.++|||||||++|||++|
T Consensus 281 -IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g 358 (461)
T PHA03211 281 -IIHRDIKTENVLVN-GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVH 358 (461)
T ss_pred -EEECcCCHHHEEEC-CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHc
Confidence 99999999999997 77899999999997653321 2245799999999987 45589999999999999999998
Q ss_pred CCCCCCC-------CCHHHHHHHHHcCCCC-CC-----------------------------CC--CCCcHHHHHHHHHh
Q 008378 162 EYPYNEC-------KNPAQIYKKVTSGIKP-AS-----------------------------LS--KVTDPQVKQFIEKC 202 (568)
Q Consensus 162 ~~Pf~~~-------~~~~~i~~~i~~~~~p-~~-----------------------------~~--~~~s~el~~lI~kc 202 (568)
..|+... ....++.+.+...... .. +. ...++.+++||.+|
T Consensus 359 ~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 438 (461)
T PHA03211 359 TASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRA 438 (461)
T ss_pred CCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHH
Confidence 7665321 1234454444432110 00 00 12456899999999
Q ss_pred cC-CCCCCCCHHHHhcCCCCCC
Q 008378 203 IV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 203 L~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|+ +|.+|||+.|+|+||||+.
T Consensus 439 L~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 439 LTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cccChhhCcCHHHHhhCcccCC
Confidence 96 7999999999999999974
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=291.70 Aligned_cols=208 Identities=25% Similarity=0.437 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-----------------------
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------------- 59 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------------- 59 (568)
.+..+.+.+|+++|+.+ +|||||+++++|.... .+++|||||.+|+|.+++.+.
T Consensus 82 ~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (374)
T cd05106 82 TDEREALMSELKILSHLGQHKNIVNLLGACTHGG--PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKN 159 (374)
T ss_pred HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC--CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccc
Confidence 34567789999999999 8999999999887554 689999999999999998643
Q ss_pred -----------------------------------------------CCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeee
Q 008378 60 -----------------------------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 92 (568)
Q Consensus 60 -----------------------------------------------~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRD 92 (568)
..+++..+..++.||+.||.|||++| |+|||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrD 237 (374)
T cd05106 160 ITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRD 237 (374)
T ss_pred cchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEecc
Confidence 24788899999999999999999999 99999
Q ss_pred ccCCcEEEeCCCCcEEEeecChhhhccCCCcc----cccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-cCCCCC
Q 008378 93 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR----SVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-CEYPYN 166 (568)
Q Consensus 93 LKp~NILl~~~~g~vKI~DFGla~~~~~~~~~----s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~ 166 (568)
|||+|||++ .++.+||+|||+++........ ...+++.|||||++ ...|+.++|||||||++|+|++ |..||.
T Consensus 238 Lkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~ 316 (374)
T cd05106 238 VAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316 (374)
T ss_pred CchheEEEe-CCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 999999997 7889999999999765433221 22356689999977 4569999999999999999997 999997
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 167 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 167 ~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
.......+.+.+..+..+ ..+...+++++++|.+||+ +|.+||++.++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 317 GILVNSKFYKMVKRGYQM-SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred cccccHHHHHHHHcccCc-cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 755445555555554333 2344568999999999996 7999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=275.33 Aligned_cols=193 Identities=26% Similarity=0.454 Sum_probs=162.0
Q ss_pred CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEE
Q 008378 21 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 100 (568)
Q Consensus 21 ~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl 100 (568)
+||||++++++|.... .+++||||+++|+|.++++..+.+++..++.++.||+.||.|||+.| ++||||||+||++
T Consensus 67 ~h~~iv~~~~~~~~~~--~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~ 142 (267)
T PHA03390 67 DNPNFIKLYYSVTTLK--GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLY 142 (267)
T ss_pred cCCCEEEEEEEEecCC--eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE
Confidence 7999999999987654 79999999999999999998889999999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCCCCCCCCCH----HHHH
Q 008378 101 NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP----AQIY 175 (568)
Q Consensus 101 ~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~----~~i~ 175 (568)
+...+.++|+|||++...... ....|++.|+|||++. ..++.++||||||+++|+|++|..||...... ..+.
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 220 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP--SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL 220 (267)
T ss_pred eCCCCeEEEecCccceecCCC--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH
Confidence 843339999999998765432 3346899999999884 56899999999999999999999999754322 1222
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-HHHHhcCCCCC
Q 008378 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-ALELLKDPFLV 222 (568)
Q Consensus 176 ~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-a~ElL~hpff~ 222 (568)
... ..+....+..++.+++||.+||+ +|.+|++ .+++|+||||+
T Consensus 221 ~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 221 KRQ---QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred Hhh---cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 222 22334455788999999999997 6999996 59999999996
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=270.62 Aligned_cols=211 Identities=27% Similarity=0.522 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yL 81 (568)
....+.+.+|+.++++++||||+++++++... ...++|+||+.+++|.+++.... .+++..+..|+.|++.||.||
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 117 (256)
T cd08218 40 PKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV 117 (256)
T ss_pred hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34556889999999999999999999988644 47899999999999999987643 589999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
|+++ ++|+||+|+||+++ .++.++|+|||++....... .....|++.|+|||++ ...++.++|+||||+++|+|
T Consensus 118 h~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l 194 (256)
T cd08218 118 HDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194 (256)
T ss_pred HhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHH
Confidence 9999 99999999999997 67899999999987654322 2345689999999987 45578899999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
++|..||... +...+...+..+..+. .+...+..++++|.+||. +|.+||++.+++.||||
T Consensus 195 ~~g~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 195 CTLKHAFEAG-NMKNLVLKIIRGSYPP-VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HcCCCCccCC-CHHHHHHHHhcCCCCC-CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 9999999764 4455555555554432 345568899999999996 69999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=275.92 Aligned_cols=212 Identities=25% Similarity=0.453 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+++|+.++|+||+++++.+... ..+++||||+.++.+..+..+...+++..+..++.||+.||.|||.+
T Consensus 42 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 119 (288)
T cd07833 42 DVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119 (288)
T ss_pred cchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3457889999999999999999999998764 47999999999888887777777799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCcccc-cc-CCCccceehhhHHHHHHHh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELY-EE-EYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl-~~-~ys~ksDIWSLGiilyEml 159 (568)
+ ++||||+|+||+++ .++.+||+|||++...... ......+++.|+|||++ .. .++.++||||||+++|+|+
T Consensus 120 ~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~ 196 (288)
T cd07833 120 N--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196 (288)
T ss_pred C--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHH
Confidence 9 99999999999997 7899999999998766433 23346789999999987 34 5789999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcC--CC-------------------C--------CCCCCCCcHHHHHHHHHhcC-CCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSG--IK-------------------P--------ASLSKVTDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~--~~-------------------p--------~~~~~~~s~el~~lI~kcL~-~p~~R 209 (568)
+|..||......+.+....... .. + ..++...++++++||.+||. +|.+|
T Consensus 197 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (288)
T cd07833 197 DGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKER 276 (288)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhc
Confidence 9999998765554443322100 00 0 01223447899999999996 79999
Q ss_pred CCHHHHhcCCCC
Q 008378 210 LPALELLKDPFL 221 (568)
Q Consensus 210 psa~ElL~hpff 221 (568)
|++.++++||||
T Consensus 277 ps~~~il~~~~f 288 (288)
T cd07833 277 LTCDELLQHPYF 288 (288)
T ss_pred ccHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=273.35 Aligned_cols=208 Identities=23% Similarity=0.367 Sum_probs=168.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----NVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-----~l~e~~i~~i~~QIl~gL~ 79 (568)
+....+.+|+.+++.++||||+++++++... ...++||||+++|+|.+++.+.. .+++..+..++.||+.||.
T Consensus 37 ~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 114 (269)
T cd05042 37 DEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114 (269)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999988654 46899999999999999997653 2467888999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccc--------cCCCccce
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE--------EEYNELVD 147 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~--------~~ys~ksD 147 (568)
|||+++ |+||||||+|||++ .++.+||+|||++...... ......+++.|+|||++. ..++.++|
T Consensus 115 ~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D 191 (269)
T cd05042 115 WLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191 (269)
T ss_pred HHHhcC--EecccccHhheEec-CCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhH
Confidence 999999 99999999999997 6889999999998654221 112335677899999863 24678999
Q ss_pred ehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 008378 148 IYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 217 (568)
Q Consensus 148 IWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~---p~~~~~~~s~el~~lI~kcL~~p~~Rpsa~ElL~ 217 (568)
||||||++|||++ |..||....+...+...+..+.. ........++.+++++..|+.+|.+||++.+++.
T Consensus 192 iwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 9999999999999 78899776555544444444322 2234456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=268.28 Aligned_cols=206 Identities=23% Similarity=0.410 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHH
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILR 76 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~---------~~l~e~~i~~i~~QIl~ 76 (568)
..+.+.+|+.+++.++|+||+++++++.+ ...+++||||+++++|.+++... ..+++..+..++.||+.
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 116 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHH
Confidence 46789999999999999999999998876 45799999999999999999885 77999999999999999
Q ss_pred HHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc-cCCCccceehhh
Q 008378 77 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSF 151 (568)
Q Consensus 77 gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSL 151 (568)
||.|||+++ ++||||||+||+++ .++.+||+|||.+....... .....+++.|+|||.+. ..++.++|||||
T Consensus 117 al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (262)
T cd00192 117 GMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSF 193 (262)
T ss_pred HHHHHHcCC--cccCccCcceEEEC-CCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHH
Confidence 999999999 99999999999997 67999999999997765432 34456889999999874 468999999999
Q ss_pred HHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 152 GMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 152 GiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+++|+|++ |..||... ....+...+..+... ..+...++++.+++.+||. +|.+||++.+++.+
T Consensus 194 G~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 194 GVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 999999999 69999775 566667777665433 3445568999999999996 69999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=274.18 Aligned_cols=212 Identities=28% Similarity=0.523 Sum_probs=170.4
Q ss_pred HHHHHHHHH-HHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 8 ERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 8 e~l~~Ei~i-Lk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.++..|+.+ ++.++||||+++++++.... .+|+||||++ |+|.+++.. ...+++..+..++.||+.||.|||
T Consensus 44 ~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 120 (283)
T cd06617 44 KRLLMDLDISMRSVDCPYTVTFYGALFREG--DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120 (283)
T ss_pred HHHHHHHHHHHHHcCCCCeeeeeEEEecCC--cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 455566664 77789999999999887544 6899999997 688777654 246899999999999999999999
Q ss_pred hC-CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc-ccccCCCCccCccccc-----cCCCccceehhhHHHH
Q 008378 83 SH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCI 155 (568)
Q Consensus 83 s~-g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~-~s~~GTp~YmAPEvl~-----~~ys~ksDIWSLGiil 155 (568)
++ + ++||||||+||+++ .++.+||+|||++........ ....|+..|+|||++. ..++.++|+||||+++
T Consensus 121 ~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l 197 (283)
T cd06617 121 SKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197 (283)
T ss_pred hcCC--eecCCCCHHHEEEC-CCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHH
Confidence 97 7 99999999999997 788999999999976644332 2357899999999873 3478899999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|+|++|+.||............+..+..+.......+.++++||.+||. +|.+||++.+++.||||....
T Consensus 198 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 198 IELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999754433333333333333333334567899999999996 799999999999999998765
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=278.53 Aligned_cols=213 Identities=29% Similarity=0.517 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+++.+|+.+++.++||||+++++++.+.. ..++|+||+. |+|.+++.. .+.+++..+..++.||+.||.|||
T Consensus 56 ~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH 132 (307)
T cd06607 56 NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132 (307)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 455678999999999999999999999987654 6889999997 677776654 457999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc----ccCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl----~~~ys~ksDIWSLGiilyEm 158 (568)
+.+ ++||||+|+||+++ .+|.+||+|||++..... .....|++.|+|||++ .+.++.++||||||+++|+|
T Consensus 133 ~~~--i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 133 SHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVSP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred HCC--ceecCCCcccEEEC-CCCCEEEeecCcceecCC--CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence 999 99999999999997 788999999999865432 2345789999999976 24588999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+||..||........++ .+.....+.......+..++++|.+||. +|.+||++.+++.||||....
T Consensus 208 ~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 208 AERKPPLFNMNAMSALY-HIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HcCCCCCCCccHHHHHH-HHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999997644333333 3333333333334467899999999996 799999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=264.56 Aligned_cols=209 Identities=33% Similarity=0.617 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+++++.++||||+++++.+... ...++++||+.+++|.+++... +.+++..+..++.|++.||.|||.+
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 117 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC
Confidence 567899999999999999999999988765 4689999999999999999876 6799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
| ++||||+|+||+++ .++.+||+|||++....... .....|+..|+|||.+. ..++.++|+||||+++|+|++|.
T Consensus 118 ~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~ 194 (253)
T cd05122 118 G--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194 (253)
T ss_pred C--EecCCCCHHHEEEc-cCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCC
Confidence 8 99999999999997 68899999999987765433 34567899999999874 44788999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCC-CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 220 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~-~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpf 220 (568)
.||........+..... ...+.. .....+..++++|.+||. +|.+||++.+++.|||
T Consensus 195 ~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 195 PPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 99987544343333332 222222 122237899999999996 7999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=273.17 Aligned_cols=207 Identities=19% Similarity=0.324 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+.+.+|+.+|++++||||+++++++... ..+++||||+.+|+|.+++.+. +.+++..+..++.||+.||+|||
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH 124 (266)
T cd05064 47 DKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124 (266)
T ss_pred HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999988654 4689999999999999999875 57899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
+++ ++||||||+|||++ .++.+|++|||++....... .....+++.|+|||++ ...++.++|||||||++|||
T Consensus 125 ~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 201 (266)
T cd05064 125 EMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201 (266)
T ss_pred HCC--EeeccccHhhEEEc-CCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHH
Confidence 999 99999999999997 78899999999876542221 1123456789999977 45689999999999999997
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++ |..||... ....+.+.+..+..+. .+...+..+.+++.+||+ +|.+||++.++++
T Consensus 202 l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 202 MSYGERPYWDM-SGQDVIKAVEDGFRLP-APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred hcCCCCCcCcC-CHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 75 99999764 4455566666654433 455678899999999997 6999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=279.06 Aligned_cols=212 Identities=24% Similarity=0.331 Sum_probs=171.1
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
.+.+|+.+|++++|+||+++++++.+.....+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++|
T Consensus 52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-- 128 (309)
T cd07845 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF-- 128 (309)
T ss_pred hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4568999999999999999999988766567999999997 5888887753 67999999999999999999999999
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcCC
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
++||||||+||+++ ..+.+||+|||++...... ......+++.|+|||++. ..++.++||||||+++|+|++|+.
T Consensus 129 i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 207 (309)
T cd07845 129 IIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207 (309)
T ss_pred eecCCCCHHHEEEC-CCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence 99999999999997 7889999999999766433 222335688999999874 357899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCC---------------------CCC------CCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 008378 164 PYNECKNPAQIYKKVTSGIKP---------------------ASL------SKVTDPQVKQFIEKCIV-PASLRLPALEL 215 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p---------------------~~~------~~~~s~el~~lI~kcL~-~p~~Rpsa~El 215 (568)
||........+.........+ ..+ ....++.+++||.+||. +|.+||++.++
T Consensus 208 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i 287 (309)
T cd07845 208 LLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287 (309)
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 998754443333222210000 000 01247889999999996 79999999999
Q ss_pred hcCCCCCCC
Q 008378 216 LKDPFLVTD 224 (568)
Q Consensus 216 L~hpff~~~ 224 (568)
+.||||+..
T Consensus 288 l~h~~f~~~ 296 (309)
T cd07845 288 LESSYFKEK 296 (309)
T ss_pred hcChhhccC
Confidence 999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=301.52 Aligned_cols=217 Identities=29% Similarity=0.512 Sum_probs=187.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++..++.+.+|+++|+.|+|||||++|.+...+ ..+|+||||+.+|.+++|+.++++..+..++.++.|++.+++|||
T Consensus 95 n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~--~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH 172 (596)
T KOG0586|consen 95 NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE--ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH 172 (596)
T ss_pred ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh
Confidence 355667799999999999999999999976544 579999999999999999999999999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-CCcccccCCCCccCccccccC-C-CccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl~~~-y-s~ksDIWSLGiilyEml 159 (568)
+++ |+|||||.+|||++ .+-.+||+|||++..+.. ....+++|+|.|.|||++.+. | ++.+|+||+|+++|.|+
T Consensus 173 ~k~--ivHrdLk~eNilL~-~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV 249 (596)
T KOG0586|consen 173 SKN--IVHRDLKAENILLD-ENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALV 249 (596)
T ss_pred hcc--eeccccchhhcccc-cccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeee
Confidence 999 99999999999998 566799999999988864 346789999999999998543 4 68999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 227 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~ 227 (568)
.|..||.+ .+...+..++..+... ++..++-+++++|+++|+ +|.+|++.+++.+|+|.......
T Consensus 250 ~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 250 EGSLPFDG-QNLKELRPRVLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ecccccCC-cccccccchheeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 99999987 4455555555555433 445567899999999996 79999999999999998765543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.26 Aligned_cols=208 Identities=33% Similarity=0.531 Sum_probs=180.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
++++++.|++||.+||+-+|.||+-|.+++..+. +.+|+-+|+|.+|..++.-. .+|+....+.|++||++|+.||
T Consensus 428 t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YL 504 (678)
T KOG0193|consen 428 TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYL 504 (678)
T ss_pred CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhh
Confidence 6789999999999999999999999999986543 58999999999999988643 4699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC----CCcccccCCCCccCccccc----cCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~----~~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGi 153 (568)
|.++ |||||||..|||+. +++.|||+||||+..-.. .....-.|...|||||++. ..|++.+||||||+
T Consensus 505 HAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGi 581 (678)
T KOG0193|consen 505 HAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGI 581 (678)
T ss_pred hhhh--hhhhhccccceEEc-cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhH
Confidence 9999 99999999999997 679999999999965422 2233345778899999883 34999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~---p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++|||+||..||. ..+.++|.-.+.+|.. +.......+.++++|+..||. ++.+||...+||.
T Consensus 582 V~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 582 VWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999 7899999999999944 333445566799999999997 6999999999876
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=278.40 Aligned_cols=207 Identities=25% Similarity=0.389 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-------------------CCCH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------------------NVDM 64 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-------------------~l~e 64 (568)
......+.+|+++|++++||||+++++++.+.. .+++||||+.+|+|.+++.... .+++
T Consensus 60 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (304)
T cd05096 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISY 137 (304)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccH
Confidence 345677999999999999999999999987654 6899999999999999987542 3677
Q ss_pred HHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-c
Q 008378 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E 139 (568)
Q Consensus 65 ~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~ 139 (568)
..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++...... .....+++.|||||++ .
T Consensus 138 ~~~~~i~~~i~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 214 (304)
T cd05096 138 SSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM 214 (304)
T ss_pred HHHHHHHHHHHHHHHHHHHCC--ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc
Confidence 889999999999999999999 99999999999997 78899999999997653322 2233567889999976 5
Q ss_pred cCCCccceehhhHHHHHHHhh--cCCCCCCCCCHHHHHHHHHc----CCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCC
Q 008378 140 EEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTS----GIK--PASLSKVTDPQVKQFIEKCIV-PASLRL 210 (568)
Q Consensus 140 ~~ys~ksDIWSLGiilyEmlt--G~~Pf~~~~~~~~i~~~i~~----~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rp 210 (568)
+.++.++||||||+++|+|++ +..||...... ++...+.. ... ....+...++.++++|.+||. +|.+||
T Consensus 215 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 293 (304)
T cd05096 215 GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE-QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP 293 (304)
T ss_pred CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH-HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc
Confidence 668999999999999999986 66788765433 33222211 111 111233457899999999996 799999
Q ss_pred CHHHHh
Q 008378 211 PALELL 216 (568)
Q Consensus 211 sa~ElL 216 (568)
++.++.
T Consensus 294 s~~~i~ 299 (304)
T cd05096 294 SFSDIH 299 (304)
T ss_pred CHHHHH
Confidence 999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=274.74 Aligned_cols=215 Identities=30% Similarity=0.557 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+.+++.++||||+++++++.+. ...++||||+.+|+|.+++.. +++++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~ 119 (277)
T cd06640 43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS 119 (277)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45677899999999999999999999988764 479999999999999999876 568999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
.+ ++|+||+|+||+++ .++.++|+|||++....... .....++..|+|||++. ..++.++|+||||+++|+|+|
T Consensus 120 ~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06640 120 EK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAK 196 (277)
T ss_pred CC--ccCcCCChhhEEEc-CCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHH
Confidence 98 99999999999997 78899999999997654322 23456889999999874 457899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
|..||.... +......+..+. +.......+..+.++|.+||. +|.+||++.++++||||.....
T Consensus 197 g~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 197 GEPPNSDMH-PMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred CCCCCCCcC-hHhHhhhhhcCC-CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 999997643 333333333332 333455567899999999996 6999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=272.25 Aligned_cols=206 Identities=24% Similarity=0.420 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--------------CCCHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--------------NVDMKAIKNW 70 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--------------~l~e~~i~~i 70 (568)
+..+.+.+|+++|+.++||||+++++++... ...++||||+++|+|.+++...+ .+++..+..+
T Consensus 50 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 127 (280)
T cd05049 50 DARKDFEREAELLTNFQHENIVKFYGVCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127 (280)
T ss_pred HHHHHHHHHHHHHHhcCCCCchheeeEEecC--CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHH
Confidence 3567899999999999999999999998765 46899999999999999997653 4788999999
Q ss_pred HHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-ccCCCcc
Q 008378 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EEEYNEL 145 (568)
Q Consensus 71 ~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~~ys~k 145 (568)
+.||+.||.|||++| ++||||||+||+++ .++.+||+|||++...... ......+++.|+|||++ ...++.+
T Consensus 128 ~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 204 (280)
T cd05049 128 AVQIASGMVYLASQH--FVHRDLATRNCLVG-YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 204 (280)
T ss_pred HHHHHHHHHHHhhCC--eeccccccceEEEc-CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchh
Confidence 999999999999999 99999999999997 7799999999998754221 12334567899999987 4568999
Q ss_pred ceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 146 VDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 146 sDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+||||||+++|+|++ |..||... +.......+..+..+. .+...+..++++|.+||. +|.+||++.|++.
T Consensus 205 ~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 205 SDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999999999998 99999764 4455666666554433 345678899999999996 6999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=280.43 Aligned_cols=216 Identities=30% Similarity=0.541 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+++.++||||+++++++.... ..|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||++
T Consensus 58 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~ 134 (293)
T cd06647 58 PKKELIINEILVMRENKHPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 134 (293)
T ss_pred hHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--cEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34577899999999999999999999887654 689999999999999998764 588999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
| ++||||||+||+++ .++.+||+|||++...... ......|++.|+|||.+ ...++.++|+||||+++|+|++|
T Consensus 135 g--i~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g 211 (293)
T cd06647 135 Q--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (293)
T ss_pred C--EeeccCCHHHEEEc-CCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9 99999999999997 7789999999988655332 22345789999999977 45588999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
..||.......++......+.+....+...++.++++|.+||. +|.+||++.+++.||||+..++
T Consensus 212 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 212 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred CCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 9999765443333332222222222334467889999999996 7999999999999999987664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=289.27 Aligned_cols=208 Identities=24% Similarity=0.394 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-----------------------
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------------- 60 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------------- 60 (568)
...+.+.+|+++|+.+ +|||||+++++|.+.. ..++|||||++|+|.+++....
T Consensus 80 ~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (375)
T cd05104 80 TEREALMSELKVLSYLGNHINIVNLLGACTVGG--PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQ 157 (375)
T ss_pred HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC--cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhh
Confidence 3456789999999999 8999999999886554 6899999999999999986432
Q ss_pred ----------------------------------------------------CCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 61 ----------------------------------------------------NVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 61 ----------------------------------------------------~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
.+++..+..++.||+.||.|||+++ |
T Consensus 158 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i 235 (375)
T cd05104 158 REMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--C 235 (375)
T ss_pred hcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence 4788889999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc----ccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-cC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-CE 162 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~----~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt-G~ 162 (568)
+||||||+|||++ .++.+||+|||+++....... ....+++.|+|||++ ...++.++||||||+++|+|++ |.
T Consensus 236 vH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~ 314 (375)
T cd05104 236 IHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 314 (375)
T ss_pred eccCCchhhEEEE-CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence 9999999999997 678999999999976543221 123356679999987 4568999999999999999998 89
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
.||........+.+.+..+..+. .+...+.+++++|.+||. +|.+||++.+++..
T Consensus 315 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 315 SPYPGMPVDSKFYKMIKEGYRML-SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCCCCchHHHHHHHHhCccCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99987666666777776665433 334567899999999996 69999999998763
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=270.01 Aligned_cols=211 Identities=29% Similarity=0.512 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLH 82 (568)
...+.+.+|+++++.++|+||+++++.+... ..+++|+||+.+++|.+++.+.. .+++..+..|+.||+.||.|||
T Consensus 41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 118 (257)
T cd08225 41 KEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118 (257)
T ss_pred hhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999999999999987654 47999999999999999987654 4799999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
+++ ++|+||||+||+++..+..+||+|||.+....... .....|++.|+|||++ ...++.++|+||||+++|+|+
T Consensus 119 ~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~ 196 (257)
T cd08225 119 DRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELC 196 (257)
T ss_pred HCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 999 99999999999997444567999999987664332 2334689999999977 456889999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
+|..||.... .......+..+..+ ......+..++++|.+||. +|.+||++.++++||||
T Consensus 197 ~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 197 TLKHPFEGNN-LHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred hCCCCCCCcc-HHHHHHHHhcccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999997644 34444444443322 2334567899999999996 79999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=265.79 Aligned_cols=211 Identities=32% Similarity=0.576 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~QIl~gL~ 79 (568)
++..+.+.+|+++++.++|||++++++.+... ..+++|+||+++++|.+++.+. ..+++..+..++.||+.||.
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~ 117 (258)
T cd08215 40 EKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117 (258)
T ss_pred hHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHH
Confidence 46677899999999999999999999988765 5789999999999999998864 67999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
|||++| ++|+||+|+||+++ .++.++|+|||++...... ......|++.|+|||.+ ...++.++|+||||++++
T Consensus 118 ~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~ 194 (258)
T cd08215 118 YLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLY 194 (258)
T ss_pred HHHhCC--EecccCChHHeEEc-CCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHH
Confidence 999998 99999999999997 6789999999999765443 23445789999999976 455889999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
+|++|..||.... ...+...+.... ...++...+..++++|.+||. +|.+||++.++|.||||
T Consensus 195 ~l~~g~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 195 ELCTLKHPFEGEN-LLELALKILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHcCCCCCCCCc-HHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999997643 555555555443 333455678899999999996 79999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=268.69 Aligned_cols=206 Identities=21% Similarity=0.370 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+...+.+.+|+.+|+.++||||+++++++.. ...++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+
T Consensus 37 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~ 113 (257)
T cd05116 37 PALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113 (257)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4556789999999999999999999997643 2578999999999999999988889999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc-----ccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~-----~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
+| ++||||||.||+++ .++.+||+|||++........ ....+++.|+|||.+. ..++.++||||||+++||
T Consensus 114 ~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 190 (257)
T cd05116 114 TN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190 (257)
T ss_pred CC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHH
Confidence 99 99999999999997 678999999999976643221 1223467899999874 458889999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|++ |..||.. .+...+...+..+..+. .+...+++++++|.+||+ +|.+||++.++..
T Consensus 191 l~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 191 AFSYGQKPYKG-MKGNEVTQMIESGERME-CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 998 9999976 34566777777665433 455678999999999996 6999999988754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=273.53 Aligned_cols=214 Identities=33% Similarity=0.560 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHHHHhCC---CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 4 PDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~---HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+...+++.+|+.+++.++ ||||+++++++.+. ...++||||+.+++|.++++.. .+++..+..++.||+.||.|
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~ 116 (277)
T cd06917 40 DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKY 116 (277)
T ss_pred chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEEEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHH
Confidence 455678899999999997 99999999988754 4789999999999999998764 79999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccccc--CCCccceehhhHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCIL 156 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiily 156 (568)
||+.| ++||||+|+||+++ ..+.++|+|||++....... .....|++.|+|||.+.. .++.++|+||||+++|
T Consensus 117 lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~ 193 (277)
T cd06917 117 IHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIY 193 (277)
T ss_pred HHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHH
Confidence 99999 99999999999997 68999999999987664332 234578999999998743 4688999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK-VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~-~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|++|..||..... ......+.... +..+.. ..++++.+||.+||. +|.+||++.+++.||||+...
T Consensus 194 ~ll~g~~p~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 194 EMATGNPPYSDVDA-FRAMMLIPKSK-PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHhCCCCCCCCCh-hhhhhccccCC-CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999976433 22223332222 223333 367899999999996 699999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=277.22 Aligned_cols=213 Identities=27% Similarity=0.397 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
...+..|+++++.++|+||+++++++.+. ..+++||||+ +|+|..++.... .+++..+..++.||+.||.|||++|
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 122 (298)
T cd07841 46 NFTALREIKLLQELKHPNIIGLLDVFGHK--SNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122 (298)
T ss_pred hHHHHHHHHHHhhcCCCCChhhhheeecC--CEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45677899999999999999999998763 5799999999 899999998776 7999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhc
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG 161 (568)
++||||||+||+++ .+|.+||+|||++...... ......+++.|+|||.+. ..++.++||||||+++|+|++|
T Consensus 123 --i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g 199 (298)
T cd07841 123 --ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR 199 (298)
T ss_pred --eeecCCChhhEEEc-CCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcC
Confidence 99999999999998 7899999999999766433 223346788999999773 3578999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCC-------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKP-------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALEL 215 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p-------------------------~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~El 215 (568)
..||........+.+.......+ .......+..+++||.+||. +|.+||++.++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~ 279 (298)
T cd07841 200 VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA 279 (298)
T ss_pred CccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHH
Confidence 77776644433332222110000 00112346789999999996 69999999999
Q ss_pred hcCCCCCCCC
Q 008378 216 LKDPFLVTDN 225 (568)
Q Consensus 216 L~hpff~~~~ 225 (568)
+.||||+...
T Consensus 280 l~~~~~~~~~ 289 (298)
T cd07841 280 LEHPYFSNDP 289 (298)
T ss_pred hhCccccCCC
Confidence 9999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=273.02 Aligned_cols=207 Identities=21% Similarity=0.350 Sum_probs=166.0
Q ss_pred HHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 9 RLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 9 ~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
...+|+.+++++. ||||+++++++.+.....+++||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+++
T Consensus 43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~- 120 (282)
T cd07831 43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG- 120 (282)
T ss_pred hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3457999999995 999999999988765568999999997 577777765 457899999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccc-c-cCCCccceehhhHHHHHHHhhcCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl-~-~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
++||||||+||+++ . |.+||+|||++....... .....+++.|+|||++ . ..++.++|||||||++|+|++|..
T Consensus 121 -i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~ 197 (282)
T cd07831 121 -IFHRDIKPENILIK-D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197 (282)
T ss_pred -ceecccCHHHEEEc-C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCc
Confidence 99999999999998 4 999999999997664332 2345789999999976 3 347889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcC--C--------------CCCCC-----------CCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 008378 164 PYNECKNPAQIYKKVTSG--I--------------KPASL-----------SKVTDPQVKQFIEKCIV-PASLRLPALEL 215 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~--~--------------~p~~~-----------~~~~s~el~~lI~kcL~-~p~~Rpsa~El 215 (568)
||.+....+ ....+... . ....+ ....+..++++|.+||. +|.+||++.++
T Consensus 198 p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 276 (282)
T cd07831 198 LFPGTNELD-QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA 276 (282)
T ss_pred CCCCCCHHH-HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH
Confidence 997644322 22222110 0 00001 12356899999999997 69999999999
Q ss_pred hcCCCC
Q 008378 216 LKDPFL 221 (568)
Q Consensus 216 L~hpff 221 (568)
+.||||
T Consensus 277 l~~~~~ 282 (282)
T cd07831 277 LRHPYF 282 (282)
T ss_pred hhCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=274.08 Aligned_cols=207 Identities=25% Similarity=0.437 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-------------CCCHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------------NVDMKAIKNW 70 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-------------~l~e~~i~~i 70 (568)
....+.+.+|+++|++++||||+++++++... ..+++||||+.+++|.+++..++ .+++..+..+
T Consensus 48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~ 125 (288)
T cd05093 48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125 (288)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHH
Confidence 44567899999999999999999999988754 46899999999999999997654 4899999999
Q ss_pred HHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc-cCCCcc
Q 008378 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNEL 145 (568)
Q Consensus 71 ~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~-~~ys~k 145 (568)
+.||+.||+|||++| ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||++. ..++.+
T Consensus 126 ~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 202 (288)
T cd05093 126 AQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 202 (288)
T ss_pred HHHHHHHHHHHHhCC--eeecccCcceEEEc-cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch
Confidence 999999999999999 99999999999997 78999999999987553221 22334678899999874 568999
Q ss_pred ceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 146 VDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 146 sDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+||||||+++|+|+| |..||... ....+...+..+..+. .+...++++++|+.+||+ +|.+||++.+++.
T Consensus 203 sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 203 SDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECITQGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999999998 89999764 4555666666654432 344578899999999997 6999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=273.92 Aligned_cols=215 Identities=25% Similarity=0.443 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHH-----HhCCCCCHHHHHHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYR-----KKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i-----~k~~~l~e~~i~~i~~QIl~gL 78 (568)
.....+.+|+.++.++. ||||+++++++..+. ..+++|||+. ++|.++. ...+.+++..+..++.|++.||
T Consensus 44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l 120 (288)
T cd06616 44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHH
Confidence 45667899999999996 999999999887643 5788999986 4554432 2346799999999999999999
Q ss_pred HhhhhC-CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccccc----CCCccceehhhH
Q 008378 79 HYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE----EYNELVDIYSFG 152 (568)
Q Consensus 79 ~yLHs~-g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl~~----~ys~ksDIWSLG 152 (568)
+|||+. + ++||||||+||+++ .++.+||+|||++....... .....|++.|+|||++.. .++.++||||||
T Consensus 121 ~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG 197 (288)
T cd06616 121 NYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLG 197 (288)
T ss_pred HHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHH
Confidence 999974 7 99999999999997 68899999999997664332 234578999999998843 489999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 153 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~---~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+++|+|++|+.||............+..+..+.. .....++++.+||.+||. +|.+||++.++++||||+...
T Consensus 198 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 198 ITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 9999999999999765433333333333333222 122468899999999996 699999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=269.93 Aligned_cols=211 Identities=29% Similarity=0.491 Sum_probs=175.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL 78 (568)
+.+....+.+|+.+|+.++||||+++++++.+. ..+++|+||+++|+|.+++.. ...+++..+..++.||+.||
T Consensus 42 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 119 (267)
T cd08228 42 DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119 (267)
T ss_pred CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHH
Confidence 345667889999999999999999999988765 478999999999999988753 34589999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
.|||+++ ++||||||+||+++ .++.++|+|||++....... .....|++.|+|||.+ ...++.++|+||||+++
T Consensus 120 ~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 196 (267)
T cd08228 120 EHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196 (267)
T ss_pred HHHhhCC--eeCCCCCHHHEEEc-CCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHH
Confidence 9999999 99999999999997 78899999999987654322 2345789999999977 45688999999999999
Q ss_pred HHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 156 LEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 156 yEmltG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+|++|..||.... +...+...+.....+.......+..++++|.+||. +|.+||++.++++.
T Consensus 197 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 197 YEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999996533 34556666655555544445567899999999996 79999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=275.55 Aligned_cols=217 Identities=24% Similarity=0.410 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+++.+|+++|+++ +|+||+++++.+... ..+++||||+++++|.+++...+.+++..+..++.||+.||.|||++
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~ 124 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecC--CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 356788999999999 699999999987654 47899999999999999999888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCccccc---cCCCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~---~~ys~ksDIWSLGiilyEm 158 (568)
| ++||||+|+|||++ .++.+||+|||++...... ......|++.|+|||.+. ..++.++||||||+++|+|
T Consensus 125 ~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~l 201 (290)
T cd05613 125 G--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201 (290)
T ss_pred C--eeccCCCHHHeEEC-CCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHH
Confidence 9 99999999999997 7899999999998765332 223457899999999874 3478899999999999999
Q ss_pred hhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCc
Q 008378 159 VTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 159 ltG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l 229 (568)
++|..||.... ....+...+..... .++...++.+++++.+||. +|.+|+ ++.+++.||||+..++..+
T Consensus 202 l~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 202 LTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred hcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 99999996422 22333344433322 2455678999999999996 699997 8999999999998876443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-32 Score=265.21 Aligned_cols=210 Identities=35% Similarity=0.605 Sum_probs=179.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|++++++++||||+++++++.+. ...++||||+++++|.+++...+.+++..+..++.|++.||.|||++
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 118 (254)
T cd06627 41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118 (254)
T ss_pred HHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 5678899999999999999999999988654 47899999999999999999888999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc--ccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~--~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
| ++||||||+||+++ .++.+||+|||++........ ....+++.|+|||.+. ..++.++||||||+++|+|++|
T Consensus 119 ~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g 195 (254)
T cd06627 119 G--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195 (254)
T ss_pred C--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC
Confidence 9 99999999999997 688999999999976644332 3457899999999773 4478899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
..||..........+.. ... ...++...++.++++|.+||. +|.+||++.+++.||||
T Consensus 196 ~~p~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 196 NPPYYDLNPMAALFRIV-QDD-HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCCCCccHHHHHHHHh-ccC-CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99997655333333333 222 223556678999999999996 79999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=273.59 Aligned_cols=206 Identities=27% Similarity=0.441 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 68 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~~i~ 68 (568)
...+.+.+|+++++.++||||+++++++... ...++||||+++++|.+++..++ .+++..+.
T Consensus 49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (291)
T cd05094 49 AARKDFQREAELLTNLQHEHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceEEEEEccC--CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHH
Confidence 3456789999999999999999999988654 46899999999999999997653 38899999
Q ss_pred HHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCC
Q 008378 69 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYN 143 (568)
Q Consensus 69 ~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys 143 (568)
.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||.+ ...++
T Consensus 127 ~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 203 (291)
T cd05094 127 HIASQIASGMVYLASQH--FVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 203 (291)
T ss_pred HHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC
Confidence 99999999999999999 99999999999997 78899999999997553321 2234578899999977 45688
Q ss_pred ccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 144 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 144 ~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
.++||||||+++|+|+| |..||... +.......+..+..+. .....+..++++|.+||. +|.+||++.++++
T Consensus 204 ~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 204 TESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 99999999999999999 99999764 4444555555554432 345567899999999996 7999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=284.73 Aligned_cols=215 Identities=28% Similarity=0.409 Sum_probs=171.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
+.+..+++.+|+.+++.++||||++++++|..... ...|+||||+. ++|.+++... +++..+..++.||+.||
T Consensus 55 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL 131 (353)
T cd07850 55 NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGI 131 (353)
T ss_pred ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHH
Confidence 34566788899999999999999999998864432 35799999996 5888887654 89999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
.|||++| ++||||||+||+++ .+|.+||+|||++....... .....|++.|+|||++ ...++.++|||||||++|
T Consensus 132 ~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 208 (353)
T cd07850 132 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (353)
T ss_pred HHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHH
Confidence 9999999 99999999999997 78899999999997654332 2345789999999977 456899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCC--------------------------------C--------CCCCCCcHHHH
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKP--------------------------------A--------SLSKVTDPQVK 196 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p--------------------------------~--------~~~~~~s~el~ 196 (568)
+|++|+.||..........+.+..-..| . ......++.++
T Consensus 209 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
T cd07850 209 EMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR 288 (353)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHH
Confidence 9999999997654332221111100000 0 00123456789
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 197 QFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 197 ~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
++|.+||+ +|.+||++.|+|.||||+.
T Consensus 289 ~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 289 DLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 99999996 7999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=274.58 Aligned_cols=208 Identities=29% Similarity=0.550 Sum_probs=170.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~y 80 (568)
+++..+.+.+|++.|++++||||+++++++.... .+++|+||+++|+|.+++... ..+++..+..|+.||+.||.|
T Consensus 41 ~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~ 118 (259)
T PF07714_consen 41 SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSY 118 (259)
T ss_dssp SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHH
T ss_pred ccccceeeeecccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccc
Confidence 3556899999999999999999999999998443 489999999999999999987 679999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccc-cCCCccceehhhHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 155 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiil 155 (568)
||+++ ++|++|+|.|||++ .++.+||+|||++...... ......+...|+|||.+. ..++.++||||||+++
T Consensus 119 Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l 195 (259)
T PF07714_consen 119 LHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLL 195 (259)
T ss_dssp HHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHH
T ss_pred ccccc--cccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999 99999999999998 6889999999999766221 122345677899999884 4589999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||++ |+.||... +...+...+..+..+. .+...+..+.++|.+||. +|.+||++.++++
T Consensus 196 ~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 196 YEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccccc-ccccccccccccccce-eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99999 78999775 6677777776654433 455678899999999995 7999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=269.41 Aligned_cols=208 Identities=23% Similarity=0.345 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----NVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-----~l~e~~i~~i~~QIl~gL~ 79 (568)
.....+.+|+.+++.++||||+++++++.+.. .+++||||+++|+|.+++...+ ..++..+..++.|++.||.
T Consensus 37 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~ 114 (269)
T cd05087 37 QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL 114 (269)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHH
Confidence 34457889999999999999999999886543 6889999999999999987532 4567788899999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccccc--------CCCccce
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE--------EYNELVD 147 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~~--------~ys~ksD 147 (568)
|||+++ ++||||||+||+++ .++.+||+|||++....... .....|++.|+|||++.. .++.++|
T Consensus 115 ~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D 191 (269)
T cd05087 115 HLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191 (269)
T ss_pred HHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccch
Confidence 999999 99999999999997 67899999999986543221 123457889999998742 3578999
Q ss_pred ehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 008378 148 IYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 217 (568)
Q Consensus 148 IWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~---p~~~~~~~s~el~~lI~kcL~~p~~Rpsa~ElL~ 217 (568)
|||||+++|||++ |..||............+..... ........++.+++++.+|+.+|.+||++.+++.
T Consensus 192 iwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 192 VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999996 99999775544443333332211 1222334678899999999988999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=274.70 Aligned_cols=213 Identities=30% Similarity=0.543 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+.+++.++||||+++++++... ..+++||||+++++|.+++.. +.+++..++.++.||+.||.|||+
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~ 119 (277)
T cd06642 43 EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHS 119 (277)
T ss_pred hHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc
Confidence 34567899999999999999999999988654 468999999999999998875 568999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
++ ++|+||+|+||+++ .++.+||+|||++....... .....|+..|+|||.+. ..++.++|+||||+++|+|+|
T Consensus 120 ~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06642 120 ER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAK 196 (277)
T ss_pred CC--eeccCCChheEEEe-CCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHh
Confidence 98 99999999999997 78999999999987654322 22346889999999874 458899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|..||.... +......+..+. +..+....+..+.++|.+||. +|.+||++.++++||||...
T Consensus 197 g~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 197 GEPPNSDLH-PMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCCCCcccc-hhhHHhhhhcCC-CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 999997533 333333333333 233445567889999999996 79999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=269.24 Aligned_cols=211 Identities=21% Similarity=0.351 Sum_probs=172.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHh------CCCCCHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKK------HKNVDMKAIKNWAR 72 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k------~~~l~e~~i~~i~~ 72 (568)
+....+.+.+|+++|+.++||||+++++++.... ....++||||+.+|+|.+++.. ...+++..+..++.
T Consensus 40 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (272)
T cd05075 40 TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119 (272)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHH
Confidence 4567788999999999999999999999765432 2357899999999999998742 23488999999999
Q ss_pred HHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccce
Q 008378 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVD 147 (568)
Q Consensus 73 QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksD 147 (568)
||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....... .....+++.|+|||.+ ...++.++|
T Consensus 120 ~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D 196 (272)
T cd05075 120 DIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSD 196 (272)
T ss_pred HHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHH
Confidence 9999999999998 99999999999997 78899999999998664321 1223467789999987 456899999
Q ss_pred ehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 148 IYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 148 IWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|||||+++|+|++ |+.||.. .....+...+..+..+. .+...+..++++|.+||+ +|.+||++.+++++
T Consensus 197 i~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 197 VWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK-QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999 8899976 44566777776654433 334567889999999996 79999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.23 Aligned_cols=212 Identities=22% Similarity=0.383 Sum_probs=170.5
Q ss_pred CHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEE-cC---C-CCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLK-HENIIKFYNSWV-DD---T-NRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQI 74 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~-~~---~-~~~l~lV~Ey~~gGsL~~~i~k--~~~l~e~~i~~i~~QI 74 (568)
+++.++.+.+||.+||+|+ |+|||.|+++.. .. . ...+.+.||||.||.|-+++++ ..+|++.+|.+|++|+
T Consensus 74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv 153 (738)
T KOG1989|consen 74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV 153 (738)
T ss_pred CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHH
Confidence 6788999999999999996 999999999432 11 1 2367899999999999999984 3569999999999999
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cc---------cccCCCCccCcccc----c
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--AR---------SVIGTPEFMAPELY----E 139 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~---------s~~GTp~YmAPEvl----~ 139 (568)
++|+.+||...|||||||||-+||||+ .+|..||||||.++..-... .. ...-||.|+|||++ .
T Consensus 154 ~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg 232 (738)
T KOG1989|consen 154 CEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG 232 (738)
T ss_pred HHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC
Confidence 999999999999999999999999997 78999999999986432211 11 12469999999977 2
Q ss_pred cCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 140 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 140 ~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
...++|+|||+|||+||-||....||.+....+ |..+.........++..+++||..||+ +|.+||++.+++.+
T Consensus 233 ~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 233 LPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred CCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 358999999999999999999999997743222 222222111224567899999999996 69999999988766
Q ss_pred CC
Q 008378 219 PF 220 (568)
Q Consensus 219 pf 220 (568)
-+
T Consensus 308 ~~ 309 (738)
T KOG1989|consen 308 IF 309 (738)
T ss_pred HH
Confidence 44
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=270.71 Aligned_cols=208 Identities=27% Similarity=0.451 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+++|+.++||||+++++++.......+++||||+.+|+|.+++... .+++..++.++.|++.||.|||++
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~ 126 (283)
T cd05080 48 QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ 126 (283)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3567788999999999999999999988766666799999999999999999875 599999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc-----ccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~-----~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
+ ++||||||+||+++ .++.+||+|||++........ ....++..|+|||.+ ...++.++||||||+++|+|
T Consensus 127 ~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el 203 (283)
T cd05080 127 H--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203 (283)
T ss_pred C--eeccccChheEEEc-CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHH
Confidence 9 99999999999997 678999999999976643221 122456679999977 45689999999999999999
Q ss_pred hhcCCCCCCCCCHH--------------HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VTCEYPYNECKNPA--------------QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 ltG~~Pf~~~~~~~--------------~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+||..||....... .+...+..+..+ ..+...++++++++.+||. +|++||++.+++.
T Consensus 204 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 204 LTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999986532110 111111111111 1244567899999999997 6999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=266.06 Aligned_cols=207 Identities=22% Similarity=0.406 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++....+.+|+++|+.++||||+++++++... ..+++||||+.+++|.+++.+. ..+++..+..++.|++.||.|||
T Consensus 34 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH 111 (252)
T cd05084 34 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE 111 (252)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45567899999999999999999999988654 4689999999999999998764 46899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccc----ccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s----~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
+++ ++||||||+||+++ .++.+||+|||++.......... ..++..|+|||.+ .+.++.++||||||+++|+
T Consensus 112 ~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 188 (252)
T cd05084 112 SKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188 (252)
T ss_pred hCC--ccccccchheEEEc-CCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHH
Confidence 999 99999999999997 78899999999987654322111 1234569999987 4558999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|++ |..||... ........+.....+ ..+...+..+.+++.+||+ +|.+||++.++++
T Consensus 189 ~~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 189 AFSLGAVPYANL-SNQQTREAIEQGVRL-PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHhCCCCCcccc-CHHHHHHHHHcCCCC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 998 88888653 344455555444333 3455668899999999996 6999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=280.68 Aligned_cols=216 Identities=26% Similarity=0.388 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
......+.+|+.+++++ +||||++++++|...+...+++||||+. ++|..++.+. .+++..+..++.||+.||.|||
T Consensus 47 ~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH 124 (337)
T cd07852 47 ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIH 124 (337)
T ss_pred chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Confidence 45566788999999999 9999999999987666667899999997 5999998876 7899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-------CcccccCCCCccCccccc--cCCCccceehhhHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGM 153 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-------~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGi 153 (568)
++| |+||||||+|||++ .+|.+||+|||++...... ....+.||+.|+|||++. ..++.++||||||+
T Consensus 125 ~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~ 201 (337)
T cd07852 125 SGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGC 201 (337)
T ss_pred HCC--eecCCCCHHHEEEc-CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHH
Confidence 999 99999999999997 7899999999999765322 223457899999999773 45788999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCCCCcHHHHHHHHHhcC-
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGI----------------------------KPASLSKVTDPQVKQFIEKCIV- 204 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~----------------------------~p~~~~~~~s~el~~lI~kcL~- 204 (568)
++|+|+||+.||..........+.+.... ......+..+.++.++|.+||+
T Consensus 202 ~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 281 (337)
T cd07852 202 ILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVF 281 (337)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccC
Confidence 99999999999976544433322221110 0111223357899999999996
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 008378 205 PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 205 ~p~~Rpsa~ElL~hpff~~~ 224 (568)
+|.+||++.+++.||||+..
T Consensus 282 ~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 282 NPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred CcccccCHHHHhhChhhhhh
Confidence 79999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=272.48 Aligned_cols=213 Identities=24% Similarity=0.369 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCC---CeEEEEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSLK-HENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRG 77 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~---~~l~lV~Ey~~gGsL~~~i~k~-----~~l~e~~i~~i~~QIl~g 77 (568)
...+.+|+.+++.+. ||||+++++++..... ..+|+||||+.+ +|.+++... ..+++..++.++.||+.|
T Consensus 44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~ 122 (295)
T cd07837 44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122 (295)
T ss_pred chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence 356888999999995 6999999998865432 248999999985 888887642 358999999999999999
Q ss_pred HHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc--cCCCccceehhhHH
Q 008378 78 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--EEYNELVDIYSFGM 153 (568)
Q Consensus 78 L~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGi 153 (568)
|.|||+++ ++||||||+||+++..++.+||+|||++....... .....+++.|+|||++. ..++.++||||||+
T Consensus 123 L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 200 (295)
T cd07837 123 VAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200 (295)
T ss_pred HHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence 99999999 99999999999998448899999999987653321 22346789999999773 34789999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-------------------------CCCCCCcHHHHHHHHHhcC-CCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-------------------------SLSKVTDPQVKQFIEKCIV-PAS 207 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~-------------------------~~~~~~s~el~~lI~kcL~-~p~ 207 (568)
++|+|++|..||..........+.+..-..|. ......++++++||.+||. +|.
T Consensus 201 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 99999999999987655555443322110000 0112357889999999996 699
Q ss_pred CCCCHHHHhcCCCCC
Q 008378 208 LRLPALELLKDPFLV 222 (568)
Q Consensus 208 ~Rpsa~ElL~hpff~ 222 (568)
+||++.+++.||||+
T Consensus 281 ~R~~~~eil~~~~~~ 295 (295)
T cd07837 281 KRISAKAALTHPYFD 295 (295)
T ss_pred hcCCHHHHhcCCCcC
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=272.61 Aligned_cols=208 Identities=26% Similarity=0.440 Sum_probs=164.8
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
..+.+|+++|+.++|+||+++++++... ...++||||+. ++|..++.. ...+++..++.++.||+.||.|||+++
T Consensus 48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~- 123 (291)
T cd07870 48 FTAIREASLLKGLKHANIVLLHDIIHTK--ETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123 (291)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEecC--CeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3567899999999999999999988654 47899999996 677666654 356889999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc--CCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||+++ .+|.+||+|||+++..... ......+++.|+|||++.+ .++.++||||||+++|+|++|.
T Consensus 124 -i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 201 (291)
T cd07870 124 -ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201 (291)
T ss_pred -cccCCCChHHEEEc-CCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999997 7899999999998754322 2234467999999998743 4788999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHc--CCC-----------------------CCCC---C--CCCcHHHHHHHHHhcC-CCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTS--GIK-----------------------PASL---S--KVTDPQVKQFIEKCIV-PASLRLP 211 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~--~~~-----------------------p~~~---~--~~~s~el~~lI~kcL~-~p~~Rps 211 (568)
.||............+.. +.+ +... . -..++.+++++.+|++ +|.+|||
T Consensus 202 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t 281 (291)
T cd07870 202 PAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281 (291)
T ss_pred CCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC
Confidence 999765544333222211 000 0000 0 0125789999999996 6999999
Q ss_pred HHHHhcCCCC
Q 008378 212 ALELLKDPFL 221 (568)
Q Consensus 212 a~ElL~hpff 221 (568)
+.+++.||||
T Consensus 282 ~~~~l~h~~~ 291 (291)
T cd07870 282 AQDALLHPYF 291 (291)
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=266.25 Aligned_cols=209 Identities=30% Similarity=0.497 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yL 81 (568)
....+++.+|+.+++.++||||++++++|.+. ..+|+||||+++|+|.+++... ..+++..+..|+.||+.||.||
T Consensus 39 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l 116 (255)
T cd08219 39 SSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116 (255)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999998655 4799999999999999988653 4589999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
|++| ++|+||||+||+++ .++.++|+|||++...... ......|++.|+|||++. ..++.++|+||||+++|+|
T Consensus 117 H~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l 193 (255)
T cd08219 117 HEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193 (255)
T ss_pred hhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheeh
Confidence 9999 99999999999997 7889999999998766432 233467999999999884 4588999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 219 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hp 219 (568)
++|..||.. .+.......+..+..+. .+...+..++++|.+||. +|.+||++.+++..-
T Consensus 194 ~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 194 CTLKHPFQA-NSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred hhccCCCCC-CCHHHHHHHHhcCCCCC-CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence 999999976 34555555555543332 345567899999999995 799999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=264.72 Aligned_cols=211 Identities=32% Similarity=0.530 Sum_probs=180.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL~ 79 (568)
+....++.+|+++++.++||||+++++++.+. ...++|+||+++++|.+++.+ ...+++..+..++.|++.||.
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~ 117 (256)
T cd08530 40 QKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117 (256)
T ss_pred HHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHH
Confidence 45567888999999999999999999988765 579999999999999999876 356899999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
|||+.| ++||||+|+||+++ .++.+||+|||++............|++.|+|||.+ ...++.++|+||||+++|+|
T Consensus 118 ~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l 194 (256)
T cd08530 118 ALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEM 194 (256)
T ss_pred HHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHH
Confidence 999999 99999999999998 678999999999987765544556789999999977 45588899999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
++|..||... +...+...+..+..+. .+...+.+++++|.+||. +|.+||++.++++||++
T Consensus 195 ~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 195 ATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999764 4445555555544333 334678899999999996 79999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=266.28 Aligned_cols=206 Identities=21% Similarity=0.421 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLH 82 (568)
...+.+.+|+.+++.++|+||+++++++.... ..+++|+||+++++|.+++++.+ .+++..+..++.||+.||.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 119 (256)
T cd05082 41 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119 (256)
T ss_pred chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999765443 46899999999999999998654 3889999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh-
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt- 160 (568)
++| ++||||||+||+++ .++.+||+|||++....... ....++..|+|||++. ..++.++||||||+++|+|++
T Consensus 120 ~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~ 195 (256)
T cd05082 120 ANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred hCC--EeccccchheEEEc-CCCcEEecCCccceeccccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhC
Confidence 999 99999999999997 78999999999987543322 2334567899999874 458899999999999999998
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+.||.. .+...+...+..+..+ ......++.++++|.+|+. +|.+||++.++++
T Consensus 196 g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 196 GRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999975 4566667777665443 3445678999999999996 7999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=265.19 Aligned_cols=209 Identities=28% Similarity=0.513 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+..|+.+++.++||||+++++.+... ..+++||||+.+++|.+++...+.+++..+..++.||+.||.|||+.
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~ 112 (250)
T cd05123 35 KEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112 (250)
T ss_pred HHHHHHHHHHHHHHHcCCCcHHHHHHHeecC--CeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4667899999999999999999999987544 47999999999999999999888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
+ ++|+||+|+||+++ .++.++|+|||++...... ......++..|+|||... ..++.++|+||||+++|+|++|
T Consensus 113 ~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g 189 (250)
T cd05123 113 G--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG 189 (250)
T ss_pred C--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHC
Confidence 9 99999999999997 7889999999998766443 334567899999999774 4578899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH---HHHhcCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA---LELLKDPFL 221 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa---~ElL~hpff 221 (568)
..||... +...+...+... ...++...+..++++|.+||. +|.+||++ .++++||||
T Consensus 190 ~~p~~~~-~~~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 190 KPPFYAE-DRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCCCC-CHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9999654 445555555543 233555668899999999996 79999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=268.94 Aligned_cols=209 Identities=20% Similarity=0.349 Sum_probs=167.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~QIl~gL~ 79 (568)
.+..+.+.+|+.+++.++||||+++++.+.+. ..+++||||+++|+|.+++.+. ..+++..++.++.||+.||.
T Consensus 36 ~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~ 113 (268)
T cd05086 36 SKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113 (268)
T ss_pred hHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999988754 4689999999999999998764 34677888999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC----CCcccccCCCCccCcccccc--------CCCccce
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEE--------EYNELVD 147 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~----~~~~s~~GTp~YmAPEvl~~--------~ys~ksD 147 (568)
|||+++ ++||||||+|||++ .++.+||+|||++..... .......|++.|+|||++.. .++.++|
T Consensus 114 ~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D 190 (268)
T cd05086 114 HMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSN 190 (268)
T ss_pred HHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcch
Confidence 999999 99999999999997 688999999999854321 11234578899999998732 3577899
Q ss_pred ehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 008378 148 IYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 217 (568)
Q Consensus 148 IWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~---~p~~~~~~~s~el~~lI~kcL~~p~~Rpsa~ElL~ 217 (568)
|||||+++|||++ |..||........+...+.... ....+....++.+++++..|+.+|.+||++.++++
T Consensus 191 iwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 191 VWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 9999999999997 5678876544444443333321 12233445788999999999988999999999865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=265.29 Aligned_cols=206 Identities=28% Similarity=0.451 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+..+++.+|+.+|++++||||+++++.+.+ ...++||||+++|+|.+++.+.. .+++..+..++.|++.||.|||
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH 114 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH
Confidence 467789999999999999999999998876 57899999999999999998764 6899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-cCCCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiily 156 (568)
+++ ++||||||+||+++ .++.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|
T Consensus 115 ~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~ 191 (257)
T cd05040 115 SKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLW 191 (257)
T ss_pred hCC--ccccccCcccEEEe-cCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHH
Confidence 999 99999999999997 67999999999997664321 11245778899999774 56899999999999999
Q ss_pred HHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 157 EMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 157 Emlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|++ |..||... +..++.+.+.........+...+..+.+++.+||. +|.+||++.+++.
T Consensus 192 el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 192 EMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 9998 99999764 44445555543222222344567899999999996 6999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=276.67 Aligned_cols=211 Identities=31% Similarity=0.502 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHhh
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-----~~l~e~~i~~i~~QIl~gL~yL 81 (568)
.+.+.+|+.+++.++||||+++++++.+.....+++||||+. ++|.+++..+ ..+++..++.++.||+.||.||
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 124 (316)
T cd07842 46 SQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124 (316)
T ss_pred cHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH
Confidence 467788999999999999999999998775568999999997 4777766532 3689999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCC----CCcEEEeecChhhhccCCC-----cccccCCCCccCccccc--cCCCccceehh
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGN----NGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYS 150 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~----~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~--~~ys~ksDIWS 150 (568)
|+++ ++||||||+||+++ . +|.+||+|||++....... .....+|+.|+|||++. ..++.++||||
T Consensus 125 H~~~--i~h~dlkp~Nil~~-~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 201 (316)
T cd07842 125 HSNW--VLHRDLKPANILVM-GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWA 201 (316)
T ss_pred HhCC--EeeCCCCHHHEEEc-CCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHH
Confidence 9999 99999999999997 5 7899999999987653322 23457899999999774 35889999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHH---------HH---HHHHH--------------------cCCCCCCCC----------
Q 008378 151 FGMCILEMVTCEYPYNECKNPA---------QI---YKKVT--------------------SGIKPASLS---------- 188 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~---------~i---~~~i~--------------------~~~~p~~~~---------- 188 (568)
||+++|+|++|+.||....... .+ ...+. ........+
T Consensus 202 lG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (316)
T cd07842 202 IGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK 281 (316)
T ss_pred HHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHh
Confidence 9999999999999997533211 00 00000 000000001
Q ss_pred -CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 189 -KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 189 -~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
...++.+.++|.+||. +|.+||++.|++.||||
T Consensus 282 ~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 282 HKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred ccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1456789999999997 69999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=273.60 Aligned_cols=211 Identities=28% Similarity=0.495 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+++|+.++||||++++++|.+. ...++|+||+.+++|..+......+++..+..++.||+.||.|||+.+
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 120 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRK--KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccC--CeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356688999999999999999999988644 479999999999999988877777999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhc
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG 161 (568)
++||||+|+||+++ .++.+||+|||++...... ......+++.|+|||++. ..++.++||||||+++|+|++|
T Consensus 121 --i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g 197 (286)
T cd07846 121 --IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197 (286)
T ss_pred --ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcC
Confidence 99999999999997 7889999999998765332 223457899999999874 3478899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHc-------------------CCC-CC--------CCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 162 EYPYNECKNPAQIYKKVTS-------------------GIK-PA--------SLSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~-------------------~~~-p~--------~~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
..||........+...... +.. +. ......+..+++||.+||. +|.+||++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 277 (286)
T cd07846 198 EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS 277 (286)
T ss_pred CCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH
Confidence 9999765443333222210 000 00 0112356789999999996 79999999
Q ss_pred HHHhcCCCC
Q 008378 213 LELLKDPFL 221 (568)
Q Consensus 213 ~ElL~hpff 221 (568)
.+++.||||
T Consensus 278 ~~il~~~~~ 286 (286)
T cd07846 278 SQLLHHEFF 286 (286)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=273.04 Aligned_cols=214 Identities=25% Similarity=0.399 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~--l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+.+.+|++++++++||||+++++++.+. ...++||||+. ++|.+++..... +++..++.++.||+.||+|||++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 121 (294)
T PLN00009 45 PSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121 (294)
T ss_pred hHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 45678899999999999999999998754 47999999996 688888765443 58889999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc--CCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEmlt 160 (568)
+ ++||||+|+||+++..++.+||+|||++...... ......+++.|+|||++.+ .++.++||||||+++|+|+|
T Consensus 122 ~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t 199 (294)
T PLN00009 122 R--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199 (294)
T ss_pred C--eeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 9 9999999999999855678999999999765332 2234567899999998743 47899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCC-----------------------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKP-----------------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p-----------------------~---~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
|..||........+.+.+.....| . ......++.++++|.+||. +|.+||++.
T Consensus 200 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ 279 (294)
T PLN00009 200 QKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITAR 279 (294)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHH
Confidence 999997755555544433211000 0 0112357889999999996 699999999
Q ss_pred HHhcCCCCCCCC
Q 008378 214 ELLKDPFLVTDN 225 (568)
Q Consensus 214 ElL~hpff~~~~ 225 (568)
+++.||||....
T Consensus 280 ~~l~~~~~~~~~ 291 (294)
T PLN00009 280 AALEHEYFKDLG 291 (294)
T ss_pred HHhcCchHhHHh
Confidence 999999998643
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=279.79 Aligned_cols=217 Identities=25% Similarity=0.418 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yL 81 (568)
.+..+.+.+|+.+++.++||||++++++|.... .+++|+||+.+++|.+++.+. ..+++..+..++.||+.||+||
T Consensus 40 ~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~l 117 (328)
T cd08226 40 EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYL 117 (328)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 455688999999999999999999999987654 689999999999999998865 3589999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--Cc-------ccccCCCCccCcccccc---CCCccceeh
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA-------RSVIGTPEFMAPELYEE---EYNELVDIY 149 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~-------~s~~GTp~YmAPEvl~~---~ys~ksDIW 149 (568)
|+++ ++||||||+||+++ .++.+|++||+.+...... .. ....++..|+|||++.+ .++.++|||
T Consensus 118 H~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diw 194 (328)
T cd08226 118 HQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIY 194 (328)
T ss_pred HhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHH
Confidence 9999 99999999999997 7789999999865433111 11 11235667999998843 378999999
Q ss_pred hhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-C-------------------------------------------C
Q 008378 150 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P-------------------------------------------A 185 (568)
Q Consensus 150 SLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~-p-------------------------------------------~ 185 (568)
|||+++|+|++|..||............+..... | .
T Consensus 195 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (328)
T cd08226 195 SVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT 274 (328)
T ss_pred HHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccc
Confidence 9999999999999999775544444333321100 0 0
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 186 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 186 ~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
......++.+++||.+||. +|.+|||+.++|+||||....
T Consensus 275 ~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 275 PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 0112346789999999996 799999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=265.55 Aligned_cols=204 Identities=21% Similarity=0.442 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+.+.+|+.+|+.++||||+++++++... ..+++||||+++|+|.+++... +.+++..++.++.||+.||.|||++|
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 120 (256)
T cd05114 43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120 (256)
T ss_pred HHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45788999999999999999999987654 4689999999999999998754 46899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh-
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt- 160 (568)
++||||||+||+++ .++.+||+|||+++....... ....++..|+|||++. ..++.++||||||+++|+|++
T Consensus 121 --i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~ 197 (256)
T cd05114 121 --FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTE 197 (256)
T ss_pred --ccccccCcceEEEc-CCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcC
Confidence 99999999999997 788999999999876533221 1224566899999874 568899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+.||... +..++...+..+..+. .+...++.+.+++.+||. +|.+||++.+++.
T Consensus 198 g~~p~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 198 GKMPFEKK-SNYEVVEMISRGFRLY-RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCCCC-CHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 89999764 4556666666654432 345567899999999996 6999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=271.37 Aligned_cols=208 Identities=27% Similarity=0.456 Sum_probs=165.4
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
..+.+|+.+|+.++||||+++++++.+. ...++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~- 123 (291)
T cd07844 48 FTAIREASLLKDLKHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123 (291)
T ss_pred hhHHHHHHHHhhCCCcceeeEEEEEecC--CeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3467899999999999999999988654 47999999998 5999988765 46899999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||+++ .+|.+||+|||+++..... ......+++.|+|||++. ..++.++||||||+++|+|++|.
T Consensus 124 -i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~ 201 (291)
T cd07844 124 -VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201 (291)
T ss_pred -eecccCCHHHEEEc-CCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999997 7889999999998654322 122335788999999874 35889999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCC-------------------------CCC---CCCCCc--HHHHHHHHHhcC-CCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIK-------------------------PAS---LSKVTD--PQVKQFIEKCIV-PASLRLP 211 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~-------------------------p~~---~~~~~s--~el~~lI~kcL~-~p~~Rps 211 (568)
.||..........+.+..... +.. .....+ +.+.++|.+||. +|.+||+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps 281 (291)
T cd07844 202 PLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281 (291)
T ss_pred CCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC
Confidence 999765533332222211000 000 001123 788999999996 6999999
Q ss_pred HHHHhcCCCC
Q 008378 212 ALELLKDPFL 221 (568)
Q Consensus 212 a~ElL~hpff 221 (568)
+.+++.||||
T Consensus 282 ~~e~l~~~~f 291 (291)
T cd07844 282 AAEAMKHPYF 291 (291)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=266.27 Aligned_cols=205 Identities=22% Similarity=0.438 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+.+++.++||||+++++++... ..+++||||+++++|.+++.+. +.+++..+..++.||+.||.|||++|
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 120 (256)
T cd05059 43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120 (256)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35688899999999999999999987544 4789999999999999998764 46899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccccc---CCCCccCccccc-cCCCccceehhhHHHHHHHhh-
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI---GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~---GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt- 160 (568)
++||||||+||+++ .+|.+||+|||+++........... ++..|+|||++. ..++.++||||||+++|+|++
T Consensus 121 --i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~ 197 (256)
T cd05059 121 --FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred --cccccccHhhEEEC-CCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhcc
Confidence 99999999999997 7899999999998765433222222 345799999874 568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|..||... ....+...+..+..+. .+...++++++++.+||. +|.+||++.++++.
T Consensus 198 g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 198 GKMPYERF-SNSEVVESVSAGYRLY-RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCCCC-CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 89999764 4455666666554332 345678999999999996 79999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=266.14 Aligned_cols=206 Identities=26% Similarity=0.431 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
...+.+.+|+++|+.++||||+++++++... ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH 121 (263)
T cd05052 44 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121 (263)
T ss_pred hHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999987654 3689999999999999998764 35899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcc---cccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~---s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
+++ ++||||||+||+++ .++.+||+|||++......... ...+++.|+|||.+ ...++.++||||||+++|+|
T Consensus 122 ~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 198 (263)
T cd05052 122 KKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198 (263)
T ss_pred hCC--EeecccCcceEEEc-CCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 998 99999999999997 7899999999999766443221 22346689999977 45688999999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++ |..||.+ .+.......+..+..+ ..+...+++++++|.+||. +|.+||++.++++
T Consensus 199 ~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 199 ATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 98 9999976 4566667777665443 3455678999999999996 7999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=270.17 Aligned_cols=209 Identities=28% Similarity=0.493 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~---~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+.+.+|+.++++++||||+++++++.+.. ..++||||+. ++|.+++... ..+++..+..++.||+.||.|||+
T Consensus 42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (284)
T cd07836 42 PSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118 (284)
T ss_pred hHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999987654 6899999998 5888888754 358999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEml 159 (568)
+| ++||||||+||+++ .++.+||+|||++...... ......+++.|+|||++. ..++.++||||||+++|+|+
T Consensus 119 ~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~ 195 (284)
T cd07836 119 NR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195 (284)
T ss_pred CC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 99 99999999999997 7889999999999765332 223456789999999773 34788999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCC--------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPA--------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~--------------------------~~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
+|..||.+........+.+.....|. .+....++.++++|.+||+ +|.+||++
T Consensus 196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 275 (284)
T cd07836 196 TGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA 275 (284)
T ss_pred hCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH
Confidence 99999987655443333221110000 0112346789999999996 79999999
Q ss_pred HHHhcCCCC
Q 008378 213 LELLKDPFL 221 (568)
Q Consensus 213 ~ElL~hpff 221 (568)
.+++.||||
T Consensus 276 ~~~l~~~~f 284 (284)
T cd07836 276 HDALQHPWF 284 (284)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=271.15 Aligned_cols=209 Identities=27% Similarity=0.447 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+.+.+|+++++.++||||+++++++.+. ...++||||+. ++|.+++.... .+++..+..++.||+.||.|||++
T Consensus 42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~ 118 (283)
T cd07835 42 PSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118 (283)
T ss_pred hhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35678899999999999999999988654 47899999995 79999998766 799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc--CCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEmlt 160 (568)
+ ++||||+|+||+++ .++.+||+|||++...... ......+++.|+|||++.+ .++.++||||||+++|+|++
T Consensus 119 ~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 195 (283)
T cd07835 119 R--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195 (283)
T ss_pred C--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHh
Confidence 8 99999999999997 6899999999998755322 2233467899999997743 47889999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCC--------------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIK--------------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~--------------------------p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
|..||.......++.+.+..... ........++.+.++|.+||+ +|.+||++.
T Consensus 196 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 275 (283)
T cd07835 196 RRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAK 275 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 99999775544443332221100 001123456889999999996 699999999
Q ss_pred HHhcCCCC
Q 008378 214 ELLKDPFL 221 (568)
Q Consensus 214 ElL~hpff 221 (568)
+++.||||
T Consensus 276 ~il~~~~~ 283 (283)
T cd07835 276 AALQHPYF 283 (283)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=266.52 Aligned_cols=209 Identities=32% Similarity=0.523 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL~ 79 (568)
....+++.+|+.+++.++||||++++++|.... .++++|||+.+++|.+++.. ...+++..++.++.||+.||.
T Consensus 43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 120 (267)
T cd08229 43 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120 (267)
T ss_pred HHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence 345578899999999999999999999887653 78999999999999998864 356899999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
|||++| ++|+||||+||+++ .++.++|+|||++....... .....|++.|+|||.+ ...++.++|+||||+++|
T Consensus 121 ~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~ 197 (267)
T cd08229 121 HMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 197 (267)
T ss_pred HHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHH
Confidence 999999 99999999999997 68899999999987664322 2345789999999987 456889999999999999
Q ss_pred HHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 157 EMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 157 EmltG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|++|..||.... ....+.+.+.....+.......++.++++|.+||. +|.+||++.+++.
T Consensus 198 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 198 EMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999996533 23445555555444444455678899999999996 7999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=264.70 Aligned_cols=209 Identities=21% Similarity=0.370 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+.+.+|+.+++.++||||+++++++...+ ...++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||
T Consensus 37 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 115 (262)
T cd05058 37 LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115 (262)
T ss_pred HHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999775433 3578999999999999999764 45678888999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
+.+ ++||||||+|||++ .++.+||+|||+++...... .....+++.|+|||.+ ...++.++||||||+++
T Consensus 116 ~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 192 (262)
T cd05058 116 SKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 192 (262)
T ss_pred hCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHH
Confidence 998 99999999999997 78899999999987543211 1233567789999977 45689999999999999
Q ss_pred HHHhhc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 156 LEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 156 yEmltG-~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|||++| ..||.. .+...+...+..+..+. .+...++.+.+++.+||. +|.+||++.++++.
T Consensus 193 ~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 193 WELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999995 555544 45556666666554433 344567899999999996 79999999998763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=268.49 Aligned_cols=208 Identities=24% Similarity=0.385 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-----------------CCCCHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----------------KNVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-----------------~~l~e~~ 66 (568)
.+..+.+.+|+.+++.++||||+++++++.... ..|+||||+.+|+|.+++... ..+++..
T Consensus 48 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 125 (283)
T cd05090 48 PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ--PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125 (283)
T ss_pred HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHH
Confidence 445678899999999999999999999876544 689999999999999998632 2378889
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccc-cC
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EE 141 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~-~~ 141 (568)
+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||+++..... ......++..|+|||.+. ..
T Consensus 126 ~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05090 126 FLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG-EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK 202 (283)
T ss_pred HHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCC
Confidence 9999999999999999999 99999999999997 7789999999999765322 123345677899999874 56
Q ss_pred CCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 142 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++.++||||||+++|||++ |..||.+. ....+...+.....+ ..+...++.++++|.+||+ +|.+||++.+++++
T Consensus 203 ~~~~~Dv~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 203 FSSDSDIWSFGVVLWEIFSFGLQPYYGF-SNQEVIEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCchhhhHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8999999999999999998 99999763 445556666554433 3456678999999999997 69999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=264.33 Aligned_cols=204 Identities=22% Similarity=0.383 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+++|+.+.||||+++++++.. ...++||||+.+|+|.+++.+.+.+++..+..++.|++.||.|||.++
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~ 115 (257)
T cd05060 39 GKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 45678999999999999999999997643 257899999999999999998888999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc-----ccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~-----~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
++||||||+||+++ .++.+||+|||+++....... ....++..|+|||.+ ...++.++||||||+++|+|+
T Consensus 116 --i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 192 (257)
T cd05060 116 --FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192 (257)
T ss_pred --eeccCcccceEEEc-CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHH
Confidence 99999999999997 788999999999976533221 111234679999977 456899999999999999999
Q ss_pred h-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 160 T-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 160 t-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+ |..||... +..++.+.+..+... ..+...++.++++|.+||. +|.+||++.++++
T Consensus 193 ~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 193 SYGAKPYGEM-KGAEVIAMLESGERL-PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred cCCCCCcccC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8 99999764 445666666655432 3445667899999999996 7999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=275.45 Aligned_cols=207 Identities=26% Similarity=0.461 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+++.+|+.+++.++||||+++++++... ..++|+||+.+|+|.+++.+.. .++...+..++.||+.||+|||
T Consensus 50 ~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH 126 (316)
T cd05108 50 PKANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126 (316)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH
Confidence 45667899999999999999999999988654 4678999999999999998754 6899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc----ccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~----~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
++| |+||||||+||+++ .++.+||+|||+++....... ....+++.|+|||++ ...++.++||||||+++||
T Consensus 127 ~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~e 203 (316)
T cd05108 127 ERR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 203 (316)
T ss_pred hcC--eeccccchhheEec-CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHH
Confidence 999 99999999999997 788999999999987643221 122346789999977 5568999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|++ |..||.+. ...++...+..+..+. .+...+..+.++|.+||. +|..||++.+++.+
T Consensus 204 l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 204 LMTFGSKPYDGI-PASEISSILEKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHcCCCCCCCCC-CHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 998 99999763 4555555555544332 234567899999999996 79999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=268.47 Aligned_cols=209 Identities=21% Similarity=0.389 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILR 76 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-------~l~e~~i~~i~~QIl~ 76 (568)
......+.+|+.+++.++|+||+++++++.+.. ..++||||+.+++|.+++.+.+ .+++..+..++.||+.
T Consensus 50 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~ 127 (277)
T cd05036 50 EQDESDFLMEALIMSKFNHQNIVRLIGVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127 (277)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHH
Confidence 344567899999999999999999999886554 5789999999999999998654 4899999999999999
Q ss_pred HHHhhhhCCCCeEeeeccCCcEEEeCC--CCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceeh
Q 008378 77 GLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIY 149 (568)
Q Consensus 77 gL~yLHs~g~~IiHRDLKp~NILl~~~--~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIW 149 (568)
||.|||+++ ++||||||+||+++.. ...+||+|||+++...... .....+++.|+|||++ ...++.++|||
T Consensus 128 ~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 205 (277)
T cd05036 128 GCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVW 205 (277)
T ss_pred HHHHHHHCC--EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHH
Confidence 999999999 9999999999999732 2369999999997653221 1122345689999987 45699999999
Q ss_pred hhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 150 SFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 150 SLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
||||++|+|++ |..||.... ...+...+.....+ ..+...++.+.+++.+||+ +|.+||++.++++|
T Consensus 206 slG~il~el~~~g~~pf~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 206 SFGVLLWEIFSLGYMPYPGRT-NQEVMEFVTGGGRL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999997 999998644 44555555554333 3445567899999999996 69999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=273.77 Aligned_cols=214 Identities=30% Similarity=0.517 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+.+.+|+++++.++|||++++++++.+. ...|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||
T Consensus 62 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH 138 (313)
T cd06633 62 NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138 (313)
T ss_pred hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999998765 47899999996 577776654 457999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc----cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGiilyEm 158 (568)
++| ++||||+|+||+++ .++.+||+|||++.... ......|++.|+|||++. ..++.++||||||+++|+|
T Consensus 139 ~~g--i~H~dl~p~nili~-~~~~~kL~dfg~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el 213 (313)
T cd06633 139 SHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213 (313)
T ss_pred HCC--eecCCCChhhEEEC-CCCCEEEeecCCCcccC--CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHH
Confidence 999 99999999999997 78899999999885432 233567899999999873 4588899999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
++|..||........+.... ....+.......+..+++||.+||+ +|.+||++.+++.||||.....
T Consensus 214 ~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 214 AERKPPLFNMNAMSALYHIA-QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HhCCCCCCCCChHHHHHHHH-hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 99999997755444444433 3333433444567789999999996 6999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=269.20 Aligned_cols=207 Identities=22% Similarity=0.409 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------CCCHHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQI 74 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------~l~e~~i~~i~~QI 74 (568)
....++.+|+.+++.++||||+++++++... ...++||||+++|+|.+++.+.+ .++...+..++.|+
T Consensus 51 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 128 (277)
T cd05062 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHH
Confidence 3456788999999999999999999987544 46899999999999999987632 25778899999999
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc-cCCCccceeh
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIY 149 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~-~~ys~ksDIW 149 (568)
+.||.|||+++ ++||||||+||+++ .++.+||+|||++....... .....+++.|||||++. ..++.++|||
T Consensus 129 ~~~l~~lH~~~--~vH~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 205 (277)
T cd05062 129 ADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 205 (277)
T ss_pred HHHHHHHHHCC--cccCCcchheEEEc-CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHH
Confidence 99999999998 99999999999997 78899999999987553221 11234578899999874 5589999999
Q ss_pred hhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 150 SFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 150 SLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|||+++|||++ |..||.+. ......+.+..+..+ ..+...++.++++|.+||+ +|.+||++.|++.+
T Consensus 206 slG~~l~el~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 206 SFGVVLWEIATLAEQPYQGM-SNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 78898764 444555555444322 2345567899999999997 69999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=272.73 Aligned_cols=208 Identities=24% Similarity=0.415 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHh
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~y 80 (568)
....+.+.+|+.+++++ +||||+++++++.... .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|
T Consensus 79 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~ 156 (302)
T cd05055 79 SSEREALMSELKIMSHLGNHENIVNLLGACTIGG--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156 (302)
T ss_pred hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 34457789999999999 8999999999886554 6899999999999999997643 38999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
||+++ ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||.+ ...++.++||||||+++
T Consensus 157 lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil 233 (302)
T cd05055 157 LASKN--CIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 233 (302)
T ss_pred HHHCC--eehhhhccceEEEc-CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHH
Confidence 99999 99999999999997 77899999999997653322 1223567889999976 55689999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+|++ |..||........+.+.+..+..+ ..+...++++++||.+||. +|.+||++.+++.
T Consensus 234 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 234 WEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99998 999998766555666666655443 2344568899999999996 6999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=270.16 Aligned_cols=208 Identities=26% Similarity=0.466 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------~~l~e~~ 66 (568)
.+...++.+|+.+++.+ +||||+++++++... ..+++||||+.+|+|..++... +.+++..
T Consensus 56 ~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 133 (293)
T cd05053 56 EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133 (293)
T ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHH
Confidence 45567789999999999 899999999988654 4689999999999999998642 4689999
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccC
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEE 141 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ 141 (568)
+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+.... .....++..|+|||++ ...
T Consensus 134 ~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 210 (293)
T cd05053 134 LVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV 210 (293)
T ss_pred HHHHHHHHHHHHHHHHHCC--ccccccceeeEEEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC
Confidence 9999999999999999999 99999999999997 78999999999997654322 1122346779999976 456
Q ss_pred CCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 142 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++.++|||||||++|+|++ |..||... ...++++.+..+..+. .+...++.+.+|+.+||. +|.+||++.+++.+
T Consensus 211 ~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 211 YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cCcccceeehhhHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8999999999999999997 99999764 4556666666654433 344567899999999996 69999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=272.86 Aligned_cols=215 Identities=31% Similarity=0.594 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+.+++.++||||+++++.+... ...++||||+++++|.+++.. +.+++..+..++.|++.||.|||+
T Consensus 58 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~ 134 (292)
T cd06657 58 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHA 134 (292)
T ss_pred hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 44567789999999999999999999988764 478999999999999998754 468999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
+| ++||||+|+||+++ .++.++|+|||++...... ......|++.|+|||.+. ..++.++|+||||+++|+|++
T Consensus 135 ~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~t 211 (292)
T cd06657 135 QG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD 211 (292)
T ss_pred CC--eecCCCCHHHEEEC-CCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 99 99999999999997 7789999999988655332 223457899999999774 457899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|..||... ........+....++. ......++.+.++|.+||. +|.+||++.+++.||||....
T Consensus 212 g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 212 GEPPYFNE-PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CCCCCCCC-CHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 99999763 3344444444333322 1223467899999999996 699999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=297.37 Aligned_cols=216 Identities=26% Similarity=0.405 Sum_probs=165.8
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-----~~l~e~~i~~i~~QIl~gL~y 80 (568)
....+.+|+.+|++++|||||++++++.... ..|+|++++. ++|..++... .......++.++.||+.||.|
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~y 282 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEA--NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEY 282 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECC--eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHH
Confidence 4566889999999999999999999987654 6889999995 5777766432 234467788999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
||++| |+||||||+|||++ .+|.+||+|||++..+.... ....+||+.|+|||++ ...|+.++|||||||++|
T Consensus 283 LH~~g--IiHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 359 (501)
T PHA03210 283 IHDKK--LIHRDIKLENIFLN-CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359 (501)
T ss_pred HHhCC--eecCCCCHHHEEEC-CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHH
Confidence 99999 99999999999997 78999999999998764322 2346899999999987 456999999999999999
Q ss_pred HHhhcCCCC-CCCC-C-HHHHHHHHHcCC-CCC-----------------------CC-----CCCCcHHHHHHHHHhcC
Q 008378 157 EMVTCEYPY-NECK-N-PAQIYKKVTSGI-KPA-----------------------SL-----SKVTDPQVKQFIEKCIV 204 (568)
Q Consensus 157 EmltG~~Pf-~~~~-~-~~~i~~~i~~~~-~p~-----------------------~~-----~~~~s~el~~lI~kcL~ 204 (568)
||++|..|+ .... . ..++.+.+.... ... .+ ....++.+.++|.+||.
T Consensus 360 ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~ 439 (501)
T PHA03210 360 DMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLT 439 (501)
T ss_pred HHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhc
Confidence 999988654 3221 2 233333222110 000 00 01235677888999996
Q ss_pred -CCCCCCCHHHHhcCCCCCCCCCC
Q 008378 205 -PASLRLPALELLKDPFLVTDNPK 227 (568)
Q Consensus 205 -~p~~Rpsa~ElL~hpff~~~~~~ 227 (568)
+|.+||++.|+|.||||.....+
T Consensus 440 ~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 440 FDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred cCcccCcCHHHHhhChhhhcCCch
Confidence 79999999999999999875543
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=265.94 Aligned_cols=205 Identities=24% Similarity=0.461 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+.+.+|+.++++++||||+++++++... ..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 120 (256)
T cd05113 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120 (256)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35689999999999999999999987544 3689999999999999999864 46899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccc---ccCCCCccCccccc-cCCCccceehhhHHHHHHHhh-
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s---~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt- 160 (568)
++||||||+||+++ .++.+||+|||+++......... ..++..|+|||++. ..++.++||||||+++|+|++
T Consensus 121 --i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~ 197 (256)
T cd05113 121 --FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSL 197 (256)
T ss_pred --eeccccCcceEEEc-CCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcC
Confidence 99999999999997 68899999999987654332222 23556799999884 568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|..||.... ...+...+..+..+. .+...+..+++++.+||. +|.+||++.+++.+
T Consensus 198 g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 198 GKMPYERFN-NSETVEKVSQGLRLY-RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCCcCcCC-HHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 999997644 445555565554332 344568899999999996 69999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=266.62 Aligned_cols=206 Identities=22% Similarity=0.421 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------CCCHHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQI 74 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------~l~e~~i~~i~~QI 74 (568)
.....+.+|+.+|+.++||||+++++++... ...++||||+.+|+|.+++.... .+++..+..++.||
T Consensus 51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 128 (277)
T cd05032 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTG--QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHH
Confidence 4456788999999999999999999988655 46899999999999999987532 36788999999999
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceeh
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIY 149 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIW 149 (568)
+.||.|||+++ ++||||||+|||++ .+|.+||+|||+++...... .....++..|+|||.+ ...++.++|||
T Consensus 129 ~~~l~~lH~~~--i~H~di~p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 205 (277)
T cd05032 129 ADGMAYLAAKK--FVHRDLAARNCMVA-EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVW 205 (277)
T ss_pred HHHHHHHHhCC--ccccccChheEEEc-CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchH
Confidence 99999999999 99999999999997 78999999999987653321 2233567889999977 45689999999
Q ss_pred hhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 150 SFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 150 SLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||+++|||+| |..||.. .....+.+.+..+..+ ..+...++.+.++|.+||. +|.+||++.+++.
T Consensus 206 slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 206 SFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHHHhhccCCCCCcc-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999998 9999976 3456666666644333 2344568899999999996 6999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-31 Score=268.90 Aligned_cols=214 Identities=21% Similarity=0.399 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------CCCHHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQI 74 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------~l~e~~i~~i~~QI 74 (568)
....++.+|+.+++.++||||+++++++.+. ...++||||+.+|+|.+++.+.+ .++...+..++.||
T Consensus 51 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l 128 (288)
T cd05061 51 RERIEFLNEASVMKGFTCHHVVRLLGVVSKG--QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128 (288)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHH
Confidence 3455688999999999999999999987654 36899999999999999997532 24567889999999
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceeh
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIY 149 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIW 149 (568)
+.||.|||+++ ++||||||+||+++ .++.+||+|||+++...... .....++..|+|||.+ ...++.++|||
T Consensus 129 ~~~l~~lH~~~--i~H~dikp~nili~-~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dvw 205 (288)
T cd05061 129 ADGMAYLNAKK--FVHRDLAARNCMVA-HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMW 205 (288)
T ss_pred HHHHHHHHhCC--CcCCCCChheEEEc-CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHH
Confidence 99999999999 99999999999997 78899999999987543221 1223457789999987 45689999999
Q ss_pred hhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc------CCCC
Q 008378 150 SFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK------DPFL 221 (568)
Q Consensus 150 SLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~------hpff 221 (568)
||||++|||++ |..||.+ .....+.+.+..+..+. .+...++.++++|.+||. +|.+||++.++++ ||||
T Consensus 206 slG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~ 283 (288)
T cd05061 206 SFGVVLWEITSLAEQPYQG-LSNEQVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 283 (288)
T ss_pred HHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence 99999999998 7889976 44555666655543332 334557899999999996 6999999999876 8998
Q ss_pred CCCC
Q 008378 222 VTDN 225 (568)
Q Consensus 222 ~~~~ 225 (568)
....
T Consensus 284 ~~~~ 287 (288)
T cd05061 284 PEVS 287 (288)
T ss_pred CCCC
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=264.23 Aligned_cols=206 Identities=25% Similarity=0.437 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
...+.+.+|+.+++.++||||+++++.+.+. ...++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH 120 (261)
T cd05072 43 MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120 (261)
T ss_pred hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999987654 4689999999999999998753 56899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
+++ ++||||||+||+++ .++.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|
T Consensus 121 ~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 197 (261)
T cd05072 121 RKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEI 197 (261)
T ss_pred HCC--eeccccchhhEEec-CCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHH
Confidence 998 99999999999997 78899999999997664322 12234567899999874 5588899999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+| |..||... ........+..+...+ .....+.+++++|.+|+. +|.+||++.+++.
T Consensus 198 ~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 198 VTYGKIPYPGM-SNSDVMSALQRGYRMP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HccCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 98 99999764 3445556665554433 233567899999999996 7999999998764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=267.87 Aligned_cols=212 Identities=32% Similarity=0.573 Sum_probs=178.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+++.++||||++++++|... ...++||||+.+++|.+++.. ..+++..+..++.|++.||.|||++
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (277)
T cd06641 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE 120 (277)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC
Confidence 4557788999999999999999999998755 478999999999999999875 4689999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
+ ++|+||+|+||+++ .+|.++|+|||++...... ......|+..|+|||.+. ..++.++|+||||+++|+|++|
T Consensus 121 ~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 197 (277)
T cd06641 121 K--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred C--eecCCCCHHhEEEC-CCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 9 99999999999997 7789999999998655332 223457899999999874 4578899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
..||... ........+..+. +..+....+.++.++|.+||. +|.+||++.++++||||...
T Consensus 198 ~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 198 EPPHSEL-HPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CCCCCcc-chHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 9999763 3444444444433 333555678899999999996 69999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=281.67 Aligned_cols=217 Identities=26% Similarity=0.451 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
...+.+.+|+.+|+.++||||++++++|... ....+++||||+. |+|.+++...+.+++..++.++.||+.||.|||
T Consensus 46 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 124 (334)
T cd07855 46 TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124 (334)
T ss_pred cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788899999999999999999977543 2347899999996 699999988888999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCccccc--cCCCccceehhhHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMC 154 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGii 154 (568)
+++ ++||||||+||+++ .+|.+||+|||++....... .....|+..|+|||.+. ..++.++||||||++
T Consensus 125 ~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~ 201 (334)
T cd07855 125 SAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201 (334)
T ss_pred HCC--eecCCCCHHHEEEc-CCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHH
Confidence 999 99999999999997 78999999999987653221 12457899999999873 358899999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHc-CC------------------------CCC---CCCCCCcHHHHHHHHHhcC-C
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVTS-GI------------------------KPA---SLSKVTDPQVKQFIEKCIV-P 205 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~~-~~------------------------~p~---~~~~~~s~el~~lI~kcL~-~ 205 (568)
+|+|++|+.||.......++...... +. .+. ......++.++++|.+||+ +
T Consensus 202 l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 281 (334)
T cd07855 202 FAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD 281 (334)
T ss_pred HHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCC
Confidence 99999999999765433322111110 00 000 0113357899999999996 7
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 008378 206 ASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 206 p~~Rpsa~ElL~hpff~~~~ 225 (568)
|.+||++.+++.||||....
T Consensus 282 P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 282 PEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhCcCHHHHHhChhhhhcc
Confidence 99999999999999998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=264.67 Aligned_cols=210 Identities=20% Similarity=0.346 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----CeEEEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQ 73 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----~~l~lV~Ey~~gGsL~~~i~k~------~~l~e~~i~~i~~Q 73 (568)
....+.+.+|+.+|+.++||||+++++++..... ...++|+||+.+|+|..++... ..+++..+..++.|
T Consensus 42 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 121 (273)
T cd05035 42 YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121 (273)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHH
Confidence 4556789999999999999999999997765432 3478999999999999988543 36899999999999
Q ss_pred HHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc-cCCCcccee
Q 008378 74 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDI 148 (568)
Q Consensus 74 Il~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~-~~ys~ksDI 148 (568)
++.||.|||+++ ++||||||+||+++ +++.+||+|||+++...... .....++..|+|||.+. ..++.++||
T Consensus 122 i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv 198 (273)
T cd05035 122 IALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDV 198 (273)
T ss_pred HHHHHHHHHhCC--eeccccchheEEEC-CCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccch
Confidence 999999999999 99999999999997 78899999999987653321 11223567899999874 568999999
Q ss_pred hhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 149 YSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 149 WSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
||||+++|||++ |..||.+. ....+.+.+..+..+ ..+...++.+.++|.+||+ +|.+||++.+++++
T Consensus 199 ~SlG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 199 WAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRL-KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999 88999764 455566666655433 3455678899999999997 69999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-31 Score=264.51 Aligned_cols=206 Identities=17% Similarity=0.371 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+...+.+.+|+.+|++++||||+++++++.. ...++||||+++|+|.+++.. ...+++..+..++.||+.||.|||
T Consensus 36 ~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH 112 (257)
T cd05115 36 KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE 112 (257)
T ss_pred hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3445779999999999999999999997742 368899999999999999875 457999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc-----ccccCCCCccCccccc-cCCCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~-----~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiily 156 (568)
++| ++||||||+||+++ .++.+||+|||++........ ....+++.|+|||.+. ..++.++||||||+++|
T Consensus 113 ~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 189 (257)
T cd05115 113 GKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMW 189 (257)
T ss_pred hcC--eeecccchheEEEc-CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHH
Confidence 999 99999999999997 778999999999875532211 1112357899999774 56889999999999999
Q ss_pred HHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 157 EMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 157 Emlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|++ |..||... ....+...+..+..+ ..+...+++++++|.+||. +|.+||++.++.+
T Consensus 190 el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 190 EAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9996 99999775 344556666665443 3555678999999999997 6999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=278.02 Aligned_cols=210 Identities=23% Similarity=0.422 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-----------------------
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------------- 59 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------------- 59 (568)
.+..+.+.+|+++++++ +||||+++++++...+ ..+++++||+.+|+|.+++...
T Consensus 51 ~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 129 (337)
T cd05054 51 ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129 (337)
T ss_pred HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-CCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccc
Confidence 34456788999999999 8999999999887544 4788999999999999998642
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEe
Q 008378 60 --------------------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 101 (568)
Q Consensus 60 --------------------------------------~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~ 101 (568)
..+++..+..++.||+.||.|||+++ |+||||||+||+++
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~ 207 (337)
T cd05054 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS 207 (337)
T ss_pred ccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe
Confidence 25789999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHH
Q 008378 102 GNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 175 (568)
Q Consensus 102 ~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~ 175 (568)
.++.+||+|||++..+.... .....+++.|+|||++ ...++.++|||||||++|||++ |..||.+......+.
T Consensus 208 -~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~ 286 (337)
T cd05054 208 -ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC 286 (337)
T ss_pred -CCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH
Confidence 68899999999998653221 2234567789999976 5669999999999999999998 999997644444455
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 176 ~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
..+..+..+ ..+...++++.+++.+||+ +|.+||++.++++|
T Consensus 287 ~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 287 RRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHhccCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 555554433 2345567899999999996 79999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=263.45 Aligned_cols=209 Identities=30% Similarity=0.515 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~QIl~gL~ 79 (568)
....+++.+|++++++++|+||+++++++... ...++||||+++|+|..++... ..+++..+..|+.||+.||.
T Consensus 43 ~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (267)
T cd08224 43 AKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120 (267)
T ss_pred hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHH
Confidence 44578899999999999999999999998765 4789999999999999988642 45899999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
|||++| ++||||||+||+++ .+|.++|+|||++...... ......|++.|+|||.+ ...++.++|+||||+++|
T Consensus 121 ~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 197 (267)
T cd08224 121 HMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 197 (267)
T ss_pred HHHhCC--EecCCcChhhEEEC-CCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHH
Confidence 999999 99999999999997 7889999999998765432 23345789999999977 456899999999999999
Q ss_pred HHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 157 EMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 157 EmltG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|++|..||.... +...+...+..+..+.......+..++++|.+||. +|.+||++.+++.
T Consensus 198 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 198 EMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999996533 33445555555544443344677899999999996 6999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=268.80 Aligned_cols=210 Identities=32% Similarity=0.523 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+.+.+|+.++++++ ||||+++++++.+. ..+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||
T Consensus 42 ~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh 119 (280)
T cd05581 42 EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119 (280)
T ss_pred hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345677899999999998 99999999987644 478999999999999999999889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----------------------cccccCCCCccCcccc-c
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----------------------ARSVIGTPEFMAPELY-E 139 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----------------------~~s~~GTp~YmAPEvl-~ 139 (568)
++| ++|+||+|+||+++ .+|.++|+|||++....... .....|++.|+|||++ .
T Consensus 120 ~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 196 (280)
T cd05581 120 SKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196 (280)
T ss_pred HCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC
Confidence 999 99999999999996 78999999999987653321 1234678999999977 4
Q ss_pred cCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH----HH
Q 008378 140 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LE 214 (568)
Q Consensus 140 ~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa----~E 214 (568)
..++.++|+||||+++++|++|+.||.... ....+..+... ...++...++.+.+||.+||. +|.+||++ .+
T Consensus 197 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 273 (280)
T cd05581 197 KPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273 (280)
T ss_pred CCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHH
Confidence 558889999999999999999999998654 33444444322 122344568899999999996 69999999 99
Q ss_pred HhcCCCC
Q 008378 215 LLKDPFL 221 (568)
Q Consensus 215 lL~hpff 221 (568)
+++||||
T Consensus 274 ll~~~~~ 280 (280)
T cd05581 274 LKAHPFF 280 (280)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=270.69 Aligned_cols=219 Identities=24% Similarity=0.398 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+++.+|+++++++ +||||+++++.+... ..+++||||+.+|+|.+++.+.+.+++..++.++.|++.||.|||+.
T Consensus 47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~ 124 (288)
T cd05583 47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124 (288)
T ss_pred HHHHHHHHHHHHHhccCCcchhhhheeeecC--CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 446788999999999 699999999987644 47899999999999999998888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccccc---CCCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~~---~ys~ksDIWSLGiilyEm 158 (568)
+ ++||||||.||+++ .++.++|+|||++....... .....|++.|+|||.+.. .++.++||||||+++|+|
T Consensus 125 ~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el 201 (288)
T cd05583 125 G--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201 (288)
T ss_pred C--eeccCCCHHHeEEC-CCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHH
Confidence 8 99999999999997 67899999999987653322 223468999999998743 268899999999999999
Q ss_pred hhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC---HHHHhcCCCCCCCCCCCccc
Q 008378 159 VTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDLVC 231 (568)
Q Consensus 159 ltG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps---a~ElL~hpff~~~~~~~l~~ 231 (568)
++|..||.... ....+.+.+..... ..+...++.++++|.+||+ +|..||+ +.++|+||||+...+..+..
T Consensus 202 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~ 279 (288)
T cd05583 202 LTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAA 279 (288)
T ss_pred HhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhh
Confidence 99999995422 22334444443332 2445578899999999996 6999998 57889999999877655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=268.99 Aligned_cols=208 Identities=24% Similarity=0.350 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-----------CCCHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------NVDMKAIKNWAR 72 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-----------~l~e~~i~~i~~ 72 (568)
....+.+.+|+++|++++||||++++++|... ...++||||+.+++|.+++.+.. .+++..+..++.
T Consensus 60 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (296)
T cd05051 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMAT 137 (296)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHH
Confidence 35677889999999999999999999988765 46899999999999999998766 689999999999
Q ss_pred HHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc-cCCCccce
Q 008378 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVD 147 (568)
Q Consensus 73 QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~-~~ys~ksD 147 (568)
|++.||.|||+++ ++||||||+||+++ .++.++|+|||++....... .....+++.|+|||.+. ..++.++|
T Consensus 138 ~i~~al~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 214 (296)
T cd05051 138 QIASGMRYLESLN--FVHRDLATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSD 214 (296)
T ss_pred HHHHHHHHHHHcC--ccccccchhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccch
Confidence 9999999999999 99999999999997 67899999999987653321 22345678899999774 46899999
Q ss_pred ehhhHHHHHHHhh--cCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 148 IYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTSG------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 148 IWSLGiilyEmlt--G~~Pf~~~~~~~~i~~~i~~~------~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||||+++|+|++ |..||..... ..+...+... ......+...++++.++|.+||+ +|.+||++.+++.
T Consensus 215 v~slG~~l~el~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 215 VWAFGVTLWEILTLCREQPYEHLTD-QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred hhhhHHHHHHHHhcCCCCCCCCcCh-HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 9999999999998 7788876443 3333333322 11111233456899999999996 7999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=271.09 Aligned_cols=208 Identities=24% Similarity=0.390 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~~ 66 (568)
....+.+.+|+++++++ +||||+++++++... ..+++|+||+++|+|.+++.+.+ .+++..
T Consensus 43 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 120 (297)
T cd05089 43 ENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120 (297)
T ss_pred HHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHH
Confidence 34557789999999999 799999999987654 36899999999999999997643 488899
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccc-ccCCCCccCcccc-ccCCCc
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELY-EEEYNE 144 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s-~~GTp~YmAPEvl-~~~ys~ 144 (568)
+..++.||+.||+|||++| ++||||||+||+++ .++.+||+|||++.......... ...+..|+|||++ ...++.
T Consensus 121 ~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 197 (297)
T cd05089 121 LLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTT 197 (297)
T ss_pred HHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCc
Confidence 9999999999999999999 99999999999997 68899999999986433221222 2234579999987 455899
Q ss_pred cceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 145 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 145 ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++||||||+++|+|++ |..||... ....+...+..+..+ ..+...++.+++||.+||. +|.+||++.++++.
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999997 99999763 455566666555433 2345678899999999996 69999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=273.71 Aligned_cols=208 Identities=25% Similarity=0.385 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~~ 66 (568)
....+.+.+|+.+++++ +||||+++++++... ..+|+||||+++|+|.+++.+.+ .+++..
T Consensus 48 ~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 125 (303)
T cd05088 48 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125 (303)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHH
Confidence 44567889999999999 899999999988654 46899999999999999997543 478999
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCccccc-cCCCc
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNE 144 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl~-~~ys~ 144 (568)
++.++.||+.||+|||++| ++||||||+|||++ .++.+||+|||++....... .....+++.|+|||++. ..++.
T Consensus 126 ~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 202 (303)
T cd05088 126 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT 202 (303)
T ss_pred HHHHHHHHHHHHHHHHhCC--ccccccchheEEec-CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcc
Confidence 9999999999999999999 99999999999997 78899999999986432211 11123466799999874 45789
Q ss_pred cceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 145 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 145 ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++||||||+++|+|+| |..||... +.....+.+..+..+. .+...++.+.++|.+||+ +|.+||++.+++.+
T Consensus 203 ~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 203 NSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cccchhhhhHHHHHHhcCCCCcccC-ChHHHHHHHhcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999998 99999753 4455566665543322 334467899999999996 69999999998876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=275.94 Aligned_cols=211 Identities=26% Similarity=0.380 Sum_probs=171.0
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
.+.+|+.+|++++||||+++++++... ..+++||||+. |+|.+++.....+++..+..++.||+.||.|||++| +
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i 140 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEG--DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--F 140 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecC--CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 578999999999999999999998755 47899999997 699999988888999999999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccC----------------CCcccccCCCCccCcccccc--CCCccceehh
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------------PTARSVIGTPEFMAPELYEE--EYNELVDIYS 150 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~----------------~~~~s~~GTp~YmAPEvl~~--~ys~ksDIWS 150 (568)
+||||+|+||+++ .++.+||+|||++..... .......+++.|+|||.+.+ .++.++||||
T Consensus 141 ~H~dl~~~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 219 (335)
T PTZ00024 141 MHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWS 219 (335)
T ss_pred ecccccHHHeEEC-CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHH
Confidence 9999999999997 788999999999876541 11123357889999998743 4789999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--C-----------------------CCCCCCcHHHHHHHHHhcC-
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--A-----------------------SLSKVTDPQVKQFIEKCIV- 204 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p--~-----------------------~~~~~~s~el~~lI~kcL~- 204 (568)
||+++|+|+||..||........+.........| . ......+..++++|.+||.
T Consensus 220 lG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 220 VGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCC
Confidence 9999999999999998755443332222110000 0 0012346789999999997
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 008378 205 PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 205 ~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|.+||++.++|.||||+...
T Consensus 300 ~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 300 NPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred CchhccCHHHHhcCcccCCCC
Confidence 699999999999999998653
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=267.66 Aligned_cols=207 Identities=24% Similarity=0.428 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC---------------CCCHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------------NVDMKAIK 68 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~---------------~l~e~~i~ 68 (568)
....+.+.+|+++++.++||||+++++++.+.. ..++||||+.+|+|.+++..++ .+++..+.
T Consensus 48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~ 125 (280)
T cd05092 48 ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125 (280)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC--ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHH
Confidence 455678999999999999999999999887654 6899999999999999998753 48899999
Q ss_pred HHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCC
Q 008378 69 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYN 143 (568)
Q Consensus 69 ~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys 143 (568)
.++.||+.||.|||++| ++||||||+|||++ .++.+||+|||++....... .....+++.|+|||++ ...++
T Consensus 126 ~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (280)
T cd05092 126 AIASQIASGMVYLASLH--FVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 202 (280)
T ss_pred HHHHHHHHHHHHHHHCC--eecccccHhhEEEc-CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC
Confidence 99999999999999999 99999999999997 78899999999987553221 1233457889999977 45689
Q ss_pred ccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 144 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 144 ~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
.++|||||||++|+|++ |..||.... .......+..+..+. .+...++.++++|.+||+ +|.+||++.+++.
T Consensus 203 ~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 203 TESDIWSFGVVLWEIFTYGKQPWYQLS-NTEAIECITQGRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCccCC-HHHHHHHHHcCccCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999999998 899997644 344455555544332 344567899999999996 7999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=293.87 Aligned_cols=202 Identities=24% Similarity=0.446 Sum_probs=172.8
Q ss_pred HHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 10 LYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 10 l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
..+|+.++... +||||+++++.+.+ ...+|+|||++.|+.|.+-+...+.+. ..+..|++||+.++.|||.+| +
T Consensus 362 ~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--v 436 (612)
T KOG0603|consen 362 NQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--V 436 (612)
T ss_pred cccccchhhhhcCCCcceeecceecC--CceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--e
Confidence 34567555555 89999999997754 457999999999999888777666555 778889999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNE 167 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~ 167 (568)
+||||||+|||++++.|+++|+|||.++..... ..+.+-|..|.|||++ ..+|++++||||||++||+|++|..||..
T Consensus 437 vhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 437 VHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred eecCCChhheeecCCCCcEEEEEechhhhCchh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 999999999999657899999999999887655 3344568889999988 56799999999999999999999999987
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 168 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 168 ~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
..+..+++.++..+. +....+.++++||..||+ +|.+|+++.+++.||||
T Consensus 516 ~P~~~ei~~~i~~~~----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 516 HPAGIEIHTRIQMPK----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CCchHHHHHhhcCCc----cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 666677887776543 336789999999999996 79999999999999999
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=288.59 Aligned_cols=219 Identities=22% Similarity=0.403 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+...++.|..||..-..+.||++|.+|.+++ ++||||+|++||++-.++-+-+-|+|..++.|+.++..|+++.|..
T Consensus 671 nQvaHVKAERDILAEADn~WVVrLyySFQDkd--nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm 748 (1034)
T KOG0608|consen 671 NQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM 748 (1034)
T ss_pred hhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 45677889999999999999999999998776 6999999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhc---------cCC----------------------------------
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---------QQP---------------------------------- 121 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~---------~~~---------------------------------- 121 (568)
| +|||||||+||||| .+|++||.||||.+-+ +..
T Consensus 749 G--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r 825 (1034)
T KOG0608|consen 749 G--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQR 825 (1034)
T ss_pred c--ceecccCccceEEc-cCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhh
Confidence 9 99999999999998 8999999999997532 000
Q ss_pred -CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCcHHHHHH
Q 008378 122 -TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPASLSKVTDPQVKQF 198 (568)
Q Consensus 122 -~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~-~~p~~~~~~~s~el~~l 198 (568)
.+++.+||+.|+|||++ ..+|+..+|+||.|+|||||+.|+.||........-++.+.-. .....+....++++.++
T Consensus 826 ~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~l 905 (1034)
T KOG0608|consen 826 ILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDL 905 (1034)
T ss_pred hhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHH
Confidence 12345899999999988 6679999999999999999999999998755444333332211 11122335678999999
Q ss_pred HHHhcCCCCCCCC---HHHHhcCCCCCCCCCCC
Q 008378 199 IEKCIVPASLRLP---ALELLKDPFLVTDNPKD 228 (568)
Q Consensus 199 I~kcL~~p~~Rps---a~ElL~hpff~~~~~~~ 228 (568)
|.++...+..|+. ++++..||||+..++..
T Consensus 906 i~kLc~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 906 IQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred HHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence 9998887777764 77899999999877655
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=271.48 Aligned_cols=215 Identities=30% Similarity=0.530 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+.+|+++|+.++|||++++++++.+.. ..++||||+. |+|.+++.. ...+++..+..++.||+.||.|||
T Consensus 66 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH 142 (317)
T cd06635 66 NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH--TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142 (317)
T ss_pred hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--eEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 455678999999999999999999999887654 6889999997 577776654 456999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc----ccCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl----~~~ys~ksDIWSLGiilyEm 158 (568)
+++ ++||||+|+||+++ .++.+||+|||++..... .....|++.|+|||++ .+.++.++||||||+++|+|
T Consensus 143 ~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el 217 (317)
T cd06635 143 SHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217 (317)
T ss_pred HCC--cccCCCCcccEEEC-CCCCEEEecCCCccccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHH
Confidence 999 99999999999997 688999999998865432 2345789999999976 24588999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 227 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~ 227 (568)
++|..||........+...... ..+.......++.++++|.+||+ +|.+||++.+++.|+|+.....+
T Consensus 218 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 218 AERKPPLFNMNAMSALYHIAQN-ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HhCCCCCCCccHHHHHHHHHhc-cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 9999999775444444444333 33333344567899999999996 69999999999999999765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=271.86 Aligned_cols=212 Identities=30% Similarity=0.526 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+++.+|+++++.++|+|++++++++... ...++||||+. |+|.+++.. ...+++..+..++.|++.||.|||
T Consensus 56 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH 132 (308)
T cd06634 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132 (308)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567788999999999999999999988765 46899999997 677776654 456899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc----cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGiilyEm 158 (568)
+++ ++||||||+||+++ .++.+||+|||++..... .....|++.|+|||++. +.++.++||||||+++|+|
T Consensus 133 ~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 133 SHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred hCC--cccCCCCHHhEEEC-CCCcEEECCcccceeecC--cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHH
Confidence 998 99999999999997 678999999999865532 23457899999999763 4578899999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
++|..||........+.. +..+..+.......+..+++||.+||. +|.+||++.+++.|||+...
T Consensus 208 ~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 208 AERKPPLFNMNAMSALYH-IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HcCCCCCccccHHHHHHH-HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 999999976543333333 333434443445678899999999996 69999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=277.78 Aligned_cols=217 Identities=32% Similarity=0.459 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~---~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
....+.+.+|+.+|+.++||||+++++++.... ...+|+||||+. ++|.+++.+...+++..++.++.||+.||.|
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~ 118 (330)
T cd07834 40 LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118 (330)
T ss_pred chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence 445678999999999999999999999886653 236899999997 5899999888889999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-c-CCCccceehhhHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-E-EYNELVDIYSFGM 153 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~-~ys~ksDIWSLGi 153 (568)
||++| ++||||||+|||++ .++.++|+|||++....... .....+++.|+|||++. . .++.++|+||||+
T Consensus 119 LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~ 195 (330)
T cd07834 119 LHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGC 195 (330)
T ss_pred HHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHH
Confidence 99999 99999999999997 67999999999998765432 34457899999999874 3 5889999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CC----------------------------CCCCCCcHHHHHHHHHhcC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA----------------------------SLSKVTDPQVKQFIEKCIV 204 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~-p~----------------------------~~~~~~s~el~~lI~kcL~ 204 (568)
++|+|++|..||........ ++.+..... +. ......++.+++||.+||.
T Consensus 196 il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 274 (330)
T cd07834 196 IFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLV 274 (330)
T ss_pred HHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHcc
Confidence 99999999999977543333 333322111 00 0112256889999999996
Q ss_pred -CCCCCCCHHHHhcCCCCCCCC
Q 008378 205 -PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 205 -~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|.+||++.+++.||||+...
T Consensus 275 ~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 275 FDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred CChhhCCCHHHHHhCccHHhhc
Confidence 799999999999999998644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=279.52 Aligned_cols=216 Identities=28% Similarity=0.420 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~---~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
.....++.+|+.+|+.++||||+++++++..... ..+|+|+||+. ++|.+++.+.+.+++..++.++.||+.||.|
T Consensus 45 ~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 123 (337)
T cd07858 45 RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123 (337)
T ss_pred cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3445678899999999999999999998764432 35899999996 7899999988899999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiily 156 (568)
||+++ ++||||||+||+++ .++.+||+|||++...... ......++..|+|||++. ..++.++||||||+++|
T Consensus 124 LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (337)
T cd07858 124 IHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200 (337)
T ss_pred HHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHH
Confidence 99999 99999999999997 6789999999999765432 233457899999999774 45889999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHc---------------------------CCCC--CCCCCCCcHHHHHHHHHhcC-CC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTS---------------------------GIKP--ASLSKVTDPQVKQFIEKCIV-PA 206 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~---------------------------~~~p--~~~~~~~s~el~~lI~kcL~-~p 206 (568)
+|++|..||.+..... ....+.. ...+ .......+++++++|.+||. +|
T Consensus 201 ~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 279 (337)
T cd07858 201 ELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDP 279 (337)
T ss_pred HHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCCh
Confidence 9999999996543211 1111100 0000 01123467889999999996 79
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 008378 207 SLRLPALELLKDPFLVTD 224 (568)
Q Consensus 207 ~~Rpsa~ElL~hpff~~~ 224 (568)
.+||++.++++||||...
T Consensus 280 ~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 280 SKRITVEEALAHPYLASL 297 (337)
T ss_pred hhccCHHHHHcCcchhhh
Confidence 999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=267.14 Aligned_cols=213 Identities=26% Similarity=0.407 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+.+.+|+++++.++||||+++++++.+.....+++|+||+. ++|..++.+. ..+++..++.++.||+.||+|||.
T Consensus 40 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~ 118 (287)
T cd07840 40 GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118 (287)
T ss_pred cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999987663457999999997 5898888765 579999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc--cCCCccceehhhHHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEm 158 (568)
+| ++|+||||+||+++ .+|.+||+|||++....... .....+++.|+|||.+. ..++.++||||||+++|+|
T Consensus 119 ~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el 195 (287)
T cd07840 119 NG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAEL 195 (287)
T ss_pred CC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHH
Confidence 99 99999999999997 78999999999997664432 23346788999999763 3578999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCC--CC--------------------------CCCCCcHHHHHHHHHhcC-CCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKP--AS--------------------------LSKVTDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p--~~--------------------------~~~~~s~el~~lI~kcL~-~p~~R 209 (568)
+||+.||........+.........+ .. +....++.+.++|.+||. +|.+|
T Consensus 196 ~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (287)
T cd07840 196 FLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275 (287)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhC
Confidence 99999998755443333222211000 00 111237889999999996 79999
Q ss_pred CCHHHHhcCCCC
Q 008378 210 LPALELLKDPFL 221 (568)
Q Consensus 210 psa~ElL~hpff 221 (568)
|++.+++.||||
T Consensus 276 p~~~~~l~~~~~ 287 (287)
T cd07840 276 ISADQALQHEYF 287 (287)
T ss_pred cCHHHHhhCcCC
Confidence 999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=270.67 Aligned_cols=210 Identities=25% Similarity=0.412 Sum_probs=164.2
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCC------CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHh
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDT------NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~------~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~y 80 (568)
..+.+|+.++++++||||+++++++.... ....++||||+. ++|.+++.+. ..+++..++.++.||+.||.|
T Consensus 56 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~ 134 (310)
T cd07865 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134 (310)
T ss_pred hHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence 35578999999999999999999876543 236799999996 5888777654 378999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCcccccc--CCCccceehhhH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFG 152 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLG 152 (568)
||++| ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||++.+ .++.++||||||
T Consensus 135 lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 211 (310)
T cd07865 135 IHRNK--ILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211 (310)
T ss_pred HHHCC--eeccCCCHHHEEEC-CCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence 99999 99999999999997 78899999999997653321 123467889999997743 378899999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHH--HHHHHcCCCCCC---------------------------CCCCCcHHHHHHHHHhc
Q 008378 153 MCILEMVTCEYPYNECKNPAQI--YKKVTSGIKPAS---------------------------LSKVTDPQVKQFIEKCI 203 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i--~~~i~~~~~p~~---------------------------~~~~~s~el~~lI~kcL 203 (568)
+++|+|+||..||......... ...+....++.. .....++.+++||.+||
T Consensus 212 ~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l 291 (310)
T cd07865 212 CIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291 (310)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHh
Confidence 9999999999999764332221 111111111000 01223577889999999
Q ss_pred C-CCCCCCCHHHHhcCCCC
Q 008378 204 V-PASLRLPALELLKDPFL 221 (568)
Q Consensus 204 ~-~p~~Rpsa~ElL~hpff 221 (568)
. +|.+||++.++|.||||
T Consensus 292 ~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 292 VLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cCChhhccCHHHHhcCCCC
Confidence 6 79999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=265.16 Aligned_cols=207 Identities=25% Similarity=0.385 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~~ 66 (568)
.+..+.+.+|+++++++ +||||+++++++... ..+++||||+++|+|.+++.+.+ .+++..
T Consensus 36 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~ 113 (270)
T cd05047 36 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113 (270)
T ss_pred HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHH
Confidence 45567889999999999 899999999988654 36899999999999999987543 478999
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcc-cccCCCCccCcccc-ccCCCc
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPELY-EEEYNE 144 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~-s~~GTp~YmAPEvl-~~~ys~ 144 (568)
+..++.|++.||+|||++| ++||||||+||+++ .++.+||+|||++......... ....++.|+|||++ ...++.
T Consensus 114 ~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 190 (270)
T cd05047 114 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT 190 (270)
T ss_pred HHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCc
Confidence 9999999999999999998 99999999999997 7889999999998533221111 12345679999987 456889
Q ss_pred cceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 145 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 145 ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++||||||+++|+|++ |..||... +.......+..+..+. .+...+.++.+++.+|+. +|.+||++.+++.
T Consensus 191 ~~Di~slG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 191 NSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred hhhHHHHHHHHHHHHcCCCCCcccc-CHHHHHHHHhCCCCCC-CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 9999999999999997 99999663 4455566665543332 344567899999999996 6999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=264.77 Aligned_cols=199 Identities=18% Similarity=0.289 Sum_probs=164.5
Q ss_pred HHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeE
Q 008378 10 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 89 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~Ii 89 (568)
..+|...+....||||+++++++.+. ...++||||+++|+|.+++.+...+++..+..++.|++.||.|||+++ ++
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~ 107 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG--IV 107 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 44566667777899999999988754 478999999999999999988888999999999999999999999999 99
Q ss_pred eeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCCCCCCC
Q 008378 90 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC 168 (568)
Q Consensus 90 HRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~Pf~~~ 168 (568)
||||||+||+++ .++.++++|||++...... .....+++.|+|||.+. ..++.++|+||+|+++|+|++|..|+...
T Consensus 108 H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 108 CRDLNPNNILLD-DRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred ccCCCHHHEEEc-CCCCEEEecccchhccccc-cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 999999999997 6789999999988665433 23345678899999874 55889999999999999999999887542
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH-----HHHhcCCCC
Q 008378 169 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-----LELLKDPFL 221 (568)
Q Consensus 169 ~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa-----~ElL~hpff 221 (568)
.. .+ .......++...++.++++|.+||. +|.+|+++ .++++||||
T Consensus 186 ~~--~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 186 PS--GI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ch--hc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 21 11 1111122445578899999999996 69999986 899999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=261.40 Aligned_cols=204 Identities=23% Similarity=0.421 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+++.+|+.+++.++|+||+++++++.+. ...++||||+.+++|.+++.... .+++..++.++.|++.||.|||+
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~ 120 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999999999999988753 46899999999999999998765 69999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-c
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-C 161 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt-G 161 (568)
++ ++||||||+||+++ .+|.+||+|||++........ ...++..|+|||.+ .+.++.++||||||+++|+|++ |
T Consensus 121 ~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g 196 (256)
T cd05039 121 KN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196 (256)
T ss_pred CC--ccchhcccceEEEe-CCCCEEEcccccccccccccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcC
Confidence 99 99999999999997 788999999999977633222 33456679999977 4568899999999999999997 9
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
..||... ....+...+..+..+ ..+...++.+.++|.+||. +|.+||++.++++
T Consensus 197 ~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 197 RVPYPRI-PLKDVVPHVEKGYRM-EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCCCC-CHHHHHHHHhcCCCC-CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999764 456666666655443 3345568999999999996 7999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=262.60 Aligned_cols=208 Identities=24% Similarity=0.401 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+++.+|+.+++.++||||+++++++... ..+++||||+.+++|.+++... +.+++..+..++.|++.||.|||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh 123 (266)
T cd05033 46 DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123 (266)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999987654 4689999999999999998765 46899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--c--ccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--A--RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~--~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
+++ |+||||||+|||++ .++.+||+|||++....... . ....+++.|+|||.+. ..++.++||||||+++|+
T Consensus 124 ~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~ 200 (266)
T cd05033 124 EMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 200 (266)
T ss_pred hCC--cccCCCCcceEEEc-CCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHH
Confidence 999 99999999999997 78899999999998764211 1 1223467899999874 568999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|++ |..||.... ...+...+..+..+. .+...++.+++++.+||+ +|.+||++.+++++
T Consensus 201 l~~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 201 VMSYGERPYWDMS-NQDVIKAVEDGYRLP-PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHccCCCCCCCCC-HHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 998 999997644 445556665543332 234567899999999996 79999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=267.35 Aligned_cols=206 Identities=27% Similarity=0.468 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC------------------------C
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------------------K 60 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~------------------------~ 60 (568)
...+++.+|+.+|+.++||||+++++.+.... ..++|+||+.+|+|.+++... .
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (290)
T cd05045 45 SELRDLLSEFNLLKQVNHPHVIKLYGACSQDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122 (290)
T ss_pred HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCcccc
Confidence 45678999999999999999999999886543 588999999999999998753 2
Q ss_pred CCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcc
Q 008378 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPE 136 (568)
Q Consensus 61 ~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPE 136 (568)
.+++..+..++.|++.||.|||+++ ++||||||+|||++ +++.+||+|||++....... .....++..|+|||
T Consensus 123 ~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE 199 (290)
T cd05045 123 ALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE 199 (290)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHH
Confidence 4788999999999999999999999 99999999999997 78899999999987553221 12234567899999
Q ss_pred cc-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 137 LY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 137 vl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
.+ ...++.++||||||+++|+|+| |..||.+ ..+..+...+..+..+. .+...+..+++||.+||. +|.+||++.
T Consensus 200 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~ 277 (290)
T cd05045 200 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFA 277 (290)
T ss_pred HHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 76 4568999999999999999999 9999976 45666777766654433 345667899999999996 699999999
Q ss_pred HHhc
Q 008378 214 ELLK 217 (568)
Q Consensus 214 ElL~ 217 (568)
++++
T Consensus 278 ~i~~ 281 (290)
T cd05045 278 DISK 281 (290)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=271.49 Aligned_cols=210 Identities=26% Similarity=0.412 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCC------CeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHh
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTN------RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~------~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~y 80 (568)
..+.+|+++|+.++||||+++++.+.+... ..+++|+||+.+ +|..++.. ...+++..++.++.||+.||.|
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~ 130 (311)
T cd07866 52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINY 130 (311)
T ss_pred hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence 356789999999999999999998765432 368999999974 67666554 4579999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-------------cccccCCCCccCccccc--cCCCcc
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-------------ARSVIGTPEFMAPELYE--EEYNEL 145 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-------------~~s~~GTp~YmAPEvl~--~~ys~k 145 (568)
||++| ++||||||+||+++ .+|.+||+|||++....... .....|++.|+|||++. ..++.+
T Consensus 131 lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (311)
T cd07866 131 LHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207 (311)
T ss_pred HHhCC--eecCCCCHHHEEEC-CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch
Confidence 99999 99999999999997 78999999999997653221 12346789999999774 348899
Q ss_pred ceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCCCC------------------C-------CCCCcHHHHHH
Q 008378 146 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS------------------L-------SKVTDPQVKQF 198 (568)
Q Consensus 146 sDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~--~~p~~------------------~-------~~~~s~el~~l 198 (568)
+||||||+++|+|++|..||.+.............. ..+.. . .....+.+.+|
T Consensus 208 ~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (311)
T cd07866 208 VDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDL 287 (311)
T ss_pred hHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHH
Confidence 999999999999999999997654433332222110 00000 0 01234678899
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 199 IEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 199 I~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|.+||. +|.+||++.+++.||||
T Consensus 288 i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 288 LSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHcccCcccCcCHHHHhcCCCC
Confidence 999996 79999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=269.69 Aligned_cols=207 Identities=27% Similarity=0.458 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------~~l~e~~ 66 (568)
.+..+.+.+|+++|+++ +||||+++++++.+. ..+++||||+.+|+|.+++... ..++...
T Consensus 58 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~ 135 (314)
T cd05099 58 DKDLADLISEMELMKLIGKHKNIINLLGVCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135 (314)
T ss_pred hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHH
Confidence 45567889999999999 699999999988654 4689999999999999999764 2488899
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccC
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEE 141 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ 141 (568)
+..++.||+.||.|||++| ++||||||+|||++ .++.+||+|||+++...... .....+++.|||||++ ...
T Consensus 136 ~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 212 (314)
T cd05099 136 LVSCAYQVARGMEYLESRR--CIHRDLAARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV 212 (314)
T ss_pred HHHHHHHHHHHHHHHHHCC--eeeccccceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC
Confidence 9999999999999999999 99999999999997 78899999999997653221 1112345679999977 456
Q ss_pred CCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 142 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++.++||||||+++|+|++ |..||.. .....++..+..+..+ ..+...+.+++++|.+||. +|.+||++.+++.
T Consensus 213 ~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 213 YTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred cCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8999999999999999999 8899966 4556666666665433 2344567899999999996 7999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=290.19 Aligned_cols=212 Identities=25% Similarity=0.461 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHhCC-C-----CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSLK-H-----ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~-H-----pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL 78 (568)
..+-.-||.+|..|+ | -|||+++++|.... .+++|+|++. .+|.++++.+ .+|+...++.+++||+.||
T Consensus 226 ~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~--HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L 302 (586)
T KOG0667|consen 226 LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN--HLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTAL 302 (586)
T ss_pred HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc--ceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence 455667999999997 4 49999999998665 6999999995 7999999976 4699999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEe-CCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~-~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
.+||+.+ |||+||||+||||. .....|||+|||.+........ +++-+..|+|||++ ...|+.+.||||||||++
T Consensus 303 ~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlA 379 (586)
T KOG0667|consen 303 LFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILA 379 (586)
T ss_pred HHHHhCC--eeeccCChhheeeccCCcCceeEEecccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHH
Confidence 9999999 99999999999996 2334799999999988765544 88899999999977 677999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHc-CCCCC--------------------------------------------------
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTS-GIKPA-------------------------------------------------- 185 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~-~~~p~-------------------------------------------------- 185 (568)
||++|.+.|.+....+++...+.- |.+|.
T Consensus 380 EL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~ 459 (586)
T KOG0667|consen 380 ELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRG 459 (586)
T ss_pred hHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccC
Confidence 999999999887777776544331 11000
Q ss_pred --C-------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 186 --S-------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 186 --~-------~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
. .....+..+.+||++||. +|.+|+|+.+.|+||||...
T Consensus 460 P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 460 PPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred CCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 0 011223568899999996 89999999999999999853
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=265.90 Aligned_cols=211 Identities=27% Similarity=0.474 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+++.+|+++|+.++||||+++++++.......+++||||+++++|.+++.+.. .+++..+..++.||+.||.|||
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH 126 (284)
T cd05079 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 455678999999999999999999999887765567899999999999999997654 5899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
++| ++||||||+||+++ .++.+||+|||++..+.... .....|+..|+|||++ ...++.++||||||+++|
T Consensus 127 ~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 127 SRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred HCC--eeecccchheEEEc-CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 999 99999999999997 68899999999997664322 1234567789999976 456899999999999999
Q ss_pred HHhhcCCCCCCC--------------CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 157 EMVTCEYPYNEC--------------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 157 EmltG~~Pf~~~--------------~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+|+|+..|+... .........+..+... ..+...++.+.+||.+||+ +|.+||++.+++++
T Consensus 204 ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999987665321 1112222333333222 2334568899999999996 79999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=261.73 Aligned_cols=199 Identities=22% Similarity=0.382 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
...+.+|+.+|+.++||||+++++++.. ...++||||+.+|+|.+++.+.. .++...+..++.||+.||.|||++|
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 121 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 5788999999999999999999998876 34689999999999999998776 7999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCC-------cEEEeecChhhhccCCCcccccCCCCccCcccccc---CCCccceehhhHHHH
Q 008378 86 PPIIHRDLKCDNIFVNGNNG-------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCI 155 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g-------~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~---~ys~ksDIWSLGiil 155 (568)
++||||||+||+++ ..+ .+||+|||++..... .....++..|+|||++.. .++.++||||||+++
T Consensus 122 --i~H~dlkp~Nill~-~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~ 196 (259)
T cd05037 122 --LVHGNVCGKNILVA-RYGLNEGYVPFIKLSDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTL 196 (259)
T ss_pred --eecccCccceEEEe-cCccccCCceeEEeCCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHH
Confidence 99999999999997 455 799999999876543 233457788999998843 588999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+|++ |..||.... ........... ...+......+.++|.+||. +|.+||++.++++
T Consensus 197 ~~l~~~~~~p~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 197 LEICSNGEEPLSTLS-SSEKERFYQDQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHhCCCCCcccCC-chhHHHHHhcC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999 588886643 22222222211 11122223789999999996 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=270.30 Aligned_cols=208 Identities=28% Similarity=0.478 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~~ 66 (568)
....+++.+|+.+++.+ +||||+++++++.... .+|+||||+.+|+|.+++..++ .++...
T Consensus 64 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~ 141 (307)
T cd05098 64 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141 (307)
T ss_pred hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHH
Confidence 44567789999999999 7999999999886543 6899999999999999998642 478899
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccC
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEE 141 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ 141 (568)
+..++.||+.||+|||++| ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||++ ...
T Consensus 142 ~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (307)
T cd05098 142 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 218 (307)
T ss_pred HHHHHHHHHHHHHHHHHCC--cccccccHHheEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC
Confidence 9999999999999999999 99999999999997 67899999999987553211 1112345789999977 456
Q ss_pred CCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 142 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++.++||||||+++|+|++ |..||.. .....+.+.+..+..+ ..+...+++++++|.+||. +|.+||++.+++.+
T Consensus 219 ~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 219 YTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 8999999999999999998 8888865 5566777777665433 3445678899999999996 69999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=262.11 Aligned_cols=204 Identities=26% Similarity=0.440 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+.+.+|+.++++++||||+++++++... ..+++||||+.+++|.+++.... .+++..+..++.|++.||.|||++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 122 (261)
T cd05068 45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122 (261)
T ss_pred HHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46688999999999999999999987654 36899999999999999997654 699999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccC---CCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~G---Tp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
| ++||||||+||+++ .++.+||+|||++............| +..|+|||++. ..++.++||||||+++|+|+|
T Consensus 123 ~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 199 (261)
T cd05068 123 N--YIHRDLAARNVLVG-ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199 (261)
T ss_pred C--eeeccCCcceEEEc-CCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHh
Confidence 9 99999999999997 78899999999997765332222233 45799999774 568899999999999999999
Q ss_pred -cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 161 -CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 161 -G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+.||.+. ....+...+.....+ ..+...+..+++++.+|+. +|.+||++.+++.
T Consensus 200 ~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 200 YGRMPYPGM-TNAEVLQQVDQGYRM-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred cCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999764 445555565554332 2344567899999999996 7999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=264.98 Aligned_cols=205 Identities=24% Similarity=0.434 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....++..|+.+++.++||||+++++++.. ...++++||+.+|+|.+++... +.+++..+..|+.||+.||.|||+
T Consensus 51 ~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 127 (279)
T cd05111 51 QTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127 (279)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceEEEEECC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678889999999999999999998743 2477899999999999999764 568999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
++ ++||||||+||+++ .++.+||+|||+++...... .....++..|+|||.+ ...|+.++||||||+++|||
T Consensus 128 ~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el 204 (279)
T cd05111 128 HR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204 (279)
T ss_pred CC--EeccccCcceEEEc-CCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 99 99999999999997 78899999999997653221 1234567789999987 45689999999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++ |..||.+. .+..+...+..+..+. .+...+..+.+++.+|+. +|..||++.|+++
T Consensus 205 ~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 205 MSYGAEPYAGM-RPHEVPDLLEKGERLA-QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HcCCCCCCCCC-CHHHHHHHHHCCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 98 99999763 4555555555554433 344567789999999995 7999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=278.87 Aligned_cols=215 Identities=32% Similarity=0.499 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
....+.+.+|+.+++.++||||+++++++..... ..+++|+||+ +++|.+++.. +.+++..+..++.||+.||.
T Consensus 55 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~ 132 (343)
T cd07851 55 AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLK 132 (343)
T ss_pred hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence 4456778899999999999999999987754332 3589999999 6799998876 56999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccccc--CCCccceehhhHHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILE 157 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyE 157 (568)
|||+.| ++||||||+||+++ .+|.+||+|||++...... .....+++.|+|||++.. .++.++||||||+++|+
T Consensus 133 ~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~e 208 (343)
T cd07851 133 YIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208 (343)
T ss_pred HHHHCC--eecCCCCHHHeEEC-CCCCEEEcccccccccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHH
Confidence 999999 99999999999997 7899999999999766433 345578999999998743 57899999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCC-CC----------------------------CCCCCCcHHHHHHHHHhcC-CCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIK-PA----------------------------SLSKVTDPQVKQFIEKCIV-PAS 207 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~-p~----------------------------~~~~~~s~el~~lI~kcL~-~p~ 207 (568)
|++|+.||........+ ..+..... +. ......++.+.+||.+||. +|.
T Consensus 209 lltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~ 287 (343)
T cd07851 209 LLTGKTLFPGSDHIDQL-KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD 287 (343)
T ss_pred HHhCCCCCCCCChHHHH-HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChh
Confidence 99999999765443332 22222110 00 0112347899999999996 699
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 008378 208 LRLPALELLKDPFLVTDN 225 (568)
Q Consensus 208 ~Rpsa~ElL~hpff~~~~ 225 (568)
+||++.+++.||||+...
T Consensus 288 ~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 288 KRITAAEALAHPYLAEYH 305 (343)
T ss_pred hCCCHHHHhcCCCccccC
Confidence 999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=282.79 Aligned_cols=207 Identities=28% Similarity=0.448 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC------------------------
Q 008378 5 DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------------------ 59 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~------------------------ 59 (568)
...+.+.+|+++|+++. |||||+++++|.+. ..+|+|||||.+|+|.+++.+.
T Consensus 82 ~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (400)
T cd05105 82 SEKQALMSELKIMTHLGPHLNIVNLLGACTKS--GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPA 159 (400)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcc
Confidence 44578999999999996 99999999998654 4799999999999999988642
Q ss_pred ------------------------------------------------------------------------CCCCHHHH
Q 008378 60 ------------------------------------------------------------------------KNVDMKAI 67 (568)
Q Consensus 60 ------------------------------------------------------------------------~~l~e~~i 67 (568)
+.+++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~ 239 (400)
T cd05105 160 DESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDL 239 (400)
T ss_pred cccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHH
Confidence 24778888
Q ss_pred HHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCC
Q 008378 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEY 142 (568)
Q Consensus 68 ~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~y 142 (568)
..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||+++...... .....+++.|+|||++ ...+
T Consensus 240 ~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 316 (400)
T cd05105 240 LSFTYQVARGMEFLASKN--CVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY 316 (400)
T ss_pred HHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC
Confidence 999999999999999999 99999999999997 67899999999997653221 2234577889999977 4568
Q ss_pred CccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 143 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 143 s~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+.++||||||+++|+|++ |..||........++..+..+..+. .+...++.++++|.+||. +|.+||++.++.+
T Consensus 317 ~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 317 TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 999999999999999997 9999977555556666666664433 345567899999999996 7999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=262.30 Aligned_cols=204 Identities=19% Similarity=0.350 Sum_probs=163.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+++..|+.+|+.++||||+++++++.... ..++||||+.+|+|..++.+.+ .+++..+..++.||+.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (258)
T cd05078 41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118 (258)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999987654 5789999999999999998654 58999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCC-------cEEEeecChhhhccCCCcccccCCCCccCcccccc--CCCccceehhhHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNG-------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMC 154 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g-------~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGii 154 (568)
++ |+||||||+||+++.+.. .+|++|||++..... .....+++.|+|||++.. .++.++||||||++
T Consensus 119 ~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~ 194 (258)
T cd05078 119 KG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTT 194 (258)
T ss_pred CC--eecCCCccceEEEecccccccCCCceEEecccccccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHH
Confidence 99 999999999999973322 379999998865432 234568899999998853 47899999999999
Q ss_pred HHHHhhcC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 155 ILEMVTCE-YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 155 lyEmltG~-~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+|+|++|. .||... ........... ...++....+++.++|.+||+ +|.+||++.++++.
T Consensus 195 l~~l~~g~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 195 LWEIFSGGDKPLSAL-DSQKKLQFYED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHcCCCCChhhc-cHHHHHHHHHc---cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999984 666543 33322222221 122334456789999999997 69999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=268.37 Aligned_cols=208 Identities=28% Similarity=0.468 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------~~l~e~~ 66 (568)
.+..+++.+|+.+++.+ +||||+++++++... ..+++||||+.+|+|.+++.+. ..++...
T Consensus 61 ~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (304)
T cd05101 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138 (304)
T ss_pred hHHHHHHHHHHHHHHhhccCCCchheeEEEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHH
Confidence 35567899999999999 899999999988654 3689999999999999999764 2477888
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccC
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEE 141 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ 141 (568)
+..++.||+.||.|||++| ++||||||+||+++ .++.+||+|||+++...... .....+++.|+|||++ ...
T Consensus 139 ~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 215 (304)
T cd05101 139 LVSCTYQVARGMEYLASQK--CIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV 215 (304)
T ss_pred HHHHHHHHHHHHHHHHHCC--eeecccccceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC
Confidence 9999999999999999999 99999999999997 78899999999997653221 1223457789999977 456
Q ss_pred CCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 142 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+.++||||||+++|+|++ |..||.+ .....+.+.+..+..+. .+...+..+++||.+||. +|.+||++.++++.
T Consensus 216 ~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 216 YTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8999999999999999998 7888876 45667777776654432 345667899999999996 69999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=261.23 Aligned_cols=205 Identities=25% Similarity=0.442 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+.+|+.++||||+++++++.+. ..+++||||+++|+|.+++.+. +.+++..+..++.||+.||.|||+
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 122 (261)
T cd05148 45 KQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122 (261)
T ss_pred hHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467789999999999999999999987654 3689999999999999999863 468999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+| ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||++ ...++.++||||||+++|+|++
T Consensus 123 ~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~ 199 (261)
T cd05148 123 QN--SIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199 (261)
T ss_pred CC--eeccccCcceEEEc-CCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHc
Confidence 99 99999999999997 78899999999997664322 2233467789999987 4568899999999999999998
Q ss_pred -cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 161 -CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 161 -G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|..||... +...++..+..+..+. .+...++.+.++|.+||. +|.+||++.+++.
T Consensus 200 ~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 200 YGQVPYPGM-NNHEVYDQITAGYRMP-CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCCCCCcC-CHHHHHHHHHhCCcCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 89999764 4555556666554332 345668899999999996 7999999999865
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=276.06 Aligned_cols=215 Identities=28% Similarity=0.443 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~---~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
....++.+|+.+|++++||||+++++++.... ...+++|+||+. ++|.+++.. +.+++..++.++.||+.||.||
T Consensus 45 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~L 122 (336)
T cd07849 45 TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYI 122 (336)
T ss_pred hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999998765443 235899999996 588887754 5699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc--cCCCccceehhhHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMC 154 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGii 154 (568)
|++| ++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++. ..++.++||||||++
T Consensus 123 H~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvi 199 (336)
T cd07849 123 HSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCI 199 (336)
T ss_pred HhCC--eeccCCCHHHEEEC-CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHH
Confidence 9999 99999999999997 78999999999987653221 22357899999999763 458899999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHH--------------Hc--------CCC---CC---CCCCCCcHHHHHHHHHhcC-C
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKV--------------TS--------GIK---PA---SLSKVTDPQVKQFIEKCIV-P 205 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i--------------~~--------~~~---p~---~~~~~~s~el~~lI~kcL~-~ 205 (568)
+|+|++|+.||.+......+.... .. ... .. ......++++++||.+||. +
T Consensus 200 l~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 279 (336)
T cd07849 200 LAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN 279 (336)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCC
Confidence 999999999997643222111110 00 000 00 0112346789999999996 6
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 008378 206 ASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 206 p~~Rpsa~ElL~hpff~~~ 224 (568)
|.+||++.+++.||||...
T Consensus 280 P~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 280 PHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhhCcCHHHHhcCcccccc
Confidence 9999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=263.89 Aligned_cols=207 Identities=22% Similarity=0.383 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHH
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------NVDMKAIKNWARQILR 76 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~---------~l~e~~i~~i~~QIl~ 76 (568)
..+++.+|+++|++++||||+++++++.+. ...++||||+.+|+|.+++.... .+++..+..++.||+.
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 128 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREA--EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCC--CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHH
Confidence 567899999999999999999999987554 46899999999999999998766 6899999999999999
Q ss_pred HHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCcccc-ccCCCccceehhhH
Q 008378 77 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELY-EEEYNELVDIYSFG 152 (568)
Q Consensus 77 gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLG 152 (568)
||.|||+++ ++||||||+||+++ .++.+||+|||++...... ......+++.|+|||.+ ...++.++||||||
T Consensus 129 ~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG 205 (275)
T cd05046 129 GMDHLSNAR--FVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFG 205 (275)
T ss_pred HHHHhhhcC--cccCcCccceEEEe-CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHH
Confidence 999999999 99999999999997 7889999999998654322 12334567889999976 45678999999999
Q ss_pred HHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 153 MCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 153 iilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+++|+|++ |..||.... ...+...+..+..+.......+..++++|.+||. +|.+||++.+++..
T Consensus 206 ~~l~~l~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 206 VLMWEVFTQGELPFYGLS-DEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHHHhCCCCCccccc-hHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 99999999 888996643 3445555554443333445678899999999996 79999999998864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=264.10 Aligned_cols=206 Identities=22% Similarity=0.424 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+.+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++... +.+++..+..++.||+.||.|||
T Consensus 50 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH 126 (279)
T cd05109 50 PKANKEILDEAYVMAGVGSPYVCRLLGICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126 (279)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999988643 467899999999999999764 56999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc----ccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~----~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
+++ ++||||||+||+++ +++.+||+|||+++....... ....+++.|+|||.+ ...++.++|||||||++||
T Consensus 127 ~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~e 203 (279)
T cd05109 127 EVR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWE 203 (279)
T ss_pred HCC--eeccccccceEEEc-CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHH
Confidence 999 99999999999996 778999999999976643221 122346789999977 5568999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|++ |..||.. .....+...+..+..+. .+...++.+.++|.+||. +|..||++.+++.
T Consensus 204 l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 204 LMTFGAKPYDG-IPAREIPDLLEKGERLP-QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 998 8999865 34555566665554333 344568899999999996 7999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=280.81 Aligned_cols=222 Identities=23% Similarity=0.406 Sum_probs=189.9
Q ss_pred HHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
+--..|-++|... +-|.++.++..|+.-+ .+|+||||+.||+|-.++++-+++.+..+..++.+|+-||-|||++|
T Consensus 394 ectm~EKrvLAL~~kppFL~qlHScFQTmD--RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg- 470 (683)
T KOG0696|consen 394 ECTMVEKRVLALPGKPPFLVQLHSCFQTMD--RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG- 470 (683)
T ss_pred cceehhhhheecCCCCchHHHHHHHhhhhh--heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC-
Confidence 3344566666666 5678888888886554 69999999999999999999999999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhh--ccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV--MQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~--~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
||+||||.+||+++ ..|+|||+|||+.+. ......++++|||.|+|||++ .+.|+.++|+||+|++||||+.|+.
T Consensus 471 -IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQp 548 (683)
T KOG0696|consen 471 -IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 548 (683)
T ss_pred -eeeeeccccceEec-cCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCC
Confidence 99999999999998 789999999999974 345567889999999999977 6779999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH-----HHHhcCCCCCCCCCCCcccCCCCCC
Q 008378 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLP 237 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa-----~ElL~hpff~~~~~~~l~~~~l~~p 237 (568)
||.+ .+.++++..|... ...+++..+.++.++++..|. .|.+|+.+ .++..||||+...|.++....++.|
T Consensus 549 PFdG-eDE~elF~aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPP 625 (683)
T KOG0696|consen 549 PFDG-EDEDELFQAIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPP 625 (683)
T ss_pred CCCC-CCHHHHHHHHHHc--cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCC
Confidence 9987 6778888888764 345788889999999999995 59999763 5799999999999887655444433
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=266.35 Aligned_cols=211 Identities=28% Similarity=0.463 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.....+.+|+++|+.++||||+++++++.+. ..+++|+||+.+ +|.+++.. ...+++..+..++.||+.||.|||+
T Consensus 40 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 116 (283)
T cd05118 40 GIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116 (283)
T ss_pred hhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999988655 478999999975 88887766 4679999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-c-CCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~-~ys~ksDIWSLGiilyEml 159 (568)
++ ++|+||||+||+++ .++.+||+|||.+....... .....++..|+|||.+. . .++.++|+||||+++|+|+
T Consensus 117 ~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~ 193 (283)
T cd05118 117 HG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELL 193 (283)
T ss_pred CC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence 99 99999999999997 77899999999987664432 22346888999999773 3 5889999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCC--C-------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKP--A-------------------------SLSKVTDPQVKQFIEKCIV-PASLRLP 211 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p--~-------------------------~~~~~~s~el~~lI~kcL~-~p~~Rps 211 (568)
||+.||.......++.+.......+ . ......+.++++||.+||. +|.+||+
T Consensus 194 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 273 (283)
T cd05118 194 SRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273 (283)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC
Confidence 9999997765555444433221111 0 0112356889999999996 7999999
Q ss_pred HHHHhcCCCC
Q 008378 212 ALELLKDPFL 221 (568)
Q Consensus 212 a~ElL~hpff 221 (568)
+.+++.||||
T Consensus 274 ~~~ll~~~~~ 283 (283)
T cd05118 274 AEQALAHPYF 283 (283)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=288.27 Aligned_cols=209 Identities=25% Similarity=0.422 Sum_probs=176.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~-l~e~~i~~i~~QIl~gL~yL 81 (568)
+.+++.++.+|.++|++++|||||+||++.+++. .+++|||+|.||+|.+|+++.+. ++..+...++.+.+.||+||
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YL 278 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYL 278 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHH
Confidence 4688999999999999999999999999887665 69999999999999999999874 99999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc-c-cccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-R-SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~-~-s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
|+++ +|||||-..|+|++ .++.+||+|||+++....... . ...-...|+|||.+. ..|+.++|||||||++||+
T Consensus 279 h~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Ei 355 (474)
T KOG0194|consen 279 HSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEI 355 (474)
T ss_pred HHCC--CcchhHhHHHheec-CCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEee
Confidence 9999 99999999999997 667889999999876532111 1 112456899999884 5699999999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
.+ |..||.+. ...++..+|.....+...+...++++..++.+|+. +|..||++.++.+
T Consensus 356 f~~g~~Py~g~-~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 356 FENGAEPYPGM-KNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred eccCCCCCCCC-CHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 98 88899885 45667777744334444556778899999999995 7999999988654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=277.94 Aligned_cols=215 Identities=26% Similarity=0.441 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC------------CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN------------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 72 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~------------~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~ 72 (568)
+..+.+.+|+++|+.++||||+++++++..... ..+++||||+. ++|.+++.. +.+++..++.++.
T Consensus 44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ 121 (342)
T cd07854 44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMY 121 (342)
T ss_pred chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHH
Confidence 456778899999999999999999987654432 35789999997 689888864 4699999999999
Q ss_pred HHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc--cCCCcc
Q 008378 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE--EEYNEL 145 (568)
Q Consensus 73 QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~--~~ys~k 145 (568)
||+.||.|||++| ++||||||+||+++..++.+||+|||++..+.... .....|++.|+|||++. ..++.+
T Consensus 122 qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 199 (342)
T cd07854 122 QLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA 199 (342)
T ss_pred HHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch
Confidence 9999999999999 99999999999997566789999999987653221 12236789999999763 458889
Q ss_pred ceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-----------------------CCCC----CCCCCCcHHHHHH
Q 008378 146 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-----------------------IKPA----SLSKVTDPQVKQF 198 (568)
Q Consensus 146 sDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~-----------------------~~p~----~~~~~~s~el~~l 198 (568)
+|||||||++|+|++|+.||............+... ..+. ......++++++|
T Consensus 200 ~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (342)
T cd07854 200 IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDF 279 (342)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHH
Confidence 999999999999999999997654433322222110 0000 0122467889999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 199 IEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 199 I~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|.+||+ +|.+||++.++|.||||+.
T Consensus 280 i~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 280 LEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHhCCCchhccCHHHHhCCCcccc
Confidence 999997 6999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=262.45 Aligned_cols=203 Identities=20% Similarity=0.361 Sum_probs=162.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+....+.+|+.+++.++||||+++++++.... ..++||||+++|+|..++.+. ..+++..+..++.||+.||.|||+
T Consensus 46 ~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 123 (262)
T cd05077 46 DISLAFFETASMMRQVSHKHIVLLYGVCVRDV--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED 123 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh
Confidence 34557888999999999999999999887554 578999999999999988754 569999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCc-------EEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGE-------VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMC 154 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~-------vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGii 154 (568)
++ |+||||||+|||++ .++. +|++|||++..... .....|+..|+|||.+. ..++.++||||||++
T Consensus 124 ~~--ivH~dlkp~Nill~-~~~~~~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~ 198 (262)
T cd05077 124 KD--LVHGNVCTKNILLA-REGIDGECGPFIKLSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTT 198 (262)
T ss_pred CC--eECCCCCcccEEEe-cCCccCCCCceeEeCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHH
Confidence 99 99999999999996 4443 89999999865432 23456888999999874 458999999999999
Q ss_pred HHHHh-hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 155 ILEMV-TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 155 lyEml-tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+|+|+ +|..||.... ...... +..+..+ .....+++++++|.+||. +|.+||+..+++.+
T Consensus 199 l~el~~~~~~p~~~~~-~~~~~~-~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 199 LWEICYNGEIPLKDKT-LAEKER-FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHhCCCCCCCCcc-hhHHHH-HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 99998 5888886532 222222 2222111 222345789999999996 69999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=260.29 Aligned_cols=207 Identities=24% Similarity=0.467 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+.+|+++++.++||||+++++++.+. ..++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||
T Consensus 48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH 124 (270)
T cd05056 48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124 (270)
T ss_pred HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45667899999999999999999999987643 4689999999999999998754 5899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
+++ ++||||||+||+++ ..+.+||+|||++........ ....+++.|+|||.+ ...++.++||||||+++|+|
T Consensus 125 ~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 201 (270)
T cd05056 125 SKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201 (270)
T ss_pred hCC--eeccccChheEEEe-cCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHH
Confidence 999 99999999999997 678999999999876543321 122345689999977 45689999999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++ |..||...... .....+..+..+ ..+...++.++++|.+|+. +|.+||++.+++..
T Consensus 202 ~~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 202 LMLGVKPFQGVKNN-DVIGRIENGERL-PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHcCCCCCCCCCHH-HHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 96 99999875544 444555554433 2345668899999999996 69999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=262.25 Aligned_cols=209 Identities=23% Similarity=0.367 Sum_probs=174.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--------CCCCHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--------KNVDMKAIKNWARQI 74 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--------~~l~e~~i~~i~~QI 74 (568)
+....+.+.+|+.+|+.++||||+++++++... ....+++++|+.+|+|.+++... ..+++..+..++.||
T Consensus 48 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i 126 (280)
T cd05043 48 SEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126 (280)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHH
Confidence 355678899999999999999999999987654 34678999999999999998764 358899999999999
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceeh
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIY 149 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIW 149 (568)
+.||.|||+++ ++||||||+||+++ .++.+||+|||+++.+.... .....++..|+|||++ ...++.++|||
T Consensus 127 ~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 203 (280)
T cd05043 127 ACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVW 203 (280)
T ss_pred HHHHHHHHHCC--EeecccCHhhEEEc-CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHH
Confidence 99999999999 99999999999997 77899999999997653321 1223456789999987 45589999999
Q ss_pred hhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 150 SFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 150 SLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||+++|++++ |+.||... ++..+...+..+..+. .....++++++++.+|+. +|.+||++.+++.
T Consensus 204 slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 204 SFGVLLWELMTLGQTPYVEI-DPFEMAAYLKDGYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HhHHHHHHHhcCCCCCcCcC-CHHHHHHHHHcCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999 99999764 5666777776665443 234467899999999996 7999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=262.71 Aligned_cols=207 Identities=20% Similarity=0.297 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIK 68 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------~~l~e~~i~ 68 (568)
...+.+.+|+.+++.++||||+++++++.... .+++++||+.+++|.+++... ..+++..+.
T Consensus 50 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 127 (283)
T cd05091 50 PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127 (283)
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHH
Confidence 34577899999999999999999999886554 688999999999999998532 348888999
Q ss_pred HHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCC
Q 008378 69 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYN 143 (568)
Q Consensus 69 ~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys 143 (568)
.++.|++.||.|||++| ++||||||+||+++ .++.+||+|||+++...... .....+++.|+|||.+ ...++
T Consensus 128 ~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (283)
T cd05091 128 HIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS 204 (283)
T ss_pred HHHHHHHHHHHHHHHcC--ccccccchhheEec-CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC
Confidence 99999999999999999 99999999999997 77899999999987653322 1233567899999977 56689
Q ss_pred ccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 144 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 144 ~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
.++||||||+++|||++ |..||.+. ....+...+..+..+ ..+...+..+.+++.+||+ +|.+||++.+++..
T Consensus 205 ~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 205 IDSDIWSYGVVLWEVFSYGLQPYCGY-SNQDVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 99999999999999998 88888764 455666666665432 2345678899999999996 69999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=262.95 Aligned_cols=208 Identities=31% Similarity=0.550 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
...++.+|+.+++.++||||+++++++.+.. ..++|+||+.+++|.+++.+ ...+++..++.++.|++.||.||
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 122 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH
Confidence 4456778999999999999999999886554 58899999999999988764 35699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
|++| ++|+||||+||+++ ++.+||+|||++...... ......|++.|+|||.+. ..++.++|+||||+++|+|
T Consensus 123 H~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 198 (260)
T cd08222 123 HQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198 (260)
T ss_pred HHcC--ccccCCChhheEee--cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 9999 99999999999996 467999999998765332 223456899999999774 5588899999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
++|..||... ........+..+..+ ..+...++++.++|.+||. +|.+||++.+++.||||
T Consensus 199 ~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 199 CCLAHAFEGQ-NFLSVVLRIVEGPTP-SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HhCCCCCCCc-cHHHHHHHHHcCCCC-CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999753 344444455444333 3456678899999999996 69999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=255.43 Aligned_cols=206 Identities=25% Similarity=0.393 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+....+.+|+++++.++||||+++++++.... ..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+
T Consensus 34 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 111 (250)
T cd05085 34 ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES 111 (250)
T ss_pred HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34457889999999999999999999886553 689999999999999998754 468999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
+| ++||||||+||+++ .++.+||+|||++........ ....+++.|+|||++. ..++.++||||||+++|+|+
T Consensus 112 ~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~ 188 (250)
T cd05085 112 KN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF 188 (250)
T ss_pred CC--eeecccChheEEEc-CCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHh
Confidence 99 99999999999997 788999999999865432211 1223466799999874 55889999999999999999
Q ss_pred h-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 160 T-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 160 t-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+ |..||... ........+..+... ..+...+..+.+++.+|+. +|.+||++.++++
T Consensus 189 ~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 189 SLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred cCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 8 99999765 444555555554433 2344567899999999996 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=272.62 Aligned_cols=216 Identities=30% Similarity=0.433 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
....+++.+|+++|+.++||||+++++++..... ..+++||||+ +++|..++.. ..+++..++.++.||+.||.
T Consensus 55 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~ 132 (343)
T cd07880 55 ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLK 132 (343)
T ss_pred hHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence 3445678899999999999999999998865432 2468999999 7899988864 57999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccccc--CCCccceehhhHHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILE 157 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyE 157 (568)
|||++| |+||||||+||+++ .+|.+||+|||++...... .....+++.|+|||++.. .++.++|+||||+++|+
T Consensus 133 ~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~ 208 (343)
T cd07880 133 YIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAE 208 (343)
T ss_pred HHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccccccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 999999 99999999999997 6889999999998765332 334578999999998743 48899999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCC-------------------------C---CCCCCCCcHHHHHHHHHhcC-CCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIK-------------------------P---ASLSKVTDPQVKQFIEKCIV-PASL 208 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~-------------------------p---~~~~~~~s~el~~lI~kcL~-~p~~ 208 (568)
|++|..||..........+.+..... + .......++.+.++|.+||. +|.+
T Consensus 209 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 288 (343)
T cd07880 209 MLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAES 288 (343)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhh
Confidence 99999999875443333222211100 0 01123467889999999996 7999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 008378 209 RLPALELLKDPFLVTDN 225 (568)
Q Consensus 209 Rpsa~ElL~hpff~~~~ 225 (568)
||++.+++.||||+...
T Consensus 289 R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 289 RITAAEALAHPYFEEFH 305 (343)
T ss_pred CCCHHHHhcCccHhhhc
Confidence 99999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=262.14 Aligned_cols=210 Identities=27% Similarity=0.443 Sum_probs=166.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+.+.+|+++|+.++||||+++++++...+...+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH 125 (284)
T cd05081 46 AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH
Confidence 45677899999999999999999999987766656789999999999999999765 46899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc-----ccccCCCCccCccccc-cCCCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~-----~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiily 156 (568)
++| ++||||||+||+++ .++.+||+|||++........ ....++..|+|||++. ..++.++||||||+++|
T Consensus 126 ~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 202 (284)
T cd05081 126 SKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202 (284)
T ss_pred HCC--ceeccCCHhhEEEC-CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHH
Confidence 999 99999999999997 788999999999986643221 1122345699999874 56899999999999999
Q ss_pred HHhhcCCCCCCCCCH---------------HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 157 EMVTCEYPYNECKNP---------------AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 157 EmltG~~Pf~~~~~~---------------~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
||++|..|+...... ..+...+..+..+ ......+.++.+||.+||. +|.+|||+.++++
T Consensus 203 el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 203 ELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999987775432110 0111222222221 2234567899999999996 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=255.66 Aligned_cols=205 Identities=27% Similarity=0.478 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~--l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+..|+.+|+.++||||+++++++.+. ...+++|||+.+++|.+++..... +++..+..++.||+.||.|||+
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~ 121 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc
Confidence 677899999999999999999999988765 478999999999999999986554 9999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcc---cccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~---s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
++ ++||||||+||+++ .++.++|+|||++......... ...+++.|+|||.+ ...++.++||||||+++|+|+
T Consensus 122 ~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~ 198 (258)
T smart00219 122 KN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198 (258)
T ss_pred CC--eeecccccceEEEc-cCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHH
Confidence 99 99999999999997 7789999999998765433111 12367899999977 456899999999999999999
Q ss_pred h-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 160 T-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 160 t-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+ |..||.. .+...+...+..+..+. .+...+.++.+++.+||. +|.+||++.+++.
T Consensus 199 ~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 199 TLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred hCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 8 7888865 45566666666655443 344478899999999996 7999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=259.07 Aligned_cols=207 Identities=25% Similarity=0.427 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+.+.+|+++++.++||||+++++++.+.. ..++||||+.+++|.+++.+. +.+++..+..++.|++.||.|||
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH 124 (268)
T cd05063 47 EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124 (268)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 445678899999999999999999999886543 689999999999999999764 57899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcc-----cccCCCCccCccccc-cCCCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~-----s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiily 156 (568)
+.| ++||||||+||+++ .++.+||+|||++......... ....++.|+|||++. ..++.++||||||+++|
T Consensus 125 ~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ 201 (268)
T cd05063 125 DMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201 (268)
T ss_pred HCC--eeccccchhhEEEc-CCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHH
Confidence 999 99999999999997 7889999999998765332211 112345799999874 56899999999999999
Q ss_pred HHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 157 EMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 157 Emlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|++ |..||.... ...+.+.+..+...+ .....+..+.+++.+|++ +|..||++.++++
T Consensus 202 ell~~g~~p~~~~~-~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 202 EVMSFGERPYWDMS-NHEVMKAINDGFRLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHhCCCCCCCcCC-HHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9998 999997643 455666665543322 233467899999999996 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=259.70 Aligned_cols=207 Identities=24% Similarity=0.418 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+.+|+.+|++++||||+++++++... ..+++||||+++++|.+++.+. +.+++..+..++.||+.||.|||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 123 (267)
T cd05066 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123 (267)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999988644 4789999999999999999865 46899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc-----ccccCCCCccCccccc-cCCCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~-----~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiily 156 (568)
+++ ++||||||+||+++ .++.+||+|||++........ ....++..|+|||.+. ..++.++|+||||+++|
T Consensus 124 ~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ 200 (267)
T cd05066 124 DMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 200 (267)
T ss_pred HCC--EeehhhchhcEEEC-CCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHH
Confidence 999 99999999999997 788999999999976543221 1122356899999875 56899999999999999
Q ss_pred HHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 157 EMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 157 Emlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++++ |..||.+.. ...+...+..+..+. .+...++.+++++.+|+. +|.+||++.+++.
T Consensus 201 ell~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 201 EVMSYGERPYWEMS-NQDVIKAIEEGYRLP-APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHhcCCCCCcccCC-HHHHHHHHhCCCcCC-CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 9886 999997643 455666666654332 234567899999999996 6999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=255.80 Aligned_cols=206 Identities=24% Similarity=0.416 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+..+.+.+|++++++++||||+++++++.+.. ..++||||+.+++|.+++.+. ..+++..+..++.|++.||.|||+
T Consensus 34 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~ 111 (251)
T cd05041 34 DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111 (251)
T ss_pred HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 35678999999999999999999999887554 689999999999999998753 568999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc----ccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~----~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
++ ++||||||+||+++ .++.+||+|||++........ ....++..|+|||.+. ..++.++|+||||+++|+|
T Consensus 112 ~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l 188 (251)
T cd05041 112 KN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWET 188 (251)
T ss_pred CC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHH
Confidence 99 99999999999997 788999999999876542211 1223456799999774 5689999999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+| |..||... ........+..... ...+...+.+++++|.+||. +|.+||++.|++.
T Consensus 189 ~t~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 189 FSLGDTPYPGM-SNQQTRERIESGYR-MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccCCCCccC-CHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 99 88888764 34445555544432 22345668899999999996 6999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=258.78 Aligned_cols=203 Identities=25% Similarity=0.423 Sum_probs=167.0
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+.+.+|+++++.++||||+++++++.. ...++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||+.
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 121 (260)
T cd05069 45 PEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121 (260)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3578899999999999999999987632 35789999999999999997643 488999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
| ++||||||+||+++ .++.+||+|||++........ ....++..|+|||... ..++.++||||||+++|+|+|
T Consensus 122 ~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t 198 (260)
T cd05069 122 N--YIHRDLRAANILVG-DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred C--EeecccCcceEEEc-CCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHh
Confidence 9 99999999999997 788999999999976543221 2234667899999774 568899999999999999999
Q ss_pred -cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 161 -CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 161 -G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|..||.+.. .......+..+..+ ..+...+..++++|.+||. +|.+||++.++++
T Consensus 199 ~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 199 KGRVPYPGMV-NREVLEQVERGYRM-PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCCCCCC-HHHHHHHHHcCCCC-CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999998744 44445555554333 2345567899999999996 6999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=261.93 Aligned_cols=203 Identities=20% Similarity=0.315 Sum_probs=162.1
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...++.+|+.+++.++||||+++++++.... ..++||||+++|+|..++.+ .+.+++..+..++.||+.||.|||++
T Consensus 59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 136 (274)
T cd05076 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK 136 (274)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC
Confidence 3467889999999999999999999887654 68899999999999999875 46789999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCC------CCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGN------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~------~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiily 156 (568)
+ |+||||||+||+++.. .+.+|++|||++..... .....+++.|+|||.+. ..++.++||||||+++|
T Consensus 137 ~--iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~--~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~ 212 (274)
T cd05076 137 N--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS--REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212 (274)
T ss_pred C--ccCCCCCcccEEEeccCcccCccceeeecCCcccccccc--ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHH
Confidence 8 9999999999999621 23489999998754322 12345788899999774 35899999999999999
Q ss_pred HHh-hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 157 EMV-TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 157 Eml-tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
||+ +|..||.... +......+.... ..+....+.+.++|.+||. +|.+||++.++|++
T Consensus 213 el~~~g~~p~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 213 EICFDGEVPLKERT-PSEKERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHhCCCCCccccC-hHHHHHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 995 6999997643 333222222211 1223345789999999996 69999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=271.08 Aligned_cols=215 Identities=27% Similarity=0.408 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
..+++.+|+.+++++ +||||+++++.+... ....++++++|+. ++|.+++...+.+++..++.++.||+.||.|||
T Consensus 44 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH 122 (332)
T cd07857 44 LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122 (332)
T ss_pred hHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999 599999999875432 2346788999986 799999988889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------CcccccCCCCccCccccc--cCCCccceehhhHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMC 154 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGii 154 (568)
++| ++||||||+|||++ .++.+||+|||++..+... ......||+.|+|||++. ..++.++||||||++
T Consensus 123 ~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~ 199 (332)
T cd07857 123 SAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199 (332)
T ss_pred hCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence 999 99999999999997 7889999999999765321 123457899999999763 358999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHH--------------c-----------CCCCC---CCCCCCcHHHHHHHHHhcC-C
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVT--------------S-----------GIKPA---SLSKVTDPQVKQFIEKCIV-P 205 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~--------------~-----------~~~p~---~~~~~~s~el~~lI~kcL~-~ 205 (568)
+|+|++|..||........+...+. . ..... ......++.+++||.+||+ +
T Consensus 200 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 279 (332)
T cd07857 200 LAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFD 279 (332)
T ss_pred HHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCC
Confidence 9999999999976432221111110 0 00001 1122347899999999996 7
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 008378 206 ASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 206 p~~Rpsa~ElL~hpff~~~ 224 (568)
|.+||++.+++.||||.+-
T Consensus 280 P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 280 PTKRISVEEALEHPYLAIW 298 (332)
T ss_pred cccCCCHHHHhcChhhhhh
Confidence 9999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=261.59 Aligned_cols=207 Identities=28% Similarity=0.431 Sum_probs=169.3
Q ss_pred HHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 9 RLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 9 ~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
...+|+..++.++ ||||+++++++.+. ...++||||+ +|+|.+++.... .+++..+..++.||+.||.|||++|
T Consensus 43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~ 119 (283)
T cd07830 43 MNLREVKSLRKLNEHPNIVKLKEVFREN--DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119 (283)
T ss_pred HHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567999999999 99999999988763 4789999999 789999888764 7899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~ 162 (568)
++|+||+|+||+++ .++.++|+|||++....... .....++..|+|||++. ..++.++|+||||+++++|++|+
T Consensus 120 --i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~ 196 (283)
T cd07830 120 --FFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196 (283)
T ss_pred --cccCCCChhhEEEc-CCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC
Confidence 99999999999997 78999999999997664332 23457899999999873 34789999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCC---------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPA---------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALE 214 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~---------------------------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~E 214 (568)
.||......+...+.......+. ......++.+++||.+||+ +|.+||++.|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 197 PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred CccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 99977655554443332111100 0011225789999999996 7999999999
Q ss_pred HhcCCCC
Q 008378 215 LLKDPFL 221 (568)
Q Consensus 215 lL~hpff 221 (568)
++.||||
T Consensus 277 i~~~~~~ 283 (283)
T cd07830 277 ALQHPYF 283 (283)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=262.16 Aligned_cols=207 Identities=20% Similarity=0.328 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------------C
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------------N 61 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------------~ 61 (568)
.+..+++.+|+.++++++||||+++++++.+.. .+++|+||+.+|+|.+++.... .
T Consensus 49 ~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (288)
T cd05050 49 ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccc
Confidence 345677899999999999999999999876543 6899999999999999997532 3
Q ss_pred CCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccc
Q 008378 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPEL 137 (568)
Q Consensus 62 l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEv 137 (568)
+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||+
T Consensus 127 l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 203 (288)
T cd05050 127 LSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPES 203 (288)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHH
Confidence 778889999999999999999999 99999999999997 78899999999987543221 122345677999997
Q ss_pred c-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 008378 138 Y-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE 214 (568)
Q Consensus 138 l-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~E 214 (568)
+ ...++.++|||||||++|+|++ |..||.+. ....+...+..+..+. .+...++++.+||.+||+ +|.+||++.|
T Consensus 204 ~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 204 IFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-AHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred HhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 7 4568999999999999999998 88898753 4556666665554332 334567899999999996 7999999999
Q ss_pred Hhc
Q 008378 215 LLK 217 (568)
Q Consensus 215 lL~ 217 (568)
+++
T Consensus 282 l~~ 284 (288)
T cd05050 282 INR 284 (288)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=257.72 Aligned_cols=203 Identities=24% Similarity=0.427 Sum_probs=167.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+.+.+|+.+|++++||||+++++++.. ..+++||||+.+++|.+++... ..+++..+..++.|++.||.|||++
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 121 (260)
T cd05070 45 PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121 (260)
T ss_pred HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3568899999999999999999997632 3578999999999999998764 4589999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+ ++||||||+||+++ .++.+||+|||++..+..... ....++..|+|||++ ...++.++||||||+++|+|++
T Consensus 122 ~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 198 (260)
T cd05070 122 N--YIHRDLRSANILVG-DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred C--cccCCCccceEEEe-CCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHh
Confidence 9 99999999999997 788999999999976543221 123456689999976 4568899999999999999999
Q ss_pred -cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 161 -CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 161 -G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|..||.... ...+...+..+..+ ..+...+..+++++.+||. +|.+||++.+++.
T Consensus 199 ~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 199 KGRVPYPGMN-NREVLEQVERGYRM-PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred cCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 899997643 44455555554333 2345678899999999996 6999999998763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=258.10 Aligned_cols=206 Identities=25% Similarity=0.440 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------KNVDMKAIKNWARQILRG 77 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-------~~l~e~~i~~i~~QIl~g 77 (568)
.....+.+|+.+|+.++||||+++++++.+.. ..++||||+++|+|.+++.+. ..+++..+..++.||+.|
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 118 (269)
T cd05044 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118 (269)
T ss_pred hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHH
Confidence 45678899999999999999999999886543 689999999999999998743 347889999999999999
Q ss_pred HHhhhhCCCCeEeeeccCCcEEEeCCCC-----cEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccce
Q 008378 78 LHYLHSHNPPIIHRDLKCDNIFVNGNNG-----EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVD 147 (568)
Q Consensus 78 L~yLHs~g~~IiHRDLKp~NILl~~~~g-----~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksD 147 (568)
|.|||+.+ ++|+||||+||+++ .++ .+||+|||++....... .....++..|+|||++ ...++.++|
T Consensus 119 l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 195 (269)
T cd05044 119 CVYLEQMH--FIHRDLAARNCLVS-EKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSD 195 (269)
T ss_pred HHHHHhCC--cccCCCChheEEEe-cCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchh
Confidence 99999998 99999999999997 445 89999999987653221 1223457889999977 456899999
Q ss_pred ehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 148 IYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 148 IWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||||+++|+|+| |..||.... .......+..+..+ ..+...+..+.++|.+||. +|.+||++.+++.
T Consensus 196 v~slG~il~ellt~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 196 VWSFGVLMWEILTLGQQPYPALN-NQEVLQHVTAGGRL-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHHHHHcCCCCCcccC-HHHHHHHHhcCCcc-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999998 999997643 44455555544332 2344567899999999996 6999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=264.81 Aligned_cols=210 Identities=26% Similarity=0.425 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCC--------CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHH
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDT--------NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~--------~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL 78 (568)
..+.+|+++++.++||||+++++++.+.. ...+++|+||+++ +|..++... ..+++..+..++.||+.||
T Consensus 51 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL 129 (302)
T cd07864 51 ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGL 129 (302)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence 46778999999999999999999886543 3378999999985 676766654 4799999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCccccc--cCCCccceehhhHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE--EEYNELVDIYSFGM 153 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGi 153 (568)
.|||+++ |+||||||+||+++ .++.+||+|||++........ ....+++.|+|||++. ..++.++||||||+
T Consensus 130 ~~LH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 206 (302)
T cd07864 130 NYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 206 (302)
T ss_pred HHHHhCC--eecCCCCHHHEEEC-CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHH
Confidence 9999999 99999999999997 788999999999976643321 2235688899999774 34788999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHH--cCCCCCC-------------------------CCCCCcHHHHHHHHHhcC-C
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVT--SGIKPAS-------------------------LSKVTDPQVKQFIEKCIV-P 205 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~--~~~~p~~-------------------------~~~~~s~el~~lI~kcL~-~ 205 (568)
++|+|++|..||........+..... .+..+.. .....++.++++|.+||. +
T Consensus 207 ~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 286 (302)
T cd07864 207 ILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLD 286 (302)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCC
Confidence 99999999999976443333222111 1111110 112357899999999996 7
Q ss_pred CCCCCCHHHHhcCCCC
Q 008378 206 ASLRLPALELLKDPFL 221 (568)
Q Consensus 206 p~~Rpsa~ElL~hpff 221 (568)
|.+||++.+++.||||
T Consensus 287 P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 287 PSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhCCCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=263.29 Aligned_cols=208 Identities=25% Similarity=0.382 Sum_probs=165.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC------------CCCHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK------------NVDMKAIKNWA 71 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~------------~l~e~~i~~i~ 71 (568)
....+.+.+|+++|++++||||+++++++... ..+++||||+.+++|.+++.... .+++..+..++
T Consensus 58 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~ 135 (295)
T cd05097 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMA 135 (295)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHH
Confidence 44567799999999999999999999988654 46899999999999999986542 36888999999
Q ss_pred HHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccc
Q 008378 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELV 146 (568)
Q Consensus 72 ~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ks 146 (568)
.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||++ .+.++.++
T Consensus 136 ~~i~~al~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 212 (295)
T cd05097 136 VQIASGMKYLASLN--FVHRDLATRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS 212 (295)
T ss_pred HHHHHHHHHHHhcC--eeccccChhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchh
Confidence 99999999999999 99999999999997 78899999999987653322 1223457789999976 56689999
Q ss_pred eehhhHHHHHHHhh--cCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 147 DIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTS----G--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 147 DIWSLGiilyEmlt--G~~Pf~~~~~~~~i~~~i~~----~--~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
||||||+++|+|++ |..||..... ..+...+.. . ......+...++.+++||.+||. +|.+||++.++++
T Consensus 213 DvwSlG~~l~el~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 213 DVWAFGVTLWEMFTLCKEQPYSLLSD-EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHHHHHcCCCCCCcccCh-HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999988 6778876433 333332211 1 11122344567899999999996 6999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=265.69 Aligned_cols=213 Identities=32% Similarity=0.533 Sum_probs=170.6
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-----~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...||+.+++.|+|||||.+..+|... ...++|++||.+ -+|..+|+-| +.++...++.++.||+.|+.|||+
T Consensus 73 SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~ 150 (438)
T KOG0666|consen 73 SACREIALLRELKHPNVISLVKVFLSH-DKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS 150 (438)
T ss_pred HHHHHHHHHHHhcCCcchhHHHHHhcc-CceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh
Confidence 356899999999999999999988764 468999999998 5888888744 458999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCC---CCcEEEeecChhhhccCCC-----cccccCCCCccCcccc--ccCCCccceehhhHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY--EEEYNELVDIYSFGM 153 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~---~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGi 153 (568)
+. |+||||||.|||+.++ .|.|||+|||+++.+..+- ...++.|.||+|||++ .+.|+.++|||+.||
T Consensus 151 NW--vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGC 228 (438)
T KOG0666|consen 151 NW--VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGC 228 (438)
T ss_pred hh--eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHH
Confidence 99 9999999999999843 4899999999999886653 3456789999999977 567999999999999
Q ss_pred HHHHHhhcCCCCCCCC------CH---HHHHHHHHc-CCC-----------CCC----------------------CCCC
Q 008378 154 CILEMVTCEYPYNECK------NP---AQIYKKVTS-GIK-----------PAS----------------------LSKV 190 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~------~~---~~i~~~i~~-~~~-----------p~~----------------------~~~~ 190 (568)
|+.||+|-++.|.+.. +| +++-+.+.- |.+ |.. ..++
T Consensus 229 IfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~ 308 (438)
T KOG0666|consen 229 IFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKV 308 (438)
T ss_pred HHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcC
Confidence 9999999988775421 11 122111110 100 000 0133
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 191 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 191 ~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.++...+|+.++|. +|.+|.++++.|.|+||.++.
T Consensus 309 k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 309 KDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred CCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 46678899999996 899999999999999998764
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=268.64 Aligned_cols=208 Identities=27% Similarity=0.473 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~~ 66 (568)
.+..+.+.+|+++++++ +||||+++++++... ..+++++||+.+|+|.+++.+.. .++...
T Consensus 58 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 135 (334)
T cd05100 58 DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135 (334)
T ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHH
Confidence 34567899999999999 899999999988654 36899999999999999987532 377888
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccC
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEE 141 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ 141 (568)
+..++.||+.||.|||++| ++||||||+||+++ .++.+||+|||+++...... .....++..|+|||++ ...
T Consensus 136 ~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 212 (334)
T cd05100 136 LVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV 212 (334)
T ss_pred HHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC
Confidence 9999999999999999999 99999999999997 77899999999987653321 1122345679999977 556
Q ss_pred CCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 142 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++.++||||||+++|||++ |..||.+. +...+.+.+..+..+. .+...+.++.++|.+||. +|.+||++.+++.+
T Consensus 213 ~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 213 YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred cCchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 8999999999999999998 88899763 5566666666654433 334567899999999996 69999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=262.38 Aligned_cols=207 Identities=23% Similarity=0.393 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-----------CCCHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------NVDMKAIKNWARQ 73 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-----------~l~e~~i~~i~~Q 73 (568)
...+.+.+|+++|+.++||||+++++++.... ..++||||+.+|+|.+++.+.. .+++..+..++.|
T Consensus 61 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (296)
T cd05095 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ 138 (296)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHH
Confidence 44578899999999999999999999887654 6899999999999999987643 3677899999999
Q ss_pred HHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCcccee
Q 008378 74 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDI 148 (568)
Q Consensus 74 Il~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDI 148 (568)
|+.||.|||++| ++||||||+||+++ .++.+||+|||++..+.... .....+++.|+|||+. .+.++.++||
T Consensus 139 i~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di 215 (296)
T cd05095 139 IASGMKYLSSLN--FVHRDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDV 215 (296)
T ss_pred HHHHHHHHHHCC--eecccCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhh
Confidence 999999999999 99999999999997 78899999999997653322 1223446789999965 5668999999
Q ss_pred hhhHHHHHHHhh--cCCCCCCCCCHHHHHHHHH----cCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 149 YSFGMCILEMVT--CEYPYNECKNPAQIYKKVT----SGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 149 WSLGiilyEmlt--G~~Pf~~~~~~~~i~~~i~----~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||||++|||++ |..||..... .++..... .... ....+...++.+++||.+||+ +|.+||++.+++.
T Consensus 216 wSlG~~l~el~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 216 WAFGVTLWEILTLCKEQPYSQLSD-EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hHHHHHHHHHHHhCCCCCccccCh-HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999999998 7789976433 33322221 1111 111223456899999999996 7999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=258.61 Aligned_cols=206 Identities=25% Similarity=0.462 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+...+++.+|+.+|+.++||||+++++++.. ...++||||+.+|+|.+++... ..+++..+..|+.||+.||+|||
T Consensus 50 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH 126 (279)
T cd05057 50 PKANKEILDEAYVMASVDHPHVVRLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126 (279)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4566789999999999999999999998875 3688999999999999998874 46999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc----ccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~----~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
+++ ++||||||+||+++ .++.+||+|||+++....... ....++..|+|||.+ ...++.++|+||||+++||
T Consensus 127 ~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~e 203 (279)
T cd05057 127 EKR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWE 203 (279)
T ss_pred hCC--EEecccCcceEEEc-CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHH
Confidence 998 99999999999997 788999999999976643221 112235689999977 4568999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|++ |..||... ....+...+..+... ..+...+..+.+++.+||. +|..||++.+++.
T Consensus 204 l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 204 LMTFGAKPYEGI-PAVEIPDLLEKGERL-PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HhcCCCCCCCCC-CHHHHHHHHhCCCCC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 998 99999764 566677777655433 2345577899999999995 7999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=264.44 Aligned_cols=215 Identities=25% Similarity=0.513 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....++.+|+.++..+. ||||+++++++.+.. .+|+||||+. ++|..++.. .+.+++..+..++.||+.||.|||
T Consensus 55 ~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH 131 (296)
T cd06618 55 EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS--DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131 (296)
T ss_pred HHHHHHHHHHHHHHhccCCCchHhhheeeecCC--eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45566777888777774 999999999987654 6999999985 577777665 457999999999999999999999
Q ss_pred h-CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccccc-----CCCccceehhhHHHH
Q 008378 83 S-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCI 155 (568)
Q Consensus 83 s-~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl~~-----~ys~ksDIWSLGiil 155 (568)
+ ++ ++||||+|+||+++ .++.+||+|||++..+.... .....+++.|+|||.+.. .++.++||||||+++
T Consensus 132 ~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 208 (296)
T cd06618 132 EKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISL 208 (296)
T ss_pred hhCC--EecCCCcHHHEEEc-CCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHH
Confidence 7 57 99999999999997 78999999999987654322 223457889999998743 378899999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|+|++|+.||.......+....+.....+. ......+.++++||.+||. +|.+||++.+++.||||+...
T Consensus 209 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 209 VELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 999999999976544444444444433222 1223467899999999996 799999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=273.08 Aligned_cols=215 Identities=29% Similarity=0.426 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
....+++.+|+.++++++||||+++++++.... ...++++++++ +++|.++++. +.+++..++.++.||+.||.
T Consensus 57 ~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~ 134 (345)
T cd07877 57 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLK 134 (345)
T ss_pred hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence 344677889999999999999999999875432 23478888887 7899888765 46999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyE 157 (568)
|||+++ ++||||||+||+++ .+|.+||+|||++..... ......|++.|+|||++. ..++.++||||||+++|+
T Consensus 135 ~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 210 (345)
T cd07877 135 YIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 210 (345)
T ss_pred HHHHCC--eeecCCChHHEEEc-CCCCEEEecccccccccc-cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHH
Confidence 999999 99999999999997 788999999999876533 233457899999999874 357899999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHc-------------------------CCCCC---CCCCCCcHHHHHHHHHhcC-CCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTS-------------------------GIKPA---SLSKVTDPQVKQFIEKCIV-PASL 208 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~-------------------------~~~p~---~~~~~~s~el~~lI~kcL~-~p~~ 208 (568)
|++|+.||........+...+.. ..+.. ......++++++||.+||. +|.+
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 290 (345)
T cd07877 211 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 290 (345)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhh
Confidence 99999999754332222111110 00000 0112357889999999996 6999
Q ss_pred CCCHHHHhcCCCCCCC
Q 008378 209 RLPALELLKDPFLVTD 224 (568)
Q Consensus 209 Rpsa~ElL~hpff~~~ 224 (568)
|+++.+++.||||++.
T Consensus 291 R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 291 RITAAQALAHAYFAQY 306 (345)
T ss_pred cCCHHHHhcChhhhhc
Confidence 9999999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=272.42 Aligned_cols=214 Identities=29% Similarity=0.424 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
....+.+|+.+++.++||||+++++++..... ..+++|+||+. ++|..++. ..+++..+..++.||+.||.||
T Consensus 57 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~L 133 (342)
T cd07879 57 FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYI 133 (342)
T ss_pred chhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999998865432 35789999996 57877653 4689999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccccc--CCCccceehhhHHHHHHHh
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEml 159 (568)
|+++ ++||||||+||+++ .+|.+||+|||++..... ......|++.|+|||++.+ .++.++|||||||++|+|+
T Consensus 134 H~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 134 HSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred HHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCcCCCC-CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence 9999 99999999999997 789999999999876432 2334578999999998743 4889999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCC---------------------C----CC---CCCCCcHHHHHHHHHhcC-CCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIK---------------------P----AS---LSKVTDPQVKQFIEKCIV-PASLRL 210 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~---------------------p----~~---~~~~~s~el~~lI~kcL~-~p~~Rp 210 (568)
+|+.||.+......+...+..... + .. .....++.+++||.+||+ +|.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 999999864433332222110000 0 00 012356789999999996 799999
Q ss_pred CHHHHhcCCCCCCCCC
Q 008378 211 PALELLKDPFLVTDNP 226 (568)
Q Consensus 211 sa~ElL~hpff~~~~~ 226 (568)
++.+++.||||....+
T Consensus 290 ~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 290 TATEALEHPYFDSFRD 305 (342)
T ss_pred CHHHHhcCcchhhccc
Confidence 9999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=270.69 Aligned_cols=209 Identities=25% Similarity=0.428 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC------------------------
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------------------ 59 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~------------------------ 59 (568)
+....+.+|+.+|+++ +||||+++++++.... ..+++|||||++|+|.+++...
T Consensus 52 ~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 130 (343)
T cd05103 52 SEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDI 130 (343)
T ss_pred HHHHHHHHHHHHHHhccCCccHhhhcceeecCC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccch
Confidence 4456788999999999 7899999999886544 4788999999999999998653
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCC
Q 008378 60 -------------------------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 96 (568)
Q Consensus 60 -------------------------------------------~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~ 96 (568)
..++...+..++.||+.||.|||+++ |+||||||+
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~ 208 (343)
T cd05103 131 SEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAAR 208 (343)
T ss_pred hhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccC
Confidence 23677888999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCC
Q 008378 97 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKN 170 (568)
Q Consensus 97 NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~ 170 (568)
||+++ .++.+||+|||++....... .....+++.|+|||++ ...++.++||||||+++|+|++ |..||.....
T Consensus 209 Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 287 (343)
T cd05103 209 NILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287 (343)
T ss_pred eEEEc-CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence 99997 78899999999987653221 1223456789999977 5568999999999999999997 9999977555
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 171 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 171 ~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
...+...+..+..+. .+...++.+.+++.+||+ +|.+||++.++++|
T Consensus 288 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 288 DEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred cHHHHHHHhccCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 555555555554332 344567899999999996 69999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=255.37 Aligned_cols=203 Identities=21% Similarity=0.409 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+.+++.++||||+++++++... ..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 118 (254)
T cd05083 42 TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346788999999999999999999988643 3689999999999999998654 58999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-c
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-C 161 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt-G 161 (568)
+| ++||||||+||+++ .++.+||+|||++...... ......+..|+|||.+ ...++.++|+||||+++|+|++ |
T Consensus 119 ~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g 194 (254)
T cd05083 119 KK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYG 194 (254)
T ss_pred CC--eeccccCcceEEEc-CCCcEEECCCccceecccc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCC
Confidence 98 99999999999997 6789999999998654322 2233456789999977 4568899999999999999998 9
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
..||... ........+..+..+. .....++.++++|.+||. +|..||++.+++.
T Consensus 195 ~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 195 RAPYPKM-SLKEVKECVEKGYRME-PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCCccC-CHHHHHHHHhCCCCCC-CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999764 4455666666654433 345567899999999996 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=257.97 Aligned_cols=203 Identities=25% Similarity=0.414 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+++.+|+++++.++||||+++++.+.. ...++||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 121 (262)
T cd05071 45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121 (262)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3568899999999999999999987632 3578999999999999999864 3589999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+ ++||||||+||+++ .++.+||+|||++........ ....++..|+|||+. ...++.++||||||+++|+|+|
T Consensus 122 ~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt 198 (262)
T cd05071 122 N--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198 (262)
T ss_pred C--ccccccCcccEEEc-CCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHc
Confidence 8 99999999999997 788999999999976543321 233466789999977 4568999999999999999999
Q ss_pred -cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 161 -CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 161 -G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|..||.... ...+...+..+..+. .....++.+.++|.+|++ +|.+||++.+++.
T Consensus 199 ~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 199 KGRVPYPGMV-NREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCCCCCCC-hHHHHHHHhcCCCCC-CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 888887643 445555555443322 234567899999999996 6999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=255.20 Aligned_cols=205 Identities=21% Similarity=0.449 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+.+.+|++++++++||||+++++++.... ..++|+||+.+++|.+++... +.+++..++.++.|++.||.|||+++
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 120 (256)
T cd05112 43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERS--PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEccCC--ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356889999999999999999999876543 689999999999999998764 46899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcc---cccCCCCccCccccc-cCCCccceehhhHHHHHHHhh-
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~---s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt- 160 (568)
++||||||+||+++ .++.+||+|||++......... ...++..|+|||++. +.++.++||||||+++|+|++
T Consensus 121 --i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~ 197 (256)
T cd05112 121 --VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred --ccccccccceEEEc-CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcC
Confidence 99999999999997 7889999999998755332221 223567899999874 568899999999999999998
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|..||.. .....+...+..+..+. .+...+..+.+|+.+||+ +|.+||++.+++++
T Consensus 198 g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 198 GKTPYEN-RSNSEVVETINAGFRLY-KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCCCCc-CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 9999976 34455666666554332 244567899999999996 69999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=270.17 Aligned_cols=216 Identities=27% Similarity=0.459 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+...+|.+|.+.|.||-||++|++|.-++ ..++-|+|||+|.+|.-|++.++-++++.++.|+.||+.||.||....+
T Consensus 511 hKHAcREyrIHKeLDHpRIVKlYDyfslDt-dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikp 589 (775)
T KOG1151|consen 511 HKHACREYRIHKELDHPRIVKLYDYFSLDT-DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKP 589 (775)
T ss_pred HHHHHHHHhhhhccCcceeeeeeeeeeecc-ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCC
Confidence 356788999999999999999999996544 4788899999999999999999999999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCCCc---------ccccCCCCccCcccc--c---cCCCccceehh
Q 008378 87 PIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTA---------RSVIGTPEFMAPELY--E---EEYNELVDIYS 150 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~~~---------~s~~GTp~YmAPEvl--~---~~ys~ksDIWS 150 (568)
||||-||||.|||+.. ..|.+||.||||++++....- ....||-||++||.+ . ...+.++||||
T Consensus 590 PIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWS 669 (775)
T KOG1151|consen 590 PIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWS 669 (775)
T ss_pred CeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEe
Confidence 9999999999999852 357899999999998864432 234799999999965 2 23688999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHH--HcCCC-CCCCCCCCcHHHHHHHHHhcCC-CCCCCCHHHHhcCCCCCC
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKV--TSGIK-PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVT 223 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i--~~~~~-p~~~~~~~s~el~~lI~kcL~~-p~~Rpsa~ElL~hpff~~ 223 (568)
+|+|+|.++.|+-||........|...- ..... .-....+.++++++||++||+. ...|....+|-+||+|..
T Consensus 670 vGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 670 VGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred eehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 9999999999999997755444443322 11111 1112346789999999999984 678999999999999965
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=282.86 Aligned_cols=213 Identities=26% Similarity=0.454 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~-k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
++-..+++|+.||+++.||.||.+-..|... ..+++|||-+.|.=|.-++. ..+++++...+.++.||+.||.|||-
T Consensus 605 kqesqlR~EVaILq~l~HPGiV~le~M~ET~--ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~ 682 (888)
T KOG4236|consen 605 KQESQLRNEVAILQNLHHPGIVNLECMFETP--ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF 682 (888)
T ss_pred chHHHHHHHHHHHHhcCCCCeeEEEEeecCC--ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh
Confidence 3447789999999999999999999877554 47999999997443444443 34789999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCC--CcEEEeecChhhhccC-CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~--g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
+| |+|+||||+|||+...+ .++||||||+|++... ...++++|||.|+|||++ ..+|+..-|+||.|+|+|.-+
T Consensus 683 kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsL 760 (888)
T KOG4236|consen 683 KN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSL 760 (888)
T ss_pred cc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEe
Confidence 99 99999999999997432 3799999999998864 456789999999999988 567999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~--~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
.|.+||.+.. .|...|+.. ..|...++.+++++.+||.++|+ +-.+|.+.+..|.|||++..
T Consensus 761 SGTFPFNEdE---dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 761 SGTFPFNEDE---DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred cccccCCCcc---chhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999997754 444555543 23566677789999999999995 78999999999999999864
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=256.23 Aligned_cols=205 Identities=26% Similarity=0.438 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+++.+|+.++++++||||+++++++... ..+++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~ 121 (261)
T cd05034 44 SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121 (261)
T ss_pred CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346789999999999999999999987643 46899999999999999997653 68999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++ ++||||||+||+++ .++.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|+
T Consensus 122 ~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~ 198 (261)
T cd05034 122 RN--YIHRDLAARNILVG-ENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV 198 (261)
T ss_pred CC--cccCCcchheEEEc-CCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHH
Confidence 99 99999999999997 78999999999987654321 11223567899999874 55889999999999999999
Q ss_pred h-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 160 T-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 160 t-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+ |+.||.+.. .......+..+.... .+...+.++++++.+||. +|.+||++.+++.
T Consensus 199 t~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 199 TYGRVPYPGMT-NREVLEQVERGYRMP-RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred hCCCCCCCCCC-HHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 8 999997644 445555555543322 233457899999999996 6999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=256.14 Aligned_cols=203 Identities=25% Similarity=0.419 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+++.+|+.+|+.++||||+++++++.. ...++||||+.+|+|.+++.+. ..+++..+..++.|++.||+|||++
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~ 121 (260)
T cd05067 45 PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121 (260)
T ss_pred HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 4678999999999999999999997632 3589999999999999998754 3689999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
| ++||||||+||+++ .++.++|+|||++....... .....++..|+|||++. ..++.++||||||+++|+|++
T Consensus 122 ~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~ 198 (260)
T cd05067 122 N--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198 (260)
T ss_pred C--eecccccHHhEEEc-CCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHh
Confidence 9 99999999999997 78899999999987654222 12334567899999874 558899999999999999999
Q ss_pred -cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 161 -CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 161 -G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+.||.+.. ...+...+..+..+. .+...+.+++++|.+||. +|.+||++++++.
T Consensus 199 ~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 199 YGRIPYPGMT-NPEVIQNLERGYRMP-RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCCCCCCC-hHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999998654 445555555554332 345567899999999996 6999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=256.08 Aligned_cols=208 Identities=23% Similarity=0.406 Sum_probs=169.4
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+++..+++..|+.+++.++||||+++++++.+. ..+++||||+.+|+|.+++... +.+++..+..++.|++.||.||
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~l 122 (269)
T cd05065 45 TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122 (269)
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 355678899999999999999999999987644 4688999999999999998764 5689999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc----cc-c--cCCCCccCccccc-cCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RS-V--IGTPEFMAPELYE-EEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~----~s-~--~GTp~YmAPEvl~-~~ys~ksDIWSLGi 153 (568)
|++| ++||||||+||+++ .++.+||+|||++........ .. . .++..|+|||.+. ..++.++||||||+
T Consensus 123 H~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~ 199 (269)
T cd05065 123 SEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGI 199 (269)
T ss_pred HHCC--EeecccChheEEEc-CCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHH
Confidence 9999 99999999999997 678999999999876533211 11 1 1245799999874 56899999999999
Q ss_pred HHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 154 CILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 154 ilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++|||++ |..||... ....+...+....... .+...++.+.+++.+||. +|.+||++.+++.
T Consensus 200 ~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 200 VMWEVMSYGERPYWDM-SNQDVINAIEQDYRLP-PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHhcCCCCCCCCC-CHHHHHHHHHcCCcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999886 99999764 3445555555443322 234567899999999996 6999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=259.81 Aligned_cols=216 Identities=23% Similarity=0.316 Sum_probs=169.2
Q ss_pred CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcC---CCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHH
Q 008378 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---TNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQI 74 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~---~~~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~QI 74 (568)
++.+++++..+|++..++++||||++++++.+.+ ...+.|+++.|...|+|.++++.. ..+++..+..|+.+|
T Consensus 57 ~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gi 136 (302)
T KOG2345|consen 57 HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGI 136 (302)
T ss_pred cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHH
Confidence 4568899999999999999999999999876543 335799999999999999998743 369999999999999
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----c------ccccCCCCccCcccccc---
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----A------RSVIGTPEFMAPELYEE--- 140 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~------~s~~GTp~YmAPEvl~~--- 140 (568)
++||++||...||++||||||.||++. ..+.++|.|||.++...... + .....|..|+|||++.-
T Consensus 137 c~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~ 215 (302)
T KOG2345|consen 137 CRGLEALHEKEPPYAHRDIKPANILLS-DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSH 215 (302)
T ss_pred HHHHHHHhccCCcccccCCCcceeEec-CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccC
Confidence 999999999999999999999999997 68999999999987542211 0 12246889999999843
Q ss_pred -CCCccceehhhHHHHHHHhhcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 141 -EYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 141 -~ys~ksDIWSLGiilyEmltG~~Pf~~~~~-~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
..++++|||||||++|+|+.|..||..-.. ...+.-.+..+.-...-...++..+.++|+.||+ +|.+||++.+++.
T Consensus 216 ~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 216 CTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred cccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 368899999999999999999999953100 0000011111111111112368899999999996 7999999999986
Q ss_pred C
Q 008378 218 D 218 (568)
Q Consensus 218 h 218 (568)
+
T Consensus 296 ~ 296 (302)
T KOG2345|consen 296 K 296 (302)
T ss_pred H
Confidence 4
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=254.39 Aligned_cols=205 Identities=23% Similarity=0.420 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
...+.+.+|+.+|+.++|+||+++++.+.. ...+++|||+++|+|.+++.+. ..++...+..++.||+.||.|||
T Consensus 43 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH 119 (260)
T cd05073 43 MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119 (260)
T ss_pred hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999998765 3678999999999999999864 45788999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
++| ++||||||+||+++ ..+.+||+|||++........ ....++..|+|||++. ..++.++|+||||+++|+|
T Consensus 120 ~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l 196 (260)
T cd05073 120 QRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 196 (260)
T ss_pred hCC--ccccccCcceEEEc-CCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHH
Confidence 998 99999999999997 788999999999876543221 1234567799999874 4588899999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+| |..||.... ...+...+..+.... .....+.++.+++.+|+. +|.+||++.+++.
T Consensus 197 ~t~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 197 VTYGRIPYPGMS-NPEVIRALERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HhcCCCCCCCCC-HHHHHHHHhCCCCCC-CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99 999997643 444555555554332 334567899999999996 6999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=290.37 Aligned_cols=216 Identities=29% Similarity=0.518 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCC---CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT---NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~---~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL 78 (568)
+.-+++..|..+|+.+ .|||++.||++|.-.+ .+.+|||||||.||+.-++++.. .++.|..|..|++.++.||
T Consensus 57 d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl 136 (953)
T KOG0587|consen 57 DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGL 136 (953)
T ss_pred cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHH
Confidence 3446778899999988 7999999999886432 35899999999999999998854 5799999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc------cCCCccceehh
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYS 150 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~------~~ys~ksDIWS 150 (568)
.+||.+. +||||||-.|||++ ..|.||++|||++..+... ...+.+|||.|||||++. ..|+..+|+||
T Consensus 137 ~HLH~nk--viHRDikG~NiLLT-~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~Ws 213 (953)
T KOG0587|consen 137 AHLHNNK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWS 213 (953)
T ss_pred HHHhhcc--eeeecccCceEEEe-ccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhh
Confidence 9999998 99999999999998 7899999999999887543 456789999999999983 23788999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~-~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
||++.+||.-|.+|+...-....+++ |.+..+|... ++..+.++.+||..||. +..+||+..++|.|||+...
T Consensus 214 LGITaIEladG~PPl~DmHPmraLF~-IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 214 LGITAIEMAEGAPPLCDMHPMRALFL-IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ccceeehhcCCCCCccCcchhhhhcc-CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 99999999999999977544343443 3344444333 56678999999999996 68999999999999999843
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=274.79 Aligned_cols=208 Identities=27% Similarity=0.448 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-----------------------
Q 008378 5 DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------------- 60 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------------- 60 (568)
...+.+.+|+++|..+. |||||+++++|.... .+++|||||.+|+|.+++.+.+
T Consensus 82 ~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~--~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (401)
T cd05107 82 SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG--PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGST 159 (401)
T ss_pred hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC--CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccc
Confidence 34567899999999997 999999999987653 6899999999999999987542
Q ss_pred ---------------------------------------------------------------------------CCCHH
Q 008378 61 ---------------------------------------------------------------------------NVDMK 65 (568)
Q Consensus 61 ---------------------------------------------------------------------------~l~e~ 65 (568)
.+++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 239 (401)
T cd05107 160 PLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYM 239 (401)
T ss_pred cccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHH
Confidence 25667
Q ss_pred HHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-cc
Q 008378 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EE 140 (568)
Q Consensus 66 ~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~ 140 (568)
.+..++.||+.||.|||+.+ ++||||||+|||++ ..+.+||+|||+++..... ......+++.|||||++ ..
T Consensus 240 ~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 316 (401)
T cd05107 240 DLVGFSYQVANGMEFLASKN--CVHRDLAARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN 316 (401)
T ss_pred HHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC
Confidence 78899999999999999998 99999999999997 6789999999999754321 12234678899999977 45
Q ss_pred CCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 141 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 141 ~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
.++.++||||||+++|||++ |..||............+..+..+. .+...+.+++++|.+||. +|..||++.+++..
T Consensus 317 ~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 58999999999999999998 8999987666666667676664433 344568899999999996 79999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=260.21 Aligned_cols=210 Identities=32% Similarity=0.464 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+.+++.++||||+++++++.+. ..+++|+||+. ++|.+++.+. ..+++..+..++.|++.||.|||++
T Consensus 41 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 117 (282)
T cd07829 41 IPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117 (282)
T ss_pred ccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 346778899999999999999999988654 47999999997 5999999887 5799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-c-CCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~-~ys~ksDIWSLGiilyEmlt 160 (568)
+ ++||||+|+||+++ .++.+||+|||++....... .....++..|+|||.+. . .++.++||||||+++|+|++
T Consensus 118 ~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 194 (282)
T cd07829 118 R--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194 (282)
T ss_pred C--cccCCCChheEEEc-CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHh
Confidence 9 99999999999997 68999999999987654332 22345678899999773 3 68899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCC-------------------CCC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 161 CEYPYNECKNPAQIYKKVTSGI-------------------KPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~-------------------~p~-------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
|..||........+.+...... .+. ......+..++++|.+||. +|.+||++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 274 (282)
T cd07829 195 GKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK 274 (282)
T ss_pred CCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHH
Confidence 9999977554433322221100 000 0011236789999999996 799999999
Q ss_pred HHhcCCCC
Q 008378 214 ELLKDPFL 221 (568)
Q Consensus 214 ElL~hpff 221 (568)
+++.||||
T Consensus 275 ~~l~~p~~ 282 (282)
T cd07829 275 EALKHPYF 282 (282)
T ss_pred HHhhCcCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=257.14 Aligned_cols=210 Identities=30% Similarity=0.448 Sum_probs=165.9
Q ss_pred HHHHHHHHHHHhC---CCCCeeeeeeEEEcCCC---CeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHH
Q 008378 8 ERLYSEVHLLKSL---KHENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 8 e~l~~Ei~iLk~L---~HpNIV~l~~~~~~~~~---~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~ 79 (568)
..+.+|+.+++++ +||||+++++++..... ..++++|||+. ++|.+++.+.. .+++..+..++.||+.||.
T Consensus 43 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~ 121 (287)
T cd07838 43 LSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121 (287)
T ss_pred hhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHH
Confidence 4566788877766 59999999999876542 24899999997 58988887643 5899999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
|||+++ ++|+||+|+||+++ .++.+||+|||++..+.... .....+++.|+|||++ ...++.++|+||||+++|+
T Consensus 122 ~LH~~~--i~h~~l~~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~ 198 (287)
T cd07838 122 FLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE 198 (287)
T ss_pred HHHHCC--eeeccCChhhEEEc-cCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHH
Confidence 999999 99999999999998 66999999999987664332 2344688999999977 4558899999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCC---------------------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKP---------------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p---------------------~---~~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
|++|..||......+.+.+.+.....+ . ......++.+.++|.+||. +|.+||++
T Consensus 199 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~ 278 (287)
T cd07838 199 LFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278 (287)
T ss_pred HHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence 999999997755444333332211000 0 0011235788999999996 79999999
Q ss_pred HHHhcCCCC
Q 008378 213 LELLKDPFL 221 (568)
Q Consensus 213 ~ElL~hpff 221 (568)
.+++.||||
T Consensus 279 ~~il~~~~~ 287 (287)
T cd07838 279 FEALQHPYF 287 (287)
T ss_pred HHHhcCcCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=266.92 Aligned_cols=214 Identities=32% Similarity=0.509 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+++++.++||||++++++|.... ...++|+||+ +++|..+++. ..+++..+..++.||+.||.|||++
T Consensus 51 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~ 127 (328)
T cd07856 51 VLAKRTYRELKLLKHLRHENIISLSDIFISPL-EDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSA 127 (328)
T ss_pred chhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-CcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34577889999999999999999999886543 3688999999 5789888764 4689999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcC
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~ 162 (568)
+ ++||||+|+||+++ .++.+||+|||++..... ......+++.|+|||.+. ..++.++||||||+++|+|+||.
T Consensus 128 ~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~ 203 (328)
T cd07856 128 G--VVHRDLKPSNILIN-ENCDLKICDFGLARIQDP-QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203 (328)
T ss_pred C--cccCCCCHHHEeEC-CCCCEEeCccccccccCC-CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCC
Confidence 9 99999999999997 788999999999875432 223457889999999874 35899999999999999999999
Q ss_pred CCCCCCCCHHH--------------HHHHHH---------cCC--CC---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 163 YPYNECKNPAQ--------------IYKKVT---------SGI--KP---ASLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 163 ~Pf~~~~~~~~--------------i~~~i~---------~~~--~p---~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
.||........ +...+. ... .+ .......++.++++|.+||+ +|.+||++.
T Consensus 204 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 283 (328)
T cd07856 204 PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283 (328)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 99976432111 110000 000 00 01113457899999999996 799999999
Q ss_pred HHhcCCCCCCCC
Q 008378 214 ELLKDPFLVTDN 225 (568)
Q Consensus 214 ElL~hpff~~~~ 225 (568)
+++.||||....
T Consensus 284 ell~~~~~~~~~ 295 (328)
T cd07856 284 EALAHPYLAPYH 295 (328)
T ss_pred HHhcCCcccccc
Confidence 999999997544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=247.54 Aligned_cols=210 Identities=35% Similarity=0.628 Sum_probs=181.9
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+.+|++.+++++|+||+++++.+... ...++++||+.+++|..++.....++...+..++.+++.+|.|||+++
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~- 107 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNG- 107 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 67899999999999999999999988754 478999999999999999988777999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~P 164 (568)
++|+||+|.||+++ .++.++|+|||++...... ......+++.|++||.+ ...++.++||||||+++++|++|..|
T Consensus 108 -i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 185 (244)
T smart00220 108 -IIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPP 185 (244)
T ss_pred -eecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999997 6789999999999776543 34456789999999977 46688999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCC-CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 165 YNECKNPAQIYKKVTSGIKPASLSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 165 f~~~~~~~~i~~~i~~~~~p~~~~~~-~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|....+...+...+..+..+...... .+..+.+++.+|+. +|.+||++.++++||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 186 FPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 98756677777776665444322222 67899999999996 79999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=290.61 Aligned_cols=108 Identities=27% Similarity=0.475 Sum_probs=99.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+.+++.++||||++++.++... ..+|+||||+.+++|.+++...+.+++..++.|+.||+.||.|||.
T Consensus 45 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~ 122 (669)
T cd05610 45 KNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122 (669)
T ss_pred HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 44567899999999999999999999887654 4799999999999999999988889999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
++ |+||||||+|||++ .+|.+||+|||+++
T Consensus 123 ~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 123 HG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred CC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 98 99999999999997 78999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=260.54 Aligned_cols=206 Identities=26% Similarity=0.463 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.....+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++..++ .+++..+..++.||+.||.|||+
T Consensus 51 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~ 127 (303)
T cd05110 51 KANVEFMDEALIMASMDHPHLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 127 (303)
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3445788999999999999999999988643 3578999999999999988754 68999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
++ ++||||||+||+++ .++.+||+|||+++...... .....+++.|+|||.+. ..++.++||||||+++|||
T Consensus 128 ~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el 204 (303)
T cd05110 128 RR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204 (303)
T ss_pred cC--eeccccccceeeec-CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 99 99999999999997 67899999999998654322 12234577899999774 5689999999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++ |..||.+. ....+...+..+..+. .+...+..+++++.+|+. +|.+||++.+++..
T Consensus 205 ~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 205 MTFGGKPYDGI-PTREIPDLLEKGERLP-QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HhCCCCCCCCC-CHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 97 89999763 3444555555443332 334567899999999995 79999999998774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=253.38 Aligned_cols=209 Identities=26% Similarity=0.473 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHHHh-CCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~-L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL 78 (568)
.....++.+|+.++++ ++||||+++++++... ...++||||+.+++|.+++.. ...+++..++.++.|++.||
T Consensus 49 ~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l 126 (269)
T cd08528 49 DKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126 (269)
T ss_pred hHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHH
Confidence 4456778889998875 7999999999988654 479999999999999988743 34689999999999999999
Q ss_pred Hhhhh-CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHH
Q 008378 79 HYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 155 (568)
Q Consensus 79 ~yLHs-~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiil 155 (568)
.|||+ .+ ++||||+|.||+++ .++.+||+|||++...... ......|+..|+|||.+. ..++.++|+||||+++
T Consensus 127 ~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll 203 (269)
T cd08528 127 RYLHKEKR--IVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCIL 203 (269)
T ss_pred HHhccCCc--eeecCCCHHHEEEC-CCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHH
Confidence 99996 66 99999999999997 7889999999999765443 334557899999999774 4588999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+|++|..||... +.......+..+..+.......++.++++|.+||+ +|.+||++.|+..+
T Consensus 204 ~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 204 YQMCTLQPPFYST-NMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHhCCCccccc-CHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 9999999999764 44444445544433333334568999999999996 79999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=272.00 Aligned_cols=209 Identities=27% Similarity=0.454 Sum_probs=162.7
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+|.+|+.+|.+++|||+|++++||.+... ..++|+||+.+|+|.+++.... .+++....+|+.+++.||+|||..
T Consensus 115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~ 193 (361)
T KOG1187|consen 115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEG 193 (361)
T ss_pred hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccC
Confidence 4559999999999999999999999987653 5889999999999999988665 899999999999999999999995
Q ss_pred C-CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-CCc-ccc-cCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 85 N-PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTA-RSV-IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 85 g-~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~-~s~-~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
. +||||||||+.|||+| .+...||+|||+|+.... ... .+. .||.+|+|||.+. +..+.++||||||++++||+
T Consensus 194 ~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli 272 (361)
T KOG1187|consen 194 CPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI 272 (361)
T ss_pred CCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHH
Confidence 4 5899999999999998 889999999999976543 222 222 7999999999884 67899999999999999999
Q ss_pred hcCCCCCCCC--C---HHHH-HHHHHcC-----CCCCCCCCCCc--HHH---HHHHHHhcC-CCCCCCCHHHHhc
Q 008378 160 TCEYPYNECK--N---PAQI-YKKVTSG-----IKPASLSKVTD--PQV---KQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 160 tG~~Pf~~~~--~---~~~i-~~~i~~~-----~~p~~~~~~~s--~el---~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
||+.|..... . ...+ ...+..+ ..|.-.....+ .++ ..+..+|++ +|..||+..|+++
T Consensus 273 tgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 273 TGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred hCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 9998876432 1 1121 1222222 12221102222 233 355668886 5899999998643
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=294.88 Aligned_cols=210 Identities=27% Similarity=0.410 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-----------CCCCHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----------KNVDMKAIKNWAR 72 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-----------~~l~e~~i~~i~~ 72 (568)
+...+++.+|+++++.++||||+++++++.+. ..+++||||++||+|.+++... ..++...+..++.
T Consensus 43 e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~ 120 (932)
T PRK13184 43 PLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120 (932)
T ss_pred HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHH
Confidence 44567899999999999999999999987654 4789999999999999988642 2356678889999
Q ss_pred HHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--------------------CcccccCCCCc
Q 008378 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--------------------TARSVIGTPEF 132 (568)
Q Consensus 73 QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--------------------~~~s~~GTp~Y 132 (568)
||+.||.|||++| |+||||||+||+++ .+|.+||+|||++...... .....+||+.|
T Consensus 121 QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~Y 197 (932)
T PRK13184 121 KICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDY 197 (932)
T ss_pred HHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCC
Confidence 9999999999999 99999999999997 7899999999999765110 11235799999
Q ss_pred cCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC
Q 008378 133 MAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL 210 (568)
Q Consensus 133 mAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp 210 (568)
||||++ ...++.++|||||||++|||+||..||..........................++.+.+++.+||. +|.+|+
T Consensus 198 mAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ 277 (932)
T PRK13184 198 MAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERY 277 (932)
T ss_pred CCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCc
Confidence 999987 456899999999999999999999999764333222222111111111223567899999999996 699998
Q ss_pred CHHHHhcC
Q 008378 211 PALELLKD 218 (568)
Q Consensus 211 sa~ElL~h 218 (568)
++.+.+.+
T Consensus 278 ss~eeLl~ 285 (932)
T PRK13184 278 SSVQELKQ 285 (932)
T ss_pred CHHHHHHH
Confidence 87665543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=285.69 Aligned_cols=206 Identities=24% Similarity=0.404 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------C----CCHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------N----VDMKAIKN 69 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------~----l~e~~i~~ 69 (568)
.+..+.|.||+.+|..|+|||||+|++++... +.++||+||+..|+|.++++.+. . ++..+...
T Consensus 530 ~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~ 607 (774)
T KOG1026|consen 530 NQARQDFRREAELLAELQHPNIVRLLGVCREG--DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLH 607 (774)
T ss_pred HHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHH
Confidence 45778999999999999999999999988655 47999999999999999997442 2 78889999
Q ss_pred HHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcc----cccCCCCccCcc-ccccCCCc
Q 008378 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR----SVIGTPEFMAPE-LYEEEYNE 144 (568)
Q Consensus 70 i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~----s~~GTp~YmAPE-vl~~~ys~ 144 (568)
++.||+.|++||-++. ++||||-..|+||. ++-.|||+|||+++..-...-. ...-...||||| ++.+.|++
T Consensus 608 iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTt 684 (774)
T KOG1026|consen 608 IATQIAAGMEYLSSHH--FVHRDLATRNCLVG-ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTT 684 (774)
T ss_pred HHHHHHHHHHHHHhCc--ccccchhhhhceec-cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccc
Confidence 9999999999999998 99999999999995 8889999999999754222111 112356899999 55889999
Q ss_pred cceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 008378 145 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 216 (568)
Q Consensus 145 ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL 216 (568)
++||||||++|||+++ |.-||.+..+ +++++.+..+.- -..+...++++..|+..||+ .|.+||+..|+-
T Consensus 685 eSDVWs~GVvLWEIFsyG~QPy~glSn-~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 685 ESDVWSFGVVLWEIFSYGKQPYYGLSN-QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred hhhhhhhhhhhhhhhccccCcccccch-HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9999999999999998 9999988654 556667777655 44677889999999999996 699999999863
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=255.90 Aligned_cols=208 Identities=27% Similarity=0.468 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+.+++.++||||+++++++........++||||+.+++|.+++.+.. .+++..+..++.||+.||.|||++
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 5678999999999999999999999887766668999999999999999998765 699999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc-----ccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~-----~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
| ++||||||+||+++ .++.+||+|||++........ ....++..|+|||.+ ...++.++||||||+++|+|
T Consensus 129 ~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el 205 (284)
T cd05038 129 R--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205 (284)
T ss_pred C--eecCCCCHHhEEEc-CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence 9 99999999999997 679999999999977652211 122345679999976 45688999999999999999
Q ss_pred hhcCCCCCCCCCH--------------HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VTCEYPYNECKNP--------------AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 ltG~~Pf~~~~~~--------------~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+||..|+...... ..+...+..+... ..+...+.++.+++.+||. +|.+||++.+++.
T Consensus 206 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 206 FTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred eccCCCcccccchhccccccccccccHHHHHHHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999998653221 1122223322222 2234456889999999996 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=252.53 Aligned_cols=211 Identities=22% Similarity=0.360 Sum_probs=169.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----CeEEEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWAR 72 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----~~l~lV~Ey~~gGsL~~~i~k~------~~l~e~~i~~i~~ 72 (568)
++...+++.+|+++|+.++||||+++++++..... ...+++++|+.+|+|.+++... ..++...+..++.
T Consensus 41 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 120 (273)
T cd05074 41 SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120 (273)
T ss_pred ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence 45667889999999999999999999998865432 1347889999999999887532 2478999999999
Q ss_pred HHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccce
Q 008378 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVD 147 (568)
Q Consensus 73 QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksD 147 (568)
||+.||.|||+++ |+||||||+||+++ .++.+||+|||+++...... .....+++.|++||.+ ...++.++|
T Consensus 121 ~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sD 197 (273)
T cd05074 121 DIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSD 197 (273)
T ss_pred HHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhh
Confidence 9999999999999 99999999999997 78899999999987653221 1223456789999977 455889999
Q ss_pred ehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 148 IYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 148 IWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|||||+++|+|++ |..||... +...++..+..+... ..+...++.+.+++.+||. +|..||++.+++..
T Consensus 198 i~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 198 VWAFGVTMWEIMTRGQTPYAGV-ENSEIYNYLIKGNRL-KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred hHHHHHHHHHHhhCCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999 88898763 445566665554332 2334567899999999996 69999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=261.08 Aligned_cols=214 Identities=29% Similarity=0.407 Sum_probs=176.8
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
+....++.++|..+|..++|+|||+++.+|.-.. ...+|+||||+. ++|.+.+. -.++-.+++.++.|++.|+
T Consensus 55 n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~i 131 (369)
T KOG0665|consen 55 NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGI 131 (369)
T ss_pred cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHH
Confidence 3445678899999999999999999999885332 236899999996 79988877 4588999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
.|||+.| |+||||||+||+++ .++.+||.|||+|+..... ..+.++.|..|.|||++ ..+|.+.+||||+|||+.
T Consensus 132 k~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~g 208 (369)
T KOG0665|consen 132 KHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (369)
T ss_pred HHHHhcc--eeecccCcccceec-chhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHH
Confidence 9999999 99999999999997 7899999999999876554 45667899999999976 666999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCC---------------------------------CCC------CCCCcHHHHH
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKP---------------------------------ASL------SKVTDPQVKQ 197 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p---------------------------------~~~------~~~~s~el~~ 197 (568)
||++|...|.+....++..+.+..-..| ..+ ++.....+++
T Consensus 209 Eli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ard 288 (369)
T KOG0665|consen 209 ELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARD 288 (369)
T ss_pred HHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHH
Confidence 9999999998766666665544321100 001 1233467899
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 198 FIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 198 lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
++.+||+ +|.+|.++.++|.|||++
T Consensus 289 ll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 289 LLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHhhccChhhcccHHHHhcCCeee
Confidence 9999995 899999999999999997
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=288.33 Aligned_cols=209 Identities=21% Similarity=0.391 Sum_probs=175.0
Q ss_pred CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-------CCCCHHHHHHHHHHH
Q 008378 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------KNVDMKAIKNWARQI 74 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-------~~l~e~~i~~i~~QI 74 (568)
-+.++...|++|..+|+.++|||||++.+.+.+.. ..++++|||.||+|..|+++. ..+.......++.+|
T Consensus 734 ~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~--~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dv 811 (1025)
T KOG1095|consen 734 SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG--PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDV 811 (1025)
T ss_pred CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC--CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHH
Confidence 35788999999999999999999999999988744 578899999999999999976 358999999999999
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccc----ccCCCCccCcccc-ccCCCccceeh
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFMAPELY-EEEYNELVDIY 149 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s----~~GTp~YmAPEvl-~~~ys~ksDIW 149 (568)
++|++||++++ +|||||.+.|+|++ ....|||+|||+|+.+-...-.. -.-...|||||.+ .+.|+.++|||
T Consensus 812 A~G~~YLe~~~--fvHRDLAaRNCLL~-~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvW 888 (1025)
T KOG1095|consen 812 AKGMNYLESKH--FVHRDLAARNCLLD-ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVW 888 (1025)
T ss_pred hhhhHHHHhCC--CcCcchhhhheeec-ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchh
Confidence 99999999998 99999999999998 66899999999999543221111 1224579999977 57799999999
Q ss_pred hhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 150 SFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 150 SLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||+++||++| |..||.+..+.+.+......| .-..+...+..+.++|..||+ +|.+||+...+++
T Consensus 889 sFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 889 SFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999 899998866555554455555 223456667778899999996 7999999999887
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=256.92 Aligned_cols=216 Identities=28% Similarity=0.435 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHHH-HHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-----KHKNVDMKAIKNWARQILRG 77 (568)
Q Consensus 4 ~~~~e~l~~Ei~i-Lk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~-----k~~~l~e~~i~~i~~QIl~g 77 (568)
..+.++|+.|... |+.=+-||||+||+..+.++ -.|+.||+++ .+|..+.+ +...++|..+-.+..-.+.|
T Consensus 103 ~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~A 179 (361)
T KOG1006|consen 103 EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDA 179 (361)
T ss_pred hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhH
Confidence 5678899999985 55558899999999988765 4788999996 67766433 45679999999999999999
Q ss_pred HHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccc-cCCCCccCccccc---cCCCccceehhhHH
Q 008378 78 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE---EEYNELVDIYSFGM 153 (568)
Q Consensus 78 L~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~-~GTp~YmAPEvl~---~~ys~ksDIWSLGi 153 (568)
|.||-..- .|||||+||+|||++ ..|.|||||||++-.+..+.+.+. .|-..|||||.+. .+|+.++|+||||+
T Consensus 180 L~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGI 257 (361)
T KOG1006|consen 180 LDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGI 257 (361)
T ss_pred HHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcc
Confidence 99996532 299999999999998 789999999999988877766655 7889999999873 45999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC-CC---CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SK---VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~-~~---~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+|||++||.+||.+-.+.-+-...+..|-+|.-. +. ..+..++.||.-||. +.+.||...+|+++||++.-
T Consensus 258 TL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 258 TLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred eEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 9999999999998754443344445555554432 22 257899999999995 68999999999999999753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=287.52 Aligned_cols=179 Identities=32% Similarity=0.536 Sum_probs=145.1
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhh
Q 008378 39 TINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117 (568)
Q Consensus 39 ~l~lV~Ey~~gGsL~~~i~k~~~l-~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~ 117 (568)
.+|+=||||+.-+|++++...... .....+++++||+.||.|+|+.| ||||||||.|||++ .++.|||+|||+|+.
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd-~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLD-SRNSVKIGDFGLATD 746 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEc-CCCCeeecccccchh
Confidence 578889999988888888766544 57889999999999999999999 99999999999998 788999999999976
Q ss_pred cc----------C----------CCcccccCCCCccCccccc--c--CCCccceehhhHHHHHHHhhcCCCCCCCCCHHH
Q 008378 118 MQ----------Q----------PTARSVIGTPEFMAPELYE--E--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 173 (568)
Q Consensus 118 ~~----------~----------~~~~s~~GTp~YmAPEvl~--~--~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~ 173 (568)
.. . +..++.+||.-|+|||++. . .|+.|+|+||||||++||+ +||.-.-....
T Consensus 747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~ 823 (1351)
T KOG1035|consen 747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERAS 823 (1351)
T ss_pred hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHH
Confidence 21 0 1234568999999999983 2 5999999999999999998 57865545556
Q ss_pred HHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 174 IYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 174 i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
+...+..+.-|.. +....-+.-..+|..+++ +|++||||.|||++.||..
T Consensus 824 iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 824 ILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 6666666655544 222223567789999997 7999999999999999973
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=249.34 Aligned_cols=213 Identities=23% Similarity=0.385 Sum_probs=170.6
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEc------CCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVD------DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~------~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
...+|+++|..|+|+|++.+.+.+.. .....+|+|+.+|+ -+|.-++... .+++..+|++++++++.||.|+
T Consensus 62 talreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i 140 (376)
T KOG0669|consen 62 TALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI 140 (376)
T ss_pred HHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHH
Confidence 34689999999999999998875532 22346999999997 4788877655 5799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc------ccccCCCCccCcccc--ccCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPEFMAPELY--EEEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~------~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGi 153 (568)
|... |+|||+|+.|+||+ .+|.+||+|||+++.+..+.. +..+.|.+|++||++ .++|+++.|||..||
T Consensus 141 Hr~k--ilHRDmKaaNvLIt-~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgC 217 (376)
T KOG0669|consen 141 HRNK--ILHRDMKAANVLIT-KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGC 217 (376)
T ss_pred HHhh--HHhhcccHhhEEEc-CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHH
Confidence 9998 99999999999998 789999999999987643321 122569999999966 677999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHH--cCCCCCCC------------------------------CCCCcHHHHHHHHH
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVT--SGIKPASL------------------------------SKVTDPQVKQFIEK 201 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~--~~~~p~~~------------------------------~~~~s~el~~lI~k 201 (568)
|+.||+|+.+-+.+.++..++...-. ....+..| +.+.++++.+++++
T Consensus 218 imaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ 297 (376)
T KOG0669|consen 218 IMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEK 297 (376)
T ss_pred HHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHH
Confidence 99999999998988666555432211 11111111 12346789999999
Q ss_pred hcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 202 CIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 202 cL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|. +|.+|+.++++|.|.||.++.
T Consensus 298 ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 298 LLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred HhccCcccCcchHhhhchhhhhcCC
Confidence 996 899999999999999998653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=235.32 Aligned_cols=210 Identities=25% Similarity=0.448 Sum_probs=168.7
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
...+||-+|+.|+|.|||++++....+ +.+.+|+|||. .+|..|... .+.++.+.++.++.|++.||.|+|+++
T Consensus 47 salreicllkelkhknivrl~dvlhsd--kkltlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn-- 121 (292)
T KOG0662|consen 47 SALREICLLKELKHKNIVRLHDVLHSD--KKLTLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN-- 121 (292)
T ss_pred HHHHHHHHHHHhhhcceeehhhhhccC--ceeEEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--
Confidence 467999999999999999999976443 46888999997 688888775 477999999999999999999999999
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccc--ccCCCccceehhhHHHHHHHhh-cC
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT-CE 162 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGiilyEmlt-G~ 162 (568)
+.||||||+|++++ .+|.+|++|||+++.+.-+. ....+.|.+|.+|.++ ..-|++..|+||.|||+.|+.. |.
T Consensus 122 vlhrdlkpqnllin-~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagr 200 (292)
T KOG0662|consen 122 VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_pred hhhccCCcceEEec-cCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCC
Confidence 99999999999998 89999999999999886553 2344679999999987 4459999999999999999987 66
Q ss_pred CCCCCCCCHHHHHHHHHcCCCC--CCCC------------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 008378 163 YPYNECKNPAQIYKKVTSGIKP--ASLS------------------------KVTDPQVKQFIEKCIV-PASLRLPALEL 215 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p--~~~~------------------------~~~s~el~~lI~kcL~-~p~~Rpsa~El 215 (568)
+.|.+..-.+++.+.+..--.| ..|+ ...+..-++++.++|. +|.+|.+|++.
T Consensus 201 plfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa 280 (292)
T KOG0662|consen 201 PLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA 280 (292)
T ss_pred CCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH
Confidence 6676654455554444321111 0010 1122456899999996 79999999999
Q ss_pred hcCCCCCCC
Q 008378 216 LKDPFLVTD 224 (568)
Q Consensus 216 L~hpff~~~ 224 (568)
++||||...
T Consensus 281 lqhpyf~d~ 289 (292)
T KOG0662|consen 281 LQHPYFSDF 289 (292)
T ss_pred hcCcccccc
Confidence 999999753
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=251.66 Aligned_cols=199 Identities=22% Similarity=0.263 Sum_probs=155.2
Q ss_pred HHHHHHHhCCCCCeeeeeeEEEcCCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeE
Q 008378 12 SEVHLLKSLKHENIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 89 (568)
Q Consensus 12 ~Ei~iLk~L~HpNIV~l~~~~~~~~~--~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~Ii 89 (568)
.+...+..+.|+||+++++.+..... ...+++++++. .++.+++......++..++.++.||+.||.|||+++ ++
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ii 148 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--IS 148 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 44456677899999999987654432 24567888874 577777777666889999999999999999999999 99
Q ss_pred eeeccCCcEEEeCCCCcEEEeecChhhhccCC---------CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 90 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 90 HRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
||||||+|||++ .++.+||+|||+++.+... ......||+.|+|||+.. ..|+.++|||||||++|||+
T Consensus 149 HrDiKp~Nill~-~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 149 HGDIKPENIMVD-GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred cCCCCHHHEEEc-CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999997 6789999999999765311 122347999999999874 55899999999999999999
Q ss_pred hcCCCCCCCCCHHHH--------HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 160 TCEYPYNECKNPAQI--------YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i--------~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|..||........+ .+.+..+. ......++++.+++..|+. +|.+||+..++++
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 999999876333222 22222221 1223457899999999995 7999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=241.70 Aligned_cols=216 Identities=24% Similarity=0.422 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
|-..+.+.+|+.+|+.|. |||||++++...+.......+|+||+++-+...+.. .++...++.++.|++.||.|||
T Consensus 73 PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCH 149 (338)
T KOG0668|consen 73 PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCH 149 (338)
T ss_pred hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHH
Confidence 567789999999999997 999999999998888888899999999888776654 4788899999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccc-cCCCCccCcccc--ccCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~-~GTp~YmAPEvl--~~~ys~ksDIWSLGiilyEml 159 (568)
+.| |+|||+||.|++++.....++|+|+|||..........+ +.+..|--||++ -+.|+..-|+|||||.+..|+
T Consensus 150 S~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~mi 227 (338)
T KOG0668|consen 150 SMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 227 (338)
T ss_pred hcC--cccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHH
Confidence 999 999999999999997788999999999998866544333 567788999987 456999999999999999999
Q ss_pred hcCCCC-CCCCCHHHHHHHHHc---------------CCCC-------------------CCCCCCCcHHHHHHHHHhcC
Q 008378 160 TCEYPY-NECKNPAQIYKKVTS---------------GIKP-------------------ASLSKVTDPQVKQFIEKCIV 204 (568)
Q Consensus 160 tG~~Pf-~~~~~~~~i~~~i~~---------------~~~p-------------------~~~~~~~s~el~~lI~kcL~ 204 (568)
..+.|| .+..+.+|+.+...- ...| ..-....+|++.+|+.++|.
T Consensus 228 FrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLr 307 (338)
T KOG0668|consen 228 FRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLR 307 (338)
T ss_pred hccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHh
Confidence 998887 455677777544220 0000 00112347999999999997
Q ss_pred -CCCCCCCHHHHhcCCCCCCC
Q 008378 205 -PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 205 -~p~~Rpsa~ElL~hpff~~~ 224 (568)
+..+|+||.|.+.||||...
T Consensus 308 YDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 308 YDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred hccccccchHHHhcCchHHHH
Confidence 78999999999999999753
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=274.75 Aligned_cols=166 Identities=31% Similarity=0.532 Sum_probs=142.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILR 76 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k---~~~l~e~~i~~i~~QIl~ 76 (568)
....++.-+|+++||+|+|||||++++.-.... ...-.+|||||.||+|+.++++ +.+|++.++..++..+..
T Consensus 52 ~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~ 131 (732)
T KOG4250|consen 52 LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVS 131 (732)
T ss_pred cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHH
Confidence 456788999999999999999999999543333 2345789999999999999985 457999999999999999
Q ss_pred HHHhhhhCCCCeEeeeccCCcEEEe-CCCC--cEEEeecChhhhccC-CCcccccCCCCccCccccc--cCCCccceehh
Q 008378 77 GLHYLHSHNPPIIHRDLKCDNIFVN-GNNG--EVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYE--EEYNELVDIYS 150 (568)
Q Consensus 77 gL~yLHs~g~~IiHRDLKp~NILl~-~~~g--~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWS 150 (568)
||.|||.+| |+||||||+||++- |.+| .-||+|||.|+.+.. ....+++||+.|.+||+++ +.|+..+|.||
T Consensus 132 al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS 209 (732)
T KOG4250|consen 132 ALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWS 209 (732)
T ss_pred HHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhh
Confidence 999999999 99999999999974 3444 369999999998864 4567899999999999997 46899999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCH
Q 008378 151 FGMCILEMVTCEYPYNECKNP 171 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~ 171 (568)
|||++|+++||..||-....+
T Consensus 210 ~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 210 FGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred hhhHHHHHhccCCCCCcCCCc
Confidence 999999999999999554333
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=250.19 Aligned_cols=226 Identities=18% Similarity=0.369 Sum_probs=185.7
Q ss_pred CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
..++++-+..|-++..+- +||.+|.++..|..+. .+++|.||++||+|--++++.++++++.++.+..+|+.||.||
T Consensus 290 ddedidwvqtek~vfe~asn~pflvglhscfqtes--rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~fl 367 (593)
T KOG0695|consen 290 DDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES--RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFL 367 (593)
T ss_pred CcccchhHHhhHHHHHhccCCCeEEehhhhhcccc--eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHH
Confidence 345566677788888877 8999999999887654 6999999999999999999999999999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
|++| ||+||||.+|+|++ ..|++|+.|+|..+.-- .....+++|||.|+|||+++ ..|+..+|+|+||++|+||
T Consensus 368 h~rg--iiyrdlkldnvlld-aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfem 444 (593)
T KOG0695|consen 368 HERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 444 (593)
T ss_pred hhcC--eeeeeccccceEEc-cCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHH
Confidence 9999 99999999999998 78999999999987542 33456789999999999885 5699999999999999999
Q ss_pred hhcCCCCCC-------CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC------HHHHhcCCCCCCC
Q 008378 159 VTCEYPYNE-------CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP------ALELLKDPFLVTD 224 (568)
Q Consensus 159 ltG~~Pf~~-------~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps------a~ElL~hpff~~~ 224 (568)
+.|+.||.- .+..+.+++.|... ...++...+-.+..+++..|. +|.+|.. ..++..|+||+..
T Consensus 445 magrspfdivgm~n~d~ntedylfqvilek--qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 445 MAGRSPFDIVGMDNPDMNTEDYLFQVILEK--QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred HcCCCCcceecCCCcccchhHHHHHHHhhh--cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 999999942 23345566666543 233455556666777777775 6888864 5789999999988
Q ss_pred CCCCcccCCCC
Q 008378 225 NPKDLVCDPLR 235 (568)
Q Consensus 225 ~~~~l~~~~l~ 235 (568)
.|..+.++...
T Consensus 523 dwd~leqk~v~ 533 (593)
T KOG0695|consen 523 DWDLLEQKQVL 533 (593)
T ss_pred CHHHHhhcccC
Confidence 88766555443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=273.02 Aligned_cols=211 Identities=27% Similarity=0.393 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCH---HHHHHHHHHHHHHHHh
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDM---KAIKNWARQILRGLHY 80 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e---~~i~~i~~QIl~gL~y 80 (568)
.-+...+||++|+.- +|||||+||+ .+.+..++|+..|+|. .+|.+|+..++ .+.. -..+.++.|+..||++
T Consensus 545 ~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaH 621 (903)
T KOG1027|consen 545 FFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAH 621 (903)
T ss_pred hHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHH
Confidence 345678999999999 7999999998 4556679999999997 69999999851 1111 3457889999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCC----CCcEEEeecChhhhccCCC-----cccccCCCCccCcccccc-CCCccceehh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGN----NGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYS 150 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~----~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~~-~ys~ksDIWS 150 (568)
||+.+ |+||||||+||||+.. ..+++|+|||+++.+.... ..+..||-+|+|||++.. .-..++||+|
T Consensus 622 LHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFs 699 (903)
T KOG1027|consen 622 LHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFS 699 (903)
T ss_pred HHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhh
Confidence 99999 9999999999999852 2478999999998875432 335679999999998844 3566999999
Q ss_pred hHHHHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 151 FGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 151 LGiilyEmltG-~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|||++|+.++| ..||... .+.-...+........+....+-++++||.+||. +|..||+|.++|.||||-.
T Consensus 700 lGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 700 LGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred cCceEEEEecCCccCCCch--HHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 99999999996 8999652 2222233333222222333333499999999997 6999999999999999965
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=262.14 Aligned_cols=206 Identities=26% Similarity=0.475 Sum_probs=174.4
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yL 81 (568)
++++.+.|..|.-+|+.++|||||++++.+++. .+|+|||+++-|.|+.|++..+ .++......++.||+.||.||
T Consensus 431 t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYL 507 (974)
T KOG4257|consen 431 TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYL 507 (974)
T ss_pred ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHH
Confidence 477889999999999999999999999988654 5999999999999999999775 699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
|+.+ ++||||-..|||+. ..--||++||||++.+....- ....-..-|||||-+ -+.++.++|||-||+|+||
T Consensus 508 eSkr--fVHRDIAaRNiLVs-Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWE 584 (974)
T KOG4257|consen 508 ESKR--FVHRDIAARNILVS-SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWE 584 (974)
T ss_pred Hhhc--hhhhhhhhhheeec-CcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHH
Confidence 9999 99999999999997 566899999999998865432 222234469999977 5779999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 216 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL 216 (568)
++. |.-||.+-.+.+.|. .+..|.+++ .+..++|.+..++.+||+ +|.+||...++.
T Consensus 585 Il~lGvkPfqgvkNsDVI~-~iEnGeRlP-~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 585 ILSLGVKPFQGVKNSDVIG-HIENGERLP-CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHhcCCccccccccceEE-EecCCCCCC-CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 887 999998866655543 344554433 566788999999999997 799999987653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=268.80 Aligned_cols=187 Identities=23% Similarity=0.316 Sum_probs=138.6
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccC
Q 008378 36 TNRTINMITELFTSGSLRQYRKKHKN--------------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 95 (568)
Q Consensus 36 ~~~~l~lV~Ey~~gGsL~~~i~k~~~--------------------l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp 95 (568)
....+++|+||+.+++|.+++..... .....+..++.||+.||.|||+++ |+||||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP 283 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKP 283 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCH
Confidence 44578999999999999998875421 123457789999999999999999 99999999
Q ss_pred CcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCccccc-----------------------cCCCccceeh
Q 008378 96 DNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE-----------------------EEYNELVDIY 149 (568)
Q Consensus 96 ~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~-----------------------~~ys~ksDIW 149 (568)
+|||++..++.+||+|||+++.+... ....++||+.|||||.+. ..++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 99999855789999999999865332 235678999999999652 1244567999
Q ss_pred hhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-------------CCCC------CCCCCcHHHHHHHHHhcC-CCCCC
Q 008378 150 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-------------KPAS------LSKVTDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 150 SLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~-------------~p~~------~~~~~s~el~~lI~kcL~-~p~~R 209 (568)
||||++|||+++..|+.. ...++.+.+.... .... .....+....+||.+||+ +|.+|
T Consensus 364 SlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999998776542 2223322222110 0000 011123345689999996 79999
Q ss_pred CCHHHHhcCCCCCCCCC
Q 008378 210 LPALELLKDPFLVTDNP 226 (568)
Q Consensus 210 psa~ElL~hpff~~~~~ 226 (568)
||+.++|+||||+....
T Consensus 442 ~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 442 ISAKAALAHPYFDREGL 458 (566)
T ss_pred CCHHHHhCCcCcCCCCc
Confidence 99999999999987654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=254.31 Aligned_cols=204 Identities=26% Similarity=0.437 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~--l~e~~i~~i~~QIl~gL~yLH 82 (568)
-.+++|++|..+|+.++|||+|++.++|..+. .+|+|+|||..|+|.+|++.+.+ ++.-.+...+.||..|++||.
T Consensus 305 MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep--PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE 382 (1157)
T KOG4278|consen 305 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP--PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE 382 (1157)
T ss_pred hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC--CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999999886554 69999999999999999997753 666667788999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccC---CCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~G---Tp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
.++ +|||||-..|+|+. .+..|||+||||++.+....-+...| ..-|.|||-+ ...++.++|||+||++|||+
T Consensus 383 kkn--FIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEI 459 (1157)
T KOG4278|consen 383 KKN--FIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 459 (1157)
T ss_pred Hhh--hhhhhhhhhhcccc-ccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHH
Confidence 999 99999999999994 88899999999999997654333333 3469999976 56799999999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL 215 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~El 215 (568)
+| |-.||.+ .+..++|..+..+.... -+..++|.+.+|+..||+ .|+.||+..|+
T Consensus 460 ATYGMsPYPG-idlSqVY~LLEkgyRM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 460 ATYGMSPYPG-IDLSQVYGLLEKGYRMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HhcCCCCCCC-ccHHHHHHHHhcccccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 99 7788977 67889999988886654 345678899999999998 69999998764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=230.38 Aligned_cols=177 Identities=27% Similarity=0.500 Sum_probs=150.3
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~----i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
.+..+++++|+.+-... ..|.+|.||+...++. .+|+.||.+. -+|..+ +++.+.++|..+-+++..++.||
T Consensus 85 ~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al 161 (282)
T KOG0984|consen 85 SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHAL 161 (282)
T ss_pred hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHH
Confidence 45677888999865555 7899999999887765 4888899996 577665 44667899999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccc-ccCCCCccCccccc-----cCCCccceehhhH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYE-----EEYNELVDIYSFG 152 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s-~~GTp~YmAPEvl~-----~~ys~ksDIWSLG 152 (568)
.|||++= .+||||+||+|||+| ..|+|||||||++-.+..+.+.+ -.|-..|||||.+. .+|+.++||||||
T Consensus 162 ~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLG 239 (282)
T KOG0984|consen 162 EFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLG 239 (282)
T ss_pred HHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhh
Confidence 9999873 399999999999998 78999999999999888877777 47888999999773 3699999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 008378 153 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 185 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~ 185 (568)
++++||+++++||..-..+-+..+.+.....|.
T Consensus 240 ItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 240 ITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred hhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 999999999999988777877777777665543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=255.37 Aligned_cols=207 Identities=23% Similarity=0.383 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.....|.+||++|.+|+|||||+++++|+.++ .+++||||+++|+|.+|+.++. .+.-....+++.||..|++||.
T Consensus 577 ~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe 654 (807)
T KOG1094|consen 577 NARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE 654 (807)
T ss_pred hHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH
Confidence 44578999999999999999999999998665 6999999999999999999984 3344556679999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc----ccccCCCCccCcc-ccccCCCccceehhhHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~----~s~~GTp~YmAPE-vl~~~ys~ksDIWSLGiilyE 157 (568)
+.+ ++||||.+.|+|++ ..+++||+|||.++-+-...- ...+-...||||| ++.++++.++|+|+||+++||
T Consensus 655 s~n--fVHrd~a~rNcLv~-~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE 731 (807)
T KOG1094|consen 655 SLN--FVHRDLATRNCLVD-GEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 731 (807)
T ss_pred hhc--hhhccccccceeec-CcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHH
Confidence 999 99999999999997 678999999999986543322 2335567899999 558999999999999999999
Q ss_pred Hhh--cCCCCCCCCCHHHHHHHHH---cCCCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 158 MVT--CEYPYNECKNPAQIYKKVT---SGIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 158 mlt--G~~Pf~~~~~~~~i~~~i~---~~~~p~---~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+++ .+.||+...+.+ +..... ....+. ..+...+..+.++|..|+. +..+||+.+++-.
T Consensus 732 ~~~~C~e~Py~~lt~e~-vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 732 VFMLCREQPYSQLTDEQ-VVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHhhCchhhhhHHH-HHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 865 789998765443 333322 222221 2355678889999999995 7889999999744
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-28 Score=280.01 Aligned_cols=201 Identities=19% Similarity=0.223 Sum_probs=150.0
Q ss_pred HHhCCC-CCeeeeeeEEEcC-----CCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCCCeE
Q 008378 17 LKSLKH-ENIIKFYNSWVDD-----TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPII 89 (568)
Q Consensus 17 Lk~L~H-pNIV~l~~~~~~~-----~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~~Ii 89 (568)
.+.++| +||++++++|... ....+++++||+ +++|.+++... ..+++..++.+++||+.||.|||++| |+
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--Iv 102 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IV 102 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 456678 7899999987211 123677888987 57999999753 56999999999999999999999999 99
Q ss_pred eeeccCCcEEEeC------------------CCCcEEEeecChhhhccCC------------------CcccccCCCCcc
Q 008378 90 HRDLKCDNIFVNG------------------NNGEVKIGDLGLAIVMQQP------------------TARSVIGTPEFM 133 (568)
Q Consensus 90 HRDLKp~NILl~~------------------~~g~vKI~DFGla~~~~~~------------------~~~s~~GTp~Ym 133 (568)
||||||+||||+. .++.+||+|||+++..... .....+||++||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999951 3456777788877542110 011246899999
Q ss_pred Ccccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC
Q 008378 134 APELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP 211 (568)
Q Consensus 134 APEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps 211 (568)
|||++ ...|+.++|||||||++|||++|..|+... ......+.....|.... ...+....++.+||. +|.+||+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcC
Confidence 99976 566999999999999999999998887532 22222222222222211 124567889999996 6999999
Q ss_pred HHHHhcCCCCCCC
Q 008378 212 ALELLKDPFLVTD 224 (568)
Q Consensus 212 a~ElL~hpff~~~ 224 (568)
+.|+|+||||...
T Consensus 259 ~~eil~h~~~~~~ 271 (793)
T PLN00181 259 MSELLQSEFINEP 271 (793)
T ss_pred hHHHhhchhhhhh
Confidence 9999999999763
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=261.72 Aligned_cols=208 Identities=25% Similarity=0.432 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~~ 66 (568)
..+.+.+..|+.+|+.+ +||||+.+.+++.. ...+++|+|||..|+|..|+++.+ .++...
T Consensus 342 ~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~d 419 (609)
T KOG0200|consen 342 SSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKD 419 (609)
T ss_pred cHHHHHHHHHHHHHHHhcCCcchhhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHH
Confidence 36778999999999999 79999999998876 457999999999999999998766 388899
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccc---ccC--CCCccCcccc-cc
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIG--TPEFMAPELY-EE 140 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s---~~G--Tp~YmAPEvl-~~ 140 (568)
+..++.||+.|++||++.. ++||||-+.|||+. .+..+||+|||+|+......... -.| ...|||||.+ ..
T Consensus 420 Llsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~ 496 (609)
T KOG0200|consen 420 LLSFAYQIANGMEYLASVP--CVHRDLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR 496 (609)
T ss_pred HHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC
Confidence 9999999999999999998 99999999999997 67799999999998654433222 222 2349999977 45
Q ss_pred CCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 141 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 141 ~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
.|+.++||||||+++||++| |..||.+......+++.+..|.+... +...++++.++++.||. +|.+||+..++..
T Consensus 497 ~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~-P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 497 VFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQ-PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred cccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 79999999999999999999 89999886656777888888877653 44558999999999996 7999999988654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=254.16 Aligned_cols=211 Identities=25% Similarity=0.419 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k--~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+..|++|+.+|.+|+|||+|++|+...+. .+.||||++++|+|.+.+.+ ...|-...+..|+.||+.|+.||.+
T Consensus 154 ~mddflrEas~M~~L~H~hliRLyGvVl~q---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes 230 (1039)
T KOG0199|consen 154 IMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES 230 (1039)
T ss_pred hHHHHHHHHHHHHhccCcceeEEeeeeccc---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh
Confidence 578899999999999999999999987653 58899999999999998887 2468899999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccccc-----CCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-----GTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~-----GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
++ +|||||-..|+++- .-..|||+||||.+.+.......+. ....|.|||-+ .+.++.++|+|+||+++||
T Consensus 231 kr--lvHRDLAARNllla-sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWE 307 (1039)
T KOG0199|consen 231 KR--LVHRDLAARNLLLA-SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWE 307 (1039)
T ss_pred hh--hhhhhhhhhhheec-ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHh
Confidence 99 99999999999996 5678999999999988655433332 24469999977 6779999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|+| |+.||.++ ...+|.+.|..+.... -++.++..+.+++..||. +|.+||+...|...-++...
T Consensus 308 MFtyGEePW~G~-~g~qIL~~iD~~erLp-RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 308 MFTYGEEPWVGC-RGIQILKNIDAGERLP-RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred hhccCCCCCCCC-CHHHHHHhccccccCC-CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 999 89999885 5778888887554332 456778999999999997 69999999988766555543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=252.01 Aligned_cols=211 Identities=22% Similarity=0.390 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHhCC------CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHH
Q 008378 8 ERLYSEVHLLKSLK------HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGL 78 (568)
Q Consensus 8 e~l~~Ei~iLk~L~------HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~---~l~e~~i~~i~~QIl~gL 78 (568)
+.=++|+++|++|+ .-++++||-.|... +.++||+|.+. .+|+..+++.+ .|...+++.|+.|++.||
T Consensus 473 KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk--nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflAL 549 (752)
T KOG0670|consen 473 KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK--NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLAL 549 (752)
T ss_pred hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc--ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHH
Confidence 44578999999996 35899999888544 57999999994 89999999876 488999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
..|-..| |+|.||||+||||+.....+||||||.|........+.+..+..|.|||++ .-.|+...|+||.||+|||
T Consensus 550 klLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYE 627 (752)
T KOG0670|consen 550 KLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYE 627 (752)
T ss_pred HHHHhcC--eeecccCccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEE
Confidence 9999999 999999999999997777899999999987766666666777889999976 5679999999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHH-cCCCCCC-----------C---------------------------C----------
Q 008378 158 MVTCEYPYNECKNPAQIYKKVT-SGIKPAS-----------L---------------------------S---------- 188 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~-~~~~p~~-----------~---------------------------~---------- 188 (568)
|.||+..|.+.++...+.-.+. .|..|.. + +
T Consensus 628 lYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~ 707 (752)
T KOG0670|consen 628 LYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA 707 (752)
T ss_pred eeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc
Confidence 9999999999877665532211 1111100 0 0
Q ss_pred --CC------CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 189 --KV------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 189 --~~------~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
.. .-.++++|+.+||. +|.+|.|..++|+||||+.
T Consensus 708 ~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 708 VQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred cCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 00 01368899999995 8999999999999999974
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=259.09 Aligned_cols=216 Identities=27% Similarity=0.509 Sum_probs=186.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
+..-+..|+-+++.++|||||.||+++.... .+|++||||.+|+|.+.-.-.+.+++.++...+++.+.||+|||+.|
T Consensus 55 d~~~iqqei~~~~dc~h~nivay~gsylr~d--klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g 132 (829)
T KOG0576|consen 55 DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD--KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG 132 (829)
T ss_pred cccccccceeeeecCCCcChHHHHhhhhhhc--CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC
Confidence 3445667999999999999999999887554 58889999999999998888899999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc----ccCCCccceehhhHHHHHHHh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl----~~~ys~ksDIWSLGiilyEml 159 (568)
-+|||||-.||+++ +.|.||++|||.+..++.. ..++++|||.|||||+- .++|+.++|||++|++..|+.
T Consensus 133 --k~hRdiKGanillt-d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~ 209 (829)
T KOG0576|consen 133 --KIHRDIKGANILLT-DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELG 209 (829)
T ss_pred --cccccccccceeec-ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhh
Confidence 89999999999997 8899999999999877544 45688999999999976 467999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
--+.|-..--....++-.-+++..|+.+.. ..++.+-+|++.+|. .|.+||+++.+|.|||......
T Consensus 210 eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~ 279 (829)
T KOG0576|consen 210 ELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLS 279 (829)
T ss_pred hcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchh
Confidence 988887664445556666677777765532 357899999999995 6999999999999999876543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=218.92 Aligned_cols=160 Identities=26% Similarity=0.352 Sum_probs=128.1
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccC
Q 008378 50 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 128 (568)
Q Consensus 50 GsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~G 128 (568)
|+|.+++.+. +.+++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeeccc---cCCC
Confidence 7899999874 46999999999999999999999986 99999997 7889999 9998765432 2368
Q ss_pred CCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC-----CCCCcH--HHHHHHH
Q 008378 129 TPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-----SKVTDP--QVKQFIE 200 (568)
Q Consensus 129 Tp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~-----~~~~s~--el~~lI~ 200 (568)
|+.|||||++ ...|+.++|||||||++|||+||+.||............+.....+... ....+. +++++|.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 9999999987 4568999999999999999999999997655444444444433222211 111222 6999999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 201 KCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 201 kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
+||. +|.+||++.+++.|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 9996 7999999999999999764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=256.65 Aligned_cols=209 Identities=24% Similarity=0.422 Sum_probs=176.3
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
++++...|+.|..||-++.|||||++-++.. ..+.+.+|+|||++|+|+.+++++ +.|..-++...++-|+.|++||
T Consensus 670 tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYL 747 (996)
T KOG0196|consen 670 TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYL 747 (996)
T ss_pred cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHH
Confidence 4778899999999999999999999999653 445899999999999999999876 6799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--ccccc---CCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVI---GTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~---GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
-..| ++||||-..|||+| .+-..|++||||++.+.... ..+.. ....|.|||.+ .++++.++|||||||+|
T Consensus 748 sdm~--YVHRDLAARNILVN-snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVm 824 (996)
T KOG0196|consen 748 SDMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 824 (996)
T ss_pred hhcC--chhhhhhhhheeec-cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEE
Confidence 9999 99999999999998 67789999999999885443 22222 24579999977 68899999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
||.++ |+.||.+..|.+ +++.|..+...+ .+-..+..+-+|+..||+ +...||...+++.+
T Consensus 825 WEVmSyGERPYWdmSNQd-VIkaIe~gyRLP-pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 825 WEVMSYGERPYWDMSNQD-VIKAIEQGYRLP-PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred EEecccCCCcccccchHH-HHHHHHhccCCC-CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 99665 999999876654 556666665533 234567899999999997 58999999998764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=236.80 Aligned_cols=211 Identities=19% Similarity=0.339 Sum_probs=162.9
Q ss_pred HHHHHHHHHHHHhCCC--C----CeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSLKH--E----NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~H--p----NIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL 78 (568)
.+..+-|+++|+++.+ | -+|.+.++|.- .+.+++|+|.+ |-|+.++++.+ .+++...++.+++||+.++
T Consensus 129 reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv 205 (415)
T KOG0671|consen 129 REAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESV 205 (415)
T ss_pred hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHH
Confidence 3455669999999943 2 36667666533 34799999998 56999999875 4699999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCC-------------------CCcEEEeecChhhhccCCCcccccCCCCccCcccc-
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGN-------------------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY- 138 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~-------------------~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl- 138 (568)
+|||+.+ ++|.||||+|||+... +-.|||+|||.|+.-... ..+++.|..|.|||++
T Consensus 206 ~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-hs~iVsTRHYRAPEViL 282 (415)
T KOG0671|consen 206 AFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-HSTIVSTRHYRAPEVIL 282 (415)
T ss_pred HHHHhcc--eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-cceeeeccccCCchhee
Confidence 9999999 9999999999998421 235899999999765333 3667899999999976
Q ss_pred ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHH--HHHHHcCCCCCC-----------------CC-----------
Q 008378 139 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--YKKVTSGIKPAS-----------------LS----------- 188 (568)
Q Consensus 139 ~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i--~~~i~~~~~p~~-----------------~~----------- 188 (568)
.-+.+..+||||+||||+|+.||...|..-.+.+.+ +++|... .|.. |+
T Consensus 283 gLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp-~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v 361 (415)
T KOG0671|consen 283 GLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGP-IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYV 361 (415)
T ss_pred ccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCC-CcHHHhhhhhhHhhhhcccccCccccccccchhh
Confidence 667999999999999999999999999776655533 2222221 1110 00
Q ss_pred -----------CCC---cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 189 -----------KVT---DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 189 -----------~~~---s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
... ..++-+||+++|. +|++|+|+.|+|.||||...
T Consensus 362 ~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 362 FEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred hcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 001 1357789999996 89999999999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=247.47 Aligned_cols=211 Identities=23% Similarity=0.310 Sum_probs=152.5
Q ss_pred HHHHHHHHHhCCCCCe-----eeeeeEEEcC------CCCeEEEEEecCCCCCHHHHHHhC-------------------
Q 008378 10 LYSEVHLLKSLKHENI-----IKFYNSWVDD------TNRTINMITELFTSGSLRQYRKKH------------------- 59 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNI-----V~l~~~~~~~------~~~~l~lV~Ey~~gGsL~~~i~k~------------------- 59 (568)
...|+.++.+++|.++ ++++++|... .....++|+||+.+|+|.+++...
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 3457778888877655 6677766432 124689999999999999988642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cc--cccCCCC
Q 008378 60 -----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-AR--SVIGTPE 131 (568)
Q Consensus 60 -----~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~--s~~GTp~ 131 (568)
..+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++....... .. ...+||.
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~ 375 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR 375 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcc
Confidence 12456788999999999999999999 99999999999997 67899999999997653322 11 2245899
Q ss_pred ccCccccccC---------------------CC--ccceehhhHHHHHHHhhcCC-CCCCCCCH----------HHHHHH
Q 008378 132 FMAPELYEEE---------------------YN--ELVDIYSFGMCILEMVTCEY-PYNECKNP----------AQIYKK 177 (568)
Q Consensus 132 YmAPEvl~~~---------------------ys--~ksDIWSLGiilyEmltG~~-Pf~~~~~~----------~~i~~~ 177 (568)
|+|||++... |+ .+.||||+||++|+|++|.. ||...... ...++.
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 9999976321 22 35799999999999999885 76532111 111122
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcCC-C---CCCCCHHHHhcCCCCCC
Q 008378 178 VTSGIKPASLSKVTDPQVKQFIEKCIVP-A---SLRLPALELLKDPFLVT 223 (568)
Q Consensus 178 i~~~~~p~~~~~~~s~el~~lI~kcL~~-p---~~Rpsa~ElL~hpff~~ 223 (568)
+.............++..++|+.++|.. | .+|+|+.|+|.||||..
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 2222222223345678999999999963 3 68999999999999953
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-27 Score=234.67 Aligned_cols=220 Identities=26% Similarity=0.458 Sum_probs=173.1
Q ss_pred CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~---~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
|+-..-+++++|+++|..++|.|++...+...-..- ..+|+|+|++. .+|..+|..-..++...++-+++||++||
T Consensus 91 q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGL 169 (449)
T KOG0664|consen 91 QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGL 169 (449)
T ss_pred HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhh
Confidence 344566899999999999999999998875543322 25788999995 58999998888999999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc--ccCCCccceehhhHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY--EEEYNELVDIYSFGM 153 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGi 153 (568)
+|||+.+ |.||||||.|+|+| .+-.+||||||+++...... .+..+.|..|.|||++ .+.|+.++||||.||
T Consensus 170 KYLHsA~--ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGC 246 (449)
T KOG0664|consen 170 KYLHTAN--ILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGC 246 (449)
T ss_pred HHHhhcc--hhhccCCCccEEec-cCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhH
Confidence 9999999 99999999999998 77899999999998764432 3344679999999977 567999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHH------------------------cCCCCCCCC---CCC-----cHHHHHHHHH
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVT------------------------SGIKPASLS---KVT-----DPQVKQFIEK 201 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~------------------------~~~~p~~~~---~~~-----s~el~~lI~k 201 (568)
|+.||+..+..|.......++ ..|+ .+.+++.++ +.. ..+...++.+
T Consensus 247 IFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~ 325 (449)
T KOG0664|consen 247 IFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQK 325 (449)
T ss_pred HHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHH
Confidence 999999999999764443333 2221 223333322 222 2456667777
Q ss_pred hcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 202 CIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 202 cL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
+|. +|.+|.+..+.+.|+++.+...
T Consensus 326 ~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 326 LLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HhCCCCcccccHhhhcccccccccce
Confidence 776 6999999999999999876543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=267.69 Aligned_cols=199 Identities=22% Similarity=0.353 Sum_probs=149.3
Q ss_pred HHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCeE
Q 008378 11 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPII 89 (568)
Q Consensus 11 ~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~-g~~Ii 89 (568)
.+|++.|++++|||||++++++.+.. ..|+||||+++|+|.++++. +++..+..++.||+.||+|||.+ .++|+
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 805 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVV 805 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCee
Confidence 45789999999999999999987654 68899999999999999963 88999999999999999999954 23499
Q ss_pred eeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCCCCCCC
Q 008378 90 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC 168 (568)
Q Consensus 90 HRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~Pf~~~ 168 (568)
||||||+||+++ .++..++. ||.+..... .....||+.|||||++. ..|+.++|||||||++|||+||+.||...
T Consensus 806 H~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 806 VGNLSPEKIIID-GKDEPHLR-LSLPGLLCT--DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred cCCCCHHhEEEC-CCCceEEE-ecccccccc--CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 999999999997 55666665 665543321 22347899999999874 56999999999999999999999998532
Q ss_pred C----CHHHHHHHHHcC------CCCCC-----CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 169 K----NPAQIYKKVTSG------IKPAS-----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 169 ~----~~~~i~~~i~~~------~~p~~-----~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
. ......+..... ..|.. .......++.+++.+|++ +|.+||++.|+++.
T Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 882 FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 1 111111111110 01110 000112356788999996 69999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-24 Score=201.00 Aligned_cols=175 Identities=38% Similarity=0.674 Sum_probs=155.6
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+.+.+|++.++.++|++|+++++++... ...++++||+.+++|..++... ..++...+..++.+++.+|.|||+++
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 112 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG 112 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 57899999999999999999999988654 4789999999999999999876 57999999999999999999999998
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccccc--CCCccceehhhHHHHHHHhhc
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEmltG 161 (568)
++|+||+|.||+++...+.++|+|||.+....... .....+...|++||.+.. .++.+.|+|+||+++++|
T Consensus 113 --~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--- 187 (215)
T cd00180 113 --IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--- 187 (215)
T ss_pred --eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---
Confidence 99999999999998327899999999997765543 444568889999998854 688999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 219 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hp 219 (568)
+.+.+++.+|+. +|.+||++.++++|+
T Consensus 188 -------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 678999999996 799999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=223.84 Aligned_cols=209 Identities=31% Similarity=0.550 Sum_probs=156.6
Q ss_pred HHHHHHHHHHHHhC--CCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 7 LERLYSEVHLLKSL--KHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L--~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
-+.+++|.++.+.. +|+||+.|+.+=... ....+|+|++|.+.|||.||+++ ..++.+...+++..++.||++||
T Consensus 247 E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH 325 (513)
T KOG2052|consen 247 ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLH 325 (513)
T ss_pred hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHH
Confidence 45577777777665 999999999753322 22479999999999999999998 56999999999999999999999
Q ss_pred hC-----C-CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------CcccccCCCCccCccccccCCC-------
Q 008378 83 SH-----N-PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYEEEYN------- 143 (568)
Q Consensus 83 s~-----g-~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------~~~s~~GTp~YmAPEvl~~~ys------- 143 (568)
.. | |.|.|||||..||||. ++|..-|+|+|||...... .....+||-.|||||++.+..+
T Consensus 326 ~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy 404 (513)
T KOG2052|consen 326 MEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY 404 (513)
T ss_pred HHHhcCCCCchhhccccccccEEEc-cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh
Confidence 43 3 5599999999999996 8999999999999765433 2445689999999999965433
Q ss_pred ccceehhhHHHHHHHhh----------cCCCCCCC----CCHHHHHHHHHcC-CCCCCCCC-CCcH---HHHHHHHHhc-
Q 008378 144 ELVDIYSFGMCILEMVT----------CEYPYNEC----KNPAQIYKKVTSG-IKPASLSK-VTDP---QVKQFIEKCI- 203 (568)
Q Consensus 144 ~ksDIWSLGiilyEmlt----------G~~Pf~~~----~~~~~i~~~i~~~-~~p~~~~~-~~s~---el~~lI~kcL- 203 (568)
..+||||||.++||++. -+.||.+- ...+++.+.+--. ..|..... ..++ .+-++++.||
T Consensus 405 k~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~ 484 (513)
T KOG2052|consen 405 KRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWY 484 (513)
T ss_pred hHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhc
Confidence 35899999999999985 25788552 3334444444322 22221111 1133 4457899999
Q ss_pred CCCCCCCCHHHHhc
Q 008378 204 VPASLRLPALELLK 217 (568)
Q Consensus 204 ~~p~~Rpsa~ElL~ 217 (568)
.+|..|.||--+.+
T Consensus 485 ~Np~aRltALriKK 498 (513)
T KOG2052|consen 485 ANPAARLTALRIKK 498 (513)
T ss_pred CCchhhhHHHHHHH
Confidence 57999999876543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=221.44 Aligned_cols=212 Identities=26% Similarity=0.474 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..++..|+++|..+ -+.||+++.+.+... ....+|+||++.....++... ++...++.+++.++.||.++|.+|
T Consensus 78 p~ri~~El~~L~~~gG~~ni~~~~~~~rnn--d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G 152 (418)
T KOG1167|consen 78 PSRILNELEMLYRLGGSDNIIKLNGCFRNN--DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG 152 (418)
T ss_pred chHHHHHHHHHHHhccchhhhcchhhhccC--CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC
Confidence 46789999999999 589999999987544 468899999999999888765 779999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc---------C-------C----------------C-----------
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ---------Q-------P----------------T----------- 122 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~---------~-------~----------------~----------- 122 (568)
||||||||+|++.+...++-.|+|||||.... . + .
T Consensus 153 --IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r 230 (418)
T KOG1167|consen 153 --IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGR 230 (418)
T ss_pred --ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCc
Confidence 99999999999999888999999999996210 0 0 0
Q ss_pred ---cccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcCCCCCCCCCH----HHHHHH--------HH--cCC-
Q 008378 123 ---ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNP----AQIYKK--------VT--SGI- 182 (568)
Q Consensus 123 ---~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~----~~i~~~--------i~--~~~- 182 (568)
.....|||+|.|||++- ...++++||||.|+|++-++++.+||....+. .++... .. .|.
T Consensus 231 ~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~ 310 (418)
T KOG1167|consen 231 PSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRI 310 (418)
T ss_pred cceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCce
Confidence 00125999999999873 45688999999999999999999999654332 111100 00 010
Q ss_pred ----------------------------------CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 183 ----------------------------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 183 ----------------------------------~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.+..+....++.+.+|+.+||. +|.+|.+|+++|+||||....
T Consensus 311 ~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 311 LLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred eeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 0111223345688999999994 899999999999999998543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=200.88 Aligned_cols=174 Identities=34% Similarity=0.582 Sum_probs=151.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~-l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|++.++.++|+|++++++++... ...++++||+.+++|.+++..... +++..+..++.|++.+|.|||++
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 117 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL 117 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 577899999999999999999999987654 368899999999999999998777 89999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEml 159 (568)
+ ++|+||+|.||+++ ..+.++|+|||++...... ......++..|++||.+. ..++.++|+|+||+++++|+
T Consensus 118 ~--i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~ 194 (225)
T smart00221 118 G--IVHRDLKPENILLG-MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELL 194 (225)
T ss_pred C--eecCCCCHHHEEEc-CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHH
Confidence 8 99999999999997 5689999999998776543 234557888999999872 44778999999999999999
Q ss_pred hcCCCCCC-CCCHHHHHHHHHcCCCC
Q 008378 160 TCEYPYNE-CKNPAQIYKKVTSGIKP 184 (568)
Q Consensus 160 tG~~Pf~~-~~~~~~i~~~i~~~~~p 184 (568)
+|+.||.. ..+...+.+.+..+.++
T Consensus 195 ~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 195 WGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred HCCCCccccchhHHHHHHHHhcCCcc
Confidence 99999977 56666788888776543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=222.12 Aligned_cols=209 Identities=28% Similarity=0.451 Sum_probs=159.5
Q ss_pred CHHHHHHHHHHHHHHHhC--CCCCeeeeeeEEEcCC--CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSL--KHENIIKFYNSWVDDT--NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L--~HpNIV~l~~~~~~~~--~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
.+++.+.+..|-.|.+.. +|+||++|+++-...+ ...+++|++|.+.|+|.+|++.+- +++....+++.-+.+||
T Consensus 242 p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGL 320 (534)
T KOG3653|consen 242 PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGL 320 (534)
T ss_pred CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHH
Confidence 356778888888887765 8999999998543222 347899999999999999999864 89999999999999999
Q ss_pred HhhhhC-------CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccccCCC----
Q 008378 79 HYLHSH-------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEEEYN---- 143 (568)
Q Consensus 79 ~yLHs~-------g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~~~ys---- 143 (568)
+|||.. .|+|+|||||..||||. +++..-|+|||||..+... .....+||..|||||++++-.+
T Consensus 321 a~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~ 399 (534)
T KOG3653|consen 321 AHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDR 399 (534)
T ss_pred HHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccH
Confidence 999964 46799999999999996 8999999999999877532 2345799999999999965422
Q ss_pred ---ccceehhhHHHHHHHhhcC------------CCCC----CCCCHHHHHHHHHcCCCCCC----CCCC-CcHHHHHHH
Q 008378 144 ---ELVDIYSFGMCILEMVTCE------------YPYN----ECKNPAQIYKKVTSGIKPAS----LSKV-TDPQVKQFI 199 (568)
Q Consensus 144 ---~ksDIWSLGiilyEmltG~------------~Pf~----~~~~~~~i~~~i~~~~~p~~----~~~~-~s~el~~lI 199 (568)
...||||+|.++|||++.- .||. .....+++...+.+....+. |.+. .-..+++.|
T Consensus 400 ~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~ 479 (534)
T KOG3653|consen 400 DAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETI 479 (534)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHH
Confidence 3589999999999999742 2332 11223444444444333222 2222 235789999
Q ss_pred HHhcC-CCCCCCCHH
Q 008378 200 EKCIV-PASLRLPAL 213 (568)
Q Consensus 200 ~kcL~-~p~~Rpsa~ 213 (568)
+.||. ++..|+||.
T Consensus 480 EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 480 EECWDHDAEARLTAG 494 (534)
T ss_pred HHHcCCchhhhhhhH
Confidence 99994 799999975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-24 Score=235.26 Aligned_cols=208 Identities=28% Similarity=0.475 Sum_probs=175.8
Q ss_pred CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHh
Q 008378 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~y 80 (568)
++++.-+++..|.-+|.+|+|||++++.+++... .+.+|++|++.|+|.+|++.++ ++..+....|..||++|+.|
T Consensus 737 t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~Y 813 (1177)
T KOG1025|consen 737 TSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKY 813 (1177)
T ss_pred CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 4677788999999999999999999999987654 3788999999999999999774 79999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcc----cccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR----SVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~----s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
||.+. ++||||-..||||. .-.+|||.|||+++.+...... .-.-.+-|||-|.+ .+.|+.++||||||+++
T Consensus 814 Le~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVti 890 (1177)
T KOG1025|consen 814 LEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTI 890 (1177)
T ss_pred HHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhH
Confidence 99998 99999999999997 6679999999999987543321 11224568888866 57799999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
||++| |..||.+ ...++|-+.+..|.+ -..+.+.+-++-.++.+||. ++..||+++++-.
T Consensus 891 WElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 891 WELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 99999 8999977 456777777777766 34566788899999999995 7889999887643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=231.22 Aligned_cols=153 Identities=31% Similarity=0.514 Sum_probs=140.1
Q ss_pred HHHHHHHHHhCC---CCCeeeeeeEEEcCCCCeEEEEEecC-CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 10 LYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMITELF-TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 10 l~~Ei~iLk~L~---HpNIV~l~~~~~~~~~~~l~lV~Ey~-~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
+-.||+||..|+ |+||+++.++|.+.+ ++|++||-. +|.+|++||..+.+++|..++-+++||+.|+++||+.|
T Consensus 613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd--~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ 690 (772)
T KOG1152|consen 613 VPSEIQILATLNKHSHENILKLLDFFEDDD--YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG 690 (772)
T ss_pred cchhHHHHHHhhhcCccchhhhhheeecCC--eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC
Confidence 446999999998 999999999997654 799999977 45689999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccC-C-CccceehhhHHHHHHHhhcCC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~-y-s~ksDIWSLGiilyEmltG~~ 163 (568)
|||||||-+|+.++ .+|-+||+|||.+..........++||..|.|||++.+. | +..-|||++|+++|-++..+.
T Consensus 691 --ivhrdikdenvivd-~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 691 --IVHRDIKDENVIVD-SNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred --ceecccccccEEEe-cCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 99999999999998 689999999999999888889999999999999999654 4 667899999999999999999
Q ss_pred CCCC
Q 008378 164 PYNE 167 (568)
Q Consensus 164 Pf~~ 167 (568)
||..
T Consensus 768 pyyn 771 (772)
T KOG1152|consen 768 PYYN 771 (772)
T ss_pred CCcC
Confidence 9964
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=207.52 Aligned_cols=91 Identities=26% Similarity=0.538 Sum_probs=77.6
Q ss_pred HHHHHHHHHHHhCC-----C---CCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHH
Q 008378 8 ERLYSEVHLLKSLK-----H---ENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQIL 75 (568)
Q Consensus 8 e~l~~Ei~iLk~L~-----H---pNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl 75 (568)
+...-||++|++++ | ..||++++.|... ....++||+|++ |.+|..+|++. +.++...++.|++|||
T Consensus 119 EaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL 197 (590)
T KOG1290|consen 119 EAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVL 197 (590)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHH
Confidence 55677999999994 2 4799999998653 456899999999 67888888754 6799999999999999
Q ss_pred HHHHhhhhCCCCeEeeeccCCcEEE
Q 008378 76 RGLHYLHSHNPPIIHRDLKCDNIFV 100 (568)
Q Consensus 76 ~gL~yLHs~g~~IiHRDLKp~NILl 100 (568)
.||.|||..- +|||.||||+|||+
T Consensus 198 ~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 198 TGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred HHHHHHHHhc-CccccCCCcceeee
Confidence 9999999852 39999999999998
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-20 Score=185.02 Aligned_cols=214 Identities=31% Similarity=0.488 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHHHhCCCC-CeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHhh
Q 008378 6 QLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~Hp-NIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~---~l~e~~i~~i~~QIl~gL~yL 81 (568)
....+.+|+++++.+.|+ +|+++++.+... ...+++++|+.++++.+++.... .++...+..++.|++.++.|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 117 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 567899999999999988 799999988443 34899999999999998888765 799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCC-cEEEeecChhhhccCC--------CcccccCCCCccCccccc----cCCCcccee
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQP--------TARSVIGTPEFMAPELYE----EEYNELVDI 148 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g-~vKI~DFGla~~~~~~--------~~~s~~GTp~YmAPEvl~----~~ys~ksDI 148 (568)
|+.+ ++|||+||+||+++ ..+ .++++|||++..+... ......||+.|+|||.+. ..+....|+
T Consensus 118 H~~~--~~hrd~kp~nil~~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~ 194 (384)
T COG0515 118 HSKG--IIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDI 194 (384)
T ss_pred HhCC--eeccCCCHHHeeec-CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhH
Confidence 9999 99999999999998 455 7999999999755432 235668999999999875 368899999
Q ss_pred hhhHHHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCC-CCCCCCC------cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 149 YSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKP-ASLSKVT------DPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~~~---~~~i~~~i~~~~~p-~~~~~~~------s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
||+|++++++++|..||..... .......+.....+ ....... ...+.+++.+++. +|..|.+..+...
T Consensus 195 ~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 195 WSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred HHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 9999999999999999876553 45566655554433 1111111 2578999999996 6999999999888
Q ss_pred CCCCCCC
Q 008378 218 DPFLVTD 224 (568)
Q Consensus 218 hpff~~~ 224 (568)
++|....
T Consensus 275 ~~~~~~~ 281 (384)
T COG0515 275 HDLLAHL 281 (384)
T ss_pred chHhhCc
Confidence 8666543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-21 Score=196.33 Aligned_cols=208 Identities=22% Similarity=0.330 Sum_probs=174.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--------CCCHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--------NVDMKAIKNWARQI 74 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--------~l~e~~i~~i~~QI 74 (568)
|+=++..++.|--+|..+.|||+..+.++..... ...++++.+..-|+|..+++.++ .++..++...+.|+
T Consensus 327 S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQl 405 (563)
T KOG1024|consen 327 SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQL 405 (563)
T ss_pred cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHH
Confidence 4567788999999999999999999999877644 46677889999999999998443 25566777889999
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccC-----CCCccCcccc-ccCCCcccee
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG-----TPEFMAPELY-EEEYNELVDI 148 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~G-----Tp~YmAPEvl-~~~ys~ksDI 148 (568)
..|++|||+++ +||.||-..|.+|+ +.-+|||+|=.+++.+-... ....| ...||+||.+ ...|+.++|+
T Consensus 406 a~am~hlh~~~--ViHkDiAaRNCvId-d~LqVkltDsaLSRDLFP~D-YhcLGDnEnRPvkWMslEal~n~~yssasDv 481 (563)
T KOG1024|consen 406 AMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLTDSALSRDLFPGD-YHCLGDNENRPVKWMSLEALQNSHYSSASDV 481 (563)
T ss_pred HHHHHHHHhcC--cccchhhhhcceeh-hheeEEeccchhccccCccc-ccccCCCCCCcccccCHHHHhhhhhcchhhh
Confidence 99999999999 99999999999998 77899999999998663221 12222 4469999977 6679999999
Q ss_pred hhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 149 YSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 149 WSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
||||+++|||+| |+.||.+ -+|.++...+..|.+.. .+.+.++++-.++..||+ .|.+||+..++..
T Consensus 482 WsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRla-QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 482 WSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRLA-QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccceec-CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 999999999999 9999987 68999999999987654 456778999999999996 7999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-22 Score=224.87 Aligned_cols=211 Identities=27% Similarity=0.417 Sum_probs=167.6
Q ss_pred HHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeE
Q 008378 10 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 89 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~Ii 89 (568)
+..|+-+-..|+|||++.....+.+.. .++-+||||++ +|..++...+.+....+..+++||+.|++|+|..| +.
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--ia 442 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEID--GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LA 442 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcc--cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ce
Confidence 566777788899999988766544333 34444999998 99999998888999999999999999999999999 99
Q ss_pred eeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCccccc-cCCCc-cceehhhHHHHHHHhhc
Q 008378 90 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYE-EEYNE-LVDIYSFGMCILEMVTC 161 (568)
Q Consensus 90 HRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl~-~~ys~-ksDIWSLGiilyEmltG 161 (568)
||||||+|+++. .+|.+||+|||.+..+..+. ...++|+..|+|||++. ..|++ .+||||.|++++.|++|
T Consensus 443 hrdlK~enll~~-~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~ 521 (601)
T KOG0590|consen 443 HRDLKLENLLVT-ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG 521 (601)
T ss_pred eccCccccEEEe-cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC
Confidence 999999999998 78899999999997764432 34568999999999884 55765 68999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHH-c-----CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVT-S-----GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~-~-----~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
+.||......+..+.... . ...+..+....+.+.+.+|.++|+ +|.+|.++.++++++||+...-
T Consensus 522 ~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 522 RFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred CCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 999965433332211111 0 111223344567789999999996 7999999999999999987654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=194.57 Aligned_cols=210 Identities=23% Similarity=0.372 Sum_probs=152.6
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+..|.+|.+.=-.| .|.||+.-|+.-+. +.+.+++++||++.|+|..-+... ++.|...++++.|+++||.|+|++
T Consensus 63 t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-t~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsk 140 (378)
T KOG1345|consen 63 TQADFVREFHYSFFLSPHQHIIDTYEVAFQ-TSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSK 140 (378)
T ss_pred hHHHHHHHhccceeeccchhhhHHHHHHhh-cCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhcc
Confidence 467889999876666 68999998885443 334888999999999999877654 488999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEe-CCCCcEEEeecChhhhccCCCcccccCCCCccCccccc----cC--CCccceehhhHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE----EE--YNELVDIYSFGMCILE 157 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~-~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~----~~--ys~ksDIWSLGiilyE 157 (568)
+ ++|||||.+||||- .+.-+||+||||+.+..... .+..--+..|.|||+.. +. .++..|+|.|||++|.
T Consensus 141 n--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~ 217 (378)
T KOG1345|consen 141 N--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFY 217 (378)
T ss_pred c--hhhcccccceEEEecCCccEEEeeecccccccCce-ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeee
Confidence 9 99999999999984 34458999999988654221 12222356789999763 22 4788999999999999
Q ss_pred HhhcCCCCCCCCCHHHH---HHHHHcCCCCCCCC---CCCcHHHHHHHHHhcCC-CCCC---CCHHHHhcCCCC
Q 008378 158 MVTCEYPYNECKNPAQI---YKKVTSGIKPASLS---KVTDPQVKQFIEKCIVP-ASLR---LPALELLKDPFL 221 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i---~~~i~~~~~p~~~~---~~~s~el~~lI~kcL~~-p~~R---psa~ElL~hpff 221 (568)
++||.+||....-.+.- +.....+..+ ..+ +..++.+..+.++-|.+ +.+| .++....+..|.
T Consensus 218 cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 218 CLTGKFPWQKASIMDKPYWEWEQWLKRKNP-ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred eecCCCcchhhhccCchHHHHHHHhcccCc-cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 99999999653222221 2222222222 222 33567777788888875 5555 455565555554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-21 Score=209.54 Aligned_cols=211 Identities=19% Similarity=0.295 Sum_probs=177.3
Q ss_pred HHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 9 RLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 9 ~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
+...|.+++..++ ||.+|+++..|+.+. .++++++|..||.|...+.+...+++...+.+...++.+++++|+.+
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~-- 117 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG-- 117 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeecccc--chhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--
Confidence 3445788888886 999999999887665 57888999999999999999899999999999999999999999999
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHHHHHHhhcCCCCCC
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNE 167 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG~~Pf~~ 167 (568)
++|||+|++||+++ ..|++|+.|||+++..-..... +||..|||||+.. ++..++|.||||+++++|+||..||..
T Consensus 118 iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~--cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 118 IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA--CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc--ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 99999999999998 7899999999999876443333 8999999999988 778999999999999999999999976
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCCC
Q 008378 168 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 168 ~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~l 234 (568)
.+.+.|..... ..+...++.+++++..++. .|..|.- +.|++.|+||+..++..+.....
T Consensus 194 -----~~~~~Il~~~~--~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~ 259 (612)
T KOG0603|consen 194 -----DTMKRILKAEL--EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSR 259 (612)
T ss_pred -----HHHHHHhhhcc--CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCC
Confidence 44445443222 2456677899999999885 6777765 57999999999988876544333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=173.43 Aligned_cols=198 Identities=21% Similarity=0.350 Sum_probs=144.1
Q ss_pred CCCCeeeeeeEEEcC-------------------------CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 008378 21 KHENIIKFYNSWVDD-------------------------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 75 (568)
Q Consensus 21 ~HpNIV~l~~~~~~~-------------------------~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl 75 (568)
+|||||+++.+|.+. ...++|+||.-.. .+|+.|+-.. ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 699999999888642 2357999999886 5999998764 467788889999999
Q ss_pred HHHHhhhhCCCCeEeeeccCCcEEEeCC-C--CcEEEeecChhhhccC-----CCcc---cccCCCCccCccccccC---
Q 008378 76 RGLHYLHSHNPPIIHRDLKCDNIFVNGN-N--GEVKIGDLGLAIVMQQ-----PTAR---SVIGTPEFMAPELYEEE--- 141 (568)
Q Consensus 76 ~gL~yLHs~g~~IiHRDLKp~NILl~~~-~--g~vKI~DFGla~~~~~-----~~~~---s~~GTp~YmAPEvl~~~--- 141 (568)
+|+.|||.|| |.|||||.+|||+.-+ + ..+.|+|||.+-.-.. +... ..-|.-.-||||+...-
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 9999999999998532 2 2578999997632211 1111 12367789999988432
Q ss_pred ----CCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH---
Q 008378 142 ----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL--- 213 (568)
Q Consensus 142 ----ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~--- 213 (568)
.-.++|.|+.|.+.||+++...||.+....-.-.....+ -..+.++...+|.+++++..+|+ +|++|+++.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe-~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE-SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh-hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 235899999999999999999999773221111111111 12334667788999999999996 699999843
Q ss_pred HHhcCCCCCC
Q 008378 214 ELLKDPFLVT 223 (568)
Q Consensus 214 ElL~hpff~~ 223 (568)
.+|.-..+..
T Consensus 509 Nvl~LsLw~~ 518 (598)
T KOG4158|consen 509 NVLNLSLWRM 518 (598)
T ss_pred hHHHHHHhcC
Confidence 4554444433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-18 Score=176.16 Aligned_cols=210 Identities=33% Similarity=0.532 Sum_probs=156.5
Q ss_pred HHHHHHhCCCCCeeeeeeEEEcCCC---CeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 13 EVHLLKSLKHENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 13 Ei~iLk~L~HpNIV~l~~~~~~~~~---~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
=.+.|-++.|.|||+++.||.+... ..+.|++||+..|+|.+++++. +.+....+++|+.||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 3467788899999999999976542 3678999999999999998754 46889999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc-----CC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-----QP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~-----~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
|||+|+++.|+.||+. .+|.+||+--....... .. ......+-++|.|||.- ..+-+.++|||+||++..+|
T Consensus 197 PpiihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999999997 88999987533221110 00 11123567889999965 34567789999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~~ 228 (568)
..++.--.+..........+..- .-...++.-+++|.+|+. .|..||++.++|.||.+......+
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~-----i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslk 341 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANV-----IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLK 341 (458)
T ss_pred HHheeccCCCcceeehhhhhhhh-----eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecchHH
Confidence 99886644322211111111111 111223455788999997 599999999999999987765443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.3e-18 Score=191.64 Aligned_cols=153 Identities=30% Similarity=0.522 Sum_probs=124.4
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----------------CcccccCCCCccCccc
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------TARSVIGTPEFMAPEL 137 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----------------~~~s~~GTp~YmAPEv 137 (568)
+.+++|||+.| |+|||+||+|.+|+ .-|++|+.|||+.+..-.. ..+.++|||+|+|||+
T Consensus 153 vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78999999998 99999999999997 7899999999998643110 1345689999999997
Q ss_pred c-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCcHHHHHHHHHhcC-CCCCCC---C
Q 008378 138 Y-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPASLSKVTDPQVKQFIEKCIV-PASLRL---P 211 (568)
Q Consensus 138 l-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~-~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp---s 211 (568)
+ .++|+..+|+|++|+|+||.+.|.+||.+ ..+++++..+... +...+-.....++++++|..+|+ .|..|. .
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 7 67899999999999999999999999988 4577777666553 22222245567999999999995 677775 5
Q ss_pred HHHHhcCCCCCCCCCCCccc
Q 008378 212 ALELLKDPFLVTDNPKDLVC 231 (568)
Q Consensus 212 a~ElL~hpff~~~~~~~l~~ 231 (568)
+.++.+|+||+..+++.|+.
T Consensus 309 a~evk~h~ff~~LDw~~llR 328 (1205)
T KOG0606|consen 309 ALEVKQHGFFQLLDWKSLLR 328 (1205)
T ss_pred hhhhhhccceeecccchhhh
Confidence 77999999999988875443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.3e-17 Score=173.18 Aligned_cols=130 Identities=21% Similarity=0.282 Sum_probs=100.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeee-eeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIK-FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~-l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+...+.+.+|+++|++|+|+||++ +++. ...|+|||||+|++|... .. .. ...++.|++.||.|||
T Consensus 62 ~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH 128 (365)
T PRK09188 62 PLARHLAAREIRALKTVRGIGVVPQLLAT------GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLH 128 (365)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCcEEEEc------CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHH
Confidence 345677999999999999999995 5431 247899999999999732 11 11 2578999999999999
Q ss_pred hCCCCeEeeec-cCCcEEEeCCCCcEEEeecChhhhccCCC----------cccccCCCCccCccccccC-------CCc
Q 008378 83 SHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----------ARSVIGTPEFMAPELYEEE-------YNE 144 (568)
Q Consensus 83 s~g~~IiHRDL-Kp~NILl~~~~g~vKI~DFGla~~~~~~~----------~~s~~GTp~YmAPEvl~~~-------ys~ 144 (568)
++| |+|||| ||+|||++ .++.+||+|||+++.+.... .....+++.|+|||.+... .+.
T Consensus 129 ~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~ 205 (365)
T PRK09188 129 RAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSL 205 (365)
T ss_pred HCC--CeeCCCCCcceEEEc-CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhcccccccc
Confidence 999 999999 99999996 67899999999998654322 1355789999999988422 234
Q ss_pred cceeh
Q 008378 145 LVDIY 149 (568)
Q Consensus 145 ksDIW 149 (568)
..|-|
T Consensus 206 ~~dgW 210 (365)
T PRK09188 206 PSRIW 210 (365)
T ss_pred ccCcE
Confidence 46766
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.6e-18 Score=180.28 Aligned_cols=173 Identities=24% Similarity=0.474 Sum_probs=134.6
Q ss_pred CeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecCh
Q 008378 38 RTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 114 (568)
Q Consensus 38 ~~l~lV~Ey~~gGsL~~~i~k~~---~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGl 114 (568)
.++|+.|++|...+|.+++...+ ..+......|+.|+..|++| ++ .+|||+||.||+.. .+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhh
Confidence 36899999999999999997543 46777899999999999999 67 99999999999996 777999999999
Q ss_pred hhhccCCC--------cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 008378 115 AIVMQQPT--------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 184 (568)
Q Consensus 115 a~~~~~~~--------~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p 184 (568)
.+...... ....+||++||+||.+ .+.|+.++||||||+|++|+++ ...++..+ .....+..+..|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----HhhhhhhcCCCC
Confidence 87654322 2345899999999977 5779999999999999999997 44444322 223334445444
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 185 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 185 ~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
+.+... .|+-..|+..++. .|.+||++.+.-.|+|.
T Consensus 479 ~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 333222 3667789999996 69999988887777765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.8e-16 Score=161.92 Aligned_cols=205 Identities=21% Similarity=0.243 Sum_probs=149.3
Q ss_pred HHHHHHHHHHhCCC----CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 9 RLYSEVHLLKSLKH----ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 9 ~l~~Ei~iLk~L~H----pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..|+.+|+.+.+ +++..+++... ....+-|+||+++ |.+|.+++... +.++..++..++.|++.+|++||
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH 139 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH 139 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH
Confidence 57789999999973 58888888664 3445788999998 68999988655 57999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCC----CcEEEeecChhh--hcc-C------C--C-cccccCCCCccCcccc-ccCCCcc
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNN----GEVKIGDLGLAI--VMQ-Q------P--T-ARSVIGTPEFMAPELY-EEEYNEL 145 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~----g~vKI~DFGla~--~~~-~------~--~-~~s~~GTp~YmAPEvl-~~~ys~k 145 (568)
+.| ++||||||+|+.+.... ..+.|.|||+++ .+. . . . ...+.||..|+++.+. ....+.+
T Consensus 140 ~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~ 217 (322)
T KOG1164|consen 140 SKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR 217 (322)
T ss_pred hcC--cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc
Confidence 999 99999999999996332 469999999998 321 1 1 1 1235699999999976 4568999
Q ss_pred ceehhhHHHHHHHhhcCCCCCCCCCHHHH--HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 146 VDIYSFGMCILEMVTCEYPYNECKNPAQI--YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 146 sDIWSLGiilyEmltG~~Pf~~~~~~~~i--~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
.|+||++.++.+++.|..||......... ++...............+.++.++...+-. +...+|....+..
T Consensus 218 DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 218 DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 99999999999999999999765433222 222221111111223334556666555443 4667777665543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=172.04 Aligned_cols=195 Identities=27% Similarity=0.427 Sum_probs=152.2
Q ss_pred HHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCCCe-Eeeecc
Q 008378 17 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPI-IHRDLK 94 (568)
Q Consensus 17 Lk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~~I-iHRDLK 94 (568)
|+.+.|.|+.+|++.+++. ..++.|.+||..|+|.+.+... ..++.--...+++.|+.||.|||..- | .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 5789999999999999887 4688999999999999998873 46888888899999999999999865 5 999999
Q ss_pred CCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccccC--------CCccceehhhHHHHHHHhhcC
Q 008378 95 CDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEEE--------YNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 95 p~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~~~--------ys~ksDIWSLGiilyEmltG~ 162 (568)
..|.+++ ..-.+||.|||+....... ......-..-|.|||++... .+.+.|||||||+++|+++..
T Consensus 77 s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 77 SSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999998 6779999999998766421 11111223459999988542 466799999999999999999
Q ss_pred CCCCCC---CCHHHHHHHHHc-CCC---CCCCCC-CCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 008378 163 YPYNEC---KNPAQIYKKVTS-GIK---PASLSK-VTDPQVKQFIEKCIV-PASLRLPALELL 216 (568)
Q Consensus 163 ~Pf~~~---~~~~~i~~~i~~-~~~---p~~~~~-~~s~el~~lI~kcL~-~p~~Rpsa~ElL 216 (568)
-||... ..++++..++.. +.. |.-... ...+++..++..||. +|..||+..++-
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 999652 233566666666 322 211111 344579999999995 799999988754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-16 Score=154.05 Aligned_cols=144 Identities=18% Similarity=0.137 Sum_probs=112.7
Q ss_pred HHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 9 RLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 9 ~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
.+.+|+++|++|. |++|++++++ ...+++|||+.|.+|.+.+.. . ...++.|++.+|.++|.+|
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G-- 111 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW------DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG-- 111 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--
Confidence 6789999999995 5889999884 136899999999999754322 1 2357899999999999999
Q ss_pred eEeeec-cCCcEEEeCCCCcEEEeecChhhhccCCCc------c---------cccCCCCccCcccc---ccCCCcccee
Q 008378 88 IIHRDL-KCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------R---------SVIGTPEFMAPELY---EEEYNELVDI 148 (568)
Q Consensus 88 IiHRDL-Kp~NILl~~~~g~vKI~DFGla~~~~~~~~------~---------s~~GTp~YmAPEvl---~~~ys~ksDI 148 (568)
|+|||| ||+|||++ .+|.++|+|||++........ . -...++.|+.|+-- ...--...++
T Consensus 112 IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w 190 (218)
T PRK12274 112 VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELW 190 (218)
T ss_pred CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHH
Confidence 999999 79999997 678999999999975433221 0 11368889998733 3333367889
Q ss_pred hhhHHHHHHHhhcCCCCCCC
Q 008378 149 YSFGMCILEMVTCEYPYNEC 168 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~ 168 (568)
++.|.-+|.++|+..|..+.
T Consensus 191 ~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 191 FATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHhcchHHHHHhccCCcccc
Confidence 99999999999999998653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.4e-17 Score=184.80 Aligned_cols=202 Identities=20% Similarity=0.283 Sum_probs=150.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
...+..+|++ .+.++|||+++|--+- ...+..|||-+|.. -+|.|.+....-+..-+.+-|+.||+.||.-+|..|
T Consensus 65 ~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAylvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g 140 (1431)
T KOG1240|consen 65 PFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYLVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG 140 (1431)
T ss_pred HHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHHHHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 3455566666 7777999999997643 33456788999997 589998887777888888899999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhc--c--CCCc-ccccCC----CCccCcccc-c-c---------C-CCc
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--Q--QPTA-RSVIGT----PEFMAPELY-E-E---------E-YNE 144 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~--~--~~~~-~s~~GT----p~YmAPEvl-~-~---------~-ys~ 144 (568)
|+|+|||++||||+ .-+.+.|.||..-+.. . ++.. .-+.-| .+|+|||.+ . . . ..+
T Consensus 141 --VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~p 217 (1431)
T KOG1240|consen 141 --VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTP 217 (1431)
T ss_pred --ccccccccceEEEe-eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccCh
Confidence 99999999999998 6779999999865322 1 1111 112222 379999966 2 1 1 457
Q ss_pred cceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC-CC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 145 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI-KP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 145 ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~-~p-~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+-||||+||+++||++ |++||. ..|+...-..+. .+ ..+.++.+..+|.+|..|++ +|++|.+|++.|+.
T Consensus 218 aMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 218 AMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 8999999999999998 677773 344443333221 11 11334556789999999996 89999999999876
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.3e-16 Score=154.27 Aligned_cols=129 Identities=19% Similarity=0.238 Sum_probs=101.0
Q ss_pred HHHHHHHHHhCCCCCeeeeeeEEEcCCC------CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 10 LYSEVHLLKSLKHENIIKFYNSWVDDTN------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNIV~l~~~~~~~~~------~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+.+|++.+.+|+||+|....+++.+... ...++||||++|.+|.++.. +++ ....+|+.+|..+|.
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~ 153 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ 153 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH
Confidence 6799999999999999999998775432 24789999999999988732 333 346699999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEml 159 (568)
+| ++|||+||+||+++ .+| ++|+|||.........+... =++++.|+.++|+|+||+++....
T Consensus 154 ~g--i~H~Dikp~Nili~-~~g-i~liDfg~~~~~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 154 HG--MVSGDPHKGNFIVS-KNG-LRIIDLSGKRCTAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cC--CccCCCChHHEEEe-CCC-EEEEECCCcccccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 99 99999999999997 567 99999998765432211110 023566888999999999987653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.7e-16 Score=153.00 Aligned_cols=201 Identities=18% Similarity=0.299 Sum_probs=155.6
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.-..|..|.-.|+.+.||||+.+.+.+..+. .+.++..|++.|+|...+...- .++..++.+++..|+.|++|||+
T Consensus 230 isrdfneefp~lrifshpnilpvlgacnspp--nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhs 307 (448)
T KOG0195|consen 230 ISRDFNEEFPALRIFSHPNILPVLGACNSPP--NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS 307 (448)
T ss_pred hcchhhhhCcceeeecCCchhhhhhhccCCC--CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh
Confidence 3456788899999999999999999986654 6889999999999999887654 36788899999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEE--EeecChhhhccCCCcccccCCCCccCccccccC----CCccceehhhHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVK--IGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILE 157 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vK--I~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~----ys~ksDIWSLGiilyE 157 (568)
..|-|.---|....++++ ++-..+ .+|--++-.. ....-.|.||+||.+.+. .-.++|+|||++++||
T Consensus 308 lep~ipr~~lns~hvmid-edltarismad~kfsfqe-----~gr~y~pawmspealqrkped~n~raadmwsfaillwe 381 (448)
T KOG0195|consen 308 LEPMIPRFYLNSKHVMID-EDLTARISMADTKFSFQE-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWE 381 (448)
T ss_pred cchhhhhhhcccceEEec-chhhhheecccceeeeec-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHH
Confidence 985455557888899997 444433 3342222111 112347899999988543 3468999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL 215 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~El 215 (568)
|.|.+.||.+-...+--++.-..|..+. ++...++.+..++.-|+. +|.+||..+.+
T Consensus 382 l~trevpfadlspmecgmkialeglrv~-ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 382 LNTREVPFADLSPMECGMKIALEGLRVH-IPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred hhccccccccCCchhhhhhhhhcccccc-CCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 9999999998766666666666666554 566678899999999995 79999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.4e-17 Score=181.10 Aligned_cols=216 Identities=25% Similarity=0.358 Sum_probs=174.0
Q ss_pred CHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYR-KKHK-NVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i-~k~~-~l~e~~i~~i~~QIl~gL~ 79 (568)
+....++...|..+-+.+. |+|++.+++..... ...+++++|..|+++..-+ .... ..+......++.|+..++.
T Consensus 60 ~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~ 137 (601)
T KOG0590|consen 60 SEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLS 137 (601)
T ss_pred ccchhhhcCccccccccccccccccccCCccCCC--cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCcc
Confidence 3445566777888888887 99999999976544 4678899999999999988 5554 6788899999999999999
Q ss_pred hhh-hCCCCeEeeeccCCcEEEeCCCC-cEEEeecChhhhccC-CC----cccccC-CCCccCcccccc--CCCccceeh
Q 008378 80 YLH-SHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQ-PT----ARSVIG-TPEFMAPELYEE--EYNELVDIY 149 (568)
Q Consensus 80 yLH-s~g~~IiHRDLKp~NILl~~~~g-~vKI~DFGla~~~~~-~~----~~s~~G-Tp~YmAPEvl~~--~ys~ksDIW 149 (568)
|+| ..+ +.||||||+|.+++ ..+ .+|++|||+|..+.. .. ....+| ++.|+|||.+.+ ...+..|+|
T Consensus 138 ~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~ 214 (601)
T KOG0590|consen 138 YLHPENG--VTHRDIKPSNSLLD-ESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVW 214 (601)
T ss_pred ccCcccc--cccCCCCCccchhc-cCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccc
Confidence 999 888 99999999999998 667 999999999987755 22 233478 999999998855 457899999
Q ss_pred hhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 150 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 150 SLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|.|+++.-|++|..|+.........+........ -...+...+....+++.+++. +|..|.+.+++-.+||+..
T Consensus 215 S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 215 SLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 9999999999999999764433333333322221 233455667889999999995 7999999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.9e-15 Score=146.31 Aligned_cols=105 Identities=19% Similarity=0.251 Sum_probs=85.2
Q ss_pred HHHHHHHHHHHHHhC-----CCCCeeeeeeEEEcCCC-CeEE-EEEec--CCCCCHHHHHHhCCCCCHHHHHHHHHHHHH
Q 008378 6 QLERLYSEVHLLKSL-----KHENIIKFYNSWVDDTN-RTIN-MITEL--FTSGSLRQYRKKHKNVDMKAIKNWARQILR 76 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-----~HpNIV~l~~~~~~~~~-~~l~-lV~Ey--~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~ 76 (568)
..+.+.+|+.+|++| .||||+++|+++.+... ..++ +|+|| +.+|+|.+++++. .+++. ..+++|++.
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~ 115 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLK 115 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHH
Confidence 456799999999999 67999999999876542 3434 78999 5589999999774 57766 467889998
Q ss_pred HH-HhhhhCCCCeEeeeccCCcEEEeC---CCCcEEEeecChh
Q 008378 77 GL-HYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLA 115 (568)
Q Consensus 77 gL-~yLHs~g~~IiHRDLKp~NILl~~---~~g~vKI~DFGla 115 (568)
++ +|||+++ |+||||||+||+++. ..+.++|+||+.+
T Consensus 116 ~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 116 KLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 88 9999999 999999999999972 2348999995433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.2e-15 Score=142.74 Aligned_cols=103 Identities=17% Similarity=0.193 Sum_probs=83.9
Q ss_pred HHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh-hhCCCCe
Q 008378 10 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPI 88 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL-Hs~g~~I 88 (568)
..+|+++|+.|.|+++...+.... .. .++||||+.|+++...+.+.+.+++..+..++.|++.+|.|+ |+.| |
T Consensus 66 ~~~E~~~l~~l~~~~v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--i 139 (190)
T cd05147 66 AEKEMRNLKRLVTAGIPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--L 139 (190)
T ss_pred HHHHHHHHHHHHHCCCCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 356999999999887754433221 11 279999999988876655567899999999999999999999 7988 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~ 120 (568)
+||||||+||+++ ++.++|+|||++.....
T Consensus 140 iHrDlkP~NIli~--~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 140 VHADLSEYNLLYH--DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred ccCCCCHHHEEEE--CCcEEEEEccccccCCC
Confidence 9999999999997 47899999999975433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.7e-14 Score=138.26 Aligned_cols=104 Identities=17% Similarity=0.186 Sum_probs=85.1
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh-CCCC
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPP 87 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs-~g~~ 87 (568)
.+.+|.+.+.++.|++|.....++... .++||||++|+++.........++...+..++.|++.+|.++|. +|
T Consensus 65 ~~~~E~~~l~~l~~~~i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g-- 138 (190)
T cd05145 65 WAEKEFRNLKRLYEAGVPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG-- 138 (190)
T ss_pred HHHHHHHHHHHHHhCCCCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 456899999999999986554433322 37999999988655443344678899999999999999999999 88
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhccC
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~ 120 (568)
|+||||||+||+++ ++.++|+|||++.....
T Consensus 139 ivHrDlkP~NIll~--~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 139 LVHGDLSEYNILYH--DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EecCCCChhhEEEE--CCCEEEEEcccceecCC
Confidence 99999999999997 68999999999976644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5e-14 Score=143.97 Aligned_cols=168 Identities=22% Similarity=0.381 Sum_probs=136.3
Q ss_pred HHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 9 RLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 9 ~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.-|.+..+.|. -++|...|.+ .....+-.||+|++ |-+|.|+..-+ ++|+.+++.-++.|++.-++|+|+++
T Consensus 69 QLrdEYr~YKlL~g~~GIP~vYYF--GqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~- 144 (449)
T KOG1165|consen 69 QLRDEYRTYKLLGGTEGIPQVYYF--GQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD- 144 (449)
T ss_pred hHHHHHHHHHHHcCCCCCCceeee--ccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc-
Confidence 5677889999995 5888888753 34444566899998 68999988755 46999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeC----CCCcEEEeecChhhhccCCC---------cccccCCCCccCccc-cccCCCccceehhhH
Q 008378 87 PIIHRDLKCDNIFVNG----NNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFMAPEL-YEEEYNELVDIYSFG 152 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~----~~g~vKI~DFGla~~~~~~~---------~~s~~GTp~YmAPEv-l~~~ys~ksDIWSLG 152 (568)
+|+|||||+|+||.. ....|.|+|||+|+.+..+. .++..||..||+--. +.++.+..-|+=|||
T Consensus 145 -LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLG 223 (449)
T KOG1165|consen 145 -LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALG 223 (449)
T ss_pred -eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhh
Confidence 999999999999941 22368999999999875543 346689999998763 456678899999999
Q ss_pred HHHHHHhhcCCCCCCCC--CHHHHHHHHHcC
Q 008378 153 MCILEMVTCEYPYNECK--NPAQIYKKVTSG 181 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~--~~~~i~~~i~~~ 181 (568)
-++++.+.|..||.+.. +..+.|++|-..
T Consensus 224 HvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 224 HVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 99999999999998743 456777777554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.49 E-value=1e-14 Score=149.87 Aligned_cols=158 Identities=18% Similarity=0.222 Sum_probs=100.7
Q ss_pred EEEEEecCCCCCHHHHHH---hCCC----CCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeec
Q 008378 40 INMITELFTSGSLRQYRK---KHKN----VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 112 (568)
Q Consensus 40 l~lV~Ey~~gGsL~~~i~---k~~~----l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DF 112 (568)
.+++|+-+ .++|.+++. .... +.......+..|++..+++||.+| ++|+||||+|+|++ .+|.+.|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~-~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDIKPENFLLD-QDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE--TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecccceeeEEEc-CCCCEEEcCh
Confidence 35677777 478888754 2222 223334456699999999999999 99999999999998 7899999999
Q ss_pred ChhhhccCCCcccccCCCCccCcccccc---------CCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 008378 113 GLAIVMQQPTARSVIGTPEFMAPELYEE---------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 183 (568)
Q Consensus 113 Gla~~~~~~~~~s~~GTp~YmAPEvl~~---------~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~ 183 (568)
+.....+..... ...+..|.+||+... .|+.+.|.|+||+++|.|++|..||............
T Consensus 190 ~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~~------ 262 (288)
T PF14531_consen 190 SSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEWD------ 262 (288)
T ss_dssp GGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGGG------
T ss_pred HHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccccc------
Confidence 876554332222 345678999997632 3788999999999999999999999753211100001
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCC
Q 008378 184 PASLSKVTDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 184 p~~~~~~~s~el~~lI~kcL~-~p~~R 209 (568)
-.... .++..++.+|..+|+ +|.+|
T Consensus 263 f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 263 FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 11122 567889999999997 46655
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.4e-14 Score=138.49 Aligned_cols=190 Identities=22% Similarity=0.301 Sum_probs=143.9
Q ss_pred HHHHHHHHHHhCCC-CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 9 RLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 9 ~l~~Ei~iLk~L~H-pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+..|.++.+.|+| ..|..++.++. +..+-.+||+++ |-+|.++.+-+ +.|+.+++.-++-|++.-++|+|.++
T Consensus 56 qL~yEskvY~iL~~g~GiP~i~~y~~--e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~- 131 (341)
T KOG1163|consen 56 QLLYESKVYRILQGGVGIPHIRHYGT--EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN- 131 (341)
T ss_pred chhHHHHHHHHhccCCCCchhhhhcc--ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc-
Confidence 46779999999976 56666665443 334677999998 68999988754 57999999999999999999999999
Q ss_pred CeEeeeccCCcEEEe--CCCCcEEEeecChhhhccCC---------CcccccCCCCccCcccc-ccCCCccceehhhHHH
Q 008378 87 PIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMC 154 (568)
Q Consensus 87 ~IiHRDLKp~NILl~--~~~g~vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGii 154 (568)
+|||||||+|+|.. .....+.++|||||+.+... ..+...||..|.+--.. .-..+..-|+=|+|.+
T Consensus 132 -fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYv 210 (341)
T KOG1163|consen 132 -FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYV 210 (341)
T ss_pred -cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcce
Confidence 99999999999973 23457899999999866332 23345799999875533 2345678899999999
Q ss_pred HHHHhhcCCCCCCCC--CHHHHHHHHHcCCC---CCCCCCCCcHHHHHHHHHhc
Q 008378 155 ILEMVTCEYPYNECK--NPAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCI 203 (568)
Q Consensus 155 lyEmltG~~Pf~~~~--~~~~i~~~i~~~~~---p~~~~~~~s~el~~lI~kcL 203 (568)
+.....|..||.+.. ...|.+.+|..... +..+-+..+.++--.+.=|=
T Consensus 211 LmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 211 LMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCR 264 (341)
T ss_pred eeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHh
Confidence 999999999998753 34566777665322 33344556777777776663
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.6e-12 Score=125.06 Aligned_cols=100 Identities=24% Similarity=0.329 Sum_probs=86.5
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
.++.+|+.++..+.|++|+....++.+.. ..++||||++|++|.+++..... ....++.+++.+|.++|+++
T Consensus 44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~-- 115 (211)
T PRK14879 44 ERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG-- 115 (211)
T ss_pred HHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--
Confidence 56889999999999999877666655543 46789999999999999876432 78899999999999999999
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~ 117 (568)
++|||++|.||+++ .+.++|+|||++..
T Consensus 116 i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 116 IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 99999999999997 67899999998854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.6e-13 Score=153.94 Aligned_cols=208 Identities=21% Similarity=0.387 Sum_probs=167.1
Q ss_pred HHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCC
Q 008378 17 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 96 (568)
Q Consensus 17 Lk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~ 96 (568)
+-..+||.++..+..|... ...++|++|+.+++|...+...+..+....+.++..+..+++|||+.. +.|||++|.
T Consensus 858 ~i~p~~P~v~~~~~s~~~r--sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~ 933 (1205)
T KOG0606|consen 858 LITPRSPAVVRSFPSFPCR--SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPD 933 (1205)
T ss_pred cccCCCCceecccCCCCCC--CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhccccccc
Confidence 3334568888777664433 368999999999999999998888899999999999999999999987 899999999
Q ss_pred cEEEeCCCCcEEEeecChhhhc-------cC--------------------------CCcccccCCCCccCcccc-ccCC
Q 008378 97 NIFVNGNNGEVKIGDLGLAIVM-------QQ--------------------------PTARSVIGTPEFMAPELY-EEEY 142 (568)
Q Consensus 97 NILl~~~~g~vKI~DFGla~~~-------~~--------------------------~~~~s~~GTp~YmAPEvl-~~~y 142 (568)
|++.. .+|+.++.+||..... .. ......+||+.|.+||.. ....
T Consensus 934 ~~l~~-~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h 1012 (1205)
T KOG0606|consen 934 SLLIA-YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH 1012 (1205)
T ss_pred chhhc-ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC
Confidence 99996 8899999999843210 00 001235799999999966 6678
Q ss_pred CccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHH---HHhc
Q 008378 143 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLK 217 (568)
Q Consensus 143 s~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~---ElL~ 217 (568)
...+|+|++|++++|.++|..||.. ..+.+++..+..+..+ ..-+...++++++++...+. .+.+|..+. ++-.
T Consensus 1013 gs~ad~~~~g~~l~e~l~g~pp~na-~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~ 1091 (1205)
T KOG0606|consen 1013 GSAADWWSSGVCLFEVLTGIPPFNA-ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKG 1091 (1205)
T ss_pred CCcchhhhhhhhhhhhhcCCCCCCC-cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCccccccccc
Confidence 8999999999999999999999976 5577777766665443 33445678999999999986 699999987 9999
Q ss_pred CCCCCCCCCCCcc
Q 008378 218 DPFLVTDNPKDLV 230 (568)
Q Consensus 218 hpff~~~~~~~l~ 230 (568)
||||+...|..+.
T Consensus 1092 ~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1092 HPFFQDVDWENLA 1104 (1205)
T ss_pred CCccCCCCccccc
Confidence 9999998887653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.7e-12 Score=122.96 Aligned_cols=98 Identities=24% Similarity=0.312 Sum_probs=81.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+++.+|+++++.+.|+++....-++.... ..++||||++|++|.+++..... .++.|++.+|.+||+.|
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g- 110 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG- 110 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC-
Confidence 467889999999999887554443344333 46789999999999998765332 88999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhh
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~ 117 (568)
++|||++|.||+++ ++.++++|||++..
T Consensus 111 -i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 111 -IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred -eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999999999997 68999999998855
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.5e-12 Score=142.56 Aligned_cols=98 Identities=21% Similarity=0.262 Sum_probs=85.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+++.+|+++|+.++|++|+..+.++.+.. ..++||||++|++|.+++. ....++.|++.+|.|||+++
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g- 448 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPE--EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG- 448 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC-
Confidence 467899999999999999988776666543 4679999999999999876 35678999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhc
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~ 118 (568)
++||||||+||+++ ++.++|+|||+++..
T Consensus 449 -iiHrDlkp~NILl~--~~~~~liDFGla~~~ 477 (535)
T PRK09605 449 -IVHGDLTTSNFIVR--DDRLYLIDFGLGKYS 477 (535)
T ss_pred -CccCCCChHHEEEE--CCcEEEEeCcccccC
Confidence 99999999999994 679999999998653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.1e-12 Score=126.15 Aligned_cols=104 Identities=16% Similarity=0.235 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHHHhCCCCCe--eeeeeEEEcCCCC--eEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 6 QLERLYSEVHLLKSLKHENI--IKFYNSWVDDTNR--TINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNI--V~l~~~~~~~~~~--~l~lV~Ey~~g-GsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
...++.+|++++..|+|++| ++.+.+....... ..++||||++| .+|.+++.. ..+++.. +.||+.+|.+
T Consensus 83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~ 157 (239)
T PRK01723 83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIAR 157 (239)
T ss_pred hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHH
Confidence 44678899999999998875 6666654433221 23599999997 689998865 3566543 5789999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~ 117 (568)
||.+| |+||||||.|||++ .++.++|+|||.+..
T Consensus 158 lH~~G--I~HrDlkp~NILv~-~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 158 FHDAG--VYHADLNAHNILLD-PDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHCC--CCCCCCCchhEEEc-CCCCEEEEECCCccc
Confidence 99999 99999999999997 567999999998865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.8e-12 Score=125.72 Aligned_cols=104 Identities=20% Similarity=0.203 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHhCCCC--CeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 8 ERLYSEVHLLKSLKHE--NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 8 e~l~~Ei~iLk~L~Hp--NIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+|+++++++.+. .+.+++.. . ..++||||+.|++|..+......+....+..++.||+.+|.+||.+|
T Consensus 95 ~~~~~E~~~L~~L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 95 LWAEKEFRNLQRLYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC
Confidence 3467899999999763 34444442 1 24799999999888776544556777778899999999999999986
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~ 120 (568)
+++||||||+||+++ .+.++|+|||.+.....
T Consensus 169 -~iiH~Dikp~NIli~--~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 169 -ELVHGDLSEYNILVH--DGKVVIIDVSQSVELDH 200 (237)
T ss_pred -CEEeCCCChhhEEEE--CCCEEEEEChhhhccCC
Confidence 499999999999997 67999999999875443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.1e-12 Score=147.40 Aligned_cols=145 Identities=23% Similarity=0.326 Sum_probs=118.0
Q ss_pred HHHHhCC---CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEee
Q 008378 15 HLLKSLK---HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 91 (568)
Q Consensus 15 ~iLk~L~---HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHR 91 (568)
+++.+|+ -+-|++++..++..+ .-++|+||.+.|+|.++++..+..++..+..+..|++..++.||..+ |||+
T Consensus 743 q~~~RLk~~~~~~~~~~~~a~~~~~--~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHg 818 (974)
T KOG1166|consen 743 QVMERLKPQMLPSIMHISSAHVFQN--ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHG 818 (974)
T ss_pred HHHHhhchhhhcchHHHHHHHccCC--cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecc
Confidence 4455555 345566666555443 45789999999999999999899999999999999999999999999 9999
Q ss_pred eccCCcEEEeC------CCCcEEEeecChhhhcc---CC-CcccccCCCCccCcccccc-CCCccceehhhHHHHHHHhh
Q 008378 92 DLKCDNIFVNG------NNGEVKIGDLGLAIVMQ---QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 92 DLKp~NILl~~------~~g~vKI~DFGla~~~~---~~-~~~s~~GTp~YmAPEvl~~-~ys~ksDIWSLGiilyEmlt 160 (568)
||||+|++|.. ..--++|+|||-+..+. .. ..+.+++|-.|-.+|+..+ ..+..+|.|.|+-+++-|+.
T Consensus 819 DiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF 898 (974)
T KOG1166|consen 819 DIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF 898 (974)
T ss_pred cCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH
Confidence 99999999941 23358999999996553 22 3456688999999998854 57889999999999999999
Q ss_pred cCC
Q 008378 161 CEY 163 (568)
Q Consensus 161 G~~ 163 (568)
|++
T Consensus 899 G~y 901 (974)
T KOG1166|consen 899 GKY 901 (974)
T ss_pred HHH
Confidence 974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-11 Score=135.04 Aligned_cols=207 Identities=25% Similarity=0.284 Sum_probs=161.6
Q ss_pred HHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHhh
Q 008378 8 ERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILR----GLHYL 81 (568)
Q Consensus 8 e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~-l~e~~i~~i~~QIl~----gL~yL 81 (568)
.+=++|+...+.+ .|+|.++.+..|...+ .+|+-+|+|. .+|..|...... ++...++..+.+... ||.++
T Consensus 162 ~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~--~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~ 238 (524)
T KOG0601|consen 162 KRKLREFLSHHKIDSHENPVRDSPAWEGSG--ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL 238 (524)
T ss_pred ccccchhhcccccCccccccccCcccccCC--cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhccccccccc
Confidence 3445666666677 5999999999886554 6888889995 788888876655 899999999999999 99999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcc-------cccCCCCccCccccccCCCccceehhhHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-------SVIGTPEFMAPELYEEEYNELVDIYSFGMC 154 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~-------s~~GTp~YmAPEvl~~~ys~ksDIWSLGii 154 (568)
|+.+ ++|-|+||.||+...+....+++|||+...+...... .-.|...|++||+.+.-++...|||++|.+
T Consensus 239 hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev 316 (524)
T KOG0601|consen 239 HSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEV 316 (524)
T ss_pred CCCc--ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhh
Confidence 9999 9999999999999743378999999998877554321 125777899999999999999999999999
Q ss_pred HHHHhhcCCCCCCC--CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 155 ILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 155 lyEmltG~~Pf~~~--~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
..+..++..+.... ....++ ..+..|.++-...+..++..+..++. .+..|+++..+++|++...
T Consensus 317 ~l~~~l~~~~~~~g~~~~W~~~----r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 317 ILEAILGSHLPSVGKNSSWSQL----RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hHhhHhhcccccCCCCCCcccc----ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 99999987776554 222222 12223444444455667778888886 5889999999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.4e-11 Score=114.55 Aligned_cols=97 Identities=23% Similarity=0.216 Sum_probs=78.1
Q ss_pred HHHHHHHHHHhCCCCC--eeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 9 RLYSEVHLLKSLKHEN--IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpN--IV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
...+|+.++..+.|++ ++..++ . ...++||||++|++|..+... .....++.+|+.++.++|.+|
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~--~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g- 145 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----W--NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG- 145 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----c--CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC-
Confidence 4678999999998874 444443 1 235899999999999765331 456788999999999999998
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~ 120 (568)
++||||||+||+++ .++.++|+|||++.....
T Consensus 146 -i~H~Dl~p~Nill~-~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 146 -IIHGDLSEFNILVD-DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred -CCcCCCCcccEEEc-CCCcEEEEECCccccCCC
Confidence 99999999999997 688999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.1e-10 Score=123.37 Aligned_cols=146 Identities=27% Similarity=0.365 Sum_probs=112.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh-
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS- 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs- 83 (568)
+..+...+-++-|+.|+||||++|++.+..++ .+|+|||-+. .|..++++.+ ...+.--+.||+.||.|||.
T Consensus 51 ~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d 123 (690)
T KOG1243|consen 51 EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDD 123 (690)
T ss_pred hhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeeccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhcc
Confidence 34566788899999999999999999886554 7999999884 7888888744 66777789999999999984
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccccCCCccceehhhHHHHHHHhhc
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG 161 (568)
.+ ++|++|.-+.|||+ ..|..||++|.+........ .+...---.|..|+.+... ....|.|-|||++++++.|
T Consensus 124 ~~--lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 124 CN--LVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred CC--eeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 45 99999999999998 88999999998875443222 1222222235555543211 1457999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.06 E-value=4e-10 Score=101.25 Aligned_cols=101 Identities=23% Similarity=0.163 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHHhCCC--CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~H--pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+|+.+++.++| .++++++.+.... ...++++||+.++.+..+ +......++.++..+|.++|..
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~ 105 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQL 105 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCC
Confidence 3578899999999977 5889988866443 468999999998887654 5677788899999999999985
Q ss_pred C-CCeEeeeccCCcEEEeCCCCcEEEeecChhhh
Q 008378 85 N-PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117 (568)
Q Consensus 85 g-~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~ 117 (568)
. .+++|+|++|.||+++ ..+.+++.|||.+..
T Consensus 106 ~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~ 138 (155)
T cd05120 106 PLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY 138 (155)
T ss_pred CceEEEecCCCcceEEEE-CCcEEEEEecccccC
Confidence 2 2399999999999998 578999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.5e-09 Score=103.50 Aligned_cols=98 Identities=22% Similarity=0.224 Sum_probs=71.7
Q ss_pred HHHHHHHHhCCCCC--eeeeeeEEEcCCCCeEEEEEecCCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHhhhh-CCC
Q 008378 11 YSEVHLLKSLKHEN--IIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHS-HNP 86 (568)
Q Consensus 11 ~~Ei~iLk~L~HpN--IV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~-i~k~~~l~e~~i~~i~~QIl~gL~yLHs-~g~ 86 (568)
..|.+.+..+.+.. +.+.+... ..++||||++++.+... +... ... ..+..++.+++.++.++|. ++
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~- 135 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDLN------RHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG- 135 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEecC------CCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC-
Confidence 45777777775543 44455421 25899999998543211 1111 111 6788999999999999999 88
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~ 120 (568)
|+||||||+||+++ ++.++|+|||.+.....
T Consensus 136 -ivH~Dl~p~Nili~--~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 136 -LVHGDLSEYNILVD--DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -cCcCCCChhhEEEE--CCcEEEEECcccccccC
Confidence 99999999999997 78999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.7e-09 Score=115.89 Aligned_cols=202 Identities=23% Similarity=0.245 Sum_probs=141.9
Q ss_pred HHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 10 LYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 10 l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
-..|+.+...+ .|.++++++..|..-.+ .|+=-|||.++++...+.-...+++...++...|++.++.++|+.. +
T Consensus 312 sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~ 387 (524)
T KOG0601|consen 312 SLGEVILEAILGSHLPSVGKNSSWSQLRQ--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--F 387 (524)
T ss_pred chhhhhHhhHhhcccccCCCCCCcccccc--ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--h
Confidence 35677777777 69999999999976554 4567799999998877765567899999999999999999999988 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCcc-Ccccc-c-cCCCccceehhhHHHHHHHhhcCCCC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-APELY-E-EEYNELVDIYSFGMCILEMVTCEYPY 165 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~Ym-APEvl-~-~~ys~ksDIWSLGiilyEmltG~~Pf 165 (568)
+|+|+||.||++...++.-+++|||.++.+..... ...++-+++ ++|++ + ..+..++|++|||..+.+.+++. |+
T Consensus 388 ~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~-~l 465 (524)
T KOG0601|consen 388 VHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS-PL 465 (524)
T ss_pred hcccccccceeeccchhhhhccccccccccceecc-cccccccccccchhhccccccccccccccccccccccccCc-cc
Confidence 99999999999973347889999998865322111 112333444 24544 3 34788999999999999999986 34
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 166 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 166 ~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
..... ....+..+..|. .+.. ..++..+.+.++. ++..|+.+.++..|.=|.
T Consensus 466 s~~~~---~~~~i~~~~~p~-~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 466 SESGV---QSLTIRSGDTPN-LPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred Ccccc---cceeeecccccC-CCch-HHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 32111 112222332221 1111 2566666666664 577888888888776553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.7e-08 Score=98.78 Aligned_cols=101 Identities=19% Similarity=0.244 Sum_probs=77.1
Q ss_pred HHHHHHHHhCCC--CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh-hhCCCC
Q 008378 11 YSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPP 87 (568)
Q Consensus 11 ~~Ei~iLk~L~H--pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL-Hs~g~~ 87 (568)
.+|++.|++|.. -++.+.+.+ . .-++||||+.++.+..-.-+...++...+..+..|++.+|..+ |..|
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g-- 145 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN-- 145 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 489999999953 577777763 1 2467999997654432222233466677788899999999999 8998
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhccCC
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~ 121 (568)
++|+||++.||++. +|.+.|+|||.+.....+
T Consensus 146 lVHGDLs~~NIL~~--~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 146 LVHADLSEYNMLWH--DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred eecCCCCHHHEEEE--CCcEEEEECCCceeCCCC
Confidence 99999999999996 578999999988665443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.6e-08 Score=92.23 Aligned_cols=94 Identities=23% Similarity=0.139 Sum_probs=70.1
Q ss_pred HHHHHHHHHHhCCCCCeee-eeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC-
Q 008378 9 RLYSEVHLLKSLKHENIIK-FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP- 86 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~-l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~- 86 (568)
.+.+|+.+++.+.+.++++ ++.. +.. .-++||||++|.++... ......++.+++.+|..||..+.
T Consensus 38 ~~~~E~~~l~~l~~~~~~P~~~~~--~~~--~~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~ 105 (170)
T cd05151 38 NRENEAENSKLAAEAGIGPKLYYF--DPE--TGVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLP 105 (170)
T ss_pred CHHHHHHHHHHHHHhCCCCceEEE--eCC--CCeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCC
Confidence 4678999999997665544 4443 222 23689999999887643 11124567899999999999872
Q ss_pred --CeEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 87 --PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 87 --~IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
.++|+|++|.||+++ ++.++++|||.+.
T Consensus 106 ~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 106 DLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred CceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 149999999999997 5689999999774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.5e-07 Score=90.74 Aligned_cols=98 Identities=23% Similarity=0.280 Sum_probs=74.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.++..+|.++|.+++--.|.--+-++++..+ -.++|||++|-.|++++... . ..+++.+-.-+.-||..|
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~--~~I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~g- 112 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDN--GLIVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAG- 112 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CEEEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcC-
Confidence 3567889999999965444333333355554 45688999999999998876 2 455666666677799999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhh
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~ 117 (568)
|+|+||.++||++. ++.+.++||||+..
T Consensus 113 -ivHGDLTtsNiIl~--~~~i~~IDfGLg~~ 140 (204)
T COG3642 113 -IVHGDLTTSNIILS--GGRIYFIDFGLGEF 140 (204)
T ss_pred -eecCCCccceEEEe--CCcEEEEECCcccc
Confidence 99999999999996 45599999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.3e-07 Score=98.61 Aligned_cols=179 Identities=18% Similarity=0.270 Sum_probs=125.4
Q ss_pred HHHHHHhCCCCCeeeeeeEEEcCC--CCeEEEEEecCCC-CCHHHHHH---------------hCCCCCHHHHHHHHHHH
Q 008378 13 EVHLLKSLKHENIIKFYNSWVDDT--NRTINMITELFTS-GSLRQYRK---------------KHKNVDMKAIKNWARQI 74 (568)
Q Consensus 13 Ei~iLk~L~HpNIV~l~~~~~~~~--~~~l~lV~Ey~~g-GsL~~~i~---------------k~~~l~e~~i~~i~~QI 74 (568)
=+++++++.|+|||+|.++|.... ...+++|++|.++ ++|.++.- ...+.++..+|.++.||
T Consensus 323 lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QL 402 (655)
T KOG3741|consen 323 LVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQL 402 (655)
T ss_pred HHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHH
Confidence 378899999999999999887433 2478999999986 56766431 12347899999999999
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHH
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC 154 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGii 154 (568)
..||.++|+.| +.=+-|.|.+|+++|+ -+++|...|+...+..... +.++. -.+-|.=.||.+
T Consensus 403 taaL~sIHssG--LAck~L~~~kIlv~G~-~RIriS~C~i~Dvl~~d~~------------~~le~--~Qq~D~~~lG~l 465 (655)
T KOG3741|consen 403 TAALYSIHSSG--LACKTLDLKKILVTGK-MRIRISGCGIMDVLQEDPT------------EPLES--QQQNDLRDLGLL 465 (655)
T ss_pred HHHHHHHHhcC--ceeecccHhHeEeeCc-ceEEEecccceeeecCCCC------------cchhH--HhhhhHHHHHHH
Confidence 99999999999 8779999999999854 3888888887765543321 11211 134577889999
Q ss_pred HHHHhhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCcHHHHHHHHHhcCC-CCCCCCHHHHhcC
Q 008378 155 ILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 218 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i-~~~i~~~~~p~~~~~~~s~el~~lI~kcL~~-p~~Rpsa~ElL~h 218 (568)
++.|.||..--......... .+.|+ ..++.+++++|.-+... +.+ .+..+++.+
T Consensus 466 l~aLAt~~~ns~~~d~~~~s~~~~I~---------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 466 LLALATGTENSNRTDSTQSSHLTRIT---------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHhhcccccccccchHHHHHHHhh---------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999995322111222222 22222 34567888888776653 333 677777655
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.1e-07 Score=87.59 Aligned_cols=108 Identities=22% Similarity=0.322 Sum_probs=81.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHhhhh
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS-GSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~g-GsL~~~i~k~~~--l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.++..+|+++|.++.--.|.--.-+|.|....++ +|||++| -++.+++..... ........++++|-..+.-||.
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i--~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ 131 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI--YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD 131 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE--EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh
Confidence 4678899999999975444433334566665555 5699986 378999886532 2333347889999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcE--EEeecChhhhc
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEV--KIGDLGLAIVM 118 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~v--KI~DFGla~~~ 118 (568)
++ +||+||..+||++..+++.+ .++|||++...
T Consensus 132 nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 132 ND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred CC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99 99999999999998655554 89999998543
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.8e-08 Score=68.05 Aligned_cols=32 Identities=38% Similarity=0.523 Sum_probs=27.4
Q ss_pred eEEEEEecCCCC------CcceeeeecccCCCCHhHHH
Q 008378 303 VSLTLRIGDKSG------HVSNIHFVFYLNADTAISIA 334 (568)
Q Consensus 303 i~L~Lri~d~~g------~~r~I~F~F~~~~Dta~~vA 334 (568)
|.|+||++|+++ +.++|+|+|++++|+|++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 689999999998 88999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=6e-08 Score=108.21 Aligned_cols=153 Identities=19% Similarity=0.291 Sum_probs=108.3
Q ss_pred HHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcc-----------cccCCCCccCccccc
Q 008378 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----------SVIGTPEFMAPELYE 139 (568)
Q Consensus 71 ~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~-----------s~~GTp~YmAPEvl~ 139 (568)
+.++..|+.|+|.+- .+||+.|.|++|.++ ..|..||+.|+++.....+... ...-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA-k~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA-KVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc-ceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345569999999873 599999999999998 7899999999987654332110 112345799999774
Q ss_pred -cCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 008378 140 -EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT--SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE 214 (568)
Q Consensus 140 -~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~--~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~E 214 (568)
...+.++|++|||+.+|.+.. |..-+... +....+.... .+..........++++++=+.+++. ++..||++.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN-GGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc-CCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 446789999999999999884 44444332 2111121111 1112223446678999999999995 7899999999
Q ss_pred HhcCCCCCCCCC
Q 008378 215 LLKDPFLVTDNP 226 (568)
Q Consensus 215 lL~hpff~~~~~ 226 (568)
++..|||....-
T Consensus 262 l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 262 LLSIPFFSDPGL 273 (700)
T ss_pred hhcccccCCchh
Confidence 999999987544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.2e-07 Score=101.70 Aligned_cols=103 Identities=21% Similarity=0.228 Sum_probs=69.9
Q ss_pred HHHHHHHHHhCC----CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHhhhh
Q 008378 10 LYSEVHLLKSLK----HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILR-GLHYLHS 83 (568)
Q Consensus 10 l~~Ei~iLk~L~----HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~-gL~yLHs 83 (568)
+.+|.+.+.++. |.+-|.+-..+.+.. ..-++||||++|++|.++.... ..++ ...++.+++. .+..+|.
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 566777777763 333333322222212 2357999999999998876532 1232 2345555554 4677899
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~ 119 (568)
.| ++|+|+||.||+++ .+|.++++|||++..+.
T Consensus 276 ~g--~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DG--FFHADLHPGNIFVL-KDGKIIALDFGIVGRLS 308 (437)
T ss_pred CC--ceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence 88 99999999999996 78899999999986553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.4e-06 Score=89.45 Aligned_cols=107 Identities=18% Similarity=0.156 Sum_probs=80.4
Q ss_pred HHHHHHHHHHhCCCCCe--eeeeeEEEcC---CCCeEEEEEecCCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHh
Q 008378 9 RLYSEVHLLKSLKHENI--IKFYNSWVDD---TNRTINMITELFTSG-SLRQYRKKH--KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNI--V~l~~~~~~~---~~~~l~lV~Ey~~gG-sL~~~i~k~--~~l~e~~i~~i~~QIl~gL~y 80 (568)
.+.+|.+.+..|..-+| ++...+.... ....-++|||++++- +|.+++... ...+......++.++...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 37789999988843332 2233233221 123567999999875 899998653 446677888999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeC------CCCcEEEeecChhhh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNG------NNGEVKIGDLGLAIV 117 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~------~~g~vKI~DFGla~~ 117 (568)
||.+| |+|+||++.|||++. ..+.+.++||+.+..
T Consensus 154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999 999999999999973 246899999997753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.40 E-value=2e-06 Score=84.51 Aligned_cols=109 Identities=21% Similarity=0.198 Sum_probs=83.3
Q ss_pred HHHHHHHHHHHhCCCC--CeeeeeeEEEcCC--CCeEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 8 ERLYSEVHLLKSLKHE--NIIKFYNSWVDDT--NRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 8 e~l~~Ei~iLk~L~Hp--NIV~l~~~~~~~~--~~~l~lV~Ey~~g-GsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+|...+..|..- .+++.+.+..... ....++|||++++ .+|.+++......+......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4678899888888532 2333343333222 1346899999987 479999988666888888999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCC--CcEEEeecChhhhc
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVM 118 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~--g~vKI~DFGla~~~ 118 (568)
.+| |+|+|+++.|||++... ..+.++||+-+...
T Consensus 136 ~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999 99999999999998332 26889999977543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.39 E-value=5e-07 Score=100.93 Aligned_cols=70 Identities=17% Similarity=0.256 Sum_probs=54.2
Q ss_pred eEEEEEecCCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCC----cEE
Q 008378 39 TINMITELFTSGSLRQY--RKKHK----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVK 108 (568)
Q Consensus 39 ~l~lV~Ey~~gGsL~~~--i~k~~----~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g----~vK 108 (568)
.-++||||+.|+.+.++ +.+.+ .+.+..+..++.|++. .| ++|+|+||+||+++ .+| .++
T Consensus 235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~-------~G--ffHaDpHPGNIlv~-~~g~~~~~i~ 304 (537)
T PRK04750 235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR-------DG--FFHADMHPGNIFVS-YDPPENPRYI 304 (537)
T ss_pred CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-------CC--eeeCCCChHHeEEe-cCCCCCCeEE
Confidence 45799999999999874 33333 2555566677777763 67 99999999999997 555 999
Q ss_pred EeecChhhhc
Q 008378 109 IGDLGLAIVM 118 (568)
Q Consensus 109 I~DFGla~~~ 118 (568)
++|||+...+
T Consensus 305 llDFGivg~l 314 (537)
T PRK04750 305 ALDFGIVGSL 314 (537)
T ss_pred EEecceEEEC
Confidence 9999998655
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.2e-06 Score=102.51 Aligned_cols=206 Identities=21% Similarity=0.333 Sum_probs=145.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCC--eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~--~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.++....-|+..+..+.|+|++.++.|-...... .+.+..++|..-++...++.-+.++...++.|..+++.||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 4556667788889999999999999877644322 23456789999999999999899999999999999999999999
Q ss_pred hCCCCeEeeeccCC---cEEEeCCCCcEEEe--ecChhhhccCCC-cccccCCCCccCccccccC-C--CccceehhhHH
Q 008378 83 SHNPPIIHRDLKCD---NIFVNGNNGEVKIG--DLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-Y--NELVDIYSFGM 153 (568)
Q Consensus 83 s~g~~IiHRDLKp~---NILl~~~~g~vKI~--DFGla~~~~~~~-~~s~~GTp~YmAPEvl~~~-y--s~ksDIWSLGi 153 (568)
++. ..|.-|... +--.+ ..+.+.++ ||+....+.... .....-+..+.|||..... + ..+.|+|++|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 986 666655555 22222 23456666 787776654332 2233456678888877443 3 33469999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
....+..|..+-.... . ...+ ++........++..+|+. ++.+|+++.+++.|||.+...
T Consensus 381 l~~~~~~~~~i~~~~~---~-~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA---V-PVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HHhhhhhcCccccccc---c-hhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 9999998865432211 1 1111 111222267888899995 699999999999999987543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.2e-06 Score=85.25 Aligned_cols=101 Identities=27% Similarity=0.321 Sum_probs=67.9
Q ss_pred HHHHHHHHHHHHhCCCC--CeeeeeeEEEcCCCCeEEEEEecCC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh-h
Q 008378 7 LERLYSEVHLLKSLKHE--NIIKFYNSWVDDTNRTINMITELFT--SGSLRQYRKKHKNVDMKAIKNWARQILRGLHY-L 81 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~Hp--NIV~l~~~~~~~~~~~l~lV~Ey~~--gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y-L 81 (568)
.....+|.++|+++..- ++.+.+++ .. -++||||+. |..+..+.... ++......++.+++..+.. +
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~--~~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~ 123 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDY--NR----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKML 123 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEE--ET----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEE--eC----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHH
Confidence 45678899999999766 56777753 22 257999998 65565543322 2245567778888885555 5
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~ 119 (568)
|..| ++|+||.+.||+++ .+.+.|+|||.+....
T Consensus 124 ~~~g--ivHGDLs~~NIlv~--~~~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 124 HKAG--IVHGDLSEYNILVD--DGKVYIIDFGQAVDSS 157 (188)
T ss_dssp HCTT--EEESS-STTSEEEE--TTCEEE--GTTEEETT
T ss_pred HhcC--ceecCCChhhEEee--cceEEEEecCcceecC
Confidence 7888 99999999999997 3489999999886544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.7e-06 Score=87.21 Aligned_cols=172 Identities=19% Similarity=0.304 Sum_probs=120.5
Q ss_pred eEEEEEecCCCCC-HHHHH------HhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEee
Q 008378 39 TINMITELFTSGS-LRQYR------KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 111 (568)
Q Consensus 39 ~l~lV~Ey~~gGs-L~~~i------~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~D 111 (568)
.+.|+|..+.+.. ...+. +....+++.-+.+.++.|..+..-||.+| ..-+|+.++|+|+. +++.|.+.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEEc
Confidence 4888999988742 22222 23345788899999999999999999999 99999999999996 889999987
Q ss_pred cChhhh-ccCCCcccccCCCCccCccccc------cCCCccceehhhHHHHHHHhhc-CCCCCCCC------CHHH--HH
Q 008378 112 LGLAIV-MQQPTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTC-EYPYNECK------NPAQ--IY 175 (568)
Q Consensus 112 FGla~~-~~~~~~~s~~GTp~YmAPEvl~------~~ys~ksDIWSLGiilyEmltG-~~Pf~~~~------~~~~--i~ 175 (568)
=..-.. .........+|.++|.+||+-. -+-+...|.|.||+++++++.| +.||++.. ++-+ |.
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 442222 1122223458999999999653 2346779999999999999986 99997631 1111 10
Q ss_pred -------HHHHcCCC--CCCC-CCCCcHHHHHHHHHhcCC---CCCCCCHH
Q 008378 176 -------KKVTSGIK--PASL-SKVTDPQVKQFIEKCIVP---ASLRLPAL 213 (568)
Q Consensus 176 -------~~i~~~~~--p~~~-~~~~s~el~~lI~kcL~~---p~~Rpsa~ 213 (568)
+.-..+.+ |..+ ....+|.++.+..+|+.. +.-||+++
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 11111222 2222 245689999999999963 56899965
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.3e-06 Score=83.08 Aligned_cols=110 Identities=21% Similarity=0.242 Sum_probs=79.9
Q ss_pred HHHHHHHHHHHHhCCC--CCeeeeeeEEEcCC-CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 7 LERLYSEVHLLKSLKH--ENIIKFYNSWVDDT-NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~H--pNIV~l~~~~~~~~-~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..++.+|+++++.+.+ .++.+++.+..... ....++||||++|.++...+.. ..+++.....++.+++.+|.+||+
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHS 117 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhC
Confidence 4578899999999976 44566666543221 1256899999999888765432 456777777888888888888874
Q ss_pred CC------------------------------------------------------CCeEeeeccCCcEEEeCC-CCcEE
Q 008378 84 HN------------------------------------------------------PPIIHRDLKCDNIFVNGN-NGEVK 108 (568)
Q Consensus 84 ~g------------------------------------------------------~~IiHRDLKp~NILl~~~-~g~vK 108 (568)
.. ..++|+|++|+||+++.+ .+.+.
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~ 197 (223)
T cd05154 118 VDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVA 197 (223)
T ss_pred CChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEE
Confidence 21 236999999999999843 46689
Q ss_pred EeecChhhh
Q 008378 109 IGDLGLAIV 117 (568)
Q Consensus 109 I~DFGla~~ 117 (568)
|+||+.+..
T Consensus 198 iID~e~~~~ 206 (223)
T cd05154 198 VLDWELATL 206 (223)
T ss_pred EEecccccc
Confidence 999997743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.7e-07 Score=102.21 Aligned_cols=202 Identities=21% Similarity=0.273 Sum_probs=138.1
Q ss_pred HHHHHHHHHHhCCCCC-eeeeeeEEEcCCCCeEEEEEecCCCC-CHHHHH-HhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 9 RLYSEVHLLKSLKHEN-IIKFYNSWVDDTNRTINMITELFTSG-SLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpN-IV~l~~~~~~~~~~~l~lV~Ey~~gG-sL~~~i-~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
...-++++|.+++||| .+.+++.+ +...+.+++++++.++ +-..-+ .....+.+-+.....+.=..+|+|+|+..
T Consensus 279 ~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~ 356 (829)
T KOG0576|consen 279 SRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY 356 (829)
T ss_pred hhHHHHHHHHHccCCCCcccccccC--CcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc
Confidence 3455899999999999 66666644 3345789999999887 222111 11123444456667777788999999875
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
-+||| ||+. ..+.+|.++|+.+..+... ..++..+|+.++|||+. +..+....|.|++|.-..+|.-|..
T Consensus 357 --~~~~d----~~l~--s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 357 --KVHRD----NILG--SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred --ccCcc----cccc--cccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCC
Confidence 58998 7776 4689999999998877544 45677899999999976 5668999999999998888888887
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCC---CC-CCCcH-HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 164 PYNECKNPAQIYKKVTSGIKPAS---LS-KVTDP-QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~---~~-~~~s~-el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|-... +... .. -+..|.. .. ...++ .-+++...|+. .|..|+..-..+.|.+|....
T Consensus 429 Pr~~P--~~~~-~~--~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 429 PRSSP--PAVL-PM--IGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CCCCC--cccc-CC--CCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 76541 1110 01 1111100 00 01111 22247778886 488889999999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00023 Score=70.55 Aligned_cols=107 Identities=17% Similarity=0.183 Sum_probs=79.8
Q ss_pred HHHHHHHHHHHhCCCC--Ceeeee--eEEEcCCCCeEEEEEecCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHh
Q 008378 8 ERLYSEVHLLKSLKHE--NIIKFY--NSWVDDTNRTINMITELFTS-GSLRQYRKKH--KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 8 e~l~~Ei~iLk~L~Hp--NIV~l~--~~~~~~~~~~l~lV~Ey~~g-GsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~y 80 (568)
..|.+|+.+|++|..- .+.+.. +.--......-+||+|-+.+ -+|.+++..+ .+.+......++.++...+.-
T Consensus 64 ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~ 143 (216)
T PRK09902 64 PTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKK 143 (216)
T ss_pred hHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHH
Confidence 4688999999999532 233333 21112223356799997754 5899988764 345777888999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCc--EEEeecChhhh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIV 117 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~--vKI~DFGla~~ 117 (568)
||..| +.|+|+-+.|||++ ..|. ++++||.-++.
T Consensus 144 LH~~G--v~Hgdly~khIll~-~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 144 MHSVN--RQHGCCYVRHIYVK-TEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHCC--CcCCCCCHhheeec-CCCCeeEEEEEhhccch
Confidence 99999 99999999999997 3455 99999986643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.61 E-value=8.7e-06 Score=97.31 Aligned_cols=214 Identities=14% Similarity=0.025 Sum_probs=147.8
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~QIl~gL~yL 81 (568)
..+.+..|+.-++...|+++...+.-.........|.+++|+.+|.++..+-++ ..++..-+....++.+.+..-+
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 345566777778888999999999876666667788999999999999988754 3455555555555656777666
Q ss_pred hhC---CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc-CCCccceehhhHHHH
Q 008378 82 HSH---NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~---g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~-~ys~ksDIWSLGiil 155 (568)
|+. |--.+|++||+-|.++.+ +-.+|++++|+.+..... .....+++|.|++|++..+ .++.++|+|..|+-+
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVt-ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVT-NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hhcccCCccchhhhhhhhccceec-CCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 654 223689999999999984 458999999999854332 3456788999999998854 578889999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh-cCCCCCCCCHHHHhcCCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLV 222 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kc-L~~p~~Rpsa~ElL~hpff~ 222 (568)
|+...|..+|-.. ..-..+.+.........++..+.+.-...... +-+...||+-...+..+.|.
T Consensus 1431 y~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9999888777431 11112222222233334444333333333333 34667788888877776664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00031 Score=70.01 Aligned_cols=67 Identities=22% Similarity=0.346 Sum_probs=52.2
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhh
Q 008378 39 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117 (568)
Q Consensus 39 ~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~ 117 (568)
..+|||||++|..|.++.. +++ .+...|..++.-||.+| +.|+|.+|.|++++ ++.+++.||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~--~~~i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS--NNGIRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE--CCcEEEEECccccc
Confidence 4568999999988876532 333 24456777889999999 99999999999997 45699999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00051 Score=66.93 Aligned_cols=100 Identities=26% Similarity=0.192 Sum_probs=78.1
Q ss_pred HHHHHHHHhCCC-CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC-
Q 008378 11 YSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILRGLHYLHSHN- 85 (568)
Q Consensus 11 ~~Ei~iLk~L~H-pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~---~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g- 85 (568)
..|.-+|+.+++ ++++++++++ + -++|+||...+++.. .+...-.-++....+++.+++..+++|+..-
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---G---~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---G---RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---C---CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358899999977 6999999987 2 256899998776532 1222334689999999999999999997631
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~ 117 (568)
..+.-.|++++|+-++ ++|++|+.|..-...
T Consensus 81 ~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVN-DDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEe-CCCcEEEEechhcch
Confidence 1278889999999998 789999999986643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00043 Score=70.80 Aligned_cols=95 Identities=22% Similarity=0.231 Sum_probs=69.4
Q ss_pred HHHHHHHHHHHHhCCCC--CeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHE--NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~Hp--NIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.....+|.++|+.|.-. .|.+-+++ +.-.+||||++|-.|.... ++......++..|+.-+.-+-..
T Consensus 153 Rl~A~rEf~~L~~L~~~G~~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~ 221 (304)
T COG0478 153 RLAAEREFEALQRLYPEGVKVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR 221 (304)
T ss_pred HHHHHHHHHHHHHhhhcCCCCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc
Confidence 34567899999999655 77777762 2346799999987775433 23444555555555555555566
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla 115 (568)
| ++|+|+.+-||+++ .+|.+.++||--+
T Consensus 222 G--iVHGDlSefNIlV~-~dg~~~vIDwPQ~ 249 (304)
T COG0478 222 G--IVHGDLSEFNILVT-EDGDIVVIDWPQA 249 (304)
T ss_pred C--ccccCCchheEEEe-cCCCEEEEeCccc
Confidence 7 99999999999997 7899999999644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0038 Score=62.37 Aligned_cols=45 Identities=16% Similarity=0.059 Sum_probs=32.0
Q ss_pred HHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHH
Q 008378 8 ERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 54 (568)
Q Consensus 8 e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~ 54 (568)
..+.+|+++++.+. +--+.+++.+.... ..-++|||+++|.+|..
T Consensus 36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 36 YELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHhH
Confidence 35778999999984 44456677655433 35678999999877764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0074 Score=60.35 Aligned_cols=29 Identities=24% Similarity=0.310 Sum_probs=24.3
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
+.++|+|+.|.||+++ .+| +.|+||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~-~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITS-GKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEc-CCC-cEEEechhcC
Confidence 3478999999999997 555 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.013 Score=56.67 Aligned_cols=112 Identities=23% Similarity=0.289 Sum_probs=59.5
Q ss_pred HHHHHHHHHHHHHHhCCCC--CeeeeeeEEEcC-CCCeEEEEEecCCCCCHHH----------------HHH---hC---
Q 008378 5 DQLERLYSEVHLLKSLKHE--NIIKFYNSWVDD-TNRTINMITELFTSGSLRQ----------------YRK---KH--- 59 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~Hp--NIV~l~~~~~~~-~~~~l~lV~Ey~~gGsL~~----------------~i~---k~--- 59 (568)
.....+.+|+.+++.|... .+.+++...... .....+++|++++|..+.. .+. +.
T Consensus 32 ~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~ 111 (239)
T PF01636_consen 32 DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPP 111 (239)
T ss_dssp HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTT
T ss_pred CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhccccccc
Confidence 3567788999999998533 345666533222 2345789999999988877 111 11
Q ss_pred -CCCCHHH------HH---HH------------HHHHHH-HHHhhhh-----CCCCeEeeeccCCcEEEeCCCCcEEEee
Q 008378 60 -KNVDMKA------IK---NW------------ARQILR-GLHYLHS-----HNPPIIHRDLKCDNIFVNGNNGEVKIGD 111 (568)
Q Consensus 60 -~~l~e~~------i~---~i------------~~QIl~-gL~yLHs-----~g~~IiHRDLKp~NILl~~~~g~vKI~D 111 (568)
..+.... .. .+ ...+.. .+..++. ....++|+|+.|.||+++..++.+-|+|
T Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID 191 (239)
T PF01636_consen 112 FSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIID 191 (239)
T ss_dssp CCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--
T ss_pred ccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEe
Confidence 0111000 00 00 011112 2333332 2233899999999999985567778999
Q ss_pred cChhh
Q 008378 112 LGLAI 116 (568)
Q Consensus 112 FGla~ 116 (568)
|+.+.
T Consensus 192 ~e~a~ 196 (239)
T PF01636_consen 192 FEDAG 196 (239)
T ss_dssp GTT-E
T ss_pred cccce
Confidence 98663
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0049 Score=67.98 Aligned_cols=163 Identities=19% Similarity=0.269 Sum_probs=101.9
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
++..-.++++.+.|+|...+.+.-. .......+|+|+++ .+|.++...+. +-..... .++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r-~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~~~--~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSR-GKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------AHG--V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeec-CccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------ccc--c
Confidence 4667789999999999999998543 33446889999995 79999888755 2111110 122 2
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHHHHHHhhcCCCCCCC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNEC 168 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG~~Pf~~~ 168 (568)
.|- +.++++| .++ ... .+.. ++++||||+|.++.++.-|...+..-
T Consensus 89 ~~~-------------~~~~~td-~~~---t~~--~~~~---------------~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 89 LHL-------------NIIYITD-HFL---TKY--PSPI---------------GPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred cee-------------hhhhccc-ccc---ccC--CCCC---------------CcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 221 2333344 111 000 1111 14999999999999999988777554
Q ss_pred CCHHHHHHHHHcCCCCCC---------CCCCCcHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q 008378 169 KNPAQIYKKVTSGIKPAS---------LSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 169 ~~~~~i~~~i~~~~~p~~---------~~~~~s~el~~lI~kcL-~~p~~Rpsa~ElL~hpff~~~ 224 (568)
.+..+......-...+.. +....+..+.++..+|+ ..|+.||...++.+++-|.+.
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 433333322222222211 11234567778889998 479999999999999988754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0051 Score=68.83 Aligned_cols=88 Identities=18% Similarity=0.182 Sum_probs=59.0
Q ss_pred eeeeeeEEEcCCCCeEEEEEecCCCCCHHH--HHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeC
Q 008378 25 IIKFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 102 (568)
Q Consensus 25 IV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~--~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~ 102 (568)
|.++|-.+. ..-+|+|||++|..+.+ ++.+.+ ++...+...+.+...-.-+ .+| ++|.|=+|.||++..
T Consensus 266 VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~qIf--~~G--ffHaDPHPGNilv~~ 336 (538)
T KOG1235|consen 266 VPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQIF--KTG--FFHADPHPGNILVRP 336 (538)
T ss_pred CCeehhhcC----cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHHHH--hcC--CccCCCCCCcEEEec
Confidence 666664332 13579999999976644 455554 5655555544444333322 246 999999999999973
Q ss_pred ---CCCcEEEeecChhhhccCC
Q 008378 103 ---NNGEVKIGDLGLAIVMQQP 121 (568)
Q Consensus 103 ---~~g~vKI~DFGla~~~~~~ 121 (568)
.++.+.+.|||+...+...
T Consensus 337 ~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 337 NPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCCCCccEEEEcccccccccHH
Confidence 3678999999998766443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.0086 Score=59.69 Aligned_cols=28 Identities=25% Similarity=0.291 Sum_probs=23.0
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
++|+|+.+.||+++ ..+..-|+||+.+.
T Consensus 166 l~HGD~~~~Nvlv~-~~~i~giIDw~~a~ 193 (235)
T cd05155 166 WFHGDLAPGNLLVQ-DGRLSAVIDFGCLG 193 (235)
T ss_pred EEeCCCCCCcEEEE-CCCEEEEEeCcccC
Confidence 89999999999997 44445699999763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0099 Score=66.53 Aligned_cols=102 Identities=15% Similarity=0.189 Sum_probs=64.9
Q ss_pred HHHHHHHHHhCC-----CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 10 LYSEVHLLKSLK-----HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 10 l~~Ei~iLk~L~-----HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~--i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+.+|...+.+++ .|+|.--.-+|.-.+ .-.++|||+.|-.+.++ ++. ..++.+.+...+.++..---+
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~--~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~-- 282 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTT--RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL-- 282 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccC--CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH--
Confidence 456776666663 343322222222122 34689999999888887 444 456655554444333322222
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~ 119 (568)
..| +.|.|.+|.||+++ .+|++-+.|||+...+.
T Consensus 283 ~dg--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 RDG--FFHADPHPGNILVR-SDGRIVLLDFGIVGRLD 316 (517)
T ss_pred hcC--ccccCCCccceEEe-cCCcEEEEcCcceecCC
Confidence 246 99999999999998 67999999999886553
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.0064 Score=61.68 Aligned_cols=102 Identities=20% Similarity=0.243 Sum_probs=70.5
Q ss_pred HHHHHHHHHhCC--CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh-CCC
Q 008378 10 LYSEVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNP 86 (568)
Q Consensus 10 l~~Ei~iLk~L~--HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs-~g~ 86 (568)
..+|+..|+++. +-.+.+-+.+. .-.+||||+...-+.-=.-+.-.+....+..+..+++..+.-|-. .+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~- 187 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG- 187 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence 367999999994 44555555532 135799999643111000011223344678888899999988866 67
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~ 121 (568)
++|+||+.-|||+. .|.+.|+|||-|.....+
T Consensus 188 -LVHgDLSEyNiL~~--~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 188 -LVHGDLSEYNILVH--DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred -cccccchhhheEEE--CCeEEEEECccccccCCC
Confidence 99999999999996 789999999988665544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.024 Score=67.13 Aligned_cols=110 Identities=23% Similarity=0.371 Sum_probs=67.4
Q ss_pred HHHHHHHHHHHhCC-CCCe--eeeeeEEEcCC-CCeEEEEEecCCCCCHHH--------------------HHH-hCC--
Q 008378 8 ERLYSEVHLLKSLK-HENI--IKFYNSWVDDT-NRTINMITELFTSGSLRQ--------------------YRK-KHK-- 60 (568)
Q Consensus 8 e~l~~Ei~iLk~L~-HpNI--V~l~~~~~~~~-~~~l~lV~Ey~~gGsL~~--------------------~i~-k~~-- 60 (568)
..+.+|+++|+.|. |++| .+++.++.+.. ....|+||||++|..+.+ .+. -|.
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd 162 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSAD 162 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 46889999999995 6665 66776654432 135689999999764321 111 010
Q ss_pred ----C---------CCHHHHHHHHHHH---------------HHHHHhhhhCCC---------CeEeeeccCCcEEEeCC
Q 008378 61 ----N---------VDMKAIKNWARQI---------------LRGLHYLHSHNP---------PIIHRDLKCDNIFVNGN 103 (568)
Q Consensus 61 ----~---------l~e~~i~~i~~QI---------------l~gL~yLHs~g~---------~IiHRDLKp~NILl~~~ 103 (568)
. .-...+..|..|. ...+.+|..+-| .++|+|++++||+++..
T Consensus 163 ~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~ 242 (822)
T PLN02876 163 VDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPT 242 (822)
T ss_pred chhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCC
Confidence 0 1123444443332 223566644322 29999999999999744
Q ss_pred CCc-EEEeecChhhh
Q 008378 104 NGE-VKIGDLGLAIV 117 (568)
Q Consensus 104 ~g~-vKI~DFGla~~ 117 (568)
++. +-|.||+++..
T Consensus 243 ~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 243 EDRVIGILDWELSTL 257 (822)
T ss_pred CCeEEEEEeeecccc
Confidence 444 46899998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.04 Score=54.25 Aligned_cols=100 Identities=27% Similarity=0.415 Sum_probs=68.3
Q ss_pred HHHHHHHHHHHHhCC------CCCeeeeeeEEEcCCCCeEEEEEecCCC------CCHHHHHHhCCCCCHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSLK------HENIIKFYNSWVDDTNRTINMITELFTS------GSLRQYRKKHKNVDMKAIKNWARQI 74 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~------HpNIV~l~~~~~~~~~~~l~lV~Ey~~g------GsL~~~i~k~~~l~e~~i~~i~~QI 74 (568)
.+...+|+.....+. +.+|.++|+... ++..+.+|+|.+.. -+|.++++. +.++. .+...+.++
T Consensus 55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ve--T~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~~f 130 (199)
T PF10707_consen 55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVE--TNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALDEF 130 (199)
T ss_pred hHHHHHHHHHHHHHhhccCCcccccccEeEEEe--cCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHHHH
Confidence 566777777777776 889999999654 33467888888643 468888855 44666 555444444
Q ss_pred HHHHHhhhhCCCCeEeeeccCCcEEEeCC-CC--cEEEee-cChh
Q 008378 75 LRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NG--EVKIGD-LGLA 115 (568)
Q Consensus 75 l~gL~yLHs~g~~IiHRDLKp~NILl~~~-~g--~vKI~D-FGla 115 (568)
. .||-.++ |+.+||+|.||++... +| .+.|+| ||-.
T Consensus 131 ~---~~l~~~~--Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 131 K---RYLLDHH--IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred H---HHHHHcC--CeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 4 4556667 9999999999999622 22 466776 5533
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.0064 Score=67.94 Aligned_cols=69 Identities=30% Similarity=0.450 Sum_probs=57.5
Q ss_pred CCceEEEEEecCCCC----CcceeeeecccCCCCHhHHHHHHHHccCCCCcCHHHHHHHHHHHHHHhCCCCCC
Q 008378 300 DDTVSLTLRIGDKSG----HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP 368 (568)
Q Consensus 300 ~~~i~L~Lri~d~~g----~~r~I~F~F~~~~Dta~~vA~EmV~~~~~~~~d~~~iA~~i~~~i~~l~~~~~~ 368 (568)
+..+.|.+|..+..+ ..|.|.|.|+++.|+++.||+|||+++.+++.|...+|..|..-+..+--....
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~ 388 (632)
T KOG0584|consen 316 DPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRND 388 (632)
T ss_pred cccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhc
Confidence 445666777777653 245799999999999999999999999999999999999999998888765544
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.089 Score=53.05 Aligned_cols=27 Identities=30% Similarity=0.414 Sum_probs=23.2
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
++|+|+.|.||+++ .++ +.|+||..+.
T Consensus 148 l~H~Dl~~~Nil~~-~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 148 PLHMDVHAYNLVVT-PQG-LKLIDWEYAS 174 (256)
T ss_pred eecCCCCcCcEEEe-CCC-CEEEeccccC
Confidence 79999999999997 444 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.21 Score=52.04 Aligned_cols=45 Identities=13% Similarity=0.082 Sum_probs=32.9
Q ss_pred HHHHHHHHHHHhCCC---CCeeeeeeEEEcCC-CCeEEEEEecCCCCCH
Q 008378 8 ERLYSEVHLLKSLKH---ENIIKFYNSWVDDT-NRTINMITELFTSGSL 52 (568)
Q Consensus 8 e~l~~Ei~iLk~L~H---pNIV~l~~~~~~~~-~~~l~lV~Ey~~gGsL 52 (568)
..+.+|...|+.|.. -.+.++++.+.+.. ...-++|||+++|+++
T Consensus 52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 578899999999953 36777887654321 2357899999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=92.58 E-value=0.35 Score=49.57 Aligned_cols=28 Identities=29% Similarity=0.395 Sum_probs=23.7
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
++|+|+.|.||+++ .++.+.|.||+.+.
T Consensus 177 l~HgD~~~~Nil~~-~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFD-GDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEe-CCceEEEeehhhhc
Confidence 89999999999997 45556899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.47 E-value=0.7 Score=49.72 Aligned_cols=73 Identities=19% Similarity=0.233 Sum_probs=54.1
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 37 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 37 ~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
..+.|++|++- |++|.- .+.-..+++..++.+-+..+.-+.. ..+.=||++..+||+|+ .|.|.|+||-+++
T Consensus 298 ~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId--~GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID--EGNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee--cCceEEEEeeeee
Confidence 34778888876 455532 1234567777888887766655554 45789999999999997 7999999999998
Q ss_pred h
Q 008378 117 V 117 (568)
Q Consensus 117 ~ 117 (568)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=91.31 E-value=0.68 Score=47.74 Aligned_cols=30 Identities=23% Similarity=0.367 Sum_probs=23.9
Q ss_pred CeEeeeccCCcEEEeCCCCc-EEEeecChhhh
Q 008378 87 PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAIV 117 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~-vKI~DFGla~~ 117 (568)
-++|+|++|.||+++ .++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~-~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILID-EDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEe-CCCCEEEEECcHhccc
Confidence 389999999999998 3355 46999997743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.30 E-value=1.7 Score=47.40 Aligned_cols=42 Identities=21% Similarity=0.237 Sum_probs=30.3
Q ss_pred HHHHHHHHHHHHHhCC---CCCeeeeeeEEEcCCCCeEEEEEecCCCCC
Q 008378 6 QLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMITELFTSGS 51 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~---HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGs 51 (568)
..++...|.+.|+.+. -.+++++|.+ +.. .-++||||+++..
T Consensus 73 ~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~--~~~lVME~L~~~~ 117 (401)
T PRK09550 73 TLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE--LAVTVMEDLSDHK 117 (401)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC--CCEEEEecCCCcc
Confidence 4678888999999873 3467778874 343 3578999998744
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=91.07 E-value=0.23 Score=52.63 Aligned_cols=90 Identities=22% Similarity=0.268 Sum_probs=63.3
Q ss_pred HHHHHHHHHhCC-C-CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 10 LYSEVHLLKSLK-H-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 10 l~~Ei~iLk~L~-H-pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
..+|+..|+.|. | --|.+-++. ..-++|||++.|-.|.+... ..+..++ ...++.-+.-|..+|
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~---v~d~~~l---y~~lm~~Iv~la~~G-- 222 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH------NRHCVVMELVDGYPLRQVRH---VEDPPTL---YDDLMGLIVRLANHG-- 222 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc------cceeeHHHhhcccceeeeee---cCChHHH---HHHHHHHHHHHHHcC--
Confidence 467999999994 3 344455542 24567999999988865432 2344444 344444455567888
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecCh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGL 114 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGl 114 (568)
+||+|..--||++. .++.++++||--
T Consensus 223 lIHgDFNEFNimv~-dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVK-DDDKIVVIDFPQ 248 (465)
T ss_pred ceecccchheeEEe-cCCCEEEeechH
Confidence 99999999999997 788999999953
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.14 E-value=1.8 Score=45.73 Aligned_cols=112 Identities=13% Similarity=0.224 Sum_probs=65.5
Q ss_pred HHHHHHHHHHHHHHhCCC--CCeeeeeeEEEcCCCCeEEEEEecCCCCCH---------H-HHHH--------h------
Q 008378 5 DQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSL---------R-QYRK--------K------ 58 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~H--pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL---------~-~~i~--------k------ 58 (568)
.......+|.++|+.+.- --+.+.+..+.+......|+||+|++|..+ . ++.. .
T Consensus 63 ~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida 142 (321)
T COG3173 63 ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDA 142 (321)
T ss_pred hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCC
Confidence 345667788888888854 233344555444332467899999987222 2 2211 0
Q ss_pred --------CCCCCHHHHHHHHHHH--------------HHHHHhhhhCCC------CeEeeeccCCcEEEeCCCCcEEEe
Q 008378 59 --------HKNVDMKAIKNWARQI--------------LRGLHYLHSHNP------PIIHRDLKCDNIFVNGNNGEVKIG 110 (568)
Q Consensus 59 --------~~~l~e~~i~~i~~QI--------------l~gL~yLHs~g~------~IiHRDLKp~NILl~~~~g~vKI~ 110 (568)
........+..|..+. ..-..||+.+-+ .++|+|+.+.||+++ ..+.+=+.
T Consensus 143 ~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~-~~~~~gVl 221 (321)
T COG3173 143 AGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIID-PGRPTGVL 221 (321)
T ss_pred cCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEe-CCCeeEEE
Confidence 0011222333343333 122345554433 389999999999998 44558899
Q ss_pred ecChhhh
Q 008378 111 DLGLAIV 117 (568)
Q Consensus 111 DFGla~~ 117 (568)
||+++..
T Consensus 222 Dwe~~~l 228 (321)
T COG3173 222 DWELATL 228 (321)
T ss_pred ecccccc
Confidence 9998854
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.48 E-value=0.89 Score=49.05 Aligned_cols=102 Identities=17% Similarity=0.217 Sum_probs=69.3
Q ss_pred HHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh-hhCCCCeE
Q 008378 11 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPII 89 (568)
Q Consensus 11 ~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL-Hs~g~~Ii 89 (568)
.+|++.|++|+...|.-- .-..-. .-+|||+|+.......-.-+.-.++...+..+-.|++.-+.-| |..+ ++
T Consensus 214 EKE~RNLkRl~~aGIP~P-ePIlLk---~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LV 287 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPCP-EPILLK---NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LV 287 (520)
T ss_pred HHHHHHHHHHHhcCCCCC-Cceeee---cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--ee
Confidence 578999999976654321 111111 2468999996433222222334577777888888888777766 4456 99
Q ss_pred eeeccCCcEEEeCCCCcEEEeecChhhhccC
Q 008378 90 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120 (568)
Q Consensus 90 HRDLKp~NILl~~~~g~vKI~DFGla~~~~~ 120 (568)
|.||.--|+|+. .|.+.|+|.+-+.....
T Consensus 288 HADLSEfN~Lyh--dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 288 HADLSEFNLLYH--DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred ccchhhhhheEE--CCEEEEEEccccccCCC
Confidence 999999999995 79999999987765443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=89.44 E-value=0.62 Score=47.98 Aligned_cols=29 Identities=24% Similarity=0.313 Sum_probs=24.7
Q ss_pred CeEeeeccCCcEEEeCC---CCcEEEeecChh
Q 008378 87 PIIHRDLKCDNIFVNGN---NGEVKIGDLGLA 115 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~---~g~vKI~DFGla 115 (568)
.++|+|+.|.||+++.. .+.+.++||..+
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 48999999999999732 378999999866
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=88.74 E-value=0.66 Score=45.77 Aligned_cols=29 Identities=34% Similarity=0.357 Sum_probs=24.8
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
++|+|+.+.||++++.++.+.++||..+.
T Consensus 172 l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 172 FCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 89999999999998435789999998663
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=86.57 E-value=3.2 Score=42.21 Aligned_cols=48 Identities=21% Similarity=0.296 Sum_probs=35.2
Q ss_pred HHHHHHHHHHHHHHHhCCCC---CeeeeeeEEEcCCCCeEEEEEecCCCCCHH
Q 008378 4 PDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDTNRTINMITELFTSGSLR 53 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~Hp---NIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~ 53 (568)
.+....+..|+.-|+.|.-. +|.+++. +...+...|+|+||++-|.+.
T Consensus 49 ~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 49 REQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred hhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEEEeeccCCCCC
Confidence 45567788899988888544 4566665 456667899999999876654
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=86.08 E-value=7.1 Score=41.23 Aligned_cols=28 Identities=25% Similarity=0.475 Sum_probs=24.6
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLA 115 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla 115 (568)
++|.||.+.||+++..++.++++||..|
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEccccc
Confidence 6999999999999745678999999866
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=85.34 E-value=1.3 Score=47.14 Aligned_cols=29 Identities=28% Similarity=0.432 Sum_probs=25.0
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
++|+|+++.||+++..++.+.++||..+.
T Consensus 202 ~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 202 FCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred EEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 79999999999997445789999998663
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=84.74 E-value=0.77 Score=46.36 Aligned_cols=86 Identities=21% Similarity=0.266 Sum_probs=57.4
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
-++.+.+++.++. .|+++.. + ....+.++.|+|.-... ...-. +.-=+.+|.-.|+.++..
T Consensus 104 ~y~nky~v~Armh--GilrL~N---D-n~~~yGvIlE~Cy~~~i------------~~~N~-i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKN---D-NNYKYGVILERCYKIKI------------NFSNF-ITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhHHHHhh--heeEeec---C-CCceeEEEEeeccCccc------------chhHH-HHHhHHHHHHhhccCCCe
Confidence 3456777777765 4677763 2 34456788898853211 11111 111145677789777779
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecCh
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGL 114 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGl 114 (568)
+|+|-.|+||+-+ ..|-+||.|-+.
T Consensus 165 lHGD~np~NiM~D-~~G~lKlVDP~~ 189 (308)
T PF07387_consen 165 LHGDCNPDNIMCD-KFGYLKLVDPVC 189 (308)
T ss_pred ecCCCChhheeec-CCCCEEecChhh
Confidence 9999999999998 789999999763
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=84.63 E-value=1.8 Score=44.47 Aligned_cols=28 Identities=25% Similarity=0.392 Sum_probs=23.7
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla 115 (568)
.+++|+|+.+.||++++ +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECccc
Confidence 34899999999999973 67899999855
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=83.95 E-value=1.4 Score=45.74 Aligned_cols=29 Identities=28% Similarity=0.371 Sum_probs=24.3
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla 115 (568)
..++|+|+++.||+++ .++.+.|+||+.+
T Consensus 187 ~~l~HgD~~~~Nvl~~-~~~~~~vIDfd~~ 215 (307)
T TIGR00938 187 RGVIHADLFPDNVLFD-GDSVKGVIDFYFA 215 (307)
T ss_pred CccCCCCCCcCcEEEE-CCceEEEeecccc
Confidence 3499999999999997 4566689999866
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=83.59 E-value=1.9 Score=44.79 Aligned_cols=28 Identities=29% Similarity=0.347 Sum_probs=23.0
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChh
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla 115 (568)
++||+|+.|+||+++ .+...-|+||+.+
T Consensus 188 ~liHgD~~~~Nil~~-~~~~~~iIDf~~~ 215 (319)
T PRK05231 188 GVIHADLFRDNVLFE-GDRLSGFIDFYFA 215 (319)
T ss_pred ccCCCCCCCCcEEEE-CCceEEEEecccc
Confidence 399999999999997 3334579999976
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=83.54 E-value=4.1 Score=40.46 Aligned_cols=87 Identities=21% Similarity=0.326 Sum_probs=58.3
Q ss_pred HHHHHHHHHHHhC---CCCCe--eeeeeEEEcCC---------------CC-eEEEEEecCCCCCHHHHHHhCCCCCHHH
Q 008378 8 ERLYSEVHLLKSL---KHENI--IKFYNSWVDDT---------------NR-TINMITELFTSGSLRQYRKKHKNVDMKA 66 (568)
Q Consensus 8 e~l~~Ei~iLk~L---~HpNI--V~l~~~~~~~~---------------~~-~l~lV~Ey~~gGsL~~~i~k~~~l~e~~ 66 (568)
+-|..|.++..+| .+.++ |+.|++..-.. .. ...+|.||..... .+....
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~ 169 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD 169 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH
Confidence 3567777766666 45566 99999774321 01 1246777776533 233333
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChh
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla 115 (568)
+.+|++-+..+|..| |+-+|+++.|.. + | ||+|||.+
T Consensus 170 ----~~~~~~dl~~~~k~g--I~~~Dv~~~ny~-~---G--~lvDfs~~ 206 (207)
T PF13095_consen 170 ----IPQMLRDLKILHKLG--IVPRDVKPRNYR-G---G--KLVDFSSS 206 (207)
T ss_pred ----HHHHHHHHHHHHHCC--eeeccCcccccc-C---C--EEEecccC
Confidence 567777888899999 999999999964 2 2 78999854
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=83.20 E-value=0.76 Score=44.90 Aligned_cols=29 Identities=41% Similarity=0.595 Sum_probs=19.9
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
++|.||.|.||+++..++.++++||..+.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 79999999999994478999999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=82.41 E-value=1 Score=43.96 Aligned_cols=28 Identities=21% Similarity=0.311 Sum_probs=23.8
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~ 117 (568)
.+|+|+.|+||+++ .+| ++++||+.+..
T Consensus 79 p~H~D~~~~N~~~~-~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHS-ASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEE-CCC-EEEEeCCcccC
Confidence 69999999999996 455 99999998743
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=81.34 E-value=6.9 Score=42.94 Aligned_cols=47 Identities=19% Similarity=0.125 Sum_probs=31.9
Q ss_pred HHHHHHHHHHHHHhCC---CCCeeeeeeEEEcCCCCeEEEEEecCCC--CCHHHHH
Q 008378 6 QLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMITELFTS--GSLRQYR 56 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~---HpNIV~l~~~~~~~~~~~l~lV~Ey~~g--GsL~~~i 56 (568)
..++-..|...|+.+. ..++.++|.+. ++ .-+++||++++ ..+++.+
T Consensus 77 ~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--ed--~~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 77 TKERAYFEATALREHGRLCPDHVPEVYHFD--RT--MALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CccHHHHHHHHHHHhhhcCCCCCCeEEEEC--CC--CCEEEEeecCCcceehhhhh
Confidence 5667778888888774 25788888754 33 35678999976 3455443
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=81.23 E-value=2.3 Score=43.78 Aligned_cols=52 Identities=17% Similarity=0.237 Sum_probs=37.3
Q ss_pred HHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 64 e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
...+.+.+..+-.++.-++....-++|.|+.|+|++.+ ..|.++|+||.-|.
T Consensus 131 ~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t-~~~~l~LIDWEyAg 182 (269)
T COG0510 131 NHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLT-DKGGLFLIDWEYAG 182 (269)
T ss_pred hHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEc-CCCcEEEEecccCC
Confidence 33455556666666666655412289999999999997 56899999998663
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=80.20 E-value=5.4 Score=39.05 Aligned_cols=98 Identities=22% Similarity=0.242 Sum_probs=64.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCeee-eeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIK-FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~-l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.....+..|+++|..++--++-+ +|.| +. .++.|||+.|-.|...-... +-+++. .++..---|-.
T Consensus 57 s~r~~l~kEakiLeil~g~~~~p~vy~y--g~----~~i~me~i~G~~L~~~~~~~---~rk~l~----~vlE~a~~LD~ 123 (201)
T COG2112 57 SPRRNLEKEAKILEILAGEGVTPEVYFY--GE----DFIRMEYIDGRPLGKLEIGG---DRKHLL----RVLEKAYKLDR 123 (201)
T ss_pred cchhhHHHHHHHHHHhhhcCCCceEEEe--ch----hhhhhhhhcCcchhhhhhcc---cHHHHH----HHHHHHHHHHH
Confidence 34567899999999998777765 4432 22 34569999988887654421 223333 33333333455
Q ss_pred CCCCeEeeeccCC--cEEEeCCCCcEEEeecChhhhcc
Q 008378 84 HNPPIIHRDLKCD--NIFVNGNNGEVKIGDLGLAIVMQ 119 (568)
Q Consensus 84 ~g~~IiHRDLKp~--NILl~~~~g~vKI~DFGla~~~~ 119 (568)
.| |-|..|.-- ||+++ ++.+.|+||.-|+.-.
T Consensus 124 ~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k~ 157 (201)
T COG2112 124 LG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFKK 157 (201)
T ss_pred hc--cchhhhcCCceeEEec--CCcEEEEEccchhhcc
Confidence 56 888887643 66664 5699999999887543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 568 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-66 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-27 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-20 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-19 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-19 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-04 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 4e-04 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 5e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-04 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 6e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 376 bits (968), Expect = e-128
Identities = 118/226 (52%), Positives = 160/226 (70%), Gaps = 3/226 (1%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKH 59
+ + +R E +LK L+H NI++FY+SW + I ++TEL TSG+L+ Y K+
Sbjct: 64 LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF 123
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
K + +K +++W RQIL+GL +LH+ PPIIHRDLKCDNIF+ G G VKIGDLGLA + +
Sbjct: 124 KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
Query: 120 QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VT
Sbjct: 184 ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243
Query: 180 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 224
SG+KPAS KV P+VK+ IE CI R +LL F +
Sbjct: 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-58
Identities = 66/233 (28%), Positives = 119/233 (51%), Gaps = 16/233 (6%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRK 57
+ + + L SEV+LL+ LKH NI+++Y+ +D TN T+ ++ E G L + K
Sbjct: 44 MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK 103
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGL 114
+ + +D + + Q+ L H + ++HRDLK N+F++G VK+GD GL
Sbjct: 104 ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGL 162
Query: 115 AIVMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCIL-EMVTCEYPYNECKN 170
A ++ T A++ +GTP +M+PE YNE DI+S G C+L E+ P+ +
Sbjct: 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPPFTA-FS 220
Query: 171 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 222
++ K+ G K + ++ + I + + R E+L++P ++
Sbjct: 221 QKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-57
Identities = 63/259 (24%), Positives = 119/259 (45%), Gaps = 14/259 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
S + E EV +L ++KH NI+++ S+ ++ + + ++ + G L + K
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIVQYRESFEENGS--LYIVMDYCEGGDLFKRINAQKG 119
Query: 62 VDM--KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
V I +W QI L ++H I+HRD+K NIF+ +G V++GD G+A V+
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLN 176
Query: 120 QPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
AR+ IGTP +++PE+ E + YN DI++ G + E+ T ++ + E + +
Sbjct: 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVL 235
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLR 235
K+ SG +S ++ + + R +L+ F + + + L
Sbjct: 236 KIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF-IAKRIEKFLSPQLI 293
Query: 236 LPNLVPEVMNLAHSEPHPM 254
+ + S+P P
Sbjct: 294 AEEFCLKTFSKFGSQPIPA 312
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-56
Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 10/206 (4%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKH 59
+++ EV ++K L+H NI+ F + N +I +TE + GSL +
Sbjct: 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKSGAR 131
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+ +D + + A + +G++YLH+ NPPI+HR+LK N+ V+ VK+ D GL+ +
Sbjct: 132 EQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKA 190
Query: 120 Q--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
+++S GTPE+MAPE+ E NE D+YSFG+ + E+ T + P+ +
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKC 202
+ + + +PQV IE C
Sbjct: 251 VGFKCKRL-EIPRNLNPQVAAIIEGC 275
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-56
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 14/224 (6%)
Query: 2 QSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH- 59
+ P R +EV + + +H ++ +W + + + TE SL+Q+ +
Sbjct: 95 RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI--LYLQTE-LCGPSLQQHCEAWG 151
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
++ + + R L L +LHS ++H D+K NIF+ G G K+GD GL + +
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL-GPRGRCKLGDFGLLVELG 208
Query: 120 QPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
G P +MAPEL + Y D++S G+ ILE+ + + Q+ +
Sbjct: 209 TAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268
Query: 179 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
A LS +++ + + P LR A LL P L
Sbjct: 269 LPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-56
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RK 57
++S + + E+ L + H NI+K Y + + ++ E GSL +
Sbjct: 39 IESESERKAFIVELRQLSRVNHPNIVKLYGA----CLNPVCLVMEYAEGGSLYNVLHGAE 94
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
+W Q +G+ YLHS P +IHRDLK N+ + +KI D G A
Sbjct: 95 PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
Query: 117 VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-I 174
+Q + G+ +MAPE++E Y+E D++S+G+ + E++T P++E PA I
Sbjct: 155 DIQT-HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI 213
Query: 175 YKKVTSGIKPASLSKVTDPQVKQFIEKC 202
V +G +P L K ++ + +C
Sbjct: 214 MWAVHNGTRP-PLIKNLPKPIESLMTRC 240
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 7e-55
Identities = 77/240 (32%), Positives = 113/240 (47%), Gaps = 21/240 (8%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHK 60
+ + L+ E+ L K LKH+NI+++ S+ ++ I + E GSL R K
Sbjct: 58 RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--FIKIFMEQVPGGSLSALLRSKWG 115
Query: 61 NVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--I 116
+ I + +QIL GL YLH + I+HRD+K DN+ +N +G +KI D G + +
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173
Query: 117 VMQQPTARSVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 173
P + GT ++MAPE Y + DI+S G I+EM T + P+ E P
Sbjct: 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233
Query: 174 IYKKVTSGIK----PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 228
KV P S+S + K FI KC P R A +LL D FL + K
Sbjct: 234 AMFKVGMFKVHPEIPESMS----AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-54
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 60
+ ++ + EV ++ +L H NI+K Y + M+ E G L K
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGL----MHNPPRMVMEFVPCGDLYHRLLDKAH 117
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAI 116
+ I G+ Y+ + NPPI+HRDL+ NIF+ + K+ D GL+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 117 VMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNP-- 171
+ ++G ++MAPE E Y E D YSF M + ++T E P++E
Sbjct: 178 QSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 172 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 202
I G++P ++ + P+++ IE C
Sbjct: 237 KFINMIREEGLRP-TIPEDCPPRLRNVIELC 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-54
Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 29/239 (12%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDD--------------TNRTINMITELFTSGSLR 53
E+ EV L L H NI+ + W + + + E G+L
Sbjct: 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 54 QYRKKHKNVDM--KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 111
Q+ +K + + QI +G+ Y+HS +I+RDLK NIF+ + +VKIGD
Sbjct: 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGD 165
Query: 112 LGLAIVMQQPTAR-SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 169
GL ++ R GT +M+PE + Y + VD+Y+ G+ + E++ E
Sbjct: 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS 225
Query: 170 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
+ + GI + K ++K + R E+L+ + +P+
Sbjct: 226 K---FFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 9e-54
Identities = 65/231 (28%), Positives = 111/231 (48%), Gaps = 14/231 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYR 56
+ E+ LLK L H N+IK+Y S+++D +N++ EL +G L + ++
Sbjct: 70 LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFK 127
Query: 57 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
K+ + + + + + Q+ L ++HS ++HRD+K N+F+ G VK+GDLGL
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGR 184
Query: 117 VMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN-ECKNPA 172
T A S++GTP +M+PE E YN DI+S G + EM + P+ + N
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 244
Query: 173 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 222
+ KK+ P S +++Q + CI P R + +
Sbjct: 245 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-53
Identities = 42/206 (20%), Positives = 81/206 (39%), Gaps = 11/206 (5%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHK 60
S + E L+ H N++ + +IT GSL +
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
VD +A + RG+ +LH+ P I L ++ ++ + +I + Q
Sbjct: 107 VVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQS 165
Query: 121 PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
P + P ++APE +++ D++SF + + E+VT E P+ + N K
Sbjct: 166 PG---RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK 222
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKC 202
G++P ++ P V + ++ C
Sbjct: 223 VALEGLRP-TIPPGISPHVSKLMKIC 247
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 5e-53
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
+E + E L LKH NII + + N + + E G L + + +
Sbjct: 48 QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL--VMEFARGGPLNRVLSGKR-IPP 104
Query: 65 KAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVN-------GNNGEVKIGDLGLAI 116
+ NWA QI RG++YLH PIIHRDLK NI + +N +KI D GLA
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 117 VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
+ T S G +MAPE+ +++ D++S+G+ + E++T E P+ A Y
Sbjct: 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKC 202
+ + + + +E C
Sbjct: 225 GVAMNKLAL-PIPSTCPEPFAKLMEDC 250
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 18/213 (8%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
+P QL+ +EV +L+ +H NI+ F + I +T+ SL +
Sbjct: 60 TPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAI--VTQWCEGSSLYHHLHASETK 116
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 120
+MK + + ARQ RG+ YLH+ + IIHRDLK +NIF+ + VKIGD GLA +
Sbjct: 117 FEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRW 173
Query: 121 ---PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 173
+ G+ +MAPE+ + Y+ D+Y+FG+ + E++T + PY+ N Q
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
Query: 174 IYKKVTSGIKPASLSKV---TDPQVKQFIEKCI 203
I + V G LSKV ++K+ + +C+
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECL 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-52
Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
+ DQL+ EV + +HEN++ F + + + I IT L +L R
Sbjct: 69 NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIV 126
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--- 118
+D+ + A++I++G+ YLH+ I+H+DLK N+F + NG+V I D GL +
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVL 182
Query: 119 ----QQPTARSVIGTPEFMAPEL----------YEEEYNELVDIYSFGMCILEMVTCEYP 164
++ R G +APE+ + +++ D+++ G E+ E+P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 165 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 202
+ + I ++ +G+KP ++ + C
Sbjct: 243 FKT-QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 54/248 (21%), Positives = 100/248 (40%), Gaps = 36/248 (14%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----------RTINMITELFTSGSL 52
E++ EV L L+H I++++N+W++ + + +L +L
Sbjct: 43 RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL 102
Query: 53 RQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 109
+ + R + + + QI + +LHS ++HRDLK NIF + VK+
Sbjct: 103 KDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKV 159
Query: 110 GDLGLAIVMQQPTAR--------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMC 154
GD GL M Q +GT +M+PE Y+ VDI+S G+
Sbjct: 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLI 219
Query: 155 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPAL 213
+ E++ YP++ + V + K L P ++ + P R A+
Sbjct: 220 LFELL---YPFSTQMERVRTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI 275
Query: 214 ELLKDPFL 221
++++
Sbjct: 276 NIIENAVF 283
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-51
Identities = 73/253 (28%), Positives = 111/253 (43%), Gaps = 39/253 (15%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR-----------TINMITELFTSG 50
+ ++L + SEV LL SL H+ ++++Y +W++ N T+ + E +G
Sbjct: 41 HTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENG 100
Query: 51 SLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 109
+L ++ N RQIL L Y+HS IIHRDLK NIF++ + VKI
Sbjct: 101 TLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKI 157
Query: 110 GDLGLAIVMQQPTAR----------------SVIGTPEFMAPELYEE--EYNELVDIYSF 151
GD GLA + + S IGT ++A E+ + YNE +D+YS
Sbjct: 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217
Query: 152 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASL 208
G+ EM+ YP++ I KK+ S P K+ I I +
Sbjct: 218 GIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK 274
Query: 209 RLPALELLKDPFL 221
R A LL +L
Sbjct: 275 RPGARTLLNSGWL 287
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-49
Identities = 54/231 (23%), Positives = 90/231 (38%), Gaps = 21/231 (9%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 71
E+ L I+ Y + + +N+ EL GSL Q K+ + +
Sbjct: 99 EELVACAGLSSPRIVPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYL 156
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-------PTAR 124
Q L GL YLH+ I+H D+K DN+ ++ + + D G A+ +Q T
Sbjct: 157 GQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 125 SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI- 182
+ GT MAPE+ + + VDI+S +L M+ +P+ + K +
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP 274
Query: 183 ---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 229
P S + P Q I++ + R A+EL + L
Sbjct: 275 IREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-48
Identities = 53/244 (21%), Positives = 100/244 (40%), Gaps = 26/244 (10%)
Query: 3 SPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
L+ +E+ L L+ + II+ Y+ + D I M+ E + L + KK K
Sbjct: 47 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKK 103
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
++D K++ + +L +H +H H I+H DLK N + +G +K+ D G+A MQ
Sbjct: 104 SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--VDGMLKLIDFGIANQMQP 159
Query: 121 PT----ARSVIGTPEFMAPEL------------YEEEYNELVDIYSFGMCILEMVTCEYP 164
T S +GT +M PE + + + D++S G + M + P
Sbjct: 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
Query: 165 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVT 223
+ + N + + + ++ ++ C+ R+ ELL P++
Sbjct: 220 FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
Query: 224 DNPK 227
Sbjct: 280 QTHP 283
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 7e-48
Identities = 49/248 (19%), Positives = 102/248 (41%), Gaps = 37/248 (14%)
Query: 1 MQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 59
+ + EV+ L +H ++++++++W +D + + + E GSL ++
Sbjct: 48 LAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH--MLIQNEYCNGGSLADAISEN 105
Query: 60 KNVDM----KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN----------- 104
+ +K+ Q+ RGL Y+HS + ++H D+K NIF++ +
Sbjct: 106 YRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDE 163
Query: 105 -------GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCI 155
KIGDLG + P + G F+A E+ +E + DI++ + +
Sbjct: 164 DDWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTV 221
Query: 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALE 214
+ E + ++ G P + +V + + ++ I P R A+
Sbjct: 222 VCAAGAEPLPRN----GDQWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMA 276
Query: 215 LLKDPFLV 222
L+K L+
Sbjct: 277 LVKHSVLL 284
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 9e-48
Identities = 56/239 (23%), Positives = 102/239 (42%), Gaps = 28/239 (11%)
Query: 3 SPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
L+ +E+ L L+ + II+ Y+ + D I M+ E + L + KK K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKK 122
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
++D K++ + +L +H +H H I+H DLK N + +G +K+ D G+A MQ
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--VDGMLKLIDFGIANQMQP 178
Query: 121 PT----ARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCIL-EMVTCEY 163
T S +GT +M PE ++ + D++S G CIL M +
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKT 237
Query: 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
P+ + N + + + ++ ++ C+ R+ ELL P++
Sbjct: 238 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 55/245 (22%), Positives = 101/245 (41%), Gaps = 28/245 (11%)
Query: 3 SPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
L+ +E+ L L+ + II+ Y+ + D I M+ E + L + KK K
Sbjct: 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKK 150
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
++D K++ + +L +H +H H I+H DLK N + +G +K+ D G+A MQ
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--VDGMLKLIDFGIANQMQP 206
Query: 121 PT----ARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCIL-EMVTCEY 163
T S +G +M PE ++ + D++S G CIL M +
Sbjct: 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKT 265
Query: 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 222
P+ + N + + + ++ ++ C+ R+ ELL P++
Sbjct: 266 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
Query: 223 TDNPK 227
Sbjct: 326 IQTHP 330
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 6e-45
Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 43/246 (17%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNW 70
E++ ++HENI+ F + + T + IT+ +GSL Y K +D K++
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKL 139
Query: 71 ARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
A + GL +LH+ P I HRDLK NI V NG I DLGLA+ T
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNE 198
Query: 125 ------SVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC---------- 161
+ +GT +M PE+ +E + + D+YSFG+ + E+
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 162 EYPYNECKNPAQIYKKVTSG---------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 211
+ PY++ Y+ + S Q+ + + +C + RL
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 212 ALELLK 217
AL + K
Sbjct: 319 ALRVKK 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 43/246 (17%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNW 70
E++ L+HENI+ F + D + +++ GSL Y ++ V ++ +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKL 144
Query: 71 ARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 122
A GL +LH P I HRDLK NI V NG I DLGLA+ T
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDT 203
Query: 123 ----ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC---------- 161
+GT +MAPE+ ++ E + DIY+ G+ E+
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
Query: 162 EYPYNECKNP----AQIYKKVTSG-----IKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 211
+ PY + ++ K V I S + + + +C + RL
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 212 ALELLK 217
AL + K
Sbjct: 324 ALRIKK 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-43
Identities = 64/246 (26%), Positives = 100/246 (40%), Gaps = 43/246 (17%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNW 70
E++ L+HENI+ F S + + + + IT GSL Y + +D +
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRI 110
Query: 71 ARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
I GL +LH P I HRDLK NI V NG+ I DLGLA++ Q T +
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQ 169
Query: 125 ------SVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNP 171
+GT +MAPE+ +E + + VDI++FG+ + E+ ++
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 172 AQIYKKVTSG-------------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 211
+ V I S T + + +++C S RL
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 212 ALELLK 217
AL + K
Sbjct: 290 ALRIKK 295
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-43
Identities = 50/240 (20%), Positives = 96/240 (40%), Gaps = 28/240 (11%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RK 57
+ SP ++ ++ + +N + I M +L +L+ + R
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM--QLCRKENLKDWMNRRC 156
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
++ + + QI + +LHS ++HRDLK NIF + VK+GD GL
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTA 213
Query: 118 MQQPTAR--------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCE 162
M Q +GT +M+PE Y+ VDI+S G+ + E++
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--- 270
Query: 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
Y ++ +I V + P ++ PQ ++ + P + R A +++++
Sbjct: 271 YSFSTQMERVRIITDVRNLKFPLLFTQ-KYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 71/243 (29%), Positives = 120/243 (49%), Gaps = 22/243 (9%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ P Q E++ E+ + +SL H++++ F+ + D+ + ++ EL SL + K+ K
Sbjct: 53 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK 110
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ + + RQI+ G YLH + +IHRDLK N+F+N + EVKIGD GLA ++
Sbjct: 111 ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEY 167
Query: 121 PTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
R + GTP ++APE L ++ ++ VD++S G CI+ + P E + Y +
Sbjct: 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLR 226
Query: 178 VTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL 234
+ P ++ P I+K + + R ELL D F + P
Sbjct: 227 IKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG------YIPA 276
Query: 235 RLP 237
RLP
Sbjct: 277 RLP 279
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 56/219 (25%), Positives = 86/219 (39%), Gaps = 23/219 (10%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 60
+ EV +++ L+H N++KF D +N ITE G+LR +
Sbjct: 46 FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDS 103
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
++A+ I G+ YLHS N IIHRDL N V N V + D GLA +M
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENK-NVVVADFGLARLMVD 160
Query: 121 ----------------PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY 163
+V+G P +MAPE + Y+E VD++SFG+ + E++
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
Query: 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 202
+ + G P +C
Sbjct: 221 ADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRC 259
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 71/243 (29%), Positives = 120/243 (49%), Gaps = 22/243 (9%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ P Q E++ E+ + +SL H++++ F+ + D+ + ++ EL SL + K+ K
Sbjct: 79 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK 136
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ + + RQI+ G YLH + +IHRDLK N+F+N + EVKIGD GLA ++
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEY 193
Query: 121 PTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
R + GTP ++APE L ++ ++ VD++S G CI+ + P E + Y +
Sbjct: 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLR 252
Query: 178 VTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL 234
+ P ++ P I+K + + R ELL D F + P
Sbjct: 253 IKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG------YIPA 302
Query: 235 RLP 237
RLP
Sbjct: 303 RLP 305
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 56/242 (23%), Positives = 110/242 (45%), Gaps = 14/242 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++ +L EV + L+H NI++ Y + D T + +I E G++ + +K
Sbjct: 47 LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLS 104
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
D + + ++ L Y HS +IHRD+K +N+ + G+ GE+KI D G ++
Sbjct: 105 KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPS 161
Query: 121 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
+ GT +++ PE+ E ++E VD++S G+ E + P E + YK+++
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRIS 220
Query: 180 SG-IK-PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 236
P ++ + I + + S R E+L+ P++ ++ K C
Sbjct: 221 RVEFTFPDFVT----EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276
Query: 237 PN 238
+
Sbjct: 277 AS 278
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-40
Identities = 52/239 (21%), Positives = 93/239 (38%), Gaps = 25/239 (10%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ E +LK L H+NI+K + + T R +I E GSL ++ N
Sbjct: 46 SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN 105
Query: 62 VDM---KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLA 115
R ++ G+++L + I+HR++K NI K+ D G A
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 116 IVMQQPT-ARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCIL-EMVTCE-- 162
++ S+ GT E++ P++YE ++Y VD++S G T
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLP 222
Query: 163 -YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ--VKQFIEKCIVPASLRLPALELLKD 218
P+ + ++ K+ +G ++S V + + V SL LL
Sbjct: 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 47/243 (19%), Positives = 80/243 (32%), Gaps = 29/243 (11%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT--INMITELFTSGSLRQY--- 55
E E + + H NI++ + + ++ F G+L
Sbjct: 64 CHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123
Query: 56 -RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 114
+ K + I I RGL +H+ HRDLK NI + + G+ + DLG
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLG-DEGQPVLMDLGS 180
Query: 115 AIVMQQPTARS-----------VIGTPEFMAPELYEEE----YNELVDIYSFGMCIL-EM 158
S T + APEL+ + +E D++S G C+L M
Sbjct: 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAM 239
Query: 159 VTCEYPYNECKNPAQIYK-KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELL 216
+ E PY+ V + + + + + Q + + R LL
Sbjct: 240 MFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS-SALWQLLNSMMTVDPHQRPHIPLLL 298
Query: 217 KDP 219
Sbjct: 299 SQL 301
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 56/255 (21%), Positives = 100/255 (39%), Gaps = 28/255 (10%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ E +LK L H+NI+K + + T R +I E GSL ++ N
Sbjct: 46 SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN 105
Query: 62 VDM---KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLA 115
R ++ G+++L + I+HR++K NI K+ D G A
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 116 IVMQQPT-ARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCIL-EMVTCE-- 162
++ S+ GT E++ P++YE ++Y VD++S G T
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLP 222
Query: 163 -YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPA-LELLKDPF 220
P+ + ++ K+ +G ++S V + +P S L L++L P
Sbjct: 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282
Query: 221 LVTDNPKDLVCDPLR 235
L L D +
Sbjct: 283 LA----NILEADQEK 293
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 73/241 (30%), Positives = 118/241 (48%), Gaps = 20/241 (8%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ D++E + E+ +L + K+Y S++ DT I M E GS +
Sbjct: 59 EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM--EYLGGGSALDLL-EPGP 115
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+D I R+IL+GL YLHS IHRD+K N+ ++ +GEVK+ D G+A +
Sbjct: 116 LDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDT 172
Query: 122 TAR--SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA----QI 174
+ + +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P++E +P I
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLI 231
Query: 175 YKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDP 233
K P +L +K+F+E C S R A ELLK F++ + K
Sbjct: 232 PKN-----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 286
Query: 234 L 234
L
Sbjct: 287 L 287
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-38
Identities = 70/230 (30%), Positives = 115/230 (50%), Gaps = 20/230 (8%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+Q + E + +E+ +++ K+ NI+ + +S++ + M E GSL
Sbjct: 55 LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM--EYLAGGSLTDVV-TET 111
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVM 118
+D I R+ L+ L +LHS+ +IHRD+K DNI + +G VK+ D G I
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITP 168
Query: 119 QQPTARSVIGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYK 176
+Q +++GTP +MAPE+ + Y VDI+S G+ +EM+ E PY +NP + +Y
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYL 227
Query: 177 KVTSGI----KPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 221
T+G P LS + F+ +C + R A ELL+ FL
Sbjct: 228 IATNGTPELQNPEKLS----AIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-38
Identities = 63/249 (25%), Positives = 106/249 (42%), Gaps = 38/249 (15%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-------- 53
+ ++ L E+ + H NI+ +Y S+V + M +L + GS+
Sbjct: 52 KCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM--KLLSGGSVLDIIKHIVA 109
Query: 54 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 113
+ K +D I R++L GL YLH + IHRD+K NI + +G V+I D G
Sbjct: 110 KGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFG 166
Query: 114 LA-------IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYP 164
++ + + ++ +GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T P
Sbjct: 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
Query: 165 YNEC-----------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPA 212
Y++ +P + V K ++ I C R A
Sbjct: 227 YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS----FRKMISLCLQKDPEKRPTA 282
Query: 213 LELLKDPFL 221
ELL+ F
Sbjct: 283 AELLRHKFF 291
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 43/246 (17%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNW 70
EV+ L +KHENI++F + T+ +++ IT GSL + K + V + +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHI 126
Query: 71 ARQILRGLHYLHS--------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---- 118
A + RGL YLH H P I HRD+K N+ + NN I D GLA+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGK 185
Query: 119 QQPTARSVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 172
+GT +MAPE+ ++ + +D+Y+ G+ + E+ + + +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 173 QI--------------------YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 211
+ +KK ++ + + IE+C A RL
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 212 ALELLK 217
A + +
Sbjct: 306 AGCVGE 311
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 24/264 (9%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHK 60
QS ++ + + EV L+ L+H N I++ ++ + + M E + GS K
Sbjct: 93 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM--E-YCLGSASDLLEVHKK 149
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ I L+GL YLHSHN +IHRD+K NI ++ G VK+GD G A +M
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP 206
Query: 121 PTARSVIGTPEFMAPE----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--- 173
A S +GTP +MAPE + E +Y+ VD++S G+ +E+ + P N
Sbjct: 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALY 263
Query: 174 -IYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVC 231
I + + ++ S + F++ C R + LLK F++ + P ++
Sbjct: 264 HIAQNESPALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 319
Query: 232 DPL-RLPNLVPEVMNLAHSEPHPM 254
D + R + V E+ NL + + +
Sbjct: 320 DLIQRTKDAVRELDNLQYRKMKKI 343
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 59/235 (25%), Positives = 111/235 (47%), Gaps = 19/235 (8%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKH 59
M ++R+ +EV + LKH +I++ YN + D + ++ E+ +G + +Y + +
Sbjct: 49 MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRV 106
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
K +++ QI+ G+ YLHSH I+HRDL N+ + N +KI D GLA ++
Sbjct: 107 KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLL-TRNMNIKIADFGLATQLK 163
Query: 120 QPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIY 175
P + ++ GTP +++PE + D++S G C+ ++ P+ +
Sbjct: 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPF-DTDTVKNTL 221
Query: 176 KKVTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
KV P+ LS + K I + + + RL +L PF+ ++
Sbjct: 222 NKVVLADYEMPSFLS----IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 63/245 (25%), Positives = 115/245 (46%), Gaps = 21/245 (8%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKH 59
+S ++LE E+ +L + H I+K ++ D I + E G++ +
Sbjct: 54 TKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI--EFCPGGAVDAIMLELD 111
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IV 117
+ + I+ RQ+L L++LHS IIHRDLK N+ + G++++ D G++ +
Sbjct: 112 RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNL 168
Query: 118 MQQPTARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 171
S IGTP +MAPE + + Y+ DI+S G+ ++EM E P++E NP
Sbjct: 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NP 227
Query: 172 AQ-IYKKVTSGIKPASLSKVTD--PQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPK 227
+ + K S P +L + + + F++ R A +LL+ PF+ +
Sbjct: 228 MRVLLKIAKSD--PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285
Query: 228 DLVCD 232
+ +
Sbjct: 286 KALRE 290
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 20/230 (8%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++ + E L++EV +++ +H N+++ Y S++ + M E G+L
Sbjct: 80 LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM--EFLQGGALTDIV-SQV 136
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVM 118
++ + I +L+ L YLH+ +IHRD+K D+I + +G VK+ D G I
Sbjct: 137 RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISK 193
Query: 119 QQPTARSVIGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYK 176
P +S++GTP +MAPE+ Y VDI+S G+ ++EMV E PY +P Q + +
Sbjct: 194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKR 252
Query: 177 KVTSGI----KPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 221
S +S P ++ F+E+ + R A ELL PFL
Sbjct: 253 LRDSPPPKLKNSHKVS----PVLRDFLERMLVRDPQERATAQELLDHPFL 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 56/231 (24%), Positives = 113/231 (48%), Gaps = 14/231 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++ +L E+ + L+H NI++ YN + D I ++ E G L + +KH
Sbjct: 52 LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKELQKHG 109
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
D + + ++ LHY H +IHRD+K +N+ + G GE+KI D G ++
Sbjct: 110 RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPS 166
Query: 121 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
R++ GT +++ PE+ E + ++E VD++ G+ E + P+ + + + ++++
Sbjct: 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIV 225
Query: 180 SG-IK-PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
+ +K P LS K I K + RLP +++ P++ ++ +
Sbjct: 226 NVDLKFPPFLS----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 49/237 (20%), Positives = 113/237 (47%), Gaps = 16/237 (6%)
Query: 3 SPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+ ++ +R+ ++ +LKS I++ + +++ +T+ + + EL + + + ++
Sbjct: 63 NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD--VFIAMELMGTCAEKLKKRMQGP 120
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ + + I++ L+YL + +IHRD+K NI ++ G++K+ D G++ +
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDD 178
Query: 122 TAR-SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 174
A+ G +MAPE + +Y+ D++S G+ ++E+ T ++PY CK ++
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238
Query: 175 YKKVTSGIKPASLSKVTD--PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 228
KV +P L + F++ C+ R +LL+ F+ +
Sbjct: 239 LTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-37
Identities = 66/238 (27%), Positives = 113/238 (47%), Gaps = 20/238 (8%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVD 63
L+ + E+ +++ +++K+Y S+ +T+ I M E +GS+ R ++K +
Sbjct: 66 SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM--EYCGAGSVSDIIRLRNKTLT 123
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQP 121
I + L+GL YLH IHRD+K NI +N G K+ D G+A +
Sbjct: 124 EDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMA 180
Query: 122 TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYK 176
+VIGTP +MAPE + E YN + DI+S G+ +EM + PY + +P + I
Sbjct: 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPT 239
Query: 177 KVTSGIK-PASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCD 232
+ P S F+++C + R A +LL+ PF+ + ++ D
Sbjct: 240 NPPPTFRKPELWS----DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 4e-37
Identities = 82/354 (23%), Positives = 125/354 (35%), Gaps = 35/354 (9%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN------MITELFTSGSLRQYR 56
SP ER E+ ++K L H N++ V D + + + E G LR+Y
Sbjct: 52 SPKNRERWCLEIQIMKKLNHPNVVSARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYL 109
Query: 57 KKHKNVDM---KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI--FVNGNNGEVKIGD 111
+ +N I+ I L YLH + IIHRDLK +NI KI D
Sbjct: 110 NQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIID 167
Query: 112 LGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK 169
LG A + Q +GT +++APEL E ++Y VD +SFG E +T P+
Sbjct: 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227
Query: 170 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL---------RLPALELLKDP- 219
P Q + KV + +F P L R L+
Sbjct: 228 QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR 287
Query: 220 ----FLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGT 275
N L + VMN+ H + N + S + +TG
Sbjct: 288 QRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTG- 346
Query: 276 WFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADT 329
+ E Q L + + L + V + + D ++ F+F
Sbjct: 347 --IPEEEQELLQASGLALNSAQPLTQYV-IDCTVIDGRQGEGDLIFLFDNRKTV 397
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 51/258 (19%), Positives = 102/258 (39%), Gaps = 33/258 (12%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ + + +E+ ++ +K+E + + + +I E + S+ ++ +
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFF 138
Query: 61 NVDMKA--------IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 112
+D IK + +L Y+H+ I HRD+K NI + NG VK+ D
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILM-DKNGRVKLSDF 196
Query: 113 GLAIVMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECK 169
G + M + GT EFM PE + E VDI+S G+C+ M P++
Sbjct: 197 GESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 170 NPAQIYKKVTSG-----------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 211
+ +++ + + K + + F++ + + R+
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 212 ALELLKDPFLVTDNPKDL 229
+ + LK +L N +DL
Sbjct: 317 SEDALKHEWLADTNIEDL 334
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-36
Identities = 69/247 (27%), Positives = 111/247 (44%), Gaps = 13/247 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++ E L EV LLK L H NI+K Y + D ++ E++T G L K
Sbjct: 64 VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY--FYLVGEVYTGGELFDEIISRK 121
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVM 118
RQ+L G+ Y+H + I+HRDLK +N+ + + ++I D GL+
Sbjct: 122 RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
Query: 119 QQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
+ + IGT ++APE+ Y+E D++S G IL ++ P N I KK
Sbjct: 180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTG-VILYILLSGCPPFNGANEYDILKK 238
Query: 178 VTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDP 233
V G + KV++ K I K + S+R+ A + L ++ T + + D
Sbjct: 239 VEKGKYTFELPQWKKVSE-SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297
Query: 234 LRLPNLV 240
L N +
Sbjct: 298 PSLDNAI 304
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 70/253 (27%), Positives = 118/253 (46%), Gaps = 28/253 (11%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN----MITELFTSGSLRQYRK 57
+ D+ E + E+++LK H NI +Y +++ ++ ++ E +GS+ K
Sbjct: 60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 58 KHKNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115
K +K I R+ILRGL +LH H +IHRD+K N+ + N EVK+ D G++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVS 176
Query: 116 IVMQQPTAR--SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 167
+ + R + IGTP +MAPE + Y+ D++S G+ +EM P +
Sbjct: 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
Query: 168 CKNPA----QIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLV 222
+P I + +K SK + + FIE C + S R +L+K PF+
Sbjct: 237 -MHPMRALFLIPRNPAPRLKSKKWSK----KFQSFIESCLVKNHSQRPATEQLMKHPFIR 291
Query: 223 TDNPKDLVCDPLR 235
+ V L+
Sbjct: 292 DQPNERQVRIQLK 304
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-36
Identities = 59/276 (21%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 3 SPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+ ++L ++ +++S I++FY + + + + EL ++ + Y+ +
Sbjct: 60 DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD--CWICMELMSTSFDKFYKYVYSV 117
Query: 62 VDM----KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
+D + + ++ L++L IIHRD+K NI ++ +G +K+ D G++
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISG 174
Query: 117 VMQQPTARSV-IGTPEFMAPE-----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 170
+ A++ G +MAPE + Y+ D++S G+ + E+ T +PY + +
Sbjct: 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
Query: 171 PAQIYKKVTSGIKPASLSKVTD----PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225
+V G P LS + P F+ C+ S R ELLK PF++
Sbjct: 235 VFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293
Query: 226 PKDLVCDPLRLPNLVPEVMNLAHSEP-HPMDIDLNH 260
+ + + V ++++ + P PM +D +H
Sbjct: 294 ERA-----VEVACYVCKILDQMPATPSSPMYVDHHH 324
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-36
Identities = 59/242 (24%), Positives = 95/242 (39%), Gaps = 22/242 (9%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 60
P+ EV LL+ +H N+I+++ + D + EL + +L++Y +K
Sbjct: 57 LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQF--QYIAIEL-CAATLQEYVEQKDF 113
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAI 116
+Q GL +LHS N I+HRDLK NI ++ N I D GL
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 117 VMQQP-----TARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEY-PYN 166
+ V GT ++APE+ E+ VDI+S G +++ P+
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 167 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 225
+ + K D ++ IEK I R A +LK PF +
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291
Query: 226 PK 227
+
Sbjct: 292 KQ 293
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 55/239 (23%), Positives = 107/239 (44%), Gaps = 19/239 (7%)
Query: 3 SPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRK 57
+ + +RL ++ ++++ + FY + + + + + E SL +Q
Sbjct: 45 NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD--VWICME-LMDTSLDKFYKQVID 101
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
K + + + A I++ L +LHS + +IHRD+K N+ +N G+VK+ D G++
Sbjct: 102 KGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISG 158
Query: 117 VMQQPTAR-SVIGTPEFMAPE-----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 170
+ A+ G +MAPE L ++ Y+ DI+S G+ ++E+ +PY+
Sbjct: 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218
Query: 171 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 228
P Q K+V P + + F +C+ + R EL++ PF K
Sbjct: 219 PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 54/232 (23%), Positives = 104/232 (44%), Gaps = 17/232 (7%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
+ ++R E+ ++KSL H NII+ Y ++ D+T+ I ++ EL T G L + +
Sbjct: 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD--IYLVMELCTGGELFERVVHKRVFRE 105
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPT 122
+ +L + Y H N + HRDLK +N + + +K+ D GLA +
Sbjct: 106 SDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
Query: 123 A-RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVT 179
R+ +GTP +++P++ E Y D +S G ++ ++ C YP +++ K+
Sbjct: 164 MMRTKVGTPYYVSPQVLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIR 220
Query: 180 SGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
G V+ Q + I + + R+ +L+ L+ +
Sbjct: 221 EGTFTFPEKDWLNVSP-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 58/269 (21%), Positives = 104/269 (38%), Gaps = 49/269 (18%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
P ++ E+ +L I+ FY ++ D I++ E GSL Q KK +
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIP 129
Query: 64 MKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 122
+ + + +++GL YL H I+HRD+K NI VN + GE+K+ D G++ +
Sbjct: 130 EQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM 186
Query: 123 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 181
A S +GT +M+PE L Y+ DI+S G+ ++EM YP
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246
Query: 182 IKPASLSKVTD-----------------------------------------PQVKQFIE 200
A+ + + + F+
Sbjct: 247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 306
Query: 201 KCIV-PASLRLPALELLKDPFLVTDNPKD 228
KC++ + R +L+ F+ + ++
Sbjct: 307 KCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 6e-35
Identities = 58/333 (17%), Positives = 108/333 (32%), Gaps = 68/333 (20%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
S + + L E+H+ K H NI+ + +++ D + ++T GS + H
Sbjct: 65 CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFM 122
Query: 62 VDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
M AI + +L+ L Y+H +HR +K +I ++ +G+V + L + M
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMI 179
Query: 120 QPTAR---------SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPY-- 165
R + +++PE+ ++ Y+ DIYS G+ E+ P+
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239
Query: 166 -------------------------NECKNPAQIYKKVTSGIKPASLSKVTDPQV----- 195
E + SG+ + + P
Sbjct: 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299
Query: 196 -----------KQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 243
F+E+C R A LL F + LP L+ V
Sbjct: 300 HPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA----LPELLRPV 355
Query: 244 MNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTW 276
+ + E D + + + W
Sbjct: 356 TPITNFEGSQSQ-DHSGIFGLVTNLEELEVDDW 387
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 54/281 (19%), Positives = 99/281 (35%), Gaps = 38/281 (13%)
Query: 2 QSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD-----DTNRTINMITELFTSGSLRQY 55
++ + EV +K L H NI++F ++ DT + ++ G L ++
Sbjct: 64 NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEF 123
Query: 56 RKKHKNVDM---KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 112
KK ++ + Q R + ++H PPIIHRDLK +N+ + N G +K+ D
Sbjct: 124 LKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL-SNQGTIKLCDF 182
Query: 113 GLAIVMQQPTARSV--------------IGTPEFMAPELYE----EEYNELVDIYSFGMC 154
G A + S TP + PE+ + E DI++ G C
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-C 241
Query: 155 IL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 212
IL + ++P+ + +I S + I + RL
Sbjct: 242 ILYLLCFRQHPFED-GAKLRIVNGKYSIPPHDTQY----TVFHSLIRAMLQVNPEERLSI 296
Query: 213 LELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHP 253
E++ + P + L+ + +
Sbjct: 297 AEVVHQLQEIAAARNVNPKSP--ITELLEQNGGYGSATLSR 335
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 9e-35
Identities = 70/235 (29%), Positives = 112/235 (47%), Gaps = 17/235 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
+ EV LLK L H NI+K + D ++ ++ EL+T G L K K
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRF 118
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 120
+Q+ G+ Y+H HN I+HRDLK +NI + + ++KI D GL+ QQ
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 121 PTA-RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKK 177
T + IGT ++APE+ Y+E D++S G IL ++ P Y + N I K+
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKR 233
Query: 178 VTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 228
V +G ++D K I K + SLR+ A + L+ P++ + ++
Sbjct: 234 VETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 54/233 (23%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRK 57
+S +E++ +E+ +LKSL H NIIK + + D N + ++ E G L +
Sbjct: 59 RSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQA 116
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLA 115
+ K + + +Q++ L Y HS + ++H+DLK +NI F + + +KI D GLA
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 116 IVMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 174
+ + + GT +MAPE+++ + DI+S G ++ + + ++
Sbjct: 175 ELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEV 233
Query: 175 YKKVTSGI-----KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
+K T + L+ PQ +++ + R A ++L +
Sbjct: 234 QQKATYKEPNYAVECRPLT----PQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 70/245 (28%), Positives = 110/245 (44%), Gaps = 13/245 (5%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
+ EV LLK L H NI+K + D ++ ++ EL+T G L K K
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRF 118
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 120
+Q+ G+ Y+H HN I+HRDLK +NI + + ++KI D GL+ QQ
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 121 -PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
+ IGT ++APE+ Y+E D++S G IL ++ P KN I K+V
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGKNEYDILKRVE 235
Query: 180 SGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLR 235
+G ++D K I K + SLR+ A + L+ P++ + + L
Sbjct: 236 TGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLP 294
Query: 236 LPNLV 240
Sbjct: 295 SLESA 299
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 19/239 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+ D + +E+ +LK L H IIK N D + ++ EL G L +K
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNF-FDAED--YYIVLELMEGGELFDKVVGNKR 235
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ 119
+ K + Q+L + YLH + IIHRDLK +N+ + + +KI D G + ++
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 120 QPTA-RSVIGTPEFMAPE----LYEEEYNELVDIYSFGMCILEMVTCEY-PYNECKNPAQ 173
+ + R++ GTP ++APE + YN VD +S G IL + Y P++E +
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEHRTQVS 352
Query: 174 IYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 228
+ ++TSG P ++V++ ++K +V R E L+ P+L ++ K
Sbjct: 353 LKDQITSGKYNFIPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 67/260 (25%), Positives = 116/260 (44%), Gaps = 21/260 (8%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ D + +E+ +LK L H IIK N + D + ++ EL G L +K
Sbjct: 53 AREADPALNVETEIEILKKLNHPCIIKIKN-FFDAED--YYIVLELMEGGELFDKVVGNK 109
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVM 118
+ K + Q+L + YLH + IIHRDLK +N+ + + +KI D G + ++
Sbjct: 110 RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 119 QQPTA-RSVIGTPEFMAPE----LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNP 171
+ + R++ GTP ++APE + YN VD +S G IL + YP +
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEH-RTQ 225
Query: 172 AQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
+ ++TSG P ++V++ ++K +V R E L+ P+L ++ K
Sbjct: 226 VSLKDQITSGKYNFIPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284
Query: 228 DLVCDPLRLPNLVPEVMNLA 247
D L N + +
Sbjct: 285 RKFQDLLSEENESTALPQVL 304
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-34
Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 13/245 (5%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
S +L EV +LK L H NI+K Y+ + D N ++ E + G L
Sbjct: 76 STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN--YYLVMECYKGGELFDEIIHRMKF 133
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 120
+ +Q+L G+ YLH HN I+HRDLK +N+ + + +KI D GL+ V +
Sbjct: 134 NEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
Query: 121 -PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
+ +GT ++APE+ ++Y+E D++S G IL ++ YP + +I +KV
Sbjct: 192 QKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIG-VILFILLAGYPPFGGQTDQEILRKVE 250
Query: 180 SGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLR 235
G V++ K I++ + + R+ A + L+ P++ K L
Sbjct: 251 KGKYTFDSPEWKNVSE-GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELP 309
Query: 236 LPNLV 240
Sbjct: 310 SLANA 314
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 35/235 (14%), Positives = 71/235 (30%), Gaps = 31/235 (13%)
Query: 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS------GSLRQYRKKH 59
R L+K + + +I+ D + + S L + H
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
K++ A Q++R L LH + ++H L+ +I ++ G V + +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRDG 257
Query: 120 QPTARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCILEMVTCEYPYNE 167
+ F PEL D ++ G+ I + + P +
Sbjct: 258 ARV--VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 168 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
+ + K V+ +E + RL L+ ++ P
Sbjct: 316 -DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 72/251 (28%), Positives = 115/251 (45%), Gaps = 13/251 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
E +Y+E+ LLKSL H NIIK ++ + D ++TE + G L +
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHK 142
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ 119
D N +QIL G+ YLH HN I+HRD+K +NI N + +KI D GL+
Sbjct: 143 FDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 120 Q-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
+ R +GT ++APE+ +++YNE D++S G I+ ++ C YP +N I KKV
Sbjct: 201 KDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 179 TSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL 234
G ++ + K+ I+ + + R A E L ++ D
Sbjct: 260 EKGKYYFDFNDWKNIS-DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318
Query: 235 RLPNLVPEVMN 245
L + +
Sbjct: 319 TLCGALSNMRK 329
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-33
Identities = 58/236 (24%), Positives = 112/236 (47%), Gaps = 18/236 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
S ++L E + + L+H NI++ ++S +++ ++ +L T G L + +
Sbjct: 45 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFY 102
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ- 119
+ +QIL + Y HS+ I+HR+LK +N+ + VK+ D GLAI +
Sbjct: 103 SEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 120 QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYK 176
GTP +++PE L ++ Y++ VDI++ G IL ++ YP ++E + ++Y
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYA 217
Query: 177 KVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 228
++ +G VT + K I+ + R+ A + LK P++
Sbjct: 218 QIKAGAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 6e-33
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 30/176 (17%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKN 69
++ + ++H+NI +F T ++ E + +GSL +Y H D +
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCR 115
Query: 70 WARQILRGLHYLHS-------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---- 118
A + RGL YLH+ + P I HRDL N+ V N+G I D GL++ +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNR 174
Query: 119 ------QQPTARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT 160
+ A S +GT +MAPE+ E E + VD+Y+ G+ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 20/231 (8%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMK 65
+ +E+ ++ L H +I ++++ D + +I E + G L R + +K + +
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAE 150
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA- 123
I N+ RQ GL ++H H+ I+H D+K +NI VKI D GLA +
Sbjct: 151 VI-NYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207
Query: 124 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTS 180
+ T EF APE + E D+++ G + ++ E + + + V
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVKR 264
Query: 181 GI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
+ S V+ + K FI+ + RL + L+ P+L D+
Sbjct: 265 CDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 4e-32
Identities = 60/243 (24%), Positives = 111/243 (45%), Gaps = 21/243 (8%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMK 65
L +E+ +LK +KHENI+ + + T+ ++ +L + G L R + K
Sbjct: 51 SSLENEIAVLKKIKHENIVTLEDIYESTTH--YYLVMQLVSGGELFDRILERGVYT--EK 106
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA 123
+Q+L + YLH + I+HRDLK +N+ N ++ I D GL+ + Q
Sbjct: 107 DASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164
Query: 124 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTS 180
+ GTP ++APE L ++ Y++ VD +S G I ++ C YP Y E +++++K+
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKE 221
Query: 181 GI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 236
G + +++ K FI + + R + L P++ + P
Sbjct: 222 GYYEFESPFWDDISE-SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVS 280
Query: 237 PNL 239
+
Sbjct: 281 LQI 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 61/249 (24%), Positives = 115/249 (46%), Gaps = 19/249 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+ E + EV +L+ + H N+I ++ + + T+ + +I EL + G L + + ++
Sbjct: 54 RRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKES 111
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVM 118
+ + ++ +QIL G++YLH+ I H DLK +NI + N +K+ D GLA +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 119 QQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 174
+ +++ GTPEF+APE + E D++S G I ++ + +
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQET 226
Query: 175 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 230
+TS S ++ K FI K +V RL E L+ P++ + + +
Sbjct: 227 LANITSVSYDFDEEFFSHTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAM 285
Query: 231 CDPLRLPNL 239
+ NL
Sbjct: 286 VRRESVVNL 294
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 25/248 (10%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDM- 64
E L E + LKH +I++ ++ D + M+ E L ++
Sbjct: 71 EDLKREASICHMLKHPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYS 128
Query: 65 -KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQP 121
++ RQIL L Y H +N IIHRD+K + + N+ VK+G G+AI + +
Sbjct: 129 EAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 122 --TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYK 176
A +GTP FMAPE + E Y + VD++ G IL ++ Y ++++
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFE 242
Query: 177 KVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK-DLVC 231
+ G P S +++ K + + ++ + R+ E L P+L + +
Sbjct: 243 GIIKGKYKMNPRQWSHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIH 301
Query: 232 DPLRLPNL 239
P + L
Sbjct: 302 LPETVEQL 309
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 43/240 (17%), Positives = 88/240 (36%), Gaps = 32/240 (13%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+P + + LK +KFY++ + ++ EL++ G+L +KN
Sbjct: 106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKN 163
Query: 62 VDMKAIKN-----WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----------NNGE 106
K + +A ++L + +H IIH D+K DN + +
Sbjct: 164 TPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 107 VKIGDLGLAIVMQQP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC 161
+ + DLG +I M+ + T F E L + +N +D + + M+
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPF 220
Y + + + + + + +F + +P LP+L+LL+
Sbjct: 282 TYMKVKNEGGECKPEGLFRRLPHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 37/274 (13%), Positives = 80/274 (29%), Gaps = 31/274 (11%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS---------GS 51
+++ Q + + +K K +D+ + + L+
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 52 LRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 111
L + HK++ A Q++R L LH + ++H L+ +I + G V +
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVL-DQRGGVFLTG 254
Query: 112 LGLAIVMQQPT---ARSVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCE 162
+ PE A + D ++ G+ I + +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
P + + + K V+ +E + RL L+ ++ P
Sbjct: 315 LPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 367
Query: 222 VTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 255
+ + + L L E + P
Sbjct: 368 --EQLRTELSAALPLYQTDGEPTREGGAPPSGTS 399
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 59/245 (24%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKH 59
+ E + +E+ ++ L H N+I+ Y+++ + I ++ E G L R + +
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESY 182
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVM 118
++ I + +QI G+ ++H I+H DLK +NI VN + ++KI D GLA
Sbjct: 183 NLTELDTI-LFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 119 QQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 174
+ + GTPEF+APE + + + D++S G+ I M+ + N A+
Sbjct: 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAET 296
Query: 175 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 230
+ + + +++ + K+FI K ++ S R+ A E LK P+L +
Sbjct: 297 LNNILACRWDLEDEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRL 355
Query: 231 CDPLR 235
+
Sbjct: 356 SAQKK 360
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 62/245 (25%), Positives = 122/245 (49%), Gaps = 17/245 (6%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
+P L++L+ EV ++K L H NI+K + V +T +T+ +I E + G + Y H +
Sbjct: 54 NPTSLQKLFREVRIMKILNHPNIVKLFE--VIETEKTLYLIMEYASGGEVFDYLVAHGRM 111
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 122
K ++ RQI+ + Y H I+HRDLK +N+ + + +KI D G +
Sbjct: 112 KEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLL-DADMNIKIADFGFSNEFTVGG 168
Query: 123 A-RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
+ G P + APEL++ ++Y+ VD++S G+ + +V+ P++ +N ++ ++V
Sbjct: 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVL 227
Query: 180 SGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 236
G P +S + +++ +V R +++KD ++ + +D + P
Sbjct: 228 RGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL-KPFVE 282
Query: 237 PNLVP 241
P L
Sbjct: 283 PELDI 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 21/233 (9%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
+ + +E+ +L L H NIIK + T I+++ EL T G L + +
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVTGGELFDRIVEKGYYSERDA 150
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-R 124
+ +QIL + YLH + I+HRDLK +N+ + + +KI D GL+ +++ +
Sbjct: 151 ADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 125 SVIGTPEFMAPE-LYEEEYNELVDIYSFG--MCILEMVTCEYP--YNECKNPAQIYKKVT 179
+V GTP + APE L Y VD++S G IL C + Y+E + +++++
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFMFRRIL 264
Query: 180 SGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 228
+ +V+ K + K IV RL + L+ P++
Sbjct: 265 NCEYYFISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 59/234 (25%), Positives = 113/234 (48%), Gaps = 18/234 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
S ++L E + + L+H NI++ ++S +++ ++ +L T G L + +
Sbjct: 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFY 125
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 120
+ +QIL + Y HS+ I+HR+LK +N+ + VK+ D GLAI +
Sbjct: 126 SEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 121 PTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYK 176
A GTP +++PE L ++ Y++ VDI++ G IL ++ YP ++E + ++Y
Sbjct: 184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYA 240
Query: 177 KVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 226
++ +G VT + K I+ + R+ A + LK P++
Sbjct: 241 QIKAGAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 61/249 (24%), Positives = 116/249 (46%), Gaps = 19/249 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+ E + EV +L+ + H NII ++ + + T+ + +I EL + G L + + ++
Sbjct: 54 RRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD--VVLILELVSGGELFDFLAQKES 111
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVM 118
+ + ++ +QIL G++YLH+ I H DLK +NI + N +K+ D GLA +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 119 QQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 174
+ +++ GTPEF+APE + E D++S G I ++ + +
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQET 226
Query: 175 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 230
+T+ S+ ++ K FI K +V RL E L+ P++ + + +
Sbjct: 227 LANITAVSYDFDEEFFSQTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM 285
Query: 231 CDPLRLPNL 239
+ NL
Sbjct: 286 VRRESVVNL 294
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 47/231 (20%), Positives = 100/231 (43%), Gaps = 20/231 (8%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--K 65
+ E+ +L +H NI+ + S+ + MI E + + + R ++ +
Sbjct: 46 VLVKKEISILNIARHRNILHLHESFESMEE--LVMIFEFISGLDIFE-RINTSAFELNER 102
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA- 123
I ++ Q+ L +LHSHN I H D++ +NI + + +KI + G A ++
Sbjct: 103 EIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
Query: 124 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTS 180
R + PE+ APE + + D++S G ++ ++ E QI + + +
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMN 217
Query: 181 GI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
+ +++ + F+++ +V R+ A E L+ P+L +
Sbjct: 218 AEYTFDEEAFKEISI-EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 57/239 (23%), Positives = 112/239 (46%), Gaps = 19/239 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+ E + EV++L+ ++H NII ++ + + T+ + +I EL + G L + + ++
Sbjct: 47 RRGVSREEIEREVNILREIRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEKES 104
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVM 118
+ + +QIL G+HYLHS I H DLK +NI + N N +K+ D G+A +
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162
Query: 119 QQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 174
+ +++ GTPEF+APE + E D++S G I ++ E +
Sbjct: 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQET 219
Query: 175 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 229
+++ S ++ K FI + +V R+ + L+ ++ +++
Sbjct: 220 LTNISAVNYDFDEEYFSNTSE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
PDQ E+ +LK+L + I+K+ +++ ++ E SG LR + ++H+
Sbjct: 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR 123
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+D + ++ QI +G+ YL S +HRDL NI V + VKI D GLA ++
Sbjct: 124 LDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLD 180
Query: 122 ----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 174
R +P F APE L + ++ D++SFG+ + E+ T C+ + ++
Sbjct: 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240
Query: 175 YKKVTSGIKPASLSKVTDPQVKQFIEK 201
++ + +E+
Sbjct: 241 MGCERDVP--------ALSRLLELLEE 259
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 58/232 (25%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
E + EV +LK ++H N+I + + + T+ + +I EL G L + + +++ +
Sbjct: 59 EDIEREVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEA 116
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA- 123
+ +QIL G++YLHS I H DLK +NI + N +KI D GLA +
Sbjct: 117 TEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 124 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTS 180
+++ GTPEF+APE + E D++S G I ++ + + V++
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSA 231
Query: 181 GI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 228
+ S + K FI + +V R+ + L+ P++ + +
Sbjct: 232 VNYEFEDEYFSNTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 59/279 (21%), Positives = 100/279 (35%), Gaps = 60/279 (21%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
+P +ER+ +EV L+K L H NI + Y + D+ I ++ EL G L +
Sbjct: 68 NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDD 125
Query: 63 DMKAIKNWA----------------------------------------RQILRGLHYLH 82
RQI LHYLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 83 SHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPEFMAP 135
+ I HRD+K +N F + E+K+ D GL+ + + GTP F+AP
Sbjct: 186 NQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 136 EL---YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSK 189
E+ E Y D +S G +L ++ N A +V + + + +
Sbjct: 244 EVLNTTNESYGPKCDAWSAG-VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNV 302
Query: 190 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
++ + + + R A+ L+ P++ + K
Sbjct: 303 LSP-LARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 49/187 (26%), Positives = 95/187 (50%), Gaps = 11/187 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+Q +E++Y E+ +LK L H N++K D + M+ EL G + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ +A + + +++G+ YLH IIHRD+K N+ V G +G +KI D G++ +
Sbjct: 134 LSEDQARF-YFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIKIADFGVSNEFKG 189
Query: 121 PTA--RSVIGTPEFMAPEL---YEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQI 174
A + +GTP FMAPE + ++ + +D+++ G+ + V + P+ + + +
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCL 248
Query: 175 YKKVTSG 181
+ K+ S
Sbjct: 249 HSKIKSQ 255
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-30
Identities = 60/249 (24%), Positives = 116/249 (46%), Gaps = 20/249 (8%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
S ++L E + + LKH NI++ ++S ++ + +I +L T G L + +
Sbjct: 50 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH--HYLIFDLVTGGELFEDIVAREYY 107
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 120
+ +QIL + + H ++HR+LK +N+ + VK+ D GLAI ++
Sbjct: 108 SEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 121 PTA--RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIY 175
GTP +++PE L ++ Y + VD+++ G IL ++ YP ++E + ++Y
Sbjct: 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG-VILYILLVGYPPFWDE--DQHRLY 222
Query: 176 KKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP-KDLV 230
+++ +G VT + K I K + S R+ A E LK P++ + +
Sbjct: 223 QQIKAGAYDFPSPEWDTVTP-EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCM 281
Query: 231 CDPLRLPNL 239
+ L
Sbjct: 282 HRQETVDCL 290
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
+ + L E+ +LKSL+H+NI+K+ R + +I E GSLR Y +KHK
Sbjct: 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 110
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
+D + + QI +G+ YL + IHRDL NI V N VKIGD GL +
Sbjct: 111 IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQD 167
Query: 120 QPTARSVIGT--PEF-MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
+ + P F APE L E +++ D++SFG+ + E+ T Y E
Sbjct: 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAE 223
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEK 201
G ++ + + ++
Sbjct: 224 FMRMIGNDK--QGQMIVFHLIELLKN 247
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-30
Identities = 56/250 (22%), Positives = 107/250 (42%), Gaps = 20/250 (8%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHK 60
E + E+ + L+H ++ ++++ DD + MI E + G L + +H
Sbjct: 193 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHN 250
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQ 119
+ + RQ+ +GL ++H +N +H DLK +NI F + E+K+ D GL +
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 120 QPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIY 175
+ + GT EF APE + D++S G + ++ E N +
Sbjct: 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETL 365
Query: 176 KKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN--PKDL 229
+ V S ++ S +++ K FI K ++ + R+ + L+ P+L N +D
Sbjct: 366 RNVKSCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 424
Query: 230 VCDPLRLPNL 239
R +
Sbjct: 425 QIPSSRYTKI 434
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
+ + L E+ +LKSL+H+NI+K+ R + +I E GSLR Y +KHK
Sbjct: 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 141
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
+D + + QI +G+ YL + IHRDL NI V N VKIGD GL +
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQD 198
Query: 120 QPTARSVIGT--PEF-MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
+ + P F APE L E +++ D++SFG+ + E+ T Y E
Sbjct: 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAE 254
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEK 201
G ++ + + ++
Sbjct: 255 FMRMIGNDK--QGQMIVFHLIELLKN 278
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 57/263 (21%), Positives = 97/263 (36%), Gaps = 43/263 (16%)
Query: 3 SPDQLERLYSEVHLL-KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-------RQ 54
D + E+ LL +S H N+I++Y S D + + EL + +L
Sbjct: 48 LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRF--LYIALEL-CNLNLQDLVESKNV 104
Query: 55 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------G 102
+ K + RQI G+ +LHS IIHRDLK NI V+
Sbjct: 105 SDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGA 162
Query: 103 NNGEVKIGDLGLAIVMQ------QPTARSVIGTPEFMAPEL--------YEEEYNELVDI 148
N + I D GL + + + GT + APEL + +DI
Sbjct: 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222
Query: 149 YSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCIVP 205
+S G +++ ++ + I + + S + L + + I + I
Sbjct: 223 FSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282
Query: 206 -ASLRLPALELLKDPFLVTDNPK 227
R A+++L+ P + K
Sbjct: 283 DPLKRPTAMKVLRHPLFWPKSKK 305
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 56/263 (21%), Positives = 106/263 (40%), Gaps = 25/263 (9%)
Query: 8 ERLYSEVHLLKSL-KHENIIKFYNSWVDDTN--RTINMITELFTSGSL--RQYRKKHKNV 62
+ EV +I+ + + + + R + +I E G L R + +
Sbjct: 66 PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF 125
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 120
+ R I + +LHSHN I HRD+K +N+ + + + +K+ D G A Q
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 121 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKN--PAQIY 175
++ TP ++APE L E+Y++ D++S G I+ ++ C +P Y+ +
Sbjct: 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 176 KKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL-----VTDNP 226
+++ G S+V++ KQ I + + RL + + P++ V P
Sbjct: 243 RRIRLGQYGFPNPEWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
Query: 227 KDLVCDPLRLPNLVPEVMNLAHS 249
+ EV S
Sbjct: 302 LHTARVLQEDKDHWDEVKEEMTS 324
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 49/162 (30%), Positives = 87/162 (53%), Gaps = 19/162 (11%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 71
E+ LLK LKH+NI++ ++ V +++ + ++ E F L++Y D + +K++
Sbjct: 51 EICLLKELKHKNIVRLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 131
Q+L+GL + HS N ++HRDLK N+ +N NGE+K+ + GLA P R + E
Sbjct: 108 FQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV-RCY--SAE 161
Query: 132 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY 165
+ P++ + Y+ +D++S G CI E+ P
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 24/168 (14%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA------ 66
E+ LL+ LKH N+I ++ +R + ++ + + L K H+
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 67 ---IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQ 120
+K+ QIL G+HYLH++ ++HRDLK NI V G G VKI D+G A +
Sbjct: 127 RGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 121 PTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 160
P P + APEL Y + +DI++ G CI E++T
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 60/294 (20%)
Query: 13 EVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTS---GSLRQYRKKHKNVDMK 65
E+ +++ +KH N++ FY++ +N++ E + R Y K + + M
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTAR 124
IK + Q+LR L Y+HS I HRD+K N+ ++ +G +K+ D G A I++
Sbjct: 142 LIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 125 SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE------------------- 162
S I + + APEL Y +DI+S G C++ E++ +
Sbjct: 200 SYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFPGESGIDQLVEIIKVL 258
Query: 163 -YPYNE---CKNPAQIYKKVTSGIKPASLSKV----TDPQVKQFIEKCIV--PASLRLPA 212
P E NP + K I+P SKV T P I + + P S RL A
Sbjct: 259 GTPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTP-SARLTA 316
Query: 213 LELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD 266
+E L PF D LR + + P + +++S
Sbjct: 317 IEALCHPFF----------DELRTGE-----ARMPNGRELPPLFNWTKEELSVR 355
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 7e-29
Identities = 34/231 (14%), Positives = 67/231 (29%), Gaps = 22/231 (9%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS------GSLRQYRKKHKN 61
RL + + D ++ + +L +
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ A+ Q++R L S ++H DN+F+ +G + +GD+ +
Sbjct: 191 EGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFI-MPDGRLMLGDVSAL--WKVG 245
Query: 122 TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
T P AP + + ++ + G+ I + P+ + K
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305
Query: 178 VTSGIKPA------SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
S P VK I + + RL LE ++ P
Sbjct: 306 RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 24/240 (10%)
Query: 5 DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
+ E EV +L+ + H NII+ +++ +T ++ +L G L Y + +
Sbjct: 65 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLS 122
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
K + R +L + LH N I+HRDLK +NI ++ ++ +K+ D G + +
Sbjct: 123 EKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEK 179
Query: 124 -RSVIGTPEFMAPE-------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ 173
R V GTP ++APE Y + VD++S G I+ + P ++
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAGSPPFWHR--KQML 236
Query: 174 IYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 229
+ + + SG +D VK + + +V R A E L PF +++
Sbjct: 237 MLRMIMSGNYQFGSPEWDDYSDT-VKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 59/261 (22%), Positives = 109/261 (41%), Gaps = 25/261 (9%)
Query: 6 QLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
E+ LK + H NI+K + + D + ++ EL G L + KK K+
Sbjct: 48 MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSE 105
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ--Q 120
R+++ + ++H ++HRDLK +N+ F + +N E+KI D G A +
Sbjct: 106 TEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 121 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP-------YNECKNPA 172
++ T + APE L + Y+E D++S G IL + C +
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAV 222
Query: 173 QIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 228
+I KK+ G + + V+ + K I+ + + RL L + +L +
Sbjct: 223 EIMKKIKKGDFSFEGEAWKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
Query: 229 LVCDPLRLPNLVPEVMNLAHS 249
+PL P+++ H+
Sbjct: 282 S--NPLMTPDILGSSGAAVHT 300
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 21/160 (13%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 72
EV LLK L+H NII+ + V N +++I E + L++Y K+ +V M+ IK++
Sbjct: 83 EVSLLKELQHRNIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLY 139
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQPTARSVIG 128
Q++ G+++ HS +HRDLK N+ ++ +KIGD GLA P +
Sbjct: 140 QLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--- 194
Query: 129 TPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 160
T E + PE+ Y+ VDI+S CI EM+
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 21/241 (8%)
Query: 3 SPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKH 59
D + E+ +L+ K +I + + + + I +I E G + +
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE--IILILEYAAGGEIFSLCLPELA 125
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGN-NGEVKIGDLGLAIV 117
+ V + +QIL G++YLH +N I+H DLK NI + G++KI D G++
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183
Query: 118 MQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ 173
+ R ++GTPE++APE L + D+++ G+ I M+ E + +
Sbjct: 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQE 240
Query: 174 IYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 229
Y ++ + S V+ FI+ +V R A L +L + ++L
Sbjct: 241 TYLNISQVNVDYSEETFSSVSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299
Query: 230 V 230
Sbjct: 300 F 300
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 19/157 (12%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 71
E+ LLK L H NI+ + V + R + ++ E F L++ ++K IK +
Sbjct: 69 EISLLKELHHPNIVSLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 131
Q+LRG+ + H H I+HRDLK N+ +N ++G +K+ D GLA P T E
Sbjct: 126 YQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY---THE 179
Query: 132 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 160
+ AP++ ++Y+ VDI+S G CI EM+T
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 53/269 (19%), Positives = 112/269 (41%), Gaps = 21/269 (7%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGS--LRQYRKK 58
+ P+ + E+ LL+ L+H+N+I+ + ++ + + M+ E G + +
Sbjct: 44 RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE 103
Query: 59 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
+ +A + Q++ GL YLHS I+H+D+K N+ + G +KI LG+A +
Sbjct: 104 KRFPVCQAHG-YFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEAL 159
Query: 119 QQPTARSVI----GTPEFMAPELY--EEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNP 171
A G+P F PE+ + ++ VDI+S G+ + + T YP+ N
Sbjct: 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNI 218
Query: 172 AQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 228
++++ + G P P + ++ + + R ++ + + +P
Sbjct: 219 YKLFENIGKGSYAIPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274
Query: 229 LVCDPLRLPNLVPEVMNLAHSEPHPMDID 257
P+ + P+ D+
Sbjct: 275 EAPVPIPPSPDTKDRWRSMTVVPYLEDLH 303
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 54/165 (32%), Positives = 90/165 (54%), Gaps = 10/165 (6%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
+ + L E+ +L++L HENI+K+ +D I +I E SGSL++Y K+K
Sbjct: 63 GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+++K +A QI +G+ YL S +HRDL N+ V + +VKIGD GL ++
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGLTKAIETD 179
Query: 122 ----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 160
T + +P F APE L + ++ D++SFG+ + E++T
Sbjct: 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (284), Expect = 4e-28
Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 71
E+ +LK LKH NI+K Y+ V T + + ++ E L++ + + K++
Sbjct: 50 EISILKELKHSNIVKLYD--VIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFL 106
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 131
Q+L G+ Y H ++HRDLK N+ +N GE+KI D GLA P R T E
Sbjct: 107 LQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV-RKY--THE 160
Query: 132 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 160
+ AP++ ++Y+ +DI+S G CI EMV
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 10/164 (6%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
P E+ +L++L HE+IIK+ D ++ ++ E GSLR Y +H +
Sbjct: 73 GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-I 131
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 121
+ + +A+QI G+ YLH+ + IHRDL N+ + N+ VKIGD GLA + +
Sbjct: 132 GLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGH 188
Query: 122 ---TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 160
R +P F APE L E ++ D++SFG+ + E++T
Sbjct: 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 57/267 (21%)
Query: 13 EVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTS---GSLRQYRKKHKNVDMK 65
E+ +++ L H NI++ FY+S +N++ + R Y + + + +
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTAR 124
+K + Q+ R L Y+HS I HRD+K N+ ++ + +K+ D G A +++
Sbjct: 157 YVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 125 SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE------------------- 162
S I + + APEL +Y +D++S G C+L E++ +
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQPIFPGDSGVDQLVEIIKVL 273
Query: 163 -YPYNE---CKNPAQIYKKVT-SGIKPASLSKV----TDPQVKQFIEKCIV--PASLRLP 211
P E NP Y + IK +KV T P+ + + P + RL
Sbjct: 274 GTPTREQIREMNPN--YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP-TARLT 330
Query: 212 ALELLKDPFLVTDNPKDLVCDPLRLPN 238
LE F D LR PN
Sbjct: 331 PLEACAHSFF----------DELRDPN 347
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 49/186 (26%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
SP + + E +++ S+ + ++ + + T+ +IT+L G L Y ++HK N
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLG--IC-LTSTVQLITQLMPFGCLLDYVREHKDN 113
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQ 120
+ + + NW QI +G++YL ++HRDL N+ V VKI D GLA ++ +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAE 170
Query: 121 PTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 175
G P ++MA E + Y D++S+G+ + E++T PY+ ++I
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEIS 229
Query: 176 KKVTSG 181
+ G
Sbjct: 230 SILEKG 235
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 19/157 (12%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 71
EV LLK LKH NI+ ++ + T +++ ++ E + L+QY N+ +M +K +
Sbjct: 50 EVSLLKDLKHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFL 106
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 131
Q+LRGL Y H ++HRDLK N+ +N GE+K+ D GLA PT E
Sbjct: 107 FQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY---DNE 160
Query: 132 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 160
+ P++ +Y+ +D++ G CI EM T
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 12/235 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ D E + E+ + K L HEN++KFY + E + G L +
Sbjct: 44 RAVDCPENIKKEICINKMLNHENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ + + Q++ G+ YLH I HRD+K +N+ ++ +KI D GLA V +
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYN 158
Query: 122 TARSVI----GTPEFMAPE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
++ GT ++APE L E++ E VD++S G+ + M+ E P+++ + Q Y
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 229
+ K D + K +V S R+ ++ KD + K
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 19/157 (12%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWA 71
E+ +LK LKH N++ V R ++++ E + ++ +++ V +K+
Sbjct: 52 EIRMLKQLKHPNLVNLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSIT 108
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 131
Q L+ +++ H HN IHRD+K +NI + + +K+ D G A ++ P+ E
Sbjct: 109 WQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYY---DDE 162
Query: 132 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 160
+PEL + +Y VD+++ G C+ E+++
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIG-CVFAELLS 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 19/223 (8%)
Query: 16 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 75
LL+ +H NII + V D + + ++TEL G L + K + I
Sbjct: 69 LLRYGQHPNIITLKD--VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 76 RGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP 130
+ + YLH+ ++HRDLK NI +GN ++I D G A ++ + T
Sbjct: 127 KTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184
Query: 131 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECK-NPAQIYKKVTSG---IK 183
F+APE L + Y+ DI+S G +L + Y N P +I ++ SG +
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243
Query: 184 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 225
+ V+D K + K + RL A +L+ P++V +
Sbjct: 244 GGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 24/162 (14%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA------ 66
E+ L+K LKHENI++ Y+ V T + ++ E F L++Y +
Sbjct: 53 EISLMKELKHENIVRLYD--VIHTENKLTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNL 109
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 126
+K + Q+L+GL + H + I+HRDLK N+ +N G++K+GD GLA P
Sbjct: 110 VKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTF- 165
Query: 127 IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 160
+ E + AP++ Y+ +DI+S G CIL EM+T
Sbjct: 166 --SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 53/232 (22%), Positives = 104/232 (44%), Gaps = 24/232 (10%)
Query: 5 DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
+ E E H+L+ + H +II +S+ + + ++ +L G L Y + +
Sbjct: 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKVALS 198
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
K ++ R +L + +LH++N I+HRDLK +NI ++ +N ++++ D G + ++
Sbjct: 199 EKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEK 255
Query: 124 -RSVIGTPEFMAPE-------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ 173
R + GTP ++APE Y + VD+++ G IL + P ++
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFWHR--RQIL 312
Query: 174 IYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
+ + + G + VK I + + RL A + L+ PF
Sbjct: 313 MLRMIMEGQYQFSSPEWDDRSST-VKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 59/264 (22%), Positives = 109/264 (41%), Gaps = 14/264 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ D E + E+ + K L HEN++KFY + E + G L +
Sbjct: 44 RAVDCPENIKKEICINKMLNHENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ + + Q++ G+ YLH I HRD+K +N+ ++ +KI D GLA V +
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYN 158
Query: 122 TARSVI----GTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
++ GT ++APEL + E++ E VD++S G+ + M+ E P+++ + Q Y
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 176 -KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDP 233
K+ D + K +V S R+ ++ KD + K
Sbjct: 219 SDWKEKKTYLNPWKKI-DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPR 277
Query: 234 LRLPNLVPEVMNLAHSEPHPMDID 257
+ + + +D
Sbjct: 278 VTSGGVSESPSGFSKHIQSNLDFS 301
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 66/266 (24%), Positives = 106/266 (39%), Gaps = 52/266 (19%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWA 71
E+ LLK L+HEN++ V + ++ E F ++ + N +D + ++ +
Sbjct: 74 EIKLLKQLRHENLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYL 130
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 131
QI+ G+ + HSHN IIHRD+K +NI V+ +G VK+ D G A + P E
Sbjct: 131 FQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY---DDE 184
Query: 132 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY------------------ 165
APEL + +Y + VD+++ G C++ EM E P
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHIMMCLG 242
Query: 166 --NE------CKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PASLRLPA 212
KNP ++ + L + V +KC+ P R
Sbjct: 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK-RPFC 301
Query: 213 LELLKDPFLVTDNPKDLVCDPLRLPN 238
ELL F D + L+L
Sbjct: 302 AELLHHDFFQMDGFAERFSQELQLKV 327
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 71
E+ LL+ L H NII +++ +N I+++ + F L K + V IK +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSN--ISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 131
L+GL YLH H I+HRDLK +N+ ++ NG +K+ D GLA P R+ T +
Sbjct: 119 LMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN-RAY--THQ 172
Query: 132 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 160
+ APEL Y VD+++ G CIL E++
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 19/226 (8%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
+ L+R EVH L H+NI+ + +D + M E +L +Y + H +
Sbjct: 52 EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM--EYIEGPTLSEYIESHGPLS 109
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 122
+ N+ QIL G+ + H I+HRD+K NI + +N +KI D G+A + + +
Sbjct: 110 VDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSL 166
Query: 123 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKV 178
V+GT ++ +PE + E +E DIYS G+ + EM+ E P+N + I K +
Sbjct: 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHI 225
Query: 179 TSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP------ALELLKD 218
+ P + V + Q + I+ A+ + E+ D
Sbjct: 226 QDSV-PNVTTDV-RKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 50/235 (21%), Positives = 101/235 (42%), Gaps = 21/235 (8%)
Query: 8 ERLYSEVHLLKSL-KHENIIKFYNSWVD--DTNRTINMITELFTSGSL--RQYRKKHKNV 62
+ EV L + +I++ + + + + + ++ E G L R + +
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ- 119
+ + I + YLHS N I HRD+K +N+ + + N +K+ D G A
Sbjct: 159 TEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 120 QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ--I 174
+ + TP ++APE L E+Y++ D++S G I+ ++ C YP Y+ +
Sbjct: 217 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGM 275
Query: 175 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 225
++ G S+V++ +VK I + + R+ E + P+++
Sbjct: 276 KTRIRMGQYEFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 49/244 (20%), Positives = 93/244 (38%), Gaps = 27/244 (11%)
Query: 5 DQLERLYSEVHLLKSL----KHENIIKFYNSWVDDTNRTINMITELFTSGS-LRQYRKKH 59
EV LL + H +I+ + +T ++ E L Y +
Sbjct: 76 SDSVTCPLEVALLWKVGAGGGHPGVIRLLD--WFETQEGFMLVLERPLPAQDLFDYITEK 133
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+ + + Q++ + + HS ++HRD+K +NI ++ G K+ D G ++
Sbjct: 134 GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
Query: 120 QPTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYK 176
GT + PE +Y+ ++S G+ +L +MV + P+ +
Sbjct: 192 DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI-LLYDMVCGDIPFER-------DQ 243
Query: 177 KVTSGI--KPASLSKVTDPQVKQFIEKCIVPA-SLRLPALELLKDPFLVTDNPKDLVCDP 233
++ PA +S P I +C+ P S R E+L DP++ T +
Sbjct: 244 EILEAELHFPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPS 299
Query: 234 LRLP 237
P
Sbjct: 300 KGGP 303
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 18/236 (7%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++S D + ++ E+ LK +H +IIK Y V T M+ E + G L Y KH
Sbjct: 49 IRSLDVVGKIKREIQNLKLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHG 106
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V+ + +QIL + Y H H ++HRDLK +N+ ++ + KI D GL+ +M
Sbjct: 107 RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSD 163
Query: 121 PTA-RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYK 176
R+ G+P + APE+ Y VDI+S G+ IL + C P+++ ++ ++K
Sbjct: 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGV-ILYALLCGTLPFDD-EHVPTLFK 221
Query: 177 KVTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 229
K+ G+ P L+ V + + R ++ + + D P L
Sbjct: 222 KIRGGVFYIPEYLN----RSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 45/249 (18%), Positives = 96/249 (38%), Gaps = 24/249 (9%)
Query: 2 QSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVDDTNRTINMITELFT-SGSLRQYRKK 58
R+ EV LLK + +I+ + + + +I E L + +
Sbjct: 85 GELPNGTRVPMEVVLLKKVSSGFSGVIRLLD--WFERPDSFVLILERPEPVQDLFDFITE 142
Query: 59 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
+ + +++ Q+L + + H+ ++HRD+K +NI ++ N GE+K+ D G ++
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL 200
Query: 119 QQPTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
+ GT + PE Y+ ++S G+ + +MV + P+ +
Sbjct: 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DE 253
Query: 177 KVTSGI--KPASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCDP 233
++ G +S + + I C+ P E+ P++
Sbjct: 254 EIIRGQVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA-E 308
Query: 234 LRLPNLVPE 242
+ L +L P
Sbjct: 309 IHLHSLSPG 317
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 56/266 (21%), Positives = 107/266 (40%), Gaps = 43/266 (16%)
Query: 8 ERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA 66
R++ EV +L + H N+++ + ++ ++ E GS+ + K ++ +
Sbjct: 55 SRVFREVEMLYQCQGHRNVLELIEFFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNELE 112
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ----- 119
+ + L +LH+ I HRDLK +NI + VKI D L ++
Sbjct: 113 ASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 120 ----QPTARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNE 167
P + G+ E+MAPE Y++ D++S G IL ++ YP
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFVGR 229
Query: 168 CK-------------NPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRL 210
C +++ + G + ++ K I K +V A RL
Sbjct: 230 CGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQRL 288
Query: 211 PALELLKDPFLVTDNPKDLVCDPLRL 236
A ++L+ P++ P++ + P+ L
Sbjct: 289 SAAQVLQHPWVQGCAPENTLPTPMVL 314
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 48/186 (25%), Positives = 73/186 (39%), Gaps = 13/186 (6%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
PD + E +LK H NI++ V + I ++ EL G + R +
Sbjct: 152 PPDLKAKFLQEARILKQYSHPNIVRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGAR 209
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ +K + G+ YL S IHRDL N V N +KI D G++
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKN-VLKISDFGMSREEADG 266
Query: 122 TARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 175
+ G + APE L Y+ D++SFG+ + E + PY N Q
Sbjct: 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTR 325
Query: 176 KKVTSG 181
+ V G
Sbjct: 326 EFVEKG 331
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 53/250 (21%), Positives = 103/250 (41%), Gaps = 24/250 (9%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGS-LRQYRKKH 59
+L ++ E+ +L ++H NIIK + + + ++ E SG L + +H
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGLDLFAFIDRH 124
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+D RQ++ + YL + IIHRD+K +NI + + +K+ D G A ++
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAE-DFTIKLIDFGSAAYLE 181
Query: 120 Q-PTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
+ + GT E+ APE+ Y ++++S G+ L + E NP +
Sbjct: 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV-TLYTLVFEE------NPFCELE 234
Query: 177 KVTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD-NPKDLVCD 232
+ P +S ++ + + P R +L+ DP++ N D +
Sbjct: 235 ETVEAAIHPPYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWE 290
Query: 233 PLRLPNLVPE 242
+ N
Sbjct: 291 EVFRVNKPES 300
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 62/268 (23%), Positives = 115/268 (42%), Gaps = 31/268 (11%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
E + E+ +SL+H NI++F V T + +I E + G L +
Sbjct: 61 ENVQREIINHRSLRHPNIVRFKE--VILTPTHLAIIMEYASGGELYERICNAGRFSEDEA 118
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTA-RS 125
+ + +Q+L G+ Y HS I HRDLK +N ++G+ +KI D G + + +S
Sbjct: 119 RFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176
Query: 126 VIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 183
+GTP ++APE+ +EY+ ++ D++S G+ + M+ YP+ E + Y+K I
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRIL 235
Query: 184 PAS--------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL 234
+S P+ I + V + R+ E+ + + + P DL+ +
Sbjct: 236 SVKYSIPDDIRIS----PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESN 291
Query: 235 RLPNL---------VPEVMNLAHSEPHP 253
+ +M + P
Sbjct: 292 TGSQFQEPEQPMQSLDTIMQIISEATIP 319
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 22/298 (7%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++ D R+ E+ LK L+H +IIK Y+ V T I M+ E + G L Y + K
Sbjct: 47 LKKSDMHMRVEREISYLKLLRHPHIIKLYD--VITTPTDIVMVIE-YAGGELFDYIVEKK 103
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ + + +QI+ + Y H H I+HRDLK +N+ ++ +N VKI D GL+ +M
Sbjct: 104 RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTD 160
Query: 121 PT-ARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
++ G+P + APE+ + Y VD++S G+ + M+ P+++ + ++KK
Sbjct: 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKK 219
Query: 178 VTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL 234
V S + P LS P + I + IV R+ E+ +DP+ + P L
Sbjct: 220 VNSCVYVMPDFLS----PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEE 275
Query: 235 RLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSN--TGTWFLTLELQRLTENNE 290
+ + E D + + +D ++N + L E Q + E E
Sbjct: 276 VQGSYADSRIVSKLGEAMGFSEDYIVEALRSD---ENNEVKEAYNLLHENQVIQEKLE 330
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 43/168 (25%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 4 PDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
P + +++ E+ +L++L+ NII + D +RT ++ E + +Q + +
Sbjct: 71 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY 130
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQ 119
D I+ + +IL+ L Y HS I+HRD+K N+ ++ + ++++ D GLA Q
Sbjct: 131 D---IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 120 QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCEYP 164
+ R + + F PE + + Y+ +D++S G C+L M+ + P
Sbjct: 186 EYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEP 230
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 37/196 (18%), Positives = 77/196 (39%), Gaps = 30/196 (15%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 61
+ E + ++ L H++++ Y V ++ E GSL Y KK+KN
Sbjct: 52 HRNYSESFFEAASMMSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNC 109
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-------GNNGEVKIGDLGL 114
+++ A+Q+ +H+L + +IH ++ NI + GN +K+ D G+
Sbjct: 110 INILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
Query: 115 AIVMQQPTARSVIGTPEF------MAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPY 165
+ +V+ + PE + N D +SFG + E+ + + P
Sbjct: 168 --------SITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
Query: 166 NECKNPAQIYKKVTSG 181
+ + + +
Sbjct: 220 SALDS-QRKLQFYEDR 234
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 51/228 (22%), Positives = 116/228 (50%), Gaps = 20/228 (8%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
+++ ++ E+ +++ L+H ++ + S+ D+ + + M+ +L G LR + +++ +
Sbjct: 57 NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKE 114
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A 123
+ +K + +++ L YL + IIHRD+K DNI ++ +G V I D +A ++ + T
Sbjct: 115 ETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQI 171
Query: 124 RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKK 177
++ GT +MAPE++ Y+ VD +S G+ E++ PY + +I
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
Query: 178 VTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD-PFL 221
+ + P++ S ++ ++K + P R L +++ P++
Sbjct: 232 FETTVVTYPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 49/186 (26%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
SP + + E +++ S+ + ++ + T+ +IT+L G L Y ++HK N
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDN 113
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
+ + + NW QI +G++YL ++HRDL N+ V VKI D GLA + +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAE 170
Query: 120 QPTARSVIG-TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 175
+ + G P ++MA E + Y D++S+G+ + E++T PY+ ++I
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEIS 229
Query: 176 KKVTSG 181
+ G
Sbjct: 230 SILEKG 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 13 EVHLLKSLK---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DM 64
EV +L+ L+ H N+++ ++ D + ++ E L Y K
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPT 119
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
+ IK+ Q+LRGL +LHSH ++HRDLK NI V ++G++K+ D GLA + A
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 125 SVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 160
T + APE L + Y VD++S G CI EM
Sbjct: 177 ----TSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 56/163 (34%), Positives = 80/163 (49%), Gaps = 24/163 (14%)
Query: 13 EVHLLKSLK---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA 66
EV LL+ L+ H N+++ + + D + ++ E LR Y K + A
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPA 119
Query: 67 --IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
IK+ RQ LRGL +LH++ I+HRDLK +NI V + G VK+ D GLA + A
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 176
Query: 125 SVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 160
TP + APE L + Y VD++S G CI EM
Sbjct: 177 ----TPVVVTLWYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 40/186 (21%), Positives = 85/186 (45%), Gaps = 14/186 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
P + L +E ++++ L + I++ + + ++ E+ G L +Y +++++V
Sbjct: 58 DPALKDELLAEANVMQQLDNPYIVRMIG--IC-EAESWMLVMEMAELGPLNKYLQQNRHV 114
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQ 120
K I Q+ G+ YL N +HRDL N+ + KI D GL+ + +
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADE 171
Query: 121 PTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 175
++ P ++ APE + +++ D++SFG+ + E + + PY K ++
Sbjct: 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVT 230
Query: 176 KKVTSG 181
+ G
Sbjct: 231 AMLEKG 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 15/168 (8%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT----ELFTSGSLRQYRKKH 59
+ +E L + H +I++ +N +V+ T+R + + E SL++ + +
Sbjct: 120 AEAQAMAMAERQFLAEVVHPSIVQIFN-FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK 178
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
V +AI + +IL L YLHS +++ DLK +NI + ++K+ DLG +
Sbjct: 179 LPVA-EAI-AYLLEILPALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRIN 232
Query: 120 QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL-EMVTCEYPYN 166
+ GTP F APE+ DIY+ G L + N
Sbjct: 233 SFGY--LYGTPGFQAPEIVRTGPTVATDIYTVG-RTLAALTLDLPTRN 277
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 16/239 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++S D + ++ E+ LK +H +IIK Y V T I M+ E + G L Y K+
Sbjct: 54 IRSLDVVGKIRREIQNLKLFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYICKNG 111
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+D K + +QIL G+ Y H H ++HRDLK +N+ ++ + KI D GL+ +M
Sbjct: 112 RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSD 168
Query: 121 -PTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
R+ G+P + APE+ Y VDI+S G+ + ++ P+++ + ++KK
Sbjct: 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKK 227
Query: 178 VTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDP 233
+ GI P L+ P V ++ + R ++ + + D PK L +
Sbjct: 228 ICDGIFYTPQYLN----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPED 282
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 15/186 (8%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ P+ ++ EV+ + SL H N+I+ Y V + M+TEL GSL +KH+
Sbjct: 59 LSQPEAMDDFIREVNAMHSLDHRNLIRLYG--V-VLTPPMKMVTELAPLGSLLDRLRKHQ 115
Query: 61 -NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IV 117
+ + + +A Q+ G+ YL S IHRDL N+ + + VKIGD GL +
Sbjct: 116 GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALP 172
Query: 118 MQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPA 172
P + APE L ++ D + FG+ + EM T + P+ +
Sbjct: 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-S 231
Query: 173 QIYKKV 178
QI K+
Sbjct: 232 QILHKI 237
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 41/186 (22%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
+ + + + SL H +I++ ++ ++T+ GSL + ++H+
Sbjct: 55 GRQSFQAVTDHMLAIGSLDHAHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRGA 111
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ + + NW QI +G++YL H ++HR+L N+ + + +V++ D G+A ++
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPD 168
Query: 122 ---TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 175
S TP ++MA E ++ +Y D++S+G+ + E++T PY + A++
Sbjct: 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVP 227
Query: 176 KKVTSG 181
+ G
Sbjct: 228 DLLEKG 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 13 EVHLLKSLKHENIIKFY------NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMK 65
E+ +L+ LKHEN++ S + +I ++ + F L +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLS 124
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
IK + +L GL+Y+H + I+HRD+K N+ + +G +K+ D GLA
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQ 181
Query: 126 VIG-TPE-----FMAPELY--EEEYNELVDIYSFGMCIL-EMVT 160
T + PEL E +Y +D++ G CI+ EM T
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
+++ + E ++ L H +K Y ++ DD + +G L +Y +K + D
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDE 129
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQ 120
+ + +I+ L YLH IIHRDLK +NI +N + ++I D G A +Q
Sbjct: 130 TCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQ 186
Query: 121 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
A S +GT ++++PE L E+ + D+++ G I ++V P+ N I++K+
Sbjct: 187 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKII 245
Query: 180 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL 210
+ P+ + +EK +V A+ RL
Sbjct: 246 KL--EYDFPEKFFPKARDLVEKLLVLDATKRL 275
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 14/177 (7%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNW 70
E ++ L H +++ Y V I ++TE G L Y + + + +
Sbjct: 52 EEAEVMMKLSHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM 109
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 130
+ G+ YL +IHRDL N V G N +K+ D G+ + S GT
Sbjct: 110 CLDVCEGMAYLEEAC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT- 165
Query: 131 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
+F +PE Y+ D++SFG+ + E+ + + PY N +++ + +++G
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA 66
+ + E + L H ++KFY V I ++TE ++G L Y R K ++
Sbjct: 48 DEFFQEAQTMMKLSHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ 105
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 126
+ + G+ +L SH IHRDL N V+ + VK+ D G+ + S
Sbjct: 106 LLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSS 162
Query: 127 IGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 180
+GT +F APE + +Y+ D+++FG+ + E+ + + PY+ N +++ KV+
Sbjct: 163 VGT-KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQ 220
Query: 181 G 181
G
Sbjct: 221 G 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
Q+E +E +L+++ ++K S+ D++N + M+ E G + + ++
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
+ +A QI+ YLHS + +I+RDLK +N+ ++ G +++ D G A ++ T
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-W 196
Query: 125 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-I 182
++ GTPE +APE + + YN+ VD ++ G+ I EM P+ P QIY+K+ SG +
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKV 255
Query: 183 K-PASLSKVTDPQVKQFIEKCIVP 205
+ P+ S +K + +
Sbjct: 256 RFPSHFS----SDLKDLLRNLLQV 275
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 13/185 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
S E+ E ++ H +I+K V T + +I EL T G LR + + K +
Sbjct: 56 SDSVREKFLQEALTMRQFDHPHIVKLIG--V-ITENPVWIIMELCTLGELRSFLQVRKYS 112
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+D+ ++ +A Q+ L YL S +HRD+ N+ V+ N+ VK+GD GL+ M+
Sbjct: 113 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDS 169
Query: 122 TARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 176
T P ++MAPE + + D++ FG+C+ E++ P+ KN +
Sbjct: 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIG 228
Query: 177 KVTSG 181
++ +G
Sbjct: 229 RIENG 233
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 13/181 (7%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 65
E E ++K +KH N+++ V +ITE T G+L Y ++ + V
Sbjct: 261 EEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 318
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 123
+ A QI + YL N IHR+L N V G N VK+ D GL+ +M TA
Sbjct: 319 VLLYMATQISSAMEYLEKKN--FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTA 375
Query: 124 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 180
+ P ++ APE L +++ D+++FG+ + E+ T PY +Q+Y+ +
Sbjct: 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEK 434
Query: 181 G 181
Sbjct: 435 D 435
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 45/185 (24%), Positives = 88/185 (47%), Gaps = 13/185 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
+ D E+ SE ++K+L H +I+K + +I EL+ G L Y + +
Sbjct: 53 TLDNKEKFMSEAVIMKNLDHPHIVKLIG--II-EEEPTWIIMELYPYGELGHYLERNKNS 109
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ + + ++ QI + + YL S N +HRD+ NI V + VK+GD GL+ ++
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDE 166
Query: 122 TARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 176
T P ++M+PE + + D++ F +C+ E+++ + P+ +N +
Sbjct: 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIG 225
Query: 177 KVTSG 181
+ G
Sbjct: 226 VLEKG 230
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNW 70
E ++ +L HE +++ Y V R I +ITE +G L Y R+ + +
Sbjct: 68 EEAKVMMNLSHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 130
+ + + YL S +HRDL N VN VK+ D GL+ + S +G+
Sbjct: 126 CKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGS- 181
Query: 131 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
+F PE L +++ DI++FG+ + E+ + + PY N ++ + + G
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQG 237
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 65
E E ++K L+HE +++ Y + I ++TE + GSL + K K + +
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP 280
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 123
+ + A QI G+ Y+ N +HRDL+ NI V N K+ D GLA +++ TA
Sbjct: 281 QLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTA 337
Query: 124 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 180
R P ++ APE + D++SFG+ + E+ T PY N ++ +V
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER 396
Query: 181 G 181
G
Sbjct: 397 G 397
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/270 (21%), Positives = 104/270 (38%), Gaps = 71/270 (26%)
Query: 9 RLYSEVHLLKSLKHENIIKFYN------------SWVDDTNRTINMITEL--------FT 48
E+ +++ L H+NI+K + ++ ++ E
Sbjct: 54 HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 49 SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 108
G L ++H + + Q+LRGL Y+HS N ++HRDLK N+F+N + +K
Sbjct: 114 QGPLL---EEH-------ARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLK 161
Query: 109 IGDLGLAIVMQQPTARSVIGTPE-----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 160
IGD GLA +M + + + +P L Y + +D+++ G CI EM+T
Sbjct: 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLT 220
Query: 161 ------------------------CEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDP 193
E E + +Y + L+++
Sbjct: 221 GKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 194 QVKQFIEKCIV--PASLRLPALELLKDPFL 221
+ F+E+ + P RL A E L P++
Sbjct: 281 EAVDFLEQILTFSPMD-RLTAEEALSHPYM 309
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 49/241 (20%)
Query: 9 RLYSEVHLLKSLKHENIIKFYN---SWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDM 64
R+ E+ LL H NI+ + + + + ++TEL + L Q + +
Sbjct: 75 RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISP 133
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
+ I+ + IL GLH LH ++HRDL NI + NN ++ I D L AR
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNN-DITICDFNL--------AR 182
Query: 125 SVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVTCE--YPYNECK 169
APE + + + +LVD++S G C++ EM + + +
Sbjct: 183 E-DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRKALFRGSTFY 240
Query: 170 NPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCI-----VPASLRLP-----ALELL 216
N Q+ K+ + K + + P + ++ + + +P AL+L+
Sbjct: 241 N--QL-NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI 297
Query: 217 K 217
Sbjct: 298 A 298
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 65
E E ++K L+HE +++ Y + I ++TE + GSL + K K + +
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP 363
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 123
+ + A QI G+ Y+ N +HRDL+ NI V N K+ D GLA +++ TA
Sbjct: 364 QLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTA 420
Query: 124 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 180
R P ++ APE + D++SFG+ + E+ T PY N ++ +V
Sbjct: 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER 479
Query: 181 G 181
G
Sbjct: 480 G 480
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 13/185 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 61
S E+ E ++ H +I+K T + +I EL T G LR + + K
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFS 487
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+D+ ++ +A Q+ L YL S +HRD+ N+ V+ N+ VK+GD GL+ M+
Sbjct: 488 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDS 544
Query: 122 TARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 176
T P ++MAPE + + D++ FG+C+ E++ P+ KN +
Sbjct: 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIG 603
Query: 177 KVTSG 181
++ +G
Sbjct: 604 RIENG 608
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 36/187 (19%), Positives = 79/187 (42%), Gaps = 15/187 (8%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
E + E ++ L + I++ V + ++ E+ G L ++ K +
Sbjct: 50 EKADTEEMMREAQIMHQLDNPYIVRLIG--VC-QAEALMLVMEMAGGGPLHKFLVGKREE 106
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
+ + + Q+ G+ YL N +HRDL N+ + + KI D GL+ +
Sbjct: 107 IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRH-YAKISDFGLSKALGAD 163
Query: 120 QPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 174
+ P ++ APE + +++ D++S+G+ + E ++ + PY + K ++
Sbjct: 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEV 222
Query: 175 YKKVTSG 181
+ G
Sbjct: 223 MAFIEQG 229
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 26/232 (11%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT----INMITELFTSGSLRQYRKKH 59
P R E +L H I+ Y++ +T I M E +LR
Sbjct: 53 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM--EYVDGVTLRDIVHTE 110
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+ K + L++ H + IIHRD+K NI + VK+ D G+A +
Sbjct: 111 GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIA 167
Query: 120 QPTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 173
+VIGT ++++PE + + D+YS G + E++T E P+ +P
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVS 226
Query: 174 I-YKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP------ALELLKD 218
+ Y+ V P S + ++ ++ A + P A E+ D
Sbjct: 227 VAYQHVREDPIPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 14/188 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
++ + +E ++K H N++ + + ++ G LR + R + N
Sbjct: 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHN 124
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+K + + Q+ +G+ YL S +HRDL N ++ VK+ D GLA M
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK 181
Query: 122 TARSVIGTPEF------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 173
SV MA E L +++ D++SFG+ + E++T PY +
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FD 240
Query: 174 IYKKVTSG 181
I + G
Sbjct: 241 ITVYLLQG 248
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 59/282 (20%), Positives = 95/282 (33%), Gaps = 73/282 (25%)
Query: 9 RLYSEVHLLKSLKHENIIK----FYNSWVDDTNRT-INMITELFTS---GSLRQYRKKHK 60
R + L L H NI++ FY D +N++ E R Y ++
Sbjct: 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV 124
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
IK + Q++R + LH + + HRD+K N+ VN +G +K+ D G
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS------ 178
Query: 121 PTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EMVTCE--YPY 165
A+ + + E APEL + Y VDI+S G CI EM+ E +
Sbjct: 179 --AKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRG 234
Query: 166 NECKN------------PAQIYKKVTSG--------IKPASLSKV-------TDPQVKQF 198
+ ++ +K+ K S V +
Sbjct: 235 DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDL 294
Query: 199 IEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 238
+ + P R+ E L P+ D L P
Sbjct: 295 LSALLQYLP-EERMKPYEALCHPYF----------DELHDPA 325
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 42/188 (22%), Positives = 77/188 (40%), Gaps = 14/188 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
Q+E E L++ L H N++ + +++ G L Q+ R +N
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
+K + ++ Q+ RG+ YL +HRDL N ++ + VK+ D GLA I+ +
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDR 177
Query: 120 QPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQ 173
+ + A E L + D++SFG+ + E++T PY
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FD 236
Query: 174 IYKKVTSG 181
+ + G
Sbjct: 237 LTHFLAQG 244
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 54/170 (31%), Positives = 76/170 (44%), Gaps = 24/170 (14%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMK 65
R E+ +LK KHENII +N D+ N +I EL + L + D
Sbjct: 55 RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDH 113
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTA 123
I+ + Q LR + LH N +IHRDLK N+ +N N ++K+ D GLA I
Sbjct: 114 -IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADN 169
Query: 124 RSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 160
G M APE L +Y+ +D++S G CIL E+
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFL 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-23
Identities = 61/335 (18%), Positives = 119/335 (35%), Gaps = 99/335 (29%)
Query: 13 EVHLLKSLKHENIIK----FYNSWVDDTNRT----------------------------- 39
E+ ++K L H NIIK FY + ++
Sbjct: 50 ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQ 109
Query: 40 ---INMITELFTS---GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 93
+N+I E L+ + + +++ M I + Q+ R + ++HS I HRD+
Sbjct: 110 NKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDI 167
Query: 94 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APELY--EEE 141
K N+ VN + +K+ D G A+ +I + E APEL E
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGS--------AKKLIPS-EPSVAYICSRFYRAPELMLGATE 218
Query: 142 YNELVDIYSFGMCIL-EMVTCE--YPYNECKN------------PAQIYKKVTSG----- 181
Y +D++S G C+ E++ + + + + ++
Sbjct: 219 YTPSIDLWSIG-CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR 277
Query: 182 ---IKPASLSKV----TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVT-DNPKDL-V 230
+K K+ T +E+ + P LR+ E + PF N + V
Sbjct: 278 FPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP-DLRINPYEAMAHPFFDHLRNSYESEV 336
Query: 231 CDPLRLPNL----VPEVMNLAHSEPHPMDIDLNHK 261
+ P+ +P++ N + E + ++ ++
Sbjct: 337 KNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNR 371
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 15/182 (8%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 65
E E ++K +KH N+++ V +ITE T G+L Y ++ + V
Sbjct: 54 EEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 111
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
+ A QI + YL N IHRDL N V N+ VK+ D GL+ +M T +
Sbjct: 112 VLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTA 168
Query: 126 VIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVT 179
G +F APE L +++ D+++FG+ + E+ T PY +Q+Y+ +
Sbjct: 169 HAGA-KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLE 226
Query: 180 SG 181
Sbjct: 227 KD 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 52/163 (31%), Positives = 79/163 (48%), Gaps = 17/163 (10%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMK 65
R E+ +L +HENII + T + ++ +L + L + K +
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDH 129
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
I + QILRGL Y+HS N ++HRDLK N+ +N ++KI D GLA V +
Sbjct: 130 -ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHT 185
Query: 126 VIGTPE-----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 160
T + APE L + Y + +DI+S G CIL EM++
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG-CILAEMLS 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 1e-22
Identities = 45/191 (23%), Positives = 75/191 (39%), Gaps = 40/191 (20%)
Query: 9 RLYSEVHLLKSLKHENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 65
R+ E+ +L L H++++K + + + ++ E+ S ++ + +
Sbjct: 98 RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTEL 156
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------- 115
IK +L G+ Y+HS I+HRDLK N VN + VK+ D GLA
Sbjct: 157 HIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGN 213
Query: 116 ---------IVMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMC 154
M T + APE L +E Y E +D++S G C
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-C 272
Query: 155 IL-EMVTCEYP 164
I E++
Sbjct: 273 IFAELLNMIKE 283
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYN----SWVDDTNRTINMITELFTSGSLRQYRK 57
QS +R Y E+ LLK ++HEN+I + + ++ + L++
Sbjct: 62 QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG 120
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
+ I+ Q+L+GL Y+HS ++HRDLK N+ VN + E+KI D GLA
Sbjct: 121 --LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNE-DCELKILDFGLARH 175
Query: 118 MQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 160
V+ T + APE L YN+ VDI+S G CI+ EM+T
Sbjct: 176 ADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVG-CIMAEMLT 219
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 14/187 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 61
+ Q SE ++ H NII+ V R ++TE +GSL + + H
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQ 147
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
+ + R + G+ YL +HRDL N+ V+ N K+ D GL+ +
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDD 204
Query: 120 QPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 174
A + G P + APE + ++ D++SFG+ + E++ E PY N +
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDV 263
Query: 175 YKKVTSG 181
V G
Sbjct: 264 ISSVEEG 270
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 53/181 (29%), Positives = 93/181 (51%), Gaps = 14/181 (7%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMK 65
E +E +++K+L+H+ ++K + T I +ITE GSL + K + +
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP 284
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 123
+ +++ QI G+ ++ N IHRDL+ NI V+ + KI D GLA V++ TA
Sbjct: 285 KLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTA 341
Query: 124 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 180
R P ++ APE + + D++SFG+ ++E+VT PY NP ++ + +
Sbjct: 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALER 400
Query: 181 G 181
G
Sbjct: 401 G 401
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 3e-22
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
Q+E E +L + H II+ + ++ D I MI + G L +K +
Sbjct: 48 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPN 105
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
K +A ++ L YLHS + II+RDLK +NI ++ NG +KI D G A + T
Sbjct: 106 PVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-Y 161
Query: 125 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 183
++ GTP+++APE + + YN+ +D +SFG+ I EM+ P+ N + Y+K+ +
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNA-- 218
Query: 184 PASLSKVTDPQVKQFIEKCIVP 205
+ VK + + I
Sbjct: 219 ELRFPPFFNEDVKDLLSRLITR 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 5e-22
Identities = 41/170 (24%), Positives = 82/170 (48%), Gaps = 9/170 (5%)
Query: 36 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 95
T ++ I +L G L + +H ++ +A +I+ GL ++H+ +++RDLK
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKP 320
Query: 96 DNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGM 153
NI ++ +G V+I DLGLA + + +GT +MAPE Y+ D +S G
Sbjct: 321 ANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 154 CILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 201
+ +++ P+ ++ K+ +I + + L P+++ +E
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEG 427
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-22
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 35/182 (19%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMK 65
R+ E+ +L LK + II+ Y+ + D + ++ E+ S L++ K + +
Sbjct: 71 RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEE 129
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------- 115
IK +L G +++H IIHRDLK N +N + VK+ D GLA
Sbjct: 130 HIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTN 186
Query: 116 ----IVMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EM 158
+ + + + APE L +E Y + +DI+S G CI E+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAEL 245
Query: 159 VT 160
+
Sbjct: 246 LN 247
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 14/188 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
++ + +E ++K H N++ + + ++ G LR + R + N
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHN 188
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+K + + Q+ +G+ +L S +HRDL N ++ VK+ D GLA M
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK 245
Query: 122 TARSVIGTPE------FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 173
SV +MA E L +++ D++SFG+ + E++T PY +
Sbjct: 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FD 304
Query: 174 IYKKVTSG 181
I + G
Sbjct: 305 ITVYLLQG 312
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 59/169 (34%), Positives = 84/169 (49%), Gaps = 34/169 (20%)
Query: 9 RLYSEVHLLKSLKHENIIKFYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
R Y E+ LLK +KHEN+I + + + + ++T L + L K + +
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNI-VKCQKLTD 131
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
++ QILRGL Y+HS + IIHRDLK N+ VN + E+KI D GL AR
Sbjct: 132 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGL--------AR 180
Query: 125 SVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 160
T + M APE L YN+ VDI+S G CI+ E++T
Sbjct: 181 H---TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 225
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 7e-22
Identities = 35/187 (18%), Positives = 78/187 (41%), Gaps = 15/187 (8%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 61
E + E ++ L + I++ + ++ E+ G L ++ +
Sbjct: 376 EKADTEEMMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREE 432
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 119
+ + + Q+ G+ YL N +HR+L N+ + N KI D GL+ +
Sbjct: 433 IPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL-VNRHYAKISDFGLSKALGAD 489
Query: 120 QPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 174
+ P ++ APE + +++ D++S+G+ + E ++ + PY + K P ++
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EV 548
Query: 175 YKKVTSG 181
+ G
Sbjct: 549 MAFIEQG 555
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 50/187 (26%), Positives = 86/187 (45%), Gaps = 14/187 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 61
+ Q E ++ H NII+ V + + +ITE +G+L ++ ++
Sbjct: 86 TEKQRVDFLGEAGIMGQFSHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGE 143
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-- 119
+ + R I G+ YL + N +HRDL NI VN N K+ D GL+ V++
Sbjct: 144 FSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDD 200
Query: 120 QPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 174
+ G P + APE + ++ D++SFG+ + E++T E PY E N ++
Sbjct: 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEV 259
Query: 175 YKKVTSG 181
K + G
Sbjct: 260 MKAINDG 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 61
+ Q E ++ H NII+ V ++ + ++TE +GSL + +KH
Sbjct: 86 TEKQRRDFLGEASIMGQFDHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-- 119
+ + R I G+ YL +HRDL NI +N N K+ D GL V++
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDD 200
Query: 120 QPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 174
A + G P + +PE + ++ D++S+G+ + E+++ E PY E N +
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 175 YKKVTSG 181
K V G
Sbjct: 260 IKAVDEG 266
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 8e-22
Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 14/181 (7%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMK 65
+ +E +L+K L+H+ +++ Y T I +ITE +GSL + K + +
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 123
+ + A QI G+ ++ N IHRDL+ NI V+ KI D GLA +++ TA
Sbjct: 110 KLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTA 166
Query: 124 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 180
R P ++ APE + + D++SFG+ + E+VT PY NP ++ + +
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLER 225
Query: 181 G 181
G
Sbjct: 226 G 226
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 45/221 (20%), Positives = 93/221 (42%), Gaps = 19/221 (8%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
M + E ++ +++ + ++ DD + M+ E G L +
Sbjct: 107 MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYD 164
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
V K + + +++ L +HS IHRD+K DN+ ++ +G +K+ D G + M +
Sbjct: 165 -VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNK 220
Query: 121 P---TARSVIGTPEFMAPEL-----YEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNP 171
+ +GTP++++PE+ + Y D +S G+ + EM+ + P Y + +
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SL 278
Query: 172 AQIYKKVTSGIKPASLSKVTD--PQVKQFIEKCIVPASLRL 210
Y K+ + + D + K I + +RL
Sbjct: 279 VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRL 319
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHK 60
+ E +L + I+ ++ +T + ++ + G + + +
Sbjct: 227 KGYQGAMVEKKILAKVHSRFIVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVM 118
+ QI+ GL +LH N II+RDLK +N+ ++ ++G V+I DLGLA +
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKA 341
Query: 119 QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQI 174
Q + GTP FMAPE L EEY+ VD ++ G+ + EM+ P+ E ++
Sbjct: 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401
Query: 175 YKKVTSGIKPASLSKVTDPQVKQFIEK 201
++V + P K F E
Sbjct: 402 KQRVLEQ--AVTYPDKFSPASKDFCEA 426
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 44/221 (19%), Positives = 77/221 (34%), Gaps = 23/221 (10%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
P R+ E L+ +++ ++ D ++M L L ++ +
Sbjct: 75 PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM--RLINGVDLAAMLRRQGPLA 132
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 122
RQI L H+ HRD+K +NI V + + D G+A
Sbjct: 133 PPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILV-SADDFAYLVDFGIASATTDEKL 189
Query: 123 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKV 178
+ +GT +MAPE + DIY+ C+L E +T PY + + + +
Sbjct: 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALT-CVLYECLTGSPPY-QGDQLSVMGAHI 247
Query: 179 TSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDP 219
I S P + + I + K+P
Sbjct: 248 NQAIPRPS---TVRPGIPVAFDAVIARG--------MAKNP 277
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 43/203 (21%), Positives = 76/203 (37%), Gaps = 36/203 (17%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFY----NSWVDDTNRTINMITELFTSGSLRQYRKK 58
+ +E E +K H ++ K S +I G L +
Sbjct: 65 ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 59 HK------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 112
+ N+ ++ + + I G+ YL S N IHRDL N + + V + D
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADF 181
Query: 113 GLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMV 159
GL+ R + + +A E L + Y D+++FG+ + E++
Sbjct: 182 GLS--------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
Query: 160 TC-EYPYNECKNPAQIYKKVTSG 181
T + PY +N A+IY + G
Sbjct: 234 TRGQTPYAGIEN-AEIYNYLIGG 255
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 57/166 (34%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT----INMITELFTSGSLRQYRK 57
QS +R Y E+ LLK ++HEN+I + + D ++ + L +
Sbjct: 63 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKL-M 120
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 117
KH+ + I+ Q+L+GL Y+H+ IIHRDLK N+ VN + E+KI D GLA
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNE-DCELKILDFGLARQ 177
Query: 118 MQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 160
V+ T + APE L Y + VDI+S G CI+ EM+T
Sbjct: 178 ADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVG-CIMAEMIT 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 46/195 (23%), Positives = 79/195 (40%), Gaps = 22/195 (11%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY------- 55
S + +E ++K ++++ V + +I EL T G L+ Y
Sbjct: 68 SMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125
Query: 56 ---RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 112
+ + A +I G+ YL+++ +HRDL N V + VKIGD
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDF 182
Query: 113 GLAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYN 166
G+ + + G M+PE L + + D++SFG+ + E+ T E PY
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 167 ECKNPAQIYKKVTSG 181
N Q+ + V G
Sbjct: 243 GLSN-EQVLRFVMEG 256
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 54/163 (33%), Positives = 82/163 (50%), Gaps = 22/163 (13%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDM 64
R Y E+ L+K + H+NII N + + + ++ EL + +L Q + +D
Sbjct: 70 RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDH 126
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
+ + Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA +
Sbjct: 127 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGT 179
Query: 125 SVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 160
S + TP + APE + Y E VDI+S G CI+ EM+
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMIK 221
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 42/187 (22%), Positives = 73/187 (39%), Gaps = 49/187 (26%)
Query: 9 RLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITEL--------FTSGSLRQYRKKH 59
R + E+ +L L HENI+ N D +R + ++ + + L H
Sbjct: 54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL---EPVH 110
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---- 115
+ Q+++ + YLHS ++HRD+K NI +N VK+ D GL+
Sbjct: 111 -------KQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNA-ECHVKVADFGLSRSFV 160
Query: 116 ---------IVMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMC 154
+ + + APE L +Y + +D++S G C
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-C 219
Query: 155 IL-EMVT 160
IL E++
Sbjct: 220 ILGEILC 226
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 20/194 (10%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 59
S E ++ H+NI++ V + ++ EL G L+ + ++
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPR 130
Query: 60 ----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLG 113
++ M + + AR I G YL ++ IHRD+ N + G KIGD G
Sbjct: 131 PSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 114 LAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNE 167
+A + + + G M PE E + D +SFG+ + E+ + PY
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 168 CKNPAQIYKKVTSG 181
N ++ + VTSG
Sbjct: 249 KSN-QEVLEFVTSG 261
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 44/209 (21%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 59
+ + E LL +L+HE+I+KFY V + M+ E G L ++ + H
Sbjct: 57 TLAARKDFQREAELLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPD 114
Query: 60 -------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 106
+ + + + A QI G+ YL S + +HRDL N V N
Sbjct: 115 AMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-L 171
Query: 107 VKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGM 153
VKIGD G+ +R V T + M PE + ++ D++SFG+
Sbjct: 172 VKIGDFGM--------SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 223
Query: 154 CILEMVT-CEYPYNECKNPAQIYKKVTSG 181
+ E+ T + P+ + N ++ + +T G
Sbjct: 224 ILWEIFTYGKQPWFQLSN-TEVIECITQG 251
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 39/179 (21%), Positives = 80/179 (44%), Gaps = 12/179 (6%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 65
+ +E ++ L+H N+++ + + + ++TE GSL Y + +
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
+ ++ + + YL +N +HRDL N+ V+ +N K+ D GL
Sbjct: 118 CLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTG 174
Query: 126 VIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
+ P ++ APE L E++++ D++SFG+ + E+ + PY + +V G
Sbjct: 175 KL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 41/202 (20%), Positives = 81/202 (40%), Gaps = 35/202 (17%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKH 59
S ++E SE +K H N+I+ ++ +++ I +I G L Y
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 60 K------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 113
+ ++ ++ + + I G+ YL + N +HRDL N + + V + D G
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFG 192
Query: 114 LAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 160
L ++ + + +A E L + Y D+++FG+ + E+ T
Sbjct: 193 L--------SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
Query: 161 C-EYPYNECKNPAQIYKKVTSG 181
PY +N ++Y + G
Sbjct: 245 RGMTPYPGVQN-HEMYDYLLHG 265
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 49/234 (20%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT------ELFTSGSLRQ 54
M + E +L + + I + ++ DD N + ++ +L T L +
Sbjct: 112 MLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN--LYLVMDYYVGGDLLTL--LSK 167
Query: 55 YRKKHKNVDMKAIKNWAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 110
+ + AR +++ + +H + +HRD+K DNI ++ NG +++
Sbjct: 168 FEDRLPE-------EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLA 217
Query: 111 DLGLA---IVMQQPTARSVIGTPEFMAPELYEEE------YNELVDIYSFGMCILEMVTC 161
D G + + +GTP++++PE+ + Y D +S G+C+ EM+
Sbjct: 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
Query: 162 EYP-YNECKNPAQIYKKVTSGIK----PASLSKVTDPQVKQFIEKCIVPASLRL 210
E P Y E + + Y K+ + + P ++ V K I + I RL
Sbjct: 278 ETPFYAE--SLVETYGKIMNHKERFQFPTQVTDV-SENAKDLIRRLICSREHRL 328
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 8e-21
Identities = 56/168 (33%), Positives = 80/168 (47%), Gaps = 32/168 (19%)
Query: 9 RLYSEVHLLKSLKHENIIKFYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
R Y E+ L+K + H+NII N + + + ++ EL + +L Q + +D
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDH 163
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
+ + Q+L G+ +LHS IIHRDLK NI V + +KI D GL AR
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGL--------AR 212
Query: 125 SVIGTPEFM----------APE-LYEEEYNELVDIYSFGMCIL-EMVT 160
+ GT M APE + Y E VDI+S G CI+ EMV
Sbjct: 213 T-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMVR 258
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 27/200 (13%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 59
S + E LL L+H++I++F+ V R + M+ E G L ++ + H
Sbjct: 83 SESARQDFQREAELLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 140
Query: 60 ------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 107
+ + + A Q+ G+ YL + +HRDL N V V
Sbjct: 141 AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VV 197
Query: 108 KIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-C 161
KIGD G++ + V G M PE + ++ D++SFG+ + E+ T
Sbjct: 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 162 EYPYNECKNPAQIYKKVTSG 181
+ P+ + N + +T G
Sbjct: 258 KQPWYQLSN-TEAIDCITQG 276
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 38/124 (30%), Positives = 69/124 (55%), Gaps = 9/124 (7%)
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 128
A +I L YLHS N I++RDLK +NI ++ + G + + D GL + T + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 129 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PA 185
TPE++APE L+++ Y+ VD + G + EM+ P+ +N A++Y + + ++
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKP 260
Query: 186 SLSK 189
+++
Sbjct: 261 NITN 264
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 39/185 (21%), Positives = 80/185 (43%), Gaps = 24/185 (12%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 65
+ +E ++ L+H N+++ + + + ++TE GSL Y + +
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 289
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 125
+ ++ + + YL +N +HRDL N+ V+ +N K+ D GL +
Sbjct: 290 CLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGL--------TKE 338
Query: 126 VIGTPE-------FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 176
T + + APE L E++++ D++SFG+ + E+ + PY +
Sbjct: 339 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVP 397
Query: 177 KVTSG 181
+V G
Sbjct: 398 RVEKG 402
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 43/201 (21%), Positives = 79/201 (39%), Gaps = 28/201 (13%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 59
E E L L+H N++ V ++ ++MI + G L ++
Sbjct: 52 EGPLREEFRHEAMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109
Query: 60 -------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 106
++ + QI G+ YL SH+ ++H+DL N+ V
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-N 166
Query: 107 VKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT- 160
VKI DLGL + ++G MAPE + +++ DI+S+G+ + E+ +
Sbjct: 167 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 226
Query: 161 CEYPYNECKNPAQIYKKVTSG 181
PY N + + + +
Sbjct: 227 GLQPYCGYSN-QDVVEMIRNR 246
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 59
+ + L SE+ +L + H N++ + + +I E G+L Y +
Sbjct: 70 THSEHRALMSELKILIHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRN 128
Query: 60 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 105
+ ++ + ++ Q+ +G+ +L S IHRDL NI ++ N
Sbjct: 129 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN- 185
Query: 106 EVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFG 152
VKI D GL AR + P++ MAPE +++ Y D++SFG
Sbjct: 186 VVKICDFGL--------ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 153 MCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
+ + E+ + PY K + +++ G
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 20/194 (10%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-- 60
S E ++ H+NI++ V + ++ EL G L+ + ++ +
Sbjct: 114 SEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPR 171
Query: 61 -----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLG 113
++ M + + AR I G YL ++ IHRD+ N + G KIGD G
Sbjct: 172 PSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 114 LAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNE 167
+A + + G M PE E + D +SFG+ + E+ + PY
Sbjct: 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 168 CKNPAQIYKKVTSG 181
N ++ + VTSG
Sbjct: 290 KSN-QEVLEFVTSG 302
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 44/233 (18%), Positives = 91/233 (39%), Gaps = 38/233 (16%)
Query: 8 ERLYSEVHLLKSL-KHENIIKFYNSWVD--DTNRTINMITELFTSGSL--RQYRKKHKNV 62
+ EV L + +I++ + + + + + ++ E G L R + +
Sbjct: 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 120
+ + I + YLHS N I HRD+K +N+ + + N +K+ D G
Sbjct: 115 TEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------ 166
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP----YNECKNPAQIYK 176
A E E+Y++ D++S G I+ ++ C YP + +
Sbjct: 167 -------------AKETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKT 212
Query: 177 KVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 225
++ G S+V++ +VK I + + R+ E + P+++
Sbjct: 213 RIRMGQYEFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 39/122 (31%), Positives = 61/122 (50%), Gaps = 9/122 (7%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 130
+I L +LH II+RDLK +NI +N + G VK+ D GL + + GT
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 131 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASL 187
E+MAPE L +N VD +S G + +M+T P+ +N + K+ + P L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYL 244
Query: 188 SK 189
++
Sbjct: 245 TQ 246
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 38/122 (31%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 130
++ L +LHS II+RDLK +NI ++ G +K+ D GL+ + + A S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 131 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 187
E+MAPE + + + D +SFG+ + EM+T P+ + K+ + + P L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFL 249
Query: 188 SK 189
S
Sbjct: 250 SP 251
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 14/128 (10%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGT 129
+I+ L +LH II+RD+K +NI ++ +NG V + D GL+ + + A GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 130 PEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSG-I 182
E+MAP++ +++ VD +S G+ + E++T P+ E + A+I +++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 183 K-PASLSK 189
P +S
Sbjct: 284 PYPQEMSA 291
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 36/124 (29%), Positives = 70/124 (56%), Gaps = 9/124 (7%)
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 128
+I+ L YLHS + +++RD+K +N+ ++ +G +KI D GL + T ++ G
Sbjct: 111 GAEIVSALEYLHSRD--VVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 129 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PA 185
TPE++APE L + +Y VD + G+ + EM+ P+ ++ ++++ + I+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPR 226
Query: 186 SLSK 189
+LS
Sbjct: 227 TLSP 230
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 48/212 (22%), Positives = 83/212 (39%), Gaps = 46/212 (21%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 59
+ E L SE+ +L L H NI+ +ITE G L + ++
Sbjct: 66 HLTEREALMSELKVLSYLGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 60 ----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 103
+D++ + +++ Q+ +G+ +L S N IHRDL NI + +
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-TH 180
Query: 104 NGEVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYS 150
KI D GL AR + + MAPE ++ Y D++S
Sbjct: 181 GRITKICDFGL--------ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232
Query: 151 FGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
+G+ + E+ + PY ++ YK + G
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 33/160 (20%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 69 NWAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQP 121
AR +I+ + +H +HRD+K DNI ++ G +++ D G
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTV 218
Query: 122 TARSVIGTPEFMAPEL--------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 173
+ +GTP++++PE+ Y D ++ G+ EM + P+ + A+
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAE 277
Query: 174 IYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVPASLRL 210
Y K+ + + + + + FI++ + P RL
Sbjct: 278 TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRL 317
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 42/208 (20%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 60
D+ E L SE+ ++ L +HENI+ + +ITE G L + R+K +
Sbjct: 89 HADEKEALMSELKIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
Query: 61 NVDMKAIKN-------------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 107
++ ++ Q+ +G+ +L S N IHRD+ N+ + N
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVA 203
Query: 108 KIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMC 154
KIGD GL AR ++ + MAPE +++ Y D++S+G+
Sbjct: 204 KIGDFGL--------ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 155 ILEMVTC-EYPYNECKNPAQIYKKVTSG 181
+ E+ + PY ++ YK V G
Sbjct: 256 LWEIFSLGLNPYPGILVNSKFYKLVKDG 283
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 46/204 (22%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNV 62
+E +L+ + ++ ++ +T + ++ L G L+ Y
Sbjct: 226 KGEAMALNEKQILEKVNSRFVVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGQAGF 283
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 121
+A +I GL LH I++RDLK +NI ++ ++G ++I DLGLA+ + +
Sbjct: 284 PEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQ 340
Query: 122 TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKK 177
T + +GT +MAPE + E Y D ++ G + EM+ + P+ + ++ +
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 400
Query: 178 VTSGIKPASLSKVTDPQVKQFIEK 201
V P S+ PQ + +
Sbjct: 401 VKE--VPEEYSERFSPQARSLCSQ 422
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 128
+ +I L+YLH II+RDLK DN+ ++ G +K+ D G+ + T + G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 129 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
TP ++APE L E+Y VD ++ G+ + EM+ P++ + +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 130
+I+ GL +LHS I++RDLK DNI ++ +G +KI D G+ ++ + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 131 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 187
+++APE L ++YN VD +SFG+ + EM+ + P+ ++ +++ + P L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWL 241
Query: 188 SKVTDPQVKQFIEKCIVPASLRLPALELLKD-PF 220
K + + + RL ++ P
Sbjct: 242 EKEAKDLLVKLFVRE---PEKRLGVRGDIRQHPL 272
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 36/122 (29%), Positives = 64/122 (52%), Gaps = 9/122 (7%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 130
+I+ L +LH II+RDLK DN+ ++ G K+ D G+ + T + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 131 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 187
+++APE L E Y VD ++ G+ + EM+ P+ E +N +++ + + + P L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWL 247
Query: 188 SK 189
+
Sbjct: 248 HE 249
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 38/122 (31%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 130
+I GL +L S II+RDLK DN+ ++ + G +KI D G+ + T ++ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 131 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 187
+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 188 SK 189
SK
Sbjct: 245 SK 246
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 128
+ +I L+YLH II+RDLK DN+ ++ G +K+ D G+ + T + G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 129 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
TP ++APE L E+Y VD ++ G+ + EM+ P++ + +
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 41/217 (18%), Positives = 72/217 (33%), Gaps = 52/217 (23%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 59
S D E L+ + NI+K + + ++ E G L ++ +
Sbjct: 90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPH 147
Query: 60 ---------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 98
+ ARQ+ G+ YL +HRDL N
Sbjct: 148 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNC 205
Query: 99 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNEL 145
V N VKI D GL+ R++ + M PE ++ Y
Sbjct: 206 LVGENM-VVKIADFGLS--------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 256
Query: 146 VDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 181
D++++G+ + E+ + PY + ++ V G
Sbjct: 257 SDVWAYGVVLWEIFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 52/217 (23%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 59
SP +L L SE ++LK + H ++IK Y + + +I E GSLR + ++
Sbjct: 66 SPSELRDLLSEFNVLKQVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 60 ---------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 98
+ + M + ++A QI +G+ YL ++HRDL NI
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNI 181
Query: 99 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNEL 145
V ++KI D GL +R V + MA E L++ Y
Sbjct: 182 LVAEGR-KMKISDFGL--------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 146 VDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
D++SFG+ + E+VT PY +++ + +G
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTG 268
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 2e-18
Identities = 39/124 (31%), Positives = 71/124 (57%), Gaps = 9/124 (7%)
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 128
A +I GL +L S II+RDLK DN+ ++ G +KI D G+ + T ++ G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 129 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPA 185
TP+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563
Query: 186 SLSK 189
S+SK
Sbjct: 564 SMSK 567
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 45/210 (21%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 59
+ L L SE+ ++K + KH+NII + + +I E + G+LR+Y +
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 60 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 105
+ + K + + Q+ RG+ YL S IHRDL N+ V NN
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 106 EVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFG 152
+KI D GL AR + + MAPE L++ Y D++SFG
Sbjct: 195 VMKIADFGL--------ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 153 MCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
+ + E+ T PY +++K + G
Sbjct: 247 VLMWEIFTLGGSPYPGIPV-EELFKLLKEG 275
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 51/217 (23%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+ E L SE+ ++ L HENI+ + I +I E G L Y + +
Sbjct: 88 DSSEREALMSELKMMTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKRE 145
Query: 62 VDMKAIKN-----------------------WARQILRGLHYLHSHNPPIIHRDLKCDNI 98
+ +A Q+ +G+ +L + +HRDL N+
Sbjct: 146 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNV 203
Query: 99 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNEL 145
V VKI D GL AR ++ + MAPE L+E Y
Sbjct: 204 LVTHGK-VVKICDFGL--------ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254
Query: 146 VDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
D++S+G+ + E+ + PY A YK + +G
Sbjct: 255 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG 291
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 47/202 (23%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 64
D++ +E +L++ +H + S+ T+ + + E G L + + +
Sbjct: 190 DEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSE 247
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPT 122
+ + +I+ L YLHS +++RDLK +N+ ++ + G +KI D GL + T
Sbjct: 248 DRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGAT 305
Query: 123 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 181
++ GTPE++APE L + +Y VD + G+ + EM+ P+ ++ ++++ +
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILME 364
Query: 182 -IK-PASLSKVTDPQVKQFIEK 201
I+ P +L P+ K +
Sbjct: 365 EIRFPRTLG----PEAKSLLSG 382
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 45/210 (21%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 59
+ L L SE+ ++K + KH+NII + + +I E + G+LR+Y +
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 60 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 105
+ + K + + Q+ RG+ YL S IHRDL N+ V NN
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 240
Query: 106 EVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFG 152
+KI D GLA R + + MAPE L++ Y D++SFG
Sbjct: 241 VMKIADFGLA--------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 153 MCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
+ + E+ T PY +++K + G
Sbjct: 293 VLMWEIFTLGGSPYPGIPV-EELFKLLKEG 321
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 45/210 (21%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 59
+ L L SE+ ++K + KH+NII + + +I E + G+LR+Y +
Sbjct: 114 TEKDLSDLISEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRP 171
Query: 60 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 105
+ + K + + A Q+ RG+ YL S IHRDL N+ V +N
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN- 228
Query: 106 EVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFG 152
+KI D GLA R + + MAPE L++ Y D++SFG
Sbjct: 229 VMKIADFGLA--------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 153 MCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
+ + E+ T PY +++K + G
Sbjct: 281 VLLWEIFTLGGSPYPGVPV-EELFKLLKEG 309
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 47/180 (26%), Positives = 82/180 (45%), Gaps = 30/180 (16%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW- 70
+EV ++ H N+++ + T R + + +GS+ + + + +W
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLL--VYPYMANGSVASCL--RERPESQPPLDWP 131
Query: 71 ARQ-----ILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 124
RQ RGL YLH H +P IIHRD+K NI ++ E +GD GLA +M
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM--DYKD 188
Query: 125 S-----VIGTPEFMAPELYEEEY------NELVDIYSFGMCILEMVTCEYPYNECKNPAQ 173
+ V GT +AP EY +E D++ +G+ +LE++T + ++ +
Sbjct: 189 THVTTAVRGTIGHIAP-----EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 49/199 (24%), Positives = 79/199 (39%), Gaps = 26/199 (13%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
S D E+ +L L H NII + + + E G+L + +K +
Sbjct: 65 SKDDHRDFAGELEVLCKLGHHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRV 122
Query: 62 VDMKAIKNW----------------ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 105
++ A + RG+ YL IHRDL NI V N
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY- 179
Query: 106 EVKIGDLGLAIVMQQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-E 162
KI D GL+ + +++ P +MA E L Y D++S+G+ + E+V+
Sbjct: 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 239
Query: 163 YPYNECKNPAQIYKKVTSG 181
PY A++Y+K+ G
Sbjct: 240 TPYCGMTC-AELYEKLPQG 257
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNW 70
E+ L +H +++ + + I + +G+L++ Y + M +W
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMIL--IYKYMENGNLKRHLYGSDLPTMSM----SW 138
Query: 71 AR--QIL----RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 121
+ +I RGLHYLH IIHRD+K NI ++ N KI D G++ +
Sbjct: 139 EQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQT 195
Query: 122 ---TARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCILEMVT 160
T V GT ++ PE + + E D+YSFG+ + E++
Sbjct: 196 HLSTV--VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 24/172 (13%)
Query: 13 EVHLLKSLK-----------HENIIKFYNS--WVDDTNRTINMITELFTSGSLRQYRKKH 59
E+ LL+ + +I+K + + M+ E+ +L KK+
Sbjct: 65 EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKY 123
Query: 60 KNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-----NGNNGEVKIGDL 112
++ + +K ++Q+L GL Y+H IIH D+K +N+ + N ++KI DL
Sbjct: 124 EHRGIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
Query: 113 GLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY 163
G A + + I T E+ +PE L + DI+S I E++T ++
Sbjct: 183 GNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 9/158 (5%)
Query: 30 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 89
+S ++ + + + ++ + ++ Q+ +G+ +L S I
Sbjct: 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CI 215
Query: 90 HRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTP---EFMAPE-LYEEEYNE 144
HRDL NI + VKI D GLA + + P ++MAPE +++ Y
Sbjct: 216 HRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 145 LVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 181
D++SFG+ + E+ + PY K + +++ G
Sbjct: 275 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 12 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVD----M 64
E+ ++ +HEN+++ D + ++ +GSL +
Sbjct: 79 QEIKVMAKCQHENLVELLGFSSDGDDLC--LVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPT 122
K + A G+++LH IHRD+K NI ++ KI D GLA T
Sbjct: 137 KIAQGAAN----GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQT 189
Query: 123 ARS--VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 160
+ ++GT +MAPE E DIYSFG+ +LE++T
Sbjct: 190 VMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 16/159 (10%)
Query: 13 EVHLLKSLKHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDM 64
EV LL+ + I+ N ++ E+ S +L + V +
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKR-HFMFRNHLC-LVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA 123
+ +A+Q+ L +L + IIH DLK +NI N +KI D G + + Q
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 124 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 160
I + + +PE L Y+ +D++S G CIL EM T
Sbjct: 217 -QYIQSRFYRSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 13 EVHLLKSLKHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DM 64
E+ +L+ L+ + N+I N M EL S +L + KK+K +
Sbjct: 143 EIRILEHLRKQDKDNTMNVIHMLE-NFTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSL 199
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA 123
++ +A IL+ L LH + IIH DLK +NI +K+ D G + Q
Sbjct: 200 PLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257
Query: 124 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 160
+ I + + APE + Y +D++S G CIL E++T
Sbjct: 258 -TYIQSRFYRAPEVILGARYGMPIDMWSLG-CILAELLT 294
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 22/220 (10%), Positives = 50/220 (22%), Gaps = 47/220 (21%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
D L+ S L + + + + + E GSL++ +
Sbjct: 72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA--EWIRGGSLQEVADTSPSPV 129
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 123
+ + H + + V +G+V + M
Sbjct: 130 GAI--RAMQSLAAAADAAHRAG--VALSIDHPSRVRV-SIDGDVVLAYPA---TMPDANP 181
Query: 124 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI---YKKVTS 180
+ DI G + ++ +P E + + +
Sbjct: 182 QD---------------------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAG 220
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELL-KDP 219
+ D +P + A + D
Sbjct: 221 QPIEPA---DIDRD---------IPFQISAVAARSVQGDG 248
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 34/176 (19%), Positives = 72/176 (40%), Gaps = 35/176 (19%)
Query: 13 EVHLLKSLKHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DM 64
E+++LK +K + + + W + + + EL + ++ K++ +
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSD-WFNFHGH-MCIAFELL-GKNTFEFLKENNFQPYPL 122
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGE 106
+++ A Q+ L +LH + + H DLK +NI + N
Sbjct: 123 PHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 107 VKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 160
+++ D G A + +++ T + PE + E + + D++S G CIL E
Sbjct: 181 IRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 51/279 (18%), Positives = 101/279 (36%), Gaps = 77/279 (27%)
Query: 13 EVHLLKSLKHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DM 64
E+ +L+ L ++ W + I ++ EL S + K++ + +
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLE-WFEHHGH-ICIVFELL-GLSTYDFIKENGFLPFRL 117
Query: 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGE 106
I+ A QI + +++LHS+ + H DLK +NI + N +
Sbjct: 118 DHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 107 VKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL--------- 156
+K+ D G A + +++ T + APE + +++ D++S G CIL
Sbjct: 176 IKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYLGFTV 233
Query: 157 -------EMVTC-------------------------EYPYNECKNPAQIYKKVTSGIKP 184
E + ++E + + + +K
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293
Query: 185 ASLSK-VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
LS+ V ++ I+K + + R+ E LK PF
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 41/181 (22%), Positives = 79/181 (43%), Gaps = 40/181 (22%)
Query: 13 EVHLLKSLKHE-----NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMK 65
E +LK ++++ NI+K++ + + +I E SL + ++ ++
Sbjct: 81 EADILKKIQNDDINNNNIVKYHG-KFMYYDH-MCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------------------ 101
IK + +IL+ L+YL + + H DLK +NI ++
Sbjct: 138 DIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 102 GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMV 159
+ +K+ D G A S+I T ++ APE + ++ D++SFG C+L E+
Sbjct: 196 TKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELY 253
Query: 160 T 160
T
Sbjct: 254 T 254
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 4e-10
Identities = 96/648 (14%), Positives = 184/648 (28%), Gaps = 207/648 (31%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN------------RTINMITELFT 48
+ S D + L S K E +++ + V N R +M+T ++
Sbjct: 55 IMSKDAVSGTLRLFWTLLS-KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113
Query: 49 SGSLRQYR-----KKHKNV----DMKAIKNWARQILRGLHYLHSHNPPIIH--------- 90
R Y K+ NV ++ + LR + +I
Sbjct: 114 EQRDRLYNDNQVFAKY-NVSRLQPYLKLRQALLE-LRPAKNV------LIDGVLGSGKTW 165
Query: 91 ------RDLKCDNIFVNG----NNGEVKIGDLGLAI-------VMQQPTARSVIGTPEFM 133
K N + L + + T+RS + +
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225
Query: 134 APELYEEEYNELVDIYSFGMC--ILEMV----TCEYPYNECKNPAQI-----YKKVTSGI 182
+ E L+ + C +L V CK I +K+VT +
Sbjct: 226 RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK----ILLTTRFKQVTDFL 281
Query: 183 KPASLSKVT-DPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 241
A+ + ++ D LL K L C P LP
Sbjct: 282 SAATTTHISLDHHSMTLTPD---------EVKSLLL---------KYLDCRPQDLP---R 320
Query: 242 EVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTW--FLTLELQRLTENNEFTLRGEKND 299
EV+ +P + + A+S + TW + + +LT E +L +
Sbjct: 321 EVLTT-----NPRRLSI-----IAESI-RDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 300 DDT---VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQL--DLSHEDVVSIAEL 354
+ L VF +A I ++ + D+ DV +
Sbjct: 370 EYRKMFDRL---------------SVFPPSAH----IPTILLSLIWFDVIKSDV----MV 406
Query: 355 IDNLIMK--LVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQ 412
+ N + K LV ST S + L+ + +K E + + +
Sbjct: 407 VVNKLHKYSLVEKQPKE--STISIPSIYLE---------LKVKLENEYALHRSIVD---- 451
Query: 413 QGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEV 472
Y + D+ + D Y + + H +
Sbjct: 452 ----------HYNIPKTFDSDDLIPPYL---------------DQYFYSHIGH-HLKNIE 485
Query: 473 KADEVSLGESILFNESTQNSETSFIDS---CSGMSKNLSFSSISSLS--------LADKE 521
+ ++L + + F++ + N S S +++L + D +
Sbjct: 486 HPERMTLFRMVFLD-------FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDND 538
Query: 522 -HSDGL---------KLELDAINSKYQQCFQELLRQREDEM--ENARK 557
+ L K+E + I SKY + L ++ + E ++
Sbjct: 539 PKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 2e-06
Identities = 76/502 (15%), Positives = 150/502 (29%), Gaps = 159/502 (31%)
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
N D K +++ + IL + D+I ++ + V ++
Sbjct: 31 DNFDCKDVQDMPKSIL---------------SKEEIDHIIMSKD--AVSGTLRLFWTLLS 73
Query: 120 QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKK 177
+ +F+ E+ Y L+ M+T Y + N Q++ K
Sbjct: 74 KQEE----MVQKFVE-EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK 128
Query: 178 --VT------------SGIKPAS----------------LSKVTDPQVKQFIE------- 200
V+ ++PA L +V+ ++
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN 188
Query: 201 --KCIVPASLRLPALELLKDPFLVTDNPKDLVCD-----PLRLPNLVPEVMNLAHSEPHP 253
C P ++ LE+L+ D D LR+ ++ E+ L S+P+
Sbjct: 189 LKNCNSPETV----LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 254 -----MDIDLNHKKVSAD---SCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSL 305
+ ++ + K SC K L T R K D +S
Sbjct: 245 NCLLVLL-NVQNAKAWNAFNLSC-K--------IL----------LTTR-FKQVTDFLS- 282
Query: 306 TLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQ--LDLSHEDVVSIAELIDNLIMKLV 363
+ H+S H L D S+ + ++ DL E V++ ++I + +
Sbjct: 283 ----AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE-VLTTNPRRLSIIAESI 337
Query: 364 PS----WNPSLGSTASQQNGLLKGSPVSQGNSISLKC--PGEPGSNNAFAEAVSQQGVLS 417
W+ + +++ SL P E + + + V
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIE---------SSLNVLEPAE------YRKMFDRLSVFP 382
Query: 418 ELASGKYQYNQESSDSDISA-----------EFDVPVILDAHIDKSLVPDGYSAHYAVYD 466
+ I + DV V+++ SLV + +
Sbjct: 383 P-------------SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV-EKQPKESTISI 428
Query: 467 HGGH-EVKA---DEVSLGESIL 484
+ E+K +E +L SI+
Sbjct: 429 PSIYLELKVKLENEYALHRSIV 450
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 37/165 (22%), Positives = 58/165 (35%), Gaps = 53/165 (32%)
Query: 51 SLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-------- 100
L ++ K + + +K +Q+L+GL YLH+ IIH D+K +NI +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIR 188
Query: 101 ----------------------------------------NGNNGEVKIGDLGLAIVMQQ 120
N +VKI DLG A + +
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248
Query: 121 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 164
I T ++ + E L YN DI+S E+ T +Y
Sbjct: 249 HF-TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 22/129 (17%), Positives = 45/129 (34%), Gaps = 16/129 (12%)
Query: 17 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQI 74
L S I V ++ SL+ + +++ A ++
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168
Query: 75 LRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQPTAR 124
L L +LH + +H ++ +NIFV+ + +V + G A + + +
Sbjct: 169 LDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226
Query: 125 SVIGTPEFM 133
G EF+
Sbjct: 227 PHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 27/154 (17%), Positives = 54/154 (35%), Gaps = 34/154 (22%)
Query: 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG------------------ 50
L+SE+ + + ++ I W++ I + SG
Sbjct: 79 PLFSELKFYQRVAKKDCI---KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLG 135
Query: 51 -SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVK 108
L++ ++ + ++L L Y+H + +H D+K N+ + N +V
Sbjct: 136 IDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVY 193
Query: 109 IGDLGLA---------IVMQQPTARSVIGTPEFM 133
+ D GL+ Q+ + GT EF
Sbjct: 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 31/137 (22%), Positives = 51/137 (37%), Gaps = 18/137 (13%)
Query: 10 LYSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAI 67
L+ E + K ++ I + M+ EL SL + +K +
Sbjct: 51 LHIESKIYKMMQGGVGIPTIRWCGAEGDYNV--MVMELLGP-SLEDLFNFCSRKFSLKTV 107
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP---- 121
A Q++ + Y+HS N IHRD+K DN + V I D GLA +
Sbjct: 108 LLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 122 -----TARSVIGTPEFM 133
+++ GT +
Sbjct: 166 HIPYRENKNLTGTARYA 182
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 22/73 (30%), Positives = 31/73 (42%), Gaps = 12/73 (16%)
Query: 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQ 120
+ +IL L Y+H H +H D+K N+ +N N +V + D GLA
Sbjct: 158 SLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 121 PTARSVIGTPEFM 133
R GT EF
Sbjct: 216 DPKRCHDGTIEFT 228
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 4e-06
Identities = 20/73 (27%), Positives = 33/73 (45%), Gaps = 6/73 (8%)
Query: 296 EKNDDDTVSLTLRIGD----KSGHVSN--IHFVFYLNADTAISIAEEMVEQLDLSHEDVV 349
+ + + L LRI D K + N I F F L D +A+EMVE + D
Sbjct: 19 DDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHK 78
Query: 350 SIAELIDNLIMKL 362
++A+ I + + +
Sbjct: 79 TMAKAIKDRVSLI 91
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 25/110 (22%), Positives = 46/110 (41%), Gaps = 9/110 (8%)
Query: 10 LYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAI 67
L E + + L+ I V+ ++ +L SL + + +K +
Sbjct: 49 LLYESKIYRILQGGTGIPNVRWFGVEGDYNV--LVMDLLGP-SLEDLFNFCSRKLSLKTV 105
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLA 115
A Q++ + ++HS + +HRD+K DN + +V I D GLA
Sbjct: 106 LMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 1e-05
Identities = 40/241 (16%), Positives = 72/241 (29%), Gaps = 37/241 (15%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL-FTSGSLRQYRKKHKNV 62
P L + + + K ++ F + + ++ E F L Q R K ++
Sbjct: 108 PPLLLKAWDHYNSTKGSANDRPDFF-------KDDQLFIVLEFEFGGIDLEQMRTKLSSL 160
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----------GNNGEVKIGDL 112
K+ Q+ L + HRDL N+ + N I
Sbjct: 161 AT--AKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC 217
Query: 113 GLAIVMQQPTAR--SVIGTPEFM----APELYEEEYNELVDIYSFGMCILEMVTCEY-PY 165
GL + + T G F +L+ + + DIY EY PY
Sbjct: 218 GLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPY 277
Query: 166 NECK-----NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPF 220
+ + + K ++++F + +S A +LL
Sbjct: 278 SNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSS----ATDLLCQHS 333
Query: 221 L 221
L
Sbjct: 334 L 334
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 28/112 (25%), Positives = 45/112 (40%), Gaps = 11/112 (9%)
Query: 10 LYSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAI 67
L+ E K L + I + Y M+ EL SL + +K +
Sbjct: 51 LHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA--MVLELLGP-SLEDLFDLCDRTFSLKTV 107
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDLGLA 115
A Q++ + Y+HS N +I+RD+K +N + N + I D LA
Sbjct: 108 LMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 22/112 (19%), Positives = 44/112 (39%), Gaps = 11/112 (9%)
Query: 10 LYSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAI 67
L E K L I Y + + ++ +L SL + +K +
Sbjct: 52 LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV--LVIDLLGP-SLEDLLDLCGRKFSVKTV 108
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLA 115
A+Q+L + +H + +++RD+K DN + N + + + D G+
Sbjct: 109 AMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 568 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 99.69 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.64 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.19 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.38 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.88 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.57 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.4 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.34 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.33 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.71 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.62 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.39 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.95 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.55 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.99 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.77 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 94.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.34 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 93.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 91.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 91.48 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 89.8 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=438.28 Aligned_cols=221 Identities=53% Similarity=0.998 Sum_probs=204.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+....+++.+|+++|++|+|||||++|++|.+. ....+|||||||+||+|.+++++.+.+++..++.|++||+.||+|
T Consensus 65 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~y 144 (290)
T 3fpq_A 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence 456678899999999999999999999998753 345799999999999999999999999999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHHHHHHhh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmlt 160 (568)
||+++++||||||||+|||+++.+|.+||+|||+|+........+.+|||.|||||++.+.|+.++|||||||++|||+|
T Consensus 145 lH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyellt 224 (290)
T 3fpq_A 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMAT 224 (290)
T ss_dssp HHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHH
T ss_pred HHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHH
Confidence 99999889999999999999866899999999999877666677889999999999998889999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|+.||.+..+..++++.+..+..|..++...++++++||.+||+ +|.+|||+.|+|+||||++
T Consensus 225 g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 225 SEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999988889999999999888877888889999999999996 6999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=412.77 Aligned_cols=218 Identities=27% Similarity=0.459 Sum_probs=194.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+..+++.+|+++|++|+|||||++|++|.+. ..+|+|||||+||+|.+++++.+.+++..++.|++||+.||+|||++
T Consensus 74 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~ 151 (311)
T 4aw0_A 74 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151 (311)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3467899999999999999999999999765 47999999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
| |+||||||+|||++ .+|.+||+|||+|+.+... ...+++|||.|||||++. ..|+.++|||||||++|+|+
T Consensus 152 ~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml 228 (311)
T 4aw0_A 152 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228 (311)
T ss_dssp T--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred C--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 9 99999999999997 7899999999999876422 345779999999999884 56999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHH------HhcCCCCCCCCCCCcc
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLV 230 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~E------lL~hpff~~~~~~~l~ 230 (568)
||..||.+ .+..+++..+..+.. .++...++++++||.+||+ +|.+|+|+.| +++||||+..+|..+.
T Consensus 229 ~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 229 AGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp HSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred hCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 99999976 567777777776543 3566789999999999996 7999999987 5899999999887764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=413.09 Aligned_cols=212 Identities=32% Similarity=0.604 Sum_probs=186.6
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+.+|+++|++|+|||||++|++|.+.+ .+|||||||+||+|.+++.+ +++++..++.|++||+.||+|||++|
T Consensus 115 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~- 190 (346)
T 4fih_A 115 RELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG- 190 (346)
T ss_dssp GGGGHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 456889999999999999999999998764 79999999999999999986 56999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
||||||||+|||++ .+|.+||+|||+|+.+... ...+.+|||.|||||++. ..|+.++|||||||++|||+||+.
T Consensus 191 -IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 268 (346)
T 4fih_A 191 -VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 268 (346)
T ss_dssp -EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -cccccCCHHHEEEC-CCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999997 7899999999999876443 356789999999999884 569999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 164 PYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||.+ .+...++..+..+..+. ..+..+++++++||.+||+ +|.+|||+.|+|+||||++..
T Consensus 269 PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 269 PYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp TTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 9987 45666677776654432 2334578999999999996 799999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=400.18 Aligned_cols=214 Identities=27% Similarity=0.533 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+..+++.+|+++|++|+|||||+++++|.+. ..+|+||||| +|+|.+++.+.+.+++..++.|++||+.||+|||+
T Consensus 54 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~ 130 (275)
T 3hyh_A 54 SDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130 (275)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999998765 4799999999 68999999999999999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccccc-CC-CccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~-~y-s~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++ .+|.+||+|||+|+..... ...+.+|||.|||||++.+ .| +.++|||||||++|+|+|
T Consensus 131 ~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt 207 (275)
T 3hyh_A 131 HK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC 207 (275)
T ss_dssp TT--CCCCCCCTTTEEEC-TTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH
T ss_pred CC--cccccCChHHeEEC-CCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH
Confidence 99 99999999999997 7899999999999876543 3456799999999998854 44 689999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
|+.||.+ .+...+++.+..+.. .++...++++++||.+||+ +|.+|||+.|+|+||||+..-+
T Consensus 208 g~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p 271 (275)
T 3hyh_A 208 RRLPFDD-ESIPVLFKNISNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP 271 (275)
T ss_dssp SSCSSCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred CCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCCC
Confidence 9999976 567778888877643 3566789999999999996 6999999999999999986544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=409.55 Aligned_cols=221 Identities=24% Similarity=0.369 Sum_probs=187.3
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
.++.+|+++|++|+|||||++|++|.+++ .+|+|||||+||+|.+++.+.+.+++..++.|++||+.||+|||++|
T Consensus 71 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~-- 146 (304)
T 3ubd_A 71 VRTKMERDILVEVNHPFIVKLHYAFQTEG--KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG-- 146 (304)
T ss_dssp C------CCCCCCCCTTEECEEEEEEETT--EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 46788999999999999999999997654 79999999999999999999999999999999999999999999999
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCC
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~P 164 (568)
|+||||||+|||++ .+|.+||+|||+|+.... ....+.+|||.|||||++ ...|+.++|||||||++|||+||+.|
T Consensus 147 IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P 225 (304)
T 3ubd_A 147 IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225 (304)
T ss_dssp CCCSSCCGGGEEEC-TTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCCCCHHHeEEc-CCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCC
Confidence 99999999999997 789999999999986533 335577999999999988 45699999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCCCCC
Q 008378 165 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRL 236 (568)
Q Consensus 165 f~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~l~~ 236 (568)
|.+ .+..+++..+..+.. .++...++++++||.+||+ +|.+||| ++|+++||||+..++..+....+..
T Consensus 226 F~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~p 300 (304)
T 3ubd_A 226 FQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHP 300 (304)
T ss_dssp SCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred CCC-cCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCc
Confidence 986 466777777776543 3566789999999999996 7999998 4799999999998876665444433
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=410.45 Aligned_cols=215 Identities=27% Similarity=0.498 Sum_probs=188.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~y 80 (568)
+.+..+++.+|+++|++|+|||||++|++|.+. ..+|||||||+||+|.+++...+ .+++..++.|+.||+.||.|
T Consensus 63 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~y 140 (350)
T 4b9d_A 63 SSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140 (350)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999765 47999999999999999997653 57999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
||++| ||||||||+|||++ .+|.+||+|||+|+.+... ...+.+|||.|||||++. ..|+.++|||||||++||
T Consensus 141 lH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilye 217 (350)
T 4b9d_A 141 VHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYE 217 (350)
T ss_dssp HHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHCC--eeeccCCHHHEEEC-CCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHH
Confidence 99999 99999999999997 7899999999999876543 235678999999999885 569999999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|+||+.||.+ .+..+++..+..+..|. .+..+++++++||.+||+ +|.+|||+.|+|+||||++.
T Consensus 218 mltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 218 LCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999987 45666666776665443 455678999999999996 79999999999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=417.18 Aligned_cols=213 Identities=31% Similarity=0.603 Sum_probs=187.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+|++|+|||||++|++|.+.+ .+|||||||+||+|.++++. +++++..++.|++||+.||+|||++|
T Consensus 191 ~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~ 267 (423)
T 4fie_A 191 RRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG 267 (423)
T ss_dssp SGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEEECC--EEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567899999999999999999999998754 79999999999999999875 56999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
||||||||+|||++ .+|.+||+|||+|+.+... ...+.+||+.|||||++. ..|+.++|||||||++|||++|+
T Consensus 268 --IiHRDiKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~ 344 (423)
T 4fie_A 268 --VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344 (423)
T ss_dssp --EECCCCSTTTEEEC-TTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --eecccCCHHHEEEc-CCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99999999999997 7899999999999876433 356789999999999884 56999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||.+ .+...++..+..+..+ ......+++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 345 ~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 345 PPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp CTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 99987 4566666666665443 23445678999999999996 799999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=397.90 Aligned_cols=208 Identities=27% Similarity=0.394 Sum_probs=177.3
Q ss_pred HHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEe
Q 008378 11 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 90 (568)
Q Consensus 11 ~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiH 90 (568)
.+|+.+|+.|+|||||++|++|.+.. .+|||||||+||+|.+++++.+.+++..++.|+.||+.||+|||++| |||
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~--~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiH 173 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILH 173 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETT--EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EEC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cee
Confidence 47999999999999999999997654 79999999999999999999999999999999999999999999999 999
Q ss_pred eeccCCcEEEeCCCC-cEEEeecChhhhccCC-------CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 91 RDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 91 RDLKp~NILl~~~~g-~vKI~DFGla~~~~~~-------~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
|||||+|||++ .+| ++||+|||+|+.+... ...+++|||.|||||++. ..|+.++|||||||++|||+||
T Consensus 174 RDlKp~NILl~-~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG 252 (336)
T 4g3f_A 174 GDVKADNVLLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252 (336)
T ss_dssp SCCCGGGEEEC-TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccCHHHEEEe-CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999997 555 7999999999876432 123468999999999884 5699999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHH-------------hcCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALEL-------------LKDPFLVTD 224 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~El-------------L~hpff~~~ 224 (568)
+.||.+.... .+...+..+.. ...++..+++++++||.+||+ +|.+|||+.|+ |+|||+.+.
T Consensus 253 ~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 253 CHPWTQYFRG-PLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SCSSTTTCCS-CCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred cCCCCCCCHH-HHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 9999875443 34444444433 334667789999999999996 79999999997 578998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=378.91 Aligned_cols=209 Identities=31% Similarity=0.509 Sum_probs=178.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+++..++|.+|+.+|++|+|||||++++++.. ..+|+|||||++|+|.+++... +.+++..+..|+.||+.||+||
T Consensus 72 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yL 148 (307)
T 3omv_A 72 TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 148 (307)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999999999999997743 2478999999999999999765 5799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccc----cCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGi 153 (568)
|+++ ||||||||+|||++ .++.+||+|||+|+..... ...+.+||+.|||||++. +.|+.++|||||||
T Consensus 149 H~~~--IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gv 225 (307)
T 3omv_A 149 HAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGI 225 (307)
T ss_dssp HHTT--CBCSCCCSSSEEEE-TTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHH
T ss_pred HHCC--ccCCccCHHHEEEC-CCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHH
Confidence 9999 99999999999998 7899999999999865422 234568999999999883 34899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++|||+||+.||.+..+...+...+..+..++ ..+...++++++||.+||+ +|.+|||+.|++.
T Consensus 226 vl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 226 VLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp HHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999998888888888887775543 3445678999999999996 6999999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=389.29 Aligned_cols=219 Identities=27% Similarity=0.423 Sum_probs=181.8
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcC----CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~----~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
.....+++.+|+++|+.|+|||||++++++... +...+|||||||. |+|.+++.+.+.+++..++.|++||+.||
T Consensus 93 ~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al 171 (398)
T 4b99_A 93 VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGL 171 (398)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Confidence 356678899999999999999999999987643 2357999999996 68999999999999999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC------CCcccccCCCCccCccccc--cCCCccceehh
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ------PTARSVIGTPEFMAPELYE--EEYNELVDIYS 150 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~------~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWS 150 (568)
.|||++| ||||||||+|||++ .+|.+||+|||+|+.+.. ....+++||+.|||||++. ..|+.++||||
T Consensus 172 ~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWS 248 (398)
T 4b99_A 172 KYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWS 248 (398)
T ss_dssp HHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred HHHHHCc--CcCCCcCccccccC-CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheeh
Confidence 9999999 99999999999997 789999999999986532 2345679999999999874 34799999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-C---------------------------CCCCCcHHHHHHHHHh
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-S---------------------------LSKVTDPQVKQFIEKC 202 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~-~---------------------------~~~~~s~el~~lI~kc 202 (568)
+|||+|||++|+.||.+.+...++...+.....|. . .....++++++||.+|
T Consensus 249 lG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m 328 (398)
T 4b99_A 249 VGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRM 328 (398)
T ss_dssp HHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred hHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHH
Confidence 99999999999999987555444443332111110 0 1124578999999999
Q ss_pred cC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 203 IV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 203 L~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|+ +|.+||||.|+|+||||+...
T Consensus 329 L~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 329 LRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp SCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CcCChhHCcCHHHHhcCHhhCcCC
Confidence 96 799999999999999998643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=379.92 Aligned_cols=216 Identities=23% Similarity=0.431 Sum_probs=169.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----------CeEEEEEecCCCCCHHHHHHhCCC---CCHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----------RTINMITELFTSGSLRQYRKKHKN---VDMKAIKN 69 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----------~~l~lV~Ey~~gGsL~~~i~k~~~---l~e~~i~~ 69 (568)
++...+++.+|+++|++|+|||||++|++|.+.+. .++|+|||||.+|+|.+++++.+. .+...++.
T Consensus 43 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~ 122 (299)
T 4g31_A 43 RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122 (299)
T ss_dssp SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHH
Confidence 34566889999999999999999999999976542 258999999999999999998765 44567899
Q ss_pred HHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--------------cccccCCCCccCc
Q 008378 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--------------ARSVIGTPEFMAP 135 (568)
Q Consensus 70 i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--------------~~s~~GTp~YmAP 135 (568)
|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+.+.... ..+.+|||.||||
T Consensus 123 i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP 199 (299)
T 4g31_A 123 IFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199 (299)
T ss_dssp HHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCCCC--------------------------CCCTTSCH
T ss_pred HHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCH
Confidence 9999999999999999 99999999999997 78999999999998764321 2346899999999
Q ss_pred cccc-cCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 136 ELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 136 Evl~-~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
|++. ..|+.++|||||||++|||++ ||....+.......+.....|..+ ...++.+++||.+||+ +|.+|||+.
T Consensus 200 E~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~ 275 (299)
T 4g31_A 200 EQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAI 275 (299)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHH
Confidence 9885 569999999999999999996 886533333344444444333221 2235678899999996 699999999
Q ss_pred HHhcCCCCCCCC
Q 008378 214 ELLKDPFLVTDN 225 (568)
Q Consensus 214 ElL~hpff~~~~ 225 (568)
|+|+||||+..+
T Consensus 276 eil~h~~~~~~~ 287 (299)
T 4g31_A 276 NIIENAVFEDLD 287 (299)
T ss_dssp HHHTSGGGCCC-
T ss_pred HHhcCHhhCCCC
Confidence 999999998654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=410.98 Aligned_cols=223 Identities=22% Similarity=0.380 Sum_probs=194.1
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
+...++.+++.++|||||++|++|.+.+ .+|||||||.||+|.+++.+.+.+++..++.|++||+.||+|||++| |
T Consensus 238 ~E~~~l~ll~~~~HP~IV~l~~~f~~~~--~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--I 313 (689)
T 3v5w_A 238 NERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--V 313 (689)
T ss_dssp HHHHHHHHHSSSCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--E
T ss_pred HHHHHHHHHhhCCCCCEeEEEEEEEECC--EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 3345577888899999999999997654 79999999999999999999999999999999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcCCCCC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYN 166 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~~Pf~ 166 (568)
|||||||+|||++ .+|++||+|||+|+.+......+.+|||.|||||++. ..|+.++|||||||++|||++|..||.
T Consensus 314 iHRDLKPeNILld-~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 314 VYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp ECCCCSGGGEEEC-TTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccCCchHHeEEe-CCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999997 7899999999999988777778889999999999884 359999999999999999999999997
Q ss_pred CC--CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCCCCCCC
Q 008378 167 EC--KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN 238 (568)
Q Consensus 167 ~~--~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~l~~p~ 238 (568)
+. .+...+...+.... ..++..+++++++||.+||+ +|.+|++ +.|+++||||+..+|..+....+..|.
T Consensus 393 ~~~~~~~~~i~~~i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~ 470 (689)
T 3v5w_A 393 QHKTKDKHEIDRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470 (689)
T ss_dssp GGGCCCHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSC
T ss_pred CCChHHHHHHHHhhcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCc
Confidence 53 34455666665543 33566789999999999996 7999998 799999999999999877655554443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=371.62 Aligned_cols=211 Identities=25% Similarity=0.427 Sum_probs=183.2
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-------------CCCHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------------NVDMKAIKN 69 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-------------~l~e~~i~~ 69 (568)
+.+..++|.+|+++|++|+|||||++|+++.+.. .+|+|||||++|+|.+++.+++ .+++..+..
T Consensus 55 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~ 132 (299)
T 4asz_A 55 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132 (299)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHH
Confidence 4567789999999999999999999999987654 6899999999999999998653 699999999
Q ss_pred HHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCc
Q 008378 70 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNE 144 (568)
Q Consensus 70 i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ 144 (568)
|+.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+|+...... .....||+.|||||++ .+.|+.
T Consensus 133 i~~qia~gl~yLH~~~--iiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~ 209 (299)
T 4asz_A 133 IAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 209 (299)
T ss_dssp HHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhCC--cccCccCHhhEEEC-CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCc
Confidence 9999999999999999 99999999999997 78899999999998764332 2345799999999988 567999
Q ss_pred cceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 145 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 145 ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
++|||||||++|||+| |+.||.+. +..++...+..+..+. .+...++++++||.+||+ +|.+|||+.++ ++|++
T Consensus 210 k~DVwS~Gvvl~Ellt~G~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 210 ESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 9999999999999999 89999874 5677778887776543 456788999999999996 79999999998 44554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=378.31 Aligned_cols=211 Identities=18% Similarity=0.346 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..++.+|+++|+.+ +|||||+++++|.+. ..+|+|||||+||+|.++++ .+++..++.+++||+.||+|||++|
T Consensus 63 ~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g 137 (361)
T 4f9c_A 63 PIRIAAELQCLTVAGGQDNVMGVKYCFRKN--DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG 137 (361)
T ss_dssp HHHHHHHHHHHHHTCSBTTBCCCSEEEEET--TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCCCCCceEEEEEEEC--CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45688999999999 699999999998765 47999999999999999984 5999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------------------------------CcccccCCCCccCc
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------------------------------TARSVIGTPEFMAP 135 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------------------------------~~~s~~GTp~YmAP 135 (568)
|+||||||+|||++.+.|.+||+|||+|+..... ...+.+|||.||||
T Consensus 138 --IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 215 (361)
T 4f9c_A 138 --IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAP 215 (361)
T ss_dssp --EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCH
T ss_pred --eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCH
Confidence 9999999999999866689999999999754221 12345899999999
Q ss_pred ccccc--CCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHc---------------------------------
Q 008378 136 ELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------------------------- 180 (568)
Q Consensus 136 Evl~~--~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~--------------------------------- 180 (568)
|++.+ .|+.++||||+||++|||+||+.||....+.......+..
T Consensus 216 E~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 295 (361)
T 4f9c_A 216 EVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLC 295 (361)
T ss_dssp HHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHH
T ss_pred HHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHH
Confidence 98743 5899999999999999999999999765554332222211
Q ss_pred ----C---------------CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 181 ----G---------------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 181 ----~---------------~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+ ..........++++++||.+||+ +|.+|+||.|+|+||||++.
T Consensus 296 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 296 ERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0 00001223567899999999996 79999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=372.70 Aligned_cols=209 Identities=22% Similarity=0.412 Sum_probs=175.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC---------------CCCCHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------KNVDMKAI 67 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~---------------~~l~e~~i 67 (568)
+++..++|.+|+++|++|+|||||++|++|.+. ..+|+|||||++|+|.+++.++ +.+++..+
T Consensus 83 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 160 (329)
T 4aoj_A 83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160 (329)
T ss_dssp SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHH
Confidence 456778999999999999999999999998754 3699999999999999999865 35899999
Q ss_pred HHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-ccCC
Q 008378 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EEEY 142 (568)
Q Consensus 68 ~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~~y 142 (568)
..|+.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++..... .....+||+.|||||++ ...|
T Consensus 161 ~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~ 237 (329)
T 4aoj_A 161 LAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237 (329)
T ss_dssp HHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHhcCC--eecccccHhhEEEC-CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC
Confidence 999999999999999999 99999999999998 7899999999999876432 22356899999999987 4569
Q ss_pred CccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 143 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 143 s~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+.++|||||||++|||+| |+.||.+. +..++...+..+..+. .+...++++++||.+||+ +|.+|||+.|++.+
T Consensus 238 ~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-~~~~~~~~i~~g~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 238 TTESDVWSFGVVLWEIFTYGKQPWYQL-SNTEAIDCITQGRELE-RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTCSS-CHHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CccccccchHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCCCC-CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 999999999999999999 89999874 5666777777776543 456788999999999996 69999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=365.31 Aligned_cols=207 Identities=22% Similarity=0.315 Sum_probs=179.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIK 68 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------~~l~e~~i~ 68 (568)
...++|.+|+.+|++|+|||||++++++.+.. .+++|||||++|+|.+++... ..+++..+.
T Consensus 71 ~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~--~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 148 (308)
T 4gt4_A 71 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148 (308)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCcceEEEECC--EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHH
Confidence 34578999999999999999999999986543 689999999999999999753 358999999
Q ss_pred HHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-ccCCC
Q 008378 69 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EEEYN 143 (568)
Q Consensus 69 ~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~~ys 143 (568)
.++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++..... .....+||+.|||||++ .+.|+
T Consensus 149 ~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~-~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s 225 (308)
T 4gt4_A 149 HLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS 225 (308)
T ss_dssp HHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHhCC--CCCCCccccceEEC-CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC
Confidence 99999999999999999 99999999999997 7899999999999866432 23456899999999987 56799
Q ss_pred ccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 144 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 144 ~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
.++|||||||++|||+| |..||.+. +..++...+..+..++ .+...++++.+||.+||. +|.+||++.|++.+
T Consensus 226 ~ksDVwSfGvvl~El~t~g~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 226 IDSDIWSYGVVLWEVFSYGLQPYCGY-SNQDVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTC-CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchhhhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999998 89999874 5677777887775543 456678999999999996 69999999999765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=372.12 Aligned_cols=210 Identities=24% Similarity=0.410 Sum_probs=183.0
Q ss_pred HHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHH
Q 008378 4 PDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~H-pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------~~l~e~~ 66 (568)
....+.+.+|+++|++++| ||||+++++|.... ..+++|||||++|+|.+++++. ..+++..
T Consensus 108 ~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~ 186 (353)
T 4ase_A 108 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186 (353)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHH
Confidence 4567889999999999965 99999999886543 4689999999999999999864 2489999
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccC
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEE 141 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ 141 (568)
+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+.... ..+.+||+.|||||++ .+.
T Consensus 187 ~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~ 263 (353)
T 4ase_A 187 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 263 (353)
T ss_dssp HHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHhHhhCC--eecCccCccceeeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC
Confidence 9999999999999999999 99999999999997 78999999999998764322 2346799999999987 567
Q ss_pred CCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 142 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+.++|||||||++|||+| |+.||.+......+.+.+..+..+. .+...+++++++|.+||+ +|.+|||+.|+++|
T Consensus 264 y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 264 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999999999998 9999988777778888888876554 456678999999999996 79999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=391.08 Aligned_cols=219 Identities=25% Similarity=0.410 Sum_probs=188.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
.....+.+.+|+++|+.|+|||||+++++|.+. ..+|||||||.||+|.+++.+ .+.+++..++.|++||+.||.||
T Consensus 194 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~yl 271 (573)
T 3uto_A 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271 (573)
T ss_dssp SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345667899999999999999999999999765 479999999999999999864 46799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeC-CCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~-~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
|++| |+||||||+|||++. ..|.+||+|||+++.+... ...+.+||+.|||||++. ..|+.++|||||||++|+|
T Consensus 272 H~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyem 349 (573)
T 3uto_A 272 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 349 (573)
T ss_dssp HHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHH
T ss_pred HHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 9999 999999999999974 2489999999999877543 345678999999999884 5699999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
++|..||.+. +..+.+..+..+.. +......+++++++||.+||+ +|.+||++.|+|+||||+..++
T Consensus 350 l~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 350 LSGLSPFGGE-NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHSCCSSCCS-SHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHCCCCCCCc-CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999874 55666666665432 333445678999999999996 7999999999999999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.24 Aligned_cols=222 Identities=53% Similarity=0.998 Sum_probs=202.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+....+++.+|+.+|++++||||++++++|... ....+++||||+++|+|.+++.+.+.+++..++.|+.||+.||.|
T Consensus 65 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~ 144 (290)
T 1t4h_A 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHH
Confidence 456778899999999999999999999988653 345789999999999999999998899999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHHHHHHhh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmlt 160 (568)
||+++++++||||||+|||+++.++.+||+|||++............||+.|+|||++.+.++.++||||||+++|+|++
T Consensus 145 lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~ 224 (290)
T 1t4h_A 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMAT 224 (290)
T ss_dssp HHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHH
T ss_pred HHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHh
Confidence 99998789999999999999767889999999999877666666778999999999998889999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|..||....+...+...+..+..+..++...++++++||.+||. +|.+||++.++|+||||+..
T Consensus 225 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 225 SEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp SSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 99999998889999999988888877778888999999999996 69999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=341.26 Aligned_cols=215 Identities=25% Similarity=0.520 Sum_probs=189.0
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++...+++.+|+++|+.++||||+++++++... ..+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||
T Consensus 54 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH 131 (328)
T 3fe3_A 54 NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131 (328)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788899999999999999999999988654 479999999999999999999899999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccccc-CC-CccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~-~y-s~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++ .+|.+||+|||++...... .....+||+.|+|||++.+ .| +.++|||||||++|+|+
T Consensus 132 ~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 208 (328)
T 3fe3_A 132 QKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208 (328)
T ss_dssp HTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHH
T ss_pred HCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHH
Confidence 999 99999999999997 7899999999999876533 3456789999999998843 44 57999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||..||.+ .+...+...+..+... ++...++++++||.+||. +|.+|||+.|+++||||....
T Consensus 209 ~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 209 SGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred hCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999976 4567777777766433 445678999999999996 799999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=343.64 Aligned_cols=221 Identities=22% Similarity=0.452 Sum_probs=192.3
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+.+|+.++||||++++++|.+. ..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 48 ~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 125 (337)
T 1o6l_A 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 456789999999999999999999998765 479999999999999999999889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||+++... .....+.+||+.|+|||++. ..|+.++|||||||++|||++|.
T Consensus 126 --ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 202 (337)
T 1o6l_A 126 --VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp --CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred --eecCcCCHHHEEEC-CCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCC
Confidence 99999999999997 78999999999997542 23345678999999999884 56899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcccCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~~~~l 234 (568)
.||.. .+...++..+..+. ..++...++++++||.+||. +|.+|| ++.|+++||||...++..+....+
T Consensus 203 ~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~ 277 (337)
T 1o6l_A 203 LPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277 (337)
T ss_dssp CSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 99976 45666666666543 23556788999999999996 799999 899999999999988776654444
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=338.67 Aligned_cols=223 Identities=29% Similarity=0.500 Sum_probs=192.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+|+.++||||++++++|.+. ..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 49 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 126 (318)
T 1fot_A 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126 (318)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356788999999999999999999998755 479999999999999999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~P 164 (568)
|+||||||+|||++ .+|.+||+|||+++.... ...+.+||+.|+|||++ ...|+.++|||||||++|+|++|..|
T Consensus 127 --ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 202 (318)
T 1fot_A 127 --IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD-VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202 (318)
T ss_dssp --EECCCCCGGGEEEC-TTSCEEECCCSSCEECSS-CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred --ccccCCChheEEEc-CCCCEEEeecCcceecCC-ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 99999999999997 789999999999976543 34467899999999987 45689999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcccCCCCCC
Q 008378 165 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 237 (568)
Q Consensus 165 f~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~~~~l~~p 237 (568)
|... +....+..+..+. ..++...+++++++|.+||. +|.+|+ ++.++++||||+...+..+....+..|
T Consensus 203 f~~~-~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p 278 (318)
T 1fot_A 203 FYDS-NTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 278 (318)
T ss_dssp TCCS-SHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred CCCC-CHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCC
Confidence 9874 4555666665543 23456678999999999996 799999 899999999999888776655444433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=347.94 Aligned_cols=223 Identities=22% Similarity=0.409 Sum_probs=188.8
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+.+|+.+ +||||++++++|.+.. .+|+||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||++
T Consensus 66 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 143 (353)
T 3txo_A 66 DVECTMTEKRILSLARNHPFLTQLFCCFQTPD--RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143 (353)
T ss_dssp THHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCceeeEEEEEEeCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456788999999998 7999999999987654 7999999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
| |+||||||+|||++ .+|.+||+|||+++.... ....+.+||+.|+|||++ ...|+.++|||||||++|||++|
T Consensus 144 g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 220 (353)
T 3txo_A 144 G--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220 (353)
T ss_dssp T--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHS
T ss_pred C--CcccCCCHHHEEEC-CCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhC
Confidence 9 99999999999997 789999999999975432 234567899999999988 45699999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH------HHHhcCCCCCCCCCCCcccCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa------~ElL~hpff~~~~~~~l~~~~l 234 (568)
..||.. .+...++..+..+.. .++...++.+++||.+||. +|.+||++ .++++||||+..++..+....+
T Consensus 221 ~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~ 297 (353)
T 3txo_A 221 HAPFEA-ENEDDLFEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQI 297 (353)
T ss_dssp SCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcC
Confidence 999976 456677777766533 2455678999999999996 69999998 8999999999988776554444
Q ss_pred CC
Q 008378 235 RL 236 (568)
Q Consensus 235 ~~ 236 (568)
..
T Consensus 298 ~~ 299 (353)
T 3txo_A 298 EP 299 (353)
T ss_dssp CC
T ss_pred CC
Confidence 33
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=333.19 Aligned_cols=213 Identities=29% Similarity=0.515 Sum_probs=185.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+.+|+.+|+.++||||++++++|.... .+++||||+.+|+|.+++.+. .+++..++.++.||+.||.|||++|
T Consensus 61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~- 136 (297)
T 3fxz_A 61 KELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ- 136 (297)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhcCCCCCCCeEeEEEEECC--EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 467889999999999999999999987654 689999999999999999875 5999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
|+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++ ...|+.++||||||+++|+|+||..
T Consensus 137 -i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 214 (297)
T 3fxz_A 137 -VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (297)
T ss_dssp -EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -ceeCCCCHHHEEEC-CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999997 7889999999998766433 23456899999999987 4568999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||........+......+......+...++.+++||.+||. +|.+||++.|+|+||||+...
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp TTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 99876555555555555554444556678999999999996 799999999999999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.60 Aligned_cols=207 Identities=28% Similarity=0.404 Sum_probs=160.8
Q ss_pred HHHHHHHHHhCCCCCeeeeeeEEEcCCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC---
Q 008378 10 LYSEVHLLKSLKHENIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH--- 84 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNIV~l~~~~~~~~~--~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~--- 84 (568)
..+|+..+.+|+|||||++++++..... ..+|+|||||++|+|.+++++. ++++..+..++.|++.||.|||++
T Consensus 44 ~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~ 122 (303)
T 3hmm_A 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 3456777788999999999999976543 3689999999999999999874 599999999999999999999987
Q ss_pred ---CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCcccccc-------CCCcccee
Q 008378 85 ---NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDI 148 (568)
Q Consensus 85 ---g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl~~-------~ys~ksDI 148 (568)
.++||||||||+|||++ .+|.+||+|||+|+...... ....+||+.|||||++.+ .|+.++||
T Consensus 123 ~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DV 201 (303)
T 3hmm_A 123 TQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201 (303)
T ss_dssp TTCBCCEECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred ccCCCCEeeccCCcccEEEC-CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhh
Confidence 23499999999999997 78999999999998664322 234589999999998854 36789999
Q ss_pred hhhHHHHHHHhhcCCCCCC----------C----CCHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHhcC-CCCC
Q 008378 149 YSFGMCILEMVTCEYPYNE----------C----KNPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASL 208 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~----------~----~~~~~i~~~i~~~~~p~~~~~~-----~s~el~~lI~kcL~-~p~~ 208 (568)
|||||++|||+||..||.. . .....+.+.+......+.++.. ..+.+.+||.+||. +|.+
T Consensus 202 wS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~ 281 (303)
T 3hmm_A 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281 (303)
T ss_dssp HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGG
T ss_pred hhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhH
Confidence 9999999999999765532 1 1234555555444332223322 22468899999996 7999
Q ss_pred CCCHHHHhcC
Q 008378 209 RLPALELLKD 218 (568)
Q Consensus 209 Rpsa~ElL~h 218 (568)
|||+.|+++.
T Consensus 282 RPt~~ei~~~ 291 (303)
T 3hmm_A 282 RLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999998763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=349.89 Aligned_cols=225 Identities=19% Similarity=0.390 Sum_probs=189.8
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+.+.+|+.+|+++ +|||||+++++|.+. ..+|+||||+.+|+|..++.+.+.+++..++.++.||+.||.|||
T Consensus 93 ~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH 170 (396)
T 4dc2_A 93 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170 (396)
T ss_dssp ---CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44556788999999887 899999999998765 479999999999999999999899999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++ .+|.+||+|||+++... .....+.+||+.|+|||++ ...|+.++|||||||++|||+
T Consensus 171 ~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell 247 (396)
T 4dc2_A 171 ERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 247 (396)
T ss_dssp HTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred HCC--EEeccCCHHHEEEC-CCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 999 99999999999997 78999999999997532 2345567899999999987 456999999999999999999
Q ss_pred hcCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH------HHHhcCCCCCCC
Q 008378 160 TCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTD 224 (568)
Q Consensus 160 tG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa------~ElL~hpff~~~ 224 (568)
+|..||... .....++..+.... ..++...++++++||.+||+ +|.+||++ .|+++||||+..
T Consensus 248 ~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 248 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HSSCSSTTTTC------CCHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred hCCCCCcccccccccchhhHHHHHHHHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 999999642 22344666666543 23556789999999999996 79999985 799999999998
Q ss_pred CCCCcccCCCC
Q 008378 225 NPKDLVCDPLR 235 (568)
Q Consensus 225 ~~~~l~~~~l~ 235 (568)
+|..+....+.
T Consensus 326 ~w~~l~~~~~~ 336 (396)
T 4dc2_A 326 DWDMMEQKQVV 336 (396)
T ss_dssp CHHHHHTTCSC
T ss_pred CHHHHHcCCCC
Confidence 88765544443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.27 Aligned_cols=223 Identities=24% Similarity=0.435 Sum_probs=194.3
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+++|+.++||||++++++|.+. ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 84 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 161 (350)
T 1rdq_E 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161 (350)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 456789999999999999999999998764 479999999999999999999889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~P 164 (568)
|+||||||+|||++ .+|.+||+|||+++..... ..+.+||+.|+|||++ ...|+.++|||||||++|+|++|..|
T Consensus 162 --ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 237 (350)
T 1rdq_E 162 --LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp --EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred --cccccCccceEEEC-CCCCEEEcccccceeccCC-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCC
Confidence 99999999999997 7899999999999866433 3466899999999987 45689999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCCCCCC
Q 008378 165 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 237 (568)
Q Consensus 165 f~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~l~~p 237 (568)
|.. .+...++..+..+.. .++...+++++++|.+||. +|.+||+ +.++++||||...++..+.......|
T Consensus 238 f~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p 313 (350)
T 1rdq_E 238 FFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313 (350)
T ss_dssp SCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred CCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCC
Confidence 986 456777777776643 3456678999999999996 7999998 99999999999888766554444433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.39 Aligned_cols=223 Identities=19% Similarity=0.396 Sum_probs=190.4
Q ss_pred CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
..+..+.+.+|+.+|+++ +|||||+++++|.+. ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.||
T Consensus 49 ~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~L 126 (345)
T 3a8x_A 49 DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126 (345)
T ss_dssp SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 456778899999999998 899999999998765 47999999999999999999888999999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
|++| |+||||||+|||++ .+|.+||+|||+++... .....+.+||+.|+|||++. ..|+.++|||||||++|||
T Consensus 127 H~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 203 (345)
T 3a8x_A 127 HERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 203 (345)
T ss_dssp HHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred HHCC--ceecCCCHHHEEEC-CCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHH
Confidence 9999 99999999999997 78999999999997542 23345678999999999874 5689999999999999999
Q ss_pred hhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH------HHHhcCCCCCC
Q 008378 159 VTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVT 223 (568)
Q Consensus 159 ltG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa------~ElL~hpff~~ 223 (568)
++|..||... .....++..+.... ..++...++++++||.+||. +|.+||++ .++++||||+.
T Consensus 204 l~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 204 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 9999999642 23445566665543 23556788999999999996 79999995 79999999998
Q ss_pred CCCCCcccC
Q 008378 224 DNPKDLVCD 232 (568)
Q Consensus 224 ~~~~~l~~~ 232 (568)
.++..+...
T Consensus 282 ~~w~~~~~~ 290 (345)
T 3a8x_A 282 VDWDMMEQK 290 (345)
T ss_dssp CCHHHHHTT
T ss_pred CCHHHHHhC
Confidence 877554433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.03 Aligned_cols=221 Identities=24% Similarity=0.459 Sum_probs=191.6
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|..+|+.+ +||||++++++|.+. ..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 60 ~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 137 (345)
T 1xjd_A 60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137 (345)
T ss_dssp CHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356788999999987 999999999998765 47999999999999999999988999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
| |+||||||+|||++ .+|.+||+|||+++... .....+.+||+.|+|||++ ...|+.++|||||||++|||++|
T Consensus 138 ~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 214 (345)
T 1xjd_A 138 G--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214 (345)
T ss_dssp T--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred C--eEeCCCChhhEEEC-CCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcC
Confidence 9 99999999999997 78999999999997643 2334567899999999987 45689999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH-HHhcCCCCCCCCCCCcccCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL-ELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~-ElL~hpff~~~~~~~l~~~~l 234 (568)
..||.+ .+...++..+..+.. .++...++++++||.+||. +|.+||++. ++++||||+..++..+....+
T Consensus 215 ~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~ 286 (345)
T 1xjd_A 215 QSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 286 (345)
T ss_dssp SCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCS
T ss_pred CCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCC
Confidence 999976 456677777766532 3456688999999999996 799999998 999999999988766544443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=339.03 Aligned_cols=214 Identities=27% Similarity=0.463 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+.+|+.+|++++||||++++++|.+. ..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g- 135 (361)
T 2yab_A 59 REEIEREVSILRQVLHPNIITLHDVYENR--TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK- 135 (361)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCcCCCcEEEEEEeC--CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 56789999999999999999999998754 479999999999999999998889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCC----cEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 87 PIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g----~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
|+||||||+|||++ .++ .+||+|||++...... .....+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 136 -ivHrDlkp~NIll~-~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~ 213 (361)
T 2yab_A 136 -IAHFDLKPENIMLL-DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213 (361)
T ss_dssp -EECCCCSGGGEEES-CTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred -cccCCCCHHHEEEe-CCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHh
Confidence 99999999999997 444 7999999999876543 345678999999999885 469999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
|..||.+. +...+...+..+... ...+...++++++||.+||. +|.+||++.|+|+||||+...+
T Consensus 214 g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 214 GASPFLGD-TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp SCCSSCCS-SHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred CCCCCCCC-CHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 99999874 556666666655332 12335678899999999996 7999999999999999986543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.32 Aligned_cols=225 Identities=21% Similarity=0.442 Sum_probs=193.1
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+++|+.++|||||+++++|.+.. .+|+||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||++|
T Consensus 58 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g 135 (384)
T 4fr4_A 58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEE--DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR 135 (384)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3567889999999999999999999987654 79999999999999999999889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-CCcccccCCCCccCccccc----cCCCccceehhhHHHHHHHhh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGiilyEmlt 160 (568)
|+||||||+|||++ .+|.+||+|||++..... ....+.+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 136 --ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt 212 (384)
T 4fr4_A 136 --IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212 (384)
T ss_dssp --EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH
T ss_pred --ceeccCcHHHeEEC-CCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh
Confidence 99999999999997 789999999999987643 3345678999999999884 348999999999999999999
Q ss_pred cCCCCCCC--CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-HHHHhcCCCCCCCCCCCcccCCCCC
Q 008378 161 CEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-ALELLKDPFLVTDNPKDLVCDPLRL 236 (568)
Q Consensus 161 G~~Pf~~~--~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-a~ElL~hpff~~~~~~~l~~~~l~~ 236 (568)
|..||... .....+...+.... ..++...++++++||.+||. +|.+||+ +.+++.||||...++..+....+..
T Consensus 213 G~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p 290 (384)
T 4fr4_A 213 GRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290 (384)
T ss_dssp SSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred CCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCC
Confidence 99999743 34455666655543 23456678999999999996 6999998 8999999999998887765555443
Q ss_pred C
Q 008378 237 P 237 (568)
Q Consensus 237 p 237 (568)
|
T Consensus 291 ~ 291 (384)
T 4fr4_A 291 G 291 (384)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=334.22 Aligned_cols=222 Identities=25% Similarity=0.360 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+.+|+.++||||++++++|... ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+
T Consensus 62 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~ 139 (327)
T 3a62_A 62 AKDTAHTKAERNILEEVKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139 (327)
T ss_dssp ---------HHHHHHHCCCTTBCCEEEEEECS--SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34566788999999999999999999998764 4699999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++ .+|.+||+|||+++.... ......+||+.|+|||++ ...|+.++||||||+++|+|++
T Consensus 140 ~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 216 (327)
T 3a62_A 140 KG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216 (327)
T ss_dssp TT--CCCCCCCTTTEEEC-TTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred CC--EEcccCCHHHeEEC-CCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHH
Confidence 99 99999999999997 789999999999975432 234456899999999987 4568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcccCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDP 233 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~~~~ 233 (568)
|..||... +.......+..... .++...++++++||.+||. +|.+|| ++.++++||||+..++..+....
T Consensus 217 g~~pf~~~-~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~ 292 (327)
T 3a62_A 217 GAPPFTGE-NRKKTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARK 292 (327)
T ss_dssp SSCSCCCS-SHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTC
T ss_pred CCCCCCCC-CHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhcc
Confidence 99999864 45555555555432 2445678999999999996 799999 88999999999987776554433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=338.16 Aligned_cols=224 Identities=21% Similarity=0.362 Sum_probs=192.8
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|..+|+.+ +||||++++++|.+. ..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 63 ~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 140 (353)
T 2i0e_A 63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140 (353)
T ss_dssp CHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456788999999998 899999999998765 47999999999999999999888999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
| |+||||||+|||++ .+|.+||+|||+++... .....+.+||+.|+|||++ ...|+.++|||||||++|||++|
T Consensus 141 g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 217 (353)
T 2i0e_A 141 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217 (353)
T ss_dssp T--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred C--EEeccCCHHHEEEc-CCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcC
Confidence 9 99999999999997 78999999999997642 2335567899999999987 45689999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLR 235 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~l~ 235 (568)
+.||.+ .+...++..+..+.. .++...++++++||.+||. +|.+||+ +.+++.||||+..++..+....+.
T Consensus 218 ~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~ 294 (353)
T 2i0e_A 218 QAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQ 294 (353)
T ss_dssp SCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCC
Confidence 999976 456677777766532 3556788999999999996 7999994 699999999998887666544444
Q ss_pred CC
Q 008378 236 LP 237 (568)
Q Consensus 236 ~p 237 (568)
.|
T Consensus 295 ~p 296 (353)
T 2i0e_A 295 PP 296 (353)
T ss_dssp CS
T ss_pred CC
Confidence 33
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.25 Aligned_cols=213 Identities=24% Similarity=0.463 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+++.+|+++|++++||||+++++++.+.....+|+||||+++|+|.+++. .+.+++..++.++.||+.||.|||++
T Consensus 78 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp ---CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34578999999999999999999999998766678999999999999987654 45799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccccC----CCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~~~----ys~ksDIWSLGiilyEm 158 (568)
| |+||||||+|||++ .+|.+||+|||++....... .....||+.|+|||++... ++.++||||||+++|+|
T Consensus 157 ~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 157 K--IIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp T--EECCCCCGGGEEEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred C--eeccCCCHHHEEEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 9 99999999999997 78899999999998764332 3456899999999988543 37889999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
++|..||... ....+...+.....+.......++++++||.+||. +|.+||++.|+|+||||.
T Consensus 234 ~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 234 VFGQCPFMDE-RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHSSCSSCCS-SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHCCCCCCCc-cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 9999999764 45556666655543333344678999999999996 799999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=346.09 Aligned_cols=216 Identities=21% Similarity=0.390 Sum_probs=183.0
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
.+.+|+.+|+.++|||||+++++|.+. ..+|+|||||+||+|.+++++ ..+++..++.++.||+.||.|||++| |
T Consensus 115 ~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--i 189 (410)
T 3v8s_A 115 FFWEERDIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--F 189 (410)
T ss_dssp THHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--e
Confidence 478999999999999999999998764 479999999999999999976 46999999999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccccc-C----CCccceehhhHHHHHHHhh
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE-E----YNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~~-~----ys~ksDIWSLGiilyEmlt 160 (568)
+||||||+|||++ .+|.+||+|||+++...... ..+.+||+.|+|||++.. . |+.++|||||||++|||+|
T Consensus 190 vHrDLKp~NILl~-~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~ 268 (410)
T 3v8s_A 190 IHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268 (410)
T ss_dssp ECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred EeccCCHHHeeEC-CCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence 9999999999997 78999999999997664432 346789999999998843 2 7899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcCC-CCC--CCCHHHHhcCCCCCCCCCCCccc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIVP-ASL--RLPALELLKDPFLVTDNPKDLVC 231 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~~-p~~--Rpsa~ElL~hpff~~~~~~~l~~ 231 (568)
|..||.+ .+...++..+..+..... .....++++++||.+||.+ |.+ |+++.|+++||||+..++..+..
T Consensus 269 G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~ 343 (410)
T 3v8s_A 269 GDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETL 343 (410)
T ss_dssp SSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTG
T ss_pred CCCCCCC-CChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhh
Confidence 9999986 456666666655321111 2235789999999999974 666 89999999999999987765433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=345.72 Aligned_cols=215 Identities=25% Similarity=0.455 Sum_probs=186.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+.+|+.|+|||||+++++|.+. ..+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||+
T Consensus 51 ~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~ 128 (444)
T 3soa_A 51 ARDHQKLEREARICRLLKHPNIVRLHDSISEE--GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128 (444)
T ss_dssp HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45667899999999999999999999988754 4799999999999999999999999999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCCC--cccccCCCCccCcccccc-CCCccceehhhHHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEM 158 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~~-~ys~ksDIWSLGiilyEm 158 (568)
+| |+||||||+|||++. .++.+||+|||++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|
T Consensus 129 ~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel 206 (444)
T 3soa_A 129 MG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYIL 206 (444)
T ss_dssp TT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHH
Confidence 99 999999999999973 45789999999997765432 345689999999998854 699999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
++|..||.+ .+...++..+..+.. +.......++++++||.+||. +|.+||++.|+|+||||+.
T Consensus 207 l~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 207 LVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999999976 456666777766543 233345678999999999996 7999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=347.57 Aligned_cols=224 Identities=22% Similarity=0.423 Sum_probs=182.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+...++.+|+++|+.++||||++++++|.+.. .+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+
T Consensus 189 ~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~ 266 (446)
T 4ejn_A 189 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266 (446)
T ss_dssp ------------CCCCCSCTTSCCEEEEEEETT--EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 445677889999999999999999999987654 799999999999999999998999999999999999999999998
Q ss_pred -CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 84 -HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 -~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
+| |+||||||+|||++ .+|.+||+|||+++.... ......+||+.|+|||++ ...|+.++|||||||++|+|+
T Consensus 267 ~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 343 (446)
T 4ejn_A 267 EKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343 (446)
T ss_dssp HTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred cCC--EEECCCCHHHEEEC-CCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHh
Confidence 88 99999999999997 789999999999976432 234567899999999988 456999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcccCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDP 233 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~~~~ 233 (568)
+|+.||... +...+...+..... .++...++++++||.+||. +|.+|| ++.|+++||||...++..+....
T Consensus 344 ~g~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~ 420 (446)
T 4ejn_A 344 CGRLPFYNQ-DHEKLFELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKK 420 (446)
T ss_dssp HSSCSSCCS-SHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred hCCCCCCCC-CHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCc
Confidence 999999764 45566666655432 2456678999999999996 699999 99999999999988776654444
Q ss_pred CC
Q 008378 234 LR 235 (568)
Q Consensus 234 l~ 235 (568)
+.
T Consensus 421 ~~ 422 (446)
T 4ejn_A 421 LS 422 (446)
T ss_dssp SC
T ss_pred CC
Confidence 33
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.56 Aligned_cols=216 Identities=24% Similarity=0.467 Sum_probs=185.8
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+....+++.+|+.+|+.|+|||||+++++|.+. ..+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||
T Consensus 68 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH 145 (362)
T 2bdw_A 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145 (362)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356678899999999999999999999998755 478999999999999999998889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCC--CCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~--~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
++| |+||||||+|||++.. ++.+||+|||++...... .....+||+.|+|||++. ..|+.++|||||||++|+|
T Consensus 146 ~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 223 (362)
T 2bdw_A 146 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 223 (362)
T ss_dssp HTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred HCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 999 9999999999999732 356999999999776543 334568999999999885 4699999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
++|..||.+ .+...++..+..+... .......++++++||.+||. +|.+||++.++|+||||+.
T Consensus 224 l~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 224 LVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999976 4556666666665432 22234568999999999996 7999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=330.49 Aligned_cols=213 Identities=26% Similarity=0.443 Sum_probs=181.8
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+.+|+.+|+.++||||++++++|.+. ..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~- 134 (326)
T 2y0a_A 58 REDIEREVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ- 134 (326)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 57789999999999999999999998754 479999999999999999998889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCC----cEEEeecChhhhccC-CCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 87 PIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g----~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
|+||||||+|||++ .++ .+||+|||++..... .......||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 135 -ivH~Dlkp~NIll~-~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 212 (326)
T 2y0a_A 135 -IAHFDLKPENIMLL-DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212 (326)
T ss_dssp -EECCCCCGGGEEES-CSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred -eEcCCCCHHHEEEe-cCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH
Confidence 99999999999997 455 799999999987643 3345568999999999885 568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|..||.+.. .......+..... +.......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 213 g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 213 GASPFLGDT-KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp SCCSSCCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred CcCCCCCCC-HHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 999998744 4444444444322 112234568899999999996 799999999999999998644
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=346.16 Aligned_cols=217 Identities=19% Similarity=0.396 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+.+.+|+.+|+.++||||++++++|.+. ..+|+||||+.||+|.+++.+.+ .+++..++.++.||+.||.|||++|
T Consensus 105 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g 182 (412)
T 2vd5_A 105 VSCFREERDVLVNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182 (412)
T ss_dssp GCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34578999999999999999999998765 47999999999999999998754 7999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc--------cCCCccceehhhHHH
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMC 154 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~--------~~ys~ksDIWSLGii 154 (568)
|+||||||+|||++ .+|.+||+|||+++...... ....+||+.|+|||++. ..|+.++|||||||+
T Consensus 183 --iiHrDLKp~NILld-~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvi 259 (412)
T 2vd5_A 183 --YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259 (412)
T ss_dssp --EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred --eeecccCHHHeeec-CCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence 99999999999997 78999999999997764332 23468999999999885 358999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCcHHHHHHHHHhcCCCCCC---CCHHHHhcCCCCCCCCCCC
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVPASLR---LPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~~~---~~p~~~~~~~s~el~~lI~kcL~~p~~R---psa~ElL~hpff~~~~~~~ 228 (568)
+|||++|+.||.. .+...++..+... ...+......++++++||.+||.+|.+| +++.|+++||||+..+|..
T Consensus 260 lyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 260 AYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp HHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred HHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 9999999999987 4555666665542 1222234567899999999999987777 5999999999999988877
Q ss_pred c
Q 008378 229 L 229 (568)
Q Consensus 229 l 229 (568)
+
T Consensus 339 l 339 (412)
T 2vd5_A 339 L 339 (412)
T ss_dssp S
T ss_pred H
Confidence 5
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=319.99 Aligned_cols=213 Identities=25% Similarity=0.434 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
..+++.+|+++|++++||||+++++++.+. ..+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.||
T Consensus 63 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L 140 (285)
T 3is5_A 63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDY--HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140 (285)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCchHHhHHHheecC--CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 357889999999999999999999998654 479999999999999998854 36799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCC-CcccccCCCCccCccccccCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEm 158 (568)
|++| |+||||||+||+++. ..+.+||+|||++...... ......||+.|+|||++.+.++.++||||||+++|+|
T Consensus 141 H~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~l 218 (285)
T 3is5_A 141 HSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFL 218 (285)
T ss_dssp HHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHH
T ss_pred HhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHH
Confidence 9999 999999999999952 4578999999999765433 2345679999999999988899999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
++|..||.+. ....+...+...... .......++++++||.+||. +|.+||++.|+|+||||++
T Consensus 219 l~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 219 LTGCLPFTGT-SLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHSSCSSCCS-SHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HhCCCCCCCC-CHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 9999999874 445555554443322 22223468999999999996 6999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=339.67 Aligned_cols=225 Identities=25% Similarity=0.428 Sum_probs=184.6
Q ss_pred HHHHHHHHHHHH-HHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~i-Lk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+++.+|..+ ++.++|||||+++++|.+. ..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+
T Consensus 80 ~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~ 157 (373)
T 2r5t_A 80 KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 157 (373)
T ss_dssp -----------CCBCCCCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 445667788877 5788999999999998765 4799999999999999999998899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++ .+|.+||+|||+++... .....+.+||+.|+|||++ ...|+.++|||||||++|||++
T Consensus 158 ~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 234 (373)
T 2r5t_A 158 LN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234 (373)
T ss_dssp TT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred CC--ceecCCCHHHEEEC-CCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHc
Confidence 99 99999999999997 78999999999998643 2345567899999999987 4569999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH----HHHhcCCCCCCCCCCCcccCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELLKDPFLVTDNPKDLVCDPLR 235 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa----~ElL~hpff~~~~~~~l~~~~l~ 235 (568)
|..||.. .+...++..+.... ..++...++++++||.+||+ +|.+||++ .+++.||||+..+|..+....+.
T Consensus 235 G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~ 311 (373)
T 2r5t_A 235 GLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKIT 311 (373)
T ss_dssp SSCTTCC-SBHHHHHHHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCCC-CCHHHHHHHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCC
Confidence 9999976 45667777776542 33556678999999999996 79999986 69999999999888776555444
Q ss_pred CC
Q 008378 236 LP 237 (568)
Q Consensus 236 ~p 237 (568)
.|
T Consensus 312 pp 313 (373)
T 2r5t_A 312 PP 313 (373)
T ss_dssp CS
T ss_pred CC
Confidence 33
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=320.10 Aligned_cols=215 Identities=23% Similarity=0.405 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+|++++||||+++++++.+. ..+++||||+.++.+..+....+.+++..++.++.||+.||.|||++
T Consensus 43 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 120 (292)
T 3o0g_A 43 GVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120 (292)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4557889999999999999999999998765 47999999998654454555567899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc-C-CCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~-~-ys~ksDIWSLGiilyEmlt 160 (568)
| |+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++.+ . |+.++|||||||++|+|++
T Consensus 121 ~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 197 (292)
T 3o0g_A 121 N--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_dssp T--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred C--eecCCCCHHHEEEc-CCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHH
Confidence 9 99999999999997 7899999999999876432 3345689999999998743 3 8999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcC--CCC-C------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 161 CEYPYNECKNPAQIYKKVTSG--IKP-A------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~--~~p-~------------------------~~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
|..||....+.......+... .++ . ......++++++||.+||+ +|.+|||+
T Consensus 198 ~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 277 (292)
T 3o0g_A 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277 (292)
T ss_dssp TSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred cCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH
Confidence 998876656665555554321 000 0 1122467899999999996 79999999
Q ss_pred HHHhcCCCCCCC
Q 008378 213 LELLKDPFLVTD 224 (568)
Q Consensus 213 ~ElL~hpff~~~ 224 (568)
.|+|+||||+..
T Consensus 278 ~e~l~hp~f~~~ 289 (292)
T 3o0g_A 278 EEALQHPYFSDF 289 (292)
T ss_dssp HHHHTSGGGTTC
T ss_pred HHHhcCcccccC
Confidence 999999999853
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=330.95 Aligned_cols=216 Identities=26% Similarity=0.410 Sum_probs=182.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+++.++||||+++++++.+. ..+|+|||||.+|+|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 48 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g 125 (323)
T 3tki_A 48 CPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125 (323)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346788999999999999999999988754 478999999999999999988888999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccccc-C-CCccceehhhHHHHHHHh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMV 159 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~~-~-ys~ksDIWSLGiilyEml 159 (568)
|+||||||+|||++ .++.+||+|||++..+... .....+||+.|+|||++.+ . ++.++|||||||++|+|+
T Consensus 126 --ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 202 (323)
T 3tki_A 126 --ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202 (323)
T ss_dssp --EECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred --ccccccchHHEEEe-CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHH
Confidence 99999999999997 7789999999999765322 2345689999999998843 3 477899999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
+|..||.........+................++.+++||.+||. +|.+||++.|+++||||+....
T Consensus 203 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 203 AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred hCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 999999876655555555554444333345678999999999996 7999999999999999986543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.62 Aligned_cols=219 Identities=21% Similarity=0.439 Sum_probs=178.4
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~y 80 (568)
+.+..+.+.+|+.+|+.++|||||+++++|.+.. .+|+|||||.+|+|.+++... +.+++..++.++.||+.||.|
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~ 143 (389)
T 3gni_B 66 SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143 (389)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC--EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 3566788999999999999999999999997654 799999999999999999876 679999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC---------CCcccccCCCCccCcccccc---CCCcccee
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---------PTARSVIGTPEFMAPELYEE---EYNELVDI 148 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~---------~~~~s~~GTp~YmAPEvl~~---~ys~ksDI 148 (568)
||++| |+||||||+|||++ .+|.+||+|||++..... ......+||+.|+|||++.+ .|+.++||
T Consensus 144 LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 220 (389)
T 3gni_B 144 IHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 220 (389)
T ss_dssp HHHTT--EECCCCSGGGEEEC-TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHH
T ss_pred HHhCC--eecCCCCHHHEEEc-CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHH
Confidence 99999 99999999999997 789999999998864321 12233579999999998854 58999999
Q ss_pred hhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-------------------------------------------CC
Q 008378 149 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-------------------------------------------PA 185 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~-------------------------------------------p~ 185 (568)
|||||++|+|++|+.||.+......+...+....+ ..
T Consensus 221 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (389)
T 3gni_B 221 YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSH 300 (389)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------------------------------------------
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCC
Confidence 99999999999999999876555444433221110 11
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 186 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 186 ~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
.++...++++++||.+||+ +|.+|||+.|+|+||||+....
T Consensus 301 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 301 PYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp -----CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred ccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 1334568899999999996 7999999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=345.33 Aligned_cols=215 Identities=20% Similarity=0.410 Sum_probs=182.8
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
.+.+|+.+|+.++||||++++++|.+. ..+|+|||||.+|+|.+++.+ .+.+++..++.|+.||+.||.|||++|
T Consensus 120 ~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-- 195 (437)
T 4aw2_A 120 CFREERDVLVNGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH-- 195 (437)
T ss_dssp CHHHHHHHHHHSCTTTBCCEEEEEECS--SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEeeC--CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 378999999999999999999998765 479999999999999999987 478999999999999999999999999
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc------cCCCccceehhhHHHHHHH
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~------~~ys~ksDIWSLGiilyEm 158 (568)
|+||||||+|||++ .+|.+||+|||+++...... ....+||+.|+|||++. ..|+.++|||||||++|||
T Consensus 196 iiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~el 274 (437)
T 4aw2_A 196 YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274 (437)
T ss_dssp EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHH
T ss_pred eEecccCHHHeeEc-CCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHH
Confidence 99999999999997 78999999999997654322 23468999999999874 3589999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCcHHHHHHHHHhcCC-CCC--CCCHHHHhcCCCCCCCCCCCc
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-ASL--RLPALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~---~~p~~~~~~~s~el~~lI~kcL~~-p~~--Rpsa~ElL~hpff~~~~~~~l 229 (568)
++|+.||.+ .+..+.+..+... ...+......++++++||.+||.. |.+ |+++.|+++||||+..+|..+
T Consensus 275 ltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 275 LYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp HHSSCTTCC-SSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred HhCCCCCCC-CChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 999999986 4556666665432 122222345789999999999963 444 899999999999999988776
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=332.18 Aligned_cols=215 Identities=22% Similarity=0.361 Sum_probs=183.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+.+.+|+.+|+.++||||++++++|.+.. .+++|||||++|+|.+++...+ .+++..++.++.||+.||.|||+
T Consensus 43 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~ 120 (321)
T 1tki_A 43 TDQVLVKKEISILNIARHRNILHLHESFESME--ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120 (321)
T ss_dssp HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC--EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45667899999999999999999999987654 7999999999999999998654 79999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCC-CCcEEEeecChhhhccCC-CcccccCCCCccCcccccc-CCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~-~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~-~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++.. ++.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++
T Consensus 121 ~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 198 (321)
T 1tki_A 121 HN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198 (321)
T ss_dssp TT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH
T ss_pred CC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 99 9999999999999732 789999999999876443 2345679999999998854 47999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|..||... +...+...+..+.... ......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 199 g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 199 GINPFLAE-TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SSCTTCCS-SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCCcCC-CHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 99999874 4555666665543321 1224568899999999996 69999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.66 Aligned_cols=215 Identities=25% Similarity=0.416 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+++|++++||||+++++++.+. ..+++||||+. |+|.+++... ..+++..++.++.||+.||.|||++
T Consensus 62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 138 (311)
T 3niz_A 62 IPSTAIREISLLKELHHPNIVSLIDVIHSE--RCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCS--SCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHcCCCCEeeeeeEEccC--CEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356788999999999999999999988654 47999999998 4788777765 4599999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmlt 160 (568)
| |+||||||+|||++ .+|.+||+|||+++..... ......||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 139 ~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 215 (311)
T 3niz_A 139 R--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215 (311)
T ss_dssp T--EECCCCCGGGEEEC-TTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred C--cccCCCchHhEEEC-CCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh
Confidence 9 99999999999997 7889999999999876432 234457999999999874 458999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHH--cCCCCCCC-------------------------CCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 161 CEYPYNECKNPAQIYKKVT--SGIKPASL-------------------------SKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~--~~~~p~~~-------------------------~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
|+.||.+......+..... ....+..+ ....++++++||.+||. +|.+|||+
T Consensus 216 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 295 (311)
T 3niz_A 216 GKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295 (311)
T ss_dssp SSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH
T ss_pred CCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH
Confidence 9999987665554443332 11111111 12356899999999996 79999999
Q ss_pred HHHhcCCCCCCCCC
Q 008378 213 LELLKDPFLVTDNP 226 (568)
Q Consensus 213 ~ElL~hpff~~~~~ 226 (568)
.|+|+||||+..++
T Consensus 296 ~ell~hp~f~~~~~ 309 (311)
T 3niz_A 296 RDAMNHPYFKDLDP 309 (311)
T ss_dssp HHHHTSGGGTTSCT
T ss_pred HHHhcCcccccCCc
Confidence 99999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.76 Aligned_cols=218 Identities=22% Similarity=0.385 Sum_probs=180.1
Q ss_pred CCHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 2 QSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
++....+++.+|+.+|+.+. |||||+++++|...+...+|+|||||. |+|..++.. +.+++..++.++.||+.||+|
T Consensus 47 ~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~ 124 (388)
T 3oz6_A 47 QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKY 124 (388)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence 35677888999999999997 999999999998776668999999997 689998886 579999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-----------------------CCcccccCCCCccCccc
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-----------------------PTARSVIGTPEFMAPEL 137 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-----------------------~~~~s~~GTp~YmAPEv 137 (568)
||++| |+||||||+|||++ .+|.+||+|||+++.... ......+||++|+|||+
T Consensus 125 LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 201 (388)
T 3oz6_A 125 LHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEI 201 (388)
T ss_dssp HHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHH
T ss_pred HHhCC--EEeCCCCHHHeEEc-CCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHH
Confidence 99999 99999999999997 789999999999975422 11234689999999998
Q ss_pred cc--cCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC------------------------------
Q 008378 138 YE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA------------------------------ 185 (568)
Q Consensus 138 l~--~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~------------------------------ 185 (568)
+. ..|+.++|||||||++|||++|+.||.+.....++...+.....|.
T Consensus 202 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (388)
T 3oz6_A 202 LLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNK 281 (388)
T ss_dssp HTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----C
T ss_pred hcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCH
Confidence 74 4689999999999999999999999987655554444332111110
Q ss_pred --------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 186 --------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 186 --------------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
......++++++||.+||+ +|.+|||+.|+|+||||...
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 282 RDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 0112457899999999997 79999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=319.07 Aligned_cols=212 Identities=26% Similarity=0.431 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+.+.+|+++|++++||||+++++++.+. ..+++||||+.+ +|.+++... +.+++..++.++.||+.||.|||++|
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (288)
T 1ob3_A 44 PSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120 (288)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 36788999999999999999999998765 468999999985 999988865 67999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhc
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG 161 (568)
|+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..|+.++|||||||++|+|+||
T Consensus 121 --i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (288)
T 1ob3_A 121 --VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (288)
T ss_dssp --CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred --eecCCCCHHHEEEc-CCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999997 7899999999999876432 234457999999999874 3589999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHc-CCC-CC------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 008378 162 EYPYNECKNPAQIYKKVTS-GIK-PA------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALE 214 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~-~~~-p~------------------------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~E 214 (568)
..||.+......+...+.. +.. .. ......++++++||.+||. +|.+||++.|
T Consensus 198 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 277 (288)
T 1ob3_A 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (288)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 9999876554444433321 000 00 1123467899999999996 7999999999
Q ss_pred HhcCCCCCCC
Q 008378 215 LLKDPFLVTD 224 (568)
Q Consensus 215 lL~hpff~~~ 224 (568)
+|+||||+..
T Consensus 278 ~l~hp~f~~~ 287 (288)
T 1ob3_A 278 ALEHAYFKEN 287 (288)
T ss_dssp HHTSGGGGC-
T ss_pred HhcCcchhhc
Confidence 9999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.39 Aligned_cols=215 Identities=24% Similarity=0.441 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
+.+.+|+.+++.++||||++++++|.+. ..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 61 ~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~-- 136 (361)
T 3uc3_A 61 ENVQREIINHRSLRHPNIVRFKEVILTP--THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ-- 136 (361)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEeeC--CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5688999999999999999999998765 479999999999999999998889999999999999999999999999
Q ss_pred eEeeeccCCcEEEeCC-CCcEEEeecChhhhccC-CCcccccCCCCccCcccc-ccCCCcc-ceehhhHHHHHHHhhcCC
Q 008378 88 IIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELY-EEEYNEL-VDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 88 IiHRDLKp~NILl~~~-~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl-~~~ys~k-sDIWSLGiilyEmltG~~ 163 (568)
|+||||||+|||++.. .+.+||+|||+++.... ......+||+.|+|||++ ...++.+ +|||||||++|+|++|+.
T Consensus 137 ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 216 (361)
T 3uc3_A 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAY 216 (361)
T ss_dssp CCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCC
Confidence 9999999999999732 23599999999975432 334556899999999987 4456555 899999999999999999
Q ss_pred CCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 164 PYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 164 Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
||..... ...+...+.............++++++||.+||+ +|.+|||+.|+++||||....+
T Consensus 217 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 217 PFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp SCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred CCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 9976433 2344444444433322333568999999999996 7999999999999999976543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.68 Aligned_cols=213 Identities=24% Similarity=0.433 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+++|++++||||+++++++.+. ..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 126 (277)
T 3f3z_A 49 DVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126 (277)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 357889999999999999999999998754 479999999999999999998889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEe--CCCCcEEEeecChhhhccCC-CcccccCCCCccCccccccCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~--~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||++. ..++.+||+|||++...... ......||+.|+|||++.+.++.++||||||+++|+|++|.
T Consensus 127 --i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (277)
T 3f3z_A 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGY 204 (277)
T ss_dssp --EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSS
T ss_pred --ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCC
Confidence 99999999999992 26789999999999766433 34566899999999999888999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
.||... ........+..+..+.. .....++.+++||.+||. +|.+||++.++|+||||+.
T Consensus 205 ~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 205 PPFSAP-TDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp CSSCCS-SHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred CCCCCC-CHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 999874 44555555555433211 123568899999999996 6999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.77 Aligned_cols=216 Identities=30% Similarity=0.493 Sum_probs=188.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+|++++|||||+++++|.+. ..+|+|||||.+|+|.+++...+.+++..++.++.||+.||.|||++
T Consensus 68 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 145 (484)
T 3nyv_A 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145 (484)
T ss_dssp SCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3467899999999999999999999998754 47999999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEe--CCCCcEEEeecChhhhccCC-CcccccCCCCccCccccccCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~--~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG 161 (568)
| |+||||||+|||++ ..++.+||+|||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|
T Consensus 146 ~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g 223 (484)
T 3nyv_A 146 K--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 223 (484)
T ss_dssp T--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHS
T ss_pred C--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHC
Confidence 9 99999999999995 25689999999999877543 3345689999999999988899999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
..||.+ .+...+...+..+..... .+...++++++||.+||+ +|.+|||+.|+|.||||+...
T Consensus 224 ~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 224 CPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp SCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 999987 456666667766543322 234578999999999997 699999999999999998644
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=342.57 Aligned_cols=215 Identities=31% Similarity=0.528 Sum_probs=185.7
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+++|++++|||||++++++.+. ..+|+|||||.+|+|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 64 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 141 (486)
T 3mwu_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141 (486)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEEcC--CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356789999999999999999999988754 479999999999999999988889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCC-CcccccCCCCccCccccccCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++. .++.+||+|||+++..... .....+||+.|+|||++.+.|+.++|||||||++|+|++|.
T Consensus 142 --ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~ 219 (486)
T 3mwu_A 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGT 219 (486)
T ss_dssp --CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred --eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999962 4568999999999876543 34556899999999999888999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||.+ .+...+...+..+..+.. .....++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 220 ~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 220 PPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp CSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99987 456666666666544322 234568999999999996 799999999999999998644
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=325.58 Aligned_cols=215 Identities=25% Similarity=0.452 Sum_probs=182.3
Q ss_pred CHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~H--pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+....+.+.+|+.+|+.++| |||+++++++... ..+++||| +.+|+|.+++.+.+.+++..++.++.||+.||.|
T Consensus 47 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~ 123 (343)
T 3dbq_A 47 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123 (343)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence 45667889999999999987 9999999988754 47999999 5578999999999999999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc------------cCCCc
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE------------EEYNE 144 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~------------~~ys~ 144 (568)
||++| |+||||||+|||++ +|.+||+|||+++...... ....+||+.|+|||++. ..|+.
T Consensus 124 lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~ 199 (343)
T 3dbq_A 124 IHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 199 (343)
T ss_dssp HHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCH
T ss_pred HHhCC--eecCCCCcceEEEE--CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCc
Confidence 99999 99999999999996 5899999999998664322 23568999999999874 45889
Q ss_pred cceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 145 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 145 ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
++|||||||++|+|++|..||....+.......+........++...++++++||.+||. +|.+||++.|+|+||||+.
T Consensus 200 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 200 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred hhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 999999999999999999999876666555666665555556777788999999999996 6999999999999999985
Q ss_pred C
Q 008378 224 D 224 (568)
Q Consensus 224 ~ 224 (568)
.
T Consensus 280 ~ 280 (343)
T 3dbq_A 280 Q 280 (343)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.27 Aligned_cols=219 Identities=24% Similarity=0.466 Sum_probs=186.0
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+....+++.+|+.++++++||||+++++++.+. ...++||||+.+|+|.+++...+.+++..+..++.||+.||.|||
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 122 (284)
T 3kk8_A 45 SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122 (284)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456678899999999999999999999988654 478999999999999999998889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCCC-cccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
++| |+||||||+||+++. ..+.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|
T Consensus 123 ~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 200 (284)
T 3kk8_A 123 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 200 (284)
T ss_dssp HTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred HCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHH
Confidence 999 999999999999962 23459999999997665433 34568999999999874 4589999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
++|..||... +...+...+..+.. +.......++++++||.+||. +|.+||++.|+|+||||+....
T Consensus 201 ~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 201 LVGYPPFWDE-DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHCCCCCCCC-chhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999774 45556666555433 223335678999999999996 6999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=323.19 Aligned_cols=213 Identities=31% Similarity=0.595 Sum_probs=182.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+|+.++||||++++++|.... .+++||||+.+|+|.+++.+ ..+++..+..++.||+.||.|||++|
T Consensus 85 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ 161 (321)
T 2c30_A 85 RRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG 161 (321)
T ss_dssp SHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567899999999999999999999987654 79999999999999998875 56999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..|+.++||||||+++|+|++|+
T Consensus 162 --ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 238 (321)
T 2c30_A 162 --VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238 (321)
T ss_dssp --EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --eecCCCCHHHEEEC-CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999997 7889999999999766433 334568999999999884 55899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||... ........+.....+. ......++.+++||.+||. +|.+||++.++++||||....
T Consensus 239 ~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 239 PPYFSD-SPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp CTTTTS-CHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred CCCCCC-CHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 999764 4555566665554432 2233568899999999996 799999999999999998644
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=329.07 Aligned_cols=216 Identities=25% Similarity=0.425 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+|++++||||++++++|.+. ..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 168 (349)
T 2w4o_A 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168 (349)
T ss_dssp --------CHHHHHCCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 456788999999999999999999998754 479999999999999999998888999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 86 PPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
|+||||||+|||++. .++.+||+|||+++..... ......||+.|+|||++. ..|+.++|||||||++|+|++|
T Consensus 169 --ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 246 (349)
T 2w4o_A 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246 (349)
T ss_dssp --CCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred --eEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 999999999999962 3789999999999876443 234568999999999885 4689999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
..||........+...+..+... ..+....++++++||.+||. +|.+||++.++|+||||....
T Consensus 247 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp SCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred CCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99998877777677777665332 23345678999999999996 799999999999999998644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=324.84 Aligned_cols=217 Identities=26% Similarity=0.387 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+|++++||||+++++++.+.. .+++||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~ 151 (329)
T 3gbz_A 75 GVPGTAIREVSLLKELQHRNIIELKSVIHHNH--RLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151 (329)
T ss_dssp -----CHHHHHHGGGCCCTTBCCEEEEEEETT--EEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccchhHHHHHHHHHHcCCCCcceEEEEEecCC--EEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34567789999999999999999999987654 7999999998 59999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEe----CCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc--CCCccceehhhHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCIL 156 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~----~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiily 156 (568)
| |+||||||+|||++ ...+.+||+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|
T Consensus 152 ~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 229 (329)
T 3gbz_A 152 R--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWA 229 (329)
T ss_dssp T--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred C--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHH
Confidence 9 99999999999995 24456999999999876533 2345578999999998843 4899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCC--CCC-------------------------CCCcHHHHHHHHHhcC-CCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLS-------------------------KVTDPQVKQFIEKCIV-PASL 208 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~-------------------------~~~s~el~~lI~kcL~-~p~~ 208 (568)
+|++|..||........+.+.+.....|. .++ ...++++++||.+||. +|.+
T Consensus 230 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 309 (329)
T 3gbz_A 230 EMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVK 309 (329)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhh
Confidence 99999999987665555554443211111 010 1157899999999996 7999
Q ss_pred CCCHHHHhcCCCCCCCCC
Q 008378 209 RLPALELLKDPFLVTDNP 226 (568)
Q Consensus 209 Rpsa~ElL~hpff~~~~~ 226 (568)
|||+.|+|+||||+..++
T Consensus 310 R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 310 RISAKNALEHPYFSHNDF 327 (329)
T ss_dssp SCCHHHHHTSGGGSSSCS
T ss_pred CCCHHHHhCCcccCCCCC
Confidence 999999999999997664
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.83 Aligned_cols=218 Identities=27% Similarity=0.497 Sum_probs=183.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++...+++.+|+.+|++++||||+++++++.+. ..+++||||+++|+|.+++.+.+.+++..+..++.||+.||.|||
T Consensus 71 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh 148 (360)
T 3eqc_A 71 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148 (360)
T ss_dssp CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356678899999999999999999999998765 479999999999999999999889999999999999999999999
Q ss_pred hC-CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 83 SH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 83 s~-g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
+. | |+||||||+|||++ .+|.+||+|||++............||+.|+|||++. ..|+.++||||||+++|+|+|
T Consensus 149 ~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 225 (360)
T 3eqc_A 149 EKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225 (360)
T ss_dssp HHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHH
T ss_pred HhCC--EEcCCccHHHEEEC-CCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 85 8 99999999999997 7889999999999876555556678999999999874 568999999999999999999
Q ss_pred cCCCCCCCCCHHH------------------------------------------HHHHHHcCCCCCCCCCCCcHHHHHH
Q 008378 161 CEYPYNECKNPAQ------------------------------------------IYKKVTSGIKPASLSKVTDPQVKQF 198 (568)
Q Consensus 161 G~~Pf~~~~~~~~------------------------------------------i~~~i~~~~~p~~~~~~~s~el~~l 198 (568)
|..||.... ... ....+.....+.......++++++|
T Consensus 226 g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (360)
T 3eqc_A 226 GRYPIPPPD-AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 304 (360)
T ss_dssp TSCCSSCCC-HHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHH
T ss_pred CCCCCCCCC-HHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHH
Confidence 999997633 222 2223333334444445578899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 199 IEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 199 I~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
|.+||. +|.+|||+.|+|+||||+....
T Consensus 305 i~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 305 VNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp HHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 999996 7999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=332.53 Aligned_cols=215 Identities=24% Similarity=0.448 Sum_probs=183.6
Q ss_pred CHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~--HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+.+..+++.+|+.+|+.|+ |||||++++++.... .+|+||| +.+++|.+++.+.+.+++..++.++.||+.||.|
T Consensus 94 ~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~--~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~ 170 (390)
T 2zmd_A 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170 (390)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC--EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence 3567788999999999996 599999999887654 6999999 5678999999998999999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccccc------------CCCc
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE------------EYNE 144 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~~------------~ys~ 144 (568)
||++| |+||||||+|||++ ++.+||+|||+++.+.... ....+||+.|+|||++.. .|+.
T Consensus 171 lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~ 246 (390)
T 2zmd_A 171 IHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246 (390)
T ss_dssp HHTTT--CCCCCCCGGGEEES--SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCH
T ss_pred HHHCC--eeecCCCHHHEEEE--CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCC
Confidence 99999 99999999999995 5899999999998764322 345689999999998743 5899
Q ss_pred cceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 145 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 145 ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
++|||||||++|+|++|..||....+.......+........++...++++++||.+||. +|.+||++.|+|+||||+.
T Consensus 247 ~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 247 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred hhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 999999999999999999999876666555666665555555666778999999999996 7999999999999999985
Q ss_pred C
Q 008378 224 D 224 (568)
Q Consensus 224 ~ 224 (568)
.
T Consensus 327 ~ 327 (390)
T 2zmd_A 327 Q 327 (390)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=337.44 Aligned_cols=222 Identities=23% Similarity=0.357 Sum_probs=173.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~---~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
+....+++.+|+.+|+.|+|||||+++++|.... ...+|+||||+. |+|.+++...+.+++..++.++.||+.||.
T Consensus 92 ~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~ 170 (458)
T 3rp9_A 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVK 170 (458)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999999886543 257999999985 799999999889999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----------------------------CcccccCCC
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------------------TARSVIGTP 130 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----------------------------~~~s~~GTp 130 (568)
|||++| |+||||||+|||++ .+|.+||+|||+++..... .....+||+
T Consensus 171 ~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 247 (458)
T 3rp9_A 171 YVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTR 247 (458)
T ss_dssp HHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCC
T ss_pred HHHhCC--cCCCCCChhhEEEC-CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccc
Confidence 999999 99999999999997 7889999999999765321 123458999
Q ss_pred CccCcccc--ccCCCccceehhhHHHHHHHhh-----------cCCCCCCCCC--------------------HHHHHHH
Q 008378 131 EFMAPELY--EEEYNELVDIYSFGMCILEMVT-----------CEYPYNECKN--------------------PAQIYKK 177 (568)
Q Consensus 131 ~YmAPEvl--~~~ys~ksDIWSLGiilyEmlt-----------G~~Pf~~~~~--------------------~~~i~~~ 177 (568)
+|+|||++ ...|+.++||||||||+|||+| |..+|.+... ..++...
T Consensus 248 ~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i 327 (458)
T 3rp9_A 248 WYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVI 327 (458)
T ss_dssp TTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHH
T ss_pred cccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHH
Confidence 99999975 4569999999999999999999 6666654321 1111111
Q ss_pred HH----------------------cCCC---C---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCCC
Q 008378 178 VT----------------------SGIK---P---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 178 i~----------------------~~~~---p---~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~~ 228 (568)
+. ...+ . .......++++++||.+||+ +|.+|||+.|+|+||||+...+..
T Consensus 328 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 328 FNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 10 0000 0 01123458899999999996 799999999999999999866543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.68 Aligned_cols=211 Identities=26% Similarity=0.472 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+.+.+|+.+|+.++||||++++++|.+. ..+|+|||||++|+|.+++.+. ..+++..++.++.||+.||.|||
T Consensus 70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH 147 (351)
T 3c0i_A 70 TEDLKREASICHMLKHPHIVELLETYSSD--GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147 (351)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 57789999999999999999999998765 4799999999999998877643 35899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
++| |+||||||+|||++. ..+.+||+|||++....... ....+||+.|+|||++. ..|+.++|||||||++|+
T Consensus 148 ~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 225 (351)
T 3c0i_A 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225 (351)
T ss_dssp HTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HCC--ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHH
Confidence 999 999999999999973 23459999999997765432 34568999999999884 558999999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|++|..||.+ ....++..+..+..... .....++++++||.+||. +|.+||++.++|+||||+.
T Consensus 226 ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 226 LLSGCLPFYG--TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHCCCCCCC--cHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 9999999976 34556666655433221 124568899999999996 7999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=319.59 Aligned_cols=216 Identities=23% Similarity=0.390 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+++.+|+++|+++ +||||+++++++.+. ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 53 ~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 130 (316)
T 2ac3_A 53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130 (316)
T ss_dssp CHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 356789999999995 799999999998765 47999999999999999999888999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCc---EEEeecChhhhccCC---------CcccccCCCCccCccccc------cCCCccc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGE---VKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE------EEYNELV 146 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~---vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl~------~~ys~ks 146 (568)
| |+||||||+|||++ .++. +||+|||++...... .....+||+.|+|||++. ..|+.++
T Consensus 131 ~--ivH~dlkp~Nil~~-~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 207 (316)
T 2ac3_A 131 G--IAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRC 207 (316)
T ss_dssp T--CCCCCCCGGGEEES-CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTH
T ss_pred C--ceeCCCCHHHEEEc-cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCccc
Confidence 9 99999999999997 4443 999999998754321 123456999999999884 3589999
Q ss_pred eehhhHHHHHHHhhcCCCCCCCCC--------------HHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCC
Q 008378 147 DIYSFGMCILEMVTCEYPYNECKN--------------PAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 147 DIWSLGiilyEmltG~~Pf~~~~~--------------~~~i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~-~p~~R 209 (568)
|||||||++|+|++|..||..... ...+...+..+..... .....++.+++||.+||. +|.+|
T Consensus 208 DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 287 (316)
T 2ac3_A 208 DLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQR 287 (316)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred ccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhC
Confidence 999999999999999999976432 2345566655533211 113467899999999996 79999
Q ss_pred CCHHHHhcCCCCCCCCC
Q 008378 210 LPALELLKDPFLVTDNP 226 (568)
Q Consensus 210 psa~ElL~hpff~~~~~ 226 (568)
|++.|+|+||||+...+
T Consensus 288 ps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 288 LSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp CCHHHHHHSTTCC----
T ss_pred CCHHHHhcChhhcCCCC
Confidence 99999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=315.14 Aligned_cols=211 Identities=24% Similarity=0.462 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+.+|+.+++.++||||++++++|.+. ..+++||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++|
T Consensus 53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~- 129 (279)
T 3fdn_A 53 EHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 129 (279)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHHHHHHHHHHHcCCCCCCcchhheEecC--CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45688999999999999999999998755 479999999999999999998889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCCCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY 165 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~Pf 165 (568)
|+||||||+||+++ .+|.+||+|||++............||+.|+|||++. ..++.++||||||+++|+|++|..||
T Consensus 130 -i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 207 (279)
T 3fdn_A 130 -VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207 (279)
T ss_dssp -CEECCCCGGGEEEC-TTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred -EecccCChHhEEEc-CCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC
Confidence 99999999999997 7899999999998766555556678999999999874 45789999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 166 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 166 ~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.. .+.......+..... .++...++.+++||.+||. +|.+||++.|+++||||+...
T Consensus 208 ~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 208 EA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp CC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred CC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 76 455566666655432 2455678999999999996 699999999999999998643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.82 Aligned_cols=210 Identities=29% Similarity=0.519 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+++.+|+.+|+.++||||+++++++... ..+++||||+ +|+|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g- 128 (336)
T 3h4j_B 53 HMRVEREISYLKLLRHPHIIKLYDVITTP--TDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK- 128 (336)
T ss_dssp SHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 35789999999999999999999998765 4799999999 6899999998899999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccccC-C-CccceehhhHHHHHHHhhcCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~-y-s~ksDIWSLGiilyEmltG~~ 163 (568)
|+||||||+|||++ .++.+||+|||++...... .....+||+.|+|||++.+. | +.++||||||+++|+|++|..
T Consensus 129 -ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 206 (336)
T 3h4j_B 129 -IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206 (336)
T ss_dssp -CCCCCCSTTTEEEC-TTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSC
T ss_pred -eEecCCchhhEEEc-CCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCC
Confidence 99999999999997 7889999999999876543 34566899999999988543 4 789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||.+... ..+.+.+..+ ...++...++++++||.+||. +|.+|||+.|+++||||+...
T Consensus 207 Pf~~~~~-~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 207 PFDDEFI-PNLFKKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp SSBCSSS-TTCBCCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred CCCCccH-HHHHHHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 9976432 2222222222 223455678999999999996 799999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=341.42 Aligned_cols=214 Identities=28% Similarity=0.494 Sum_probs=186.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+|+.++|||||+++++|.+. ..+|+|||||.+|+|.+++.+...+++..++.++.||+.||.|||++|
T Consensus 79 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 156 (494)
T 3lij_A 79 SNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156 (494)
T ss_dssp TTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356789999999999999999999998754 479999999999999999998889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCC-CcccccCCCCccCccccccCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++. ..+.+||+|||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|.
T Consensus 157 --ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~ 234 (494)
T 3lij_A 157 --IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGY 234 (494)
T ss_dssp --EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCC
Confidence 999999999999963 2456999999999776543 34566899999999999888999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
.||.+ .....+...+..+..+. ......++.+++||.+||+ +|.+|||+.++|+||||+..
T Consensus 235 ~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 235 PPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp CSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99987 45566666666654332 2335678999999999996 79999999999999999763
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=331.64 Aligned_cols=222 Identities=24% Similarity=0.331 Sum_probs=174.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~---~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
+....+++.+|+++|+.++||||+++++++..... ..+|+||||+. |+|.++++..+.+++..++.++.||+.||.
T Consensus 65 ~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~ 143 (432)
T 3n9x_A 65 DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143 (432)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHH
Confidence 45677899999999999999999999998876532 46999999997 699999999888999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------------------------CcccccCCCCccCc
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------------------------TARSVIGTPEFMAP 135 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------------------------~~~s~~GTp~YmAP 135 (568)
|||++| |+||||||+|||++ .+|.+||+|||+++..... .....+||++|+||
T Consensus 144 ~LH~~g--ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 220 (432)
T 3n9x_A 144 FIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220 (432)
T ss_dssp HHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCH
T ss_pred HHHHCC--CCCCCCCHHHeEEC-CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCH
Confidence 999999 99999999999997 7899999999999765322 12567899999999
Q ss_pred ccc--ccCCCccceehhhHHHHHHHhhcCCCC-----------CCCCC-----------------HHHHH----------
Q 008378 136 ELY--EEEYNELVDIYSFGMCILEMVTCEYPY-----------NECKN-----------------PAQIY---------- 175 (568)
Q Consensus 136 Evl--~~~ys~ksDIWSLGiilyEmltG~~Pf-----------~~~~~-----------------~~~i~---------- 175 (568)
|++ ...|+.++|||||||++|||++|..|| .+... ..++.
T Consensus 221 E~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~ 300 (432)
T 3n9x_A 221 ELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT 300 (432)
T ss_dssp HHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCC
T ss_pred HHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCC
Confidence 975 455999999999999999999854333 22110 11111
Q ss_pred -------------HHHHcCCCCCC-----CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCCC
Q 008378 176 -------------KKVTSGIKPAS-----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 228 (568)
Q Consensus 176 -------------~~i~~~~~p~~-----~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~~ 228 (568)
+.+........ .....++++++||.+||+ +|.+|||+.|+|+||||+...+..
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 301 EDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 11111110000 113468999999999996 799999999999999999866543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=326.53 Aligned_cols=210 Identities=26% Similarity=0.434 Sum_probs=180.7
Q ss_pred HHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 10 LYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 10 l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
..+|+++|.++ +||||++++++|.+. ..+|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||++| |
T Consensus 62 ~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--i 137 (342)
T 2qr7_A 62 PTEEIEILLRYGQHPNIITLKDVYDDG--KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--V 137 (342)
T ss_dssp CHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hHHHHHHHHHhcCCCCcCeEEEEEEcC--CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 45789999888 799999999998754 479999999999999999999999999999999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCC---CcEEEeecChhhhccCC--CcccccCCCCccCcccccc-CCCccceehhhHHHHHHHhhcC
Q 008378 89 IHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 89 iHRDLKp~NILl~~~~---g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~-~ys~ksDIWSLGiilyEmltG~ 162 (568)
+||||||+|||+...+ +.+||+|||++...... ...+.+||+.|+|||++.+ .|+.++|||||||++|+|++|.
T Consensus 138 vHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 217 (342)
T 2qr7_A 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY 217 (342)
T ss_dssp ECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSS
T ss_pred EeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCC
Confidence 9999999999985333 35999999999866432 3446689999999998854 5899999999999999999999
Q ss_pred CCCCCC--CCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 163 YPYNEC--KNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 163 ~Pf~~~--~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
.||... .....+...+..+..+ ...+...++++++||.+||. +|.+||++.++++||||..
T Consensus 218 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 218 TPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred CCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 999763 4567778887766443 22345678999999999996 7999999999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=341.84 Aligned_cols=215 Identities=32% Similarity=0.503 Sum_probs=186.8
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+.+|++|+|||||+++++|.+. ..+|+|||||.+|+|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 166 (504)
T 3q5i_A 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN 166 (504)
T ss_dssp THHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 357889999999999999999999998754 479999999999999999998889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCC--CcEEEeecChhhhccCC-CcccccCCCCccCccccccCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~--g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++..+ ..+||+|||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|.
T Consensus 167 --ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~ 244 (504)
T 3q5i_A 167 --IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGY 244 (504)
T ss_dssp --EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCC
Confidence 99999999999997332 26999999999876543 34566899999999999888999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||.+ .+...+...+..+..... .....++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 245 ~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 245 PPFGG-QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCC-CCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 99987 456667777776643322 224678999999999996 799999999999999998643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.25 Aligned_cols=217 Identities=24% Similarity=0.397 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+.....+.+|+.+|+.|+|||||+++++|.+. ..+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||
T Consensus 89 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH 166 (387)
T 1kob_A 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166 (387)
T ss_dssp HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999999998754 47999999999999999987654 7999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeC-CCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~-~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++. ..+.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+
T Consensus 167 ~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 167 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp HTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred hCC--eeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 999 999999999999973 3578999999999876543 234558999999999884 55899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|..||.+. +.......+..... +.......++++++||.+||. +|.+||++.++|+||||+...
T Consensus 245 tg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 245 SGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred hCCCCCCCC-CHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 999999874 44444555544322 223345678999999999996 799999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.38 Aligned_cols=211 Identities=24% Similarity=0.471 Sum_probs=184.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+++.+|+.+++.++||||+++++++.+. ..+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||++|
T Consensus 58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~- 134 (284)
T 2vgo_A 58 EHQLRREIEIQSHLRHPNILRMYNYFHDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK- 134 (284)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 46789999999999999999999998754 479999999999999999998889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCCCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY 165 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~Pf 165 (568)
++||||||+||+++ .+|.+||+|||++............||+.|+|||++. ..++.++||||||+++|+|++|..||
T Consensus 135 -i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 212 (284)
T 2vgo_A 135 -VIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212 (284)
T ss_dssp -EECCCCSGGGEEEC-TTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred -ceecCCCHHHEEEc-CCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCC
Confidence 99999999999997 7889999999999766555556678999999999874 45899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 166 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 166 ~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
... ........+..... .++...++.++++|.+||. +|.+||++.++++||||+...
T Consensus 213 ~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 213 DSP-SHTETHRRIVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp CCS-SHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred CCC-CHhHHHHHHhcccc--CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 764 44445555554322 2445678999999999996 799999999999999998644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=317.88 Aligned_cols=219 Identities=23% Similarity=0.420 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+...+.+.+|+++|++++||||+++++++.+. ..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+
T Consensus 43 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~ 120 (311)
T 4agu_A 43 PVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120 (311)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999998765 4789999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEml 159 (568)
+| |+||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++. ..|+.++||||||+++|+|+
T Consensus 121 ~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 197 (311)
T 4agu_A 121 HN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197 (311)
T ss_dssp TT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence 99 99999999999997 7899999999999766432 234568999999999874 45899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHc-------------------CCC---CCCC------CCCCcHHHHHHHHHhcC-CCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTS-------------------GIK---PASL------SKVTDPQVKQFIEKCIV-PASLRL 210 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~-------------------~~~---p~~~------~~~~s~el~~lI~kcL~-~p~~Rp 210 (568)
+|..||.+......+...... +.. +... ....++.+.+||.+||. +|.+||
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 277 (311)
T 4agu_A 198 SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL 277 (311)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcC
Confidence 999999876554443322211 000 0000 13467889999999996 799999
Q ss_pred CHHHHhcCCCCCCCCCC
Q 008378 211 PALELLKDPFLVTDNPK 227 (568)
Q Consensus 211 sa~ElL~hpff~~~~~~ 227 (568)
|+.|+|+||||+.....
T Consensus 278 t~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 278 TCEQLLHHPYFENIREI 294 (311)
T ss_dssp CHHHHHTSGGGTTCC--
T ss_pred CHHHHhcChHHHhccCH
Confidence 99999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=322.92 Aligned_cols=216 Identities=25% Similarity=0.375 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
....+.+|+.+|+.+. ||||++++++|.+. ..+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 48 ~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 125 (325)
T 3kn6_A 48 MEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125 (325)
T ss_dssp GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3467889999999997 99999999998754 47899999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCC--CcEEEeecChhhhccCC--CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 85 NPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~--g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
| |+||||||+|||++..+ ..+||+|||+++..... .....+||+.|+|||++ ...|+.++||||||+++|+|+
T Consensus 126 ~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 203 (325)
T 3kn6_A 126 G--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML 203 (325)
T ss_dssp T--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred C--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 9 99999999999997322 28999999999765432 23456799999999988 456999999999999999999
Q ss_pred hcCCCCCCC------CCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 160 TCEYPYNEC------KNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 160 tG~~Pf~~~------~~~~~i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|..||... .....+...+..+..+.. .....++++++||.+||. +|.+||++.+++.||||+...
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred hCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 999999753 234566777766543321 123468999999999996 799999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=348.45 Aligned_cols=221 Identities=24% Similarity=0.399 Sum_probs=190.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~--l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+.+.+|+++|+.++|||||+++++|.+. ..+|+||||+.||+|.+++...+. +++..++.++.||+.||.|||++
T Consensus 228 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~ 305 (576)
T 2acx_A 228 EAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305 (576)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHcCCCCEeeEEEEEeeC--CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45688999999999999999999998765 479999999999999999987654 99999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
| |+||||||+|||++ .+|.+||+|||+++..... .....+||+.|+|||++. ..|+.++|||||||++|||++|.
T Consensus 306 g--IvHrDLKPeNILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~ 382 (576)
T 2acx_A 306 R--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382 (576)
T ss_dssp T--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSS
T ss_pred C--EeccCCchheEEEe-CCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence 9 99999999999997 7899999999999876433 334568999999999884 46999999999999999999999
Q ss_pred CCCCCCC---CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcccCC
Q 008378 163 YPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDP 233 (568)
Q Consensus 163 ~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~~~~ 233 (568)
.||.... ....+...+... +..++...++++++||.+||. +|.+|| ++.|+++||||+..++..+....
T Consensus 383 ~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~ 460 (576)
T 2acx_A 383 SPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGM 460 (576)
T ss_dssp CSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTC
T ss_pred CCCcccccchhHHHHHHHhhcc--cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCC
Confidence 9997643 345666666654 334567789999999999996 799999 79999999999998876654443
Q ss_pred C
Q 008378 234 L 234 (568)
Q Consensus 234 l 234 (568)
+
T Consensus 461 ~ 461 (576)
T 2acx_A 461 L 461 (576)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.38 Aligned_cols=217 Identities=30% Similarity=0.463 Sum_probs=181.0
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
+....+++.+|+++|+.++||||+++++++..... ..+|+||||+ +++|.++++. +.+++..++.++.||+.||
T Consensus 64 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L 141 (367)
T 1cm8_A 64 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGL 141 (367)
T ss_dssp SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999999865432 3579999999 7899999887 5799999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiily 156 (568)
.|||++| |+||||||+|||++ .+|.+||+|||+++.... .....+||++|+|||++. ..|+.++|||||||++|
T Consensus 142 ~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 217 (367)
T 1cm8_A 142 RYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADS-EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217 (367)
T ss_dssp HHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCS-SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeeccccccc-ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHH
Confidence 9999999 99999999999997 789999999999986543 345568999999999874 46999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHc-CCCC---------------------------CCCCCCCcHHHHHHHHHhcC-CCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTS-GIKP---------------------------ASLSKVTDPQVKQFIEKCIV-PAS 207 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~-~~~p---------------------------~~~~~~~s~el~~lI~kcL~-~p~ 207 (568)
+|++|+.||.+.....++...+.. +.++ ..+....++++++||.+||. +|.
T Consensus 218 ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~ 297 (367)
T 1cm8_A 218 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 297 (367)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChh
Confidence 999999999876554444433221 1110 11223468999999999996 799
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 008378 208 LRLPALELLKDPFLVTDN 225 (568)
Q Consensus 208 ~Rpsa~ElL~hpff~~~~ 225 (568)
+|||+.++|+||||+...
T Consensus 298 ~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 298 QRVTAGEALAHPYFESLH 315 (367)
T ss_dssp TSCCHHHHHHSGGGTTTC
T ss_pred HCCCHHHHhcChHHHhhc
Confidence 999999999999998644
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.44 Aligned_cols=213 Identities=27% Similarity=0.497 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHh
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~------~~l~e~~i~~i~~QIl~gL~y 80 (568)
.+.+.+|+.+|++++||||+++++++.+. ..+++||||+. |+|.+++... ..+++..++.++.||+.||.|
T Consensus 47 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~ 123 (317)
T 2pmi_A 47 PSTAIREISLMKELKHENIVRLYDVIHTE--NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123 (317)
T ss_dssp CHHHHHHHHHHTTCCBTTBCCEEEEECCT--TEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEEEEC--CeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 46788999999999999999999988654 47999999998 6999988754 359999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiily 156 (568)
||++| |+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..|+.++|||||||++|
T Consensus 124 lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (317)
T 2pmi_A 124 CHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILA 200 (317)
T ss_dssp HHHTT--EECCCCCGGGEEEC-TTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred HHHCC--eeeCCCChHHeEEc-CCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHH
Confidence 99999 99999999999997 7899999999999776432 234568999999999884 35899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHc-CCCCC------------------------------CCCCCCcHHHHHHHHHhcC-
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTS-GIKPA------------------------------SLSKVTDPQVKQFIEKCIV- 204 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~-~~~p~------------------------------~~~~~~s~el~~lI~kcL~- 204 (568)
+|+||+.||.+......+...+.. +.++. ......++++++||.+||+
T Consensus 201 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 280 (317)
T 2pmi_A 201 EMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQL 280 (317)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCC
Confidence 999999999875544433332221 11100 0112467899999999996
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 008378 205 PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 205 ~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|.+|||+.|+|+||||+...
T Consensus 281 dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 281 NPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp SGGGSCCHHHHTTSGGGGGGC
T ss_pred CcccCCCHHHHhCChhhhccc
Confidence 799999999999999998644
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=354.63 Aligned_cols=224 Identities=21% Similarity=0.363 Sum_probs=194.8
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+..|..+|..+ +||||++++++|.+. ..+||||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||++
T Consensus 384 ~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 461 (674)
T 3pfq_A 384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461 (674)
T ss_dssp TTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 456788999999998 799999999988654 47999999999999999999989999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhcc--CCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~--~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG 161 (568)
| |+||||||+|||++ .+|.+||+|||+++... .....+.+||+.|+|||++ ...|+.++||||||+++|||++|
T Consensus 462 g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG 538 (674)
T 3pfq_A 462 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538 (674)
T ss_dssp S--EECCCCCSTTEEEC-SSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHS
T ss_pred C--eEeccCChhhEEEc-CCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcC
Confidence 9 99999999999997 78999999999997542 2345567899999999988 46699999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH-----HHHhcCCCCCCCCCCCcccCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLR 235 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa-----~ElL~hpff~~~~~~~l~~~~l~ 235 (568)
+.||.+ .+...++..+..... .++...++++++||.+||. +|.+|+++ .|+++||||+..+|..+....+.
T Consensus 539 ~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~ 615 (674)
T 3pfq_A 539 QAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQ 615 (674)
T ss_dssp SCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSC
T ss_pred CCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCC
Confidence 999987 566777777776533 3566789999999999996 69999997 99999999999888776555544
Q ss_pred CC
Q 008378 236 LP 237 (568)
Q Consensus 236 ~p 237 (568)
.|
T Consensus 616 pp 617 (674)
T 3pfq_A 616 PP 617 (674)
T ss_dssp CS
T ss_pred CC
Confidence 43
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=314.86 Aligned_cols=214 Identities=28% Similarity=0.453 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHhCC---CCCeeeeeeEEEcCCCC---eEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHH
Q 008378 8 ERLYSEVHLLKSLK---HENIIKFYNSWVDDTNR---TINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLH 79 (568)
Q Consensus 8 e~l~~Ei~iLk~L~---HpNIV~l~~~~~~~~~~---~l~lV~Ey~~gGsL~~~i~k~~~--l~e~~i~~i~~QIl~gL~ 79 (568)
..+.+|+.+++.++ ||||+++++++...... .+++||||+. |+|.+++.+... +++..++.++.||+.||.
T Consensus 56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 134 (308)
T 3g33_A 56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134 (308)
T ss_dssp HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence 35667777777664 99999999998765432 5899999997 699999988754 999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
|||++| |+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++ ...|+.++|||||||++|+
T Consensus 135 ~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 211 (308)
T 3g33_A 135 FLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 211 (308)
T ss_dssp HHHHTT--CCCSCCCTTTEEEC-TTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHH
T ss_pred HHHHCC--cccCCCCHHHEEEc-CCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHH
Confidence 999999 99999999999997 7889999999999876533 34556899999999987 5669999999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHc-CCCC-CCC----------------------CCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTS-GIKP-ASL----------------------SKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~-~~~p-~~~----------------------~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
|++|..||.+......+.+.+.. +..+ ..+ ....++.+++||.+||+ +|.+|||+
T Consensus 212 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 291 (308)
T 3g33_A 212 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291 (308)
T ss_dssp TTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH
Confidence 99999999875544444333321 1111 111 12457899999999996 79999999
Q ss_pred HHHhcCCCCCCCC
Q 008378 213 LELLKDPFLVTDN 225 (568)
Q Consensus 213 ~ElL~hpff~~~~ 225 (568)
.|+|+||||+...
T Consensus 292 ~e~l~h~~~~~~~ 304 (308)
T 3g33_A 292 FRALQHSYLHKDE 304 (308)
T ss_dssp HHHHTSTTC----
T ss_pred HHHhcCccccCCC
Confidence 9999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.09 Aligned_cols=214 Identities=31% Similarity=0.548 Sum_probs=182.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~-k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+..+++.+|+++|++++||||++++++|.+.. .+++||||+. |+|.+++. ..+.+++..++.++.||+.||.|||
T Consensus 95 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH 171 (348)
T 1u5q_A 95 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171 (348)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456678999999999999999999999987654 7999999997 67877775 4567999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc----ccCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl----~~~ys~ksDIWSLGiilyEm 158 (568)
++| |+||||||+|||++ .+|.+||+|||++..... ....+||+.|+|||++ .+.|+.++|||||||++|||
T Consensus 172 ~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~el 246 (348)
T 1u5q_A 172 SHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246 (348)
T ss_dssp HTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS--BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHH
T ss_pred hCC--eeeCCCCHHHEEEC-CCCCEEEeeccCceecCC--CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHH
Confidence 999 99999999999998 789999999999976543 3456899999999987 35689999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
++|..||........+.. +..+..+.......++.+++||.+||. +|.+||++.++++||||....+
T Consensus 247 l~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 247 AERKPPLFNMNAMSALYH-IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHSSCTTTTSCHHHHHHH-HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HhCCCCCCCCChHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 999999987654444444 444444544556778999999999996 6999999999999999976543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.99 Aligned_cols=216 Identities=26% Similarity=0.418 Sum_probs=183.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+..+.+.+|+.+++.++||||+++++++.+. ..+++||||+++++|.+++.....+++..++.++.||+.||.|||++
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 124 (276)
T 2yex_A 47 DCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124 (276)
T ss_dssp THHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3567899999999999999999999988754 47899999999999999998888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccccc-C-CCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~~-~-ys~ksDIWSLGiilyEm 158 (568)
| ++||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++.+ . ++.++||||||+++|+|
T Consensus 125 ~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 201 (276)
T 2yex_A 125 G--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201 (276)
T ss_dssp T--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHH
T ss_pred C--eeccCCChHHEEEc-cCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHH
Confidence 9 99999999999997 7889999999999765322 2345679999999998854 3 47789999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
++|..||.........+..+.............++.++++|.+||. +|.+||++.++++||||+...
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 202 LAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999999876555455555554433333334578999999999996 799999999999999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=330.31 Aligned_cols=217 Identities=24% Similarity=0.389 Sum_probs=181.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+++.+|+.+|++|+|||||+++++|.+. ..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||
T Consensus 127 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH 204 (373)
T 2x4f_A 127 MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204 (373)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999998764 4799999999999999888654 46999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEe-CCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~-~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||+. ...+.+||+|||+++..... .....+||+.|+|||++. ..++.++|||||||++|+|+
T Consensus 205 ~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 282 (373)
T 2x4f_A 205 QMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282 (373)
T ss_dssp HTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH
T ss_pred HCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH
Confidence 999 99999999999984 35679999999999876443 234557999999999884 55899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+|..||.+......+...+..... +.......++++++||.+||. +|.+||++.|+|+||||+..
T Consensus 283 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 283 SGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred hCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999875544444444333322 122234578999999999996 69999999999999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.83 Aligned_cols=219 Identities=32% Similarity=0.504 Sum_probs=178.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~---~l~e~~i~~i~~QIl~gL~y 80 (568)
....+.+.+|+.+++.++||||+++++++... ..+++||||+++++|.+++.... .+++..++.++.||+.||.|
T Consensus 60 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~ 137 (295)
T 2clq_A 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137 (295)
T ss_dssp C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999998765 37899999999999999998752 46799999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc---CCCccceehhhHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCI 155 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~---~ys~ksDIWSLGiil 155 (568)
||++| ++||||||+||+++..++.+||+|||++...... ......||+.|+|||++.. .++.++||||||+++
T Consensus 138 lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 215 (295)
T 2clq_A 138 LHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 215 (295)
T ss_dssp HHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHH
T ss_pred HHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHH
Confidence 99999 9999999999999855899999999999766432 2345679999999998843 389999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
|+|++|..||.....................++...+++++++|.+||. +|.+||++.++|.||||+....
T Consensus 216 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 216 IEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 9999999999765554433333222222334566778999999999996 6999999999999999986543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.33 Aligned_cols=212 Identities=26% Similarity=0.470 Sum_probs=185.4
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+.+|+.++||||+++++++... ..+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 59 ~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 136 (476)
T 2y94_A 59 VVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136 (476)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356789999999999999999999988765 479999999999999999998889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccccC--CCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~--ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||++...... ...+.+||+.|+|||++.+. ++.++|||||||++|+|++|.
T Consensus 137 --ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 213 (476)
T 2y94_A 137 --VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213 (476)
T ss_dssp --EECSCCSGGGEEEC-TTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred --CCcccccHHHEEEe-cCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCC
Confidence 99999999999997 7889999999999876543 34567899999999988543 378999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||.+. +...++..+..+... .+...++++++||.+||. +|.+||++.+++.||||+...
T Consensus 214 ~Pf~~~-~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 214 LPFDDD-HVPTLFKKICDGIFY--TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp CSSCCS-SSHHHHHHHHTTCCC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred CCCCCC-CHHHHHHHHhcCCcC--CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 999874 455666777666432 345678999999999996 799999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=325.14 Aligned_cols=218 Identities=28% Similarity=0.465 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC------------------------
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------------------ 59 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~------------------------ 59 (568)
++..+++.+|+++|++++||||++++++|.+. ..+++|||||++|+|.+++...
T Consensus 69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (345)
T 3hko_A 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146 (345)
T ss_dssp -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceeehhhccC--CeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccc
Confidence 45678899999999999999999999998754 4799999999999999988521
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCC--cEEEeecChhhhccCC
Q 008378 60 ----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP 121 (568)
Q Consensus 60 ----------------~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g--~vKI~DFGla~~~~~~ 121 (568)
..+++..++.++.||+.||.|||++| |+||||||+|||++ .++ .+||+|||++..+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~kl~Dfg~a~~~~~~ 223 (345)
T 3hko_A 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKL 223 (345)
T ss_dssp HHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES-CSSSCCEEECCCTTCEEGGGT
T ss_pred ccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEe-cCCCceEEEeecccccccccc
Confidence 12467889999999999999999999 99999999999997 444 8999999999765321
Q ss_pred ------CcccccCCCCccCccccc---cCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCC
Q 008378 122 ------TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVT 191 (568)
Q Consensus 122 ------~~~s~~GTp~YmAPEvl~---~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~ 191 (568)
......||+.|+|||++. ..|+.++||||||+++|+|++|..||.+......+...+....... ......
T Consensus 224 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (345)
T 3hko_A 224 NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL 303 (345)
T ss_dssp TCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGS
T ss_pred CccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccC
Confidence 134567999999999874 5689999999999999999999999987655554444444332221 122346
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 192 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 192 s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
++++++||.+||. +|.+||++.++|+||||+....
T Consensus 304 ~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 8999999999996 7999999999999999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.53 Aligned_cols=215 Identities=24% Similarity=0.410 Sum_probs=183.8
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+|+.++||||+++++++.+. ..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 126 (304)
T 2jam_A 49 RDSSLENEIAVLKKIKHENIVTLEDIYEST--THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126 (304)
T ss_dssp ---HHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHhCCCCCeeehhhhcccC--CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346788999999999999999999988754 478999999999999999998889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEe--CCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~--~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||++. ..++.+||+|||++............||+.|+|||++. ..|+.++||||||+++|+|++|.
T Consensus 127 --i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 204 (304)
T 2jam_A 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY 204 (304)
T ss_dssp --CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred --ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999992 26789999999999766555455567999999999884 55899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||... ....+...+..+.. +.......++.+++||.+||. +|.+||++.++|+||||....
T Consensus 205 ~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 205 PPFYEE-TESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp CTTTTS-CHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred CCCCCC-CHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 999764 45566666666543 223445678999999999996 799999999999999997643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.29 Aligned_cols=213 Identities=27% Similarity=0.466 Sum_probs=182.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+++.+|+.+|++++||||+++++++.+. ..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~- 135 (321)
T 2a2a_A 59 REEIEREVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK- 135 (321)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecC--CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 56789999999999999999999988754 479999999999999999999889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCC----cEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 87 PIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g----~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
|+||||||+||+++ .++ .+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++
T Consensus 136 -ivH~dikp~NIl~~-~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 213 (321)
T 2a2a_A 136 -IAHFDLKPENIMLL-DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213 (321)
T ss_dssp -EECCCCSGGGEEES-CTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred -eecCCCChHHEEEe-cCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH
Confidence 99999999999997 455 7999999999766443 334567999999999874 568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|..||.+. ........+...... .......++.+++||.+||. +|.+||++.++|+||||....
T Consensus 214 g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 214 GASPFLGD-TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp SCCSSCCS-SHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred CCCCCCCC-CHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 99999774 445555555554322 12224568899999999996 799999999999999997644
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=342.58 Aligned_cols=221 Identities=25% Similarity=0.422 Sum_probs=189.0
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+.+.+|+++|++++||||++++++|.+. ..+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||
T Consensus 229 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH 306 (543)
T 3c4z_A 229 YQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306 (543)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999999999998765 4799999999999999999864 36999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++ .+|.+||+|||+++...... ....+||+.|+|||++. ..|+.++|||||||++|||+
T Consensus 307 ~~g--IvHrDLKP~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyell 383 (543)
T 3c4z_A 307 QRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383 (543)
T ss_dssp HTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred HcC--CcccCCChHHEEEe-CCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHH
Confidence 999 99999999999997 78999999999998764432 34568999999999884 56999999999999999999
Q ss_pred hcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcc
Q 008378 160 TCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLV 230 (568)
Q Consensus 160 tG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~ 230 (568)
||..||.... ....+...+.... ..++...++++++||.+||. +|.+||+ +.++++||||+..++..+.
T Consensus 384 tG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~ 461 (543)
T 3c4z_A 384 AARGPFRARGEKVENKELKQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLE 461 (543)
T ss_dssp HSSCSSCCTTCCCCHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHH
T ss_pred hCCCCCCCCccchhHHHHHHHHhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHH
Confidence 9999997643 4566777666543 23456778999999999996 7999996 5899999999998876654
Q ss_pred cCCC
Q 008378 231 CDPL 234 (568)
Q Consensus 231 ~~~l 234 (568)
....
T Consensus 462 ~~~~ 465 (543)
T 3c4z_A 462 AGML 465 (543)
T ss_dssp TTCS
T ss_pred cCCC
Confidence 4433
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.00 Aligned_cols=216 Identities=26% Similarity=0.488 Sum_probs=178.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+..+++.+|+++|+.++||||+++++++.... .+++||||+++++|.+++.+ .+.+++..++.++.||+.||.|||+
T Consensus 58 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 135 (302)
T 2j7t_A 58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135 (302)
T ss_dssp CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC--eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc
Confidence 44678999999999999999999999987654 68999999999999998876 4679999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc------ccCCCccceehhhHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY------EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl------~~~ys~ksDIWSLGiil 155 (568)
+| ++||||||+||+++ .+|.+||+|||++..... .......||+.|+|||++ ...++.++||||||+++
T Consensus 136 ~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 212 (302)
T 2j7t_A 136 KR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212 (302)
T ss_dssp TT--CCCCCCSGGGEEEC-TTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHH
T ss_pred CC--cccCCCCHHHEEEC-CCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHH
Confidence 99 99999999999997 788999999999864422 223456799999999987 34588999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
|+|++|..||..... ......+.....+ ...+...++.++++|.+||. +|.+||++.++++||||.....
T Consensus 213 ~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 213 IEMAQIEPPHHELNP-MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp HHHHHSSCTTTTSCH-HHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred HHHhcCCCCCccCCH-HHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 999999999987544 4444444443332 23345568899999999996 7999999999999999987554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=310.13 Aligned_cols=220 Identities=28% Similarity=0.502 Sum_probs=185.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~QIl~gL 78 (568)
++...+.+.+|+.+|++++||||+++++++.+.....+++||||+++|+|.+++... ..+++..++.++.||+.||
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l 124 (279)
T 2w5a_A 45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124 (279)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Confidence 456778899999999999999999999998876667899999999999999998764 3499999999999999999
Q ss_pred HhhhhCC---CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc-cCCCccceehhhH
Q 008378 79 HYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFG 152 (568)
Q Consensus 79 ~yLHs~g---~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLG 152 (568)
.|||+++ .+++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++. ..++.++||||||
T Consensus 125 ~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 203 (279)
T 2w5a_A 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203 (279)
T ss_dssp HHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHH
T ss_pred HHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHH
Confidence 9999987 3499999999999997 78899999999998764432 23457999999999874 4689999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 153 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+++|+|++|..||... +...+...+..+..+ .++...+++++++|.+||. +|.+||++.++++|+|+....
T Consensus 204 ~il~~l~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 204 CLLYELCALMPPFTAF-SQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHHHHHHCCCCCccc-CHHHHHHHHhhcccc-cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 9999999999999764 456666777666543 3455678999999999996 799999999999999997643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=315.45 Aligned_cols=211 Identities=25% Similarity=0.420 Sum_probs=174.6
Q ss_pred CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~y 80 (568)
+.....+..+|+..+..+ +||||++++++|.+. ..+++||||+ +++|.+++... ..+++..++.++.||+.||.|
T Consensus 96 ~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 172 (311)
T 3p1a_A 96 GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172 (311)
T ss_dssp SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 345556667777666666 999999999998754 4799999999 67898887765 469999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCccccccCCCccceehhhHHHHHHHh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEml 159 (568)
||+++ |+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++.+.++.++|||||||++|||+
T Consensus 173 LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~ 249 (311)
T 3p1a_A 173 LHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVA 249 (311)
T ss_dssp HHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHH
T ss_pred HHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHH
Confidence 99999 99999999999997 78899999999987664432 3445799999999999889999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
+|..|+... .....+..+..+..+....++++++||.+||. +|.+||++.|+|+||||++
T Consensus 250 ~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 250 CNMELPHGG----EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HTCCCCSSH----HHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred hCCCCCCCc----cHHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 997776542 23444555555555556678999999999996 6999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=318.61 Aligned_cols=213 Identities=25% Similarity=0.441 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----------------------------------------------
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---------------------------------------------- 37 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~---------------------------------------------- 37 (568)
+...+++.+|+++|++|+|||||+++++|.+...
T Consensus 45 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 124 (332)
T 3qd2_B 45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124 (332)
T ss_dssp TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc
Confidence 3466889999999999999999999999876432
Q ss_pred ---------CeEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCC
Q 008378 38 ---------RTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 105 (568)
Q Consensus 38 ---------~~l~lV~Ey~~gGsL~~~i~k~~~---l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g 105 (568)
..+++|||||++|+|.+++.+... .++..++.++.||+.||.|||++| |+||||||+|||++ .+|
T Consensus 125 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~ 201 (332)
T 3qd2_B 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDD 201 (332)
T ss_dssp -------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTC
T ss_pred ccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCC
Confidence 248999999999999999997654 566678999999999999999999 99999999999997 788
Q ss_pred cEEEeecChhhhccCC--------------CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCC
Q 008378 106 EVKIGDLGLAIVMQQP--------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKN 170 (568)
Q Consensus 106 ~vKI~DFGla~~~~~~--------------~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~ 170 (568)
.+||+|||+++..... ......||+.|+|||++ ...|+.++||||||+++|+|++|..|+..
T Consensus 202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--- 278 (332)
T 3qd2_B 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--- 278 (332)
T ss_dssp CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---
T ss_pred CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---
Confidence 9999999999766432 12345799999999987 45689999999999999999998776532
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 171 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 171 ~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
...+...+.....+. .....++.+++||.+||. +|.+||++.|+|+||||+.
T Consensus 279 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 279 RVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHHHHhhccCCCc-ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 334444444443322 112235788999999996 6999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.38 Aligned_cols=215 Identities=28% Similarity=0.411 Sum_probs=170.0
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
+....+++.+|+.+|+.++|||||+++++|.... ...+|+||||+.+ +|.+++. ..+++..++.++.||+.||
T Consensus 101 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL 177 (464)
T 3ttj_A 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI 177 (464)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999999986543 2478999999986 4666664 3599999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
+|||++| |+||||||+|||++ .+|.+||+|||+++..... .....+||+.|+|||++ ...|+.++|||||||++|
T Consensus 178 ~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 254 (464)
T 3ttj_A 178 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254 (464)
T ss_dssp HHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence 9999999 99999999999997 7889999999999876543 34567899999999987 457999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCC-------------------CCC---------C-----------CCcHHHHH
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPA-------------------SLS---------K-----------VTDPQVKQ 197 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~-------------------~~~---------~-----------~~s~el~~ 197 (568)
+|++|+.||.+.....++.+.+.....|. ... . ..++++++
T Consensus 255 ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 334 (464)
T 3ttj_A 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334 (464)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHH
Confidence 99999999988655555444332111110 000 0 01567999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 198 FIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 198 lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
||.+||+ +|.+|||+.|+|+||||..
T Consensus 335 Ll~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 335 LLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 9999996 7999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=315.67 Aligned_cols=216 Identities=32% Similarity=0.576 Sum_probs=176.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~---l~e~~i~~i~~QIl~gL~ 79 (568)
+.+..+++.+|+++|++++||||+++++++.+.. .+++||||+.+|+|.+++.+.+. +++..+..++.||+.||.
T Consensus 74 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~ 151 (309)
T 3p86_A 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151 (309)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH
Confidence 3566788999999999999999999999886544 58899999999999999987654 999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiily 156 (568)
|||++|++|+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++. ..++.++||||||+++|
T Consensus 152 ~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 230 (309)
T 3p86_A 152 YLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230 (309)
T ss_dssp HHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHH
Confidence 9999988899999999999997 7889999999999765433 234568999999999884 55899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc--CCCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK--DPFLV 222 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~--hpff~ 222 (568)
+|+||..||... +..+....+.........+...++++++||.+||. +|.+||++.++++ +++++
T Consensus 231 elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 231 ELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHCCCTTTTS-CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999999764 55566666654555556677889999999999996 7999999999987 44443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.80 Aligned_cols=220 Identities=28% Similarity=0.530 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--------HKNVDMKAIKNWARQILR 76 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k--------~~~l~e~~i~~i~~QIl~ 76 (568)
...+++.+|+.+|++++||||+++++++.... .+++||||+.+|+|.+++.. .+.+++..++.++.||+.
T Consensus 55 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 132 (303)
T 2vwi_A 55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132 (303)
T ss_dssp -----------CCCCCCCTTBCCEEEEEESSS--CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHH
Confidence 45677899999999999999999999987654 68999999999999999874 456999999999999999
Q ss_pred HHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-------CcccccCCCCccCccccc--cCCCccce
Q 008378 77 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPELYE--EEYNELVD 147 (568)
Q Consensus 77 gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-------~~~s~~GTp~YmAPEvl~--~~ys~ksD 147 (568)
||.|||++| ++||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++|
T Consensus 133 ~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 209 (303)
T 2vwi_A 133 GLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209 (303)
T ss_dssp HHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHH
T ss_pred HHHHHHhCC--CCCCCCChhhEEEc-CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhh
Confidence 999999999 99999999999997 7889999999999765422 123457999999999884 46899999
Q ss_pred ehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 008378 148 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 219 (568)
Q Consensus 148 IWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p-------~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hp 219 (568)
|||||+++|+|++|..||............+...... .......+++++++|.+||. +|.+||++.++++||
T Consensus 210 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 210 IWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred HHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 9999999999999999998765555444444332211 12234567899999999996 799999999999999
Q ss_pred CCCCCCCCCc
Q 008378 220 FLVTDNPKDL 229 (568)
Q Consensus 220 ff~~~~~~~l 229 (568)
||+....+.+
T Consensus 290 ~~~~~~~~~~ 299 (303)
T 2vwi_A 290 FFQKAKNKEF 299 (303)
T ss_dssp TC--------
T ss_pred hhhcCCCCcc
Confidence 9987665543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=307.89 Aligned_cols=214 Identities=29% Similarity=0.518 Sum_probs=184.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+...+++.+|+.+++.++||||+++++++.+. ..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||
T Consensus 55 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 132 (294)
T 2rku_A 55 KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132 (294)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456778899999999999999999999988654 479999999999999999998889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| ++||||||+||+++ .+|.+||+|||++..... .......||+.|+|||++. ..++.++||||||+++|+|+
T Consensus 133 ~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 209 (294)
T 2rku_A 133 RNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 209 (294)
T ss_dssp HTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHH
T ss_pred HCC--ccccCCChHhEEEc-CCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHH
Confidence 999 99999999999997 788999999999976542 2234567999999999874 45889999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+|..||... ........+..+.. .++...++.++++|.+||. +|.+||++.++++||||...
T Consensus 210 ~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 210 VGKPPFETS-CLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HSSCTTCCS-SHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred hCCCCCCCC-CHHHHHHHHhhccC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 999999764 44445555554422 3455678999999999996 69999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=321.96 Aligned_cols=212 Identities=25% Similarity=0.477 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+.+|+++ +||||++++++|... ...|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++
T Consensus 142 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 219 (365)
T 2y7j_A 142 VREATRRETHILRQVAGHPHIITLIDSYESS--SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219 (365)
T ss_dssp HHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS--SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC--CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 356788999999999 899999999998754 47999999999999999999888899999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-------cCCCccceehhhHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-------~~ys~ksDIWSLGiily 156 (568)
| ++||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..|+.++|||||||++|
T Consensus 220 g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 296 (365)
T 2y7j_A 220 N--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296 (365)
T ss_dssp T--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHH
T ss_pred C--eecCCCCHHHEEEC-CCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHH
Confidence 9 99999999999997 7899999999999766433 345668999999999874 24788999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
+|++|..||... ........+..+..... .....++.+++||.+||. +|.+||++.++|+||||++
T Consensus 297 ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 297 TLLAGSPPFWHR-RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHSSCSSCCS-SHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 999999999764 45555555555433221 123567889999999996 7999999999999999963
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=325.86 Aligned_cols=214 Identities=25% Similarity=0.376 Sum_probs=174.5
Q ss_pred HHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 11 YSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 11 ~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~---i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+|+++|+.++||||++++++|.... ..++++||||+.++.+... ....+.+++..++.|+.||+.||.|||+
T Consensus 80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (394)
T 4e7w_A 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159 (394)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47999999999999999999986533 2358899999987544433 2345689999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-CCcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++..+|.+||+|||+++.... ......+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 160 ~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 237 (394)
T 4e7w_A 160 IG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237 (394)
T ss_dssp TT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99 999999999999986789999999999987643 3345678999999999874 358999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCC----------------------C----CCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKP----------------------A----SLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p----------------------~----~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
|+.||.+.....++...+.....| . .+....++++++||.+||+ +|.+||++.
T Consensus 238 g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (394)
T 4e7w_A 238 GQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317 (394)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHH
Confidence 999998866555555444311000 0 1223467899999999996 799999999
Q ss_pred HHhcCCCCCCCCC
Q 008378 214 ELLKDPFLVTDNP 226 (568)
Q Consensus 214 ElL~hpff~~~~~ 226 (568)
|+|.||||+....
T Consensus 318 e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 318 EALCHPFFDELRT 330 (394)
T ss_dssp HHHTSGGGSTTTS
T ss_pred HHhcChhhhhhcc
Confidence 9999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=308.57 Aligned_cols=211 Identities=26% Similarity=0.506 Sum_probs=157.6
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+.++++++||||+++++++.+. ..+++||||+++++|.+++... +.+++..++.++.||+.||.|||++|
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 132 (278)
T 3cok_A 55 VQRVQNEVKIHCQLKHPSILELYNYFEDS--NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132 (278)
T ss_dssp HHHHHHHHHHHTTBCCTTBCCEEEEEECS--SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCeEeEEEEEccC--CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 47789999999999999999999998754 4799999999999999999876 67999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||+++ .++.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|.
T Consensus 133 --i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 209 (278)
T 3cok_A 133 --ILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209 (278)
T ss_dssp --EECSSCCGGGEEEC-TTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSS
T ss_pred --eecCCCCHHHEEEc-CCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999997 7889999999999766432 233567999999999874 45889999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||........+. .+.. .....+...+++++++|.+||. +|.+||++.+++.||||....
T Consensus 210 ~p~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 210 PPFDTDTVKNTLN-KVVL--ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp CSSCCCSCC------CCS--SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred CCCCChhHHHHHH-HHhh--cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9997654333222 2211 1223455678999999999996 799999999999999998644
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.32 Aligned_cols=216 Identities=25% Similarity=0.437 Sum_probs=183.0
Q ss_pred HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+.+.+|+.+|+++. ||||+++++++... ..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+
T Consensus 65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~ 142 (298)
T 1phk_A 65 ELREATLKEVDILRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34577889999999995 99999999988654 4799999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-------cCCCccceehhhHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCI 155 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-------~~ys~ksDIWSLGiil 155 (568)
+| ++||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++
T Consensus 143 ~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l 219 (298)
T 1phk_A 143 LN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219 (298)
T ss_dssp TT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred CC--cccCCCCcceEEEc-CCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHH
Confidence 99 99999999999997 7889999999999766433 344567999999999873 3478899999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
|+|++|..||... +.......+..+.... ......++.++++|.+||. +|.+||++.++|+||||+....
T Consensus 220 ~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 220 YTLLAGSPPFWHR-KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp HHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred HHHHHCCCCCcCc-cHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 9999999999764 4455555555543322 1223568899999999996 7999999999999999987554
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=305.57 Aligned_cols=211 Identities=23% Similarity=0.419 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----~~l~e~~i~~i~~QIl~gL 78 (568)
.....++.+|+.++..+ +||||++++++|.+.. .+++||||+++|+|.+++.+. +.+++..++.++.||+.||
T Consensus 51 ~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al 128 (289)
T 1x8b_A 51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD--HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128 (289)
T ss_dssp SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHH
Confidence 45667889999999999 9999999999987654 799999999999999999865 6799999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeC------------------CCCcEEEeecChhhhccCCCcccccCCCCccCcccccc
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNG------------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE 140 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~------------------~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~ 140 (568)
.|||++| |+||||||+||+++. ..+.+||+|||++...... ....||+.|+|||++.+
T Consensus 129 ~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~ 204 (289)
T 1x8b_A 129 RYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQE 204 (289)
T ss_dssp HHHHHTT--EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTT
T ss_pred HHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc--cccCCCccccChhHhcC
Confidence 9999999 999999999999962 3347999999999766443 33469999999998854
Q ss_pred C--CCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 141 E--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 141 ~--ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
. ++.++||||||+++|+|++|..|+... .....+..+..+ .++...+++++++|.+||. +|.+||++.++++
T Consensus 205 ~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 205 NYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHHHTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHHHcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 3 567999999999999999999777542 223344444333 3556778999999999996 6999999999999
Q ss_pred CCCCCCCC
Q 008378 218 DPFLVTDN 225 (568)
Q Consensus 218 hpff~~~~ 225 (568)
||||+...
T Consensus 280 h~~~~~~~ 287 (289)
T 1x8b_A 280 HSVLLSAS 287 (289)
T ss_dssp CTTC----
T ss_pred ChHhhhhc
Confidence 99998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.81 Aligned_cols=211 Identities=25% Similarity=0.401 Sum_probs=174.1
Q ss_pred HHHHHHHHhCCCCCeeeeeeEEEcC------------------------------------CCCeEEEEEecCCCCCHHH
Q 008378 11 YSEVHLLKSLKHENIIKFYNSWVDD------------------------------------TNRTINMITELFTSGSLRQ 54 (568)
Q Consensus 11 ~~Ei~iLk~L~HpNIV~l~~~~~~~------------------------------------~~~~l~lV~Ey~~gGsL~~ 54 (568)
.+|+++|+.++|||||+++++|... ...++++||||+. |+|.+
T Consensus 48 ~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 126 (383)
T 3eb0_A 48 NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHK 126 (383)
T ss_dssp CHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHH
T ss_pred HHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHH
Confidence 4799999999999999999998653 2346899999998 57666
Q ss_pred HHH----hCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-CCcccccCC
Q 008378 55 YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGT 129 (568)
Q Consensus 55 ~i~----k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~~s~~GT 129 (568)
++. ..+.+++..++.++.||+.||.|||++| |+||||||+|||++..++.+||+|||+++.... .......||
T Consensus 127 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t 204 (383)
T 3eb0_A 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICS 204 (383)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccC
Confidence 554 4678999999999999999999999999 999999999999986789999999999986643 334566899
Q ss_pred CCccCccccc--cCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC------------------C----
Q 008378 130 PEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------A---- 185 (568)
Q Consensus 130 p~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p------------------~---- 185 (568)
+.|+|||++. ..|+.++|||||||++|+|++|+.||.+....+++...+.....| .
T Consensus 205 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 284 (383)
T 3eb0_A 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284 (383)
T ss_dssp SSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCC
T ss_pred CCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcc
Confidence 9999999874 358999999999999999999999998866666555544321111 0
Q ss_pred ----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 186 ----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 186 ----~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
.++...++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 285 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred cHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 0234467899999999997 79999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=315.77 Aligned_cols=215 Identities=29% Similarity=0.513 Sum_probs=185.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.+...+.+.+|+.+++.++||||+++++++.+. ..+|+||||+.+++|.+++...+.+++..++.++.||+.||.|||
T Consensus 81 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (335)
T 2owb_A 81 KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158 (335)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456778899999999999999999999998754 479999999999999999998889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|+
T Consensus 159 ~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 235 (335)
T 2owb_A 159 RNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235 (335)
T ss_dssp HTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHH
T ss_pred HCC--CEecCCCchhEEEc-CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 999 99999999999997 7889999999999766422 234567999999999884 55889999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|+.||... .....+..+..+.. .++...++.+++||.+||. +|.+||++.++|+||||....
T Consensus 236 ~g~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 236 VGKPPFETS-CLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HSSCTTCCS-SHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HCcCCCCCC-CHHHHHHHHhcCCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 999999764 44445555544422 2455678999999999996 799999999999999998643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=334.17 Aligned_cols=214 Identities=27% Similarity=0.460 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
...+.+|+.+|++++|||||++++++... .+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 184 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~- 259 (419)
T 3i6u_A 184 ALNVETEIEILKKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG- 259 (419)
T ss_dssp -CCHHHHHHHHHHCCCTTBCCCCEEEESS---EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecC---ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 34688999999999999999999987432 57899999999999999988889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCC-CcccccCCCCccCccccc----cCCCccceehhhHHHHHHHh
Q 008378 87 PIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGiilyEml 159 (568)
|+||||||+|||++. .++.+||+|||+++..... .....+||+.|+|||++. ..|+.++|||||||++|+|+
T Consensus 260 -ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ll 338 (419)
T 3i6u_A 260 -IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338 (419)
T ss_dssp -CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHH
T ss_pred -ccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHH
Confidence 999999999999962 2346999999999876543 335678999999999873 46889999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||..||........+...+..+..+. ......++.+++||.+||+ +|.+||++.|+|+||||+...
T Consensus 339 tg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 339 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred HCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 99999987665555666666554322 1224568899999999996 799999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.26 Aligned_cols=218 Identities=23% Similarity=0.384 Sum_probs=183.4
Q ss_pred HHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+.+.+|+++|+.+ +||||+++++++.... .+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 102 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 179 (355)
T 1vzo_A 102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTET--KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179 (355)
T ss_dssp GGGCCCHHHHHHHHHTCTTBCCEEEEEEETT--EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHccCCCceeEEEEEEeeCc--eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567899999999 6999999999887654 78999999999999999998889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCcccccc---CCCccceehhhHHHHHHHh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~~---~ys~ksDIWSLGiilyEml 159 (568)
|+||||||+|||++ .+|.+||+|||+++..... .....+||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 180 --ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell 256 (355)
T 1vzo_A 180 --IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256 (355)
T ss_dssp --CCCCCCCGGGEEEC-TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH
T ss_pred --cccCCCCHHHEEEC-CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999997 7889999999999765322 2345689999999998853 4789999999999999999
Q ss_pred hcCCCCCCC---CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcc
Q 008378 160 TCEYPYNEC---KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLV 230 (568)
Q Consensus 160 tG~~Pf~~~---~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~ 230 (568)
||..||... .....+...+..... .++...++.+++||.+||. +|.+|| ++.++++||||+..++..+.
T Consensus 257 ~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~ 334 (355)
T 1vzo_A 257 TGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLA 334 (355)
T ss_dssp HSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred HCCCCCccCCccchHHHHHHHHhccCC--CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhh
Confidence 999999643 234555555554432 2455678999999999996 799999 99999999999987765544
Q ss_pred c
Q 008378 231 C 231 (568)
Q Consensus 231 ~ 231 (568)
.
T Consensus 335 ~ 335 (355)
T 1vzo_A 335 A 335 (355)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=305.30 Aligned_cols=211 Identities=25% Similarity=0.474 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+++.+|+.+|+.++||||+++++++... ..+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~- 131 (276)
T 2h6d_A 55 VGKIKREIQNLKLFRHPHIIKLYQVISTP--TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM- 131 (276)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 56789999999999999999999988654 479999999999999999998889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccccC-C-CccceehhhHHHHHHHhhcCC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~-y-s~ksDIWSLGiilyEmltG~~ 163 (568)
++||||||+||+++ .++.+||+|||++...... ......||+.|+|||++.+. + +.++||||||+++|+|++|..
T Consensus 132 -i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 209 (276)
T 2h6d_A 132 -VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTL 209 (276)
T ss_dssp -SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSC
T ss_pred -CccCCCChhhEEEC-CCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCC
Confidence 99999999999997 7889999999999876443 23455799999999988544 3 689999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||.. .....+...+..+..+ ++...++.++++|.+||. +|.+||++.++++||||+...
T Consensus 210 p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 210 PFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp SSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred CCCC-CcHHHHHHHhhcCccc--CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 9976 4556666666665432 345678999999999996 799999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=317.01 Aligned_cols=215 Identities=24% Similarity=0.390 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCC------CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDT------NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~------~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~ 79 (568)
...+.+|+.+|+.++||||+++++++.... ...+++||||+.+ +|.+++... +.+++..++.++.||+.||.
T Consensus 60 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~ 138 (351)
T 3mi9_A 60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138 (351)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence 356789999999999999999999987653 3478999999985 776666544 67999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC------CCcccccCCCCccCccccc--cCCCccceehhh
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ------PTARSVIGTPEFMAPELYE--EEYNELVDIYSF 151 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~------~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSL 151 (568)
|||++| |+||||||+|||++ .+|.+||+|||++..... .......||+.|+|||++. ..|+.++|||||
T Consensus 139 ~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 215 (351)
T 3mi9_A 139 YIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 215 (351)
T ss_dssp HHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred HHHHCC--eeCCCCCHHHEEEc-CCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence 999999 99999999999997 788999999999976532 1223457899999999874 458999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCC---------------------------CcHHHHHHHHHh
Q 008378 152 GMCILEMVTCEYPYNECKNPAQIYKKVT--SGIKPASLSKV---------------------------TDPQVKQFIEKC 202 (568)
Q Consensus 152 GiilyEmltG~~Pf~~~~~~~~i~~~i~--~~~~p~~~~~~---------------------------~s~el~~lI~kc 202 (568)
||++|+|+||..||.+......+..... ....+..++.. .++.+++||.+|
T Consensus 216 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 295 (351)
T 3mi9_A 216 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 295 (351)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHH
Confidence 9999999999999987544433332222 22222222211 267899999999
Q ss_pred cC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 203 IV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 203 L~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|+ +|.+||++.|+|+||||+...
T Consensus 296 L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 296 LVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp SCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred hcCChhhCCCHHHHhCCCCcCCCC
Confidence 96 799999999999999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.90 Aligned_cols=215 Identities=27% Similarity=0.528 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~-k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+.+|+.++||||+++++++... ..+++||||+.+|+|.+++. ....+++..++.++.||+.||.|||++|
T Consensus 68 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 145 (314)
T 3com_A 68 LQEIIKEISIMQQCDSPHVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145 (314)
T ss_dssp CHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46789999999999999999999998764 37899999999999999987 4567999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|.
T Consensus 146 --i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 222 (314)
T 3com_A 146 --KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222 (314)
T ss_dssp --EECCCCSGGGEEEC-TTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred --CcCCCcCHHHEEEC-CCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCC
Confidence 99999999999997 7789999999999766433 234567999999999874 45899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
.||........+.............+...++.+++||.+||. +|.+||++.+++.||||+....
T Consensus 223 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 223 PPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred CCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 999875444433333333222222344568899999999996 7999999999999999987654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.42 Aligned_cols=214 Identities=22% Similarity=0.371 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+.+.+|+.+|++++ ||||+++++++.+......++||||+.+++|.++++. +++..++.++.||+.||.|||++|
T Consensus 74 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ 150 (330)
T 3nsz_A 74 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG 150 (330)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 467899999999997 9999999999987666789999999999999998754 899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++..++.+||+|||+++..... ......||+.|+|||++. ..|+.++|||||||++|+|++|.
T Consensus 151 --ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 228 (330)
T 3nsz_A 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228 (330)
T ss_dssp --EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred --eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999854458999999999766433 344568999999999874 45899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHH-------------cCCC----------------------CCCCCCCCcHHHHHHHHHhcC-CC
Q 008378 163 YPYNECKNPAQIYKKVT-------------SGIK----------------------PASLSKVTDPQVKQFIEKCIV-PA 206 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~-------------~~~~----------------------p~~~~~~~s~el~~lI~kcL~-~p 206 (568)
.||............+. .... +.......++++++||.+||. +|
T Consensus 229 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 308 (330)
T 3nsz_A 229 EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 308 (330)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSG
T ss_pred CCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCc
Confidence 99965444332221111 1100 011122268999999999996 79
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q 008378 207 SLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 207 ~~Rpsa~ElL~hpff~~~~ 225 (568)
.+|||+.|+|+||||+...
T Consensus 309 ~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 309 QSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp GGSCCHHHHHTSGGGTTCC
T ss_pred ccCCCHHHHhcCccHhhhc
Confidence 9999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.00 Aligned_cols=215 Identities=20% Similarity=0.374 Sum_probs=170.0
Q ss_pred HHHHHHHHHH-HhCCCCCeeeeeeEEEc--CCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhh
Q 008378 8 ERLYSEVHLL-KSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 8 e~l~~Ei~iL-k~L~HpNIV~l~~~~~~--~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLH 82 (568)
..+.+|+.++ +.++||||++++++|.. .+...+|+|||||.||+|.+++...+ .+++..++.|+.||+.||.|||
T Consensus 99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH 178 (400)
T 1nxk_A 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178 (400)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567899987 45589999999998864 23457999999999999999998754 5999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCC--CCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~--~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
++| |+||||||+|||++.. ++.+||+|||+++..... .....+||+.|+|||++ ...|+.++|||||||++|+|
T Consensus 179 ~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 256 (400)
T 1nxk_A 179 SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256 (400)
T ss_dssp HTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHH
T ss_pred HCC--ccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHH
Confidence 999 9999999999999732 689999999999865432 34566899999999988 45699999999999999999
Q ss_pred hhcCCCCCCCCCHH---HHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 159 VTCEYPYNECKNPA---QIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 159 ltG~~Pf~~~~~~~---~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
++|..||....... .+...+..+.. +.......++++++||.+||. +|.+||++.++|+||||...
T Consensus 257 l~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 257 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 99999997643221 13333433322 222334578999999999996 79999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=325.83 Aligned_cols=215 Identities=27% Similarity=0.454 Sum_probs=166.8
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHH
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~---------~~l~e~~i~~i~~QIl~gL 78 (568)
+.+.+|+.+|++|+|||||+++++|.......+|+||||+. |+|.+++..+ ..+++..++.++.||+.||
T Consensus 63 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 141 (405)
T 3rgf_A 63 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141 (405)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHH
Confidence 46789999999999999999999998777778999999997 5888877632 2499999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEe---CCCCcEEEeecChhhhccCC-----CcccccCCCCccCcccccc--CCCcccee
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDI 148 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~---~~~g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl~~--~ys~ksDI 148 (568)
.|||++| |+||||||+|||+. ...+.+||+|||+++..... .....+||+.|+|||++.+ .|+.++||
T Consensus 142 ~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 219 (405)
T 3rgf_A 142 HYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI 219 (405)
T ss_dssp HHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHH
T ss_pred HHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhh
Confidence 9999999 99999999999993 25689999999999876432 2345689999999998743 48999999
Q ss_pred hhhHHHHHHHhhcCCCCCCCCC---------HHHHHHHHHc-CCCCCC-C------------------------------
Q 008378 149 YSFGMCILEMVTCEYPYNECKN---------PAQIYKKVTS-GIKPAS-L------------------------------ 187 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~~~---------~~~i~~~i~~-~~~p~~-~------------------------------ 187 (568)
|||||++|+|+||..||..... ..++...+.. +.++.. +
T Consensus 220 wSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (405)
T 3rgf_A 220 WAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM 299 (405)
T ss_dssp HHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhH
Confidence 9999999999999999965432 2333332221 111111 1
Q ss_pred ---CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 188 ---SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 188 ---~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
....++.+++||.+||. +|.+|||+.|+|+||||....
T Consensus 300 ~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 300 EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp HTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred hhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 01126789999999996 799999999999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=317.71 Aligned_cols=215 Identities=24% Similarity=0.433 Sum_probs=185.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY------RKK--HKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~------i~k--~~~l~e~~i~~i~~QIl~gL 78 (568)
.+.+.+|+.+|++++||||+++++++.+. ..+++||||+++|+|.++ +.+ .+.+++..++.++.||+.||
T Consensus 87 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l 164 (348)
T 2pml_X 87 YDDFKNELQIITDIKNEYCLTCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSF 164 (348)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHH
Confidence 37899999999999999999999998765 479999999999999998 665 57799999999999999999
Q ss_pred Hhhhh-CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccccc--CCCc-cceehhhHHH
Q 008378 79 HYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNE-LVDIYSFGMC 154 (568)
Q Consensus 79 ~yLHs-~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~--~ys~-ksDIWSLGii 154 (568)
.|||+ +| ++||||||+||+++ .++.+||+|||++............||+.|+|||++.+ .++. ++||||||++
T Consensus 165 ~~lH~~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~i 241 (348)
T 2pml_X 165 SYIHNEKN--ICHRDVKPSNILMD-KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241 (348)
T ss_dssp HHHHHTSC--EECCCCCGGGEEEC-TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHH
T ss_pred HHHhccCC--EeecCCChHhEEEc-CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHH
Confidence 99999 88 99999999999997 78899999999998765555566789999999998854 3555 9999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC-----------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-----------------SKVTDPQVKQFIEKCIV-PASLRLPALELL 216 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~-----------------~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL 216 (568)
+|+|++|..||........+...+..+..+... ....++++++||.+||. +|.+||++.|++
T Consensus 242 l~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l 321 (348)
T 2pml_X 242 LYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321 (348)
T ss_dssp HHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 999999999998876657777777665332211 14578999999999996 799999999999
Q ss_pred cCCCCCCCCC
Q 008378 217 KDPFLVTDNP 226 (568)
Q Consensus 217 ~hpff~~~~~ 226 (568)
+||||+..+.
T Consensus 322 ~hp~f~~~~~ 331 (348)
T 2pml_X 322 KHEWLADTNI 331 (348)
T ss_dssp TSGGGTTCCH
T ss_pred cCccccCCCH
Confidence 9999987553
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=312.17 Aligned_cols=216 Identities=30% Similarity=0.540 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHH
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL 78 (568)
..+.+.+|+.+|+++ +||||+++++++.... ...+++||||+.+|+|.+++... ..+++..++.++.||+.||
T Consensus 63 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l 142 (326)
T 2x7f_A 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142 (326)
T ss_dssp TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence 346788999999999 8999999999998643 45799999999999999999875 5799999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc------cCCCccceehh
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYS 150 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~------~~ys~ksDIWS 150 (568)
.|||++| ++||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++||||
T Consensus 143 ~~lH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s 219 (326)
T 2x7f_A 143 SHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 219 (326)
T ss_dssp HHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHH
T ss_pred HHHHHCC--ccccCCcHHHEEEc-CCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHH
Confidence 9999999 99999999999997 7899999999999766432 234567999999999873 45889999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||+++|+|++|..||.... .......+.....+.......++.+++||.+||. +|.+||++.++++||||+...
T Consensus 220 lG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 220 LGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHHHHHHHhCCCCCCCCc-HHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 9999999999999997754 4444444545444544556678999999999996 799999999999999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.29 Aligned_cols=219 Identities=21% Similarity=0.346 Sum_probs=178.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCC--eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~--~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+++..+++.+|++++++++||||+++++++...... ..|+||||+++|+|.+++...+.+++..++.++.||+.||.|
T Consensus 52 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~ 131 (311)
T 3ork_A 52 DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131 (311)
T ss_dssp SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence 456678899999999999999999999988765432 568999999999999999988899999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----CcccccCCCCccCccccc-cCCCccceehhhHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 154 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGii 154 (568)
||++| |+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++. ..++.++||||||++
T Consensus 132 lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 208 (311)
T 3ork_A 132 SHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208 (311)
T ss_dssp HHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHH
T ss_pred HHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHH
Confidence 99999 99999999999998 7889999999999765432 223457999999999874 568999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+|+|+||+.||.+..........+.....+. ......+++++++|.+||. +|.+||++.+++.|+|++..
T Consensus 209 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 209 LYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 9999999999987554454555554443322 2234578899999999996 69999999999999999753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=316.67 Aligned_cols=215 Identities=27% Similarity=0.464 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
....+.+|+++|++++||||+++++++... .+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 58 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 134 (322)
T 2ycf_A 58 PALNVETEIEILKKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134 (322)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhHHHHHHHHHhCCCCCCceEeeEEcCC---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345688999999999999999999988643 37999999999999999998889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCC--CCcEEEeecChhhhccCCC-cccccCCCCccCcccc----ccCCCccceehhhHHHHHHH
Q 008378 86 PPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~--~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl----~~~ys~ksDIWSLGiilyEm 158 (568)
|+||||||+|||++.. .+.+||+|||++....... .....||+.|+|||++ ...|+.++||||||+++|+|
T Consensus 135 --ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l 212 (322)
T 2ycf_A 135 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212 (322)
T ss_dssp --EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHH
T ss_pred --eeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999732 2359999999997664332 2345799999999986 35689999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
++|..||........+...+..+..+. ......++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 213 LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp HHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred HhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 999999987655545555555543321 1224567899999999996 799999999999999998644
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=314.94 Aligned_cols=219 Identities=22% Similarity=0.372 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 6 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
..+++.+|+.+|+.+ +||||++++++|.+. ..+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||
T Consensus 71 ~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH 148 (327)
T 3lm5_A 71 CRAEILHEIAVLELAKSCPRVINLHEVYENT--SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148 (327)
T ss_dssp CHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 356789999999999 569999999998654 4799999999999999988653 67999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
++| |+||||||+|||++. ..|.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|
T Consensus 149 ~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 226 (327)
T 3lm5_A 149 QNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 226 (327)
T ss_dssp HTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred HCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHH
Confidence 999 999999999999973 2689999999999876443 234568999999999884 5689999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCCCc
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~~l 229 (568)
++|..||.... .......+.... .+.......++.+++||.+||. +|.+||++.++|+||||+..++..+
T Consensus 227 l~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 227 LTHTSPFVGED-NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp HHSSCSSCCSS-HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred HhCCCCCCCCC-chHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 99999998754 444444444332 2333445678999999999996 6999999999999999998776554
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.97 Aligned_cols=215 Identities=23% Similarity=0.475 Sum_probs=180.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k--~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
...+++.+|+++|++++||||+++++++.+.....+++||||+.++ |.+++.. .+.+++..++.++.||+.||.|||
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 126 (305)
T 2wtk_C 48 NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126 (305)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 3567899999999999999999999998776667899999999876 7777765 356999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccccc---CCCccceehhhHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCI 155 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~~---~ys~ksDIWSLGiil 155 (568)
++| ++||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++
T Consensus 127 ~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 127 SQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp HTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred HCC--eeecCCCcccEEEc-CCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 999 99999999999997 7899999999999765321 2235579999999998854 247899999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
|+|++|..||.. .+...+...+..+.. .++...++.+++||.+||. +|.+||++.++++||||+...+
T Consensus 204 ~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 204 YNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 999999999976 456666666666533 2455678999999999996 7999999999999999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.67 Aligned_cols=212 Identities=24% Similarity=0.381 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHHHhCC-----CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLK-----HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILR 76 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~-----HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~ 76 (568)
....+.+.+|+.+|+.+. |||||+++++|.... .+++||||+ +++|.+++.... .+++..++.++.||+.
T Consensus 72 ~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~ 148 (360)
T 3llt_A 72 KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD--HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILK 148 (360)
T ss_dssp HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT--EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC--eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHH
Confidence 455677888999999997 999999999987654 799999999 899999998764 5999999999999999
Q ss_pred HHHhhhhCCCCeEeeeccCCcEEEeC------------------------CCCcEEEeecChhhhccCCCcccccCCCCc
Q 008378 77 GLHYLHSHNPPIIHRDLKCDNIFVNG------------------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEF 132 (568)
Q Consensus 77 gL~yLHs~g~~IiHRDLKp~NILl~~------------------------~~g~vKI~DFGla~~~~~~~~~s~~GTp~Y 132 (568)
||.|||++| |+||||||+|||++. ..+.+||+|||++..... ......||+.|
T Consensus 149 aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y 225 (360)
T 3llt_A 149 ALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQY 225 (360)
T ss_dssp HHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGG
T ss_pred HHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccc
Confidence 999999999 999999999999962 378999999999976433 33466899999
Q ss_pred cCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC------------------------C
Q 008378 133 MAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS------------------------L 187 (568)
Q Consensus 133 mAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~------------------------~ 187 (568)
+|||++ ...|+.++|||||||++|+|+||+.||....... ....+.....+.. +
T Consensus 226 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (360)
T 3llt_A 226 RAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAW 304 (360)
T ss_dssp CCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECT
T ss_pred cCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecC
Confidence 999987 4569999999999999999999999998754333 3332222111100 0
Q ss_pred C--------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 188 S--------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 188 ~--------------------~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
+ ...++.+.+||.+||+ +|.+|||+.|+|+||||+
T Consensus 305 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 305 PENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp TTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 0 1123778899999996 799999999999999995
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=326.49 Aligned_cols=213 Identities=20% Similarity=0.327 Sum_probs=172.7
Q ss_pred HHHHHHHHHhCCCCCeeeeeeEEEcC----CCCeEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 10 LYSEVHLLKSLKHENIIKFYNSWVDD----TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNIV~l~~~~~~~----~~~~l~lV~Ey~~gGsL~~~i~----k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
..+|+++|+.|+|||||+++++|... +..++++||||+.+ +|.+++. ....+++..++.++.||+.||.||
T Consensus 94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (420)
T 1j1b_A 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172 (420)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 34799999999999999999988642 23457899999985 5555443 356799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc--cCCCccceehhhHHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEm 158 (568)
|++| |+||||||+|||++.+.+.+||+|||+++.+... .....+||+.|+|||++. ..|+.++|||||||++|||
T Consensus 173 H~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 250 (420)
T 1j1b_A 173 HSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 250 (420)
T ss_dssp HTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHCC--ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHH
Confidence 9999 9999999999999866678999999999866433 345678999999999874 3699999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCC--------------CCC------------CCCCCcHHHHHHHHHhcC-CCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIK--------------PAS------------LSKVTDPQVKQFIEKCIV-PASLRLP 211 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~--------------p~~------------~~~~~s~el~~lI~kcL~-~p~~Rps 211 (568)
++|+.||.+....+++.+.+..... ... +....++++++||.+||+ +|.+||+
T Consensus 251 l~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t 330 (420)
T 1j1b_A 251 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330 (420)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC
Confidence 9999999886655555554431100 001 123457899999999996 7999999
Q ss_pred HHHHhcCCCCCCCC
Q 008378 212 ALELLKDPFLVTDN 225 (568)
Q Consensus 212 a~ElL~hpff~~~~ 225 (568)
+.|+|+||||+...
T Consensus 331 ~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 331 PLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHTSGGGGGGG
T ss_pred HHHHhCCHhhcccc
Confidence 99999999997643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.93 Aligned_cols=213 Identities=25% Similarity=0.431 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~----k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
..+.+.++...++.++||||+++++++.+.. .+++||||+. |+|.+++. ..+.+++..++.++.||+.||.||
T Consensus 49 ~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 125 (290)
T 3fme_A 49 QKRLLMDLDISMRTVDCPFTVTFYGALFREG--DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125 (290)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCeEEEEeeeeeccC--CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3444555666688999999999999987654 6899999997 58877665 356899999999999999999999
Q ss_pred hhC-CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccc-----ccCCCccceehhhHHH
Q 008378 82 HSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-----EEEYNELVDIYSFGMC 154 (568)
Q Consensus 82 Hs~-g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl-----~~~ys~ksDIWSLGii 154 (568)
|++ | ++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++ ...++.++||||||++
T Consensus 126 H~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 202 (290)
T 3fme_A 126 HSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202 (290)
T ss_dssp HHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred hhcCC--eecCCCCHHHEEEC-CCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence 998 8 99999999999997 67899999999998765433 3345799999999985 3458899999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+|+|+||..||..................+.......+++++++|.+||. +|.+||++.|+++||||+..
T Consensus 203 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 203 MIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 99999999999876666665555555555554556678999999999997 69999999999999999753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.95 Aligned_cols=217 Identities=27% Similarity=0.433 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+.+.+|+.+|++++||||+++++++.+. ..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+
T Consensus 65 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 142 (331)
T 4aaa_A 65 KMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142 (331)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 44567788999999999999999999998755 4789999999999999998888889999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccccc--CCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEml 159 (568)
+| |+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|+
T Consensus 143 ~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 219 (331)
T 4aaa_A 143 HN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219 (331)
T ss_dssp TT--CCCCCCCGGGEEEC-TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred CC--EEccCcChheEEEc-CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHH
Confidence 99 99999999999997 7889999999999765432 2345679999999998854 5899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHc-------------------CCCCCC---------CCCCCcHHHHHHHHHhcC-CCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTS-------------------GIKPAS---------LSKVTDPQVKQFIEKCIV-PASLRL 210 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~-------------------~~~p~~---------~~~~~s~el~~lI~kcL~-~p~~Rp 210 (568)
+|+.||........+...+.. +..... .....++.+++||.+||. +|.+||
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 299 (331)
T 4aaa_A 220 MGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299 (331)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC
Confidence 999999876655554443321 000000 012457899999999996 799999
Q ss_pred CHHHHhcCCCCCCCC
Q 008378 211 PALELLKDPFLVTDN 225 (568)
Q Consensus 211 sa~ElL~hpff~~~~ 225 (568)
++.|+|+||||+...
T Consensus 300 t~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 300 FCAELLHHDFFQMDG 314 (331)
T ss_dssp CGGGGGGSHHHHGGG
T ss_pred CHHHHhcCchhccCC
Confidence 999999999998643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.46 Aligned_cols=216 Identities=33% Similarity=0.530 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC-----------CCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-----------NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWA 71 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~-----------~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~ 71 (568)
....+.+.+|+.+|++++||||++++++|.+.. ...+|+||||+++|+|.+++...+ .+++..++.++
T Consensus 43 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 122 (303)
T 1zy4_A 43 EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122 (303)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHH
Confidence 456788999999999999999999999887532 357899999999999999998654 68899999999
Q ss_pred HHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----------------CcccccCCCCccCc
Q 008378 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----------------TARSVIGTPEFMAP 135 (568)
Q Consensus 72 ~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----------------~~~s~~GTp~YmAP 135 (568)
.||+.||.|||++| ++||||||+||+++ .+|.+||+|||++...... ......||+.|+||
T Consensus 123 ~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 199 (303)
T 1zy4_A 123 RQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT 199 (303)
T ss_dssp HHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCCCSCTTC-------------------------CTTSCH
T ss_pred HHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCc
Confidence 99999999999999 99999999999997 7889999999998765321 22345799999999
Q ss_pred ccccc--CCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCC
Q 008378 136 ELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRL 210 (568)
Q Consensus 136 Evl~~--~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~s~el~~lI~kcL~-~p~~Rp 210 (568)
|++.+ .++.++||||||+++|+|++ ||........+...+.... .|..+....++.++++|.+||. +|.+||
T Consensus 200 E~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (303)
T 1zy4_A 200 EVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276 (303)
T ss_dssp HHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC
T ss_pred ccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCc
Confidence 98853 58999999999999999998 6654444455555555432 2444556677889999999996 799999
Q ss_pred CHHHHhcCCCCCCCC
Q 008378 211 PALELLKDPFLVTDN 225 (568)
Q Consensus 211 sa~ElL~hpff~~~~ 225 (568)
++.++++||||+...
T Consensus 277 s~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 277 GARTLLNSGWLPVKH 291 (303)
T ss_dssp CHHHHHHSSCSCCCC
T ss_pred CHHHHhCCCCcCCCC
Confidence 999999999997643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.26 Aligned_cols=213 Identities=25% Similarity=0.444 Sum_probs=178.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+.+|+.+|++++||||+++++++.+. ..+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||++|
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~- 128 (283)
T 3bhy_A 52 REEIEREVNILREIRHPNIITLHDIFENK--TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR- 128 (283)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCeeehhheecCC--CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 57889999999999999999999988754 479999999999999999998889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCC----cEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh
Q 008378 87 PIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g----~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt 160 (568)
++||||||+||+++ .++ .+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++
T Consensus 129 -i~H~dl~p~Nil~~-~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 206 (283)
T 3bhy_A 129 -IAHFDLKPENIMLL-DKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206 (283)
T ss_dssp -EECSCCSGGGEEES-CSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred -ccCCCCChHHEEEe-cCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH
Confidence 99999999999997 444 8999999999766432 234557999999999884 568999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
|..||... ........+...... .......++.+++||.+||. +|.+||++.++++||||+...
T Consensus 207 g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 207 GASPFLGE-TKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp SSCTTCCS-SHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CCCCCCCc-chHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 99999874 445555555544322 11224567899999999996 699999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=323.29 Aligned_cols=218 Identities=30% Similarity=0.427 Sum_probs=165.4
Q ss_pred CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHH
Q 008378 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 77 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~g 77 (568)
++....+++.+|+.+|+.++||||++++++|.... ...+|+|+||+ +++|.++++. +.+++..++.++.||+.|
T Consensus 67 ~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~a 144 (367)
T 2fst_X 67 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRG 144 (367)
T ss_dssp SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHH
Confidence 34567788999999999999999999999886532 24689999999 6899998876 679999999999999999
Q ss_pred HHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHH
Q 008378 78 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCI 155 (568)
Q Consensus 78 L~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiil 155 (568)
|.|||++| |+||||||+|||++ .+|.+||+|||+++..... ....+||++|+|||++. ..|+.++|||||||++
T Consensus 145 L~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 220 (367)
T 2fst_X 145 LKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220 (367)
T ss_dssp HHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHH
T ss_pred HHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEeecccccccccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHH
Confidence 99999999 99999999999997 7899999999999765432 34568999999999874 4689999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCC-------------------------CC---CCCCCcHHHHHHHHHhcC-CC
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------------------AS---LSKVTDPQVKQFIEKCIV-PA 206 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p-------------------------~~---~~~~~s~el~~lI~kcL~-~p 206 (568)
|+|++|+.||.+.....++...+.....| .. .....++++++||.+||+ +|
T Consensus 221 ~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 300 (367)
T 2fst_X 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 300 (367)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCc
Confidence 99999999998765544443332210000 00 112357899999999996 79
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q 008378 207 SLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 207 ~~Rpsa~ElL~hpff~~~~ 225 (568)
.+|||+.++|.||||....
T Consensus 301 ~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 301 DKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp GGSCCHHHHHTSGGGTTTC
T ss_pred ccCcCHHHHhcChhhhhcc
Confidence 9999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.25 Aligned_cols=215 Identities=31% Similarity=0.528 Sum_probs=184.7
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+++|++++||||+++++++.+. ..+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 141 (287)
T 2wei_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141 (287)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhccCCCccEEEEEEeCC--CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 467889999999999999999999988654 479999999999999999988889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCC--CCcEEEeecChhhhccCC-CcccccCCCCccCccccccCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~--~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG~ 162 (568)
++||||||+||+++.. .+.+||+|||++...... ......||+.|+|||++.+.++.++||||||+++|+|++|.
T Consensus 142 --i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~ 219 (287)
T 2wei_A 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGT 219 (287)
T ss_dssp --CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSS
T ss_pred --eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCC
Confidence 9999999999999632 347999999999876443 23445789999999999888999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||... +...+...+..+..+... ....+++++++|.+||. +|.+||++.++|.||||+...
T Consensus 220 ~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 220 PPFYGK-NEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp CSSCCS-SHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred CCCCCC-CHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 999874 455666666665443322 24568999999999996 799999999999999997643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=313.28 Aligned_cols=212 Identities=23% Similarity=0.382 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~---l~e~~i~~i~~QIl~gL~yLH 82 (568)
..+.+.+|+++|++++||||+++++++.......+++||||+.+|+|.+++..... +++..++.++.||+.||.|||
T Consensus 50 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH 129 (319)
T 4euu_A 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129 (319)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 35678899999999999999999999987776689999999999999999987543 999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEE----eCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc---------cCCCcccee
Q 008378 83 SHNPPIIHRDLKCDNIFV----NGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDI 148 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl----~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~---------~~ys~ksDI 148 (568)
++| |+||||||+|||+ + ..+.+||+|||+++..... ......||+.|+|||++. ..|+.++||
T Consensus 130 ~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di 206 (319)
T 4euu_A 130 ENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206 (319)
T ss_dssp HTT--EECSCCSGGGEEEEECTT-SCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHH
T ss_pred HCC--EecCCCCHHHEEEeccCC-CCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHH
Confidence 999 9999999999998 4 5567999999999876443 334567999999999874 568899999
Q ss_pred hhhHHHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCC-----------------------CCCCCCcHHHHHHHHHh
Q 008378 149 YSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPA-----------------------SLSKVTDPQVKQFIEKC 202 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~~~---~~~i~~~i~~~~~p~-----------------------~~~~~~s~el~~lI~kc 202 (568)
|||||++|+|+||..||..... ...+...+..+.++. .+....++.+++||.+|
T Consensus 207 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 286 (319)
T 4euu_A 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286 (319)
T ss_dssp HHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHh
Confidence 9999999999999999964332 233444444333221 11223456899999999
Q ss_pred cC-CCCCCCCHHHHhcCCC
Q 008378 203 IV-PASLRLPALELLKDPF 220 (568)
Q Consensus 203 L~-~p~~Rpsa~ElL~hpf 220 (568)
|+ +|.+||++.|+|+||-
T Consensus 287 L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 287 LEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp SCCCTTTSCCHHHHHHHHH
T ss_pred ccCChhhhccHHHhhhccH
Confidence 96 7999999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=314.16 Aligned_cols=212 Identities=26% Similarity=0.432 Sum_probs=168.8
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
.+.+|+.+|+.++||||+++++++.+. ..+++||||+. |+|.+++...+ .+++..++.++.||+.||.|||++|
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-- 120 (324)
T 3mtl_A 46 TAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK-- 120 (324)
T ss_dssp CCCCCHHHHSCCCCTTBCCEEEEEECS--SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 455799999999999999999998755 46899999997 58988887754 5999999999999999999999999
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcCC
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
|+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..|+.++|||||||++|+|++|..
T Consensus 121 ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (324)
T 3mtl_A 121 VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199 (324)
T ss_dssp EEESSCCGGGEEEC-TTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCcCHHHEEEC-CCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999997 7789999999999765432 234557899999999874 458999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHH--cCCCCCCCC-------------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 008378 164 PYNECKNPAQIYKKVT--SGIKPASLS-------------------------KVTDPQVKQFIEKCIV-PASLRLPALEL 215 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~--~~~~p~~~~-------------------------~~~s~el~~lI~kcL~-~p~~Rpsa~El 215 (568)
||.+......+..... ....+..++ ...++++++||.+||+ +|.+|||+.|+
T Consensus 200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 279 (324)
T 3mtl_A 200 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279 (324)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence 9987554443333222 111111111 2357889999999996 79999999999
Q ss_pred hcCCCCCCCCC
Q 008378 216 LKDPFLVTDNP 226 (568)
Q Consensus 216 L~hpff~~~~~ 226 (568)
|+||||.....
T Consensus 280 l~hp~f~~~~~ 290 (324)
T 3mtl_A 280 MKHPFFLSLGE 290 (324)
T ss_dssp TTSGGGGGGCS
T ss_pred hcChhhhhccc
Confidence 99999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=307.64 Aligned_cols=215 Identities=26% Similarity=0.446 Sum_probs=175.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
..+..+++.+|+.++++++||||+++++++.+. ..+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||
T Consensus 51 ~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH 128 (294)
T 4eqm_A 51 KEETLKRFEREVHNSSQLSHQNIVSMIDVDEED--DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128 (294)
T ss_dssp CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC--CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456778999999999999999999999988654 479999999999999999999899999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
++| |+||||||+||+++ .+|.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|
T Consensus 129 ~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 205 (294)
T 4eqm_A 129 DMR--IVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEM 205 (294)
T ss_dssp HTT--CCCCCCCGGGEEEC-TTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHH
T ss_pred HCC--cccCCCCHHHEEEC-CCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHH
Confidence 999 99999999999997 78899999999998764332 33457999999999874 5588999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
+||+.||.+........+.+....++ .......++.+.++|.+||. +|.+||+..+.+.+.|..
T Consensus 206 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 206 LVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999998755444445554443322 12445678999999999996 699999666666665543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.15 Aligned_cols=204 Identities=24% Similarity=0.403 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG-SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gG-sL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+.+|++++||||++++++|.+. ..+++||||+.+| +|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 73 ~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 150 (335)
T 3dls_A 73 LGKVTLEIAILSRVEHANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150 (335)
T ss_dssp TEEEEHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEeeC--CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567899999999999999999998654 4789999999777 99999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccccc-CC-CccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~~-~y-s~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||++...... .....+||+.|+|||++.+ .+ +.++||||||+++|+|++|.
T Consensus 151 --ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 227 (335)
T 3dls_A 151 --IIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227 (335)
T ss_dssp --EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred --eEEeccCHHHEEEc-CCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCC
Confidence 99999999999997 7899999999999876543 3345689999999998743 34 78999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
.||..... .+ ......+...++++++||.+||. +|.+||++.++++||||+..
T Consensus 228 ~pf~~~~~------~~---~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 228 NPFCELEE------TV---EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CSCSSGGG------GT---TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred CchhhHHH------HH---hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 99975211 11 11222344578999999999996 69999999999999999764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.12 Aligned_cols=212 Identities=25% Similarity=0.384 Sum_probs=174.9
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
+.+.+|+++|+.++||||++++++|.+. ..+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++|
T Consensus 57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~- 132 (346)
T 1ua2_A 57 RTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132 (346)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEeeC--CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999988654 468899999985 888888765 46999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||+++..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|.
T Consensus 133 -ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 210 (346)
T 1ua2_A 133 -ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210 (346)
T ss_dssp -CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred -EECCCCCHHHEEEc-CCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 99999999999997 7899999999999876433 234568999999999874 34899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHc-CCC-CCCC-----------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 008378 163 YPYNECKNPAQIYKKVTS-GIK-PASL-----------------------SKVTDPQVKQFIEKCIV-PASLRLPALELL 216 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~-~~~-p~~~-----------------------~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL 216 (568)
.||.+......+.+.+.. +.+ +..+ ....++++++||.+||. +|.+|||+.|+|
T Consensus 211 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 211 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 999876544444443332 111 1111 13346899999999996 799999999999
Q ss_pred cCCCCCCCC
Q 008378 217 KDPFLVTDN 225 (568)
Q Consensus 217 ~hpff~~~~ 225 (568)
+||||....
T Consensus 291 ~h~~f~~~~ 299 (346)
T 1ua2_A 291 KMKYFSNRP 299 (346)
T ss_dssp TSGGGTSSS
T ss_pred cChhhhcCC
Confidence 999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=315.43 Aligned_cols=217 Identities=26% Similarity=0.404 Sum_probs=178.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~---~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
.....+++.+|+++|++++||||+++++++.... ...+|+||||+. |+|.++++. +.+++..++.++.||+.||.
T Consensus 65 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~ 142 (364)
T 3qyz_A 65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLK 142 (364)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHH
Confidence 3456688999999999999999999999886543 246899999997 599998876 46999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc--ccCCCccceehhhH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY--EEEYNELVDIYSFG 152 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLG 152 (568)
|||++| |+||||||+|||++ .+|.+||+|||++....... ....+||+.|+|||++ ...|+.++||||||
T Consensus 143 ~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 219 (364)
T 3qyz_A 143 YIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219 (364)
T ss_dssp HHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHH
T ss_pred HHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHH
Confidence 999999 99999999999997 78899999999997654322 3456899999999976 34489999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------C-----CCCCCCcHHHHHHHHHhcC
Q 008378 153 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-----------------------A-----SLSKVTDPQVKQFIEKCIV 204 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p-----------------------~-----~~~~~~s~el~~lI~kcL~ 204 (568)
|++|+|++|+.||.+......+...+.....| . ......++++++||.+||.
T Consensus 220 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 299 (364)
T 3qyz_A 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 299 (364)
T ss_dssp HHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcC
Confidence 99999999999998765544443332210000 0 0123467899999999996
Q ss_pred -CCCCCCCHHHHhcCCCCCCC
Q 008378 205 -PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 205 -~p~~Rpsa~ElL~hpff~~~ 224 (568)
+|.+|||+.|+|+||||+..
T Consensus 300 ~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 300 FNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp SSTTTSCCHHHHHTSGGGTTT
T ss_pred CChhhCCCHHHHhcCcchhhc
Confidence 79999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.49 Aligned_cols=219 Identities=25% Similarity=0.370 Sum_probs=170.3
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcC---CCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~---~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL 78 (568)
++...+++.+|+++|++++||||++++++|... ....+|+||||+. |+|.+++... ..+++..++.++.||+.||
T Consensus 69 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l 147 (362)
T 3pg1_A 69 DSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGL 147 (362)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHH
Confidence 345568999999999999999999999998653 3347899999998 6888877654 4799999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc--cCCCccceehhhHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCI 155 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiil 155 (568)
.|||++| |+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++
T Consensus 148 ~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 224 (362)
T 3pg1_A 148 HVLHEAG--VVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224 (362)
T ss_dssp HHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHH
T ss_pred HHHHHCc--CEecCCChHHEEEc-CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHH
Confidence 9999999 99999999999997 7889999999999765433 334568999999999874 4689999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCCcHHHHHHHHHhcC-C
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPA-----------------------------SLSKVTDPQVKQFIEKCIV-P 205 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~-----------------------------~~~~~~s~el~~lI~kcL~-~ 205 (568)
|+|++|+.||.+......+...+.....+. ......++.+++||.+||. +
T Consensus 225 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 304 (362)
T 3pg1_A 225 AEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN 304 (362)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCC
Confidence 999999999987554433333222110000 0123457889999999996 7
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 008378 206 ASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 206 p~~Rpsa~ElL~hpff~~~~ 225 (568)
|.+|||+.|+|+||||+...
T Consensus 305 P~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 305 PQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp GGGSCCHHHHHTSGGGTTTC
T ss_pred hhhCCCHHHHHcCchhhhcc
Confidence 99999999999999998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=306.36 Aligned_cols=215 Identities=25% Similarity=0.454 Sum_probs=180.2
Q ss_pred CHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~--HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+....+++.+|+.+|++++ ||||+++++++... ..+++||| +.+++|.+++.+.+.+++..++.++.||+.||.|
T Consensus 66 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~ 142 (313)
T 3cek_A 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHHhccccCCceEEEEEEeecC--CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence 3567789999999999997 59999999988764 47999999 5678999999998999999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccccc------------CCCc
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE------------EYNE 144 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~~------------~ys~ 144 (568)
||++| |+||||||+|||++ +|.+||+|||++....... .....||+.|+|||++.. .++.
T Consensus 143 LH~~~--ivH~dlkp~NIl~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~ 218 (313)
T 3cek_A 143 IHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218 (313)
T ss_dssp HHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCH
T ss_pred HHHCC--ceecCCCcccEEEE--CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCc
Confidence 99999 99999999999996 4899999999997664322 234579999999998753 6888
Q ss_pred cceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 145 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 145 ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
++||||||+++|+|++|..||............+........++...+++++++|.+||. +|.+||++.++|+||||+.
T Consensus 219 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 219 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred hHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 999999999999999999999876666555555555544445666778999999999996 7999999999999999975
Q ss_pred C
Q 008378 224 D 224 (568)
Q Consensus 224 ~ 224 (568)
.
T Consensus 299 ~ 299 (313)
T 3cek_A 299 Q 299 (313)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=298.56 Aligned_cols=210 Identities=20% Similarity=0.336 Sum_probs=177.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~y 80 (568)
+....+++.+|+.+|++++||||+++++++.+.....+++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|
T Consensus 47 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 126 (271)
T 3kmu_A 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126 (271)
T ss_dssp CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 4567788999999999999999999999988775568899999999999999999876 48999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccC----CCccceehhhHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCIL 156 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~----ys~ksDIWSLGiily 156 (568)
||+++++++||||||+||+++ .+|.+||+|||++.... .....||+.|+|||++.+. ++.++||||||+++|
T Consensus 127 lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 202 (271)
T 3kmu_A 127 LHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202 (271)
T ss_dssp HTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCTTS---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHH
T ss_pred HhcCCCceecCCCccceEEEc-CCcceeEEeccceeeec---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHH
Confidence 999988899999999999997 78899999988875432 2345789999999988432 344899999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|++|+.||...............+. ....+...+++++++|.+||. +|.+||++.++++
T Consensus 203 el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 203 ELVTREVPFADLSNMEIGMKVALEGL-RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHCSCTTTTSCHHHHHHHHHHSCC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCccccChHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999987554444444444443 344666788999999999996 6999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.76 Aligned_cols=219 Identities=25% Similarity=0.420 Sum_probs=177.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcC------------CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD------------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 70 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~------------~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i 70 (568)
+++..+++.+|+++|++++||||+++++++... ....+++||||+. |+|.+++.+ +.+++..++.+
T Consensus 48 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~ 125 (320)
T 2i6l_A 48 DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLF 125 (320)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHH
Confidence 567788999999999999999999999987432 2357899999998 699999865 57999999999
Q ss_pred HHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----CcccccCCCCccCccccc--cCCC
Q 008378 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE--EEYN 143 (568)
Q Consensus 71 ~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl~--~~ys 143 (568)
+.||+.||.|||++| |+||||||+||+++..++.+||+|||++...... ......||+.|+|||++. ..++
T Consensus 126 ~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (320)
T 2i6l_A 126 MYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203 (320)
T ss_dssp HHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred HHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence 999999999999999 9999999999999866789999999999765321 223456899999999773 5689
Q ss_pred ccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-----------------------C----CCCCCCCcHHHH
Q 008378 144 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-----------------------P----ASLSKVTDPQVK 196 (568)
Q Consensus 144 ~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~-----------------------p----~~~~~~~s~el~ 196 (568)
.++||||||+++|+|+||+.||.+......+...+..... + .......+++++
T Consensus 204 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (320)
T 2i6l_A 204 KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV 283 (320)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHH
T ss_pred chhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHH
Confidence 9999999999999999999999875543333322221100 0 011234688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 197 QFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 197 ~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+||.+||. +|.+||++.++|+||||+...
T Consensus 284 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 284 DFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 99999996 799999999999999998643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.27 Aligned_cols=210 Identities=25% Similarity=0.427 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC---------------------
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--------------------- 61 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~--------------------- 61 (568)
....+++.+|+++|+++ +|||||+++++|.+.. ..+++|||||.+|+|.+++.....
T Consensus 66 ~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (359)
T 3vhe_A 66 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144 (359)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------
T ss_pred HHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccc
Confidence 45667899999999999 8999999999887644 468899999999999999987643
Q ss_pred ---------------------------------------------CCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCC
Q 008378 62 ---------------------------------------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 96 (568)
Q Consensus 62 ---------------------------------------------l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~ 96 (568)
+++..++.|+.||+.||.|||++| |+||||||+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~ 222 (359)
T 3vhe_A 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 222 (359)
T ss_dssp ---------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred cchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChh
Confidence 899999999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCC
Q 008378 97 NIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKN 170 (568)
Q Consensus 97 NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~ 170 (568)
|||++ .++.+||+|||++...... ......||+.|+|||++ ...|+.++||||||+++|+|+| |..||.+...
T Consensus 223 NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 223 NILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp GEEEC-GGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEc-CCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 99997 7889999999999765332 22345789999999987 5668999999999999999998 9999988776
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 171 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 171 ~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
...+...+..+..+ ..+...+++++++|.+||. +|.+||++.+++.|
T Consensus 302 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 302 DEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp SHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 67777777665443 3456678999999999996 79999999999876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=315.36 Aligned_cols=209 Identities=28% Similarity=0.475 Sum_probs=178.1
Q ss_pred CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHH
Q 008378 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMK 65 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~ 65 (568)
.....+++.+|+.+|+.+ +|||||+++++|.+. ..+|+||||+.+|+|.+++...+ .+++.
T Consensus 126 ~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (370)
T 2psq_A 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203 (370)
T ss_dssp BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHH
T ss_pred CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHH
Confidence 346678899999999999 899999999988654 36899999999999999998754 48999
Q ss_pred HHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-cc
Q 008378 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EE 140 (568)
Q Consensus 66 ~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~ 140 (568)
.+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++..... ......||+.|+|||++ ..
T Consensus 204 ~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 280 (370)
T 2psq_A 204 DLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 280 (370)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeccccchhhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC
Confidence 99999999999999999999 99999999999997 7899999999999765432 12334678899999977 55
Q ss_pred CCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 141 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 141 ~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
.|+.++|||||||++|||+| |..||.+. ....++..+..+..+. .+...+++++++|.+||. +|.+||++.|++++
T Consensus 281 ~~~~~~DvwslG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 281 VYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 69999999999999999999 99999764 4566667776665433 455678999999999996 69999999998864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.33 Aligned_cols=219 Identities=26% Similarity=0.404 Sum_probs=176.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~---~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
.+....++.+|+.+|++++||||+++++++.... ...+++||||+. |+|.+++.. +.+++..++.++.||+.||.
T Consensus 49 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~ 126 (353)
T 2b9h_A 49 KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVK 126 (353)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHH
Confidence 3556778899999999999999999999775432 257899999997 699999887 56999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------------CcccccCCCCccCccccc--cCCCcc
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------------TARSVIGTPEFMAPELYE--EEYNEL 145 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------------~~~s~~GTp~YmAPEvl~--~~ys~k 145 (568)
|||++| |+||||||+|||++ .+|.+||+|||++...... .....+||+.|+|||++. ..++.+
T Consensus 127 ~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (353)
T 2b9h_A 127 VLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRA 203 (353)
T ss_dssp HHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHH
T ss_pred HHHHCC--eecCCCCHHHeEEc-CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccch
Confidence 999999 99999999999997 7889999999999765321 122357899999999763 568999
Q ss_pred ceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCCcHHHH
Q 008378 146 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-----------------------------SLSKVTDPQVK 196 (568)
Q Consensus 146 sDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~-----------------------------~~~~~~s~el~ 196 (568)
+|||||||++|+|++|..||.+......+.........|. ......+++++
T Consensus 204 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
T 2b9h_A 204 MDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI 283 (353)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHH
Confidence 9999999999999999999987554433332221100000 01134678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 197 QFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 197 ~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
+||.+||. +|.+||++.++|+||||+....
T Consensus 284 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 284 DLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 99999996 7999999999999999986543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.27 Aligned_cols=214 Identities=28% Similarity=0.448 Sum_probs=174.6
Q ss_pred HHHHHHHHHHhC---CCCCeeeeeeEEEc---CCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHh
Q 008378 9 RLYSEVHLLKSL---KHENIIKFYNSWVD---DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 9 ~l~~Ei~iLk~L---~HpNIV~l~~~~~~---~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~y 80 (568)
.+.+|+.+++.+ +||||+++++++.. .....+++||||+. |+|.+++.... .+++..++.++.||+.||.|
T Consensus 57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~ 135 (326)
T 1blx_A 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135 (326)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 456777777766 89999999998862 23457899999998 69999998764 49999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
||++| |+||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++ ...++.++||||||+++|+|
T Consensus 136 lH~~g--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 212 (326)
T 1blx_A 136 LHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212 (326)
T ss_dssp HHHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred HHHCC--ceeccCCHHHeEEc-CCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence 99999 99999999999997 7889999999999766432 33456899999999987 45689999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCC-C-----------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGI-K-----------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~-~-----------------------p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
++|..||.+......+.+.+.... + ...+....++.+++||.+||. +|.+||++.
T Consensus 213 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 292 (326)
T 1blx_A 213 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292 (326)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHH
Confidence 999999987654444433332100 0 011234568899999999996 799999999
Q ss_pred HHhcCCCCCCCCC
Q 008378 214 ELLKDPFLVTDNP 226 (568)
Q Consensus 214 ElL~hpff~~~~~ 226 (568)
++|.||||+....
T Consensus 293 e~l~hp~~~~~~~ 305 (326)
T 1blx_A 293 SALSHPYFQDLER 305 (326)
T ss_dssp HHHTSGGGTTCCC
T ss_pred HHhcCccccccch
Confidence 9999999987554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.71 Aligned_cols=215 Identities=29% Similarity=0.413 Sum_probs=165.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
+....+++.+|+.+|+.++||||+++++++.... ...+|+||||+. |+|.+++. ..+++..++.++.||+.||
T Consensus 64 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al 140 (371)
T 2xrw_A 64 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGI 140 (371)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHH
Confidence 4567788999999999999999999999886543 237899999997 57888886 4599999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
.|||++| |+||||||+|||++ .+|.+||+|||+++..... .....+||+.|+|||++ ...|+.++|||||||++|
T Consensus 141 ~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 217 (371)
T 2xrw_A 141 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217 (371)
T ss_dssp HHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHH
Confidence 9999999 99999999999997 7889999999999876443 23456899999999987 456899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCC-------------------CC--------------CC------CCcHHHHH
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPA-------------------SL--------------SK------VTDPQVKQ 197 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~-------------------~~--------------~~------~~s~el~~ 197 (568)
+|++|..||.+......+.+.+.....|. .+ +. ..++++++
T Consensus 218 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (371)
T 2xrw_A 218 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297 (371)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHH
Confidence 99999999987554444333332111110 00 00 01568999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 198 FIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 198 lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
||.+||. +|.+|||+.|+|+||||+.
T Consensus 298 li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 298 LLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 9999996 7999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=306.80 Aligned_cols=219 Identities=20% Similarity=0.347 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCC----eEEEEEecCCCCCHHHHHHhCC------CCCHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR----TINMITELFTSGSLRQYRKKHK------NVDMKAIKNWARQ 73 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~----~l~lV~Ey~~gGsL~~~i~k~~------~l~e~~i~~i~~Q 73 (568)
....+++.+|+++|++++||||+++++++...... ..++||||+.+|+|.+++.... .+++..++.++.|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q 145 (323)
T 3qup_A 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145 (323)
T ss_dssp CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHH
Confidence 45678899999999999999999999998765432 2489999999999999987543 5999999999999
Q ss_pred HHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCcccee
Q 008378 74 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDI 148 (568)
Q Consensus 74 Il~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDI 148 (568)
|+.||.|||++| |+||||||+|||++ .+|.+||+|||+++...... .....+|+.|+|||++ ...|+.++||
T Consensus 146 i~~al~~LH~~~--ivH~Dikp~NIli~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (323)
T 3qup_A 146 IACGMEYLSSRN--FIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV 222 (323)
T ss_dssp HHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHcCC--cccCCCCcceEEEc-CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccch
Confidence 999999999999 99999999999997 78999999999997664322 2234578899999987 4568999999
Q ss_pred hhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-------HHHHhcCC
Q 008378 149 YSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-------ALELLKDP 219 (568)
Q Consensus 149 WSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-------a~ElL~hp 219 (568)
|||||++|+|++ |..||.+.. ...+...+..+..+. .+...++++++||.+||. +|.+||+ ..+++.||
T Consensus 223 ~slG~il~ell~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 223 WAFGVTMWEIMTRGQTPYAGIE-NAEIYNYLIGGNRLK-QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hhHHHHHHHHHhCCCCCccccC-hHHHHHHHhcCCCCC-CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999 999998744 445555555554332 345678899999999996 7999999 77899999
Q ss_pred CCCCCCCC
Q 008378 220 FLVTDNPK 227 (568)
Q Consensus 220 ff~~~~~~ 227 (568)
|+......
T Consensus 301 ~~~~~~~~ 308 (323)
T 3qup_A 301 SVLSTSQD 308 (323)
T ss_dssp --------
T ss_pred hhcCCCCC
Confidence 99875543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=302.79 Aligned_cols=212 Identities=32% Similarity=0.572 Sum_probs=182.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
...+.+.+|+.+|+.++||||+++++++.+.. .+++||||+.+++|.+++.. +.+++..+..++.||+.||.|||++
T Consensus 62 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~ 138 (303)
T 3a7i_A 62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE 138 (303)
T ss_dssp TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--eEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678999999999999999999999987654 79999999999999999875 5799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
| ++||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|
T Consensus 139 ~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 215 (303)
T 3a7i_A 139 K--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215 (303)
T ss_dssp T--EECCCCSGGGEEEC-TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred C--CccCCCChheEEEC-CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccC
Confidence 9 99999999999997 7889999999999766433 234567999999999874 5689999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
..||... ........+..+.. ..+....++.+++||.+||. +|.+||++.++++||||...
T Consensus 216 ~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 216 EPPHSEL-HPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp SCTTTTS-CHHHHHHHHHHSCC-CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CCCCCCc-CHHHHHHHhhcCCC-CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 9999764 44455555554433 34556778999999999996 69999999999999999754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.54 Aligned_cols=205 Identities=28% Similarity=0.480 Sum_probs=170.3
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+.+..+.+.+|+++|++++||||+++++++.+. ..+++||||+.+|+|.++++. .+.+++..+..++.||+.||.||
T Consensus 47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l 124 (310)
T 3s95_A 47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124 (310)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 467788999999999999999999999998765 479999999999999999987 56799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc----------------ccccCCCCccCccccc-cCCCc
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----------------RSVIGTPEFMAPELYE-EEYNE 144 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~----------------~s~~GTp~YmAPEvl~-~~ys~ 144 (568)
|++| |+||||||+||+++ .++.+||+|||++........ ...+||+.|+|||++. ..|+.
T Consensus 125 H~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 201 (310)
T 3s95_A 125 HSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE 201 (310)
T ss_dssp HHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCT
T ss_pred HhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCc
Confidence 9999 99999999999997 788999999999976532211 1567999999999884 56899
Q ss_pred cceehhhHHHHHHHhhcCCCCCCCCCHH-----HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 145 LVDIYSFGMCILEMVTCEYPYNECKNPA-----QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 145 ksDIWSLGiilyEmltG~~Pf~~~~~~~-----~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++||||||+++|+|++|..||....... ........ ..+...++.+.++|.+||. +|.+||++.+++.
T Consensus 202 ~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 202 KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999986532211 11111111 1234567789999999996 7999999999886
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=302.55 Aligned_cols=209 Identities=27% Similarity=0.475 Sum_probs=178.2
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC---------------------
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--------------------- 61 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~--------------------- 61 (568)
++...+++.+|+++|++++||||+++++++.+.. .+++||||+.+|+|.+++...+.
T Consensus 66 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (314)
T 2ivs_A 66 SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143 (314)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTTTSTTEEC---------------
T ss_pred CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC--ceEEEEeecCCCCHHHHHHHHhhccCCccccccccccccccccc
Confidence 4567789999999999999999999999886543 68899999999999999987654
Q ss_pred ---CCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccC
Q 008378 62 ---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMA 134 (568)
Q Consensus 62 ---l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmA 134 (568)
+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++....... .....+|+.|+|
T Consensus 144 ~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 220 (314)
T 2ivs_A 144 ERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMA 220 (314)
T ss_dssp -CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCC
T ss_pred ccCcCHHHHHHHHHHHHHHHHHHHHCC--CcccccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccC
Confidence 899999999999999999999999 99999999999998 78899999999997653321 233467889999
Q ss_pred cccc-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC
Q 008378 135 PELY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP 211 (568)
Q Consensus 135 PEvl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps 211 (568)
||++ ...++.++||||||+++|+|+| |..||.+. ....+...+..+..+ ..+...++.++++|.+||. +|.+||+
T Consensus 221 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps 298 (314)
T 2ivs_A 221 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-PPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPV 298 (314)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcC
Confidence 9987 4558999999999999999999 99999764 455666666665443 3455678999999999996 7999999
Q ss_pred HHHHhcC
Q 008378 212 ALELLKD 218 (568)
Q Consensus 212 a~ElL~h 218 (568)
+.+++++
T Consensus 299 ~~~l~~~ 305 (314)
T 2ivs_A 299 FADISKD 305 (314)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999865
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=309.02 Aligned_cols=216 Identities=24% Similarity=0.308 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCC-----CCeEEEEEecCCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDT-----NRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRG 77 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~-----~~~l~lV~Ey~~gGsL~~~----i~k~~~l~e~~i~~i~~QIl~g 77 (568)
.++..+|++.++.++||||++++++|.... ..++++||||+.++ |... ......+++..++.++.||+.|
T Consensus 63 ~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 141 (360)
T 3e3p_A 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141 (360)
T ss_dssp CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHH
Confidence 345678888999999999999999986532 23488999999864 4433 3356779999999999999999
Q ss_pred HHhhh--hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc--cCCCccceehhhH
Q 008378 78 LHYLH--SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFG 152 (568)
Q Consensus 78 L~yLH--s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLG 152 (568)
|.||| ++| |+||||||+|||++..++.+||+|||++...... ......||+.|+|||++. ..|+.++||||||
T Consensus 142 l~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG 219 (360)
T 3e3p_A 142 IGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG 219 (360)
T ss_dssp HHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHH
Confidence 99999 777 9999999999999855899999999999876543 334568999999999873 3489999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCCCCcHHHHHHHHHhc
Q 008378 153 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-----------------------------ASLSKVTDPQVKQFIEKCI 203 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p-----------------------------~~~~~~~s~el~~lI~kcL 203 (568)
|++|+|+||..||........+...+.....+ .......++++++||.+||
T Consensus 220 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 299 (360)
T 3e3p_A 220 CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALL 299 (360)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHT
T ss_pred HHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHh
Confidence 99999999999998755444443333211000 0111225689999999999
Q ss_pred C-CCCCCCCHHHHhcCCCCCCCC
Q 008378 204 V-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 204 ~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+ +|.+||++.|+|+||||+...
T Consensus 300 ~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 300 QYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGGGGG
T ss_pred ccCccccCCHHHHhcCccccccC
Confidence 7 699999999999999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=317.60 Aligned_cols=215 Identities=24% Similarity=0.383 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHHHHHhC------CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSL------KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQIL 75 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L------~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl 75 (568)
....+.+.+|+++|+.+ +|+||++++++|... ..+++||||+. ++|.+++.... .+++..++.++.||+
T Consensus 134 ~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~ 210 (429)
T 3kvw_A 134 KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSIL 210 (429)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHH
Confidence 34456788899999888 577999999998765 47999999996 69999988764 499999999999999
Q ss_pred HHHHhhhhCCCCeEeeeccCCcEEEeCCCCc--EEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhH
Q 008378 76 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFG 152 (568)
Q Consensus 76 ~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~--vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLG 152 (568)
.||.|||++| |+||||||+|||++ .++. +||+|||++..... ...+.+||+.|+|||++ ...|+.++||||||
T Consensus 211 ~aL~~LH~~~--ivHrDlKp~NILl~-~~~~~~vkL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 286 (429)
T 3kvw_A 211 QCLDALHKNR--IIHCDLKPENILLK-QQGRSGIKVIDFGSSCYEHQ-RVYTYIQSRFYRAPEVILGARYGMPIDMWSLG 286 (429)
T ss_dssp HHHHHHHHHT--EECSCCSGGGEEES-STTSCCEEECCCTTCEETTC-CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHH
T ss_pred HHHHHHHHCC--eecCCCCHHHeEEc-cCCCcceEEeecccceecCC-cccccCCCCCccChHHHhCCCCCchHHHHhHH
Confidence 9999999999 99999999999997 5665 99999999965433 34466899999999987 45699999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCCC----------------------------------------------
Q 008378 153 MCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPA---------------------------------------------- 185 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~~~i~~~-~~p~---------------------------------------------- 185 (568)
|++|||+||..||.+......+...+... .++.
T Consensus 287 ~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (429)
T 3kvw_A 287 CILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRG 366 (429)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEEC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccC
Confidence 99999999999998765544443333210 0000
Q ss_pred ---------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 186 ---------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 186 ---------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.+....++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 367 ~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 367 PPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp STTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred CccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 0112347889999999996 799999999999999998654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=296.40 Aligned_cols=209 Identities=28% Similarity=0.464 Sum_probs=167.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+.+++.++||||+++++++.+. ..+++||||+++++|.+++. .+.+++..++.++.||+.||.|||++|
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ 125 (271)
T 3dtc_A 49 TIENVRQEAKLFAMLKHPNIIALRGVCLKE--PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEA 125 (271)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEecC--CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 357889999999999999999999988654 36899999999999999886 457999999999999999999999998
Q ss_pred C-CeEeeeccCCcEEEeC-------CCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 86 P-PIIHRDLKCDNIFVNG-------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 86 ~-~IiHRDLKp~NILl~~-------~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
. +++||||||+||+++. .++.+||+|||++............||+.|+|||++ ...++.++||||||+++|
T Consensus 126 ~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 205 (271)
T 3dtc_A 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLW 205 (271)
T ss_dssp SSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHH
T ss_pred CCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHH
Confidence 3 3889999999999973 267899999999987765555567899999999987 455899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+|++|..||.... .......+.........+...++.++++|.+||. +|.+||++.|++++
T Consensus 206 ~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 206 ELLTGEVPFRGID-GLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHCCCTTTTSC-HHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCCC-HHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 9999999998754 4444444444444445566778999999999996 69999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.26 Aligned_cols=208 Identities=17% Similarity=0.216 Sum_probs=165.4
Q ss_pred CHHHHHHHHHHH---HHHHhCCCCCeeeee-------eEEEcCCC------------C---eEEEEEecCCCCCHHHHHH
Q 008378 3 SPDQLERLYSEV---HLLKSLKHENIIKFY-------NSWVDDTN------------R---TINMITELFTSGSLRQYRK 57 (568)
Q Consensus 3 s~~~~e~l~~Ei---~iLk~L~HpNIV~l~-------~~~~~~~~------------~---~l~lV~Ey~~gGsL~~~i~ 57 (568)
++...+.+.+|+ ++|++++|||||+++ +++.+... . ..|+||||+ +|+|.+++.
T Consensus 113 ~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~ 191 (377)
T 3byv_A 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGE 191 (377)
T ss_dssp CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHH
T ss_pred chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHH
Confidence 345678899999 556666899999998 55543321 0 378999999 689999998
Q ss_pred hCCCCCH-------HHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCC
Q 008378 58 KHKNVDM-------KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 130 (568)
Q Consensus 58 k~~~l~e-------~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp 130 (568)
+.+.+++ ..+..|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.... .....+| +
T Consensus 192 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~-~~~~~~g-~ 266 (377)
T 3byv_A 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGA-RVVSSVS-R 266 (377)
T ss_dssp HHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCGGGCEETTC-EEECCCC-T
T ss_pred hccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEEechhheecCC-cccCCCC-c
Confidence 7666666 788899999999999999999 99999999999997 779999999999976433 3345678 9
Q ss_pred CccCccccc-c-----------CCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 008378 131 EFMAPELYE-E-----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 198 (568)
Q Consensus 131 ~YmAPEvl~-~-----------~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~l 198 (568)
.|+|||++. . .|+.++|||||||++|||+||+.||.+.... .....+.. .....++++++|
T Consensus 267 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~-~~~~~~~~------~~~~~~~~~~~l 339 (377)
T 3byv_A 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL-GGSEWIFR------SCKNIPQPVRAL 339 (377)
T ss_dssp TCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-------CCSGGGGS------SCCCCCHHHHHH
T ss_pred CccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccc-cchhhhhh------hccCCCHHHHHH
Confidence 999999884 3 5999999999999999999999999763321 11111111 124567999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 199 IEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 199 I~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|.+||. +|.+||++.++++||||+.
T Consensus 340 i~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 340 LEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999996 6999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.55 Aligned_cols=216 Identities=29% Similarity=0.413 Sum_probs=172.8
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCC----eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR----TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~----~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
+....+++.+|+.+|+.++||||++++++|...... .+++||||+. ++|.+++. ..+++..++.++.||+.||
T Consensus 81 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL 157 (371)
T 4exu_A 81 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGL 157 (371)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHH
Confidence 455678899999999999999999999998765432 3489999997 68888774 4599999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiily 156 (568)
.|||++| |+||||||+|||++ .+|.+||+|||+++..... ....+||+.|+|||++. ..|+.++||||||+++|
T Consensus 158 ~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (371)
T 4exu_A 158 KYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 233 (371)
T ss_dssp HHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTCC---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred HHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCcccccccC-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHH
Confidence 9999999 99999999999997 7899999999999765432 34568999999999874 46899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCC-C---------------------------CCCCCCcHHHHHHHHHhcC-CCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIKP-A---------------------------SLSKVTDPQVKQFIEKCIV-PAS 207 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~p-~---------------------------~~~~~~s~el~~lI~kcL~-~p~ 207 (568)
+|++|..||.+......+...+.....+ . ......++.+++||.+||+ +|.
T Consensus 234 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 313 (371)
T 4exu_A 234 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD 313 (371)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTT
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChh
Confidence 9999999998755444443333211111 0 0123457899999999996 799
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 008378 208 LRLPALELLKDPFLVTDN 225 (568)
Q Consensus 208 ~Rpsa~ElL~hpff~~~~ 225 (568)
+||++.|+|+||||+...
T Consensus 314 ~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 314 KRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp TSCCHHHHHTSGGGTTTC
T ss_pred hcCCHHHHhcCcccccCC
Confidence 999999999999998643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.80 Aligned_cols=208 Identities=22% Similarity=0.382 Sum_probs=175.2
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+....+++.+|+.+|++++||||++++++|.+. ..+++||||+++|+|.+++... +.+++..+..++.||+.||.||
T Consensus 90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L 167 (325)
T 3kul_A 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG--RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167 (325)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG--GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 456678899999999999999999999988654 4688999999999999999765 5799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-cCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiil 155 (568)
|++| |+||||||+|||++ .++.+||+|||+++...... .....+|+.|+|||++. ..|+.++||||||+++
T Consensus 168 H~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 244 (325)
T 3kul_A 168 SDLG--YVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244 (325)
T ss_dssp HHTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HHCC--eeCCCCCcceEEEC-CCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHH
Confidence 9999 99999999999997 78999999999998764322 12235678899999884 5689999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+|++ |..||... ....+...+..+..+. .+...++.++++|.+||. +|.+||++.+++.
T Consensus 245 ~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 245 WEVLAYGERPYWNM-TNRDVISSVEEGYRLP-APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHTTSCCTTTTS-CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCcccC-CHHHHHHHHHcCCCCC-CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999 99999774 4566666666654433 445678999999999996 6999999999876
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=293.37 Aligned_cols=205 Identities=20% Similarity=0.450 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+++|++++||||+++++++.+. ..+++||||+++|+|.+++... +.+++..++.++.||+.||.|||++|
T Consensus 49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 126 (269)
T 4hcu_A 49 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 126 (269)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecC--CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46789999999999999999999988654 3689999999999999999764 46999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh-
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt- 160 (568)
++||||||+||+++ .++.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++
T Consensus 127 --i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~ 203 (269)
T 4hcu_A 127 --VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 203 (269)
T ss_dssp --CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eecCCcchheEEEc-CCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcC
Confidence 99999999999997 6789999999999866432 233446788999999884 669999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|..||.. .....+...+..+..+. .+...++.++++|.+||. +|.+||++.++++|
T Consensus 204 g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 204 GKIPYEN-RSNSEVVEDISTGFRLY-KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp SCCTTTT-CCHHHHHHHHHTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCC-CCHHHHHHHHhcCccCC-CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999976 45666777776664432 445678999999999996 69999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.82 Aligned_cols=216 Identities=23% Similarity=0.367 Sum_probs=182.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQIL 75 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-------~l~e~~i~~i~~QIl 75 (568)
+.....++.+|+.+|++++|||||++++++.+.. ..++||||+.+|+|.+++...+ .+++..++.++.||+
T Consensus 114 ~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~ 191 (367)
T 3l9p_A 114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191 (367)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHH
T ss_pred ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHH
Confidence 4566778999999999999999999999886544 5789999999999999998653 589999999999999
Q ss_pred HHHHhhhhCCCCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccC----CCcccccCCCCccCcccc-ccCCCcccee
Q 008378 76 RGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELY-EEEYNELVDI 148 (568)
Q Consensus 76 ~gL~yLHs~g~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~----~~~~s~~GTp~YmAPEvl-~~~ys~ksDI 148 (568)
.||.|||++| |+||||||+|||++. .+..+||+|||+++.... .......||+.|+|||++ ...|+.++||
T Consensus 192 ~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv 269 (367)
T 3l9p_A 192 CGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 269 (367)
T ss_dssp HHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHH
Confidence 9999999999 999999999999972 333599999999976532 223345789999999987 5679999999
Q ss_pred hhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 149 YSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 149 WSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|||||++|||+| |..||.. .....+...+..+..+. .+...++.+++||.+||. +|.+||++.+++++.++...
T Consensus 270 wslG~il~ellt~g~~pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 270 WSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 999999999998 9999976 45666777777665433 455678899999999996 69999999999999877543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.68 Aligned_cols=210 Identities=25% Similarity=0.391 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------------
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------------------- 60 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~---------------------- 60 (568)
....+++.+|+.+|+++ +||||+++++++... ..+++||||+++|+|.+++....
T Consensus 89 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (344)
T 1rjb_A 89 SSEREALMSELKMMTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166 (344)
T ss_dssp ---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHTTTTCC-------------------
T ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--CccEEEEecCCCCcHHHHHhhccccccccccchhhhccccccccc
Confidence 34567899999999999 999999999988654 36899999999999999998753
Q ss_pred -CCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCc
Q 008378 61 -NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAP 135 (568)
Q Consensus 61 -~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAP 135 (568)
.+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....... .....||+.|+||
T Consensus 167 ~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 243 (344)
T 1rjb_A 167 NVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243 (344)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence 2799999999999999999999999 99999999999998 78899999999997664332 2234678899999
Q ss_pred ccc-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 136 ELY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 136 Evl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
|++ ...|+.++||||||+++|+|+| |..||.+......+...+..+..+. .+...+++++++|.+||. +|.+||++
T Consensus 244 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 244 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 977 5669999999999999999998 9999988776677777776654433 445678999999999996 69999999
Q ss_pred HHHhcCC
Q 008378 213 LELLKDP 219 (568)
Q Consensus 213 ~ElL~hp 219 (568)
.+++.+-
T Consensus 323 ~~l~~~l 329 (344)
T 1rjb_A 323 PNLTSFL 329 (344)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.13 Aligned_cols=209 Identities=20% Similarity=0.312 Sum_probs=177.2
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-----------------------
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------------- 59 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------------- 59 (568)
+.+..+++.+|+.+|++++||||+++++++.+. ..+++||||+.+|+|.+++...
T Consensus 90 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T 1luf_A 90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167 (343)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHHTCC---------------------
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC--CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccC
Confidence 345678899999999999999999999988654 4689999999999999999874
Q ss_pred -CCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccC
Q 008378 60 -KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMA 134 (568)
Q Consensus 60 -~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmA 134 (568)
..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ......||+.|+|
T Consensus 168 ~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a 244 (343)
T 1luf_A 168 PPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP 244 (343)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecC
Confidence 56999999999999999999999999 99999999999997 7889999999999765432 2234568999999
Q ss_pred cccc-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC
Q 008378 135 PELY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP 211 (568)
Q Consensus 135 PEvl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps 211 (568)
||++ ...|+.++||||||+++|+|+| |..||.+. ....+...+..+..+ ..+...++.++++|.+||. +|.+||+
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps 322 (343)
T 1luf_A 245 PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-AHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPS 322 (343)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC-ChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 9987 4569999999999999999999 99999764 456666666665443 3456678999999999996 6999999
Q ss_pred HHHHhcC
Q 008378 212 ALELLKD 218 (568)
Q Consensus 212 a~ElL~h 218 (568)
+.+++++
T Consensus 323 ~~~~~~~ 329 (343)
T 1luf_A 323 FCSIHRI 329 (343)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.21 Aligned_cols=214 Identities=22% Similarity=0.347 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCC------eeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHEN------IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQIL 75 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpN------IV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl 75 (568)
....+.+.+|+++|+.++|+| |++++++|.... .+++||||+ +++|.+++...+ .+++..++.++.||+
T Consensus 52 ~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~ 128 (339)
T 1z57_A 52 DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG--HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC--cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHH
Confidence 455678899999999997765 999999887654 799999999 899999998775 689999999999999
Q ss_pred HHHHhhhhCCCCeEeeeccCCcEEEeCC------------------CCcEEEeecChhhhccCCCcccccCCCCccCccc
Q 008378 76 RGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 137 (568)
Q Consensus 76 ~gL~yLHs~g~~IiHRDLKp~NILl~~~------------------~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEv 137 (568)
.||.|||++| |+||||||+|||++.. ++.+||+|||++..... ......||+.|+|||+
T Consensus 129 ~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~ 205 (339)
T 1z57_A 129 KSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEV 205 (339)
T ss_dssp HHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHH
T ss_pred HHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc-ccccccCCccccChHH
Confidence 9999999999 9999999999999732 56899999999976433 3345689999999998
Q ss_pred c-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCCC-----------------------------
Q 008378 138 Y-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA----------------------------- 185 (568)
Q Consensus 138 l-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~--~~~p~----------------------------- 185 (568)
+ ...|+.++||||||+++|+|++|..||........+ ..+.. +..|.
T Consensus 206 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (339)
T 1z57_A 206 ILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL-AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV 284 (339)
T ss_dssp HTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH-HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHH
T ss_pred hhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchh
Confidence 7 456899999999999999999999999875433322 22211 10010
Q ss_pred -----------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 186 -----------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 186 -----------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred hhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 0011235678999999996 79999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.94 Aligned_cols=209 Identities=31% Similarity=0.530 Sum_probs=170.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
++...+.+.+|+.+|++++||||++++++... ..+++||||+.+++|.+++... ..+++..+..++.||+.||.||
T Consensus 60 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~l 136 (289)
T 3og7_A 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136 (289)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999999999999996532 3578999999999999998644 5699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC----CCcccccCCCCccCccccc----cCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~----~~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGi 153 (568)
|++| |+||||||+||+++ .+|.+||+|||++..... .......||+.|+|||++. ..++.++||||||+
T Consensus 137 H~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~ 213 (289)
T 3og7_A 137 HAKS--IIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213 (289)
T ss_dssp HHTT--CCCSCCCGGGEEEE-TTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHH
T ss_pred HhCC--cccccCccceEEEC-CCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHH
Confidence 9999 99999999999998 678999999999976542 2233457999999999873 45788999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~---~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++|+|++|+.||........+...+..+..+.. .....++.+++||.+||. +|.+||++.++++
T Consensus 214 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 214 VLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999999988888888888777654433 334568999999999996 6999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=312.59 Aligned_cols=215 Identities=27% Similarity=0.413 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHHHHhCC--------CCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLK--------HENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWA 71 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~--------HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~ 71 (568)
....+.+.+|+.+|+.++ ||||++++++|... ....+++||||+ +++|.+++.+. +.+++..++.++
T Consensus 74 ~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~ 152 (397)
T 1wak_A 74 EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHH
Confidence 455678899999999996 78899999988732 345799999999 56666666544 569999999999
Q ss_pred HHHHHHHHhhhhC-CCCeEeeeccCCcEEEeCCCC---------------------------------------------
Q 008378 72 RQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNG--------------------------------------------- 105 (568)
Q Consensus 72 ~QIl~gL~yLHs~-g~~IiHRDLKp~NILl~~~~g--------------------------------------------- 105 (568)
.||+.||.|||++ | |+||||||+|||++ .+|
T Consensus 153 ~qi~~aL~~lH~~~g--ivHrDikp~NIll~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (397)
T 1wak_A 153 QQVLQGLDYLHTKCR--IIHTDIKPENILLS-VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229 (397)
T ss_dssp HHHHHHHHHHHHTTC--EECCCCSGGGEEEC-CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGG
T ss_pred HHHHHHHHHHHHhCC--EecCCCCHHHeeEe-ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccc
Confidence 9999999999998 8 99999999999997 443
Q ss_pred ----cEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCCCCC------HHHH
Q 008378 106 ----EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKN------PAQI 174 (568)
Q Consensus 106 ----~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~------~~~i 174 (568)
.+||+|||++...... ....+||+.|+|||++ ...|+.++|||||||++|+|+||..||..... ...+
T Consensus 230 ~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 308 (397)
T 1wak_A 230 AEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308 (397)
T ss_dssp GGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHH
T ss_pred ccccceEecccccccccccc-CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHH
Confidence 7999999999766433 3456899999999987 45599999999999999999999999975432 1111
Q ss_pred HHHHH-cCCCCC--------------------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 008378 175 YKKVT-SGIKPA--------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALE 214 (568)
Q Consensus 175 ~~~i~-~~~~p~--------------------------------------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~E 214 (568)
...+. .+..|. .++...++.+++||.+||. +|.+|||+.|
T Consensus 309 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 388 (397)
T 1wak_A 309 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388 (397)
T ss_dssp HHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHH
T ss_pred HHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHH
Confidence 11111 011100 0112234678999999996 7999999999
Q ss_pred HhcCCCCCC
Q 008378 215 LLKDPFLVT 223 (568)
Q Consensus 215 lL~hpff~~ 223 (568)
+|+||||+.
T Consensus 389 ~l~hp~~~~ 397 (397)
T 1wak_A 389 CLRHPWLNS 397 (397)
T ss_dssp HHTSGGGGC
T ss_pred HhhCccccC
Confidence 999999963
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=296.70 Aligned_cols=208 Identities=26% Similarity=0.472 Sum_probs=165.8
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yL 81 (568)
++...+++.+|+.+|++++||||+++++++.+ ..+++||||+.+|+|.+++...+ .+++..+..++.||+.||.||
T Consensus 56 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l 132 (281)
T 1mp8_A 56 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132 (281)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 35667889999999999999999999998733 35789999999999999998664 699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
|++| ++||||||+||+++ .++.+||+|||++....... .....+|+.|+|||++. ..|+.++||||||+++|+
T Consensus 133 H~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 209 (281)
T 1mp8_A 133 ESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 209 (281)
T ss_dssp HHTT--CCCSCCSGGGEEEE-ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHH
T ss_pred HhCC--eecccccHHHEEEC-CCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHH
Confidence 9999 99999999999998 67899999999998764332 22345788999999884 668999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|++ |..||.... ...+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++.+
T Consensus 210 ll~~g~~pf~~~~-~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 210 ILMHGVKPFQGVK-NNDVIGRIENGERL-PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHTTSCCTTTTCC-GGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCcCC-HHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 997 999998754 44455555555433 3456678999999999996 79999999998764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.03 Aligned_cols=216 Identities=29% Similarity=0.422 Sum_probs=172.4
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
++...+++.+|+.+|+.++||||+++++++..... ..+|+||||+. |+|.+++. ..+++..++.++.||+.||
T Consensus 63 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al 139 (353)
T 3coi_A 63 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGL 139 (353)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999998876543 24589999997 68887764 3599999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiily 156 (568)
.|||++| |+||||||+||+++ .+|.+||+|||++...... .....||+.|+|||++. ..++.++||||||+++|
T Consensus 140 ~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~ 215 (353)
T 3coi_A 140 KYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215 (353)
T ss_dssp HHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTCTTC---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred HHHHHCC--cccCCCCHHHEeEC-CCCcEEEeecccccCCCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHH
Confidence 9999999 99999999999997 7889999999999765432 34567999999999874 46899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHc-C---------------------C------CCCCCCCCCcHHHHHHHHHhcC-CCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTS-G---------------------I------KPASLSKVTDPQVKQFIEKCIV-PAS 207 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~-~---------------------~------~p~~~~~~~s~el~~lI~kcL~-~p~ 207 (568)
+|++|..||.+......+...+.. + . .........++++++||.+||. +|.
T Consensus 216 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 295 (353)
T 3coi_A 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD 295 (353)
T ss_dssp HHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcc
Confidence 999999999875443333322211 0 0 0111233568999999999996 799
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 008378 208 LRLPALELLKDPFLVTDN 225 (568)
Q Consensus 208 ~Rpsa~ElL~hpff~~~~ 225 (568)
+||++.++|.||||+...
T Consensus 296 ~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 296 KRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp TSCCHHHHHTSGGGTTTC
T ss_pred cCCCHHHHhcCcchhhcc
Confidence 999999999999997543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=293.55 Aligned_cols=204 Identities=26% Similarity=0.473 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
+++.+|+++|++++||||+++++++.+.. ++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++|+
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 143 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSS
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCC
Confidence 78899999999999999999999875432 6899999999998888654 479999999999999999999999988
Q ss_pred CeEeeeccCCcEEEeCCCCc-----EEEeecChhhhccCCCcccccCCCCccCccccc---cCCCccceehhhHHHHHHH
Q 008378 87 PIIHRDLKCDNIFVNGNNGE-----VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~-----vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~---~~ys~ksDIWSLGiilyEm 158 (568)
||+||||||+|||++ .++. +||+|||++..... ......||+.|+|||++. ..++.++||||||+++|+|
T Consensus 144 ~ivH~dikp~Nil~~-~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l 221 (287)
T 4f0f_A 144 PIVHRDLRSPNIFLQ-SLDENAPVCAKVADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221 (287)
T ss_dssp CCBCSCCSGGGEEES-CCCTTCSCCEEECCCTTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHH
T ss_pred CeecCCCCcceEEEe-ccCCCCceeEEeCCCCccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHH
Confidence 899999999999997 4554 99999999975433 334567999999999872 3478999999999999999
Q ss_pred hhcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VTCEYPYNECKNPA-QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 ltG~~Pf~~~~~~~-~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++|+.||....... .....+.....+...+...+++++++|.+||. +|.+||++.++++
T Consensus 222 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 222 LTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999997755433 33444444444445667788999999999996 7999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=298.11 Aligned_cols=209 Identities=23% Similarity=0.393 Sum_probs=179.2
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC------------------CCCH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK------------------NVDM 64 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~------------------~l~e 64 (568)
....+.+.+|+.+|+++ +||||+++++++.+.. ..++||||+++|+|.+++...+ .+++
T Consensus 67 ~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (313)
T 1t46_A 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144 (313)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCH
T ss_pred HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCH
Confidence 45678899999999999 9999999999886554 6789999999999999998764 4899
Q ss_pred HHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-c
Q 008378 65 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E 139 (568)
Q Consensus 65 ~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~ 139 (568)
..++.++.||+.||.|||++| ++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++ .
T Consensus 145 ~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 221 (313)
T 1t46_A 145 EDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC
Confidence 999999999999999999999 99999999999998 78999999999997764432 2234578899999977 5
Q ss_pred cCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 140 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 140 ~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
..++.++||||||+++|+|+| |..||........+...+..+..+. .+...++.++++|.+||. +|.+||++.++++
T Consensus 222 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC-CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 668999999999999999999 9999988766666666666654433 345678999999999996 6999999999887
Q ss_pred C
Q 008378 218 D 218 (568)
Q Consensus 218 h 218 (568)
+
T Consensus 301 ~ 301 (313)
T 1t46_A 301 L 301 (313)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=302.83 Aligned_cols=207 Identities=26% Similarity=0.462 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++..+++.+|+.+|++++||||+++++++... ..++|+||+.+|+|.+++.+. +.+++..+..|+.||+.||.|||
T Consensus 58 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH 134 (327)
T 3poz_A 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134 (327)
T ss_dssp --CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 34567899999999999999999999998764 378899999999999999874 57999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
++| |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||++ ...|+.++||||||+++|+
T Consensus 135 ~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 211 (327)
T 3poz_A 135 DRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 211 (327)
T ss_dssp HTT--CCCSCCCGGGEEEE-ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC--eeCCCCChheEEEC-CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHH
Confidence 999 99999999999998 78899999999998764332 2234578899999977 5669999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+| |..||.+. ....+...+..+..+. .+...++.+.++|.+||. +|.+||++.+++.+
T Consensus 212 llt~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 212 LMTFGSKPYDGI-PASEISSILEKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHTTSCCTTTTC-CGGGHHHHHHTTCCCC-CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHhcCCCCccCC-CHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999 99999764 4555666666554333 445678899999999996 69999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=293.12 Aligned_cols=205 Identities=22% Similarity=0.437 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+++|++++||||+++++++.+. ..+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++|
T Consensus 63 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 140 (283)
T 3gen_A 63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140 (283)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEecC--CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35688999999999999999999988654 468999999999999999987 467999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh-
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt- 160 (568)
|+||||||+||+++ .++.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++|+|+|
T Consensus 141 --i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~ 217 (283)
T 3gen_A 141 --FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 217 (283)
T ss_dssp --CCCSSCSGGGEEEC-TTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred --ccCCCCccceEEEc-CCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999997 78899999999998764332 23345788899999874 669999999999999999998
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|..||... ........+..+..+. .+...++.++++|.+||. +|.+||++.++++|
T Consensus 218 g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 218 GKMPYERF-TNSETAEHIAQGLRLY-RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TCCTTTTS-CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccc-ChhHHHHHHhcccCCC-CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999774 4566666666654332 345668999999999996 69999999999876
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.02 Aligned_cols=218 Identities=19% Similarity=0.323 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCC------eeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHEN------IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQIL 75 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpN------IV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl 75 (568)
....+.+.+|+.+|+.++|++ ++.+++++.... .+++||||+ +++|.+++... ..+++..++.++.||+
T Consensus 57 ~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~ 133 (355)
T 2eu9_A 57 GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG--HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHH
T ss_pred ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC--eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHH
Confidence 455678899999999998766 899999886554 799999999 56777777655 3699999999999999
Q ss_pred HHHHhhhhCCCCeEeeeccCCcEEEe------------------CCCCcEEEeecChhhhccCCCcccccCCCCccCccc
Q 008378 76 RGLHYLHSHNPPIIHRDLKCDNIFVN------------------GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 137 (568)
Q Consensus 76 ~gL~yLHs~g~~IiHRDLKp~NILl~------------------~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEv 137 (568)
.||.|||++| |+||||||+|||++ ...+.+||+|||++..... ......||+.|+|||+
T Consensus 134 ~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~ 210 (355)
T 2eu9_A 134 HALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEV 210 (355)
T ss_dssp HHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHH
T ss_pred HHHHHHHHCC--cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc-cccCCcCCCcccCCee
Confidence 9999999999 99999999999993 1568999999999976433 3345689999999998
Q ss_pred c-ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCCC------------------------------
Q 008378 138 Y-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA------------------------------ 185 (568)
Q Consensus 138 l-~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~-~~~p~------------------------------ 185 (568)
+ ...|+.++||||||+++|+|++|..||........+...... +..|.
T Consensus 211 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 2eu9_A 211 ILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVK 290 (355)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHH
T ss_pred eecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcccc
Confidence 7 556999999999999999999999999875443332221111 11110
Q ss_pred ----------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCC
Q 008378 186 ----------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 227 (568)
Q Consensus 186 ----------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~ 227 (568)
......++++++||.+||. +|.+|||+.|+|+||||+...+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 291 ENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp HHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHH
T ss_pred ccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCChh
Confidence 0011124588999999996 79999999999999999876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=308.59 Aligned_cols=209 Identities=28% Similarity=0.470 Sum_probs=180.1
Q ss_pred CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHH
Q 008378 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMK 65 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~ 65 (568)
+.+..+++.+|+++|+++ +|||||++++++.... .+++||||+.+|+|.+++...+ .+++.
T Consensus 114 ~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~ 191 (382)
T 3tt0_A 114 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191 (382)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHH
T ss_pred CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHH
Confidence 356678899999999999 9999999999886543 6899999999999999998764 49999
Q ss_pred HHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-cc
Q 008378 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EE 140 (568)
Q Consensus 66 ~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~ 140 (568)
.++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++ ..
T Consensus 192 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 268 (382)
T 3tt0_A 192 DLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 268 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC
T ss_pred HHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC
Confidence 99999999999999999999 99999999999997 7899999999999866432 22344678999999987 55
Q ss_pred CCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 141 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 141 ~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
.++.++|||||||++|+|+| |..||.+ .....+...+..+..+. .+...++++++||.+||. +|.+||++.+++++
T Consensus 269 ~~~~~~DiwslG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 269 IYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 68999999999999999999 9999976 45677777777765443 445678999999999996 69999999999886
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.13 Aligned_cols=211 Identities=27% Similarity=0.446 Sum_probs=170.8
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yL 81 (568)
+.+..+++.+|+++|++++||||+++++++.......+++||||+++|+|.+++.+.+ .+++..+..++.||+.||.||
T Consensus 51 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l 130 (295)
T 3ugc_A 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130 (295)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH
Confidence 4566788999999999999999999999987655557899999999999999998765 499999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
|++| |+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++ ...|+.++||||||+++
T Consensus 131 H~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 207 (295)
T 3ugc_A 131 GTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207 (295)
T ss_dssp HHTT--CCCSCCSGGGEEEE-ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred hcCC--cccCCCCHhhEEEc-CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHH
Confidence 9999 99999999999998 67899999999998764322 2234577889999987 46699999999999999
Q ss_pred HHHhhcCCCCCCCCCH---------------HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVTCEYPYNECKNP---------------AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~---------------~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+|+||..||...... ..+...+..+..+ ..+...++++.++|.+||. +|.+||++.+++.
T Consensus 208 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 208 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcC-CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999998542100 0222333333322 3455678999999999996 6999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.48 Aligned_cols=210 Identities=25% Similarity=0.427 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC----------------CCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN----------------VDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~----------------l~e~~ 66 (568)
....+++.+|+.+|+++ +||||+++++++.... ..+++||||+.+|+|.+++..... +++..
T Consensus 71 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (316)
T 2xir_A 71 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149 (316)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHH
T ss_pred cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHH
Confidence 45667899999999999 7999999999886543 468999999999999999987654 89999
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccC
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEE 141 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ 141 (568)
++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++....... .....||+.|+|||++ ...
T Consensus 150 ~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 226 (316)
T 2xir_A 150 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 226 (316)
T ss_dssp HHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc
Confidence 9999999999999999999 99999999999997 67899999999997654322 2344688999999987 566
Q ss_pred CCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 142 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++.++||||||+++|+|+| |..||.+......+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++.|
T Consensus 227 ~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 227 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999998 999998876666777777665443 3445678999999999996 79999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=293.14 Aligned_cols=211 Identities=21% Similarity=0.354 Sum_probs=178.2
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
.....+++.+|+.+|+.++||||+++++++.+.. ...++||||+.+|+|.+++.. .+.+++..+..++.||+.||.||
T Consensus 62 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 140 (298)
T 3pls_A 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140 (298)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999999887554 345789999999999999987 45799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------CcccccCCCCccCccccc-cCCCccceehhhHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 154 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGii 154 (568)
|++| ++||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++||||||++
T Consensus 141 H~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 217 (298)
T 3pls_A 141 AEQK--FVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVL 217 (298)
T ss_dssp HHTT--CCCSCCSGGGEEEC-TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHH
T ss_pred HhCC--cccCCCCcceEEEc-CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHH
Confidence 9999 99999999999997 7889999999999755322 233457889999999884 468999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 155 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+|+|++|..|+....+...+...+..+..+. .+...++.++++|.+||. +|.+||++.+++..
T Consensus 218 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 218 LWELLTRGAPPYRHIDPFDLTHFLAQGRRLP-QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhhCCCCCCccCCHHHHHHHhhcCCCCC-CCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999997767666667777777776665433 455678899999999996 69999999998763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=290.68 Aligned_cols=205 Identities=22% Similarity=0.435 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+++|++++||||+++++++.+. ..+++||||+++++|.+++...+ .+++..++.++.||+.||.|||++|
T Consensus 47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 124 (268)
T 3sxs_A 47 EDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124 (268)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEccC--CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45689999999999999999999988544 46899999999999999998764 5999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh-
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt- 160 (568)
++||||||+||+++ .++.+||+|||++........ ....||+.|+|||++. ..++.++||||||+++|+|+|
T Consensus 125 --i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (268)
T 3sxs_A 125 --FIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSL 201 (268)
T ss_dssp --EEESSCSGGGEEEC-TTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTT
T ss_pred --eecCCcCcceEEEC-CCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcC
Confidence 99999999999997 788999999999976644322 2345677899999884 468999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|..||... ........+..+..+ ..+...++.++++|.+||. +|.+||++.+++++
T Consensus 202 g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 202 GKMPYDLY-TNSEVVLKVSQGHRL-YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TCCTTTTS-CHHHHHHHHHTTCCC-CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccc-ChHHHHHHHHcCCCC-CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999764 445555555555433 2345568899999999996 69999999999886
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.93 Aligned_cols=211 Identities=22% Similarity=0.444 Sum_probs=167.0
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhC-C
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH-N 85 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~-g 85 (568)
+.+..+..+++.++||||+++++++.+. ..+++||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ |
T Consensus 69 ~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 145 (318)
T 2dyl_A 69 RILMDLDVVLKSHDCPYIVQCFGTFITN--TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145 (318)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 4444555678899999999999998765 4799999999 5666666554 56799999999999999999999995 8
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc------cCCCccceehhhHHHHHHH
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~------~~ys~ksDIWSLGiilyEm 158 (568)
++||||||+||+++ .++.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|
T Consensus 146 --i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l 222 (318)
T 2dyl_A 146 --VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222 (318)
T ss_dssp --CCCCCCCGGGEEEC-TTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHH
T ss_pred --EEeCCCCHHHEEEC-CCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHH
Confidence 99999999999997 7889999999999765433 234557999999999873 3588999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~-~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
++|+.||............+..+..+.. .....++++++||.+||. +|.+||++.++++||||+..
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 223 ATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 9999999886666666666665544322 223578999999999996 79999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=296.74 Aligned_cols=204 Identities=20% Similarity=0.346 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~-l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+++.+|+.+|++++||||+++++++.+.. ..++||||+.+|+|.+++.+.+. +++..+..++.||+.||.|||+
T Consensus 54 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 131 (289)
T 4fvq_A 54 NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131 (289)
T ss_dssp GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 44578999999999999999999999887644 57899999999999999988765 9999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCc--------EEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGE--------VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGM 153 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~--------vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGi 153 (568)
+| |+||||||+|||++ .++. +||+|||++...... ....||+.|+|||++. ..++.++||||||+
T Consensus 132 ~~--ivH~Dlkp~NIll~-~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 206 (289)
T 4fvq_A 132 NT--LIHGNVCAKNILLI-REEDRKTGNPPFIKLSDPGISITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGT 206 (289)
T ss_dssp TT--CCCCCCCGGGEEEE-ECCBGGGTBCCEEEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHH
T ss_pred CC--eECCCcCcceEEEe-cCCcccccccceeeeccCcccccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHH
Confidence 99 99999999999997 4555 999999998654322 3346899999999884 55899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++|+|++|..|+................ ...+...+++++++|.+||. +|.+||++.++++|
T Consensus 207 il~el~~g~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 207 TLWEICSGGDKPLSALDSQRKLQFYEDR---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCccccchHHHHHHhhcc---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999665555545555555444432 22334457789999999996 69999999999886
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.44 Aligned_cols=209 Identities=28% Similarity=0.380 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC--CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~--~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
.......+|+.+|++++|||||++++++.... ...+++||||+++|+|.++++.. .+++..++.++.||+.||.|||
T Consensus 60 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH 138 (322)
T 3soc_A 60 KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLH 138 (322)
T ss_dssp HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH
Confidence 34456677999999999999999999987654 34589999999999999999874 5999999999999999999999
Q ss_pred hC----------CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccccc------CC
Q 008378 83 SH----------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE------EY 142 (568)
Q Consensus 83 s~----------g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~~------~y 142 (568)
++ + |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||++.+ .+
T Consensus 139 ~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 215 (322)
T 3soc_A 139 EDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDA 215 (322)
T ss_dssp CCEEEETTEEECE--EECSCCSGGGEEEC-TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHH
T ss_pred hhccccccccCCC--EEeCCCChHhEEEC-CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCC
Confidence 98 8 99999999999997 78899999999997654322 334689999999998854 46
Q ss_pred CccceehhhHHHHHHHhhcCCCCCCCC---------------CHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHh
Q 008378 143 NELVDIYSFGMCILEMVTCEYPYNECK---------------NPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKC 202 (568)
Q Consensus 143 s~ksDIWSLGiilyEmltG~~Pf~~~~---------------~~~~i~~~i~~~~~p~~~~~~-----~s~el~~lI~kc 202 (568)
+.++|||||||++|+|+||+.||.+.. ....+...+........+... .++++++||.+|
T Consensus 216 ~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (322)
T 3soc_A 216 FLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHH
T ss_pred CccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHH
Confidence 678999999999999999999996532 233444444443333222221 235699999999
Q ss_pred cC-CCCCCCCHHHHhc
Q 008378 203 IV-PASLRLPALELLK 217 (568)
Q Consensus 203 L~-~p~~Rpsa~ElL~ 217 (568)
|. +|.+|||+.++++
T Consensus 296 l~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 296 WDHDAEARLSAGCVGE 311 (322)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhhCcCHHHHHH
Confidence 96 7999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=293.57 Aligned_cols=209 Identities=22% Similarity=0.380 Sum_probs=172.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+....+++.+|+.+|++++||||+++++++.... ...++||||+.+|+|.+++.+. ..+++..+..++.||+.||.||
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l 144 (298)
T 3f66_A 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144 (298)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 4567788999999999999999999999876543 4678999999999999999864 5689999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------CcccccCCCCccCcccc-ccCCCccceehhhHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMC 154 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGii 154 (568)
|++| ++||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++ ...++.++||||||++
T Consensus 145 H~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 221 (298)
T 3f66_A 145 ASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221 (298)
T ss_dssp HHTT--CCCSCCSGGGEEEC-TTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HhCC--ccCCCCchheEEEC-CCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHH
Confidence 9999 99999999999997 7889999999999765332 12344678899999987 4568999999999999
Q ss_pred HHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 155 ILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 155 lyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|+|++ |..||.. .+...+...+..+..+ ..+...++.++++|.+||. +|.+||++.++++
T Consensus 222 l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 222 LWELMTRGAPPYPD-VNTFDITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHTTSCCSSTT-SCTTTHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCcc-CCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999 5555654 4444455555554433 2345568899999999996 6999999999876
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.23 Aligned_cols=216 Identities=14% Similarity=0.189 Sum_probs=156.0
Q ss_pred HHHHHHHHHHHHHHHhC--CCCCeeeee-------eEEEcCCC---------------CeEEEEEecCCCCCHHHHHHhC
Q 008378 4 PDQLERLYSEVHLLKSL--KHENIIKFY-------NSWVDDTN---------------RTINMITELFTSGSLRQYRKKH 59 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L--~HpNIV~l~-------~~~~~~~~---------------~~l~lV~Ey~~gGsL~~~i~k~ 59 (568)
....+.+.+|+.+++.| +||||++++ +++..... ..+|+||||+. |+|.+++...
T Consensus 103 ~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~ 181 (371)
T 3q60_A 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH
T ss_pred ccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh
Confidence 45677888886555555 699988865 44433222 35899999999 8999999864
Q ss_pred -CCCCHHHH------HHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCc
Q 008378 60 -KNVDMKAI------KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 132 (568)
Q Consensus 60 -~~l~e~~i------~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~Y 132 (568)
..++...+ ..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++....... ...||+.|
T Consensus 182 ~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y 257 (371)
T 3q60_A 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIM-PDGRLMLGDVSALWKVGTRGP-ASSVPVTY 257 (371)
T ss_dssp HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEC-TTSCEEECCGGGEEETTCEEE-GGGSCGGG
T ss_pred ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCHHHEEEC-CCCCEEEEecceeeecCCCcc-CccCCcCC
Confidence 33444555 567799999999999999 99999999999997 789999999999986643322 45677999
Q ss_pred cCccccc---cCCCccceehhhHHHHHHHhhcCCCCCCCCCHH-HHHHH---HHcCCCCC--CCCCCCcHHHHHHHHHhc
Q 008378 133 MAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKK---VTSGIKPA--SLSKVTDPQVKQFIEKCI 203 (568)
Q Consensus 133 mAPEvl~---~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~-~i~~~---i~~~~~p~--~~~~~~s~el~~lI~kcL 203 (568)
+|||++. ..|+.++|||||||++|+|+||+.||....... ..+.. ........ ......++.+++||.+||
T Consensus 258 ~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 337 (371)
T 3q60_A 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL 337 (371)
T ss_dssp CCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHT
T ss_pred cChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHc
Confidence 9999885 469999999999999999999999997642210 00000 00001111 122356899999999999
Q ss_pred C-CCCCCCCHHHHhcCCCCCCC
Q 008378 204 V-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 204 ~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
. +|.+||++.++|+||||+..
T Consensus 338 ~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 338 NFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCChhhCCCHHHHhcCHHHHHH
Confidence 6 79999999999999999764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=291.39 Aligned_cols=208 Identities=25% Similarity=0.436 Sum_probs=172.2
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yL 81 (568)
..+..+++.+|+.+|+.++||||+++++++.+. ..++||||+.+++|.+++.+.+ .+++..+..++.||+.||.||
T Consensus 53 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l 129 (281)
T 3cc6_A 53 TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129 (281)
T ss_dssp CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH
T ss_pred CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH
Confidence 356778899999999999999999999987543 4689999999999999997654 599999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
|++| ++||||||+||+++ .++.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++|+
T Consensus 130 H~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 206 (281)
T 3cc6_A 130 ESIN--CVHRDIAVRNILVA-SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWE 206 (281)
T ss_dssp HHTT--CCCCCCSGGGEEEE-ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHCC--cccCCCccceEEEC-CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHH
Confidence 9999 99999999999998 67899999999998664332 23346788999999884 568999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+| |..||..... ..+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++.+
T Consensus 207 llt~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 207 ILSFGKQPFFWLEN-KDVIGVLEKGDRL-PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHTTTCCTTTTSCG-GGHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCcccCCh-HHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 998 9999976443 3344445444333 2345678999999999996 69999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=300.08 Aligned_cols=208 Identities=25% Similarity=0.384 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~~ 66 (568)
++..+++.+|+.+|+++ +||||+++++++.+. ..+++||||+++|+|.+++.+.+ .+++..
T Consensus 66 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (327)
T 1fvr_A 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143 (327)
T ss_dssp ----CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHH
Confidence 45667899999999999 999999999998765 47999999999999999998764 699999
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCc
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNE 144 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ 144 (568)
++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ......+|+.|+|||++. ..++.
T Consensus 144 ~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 220 (327)
T 1fvr_A 144 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT 220 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEc-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCc
Confidence 9999999999999999999 99999999999997 6789999999998754322 223346788999999884 45899
Q ss_pred cceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 145 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 145 ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++||||||+++|+|+| |..||.. .....+...+..+..+. .+...++.++++|.+||. +|.+||++.+++.+
T Consensus 221 ~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 221 NSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHHHhhcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999998 9999976 45666777776664433 345678999999999996 69999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=292.46 Aligned_cols=206 Identities=19% Similarity=0.342 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+...+++.+|+++|+.++||||+++++++.. ..+++||||+.+++|.+++...+.+++..+..++.||+.||.|||+
T Consensus 59 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~ 135 (291)
T 1xbb_A 59 PALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135 (291)
T ss_dssp CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3457889999999999999999999998832 3588999999999999999998899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
+| ++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++ ...++.++||||||+++|+
T Consensus 136 ~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 212 (291)
T 1xbb_A 136 SN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212 (291)
T ss_dssp TT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred CC--eEcCCCCcceEEEe-CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHH
Confidence 99 99999999999998 67899999999997664322 1223567899999988 4458899999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+| |..||.. .....+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++.
T Consensus 213 l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 213 AFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999 9999976 4566667777666543 3456678999999999996 7999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=300.52 Aligned_cols=216 Identities=24% Similarity=0.450 Sum_probs=156.0
Q ss_pred HHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-----HKNVDMKAIKNWARQILRG 77 (568)
Q Consensus 4 ~~~~e~l~~Ei~-iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-----~~~l~e~~i~~i~~QIl~g 77 (568)
.....++.+|+. +++.++||||+++++++.+. ..+++||||+.+ +|.+++.. ...+++..+..++.|++.|
T Consensus 61 ~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~ 137 (327)
T 3aln_A 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137 (327)
T ss_dssp HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHH
Confidence 345566677776 77888999999999998765 478999999985 88887763 5679999999999999999
Q ss_pred HHhhhhC-CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccc-----ccCCCccceehh
Q 008378 78 LHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-----EEEYNELVDIYS 150 (568)
Q Consensus 78 L~yLHs~-g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl-----~~~ys~ksDIWS 150 (568)
|.|||++ | ++||||||+|||++ .+|.+||+|||++....... .....||+.|+|||++ ...++.++||||
T Consensus 138 l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~s 214 (327)
T 3aln_A 138 LNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWS 214 (327)
T ss_dssp HHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEECCCSSSCC------------------------------CCSHHHHHH
T ss_pred HHHHhccCC--EeECCCCHHHEEEc-CCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHH
Confidence 9999998 8 99999999999998 78999999999997664432 2344799999999987 345899999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||+++|+|++|..||............+..+..+. ......++.+++||.+||. +|.+||++.++++||||....
T Consensus 215 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 215 LGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp HHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 99999999999999976443333332333332221 1224578999999999996 799999999999999997643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=297.10 Aligned_cols=207 Identities=29% Similarity=0.499 Sum_probs=165.8
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~---~l~e~~i~~i~~QIl~gL~ 79 (568)
+....+++.+|+++|++++||||+++++++.+ ..++||||+++|+|.+++...+ .++...+..|+.||+.||.
T Consensus 41 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~ 116 (307)
T 2eva_A 41 SESERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116 (307)
T ss_dssp STTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHH
T ss_pred ChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999997752 3689999999999999998765 3789999999999999999
Q ss_pred hhhh---CCCCeEeeeccCCcEEEeCCCCc-EEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHH
Q 008378 80 YLHS---HNPPIIHRDLKCDNIFVNGNNGE-VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 154 (568)
Q Consensus 80 yLHs---~g~~IiHRDLKp~NILl~~~~g~-vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGii 154 (568)
|||+ +| |+||||||+|||++ .+|. +||+|||++...... .....||+.|+|||++. ..++.++||||||++
T Consensus 117 ~LH~~~~~~--ivH~dlkp~NIll~-~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 192 (307)
T 2eva_A 117 YLHSMQPKA--LIHRDLKPPNLLLV-AGGTVLKICDFGTACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGII 192 (307)
T ss_dssp HHHTCSSSC--CCCCCCSGGGEEEE-TTTTEEEECCCCC-------------CCTTSSCHHHHTCCCCCTHHHHHHHHHH
T ss_pred HHHhCCCCC--eecCCCChhHEEEe-CCCCEEEEcccccccccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHH
Confidence 9999 67 99999999999998 4554 899999999765432 23456999999999884 468999999999999
Q ss_pred HHHHhhcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 155 ILEMVTCEYPYNECKN-PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~-~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+|+|+||+.||..... ...+...+..+..+ ......++.++++|.+||. +|.+||++.+++++
T Consensus 193 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 193 LWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHCCCCchhhCccHHHHHHHHhcCCCC-CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999976443 33444445444443 3445678999999999996 69999999998873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.39 Aligned_cols=211 Identities=20% Similarity=0.349 Sum_probs=170.0
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCC---eEEEEEecCCCCCHHHHHHh------CCCCCHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR---TINMITELFTSGSLRQYRKK------HKNVDMKAIKNWARQ 73 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~---~l~lV~Ey~~gGsL~~~i~k------~~~l~e~~i~~i~~Q 73 (568)
+....+++.+|+.+|++++||||+++++++.+.... ..++||||+.+|+|.+++.. .+.+++..++.++.|
T Consensus 76 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q 155 (313)
T 3brb_A 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155 (313)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHH
Confidence 456678899999999999999999999998765533 46999999999999999853 356999999999999
Q ss_pred HHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCcccee
Q 008378 74 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDI 148 (568)
Q Consensus 74 Il~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDI 148 (568)
|+.||.|||++| |+||||||+||+++ .+|.+||+|||++....... .....+++.|+|||++ ...|+.++||
T Consensus 156 i~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 232 (313)
T 3brb_A 156 IALGMEYLSNRN--FLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDV 232 (313)
T ss_dssp HHHHHHHHHTTT--CCCCCCSGGGEEEC-TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHH
T ss_pred HHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhh
Confidence 999999999999 99999999999997 77899999999997654321 2234678899999987 4568999999
Q ss_pred hhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 149 YSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 149 WSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
||||+++|+|++ |..||... ....+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++.+
T Consensus 233 ~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 233 WAFGVTMWEIATRGMTPYPGV-QNHEMYDYLLHGHRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCccC-CHHHHHHHHHcCCCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999 88999764 445555566655443 3445678899999999996 79999999998864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=306.77 Aligned_cols=217 Identities=23% Similarity=0.369 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHHHHhCC-CC-----CeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLK-HE-----NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQIL 75 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~-Hp-----NIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl 75 (568)
....+.+.+|+.+++.++ |+ +|++++++|... ..+++||||+. |+|.+++... +.+++..++.++.||+
T Consensus 91 ~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~ 167 (382)
T 2vx3_A 91 KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMC 167 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHH
Confidence 345677888999999985 55 499999988765 47999999996 5999998875 4699999999999999
Q ss_pred HHHHhhhhCCCCeEeeeccCCcEEEeC-CCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHH
Q 008378 76 RGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 153 (568)
Q Consensus 76 ~gL~yLHs~g~~IiHRDLKp~NILl~~-~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGi 153 (568)
.||.|||++..+|+||||||+|||++. .++.+||+|||+++.... .....+||+.|+|||++. ..|+.++|||||||
T Consensus 168 ~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 246 (382)
T 2vx3_A 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246 (382)
T ss_dssp HHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred HHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc-ccccccCCccccChHHHcCCCCCcHHHHHHHHH
Confidence 999999964344999999999999952 467899999999977643 234568999999999874 56999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCCCCC---------------------------------CC----------
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASL---------------------------------SK---------- 189 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~-~~~p~~~---------------------------------~~---------- 189 (568)
++|+|+||+.||.+......+...+.. +.++..+ +.
T Consensus 247 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 326 (382)
T 2vx3_A 247 ILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV 326 (382)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTT
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhc
Confidence 999999999999875544444333321 1111000 00
Q ss_pred -----------------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 190 -----------------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 190 -----------------~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
...+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 001478999999996 79999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=299.44 Aligned_cols=212 Identities=24% Similarity=0.406 Sum_probs=177.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
++...+++.+|+++|++++||||+++++++.......+++||||+++|+|.+++... ..+++..++.++.||+.||.||
T Consensus 64 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l 143 (327)
T 3lxl_A 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143 (327)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 456778899999999999999999999999877777899999999999999999874 5699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-cCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiil 155 (568)
|++| |+||||||+|||++ .+|.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++
T Consensus 144 H~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 220 (327)
T 3lxl_A 144 GSRR--CVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220 (327)
T ss_dssp HHTT--EECSCCSGGGEEEE-ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HhCC--ccCCCCChhhEEEC-CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHH
Confidence 9999 99999999999998 68899999999997664322 23346888999999874 5589999999999999
Q ss_pred HHHhhcCCCCCCCCC--------------HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 156 LEMVTCEYPYNECKN--------------PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 156 yEmltG~~Pf~~~~~--------------~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+|++|..||..... ...+...+..+..+ ..+...++.+++||.+||. +|.+||++.+++++
T Consensus 221 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 221 YELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL-PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999854211 12334444444333 3456678999999999996 69999999999654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=290.93 Aligned_cols=209 Identities=18% Similarity=0.370 Sum_probs=177.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
++...+++.+|+++|++++||||+++++++.. ..+++||||+.+++|.+++... +.+++..+..++.||+.||.||
T Consensus 50 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l 126 (287)
T 1u59_A 50 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126 (287)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHH
Confidence 45678889999999999999999999998843 2589999999999999998754 5699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-cCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiil 155 (568)
|++| ++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++
T Consensus 127 H~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 203 (287)
T 1u59_A 127 EEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203 (287)
T ss_dssp HHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HHCC--EeeCCCchheEEEc-CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 9999 99999999999998 67899999999997664322 22345789999999884 5689999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 219 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hp 219 (568)
|+|+| |+.||.... ...+...+..+..+ ..+...+++++++|.+||. +|.+||++.+++.+.
T Consensus 204 ~ellt~g~~p~~~~~-~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 204 WEALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHTTSCCTTTTCC-THHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCcccCC-HHHHHHHHhcCCcC-CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99998 999998754 45556666665443 3456778999999999996 799999999998874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.10 Aligned_cols=209 Identities=22% Similarity=0.396 Sum_probs=176.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWAR 72 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------~~l~e~~i~~i~~ 72 (568)
+....+++.+|+.+|+.++||||+++++++.+. ..+++||||+.+|+|.+++... ..+++..+..++.
T Consensus 68 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~ 145 (322)
T 1p4o_A 68 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145 (322)
T ss_dssp CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC--CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHH
Confidence 345667899999999999999999999988654 3688999999999999998753 4579999999999
Q ss_pred HHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccce
Q 008378 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVD 147 (568)
Q Consensus 73 QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksD 147 (568)
||+.||.|||++| |+||||||+||+++ .+|.+||+|||++....... .....||+.|+|||++ ...++.++|
T Consensus 146 qi~~~l~~lH~~~--i~H~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 222 (322)
T 1p4o_A 146 EIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD 222 (322)
T ss_dssp HHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHCC--CccCCCccceEEEc-CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhh
Confidence 9999999999999 99999999999997 78899999999997653322 2334678999999987 456899999
Q ss_pred ehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 148 IYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 148 IWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|||||+++|+|+| |..||... ...++...+..+..+ ..+...++.++++|.+||. +|.+||++.+++++
T Consensus 223 i~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 223 VWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHHHHHHHTSCCTTTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCccccC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999 89999764 556666666655433 2445678999999999996 69999999999886
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=305.01 Aligned_cols=218 Identities=24% Similarity=0.374 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHHHHHhCC-----------CCCeeeeeeEEEcCC--CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLK-----------HENIIKFYNSWVDDT--NRTINMITELFTSGSLRQYRKKH--KNVDMKAIK 68 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~-----------HpNIV~l~~~~~~~~--~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~ 68 (568)
....+.+.+|+.+|++++ ||||+++++++.... ...+++||||+ +++|.+++.+. +.+++..++
T Consensus 56 ~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~ 134 (373)
T 1q8y_A 56 KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHH
T ss_pred ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHH
Confidence 345677889999999987 899999999887543 33789999999 89999999874 459999999
Q ss_pred HHHHHHHHHHHhhhhC-CCCeEeeeccCCcEEEeC-----CCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccC
Q 008378 69 NWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNG-----NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEE 141 (568)
Q Consensus 69 ~i~~QIl~gL~yLHs~-g~~IiHRDLKp~NILl~~-----~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ 141 (568)
.++.||+.||.|||++ | |+||||||+|||++. ..+.+||+|||++...... .....||+.|+|||++ ...
T Consensus 135 ~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~ 211 (373)
T 1q8y_A 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAP 211 (373)
T ss_dssp HHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCC
T ss_pred HHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCC
Confidence 9999999999999998 9 999999999999952 3348999999999766433 3445799999999988 455
Q ss_pred CCccceehhhHHHHHHHhhcCCCCCCCCC------HHHHHHHHHc-CCCC------------------------------
Q 008378 142 YNELVDIYSFGMCILEMVTCEYPYNECKN------PAQIYKKVTS-GIKP------------------------------ 184 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmltG~~Pf~~~~~------~~~i~~~i~~-~~~p------------------------------ 184 (568)
|+.++|||||||++|+|+||..||..... ...+...+.. +..|
T Consensus 212 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (373)
T 1q8y_A 212 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 291 (373)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc
Confidence 89999999999999999999999975431 1112111110 1000
Q ss_pred --------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 185 --------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 185 --------~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
..++...++++++||.+||. +|.+||++.|+|+||||+...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 292 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 01122335789999999996 799999999999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=291.93 Aligned_cols=208 Identities=26% Similarity=0.422 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++..+++.+|+++|++++||||+++++++.... .++||||+.+|+|.+++.+. +.+++..+..++.||+.||.|||
T Consensus 62 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH 138 (291)
T 1u46_A 62 PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138 (291)
T ss_dssp CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999886543 78999999999999998764 56999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-cCCCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiily 156 (568)
++| ++||||||+||+++ .++.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++|
T Consensus 139 ~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (291)
T 1u46_A 139 SKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215 (291)
T ss_dssp HTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred hCC--cccCCCchheEEEc-CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHH
Confidence 999 99999999999997 67899999999997664322 22346788999999884 55889999999999999
Q ss_pred HHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 157 EMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 157 Emlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+|++ |..||... +...+...+.........+...++.++++|.+||. +|.+||++.+++++
T Consensus 216 ~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 216 EMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHTTSCCTTTTC-CHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCcccC-CHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999 99999774 45566666655544444556678999999999996 79999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=298.07 Aligned_cols=206 Identities=21% Similarity=0.373 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHhC----CCCCeeeeeeEEEcCCCCeEEEEEec-CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 7 LERLYSEVHLLKSL----KHENIIKFYNSWVDDTNRTINMITEL-FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L----~HpNIV~l~~~~~~~~~~~l~lV~Ey-~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
...+.+|+.+++++ +||||+++++++... ...++|+|| +.+++|.+++.+.+.+++..++.++.||+.||.||
T Consensus 78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~l 155 (312)
T 2iwi_A 78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155 (312)
T ss_dssp -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 44567899999999 899999999988654 367889999 78999999999888999999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCC-CccceehhhHHHHHHHh
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEY-NELVDIYSFGMCILEMV 159 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~y-s~ksDIWSLGiilyEml 159 (568)
|++| |+||||||+||+++..+|.+||+|||++............||+.|+|||++. ..+ +.++||||||+++|+|+
T Consensus 156 H~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 233 (312)
T 2iwi_A 156 HSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233 (312)
T ss_dssp HHHT--EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred HHCC--eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence 9999 9999999999999867889999999999877666666778999999999874 334 45899999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
+|+.||... ..+ ... ...++...++.+++||.+||. +|.+||++.|+++||||+...
T Consensus 234 ~g~~pf~~~---~~~----~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 234 CGDIPFERD---QEI----LEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HSSCSCCSH---HHH----HHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HCCCCCCCh---HHH----hhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 999999652 221 111 123445678999999999996 799999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=286.27 Aligned_cols=205 Identities=20% Similarity=0.458 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+.+.+|++++++++||||+++++++.+. ..+++||||+++++|.+++.+. +.+++..+..++.||+.||.|||++|
T Consensus 47 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 124 (267)
T 3t9t_A 47 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124 (267)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 36789999999999999999999988654 3688999999999999999876 56999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh-
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt- 160 (568)
++||||||+||+++ .++.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++
T Consensus 125 --i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (267)
T 3t9t_A 125 --VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 201 (267)
T ss_dssp --CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --cccCCCchheEEEC-CCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhcc
Confidence 99999999999997 6789999999999866432 223446788999999884 668999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|..||.. .....+...+..+..+. .+...++.++++|.+||. +|.+||++.+++++
T Consensus 202 g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 202 GKIPYEN-RSNSEVVEDISTGFRLY-KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp SCCTTTT-CCHHHHHHHHHTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCC-CCHHHHHHHHhcCCcCC-CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8999976 45666666776664432 445678999999999996 69999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=297.39 Aligned_cols=205 Identities=20% Similarity=0.367 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHhCC--CCCeeeeeeEEEcCCCCeEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 8 ERLYSEVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 8 e~l~~Ei~iLk~L~--HpNIV~l~~~~~~~~~~~l~lV~Ey~~g-GsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+++.+|+.+|++++ ||||+++++++... ..+++||||+.+ ++|.+++...+.+++..++.++.||+.||.|||++
T Consensus 91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 168 (320)
T 3a99_A 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168 (320)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECS--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHhhccCCCCceEEEEEEecC--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44668999999996 59999999988754 478999999986 89999999888999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cC-CCccceehhhHHHHHHHhhcC
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EE-YNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~-ys~ksDIWSLGiilyEmltG~ 162 (568)
| |+||||||+|||++..++.+||+|||++............||+.|+|||++. .. ++.++||||||+++|+|++|.
T Consensus 169 ~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 169 G--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp T--EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred C--cEeCCCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC
Confidence 9 9999999999999866789999999999877666566678999999999874 33 468899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||... .. +..+ ...+....++++++||.+||. +|.+||++.++++||||+...
T Consensus 247 ~pf~~~---~~----~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 247 IPFEHD---EE----IIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CSCCSH---HH----HHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CCCCCh---hh----hhcc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 999652 21 2222 122445678999999999996 699999999999999998643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.65 Aligned_cols=208 Identities=27% Similarity=0.467 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+++.+|+++|+.++||||+++++++.+.....+++||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||++
T Consensus 66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 145 (302)
T 4e5w_A 66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145 (302)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence 45788999999999999999999999987766679999999999999999954 45799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
| |+||||||+||+++ .+|.+||+|||++....... .....||+.|+|||++ ...++.++||||||+++|+|
T Consensus 146 ~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (302)
T 4e5w_A 146 Q--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222 (302)
T ss_dssp T--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred C--cccCCCchheEEEc-CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence 9 99999999999997 67899999999997664332 2345688899999987 45688999999999999999
Q ss_pred hhcCCCCCCC--------------CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VTCEYPYNEC--------------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 ltG~~Pf~~~--------------~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+||..|+... .....+...+..+... ..+...++.+++||.+||. +|.+||++.++++
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 223 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL-PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9999876321 1223334444444333 3455678999999999996 7999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=299.01 Aligned_cols=209 Identities=24% Similarity=0.427 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--------------CCCCHHHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--------------KNVDMKAIK 68 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--------------~~l~e~~i~ 68 (568)
.+..+.+.+|+.+|+.+ +||||+++++++.... .+++||||+++|+|.+++... ..+++..+.
T Consensus 90 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (333)
T 2i1m_A 90 ADEKEALMSELKIMSHLGQHENIVNLLGACTHGG--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167 (333)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHH
T ss_pred hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC--ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHH
Confidence 45678899999999999 8999999999886543 688999999999999998753 358999999
Q ss_pred HHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCC
Q 008378 69 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYN 143 (568)
Q Consensus 69 ~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys 143 (568)
.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++ ...++
T Consensus 168 ~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 244 (333)
T 2i1m_A 168 HFSSQVAQGMAFLASKN--CIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 244 (333)
T ss_dssp HHHHHHHHHHHHHHHTT--EECSCCSGGGCEEE-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHhcCC--cccCCcccceEEEC-CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC
Confidence 99999999999999999 99999999999998 77899999999997654322 2334578899999977 55689
Q ss_pred ccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 144 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 144 ~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
.++||||||+++|+|+| |..||.+......+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++.+
T Consensus 245 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 245 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 99999999999999999 999998876666666666655443 2345568999999999996 79999999998863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=291.27 Aligned_cols=211 Identities=30% Similarity=0.512 Sum_probs=170.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL 78 (568)
+....+++.+|+.+|+.++||||+++++++.... .+++||||+.+|+|.+++.. ...+++..++.++.||+.||
T Consensus 72 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l 149 (310)
T 2wqm_A 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149 (310)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHH
Confidence 4567788999999999999999999999987654 79999999999999999874 45699999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
.|||++| ++||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++ ...++.++||||||+++
T Consensus 150 ~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 226 (310)
T 2wqm_A 150 EHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 226 (310)
T ss_dssp HHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred HHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHH
Confidence 9999999 99999999999997 7889999999999766433 23455799999999987 45689999999999999
Q ss_pred HHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 156 LEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 156 yEmltG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+|++|..||.+.. +...+...+..+..+.......+++++++|.+||. +|.+||++.+++.+
T Consensus 227 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 227 YEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999997543 44566667766655554556678999999999996 79999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.08 Aligned_cols=205 Identities=22% Similarity=0.433 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~--l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+.+|++++|||||++++++.... ..+++||||+.+|+|.+++.+.+. +++..+..++.||+.||.|||+
T Consensus 229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 307 (450)
T 1k9a_A 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307 (450)
T ss_dssp TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4567999999999999999999999887643 368999999999999999987654 7999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-c
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-C 161 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt-G 161 (568)
++ |+||||||+|||++ .+|.+||+|||+++..... .....+|+.|+|||++ ...|+.++||||||+++|||+| |
T Consensus 308 ~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g 383 (450)
T 1k9a_A 308 NN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 383 (450)
T ss_dssp TT--EECSCCCGGGEEEC-TTSCEEECCCTTCEECC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CC--eeCCCCCHhhEEEC-CCCCEEEeeCCCccccccc-ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99 99999999999997 7899999999999754332 2234678999999987 5569999999999999999998 9
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
..||.... ..++...+..+..+. .+...++.+.++|.+||. +|.+||++.+++.
T Consensus 384 ~~P~~~~~-~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 384 RVPYPRIP-LKDVVPRVEKGYKMD-APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCSSTTSC-TTTHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCC-HHHHHHHHHcCCCCC-CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99998754 345556666665443 456678999999999996 7999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=308.16 Aligned_cols=207 Identities=22% Similarity=0.380 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++..+++.+|+++|++++|||||++++++... ..+++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||
T Consensus 153 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH 230 (377)
T 3cbl_A 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230 (377)
T ss_dssp HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999988654 36899999999999999998654 6999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc----ccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~----~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
++| |+||||||+|||++ .+|.+||+|||+++....... ....+++.|+|||++. ..|+.++|||||||++||
T Consensus 231 ~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~e 307 (377)
T 3cbl_A 231 SKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307 (377)
T ss_dssp HTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred HCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHH
Confidence 999 99999999999997 788999999999976433221 1223577899999884 568999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+| |..||... ...++...+..+..+. .+...++++.++|.+||. +|.+||++.+++.
T Consensus 308 l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 308 TFSLGASPYPNL-SNQQTREFVEKGGRLP-CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHTTSCCSSTTS-CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 998 99999774 4555666666654432 455678999999999996 7999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.25 Aligned_cols=207 Identities=22% Similarity=0.364 Sum_probs=147.6
Q ss_pred HHHHhCCCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhhCCCCeEe
Q 008378 15 HLLKSLKHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIH 90 (568)
Q Consensus 15 ~iLk~L~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs~g~~IiH 90 (568)
..++.++||||++++++|... ....+++||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+|
T Consensus 74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH 151 (336)
T 3fhr_A 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAH 151 (336)
T ss_dssp HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 346778999999999988652 2346899999999999999998764 6999999999999999999999999 999
Q ss_pred eeccCCcEEEeC--CCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcCCCCCC
Q 008378 91 RDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNE 167 (568)
Q Consensus 91 RDLKp~NILl~~--~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~~Pf~~ 167 (568)
|||||+|||++. ..+.+||+|||++............||+.|+|||++ ...|+.++||||||+++|+|++|..||..
T Consensus 152 ~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999973 255699999999987765555667899999999988 45688999999999999999999999976
Q ss_pred CCCHHH---HHHHHHcC--CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 168 CKNPAQ---IYKKVTSG--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 168 ~~~~~~---i~~~i~~~--~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
...... ....+..+ ..+.......++++++||.+||. +|.+||++.++|+||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 232 NTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 432221 11222211 11222334678999999999996 7999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=297.58 Aligned_cols=209 Identities=28% Similarity=0.473 Sum_probs=178.4
Q ss_pred CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHH
Q 008378 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMK 65 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~ 65 (568)
+....+++.+|+.+|+++ +||||+++++++.+. ..+++||||+.+|+|.+++...+ .+++.
T Consensus 80 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (334)
T 2pvf_A 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157 (334)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHH
T ss_pred cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHH
Confidence 356678899999999999 999999999988654 46899999999999999998754 38999
Q ss_pred HHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-cc
Q 008378 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE 140 (568)
Q Consensus 66 ~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~ 140 (568)
.+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....... .....+|+.|+|||++ ..
T Consensus 158 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 234 (334)
T 2pvf_A 158 DLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234 (334)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC
Confidence 99999999999999999999 99999999999997 78999999999997654321 2334678899999987 45
Q ss_pred CCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 141 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 141 ~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
.++.++||||||+++|+|+| |..||.+ .....+...+..+..+. .+...+++++++|.+||. +|.+||++.+++.+
T Consensus 235 ~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcChHHHHHHHHHHHHHHHhCCCCCcCc-CCHHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 68999999999999999999 9999976 45666777776665433 445678999999999996 69999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.38 Aligned_cols=208 Identities=20% Similarity=0.247 Sum_probs=167.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+...+++.+|+.++++++||||+++++++... ..+|+||||+++++|.+++.+.+.+++..+..++.||+.||.|||+
T Consensus 75 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~ 152 (309)
T 2h34_A 75 PVFRTRMQREARTAGRLQEPHVVPIHDFGEID--GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA 152 (309)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45568899999999999999999999998764 4799999999999999999988899999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
+| |+||||||+|||++ .+|.+||+|||++....... .....||+.|+|||++ ...++.++||||||+++|+|+
T Consensus 153 ~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 229 (309)
T 2h34_A 153 AG--ATHRDVKPENILVS-ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229 (309)
T ss_dssp TT--CCCSCCCGGGEEEC-TTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHH
T ss_pred Cc--CCcCCCChHHEEEc-CCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHH
Confidence 99 99999999999997 77899999999997664332 2345799999999988 456889999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHHHHHHHHHhcC-CCCCCC-CHHHHhc
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRL-PALELLK 217 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~el~~lI~kcL~-~p~~Rp-sa~ElL~ 217 (568)
+|..||... ....+...+..... +.......+++++++|.+||. +|.+|| ++.+++.
T Consensus 230 ~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 230 TGSPPYQGD-QLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HSSCSSCSC-HHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HCCCCCCCc-hHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 999999764 33444455544433 334556678999999999996 699999 7877764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.00 Aligned_cols=216 Identities=23% Similarity=0.374 Sum_probs=181.4
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQIL 75 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-------~l~e~~i~~i~~QIl 75 (568)
+.....++.+|+.+|++++||||+++++++.... ..|+||||+++|+|.+++...+ .+++..++.++.||+
T Consensus 73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~ 150 (327)
T 2yfx_A 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150 (327)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC--CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHH
Confidence 4566778999999999999999999999886544 5789999999999999998763 489999999999999
Q ss_pred HHHHhhhhCCCCeEeeeccCCcEEEe--CCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-ccCCCcccee
Q 008378 76 RGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EEEYNELVDI 148 (568)
Q Consensus 76 ~gL~yLHs~g~~IiHRDLKp~NILl~--~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~~ys~ksDI 148 (568)
.||.|||++| |+||||||+|||++ +..+.+||+|||++...... ......||+.|+|||++ ...++.++||
T Consensus 151 ~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 228 (327)
T 2yfx_A 151 CGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228 (327)
T ss_dssp HHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhH
Confidence 9999999999 99999999999997 23456999999999765332 22345789999999987 5668999999
Q ss_pred hhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 149 YSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 149 WSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
||||+++|+|+| |..||... ....+...+..+..+. .+...++.++++|.+||. +|.+||++.+++++.++...
T Consensus 229 ~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 229 WSFGVLLWEIFSLGYMPYPSK-SNQEVLEFVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCc-CHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 999999999998 99999764 5566666666654433 455678999999999996 69999999999999887543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=290.74 Aligned_cols=207 Identities=28% Similarity=0.496 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEc--------------CCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHH
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVD--------------DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWA 71 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~--------------~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~ 71 (568)
+.+.+|+++|++++||||++++++|.. .....+++||||+++|+|.+++.+. ..+++..++.++
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 128 (284)
T 2a19_B 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128 (284)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence 356789999999999999999998854 2234689999999999999999764 579999999999
Q ss_pred HHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceeh
Q 008378 72 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIY 149 (568)
Q Consensus 72 ~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIW 149 (568)
.||+.||.|||++| |+||||||+||+++ .++.+||+|||++...... ......||+.|+|||++. ..++.++|||
T Consensus 129 ~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 205 (284)
T 2a19_B 129 EQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLY 205 (284)
T ss_dssp HHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHH
T ss_pred HHHHHHHHHHHhCC--eeeccCCHHHEEEc-CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhH
Confidence 99999999999999 99999999999998 6889999999999776443 334567999999999874 5589999999
Q ss_pred hhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 150 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 150 SLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|||+++|+|++|..||.. .......+..+. ++...++.++++|.+||. +|.+||++.+++++.+....
T Consensus 206 slG~il~~l~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 206 ALGLILAELLHVCDTAFE---TSKFFTDLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHHHSCCSSHHH---HHHHHHHHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHhcCCcchh---HHHHHHHhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 999999999999988853 334444444433 335678899999999996 69999999999999876543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.82 Aligned_cols=208 Identities=23% Similarity=0.411 Sum_probs=166.0
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yL 81 (568)
++...+++.+|+.+|++++||||+++++++... ..+++||||+++|+|.+++.+.+ .+++..+..++.||+.||.||
T Consensus 86 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L 163 (373)
T 2qol_A 86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163 (373)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 456778899999999999999999999988654 46899999999999999998764 699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
|++| |+||||||+|||++ .++.+||+|||+++...... .....+|+.|+|||++ ...|+.++||||||+++
T Consensus 164 H~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il 240 (373)
T 2qol_A 164 SDMG--YVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240 (373)
T ss_dssp HHTT--CCCSCCCGGGEEEC-TTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHCC--eeCCCCCcceEEEc-CCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHH
Confidence 9999 99999999999997 78999999999998764322 1122457889999987 46699999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||++ |+.||... ....+...+..+..+. .+...++.+.++|.+||. +|.+||++.+++.
T Consensus 241 ~ellt~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 241 WEVMSYGERPYWEM-SNQDVIKAVDEGYRLP-PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHTTC-CTTTTC-CHHHHHHHHHTTEECC-CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 99998 99999774 4566666666654332 334568899999999996 6999999998876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=313.18 Aligned_cols=209 Identities=27% Similarity=0.352 Sum_probs=162.7
Q ss_pred HHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 9 RLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 9 ~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+|+++|+++ +|||||++++++.+. ..+|+|||||. |+|.+++.... .+.+..+..++.||+.||.|||++|
T Consensus 63 ~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 138 (432)
T 3p23_A 63 FADREVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN- 138 (432)
T ss_dssp ECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhccCCCCcCeEEEEEecC--CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc-
Confidence 357899999999 899999999988754 47899999996 69999998664 4666677899999999999999999
Q ss_pred CeEeeeccCCcEEEeC--CC--CcEEEeecChhhhccCC-----CcccccCCCCccCccccc----cCCCccceehhhHH
Q 008378 87 PIIHRDLKCDNIFVNG--NN--GEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGM 153 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~--~~--g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGi 153 (568)
|+||||||+|||++. .+ ..+||+|||+++..... .....+||+.|+|||++. ..++.++|||||||
T Consensus 139 -ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~ 217 (432)
T 3p23_A 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217 (432)
T ss_dssp -CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHH
T ss_pred -CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHH
Confidence 999999999999952 12 36889999999766432 234568999999999884 45778999999999
Q ss_pred HHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 154 CILEMVT-CEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 154 ilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
++|+|+| |..||.... ..+... +...... .......++.+++||.+||. +|.+||++.++++||||...
T Consensus 218 il~ellt~g~~pf~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 218 VFYYVISEGSHPFGKSL-QRQANI-LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHTTSCBTTBSTT-THHHHH-HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred HHHHHHcCCCCCcchhh-HHHHHH-HhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 9999999 999996533 222222 2222111 11223346778999999996 79999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=289.95 Aligned_cols=207 Identities=25% Similarity=0.401 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yL 81 (568)
....+++.+|+++|++++||||+++++++.+. ..+++||||+.+++|.+++.+.. .+++..++.++.||+.||.||
T Consensus 50 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 127 (288)
T 3kfa_A 50 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127 (288)
T ss_dssp STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999988654 46899999999999999998753 499999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
|++| |+||||||+||+++ .++.+||+|||++........ ....+|+.|+|||++ ...++.++||||||+++|+
T Consensus 128 H~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 204 (288)
T 3kfa_A 128 EKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204 (288)
T ss_dssp HHHT--CCCSCCSGGGEEEC-GGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHCC--ccCCCCCcceEEEc-CCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHH
Confidence 9999 99999999999997 778999999999987654332 234578899999987 4668999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|++ |..||.. .+...+...+.....+. .+...++.+++||.+||. +|.+||++.++++
T Consensus 205 ll~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 205 IATYGMSPYPG-IDLSQVYELLEKDYRME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHTTSCCSSTT-CCGGGHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCCC-CCHHHHHHHHhccCCCC-CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 999 9999976 44555666666554433 445678999999999996 6999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.15 Aligned_cols=203 Identities=22% Similarity=0.427 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
+++.+|+.++++++||||+++++++.+ ..+++||||+.+|+|.+++... +.+++..+..|+.||+.||.|||++|
T Consensus 60 ~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~- 135 (325)
T 3kex_A 60 QAVTDHMLAIGSLDHAHIVRLLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG- 135 (325)
T ss_dssp CSCCHHHHHHHTCCCTTBCCEEEEECB---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhcCCCCCcCeEEEEEcC---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 456789999999999999999998743 3588999999999999999875 57999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhh-
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmlt- 160 (568)
|+||||||+|||++ .+|.+||+|||+++...... .....||+.|+|||++. ..|+.++||||||+++|+|+|
T Consensus 136 -ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 213 (325)
T 3kex_A 136 -MVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF 213 (325)
T ss_dssp -CCCSCCSSTTEEES-SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred -CCCCccchheEEEC-CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhC
Confidence 99999999999997 78999999999998764332 23456888999999884 669999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|..||.+. ....+...+..+..+ ..+...++++.++|.+||. +|.+||++.+++++
T Consensus 214 g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 214 GAEPYAGL-RLAEVPDLLEKGERL-AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp SCCTTTTS-CTTHHHHHHHTTCBC-CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCCcccc-CHHHHHHHHHcCCCC-CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999874 344555555554333 2344567889999999996 79999999999887
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=291.13 Aligned_cols=206 Identities=22% Similarity=0.440 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~--l~e~~i~~i~~QIl~gL~yLH 82 (568)
...+++.+|+++|++++||||+++++++.... ..+++||||+.+|+|.+++.+.+. +++..+..++.||+.||.|||
T Consensus 56 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 134 (278)
T 1byg_A 56 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134 (278)
T ss_dssp C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999999876543 468999999999999999987654 899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh-
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT- 160 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt- 160 (568)
++| ++||||||+||+++ .+|.+||+|||++...... .....+++.|+|||++ ...++.++||||||+++|+|+|
T Consensus 135 ~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 210 (278)
T 1byg_A 135 GNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 210 (278)
T ss_dssp HTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred hCC--ccccCCCcceEEEe-CCCcEEEeecccccccccc-ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhC
Confidence 999 99999999999997 7889999999998765432 2334678999999987 4568999999999999999998
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|..||... ....+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++.
T Consensus 211 g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 211 GRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp SCCSCTTS-CGGGHHHHHTTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCC-CHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 99999764 445566666655433 3455678999999999996 6999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.88 Aligned_cols=210 Identities=26% Similarity=0.445 Sum_probs=174.8
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+++..+.+.+|+++|++++||||+++++++.+.....+++||||+++|+|.+++.+. .+++..+..++.||+.||.|||
T Consensus 73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH 151 (318)
T 3lxp_A 73 GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLH 151 (318)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHH
Confidence 356678899999999999999999999999887667899999999999999999775 4999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-cCCCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiily 156 (568)
++| |+||||||+||+++ .++.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|
T Consensus 152 ~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 228 (318)
T 3lxp_A 152 AQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228 (318)
T ss_dssp HTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred hCC--ccCCCCchheEEEc-CCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHH
Confidence 999 99999999999997 78899999999998764332 23446888999999884 46889999999999999
Q ss_pred HHhhcCCCCCCCCCH--------------HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 157 EMVTCEYPYNECKNP--------------AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 157 EmltG~~Pf~~~~~~--------------~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|+||..||...... ..+...+..+.. ...+...++++++||.+||. +|.+||++.+++.
T Consensus 229 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 229 ELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999652111 122233333333 33456678999999999996 6999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=303.07 Aligned_cols=205 Identities=18% Similarity=0.255 Sum_probs=166.3
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+.+|+.+++.++||||+++++++... ....+|+||||+ +++|.+++.+.+.+++..++.++.||+.||.|||++|
T Consensus 94 ~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 171 (345)
T 2v62_A 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE- 171 (345)
T ss_dssp HHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 467899999999999999999998762 245899999999 9999999988889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCC--cEEEeecChhhhccCC---------CcccccCCCCccCccccc-cCCCccceehhhHHH
Q 008378 87 PIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 154 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g--~vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGii 154 (568)
|+||||||+|||++ .++ .+||+|||+++.+... ......||+.|+|||++. ..|+.++|||||||+
T Consensus 172 -ivH~Dlkp~NIll~-~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 249 (345)
T 2v62_A 172 -YVHGDIKAANLLLG-YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYC 249 (345)
T ss_dssp -EECSCCSGGGEEEE-SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHH
T ss_pred -eeCCCcCHHHEEEc-cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHH
Confidence 99999999999997 455 9999999999765321 124557999999999885 458999999999999
Q ss_pred HHHHhhcCCCCCCC-CCHHHHHHH---HHcCCCCC----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 155 ILEMVTCEYPYNEC-KNPAQIYKK---VTSGIKPA----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 155 lyEmltG~~Pf~~~-~~~~~i~~~---i~~~~~p~----~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|+|+||+.||... .+...+... .....++. ......+++++++|.+||. +|.+||++.++++
T Consensus 250 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 250 MLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999543 233322211 11111110 0112567899999999996 7999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=294.45 Aligned_cols=209 Identities=23% Similarity=0.406 Sum_probs=172.0
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+....+++.+|+.+|++++||||+++++++.+. ..+++||||+.+|+|.+++... +.+++..+..++.||+.||.||
T Consensus 86 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L 163 (333)
T 1mqb_A 86 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163 (333)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345677899999999999999999999988544 4689999999999999999865 5799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-cCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiil 155 (568)
|++| |+||||||+|||++ .++.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++
T Consensus 164 H~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 240 (333)
T 1mqb_A 164 ANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240 (333)
T ss_dssp HHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred HhCC--eeCCCCChheEEEC-CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHH
Confidence 9999 99999999999997 78899999999998764322 12235688999999874 5689999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+|++ |..||... ....+...+..+..+. .+...++.++++|.+||. +|.+||++.+++.+
T Consensus 241 ~ellt~g~~pf~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 241 WEVMTYGERPYWEL-SNHEVMKAINDGFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHTTSCCTTTTC-CHHHHHHHHHTTCCCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHcCCCCCcccC-CHHHHHHHHHCCCcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999 99999764 4566677776664433 345678999999999996 69999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=297.77 Aligned_cols=206 Identities=25% Similarity=0.456 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+++.+|+.+|++++||||+++++++... ..++|++|+.+|+|.+++... +.+++..++.|+.||+.||.|||+
T Consensus 59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 135 (327)
T 3lzb_A 59 KANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135 (327)
T ss_dssp CCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 4567899999999999999999999998764 378899999999999999874 579999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
+| |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||++ ...|+.++||||||+++|+|
T Consensus 136 ~~--ivH~Dikp~NIl~~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 212 (327)
T 3lzb_A 136 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212 (327)
T ss_dssp TT--CCCSCCCGGGEEEE-ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC--CcCCCCCHHHEEEc-CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHH
Confidence 99 99999999999997 68899999999998764322 2234578899999977 55689999999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 159 VT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 159 lt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++ |..||.+. ....+...+..+..+. .+...++++.++|.+||. +|.+||++.|++..
T Consensus 213 l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 213 MTFGSKPYDGI-PASEISSILEKGERLP-QPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HTTSCCTTTTC-CGGGHHHHHHTTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCCCC-CHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99 99999764 4555666666554333 455678899999999996 69999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=308.41 Aligned_cols=210 Identities=26% Similarity=0.363 Sum_probs=160.3
Q ss_pred HHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCC-------HHHHHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD-------MKAIKNWARQILRGL 78 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~-------e~~i~~i~~QIl~gL 78 (568)
.+.+.+|+++|+++ +|||||++++++.+. ..+|+|||||. |+|.+++...+... +..+..++.||+.||
T Consensus 52 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 128 (434)
T 2rio_A 52 CDIALMEIKLLTESDDHPNVIRYYCSETTD--RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128 (434)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCcCeEEEEEecC--CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHH
Confidence 45678999999986 899999999988654 47999999996 69999998765433 224568999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeC------------CCCcEEEeecChhhhccCCC------cccccCCCCccCccccc-
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNG------------NNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYE- 139 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~------------~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl~- 139 (568)
.|||++| |+||||||+|||++. ..+.+||+|||++....... .....||+.|+|||++.
T Consensus 129 ~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 129 AHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp HHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred HHHHHCC--ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 9999999 999999999999973 23589999999998764321 23457999999999874
Q ss_pred -------cCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC----CCcHHHHHHHHHhcC-CC
Q 008378 140 -------EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK----VTDPQVKQFIEKCIV-PA 206 (568)
Q Consensus 140 -------~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~----~~s~el~~lI~kcL~-~p 206 (568)
..++.++|||||||++|||+| |..||....... ...+........... ..++++++||.+||. +|
T Consensus 207 ~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 284 (434)
T 2rio_A 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284 (434)
T ss_dssp CCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSG
T ss_pred ccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCCh
Confidence 458999999999999999999 999997644332 222222222221211 235789999999996 69
Q ss_pred CCCCCHHHHhcCCCCCC
Q 008378 207 SLRLPALELLKDPFLVT 223 (568)
Q Consensus 207 ~~Rpsa~ElL~hpff~~ 223 (568)
.+||++.++++||||..
T Consensus 285 ~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 285 LKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp GGSCCHHHHHTSGGGSC
T ss_pred hhCCCHHHHHhCCccCC
Confidence 99999999999999964
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.83 Aligned_cols=210 Identities=22% Similarity=0.366 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k---~~~l~e~~i~~i~~QIl~gL~y 80 (568)
.+..+++.+|+.+|++++||||+++++++.+. ..+++||||+++|+|.+++.. ...+++..+..++.||+.||.|
T Consensus 71 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 148 (307)
T 2nru_A 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINF 148 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999988654 368899999999999999874 3469999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCccccccCCCccceehhhHHHHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiily 156 (568)
||++| ++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++.+.++.++||||||+++|
T Consensus 149 lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~ 225 (307)
T 2nru_A 149 LHENH--HIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLL 225 (307)
T ss_dssp HHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHH
T ss_pred HhcCC--eecCCCCHHHEEEc-CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHH
Confidence 99999 99999999999997 78899999999987654321 2345799999999999888999999999999999
Q ss_pred HHhhcCCCCCCCCCHH---HHHHHHHcCCC---------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 157 EMVTCEYPYNECKNPA---QIYKKVTSGIK---------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~---~i~~~i~~~~~---------p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+|++|..||....... .+...+..... ........++.+.++|.+||. +|.+||++.+++.+
T Consensus 226 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 226 EIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999997644322 23333322211 111122235678999999996 69999999998864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.57 Aligned_cols=212 Identities=21% Similarity=0.273 Sum_probs=170.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILR 76 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~ 76 (568)
+....+.+.+|+.+++.++||||+++++++... ....+++||||+.+|+|.+++.. ...+++..++.++.||+.
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~ 145 (317)
T 2buj_A 66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145 (317)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 456778899999999999999999999988643 33478999999999999999876 467999999999999999
Q ss_pred HHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----------cccccCCCCccCcccccc----C
Q 008378 77 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----------ARSVIGTPEFMAPELYEE----E 141 (568)
Q Consensus 77 gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----------~~s~~GTp~YmAPEvl~~----~ 141 (568)
||.|||++| |+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++.. .
T Consensus 146 ~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 222 (317)
T 2buj_A 146 GLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222 (317)
T ss_dssp HHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred HHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence 999999999 99999999999997 78899999999886542211 123468999999998843 2
Q ss_pred CCccceehhhHHHHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 142 YNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmltG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++.++||||||+++|+|++|+.||.... ....+...+..... .......+++++++|.+||. +|.+||++.+++++
T Consensus 223 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS-IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC-CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 6899999999999999999999995310 01112222333222 22334568899999999996 79999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=308.90 Aligned_cols=204 Identities=24% Similarity=0.431 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+.+|++|+|||||++++++. ...+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+
T Consensus 226 ~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 302 (454)
T 1qcf_A 226 SVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302 (454)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3578999999999999999999999874 23589999999999999999854 368999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++ |+||||||+|||++ .++.+||+|||+++...... .....+|+.|+|||++. ..|+.++||||||+++|||+
T Consensus 303 ~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 379 (454)
T 1qcf_A 303 RN--YIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379 (454)
T ss_dssp TT--CCCSSCSGGGEEEC-TTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CC--ccCCCCCHHHEEEC-CCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHH
Confidence 99 99999999999997 78999999999998764321 22345678899999884 66999999999999999999
Q ss_pred h-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 160 T-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 160 t-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
| |+.||.+. ...++...+..+..+. .+...++++.++|.+||. +|.+||++.+++.
T Consensus 380 t~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 380 TYGRIPYPGM-SNPEVIRALERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TTSCCSSTTC-CHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 9 99999874 4556666666665443 345678999999999996 7999999998865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.81 Aligned_cols=205 Identities=20% Similarity=0.277 Sum_probs=163.0
Q ss_pred HHHHHHHHHhCCCCCeeeeeeEEEcCCC--CeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 10 LYSEVHLLKSLKHENIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 10 l~~Ei~iLk~L~HpNIV~l~~~~~~~~~--~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
+.+|+..++.++||||+++++++..... ..+|+||||+ +++|.+++... +.+++..++.|+.||+.||.|||++|
T Consensus 95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~- 172 (364)
T 3op5_A 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE- 172 (364)
T ss_dssp HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4456677888899999999999876432 5689999999 99999999876 67999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeC-CCCcEEEeecChhhhccCC---------CcccccCCCCccCccccc-cCCCccceehhhHHHH
Q 008378 87 PIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 155 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~-~~g~vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiil 155 (568)
|+||||||+|||++. .++.+||+|||+++.+... ......||+.|+|||++. ..|+.++|||||||++
T Consensus 173 -iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 251 (364)
T 3op5_A 173 -YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM 251 (364)
T ss_dssp -EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred -eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHH
Confidence 999999999999972 4689999999999765322 123456999999999884 4599999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIK--------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~--------p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+|+||+.||.+................ +.......++++.++|..||. +|.+||++.+++.
T Consensus 252 ~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 252 IQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 9999999999863332222211111000 000124567899999999996 7999999998775
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=289.79 Aligned_cols=208 Identities=31% Similarity=0.485 Sum_probs=164.2
Q ss_pred HHHHHHHHHHHHHh--CCCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 6 QLERLYSEVHLLKS--LKHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~--L~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
..+.+.+|.+++.. ++||||+++++++... ....+++||||+.+|+|.++++. ..+++..+..++.||+.||.||
T Consensus 43 ~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~l 121 (301)
T 3q4u_A 43 DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHL 121 (301)
T ss_dssp GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHH
T ss_pred cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHH
Confidence 34556677777777 7999999999987653 23568999999999999999964 5799999999999999999999
Q ss_pred h--------hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCccccccC------
Q 008378 82 H--------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE------ 141 (568)
Q Consensus 82 H--------s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl~~~------ 141 (568)
| +++ |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||++...
T Consensus 122 H~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 198 (301)
T 3q4u_A 122 HIEIFGTQGKPA--IAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCF 198 (301)
T ss_dssp HSCBCSTTCBCE--EECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCH
T ss_pred HHhhhhccCCCC--eecCCCChHhEEEc-CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcc
Confidence 9 888 99999999999997 78899999999997654322 2345899999999988543
Q ss_pred -CCccceehhhHHHHHHHhhc----------CCCCCCCC----CHHHHHHHHHcCCCCCCCC-----CCCcHHHHHHHHH
Q 008378 142 -YNELVDIYSFGMCILEMVTC----------EYPYNECK----NPAQIYKKVTSGIKPASLS-----KVTDPQVKQFIEK 201 (568)
Q Consensus 142 -ys~ksDIWSLGiilyEmltG----------~~Pf~~~~----~~~~i~~~i~~~~~p~~~~-----~~~s~el~~lI~k 201 (568)
++.++||||||+++|||+|| ..||.... ....+...+........++ ...++.+.+||.+
T Consensus 199 ~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 278 (301)
T 3q4u_A 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE 278 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHH
T ss_pred cCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHH
Confidence 45789999999999999999 88886532 2233334333322222222 1235789999999
Q ss_pred hcC-CCCCCCCHHHHhc
Q 008378 202 CIV-PASLRLPALELLK 217 (568)
Q Consensus 202 cL~-~p~~Rpsa~ElL~ 217 (568)
||. +|.+|||+.++++
T Consensus 279 cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 279 CWYQNPSARLTALRIKK 295 (301)
T ss_dssp HCCSSGGGSCCHHHHHH
T ss_pred HhhcChhhCCCHHHHHH
Confidence 996 6999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.72 Aligned_cols=210 Identities=21% Similarity=0.370 Sum_probs=166.4
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+....+++.+|+.+|++++||||+++++++.... ...++||||+.+|+|.+++.+. ..+++..+..++.||+.||.||
T Consensus 130 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L 208 (373)
T 3c1x_A 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208 (373)
T ss_dssp CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999999876543 4678999999999999999865 4589999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCcccc-ccCCCccceehhhHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMC 154 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGii 154 (568)
|++| |+||||||+|||++ .++.+||+|||+++...... .....+|+.|+|||++ ...|+.++||||||++
T Consensus 209 H~~~--ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~i 285 (373)
T 3c1x_A 209 ASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 285 (373)
T ss_dssp HHTT--CCCSCCCGGGEEEC-TTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHCC--EecCccchheEEEC-CCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHH
Confidence 9999 99999999999997 78899999999997653321 2234678899999987 4668999999999999
Q ss_pred HHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 155 ILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 155 lyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+|||+| |..||.... ...+...+..+..+ ..+...++.+.++|.+||. +|.+||++.+++++
T Consensus 286 l~ellt~~~~p~~~~~-~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 286 LWELMTRGAPPYPDVN-TFDITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHTTSCCSCTTSC-SSCHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCcCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999 677776543 33344455555433 2345678899999999996 69999999998875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=294.69 Aligned_cols=203 Identities=21% Similarity=0.279 Sum_probs=166.8
Q ss_pred HHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 8 ERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 8 e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
+++.+|+++|+.| +||||+++++++.+. ...++||||+ +++|.+++... +.+++..+..++.||+.||.|||++|
T Consensus 49 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (330)
T 2izr_A 49 PQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125 (330)
T ss_dssp CCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4578999999999 999999999988764 4789999999 89999999874 67999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCc-----EEEeecChhhhccCCC---------cccccCCCCccCccccc-cCCCccceehh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGE-----VKIGDLGLAIVMQQPT---------ARSVIGTPEFMAPELYE-EEYNELVDIYS 150 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~-----vKI~DFGla~~~~~~~---------~~s~~GTp~YmAPEvl~-~~ys~ksDIWS 150 (568)
|+||||||+|||++ .++. +||+|||+++...... .....||+.|+|||++. ..|+.++||||
T Consensus 126 --iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 202 (330)
T 2izr_A 126 --LIYRDVKPENFLIG-RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEA 202 (330)
T ss_dssp --EECCCCCGGGEEEC-CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred --eeccCCCHHHeeec-cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHH
Confidence 99999999999997 5565 9999999998654322 24568999999999874 55899999999
Q ss_pred hHHHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCC---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 151 FGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKP---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~--~~~~i~~~i~~~~~p---~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||++|+|++|..||.+.. .....+..+.....+ .......+ +++++|..||. +|.+||++.++++
T Consensus 203 lG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 203 LGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 9999999999999997643 334444444332111 11122233 99999999995 7999999988765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=319.98 Aligned_cols=206 Identities=19% Similarity=0.353 Sum_probs=174.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+...+++.+|+++|++|+|||||++++++... .+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+
T Consensus 411 ~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~ 487 (635)
T 4fl3_A 411 PALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 487 (635)
T ss_dssp GGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34467899999999999999999999988543 478999999999999999998999999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-cCCCccceehhhHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 157 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyE 157 (568)
+| |+||||||+|||++ .++.+||+|||+++.+.... .....||+.|+|||++. ..|+.++|||||||++||
T Consensus 488 ~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~e 564 (635)
T 4fl3_A 488 SN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 564 (635)
T ss_dssp TT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CC--EeCCCCChHhEEEe-CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHH
Confidence 99 99999999999998 77899999999998764322 22335788999999884 579999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|++ |+.||.+. ....+...+..+..+. .+...++++.+||.+||. +|.+||++.+++.
T Consensus 565 llt~G~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 565 AFSYGQKPYRGM-KGSEVTAMLEKGERMG-CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHTTTCCSSTTC-CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 998 99999874 5566777777665443 455678999999999996 6999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=294.32 Aligned_cols=207 Identities=24% Similarity=0.371 Sum_probs=165.3
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
++.+|+.+|+.++||||+++++++.+.. ..++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++
T Consensus 73 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 150 (326)
T 3uim_A 73 QFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150 (326)
T ss_dssp HHHHHHHGGGTCCCTTBCCCCEEECCSS--CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHhccCCCccceEEEEecCC--ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 6889999999999999999999886554 5789999999999999998654 399999999999999999999999
Q ss_pred ---CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 85 ---NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 85 ---g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
| |+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++ ...++.++||||||+++|+
T Consensus 151 ~~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 227 (326)
T 3uim_A 151 CDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227 (326)
T ss_dssp SSSC--EECCCCSGGGEEEC-TTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHH
T ss_pred CCCC--eEeCCCchhhEEEC-CCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHH
Confidence 8 99999999999997 78899999999998664322 2345699999999987 5568999999999999999
Q ss_pred HhhcCCCCCC----CCCHHHHHHHHHcCCCCCC------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 008378 158 MVTCEYPYNE----CKNPAQIYKKVTSGIKPAS------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 220 (568)
Q Consensus 158 mltG~~Pf~~----~~~~~~i~~~i~~~~~p~~------------~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpf 220 (568)
|+||..||.. ..........+........ .....++.+.++|.+||. +|.+|||+.++++|-.
T Consensus 228 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 9999999952 1111111111211111111 111123679999999996 6999999999998743
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=284.12 Aligned_cols=204 Identities=25% Similarity=0.428 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+++|++++||||+++++++.+ ..+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 127 (279)
T 1qpc_A 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127 (279)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999998753 24789999999999999987543 69999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
+| ++||||||+||+++ .++.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++|+|+
T Consensus 128 ~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 204 (279)
T 1qpc_A 128 RN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204 (279)
T ss_dssp TT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred CC--eeccCCCHhhEEEc-CCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence 99 99999999999997 78899999999997664332 23345788999999884 56899999999999999999
Q ss_pred h-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 160 T-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 160 t-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+ |..||.+. ....+...+..+..+. .+...+++++++|.+||. +|.+||++.+++.
T Consensus 205 ~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 205 THGRIPYPGM-TNPEVIQNLERGYRMV-RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTTCCSSTTC-CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCccc-CHHHHHHHHhcccCCC-CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9 99999764 4556666666654433 345678999999999996 7999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.07 Aligned_cols=210 Identities=22% Similarity=0.388 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~---l~e~~i~~i~~QIl~gL~yLH 82 (568)
..+.+.+|+++|++++||||+++++++.+.....+++|||||.+|+|.+++.+... +++..++.++.||+.||.|||
T Consensus 50 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 129 (396)
T 4eut_A 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129 (396)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 35678899999999999999999999987776688999999999999999986543 999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEE----eCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc---------cCCCcccee
Q 008378 83 SHNPPIIHRDLKCDNIFV----NGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDI 148 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl----~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~---------~~ys~ksDI 148 (568)
++| |+||||||+|||+ + ..+.+||+|||+++..... ......||+.|+|||++. ..|+.++||
T Consensus 130 ~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di 206 (396)
T 4eut_A 130 ENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206 (396)
T ss_dssp HTT--EECCCCCGGGEEEEECTT-SCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHH
T ss_pred HCC--EEECCcCHHHEEEeecCC-CceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHH
Confidence 999 9999999999998 4 4567999999999876443 334568999999999874 457889999
Q ss_pred hhhHHHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCC-----------------------CCCCCcHHHHHHHHHh
Q 008378 149 YSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPAS-----------------------LSKVTDPQVKQFIEKC 202 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~~---~~~~i~~~i~~~~~p~~-----------------------~~~~~s~el~~lI~kc 202 (568)
|||||++|+|+||..||.... ....+...+..+.++.. +....++.++++|.+|
T Consensus 207 wSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~ 286 (396)
T 4eut_A 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286 (396)
T ss_dssp HHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHh
Confidence 999999999999999996422 23344444544433221 1122456889999999
Q ss_pred cC-CCCCCCCHHHHhcC
Q 008378 203 IV-PASLRLPALELLKD 218 (568)
Q Consensus 203 L~-~p~~Rpsa~ElL~h 218 (568)
|. +|.+||++.+++.+
T Consensus 287 L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 287 LEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCCCTTTSCCHHHHHHH
T ss_pred hccChhhhccHHHHHHH
Confidence 96 79999999997654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=286.13 Aligned_cols=205 Identities=17% Similarity=0.221 Sum_probs=168.1
Q ss_pred HHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 8 ERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 8 e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
+.+.+|+++++.+ +|+||+++++++... ...++||||+ +++|.+++...+ .+++..+..++.||+.||.|||++|
T Consensus 50 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 126 (298)
T 1csn_A 50 PQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126 (298)
T ss_dssp CCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEeecCCC--ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4578899999999 899999999987654 4789999999 999999998764 5999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCc-----EEEeecChhhhccCCC---------cccccCCCCccCccccc-cCCCccceehh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGE-----VKIGDLGLAIVMQQPT---------ARSVIGTPEFMAPELYE-EEYNELVDIYS 150 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~-----vKI~DFGla~~~~~~~---------~~s~~GTp~YmAPEvl~-~~ys~ksDIWS 150 (568)
|+||||||+|||++ .+|. +||+|||++....... .....||+.|+|||++. ..++.++||||
T Consensus 127 --ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 203 (298)
T 1csn_A 127 --LVYRDIKPDNFLIG-RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA 203 (298)
T ss_dssp --EECCCCCGGGEEEC-CSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred --EecCCCCHHHEEec-cCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHH
Confidence 99999999999997 4444 9999999997664321 24567999999999874 56899999999
Q ss_pred hHHHHHHHhhcCCCCCCCC--CHHHHHHHHHcCC---CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 151 FGMCILEMVTCEYPYNECK--NPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~--~~~~i~~~i~~~~---~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
||+++|+|++|+.||.... .....+..+.... .........+++++++|.+||. +|.+||++.++++.
T Consensus 204 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 204 LGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999999997643 3344444443221 1122334568899999999995 79999999988653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=291.12 Aligned_cols=210 Identities=23% Similarity=0.381 Sum_probs=154.7
Q ss_pred CHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEc------CCCCeEEEEEecCCCCCHHHHHHh---CCCCCHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD------DTNRTINMITELFTSGSLRQYRKK---HKNVDMKAIKNWAR 72 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~------~~~~~l~lV~Ey~~gGsL~~~i~k---~~~l~e~~i~~i~~ 72 (568)
.....+.+.+|+.+|+++. ||||+++++++.. .....+++||||+. |+|.+++.. .+.+++..++.++.
T Consensus 65 ~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~ 143 (337)
T 3ll6_A 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFY 143 (337)
T ss_dssp SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHH
Confidence 3566788999999999996 9999999998852 33456899999996 799888765 46799999999999
Q ss_pred HHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--------------cccccCCCCccCcccc
Q 008378 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--------------ARSVIGTPEFMAPELY 138 (568)
Q Consensus 73 QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--------------~~s~~GTp~YmAPEvl 138 (568)
||+.||.|||++|++|+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++
T Consensus 144 qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp HHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEBCCCTTCBCCSSCC------------------------------
T ss_pred HHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 99999999999988899999999999997 78899999999997654321 1144699999999987
Q ss_pred ----ccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 139 ----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 139 ----~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
...++.++||||||+++|+|+||..||....... +. .+..........++.+++||.+||. +|.+||++.
T Consensus 223 ~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 297 (337)
T 3ll6_A 223 DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-IV----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIA 297 (337)
T ss_dssp -CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHH
T ss_pred hccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-hh----cCcccCCcccccchHHHHHHHHHccCChhhCcCHH
Confidence 3457899999999999999999999997633221 11 1112222334556789999999996 699999999
Q ss_pred HHhcCC
Q 008378 214 ELLKDP 219 (568)
Q Consensus 214 ElL~hp 219 (568)
|++++-
T Consensus 298 e~l~~l 303 (337)
T 3ll6_A 298 EVVHQL 303 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=301.01 Aligned_cols=211 Identities=21% Similarity=0.341 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHH
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----~l~e~~i~~i~~QIl~gL~ 79 (568)
....+++.+|+.+|+.++||||+++++++... ..+++||||+.+|+|.+++.... .+++..+..++.||+.||.
T Consensus 76 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~ 153 (321)
T 2qkw_B 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153 (321)
T ss_dssp SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT--TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHH
Confidence 44578899999999999999999999987644 46889999999999999987553 5899999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-ccCCCccceehhhHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMC 154 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGii 154 (568)
|||++| ++||||||+||+++ .++.+||+|||++...... ......||+.|+|||++ ...++.++||||||++
T Consensus 154 ~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 230 (321)
T 2qkw_B 154 YLHTRA--IIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230 (321)
T ss_dssp HHHHTT--EECSCCCSTTEEEC-TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHH
T ss_pred HhcCCC--eecCCCCHHHEEEC-CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHH
Confidence 999999 99999999999997 7899999999999764322 12345689999999987 5679999999999999
Q ss_pred HHHHhhcCCCCCCCCCHH-----HH-HHHHHcCCC-----CC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 008378 155 ILEMVTCEYPYNECKNPA-----QI-YKKVTSGIK-----PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 219 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~-----~i-~~~i~~~~~-----p~---~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hp 219 (568)
+|+|+||+.||....... .. ......+.. +. ......++.+.++|.+||. +|.+||++.+++.+.
T Consensus 231 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 231 LFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 999999999997533211 11 111111111 11 1112234678999999996 699999999998763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=310.84 Aligned_cols=205 Identities=25% Similarity=0.415 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+++.+|+.+|++++|||||++++++... ..+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+
T Consensus 259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 336 (495)
T 1opk_A 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336 (495)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457899999999999999999999988654 3689999999999999999875 458999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
+| |+||||||+|||++ .++.+||+|||+++...... .....+|+.|+|||++. ..|+.++|||||||++|||+
T Consensus 337 ~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~ 413 (495)
T 1opk_A 337 KN--FIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413 (495)
T ss_dssp TT--EECSCCSGGGEEEC-GGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred CC--cccCCCChhhEEEC-CCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHH
Confidence 99 99999999999997 78899999999998764332 22335678899999874 56899999999999999999
Q ss_pred h-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 160 T-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 160 t-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
| |..||.+. +..++...+..+..+. .+...++.+++||.+||. +|.+||++.++++
T Consensus 414 t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 414 TYGMSPYPGI-DLSQVYELLEKDYRME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TTSCCSSTTC-CGGGHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9 99999774 4556666676654433 445678999999999996 7999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.60 Aligned_cols=203 Identities=25% Similarity=0.416 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+.+.+|+++|++|+||||+++++++.+ ..+++||||+.+|+|.+++.+. +.+++..+..++.||+.||.|||++
T Consensus 223 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 299 (452)
T 1fmk_A 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299 (452)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999999999999998754 3588999999999999999743 5699999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
| |+||||||+|||++ .++.+||+|||+++...... .....+|+.|+|||++ ...|+.++||||||+++|||+|
T Consensus 300 ~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t 376 (452)
T 1fmk_A 300 N--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376 (452)
T ss_dssp T--CCCSCCSGGGEEEC-GGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred C--eeCCCCChhhEEEC-CCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHh
Confidence 9 99999999999997 78899999999998664322 2234577899999977 4679999999999999999999
Q ss_pred -cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 161 -CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 161 -G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|..||.+. ...++...+..+..+. .+...++.++++|.+||. +|.+||++.+++.
T Consensus 377 ~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 377 KGRVPYPGM-VNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp TTCCSSTTC-CHHHHHHHHHTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999874 4566667776665433 345678899999999996 7999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=315.42 Aligned_cols=204 Identities=18% Similarity=0.374 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+++.+|+++|++++|||||++++++..+ .+++||||+.+|+|.+++... +.+++..+..++.||+.||.|||+
T Consensus 378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 454 (613)
T 2ozo_A 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454 (613)
T ss_dssp TTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999998653 489999999999999998754 459999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
+| |+||||||+|||++ .++.+||+|||+++...... .....+|+.|+|||++ ...|+.++|||||||++||
T Consensus 455 ~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~e 531 (613)
T 2ozo_A 455 KN--FVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 531 (613)
T ss_dssp TT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CC--EEcCcCCHHHEEEc-CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHH
Confidence 99 99999999999998 78899999999998764321 1123467899999988 4679999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 216 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL 216 (568)
|+| |+.||.+.. ..++...+..+..+ ..+...++++.++|.+||. +|.+||++.+++
T Consensus 532 llt~G~~Pf~~~~-~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 532 ALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HHTTSCCTTTTCC-SHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred HHHCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 998 999998754 45566677766543 3455678999999999996 799999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.63 Aligned_cols=211 Identities=27% Similarity=0.437 Sum_probs=171.2
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+.+..+++.+|+++|++++||||+++++++.......+++||||+++|+|.+++.+. ..+++..+..++.||+.||.||
T Consensus 82 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L 161 (326)
T 2w1i_A 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161 (326)
T ss_dssp CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 356678899999999999999999999988766655789999999999999999876 4599999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCccccc-cCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiil 155 (568)
|++| |+||||||+||+++ .+|.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++
T Consensus 162 H~~~--ivH~dikp~NIli~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 238 (326)
T 2w1i_A 162 GTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238 (326)
T ss_dssp HHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HhCC--EeccCCCcceEEEc-CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHH
Confidence 9999 99999999999998 67899999999998764332 22345778899999874 5588999999999999
Q ss_pred HHHhhcCCCCCCCC-----------CH----HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVTCEYPYNECK-----------NP----AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmltG~~Pf~~~~-----------~~----~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|+|+||..||.... .. ..+...+..+..+ ..+...+++++++|.+||. +|.+||++.+++.
T Consensus 239 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999985321 00 1122333333332 2345678999999999996 7999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=291.57 Aligned_cols=205 Identities=24% Similarity=0.440 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+.++++++||||+++++++.+.. .+++||||+.+++|.+++...+ .+++..+..++.||+.||.|||++|
T Consensus 73 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 150 (319)
T 2y4i_B 73 LKAFKREVMAYRQTRHENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150 (319)
T ss_dssp CCCCCTTGGGGTTCCCTTBCCCCEEEECSS--CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCCEeEEEEEEecCC--ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345778999999999999999999987654 6899999999999999998765 6999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-------CCcccccCCCCccCcccccc----------CCCcccee
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-------PTARSVIGTPEFMAPELYEE----------EYNELVDI 148 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-------~~~~s~~GTp~YmAPEvl~~----------~ys~ksDI 148 (568)
++||||||+||+++ +|.+||+|||++..... .......||+.|+|||++.. .|+.++||
T Consensus 151 --i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di 226 (319)
T 2y4i_B 151 --ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226 (319)
T ss_dssp --CCCCCCCSTTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHH
T ss_pred --ccccCCChhhEEEe--CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhH
Confidence 99999999999996 67999999999865421 12234468999999998742 47889999
Q ss_pred hhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 149 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 149 WSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
||||+++|+|++|..||.. .....+...+..+..+.......+++++++|.+||. +|.+||++.+++..
T Consensus 227 ~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 227 FALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999976 456666677777766655555678899999999996 69999999998873
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=282.42 Aligned_cols=206 Identities=21% Similarity=0.255 Sum_probs=165.5
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
+++.+|+.+++.++|++++..+..+... ....++||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++|
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~- 125 (296)
T 3uzp_A 49 PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125 (296)
T ss_dssp CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688999999999999988877665443 35789999999 8999999984 457999999999999999999999999
Q ss_pred CeEeeeccCCcEEEe--CCCCcEEEeecChhhhccCCC---------cccccCCCCccCccccc-cCCCccceehhhHHH
Q 008378 87 PIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 154 (568)
Q Consensus 87 ~IiHRDLKp~NILl~--~~~g~vKI~DFGla~~~~~~~---------~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGii 154 (568)
|+||||||+|||++ ..++.+||+|||++....... .....||+.|+|||++. ..++.++||||||++
T Consensus 126 -ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 204 (296)
T 3uzp_A 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 204 (296)
T ss_dssp -EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred -eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHH
Confidence 99999999999994 367899999999997664332 24568999999999874 468999999999999
Q ss_pred HHHHhhcCCCCCCCCC--HHHHHHHHHcC---CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 155 ILEMVTCEYPYNECKN--PAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~--~~~i~~~i~~~---~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|+|++|+.||..... ..+.+..+... .+........+++++++|.+||. +|.+||++.++++
T Consensus 205 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 205 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 9999999999976432 11222222211 11112234567899999999996 7999999998875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=287.11 Aligned_cols=207 Identities=30% Similarity=0.511 Sum_probs=161.4
Q ss_pred HHHHHHHHHHHhC--CCCCeeeeeeEEEcCCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 8 ERLYSEVHLLKSL--KHENIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 8 e~l~~Ei~iLk~L--~HpNIV~l~~~~~~~~~--~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
....+|.+++..+ +||||+++++++..... ..+++||||+.+|+|.++++.. .+++..+..++.||+.||.|||+
T Consensus 74 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~ 152 (337)
T 3mdy_A 74 ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152 (337)
T ss_dssp HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHS
T ss_pred chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHH
Confidence 3445566666555 99999999999887643 5799999999999999999764 69999999999999999999999
Q ss_pred C--------CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCccccccC-CCc----
Q 008378 84 H--------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-YNE---- 144 (568)
Q Consensus 84 ~--------g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl~~~-ys~---- 144 (568)
+ | |+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++.+. +..
T Consensus 153 ~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 229 (337)
T 3mdy_A 153 EIFSTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229 (337)
T ss_dssp CBCSTTCBCC--EECSCCCGGGEEEC-TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHH
T ss_pred hhhhhccCCC--EEecccchHHEEEC-CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccC
Confidence 8 7 99999999999997 78899999999997653322 2355899999999988543 333
Q ss_pred --cceehhhHHHHHHHhhc----------CCCCCCCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHhc
Q 008378 145 --LVDIYSFGMCILEMVTC----------EYPYNECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCI 203 (568)
Q Consensus 145 --ksDIWSLGiilyEmltG----------~~Pf~~~~----~~~~i~~~i~~~~~p~~~~~-----~~s~el~~lI~kcL 203 (568)
++|||||||++|||+|| +.||.... ....+...+........++. ..++++++||.+||
T Consensus 230 ~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 309 (337)
T 3mdy_A 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309 (337)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHS
T ss_pred ccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhh
Confidence 38999999999999999 77775432 22333333333222222222 34567999999999
Q ss_pred C-CCCCCCCHHHHhcC
Q 008378 204 V-PASLRLPALELLKD 218 (568)
Q Consensus 204 ~-~p~~Rpsa~ElL~h 218 (568)
. +|.+||++.++++|
T Consensus 310 ~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 310 AHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred hhChhhCCCHHHHHHH
Confidence 6 69999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.18 Aligned_cols=205 Identities=18% Similarity=0.300 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHhCCCCCeee---------------eeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHH
Q 008378 8 ERLYSEVHLLKSLKHENIIK---------------FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNW 70 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~---------------l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i 70 (568)
+.+.+|+++|++++||||++ +++++... ...+++||||+ +++|.+++... +.+++..+..+
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i 164 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQV 164 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHH
Confidence 35789999999999999998 56665542 35899999999 99999999986 78999999999
Q ss_pred HHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCC--cEEEeecChhhhccCC---------CcccccCCCCccCccccc
Q 008378 71 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE 139 (568)
Q Consensus 71 ~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g--~vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl~ 139 (568)
+.||+.||.|||++| |+||||||+|||++ .++ .+||+|||+++.+... ......||+.|+|||++.
T Consensus 165 ~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 241 (352)
T 2jii_A 165 ACRLLDALEFLHENE--YVHGNVTAENIFVD-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK 241 (352)
T ss_dssp HHHHHHHHHHHHHTT--CBCSCCCGGGEEEE-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHhCC--ccCCCCCHHHEEEc-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc
Confidence 999999999999999 99999999999998 566 8999999999765322 123458999999999885
Q ss_pred -cCCCccceehhhHHHHHHHhhcCCCCCCCC-CHHHHHHHHH---cCCCCC----CCCCCCcHHHHHHHHHhcC-CCCCC
Q 008378 140 -EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVT---SGIKPA----SLSKVTDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 140 -~~ys~ksDIWSLGiilyEmltG~~Pf~~~~-~~~~i~~~i~---~~~~p~----~~~~~~s~el~~lI~kcL~-~p~~R 209 (568)
..|+.++||||||+++|+|++|+.||.... ....+..... ....+. ......++++++||.+||. +|.+|
T Consensus 242 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 321 (352)
T 2jii_A 242 GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEK 321 (352)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCC
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhC
Confidence 468999999999999999999999997754 4444433332 111110 0112457999999999996 79999
Q ss_pred CCHHHHhc
Q 008378 210 LPALELLK 217 (568)
Q Consensus 210 psa~ElL~ 217 (568)
|++.++++
T Consensus 322 ps~~~l~~ 329 (352)
T 2jii_A 322 PPYAMLRN 329 (352)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHHH
Confidence 99999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=285.59 Aligned_cols=209 Identities=27% Similarity=0.460 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHHh--CCCCCeeeeeeEEEcCCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhh
Q 008378 6 QLERLYSEVHLLKS--LKHENIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~--L~HpNIV~l~~~~~~~~~--~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
..+.+.+|+++++. ++||||+++++++..... ..+++||||+.+|+|.+++.+. .+++..++.++.||+.||.||
T Consensus 77 ~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~l 155 (342)
T 1b6c_B 77 EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHL 155 (342)
T ss_dssp GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHH
Confidence 45678889999988 799999999999876543 2789999999999999999874 699999999999999999999
Q ss_pred h--------hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC------cccccCCCCccCccccccC------
Q 008378 82 H--------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE------ 141 (568)
Q Consensus 82 H--------s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~------~~s~~GTp~YmAPEvl~~~------ 141 (568)
| +++ |+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++...
T Consensus 156 H~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 232 (342)
T 1b6c_B 156 HMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 232 (342)
T ss_dssp HCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCH
T ss_pred HHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccccccccc
Confidence 9 778 99999999999997 78899999999997664332 3455799999999988543
Q ss_pred -CCccceehhhHHHHHHHhhc----------CCCCCCCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHH
Q 008378 142 -YNELVDIYSFGMCILEMVTC----------EYPYNECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEK 201 (568)
Q Consensus 142 -ys~ksDIWSLGiilyEmltG----------~~Pf~~~~----~~~~i~~~i~~~~~p~~~~~-----~~s~el~~lI~k 201 (568)
++.++||||||+++|+|+|| ..||.... ....+...+........++. ...+.++++|.+
T Consensus 233 ~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 312 (342)
T 1b6c_B 233 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 312 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHH
T ss_pred ccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHH
Confidence 33689999999999999999 88986532 34555555544433333332 223579999999
Q ss_pred hcC-CCCCCCCHHHHhcC
Q 008378 202 CIV-PASLRLPALELLKD 218 (568)
Q Consensus 202 cL~-~p~~Rpsa~ElL~h 218 (568)
||. +|.+||++.++++|
T Consensus 313 cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 313 CWYANGAARLTALRIKKT 330 (342)
T ss_dssp HCCSSGGGSCCHHHHHHH
T ss_pred HhccChhhCCCHHHHHHH
Confidence 996 79999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=287.74 Aligned_cols=209 Identities=27% Similarity=0.385 Sum_probs=158.0
Q ss_pred HHHHHHHhCCCCCeeeeeeEEE---cCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC----
Q 008378 12 SEVHLLKSLKHENIIKFYNSWV---DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH---- 84 (568)
Q Consensus 12 ~Ei~iLk~L~HpNIV~l~~~~~---~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~---- 84 (568)
+|+..++.++||||+++++.+. ......+++|||||++|+|.+++.... .++..+..++.||+.||.|||++
T Consensus 56 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~ 134 (336)
T 3g2f_A 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRG 134 (336)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCG
T ss_pred HHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccc
Confidence 3444455689999999997553 233446889999999999999998755 58999999999999999999999
Q ss_pred -----CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----------CcccccCCCCccCcccccc--------C
Q 008378 85 -----NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----------TARSVIGTPEFMAPELYEE--------E 141 (568)
Q Consensus 85 -----g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----------~~~s~~GTp~YmAPEvl~~--------~ 141 (568)
| |+||||||+|||++ .+|.+||+|||++..+... .....+||+.|+|||++.+ .
T Consensus 135 ~~~~~~--ivH~Dikp~Nill~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 211 (336)
T 3g2f_A 135 DHYKPA--ISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211 (336)
T ss_dssp GGCBCC--EECSSCSGGGEEEC-TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHH
T ss_pred cccccc--eeecccccceEEEc-CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccc
Confidence 7 99999999999997 7789999999999765321 1234579999999998854 4
Q ss_pred CCccceehhhHHHHHHHhhcCCCCCCCCC-----------------HHHHHHHHHcCCCCCCCCCC------CcHHHHHH
Q 008378 142 YNELVDIYSFGMCILEMVTCEYPYNECKN-----------------PAQIYKKVTSGIKPASLSKV------TDPQVKQF 198 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmltG~~Pf~~~~~-----------------~~~i~~~i~~~~~p~~~~~~------~s~el~~l 198 (568)
++.++|||||||++|||+||..||..... ...+...+........++.. .++.+++|
T Consensus 212 ~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (336)
T 3g2f_A 212 ALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHH
T ss_pred cccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHH
Confidence 66789999999999999999777643221 12222223322222222222 34589999
Q ss_pred HHHhcC-CCCCCCCHHHH------hcCCCCCCC
Q 008378 199 IEKCIV-PASLRLPALEL------LKDPFLVTD 224 (568)
Q Consensus 199 I~kcL~-~p~~Rpsa~El------L~hpff~~~ 224 (568)
|.+||. +|.+|||+.|+ +.++|-+..
T Consensus 292 i~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 999996 79999999998 456666543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=279.52 Aligned_cols=207 Identities=21% Similarity=0.252 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+.+++.++|++++..+..+... ....++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++|
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (296)
T 4hgt_A 48 HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125 (296)
T ss_dssp CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34688999999999999988887766543 35789999999 8999999985 457999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEe--CCCCcEEEeecChhhhccCC---------CcccccCCCCccCccccc-cCCCccceehhhHH
Q 008378 86 PPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 153 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~--~~~g~vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGi 153 (568)
|+||||||+|||++ ..++.+||+|||++...... ......||+.|+|||++. ..++.++|||||||
T Consensus 126 --ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 203 (296)
T 4hgt_A 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 203 (296)
T ss_dssp --EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred --eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHH
Confidence 99999999999993 26789999999999766432 123568999999999874 56899999999999
Q ss_pred HHHHHhhcCCCCCCCCCH--HHHHHHHHcC---CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 154 CILEMVTCEYPYNECKNP--AQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~--~~i~~~i~~~---~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++|+|++|+.||...... ......+... .+........+++++++|.+||. +|.+||++.++++
T Consensus 204 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 204 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 999999999999764322 1122222111 11111224567899999999996 7999999999876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.11 Aligned_cols=200 Identities=21% Similarity=0.297 Sum_probs=159.4
Q ss_pred HHHHHHHHHHHHhCC---CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHH
Q 008378 7 LERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-----HKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~---HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-----~~~l~e~~i~~i~~QIl~gL 78 (568)
..++.+|+++++.++ |+||+++++++.... ..|+|||||.+|+|.+++.. .+.+++..++.|+.||+.||
T Consensus 108 ~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L 185 (365)
T 3e7e_A 108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185 (365)
T ss_dssp HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHH
Confidence 456788888888887 999999999987654 68899999999999999984 45799999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCC-----------CCcEEEeecChhhhcc----CCCcccccCCCCccCccccc-cCC
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGN-----------NGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPELYE-EEY 142 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~-----------~g~vKI~DFGla~~~~----~~~~~s~~GTp~YmAPEvl~-~~y 142 (568)
+|||++| |+||||||+|||++ . ++.+||+|||+++.+. .......+||+.|||||++. ..|
T Consensus 186 ~~lH~~~--ivHrDiKp~NIll~-~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 262 (365)
T 3e7e_A 186 EQVHDCE--IIHGDIKPDNFILG-NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262 (365)
T ss_dssp HHHHTTT--EECCCCSGGGEEEC-GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB
T ss_pred HHHhhCC--eecCCCCHHHEEec-ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC
Confidence 9999999 99999999999997 4 7899999999997553 22334568999999999884 458
Q ss_pred CccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 143 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 143 s~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
+.++|||||||++|||+||+.||........ ...........++.+.+++..||. +|..|++..+.+.+
T Consensus 263 ~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 263 NYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp STHHHHHHHHHHHHHHHHSSCCCEEEETTEE-------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred CccccHHHHHHHHHHHHhCCCccccCCCCce-------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 9999999999999999999999954321100 000000011236789999999996 57788665544443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=307.12 Aligned_cols=204 Identities=25% Similarity=0.406 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+++.+|+++|++|+|||||++++++.+ ..+|+||||+.+|+|.+++... +.+++..+..++.||+.||.|||++
T Consensus 306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 382 (535)
T 2h8h_A 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382 (535)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999999999999998754 3588999999999999999753 5699999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
+ |+||||||+|||++ .++.+||+|||+++...... .....+++.|+|||++ ...|+.++|||||||++|||+|
T Consensus 383 ~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t 459 (535)
T 2h8h_A 383 N--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459 (535)
T ss_dssp T--CCCSCCSGGGEEEC-GGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred C--eeCCCCCHhhEEEc-CCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 9 99999999999997 77899999999998764321 2234577899999977 4669999999999999999999
Q ss_pred -cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 161 -CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 161 -G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|..||.+. ...++...+..+.... .+...++.+++||.+||. +|.+||++.+++..
T Consensus 460 ~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 460 KGRVPYPGM-VNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp TTCCSSTTC-CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999874 4566667776665433 345678899999999996 79999999998763
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=310.71 Aligned_cols=207 Identities=26% Similarity=0.461 Sum_probs=173.2
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yL 81 (568)
+....+++.+|+.+|++++||||+++++++.+ ..+|+||||+.+|+|.++++..+ .+++..+..++.||+.||.||
T Consensus 431 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L 507 (656)
T 2j0j_A 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507 (656)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 35566889999999999999999999998743 35789999999999999998654 699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
|++| |+||||||+|||++ .+|.+||+|||+++...... .....||+.|+|||++ ...|+.++||||||+++||
T Consensus 508 H~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e 584 (656)
T 2j0j_A 508 ESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584 (656)
T ss_dssp HHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HhCC--ccccccchHhEEEe-CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 9999 99999999999998 68999999999998764332 2234578899999987 4569999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|++ |..||.+. ....+...+..+..+. .+...++.+.++|.+||. +|.+||++.+++.
T Consensus 585 llt~g~~Pf~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 585 ILMHGVKPFQGV-KNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHTTSCCTTTTC-CHHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCC-CHHHHHHHHHcCCCCC-CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 997 99999874 4555666666554433 456678999999999996 7999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=280.60 Aligned_cols=195 Identities=20% Similarity=0.375 Sum_probs=155.2
Q ss_pred HHHHHHHHHH-HhCCCCCeeeeeeEEEc--CCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHhhh
Q 008378 8 ERLYSEVHLL-KSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 8 e~l~~Ei~iL-k~L~HpNIV~l~~~~~~--~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~yLH 82 (568)
..+.+|+.++ +.++||||++++++|.. .....+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||
T Consensus 55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH 134 (299)
T 3m2w_A 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134 (299)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567899988 66699999999998865 33457999999999999999998764 6999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCC--CCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHHHHHHhh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~--~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmlt 160 (568)
++| |+||||||+|||++.. ++.+||+|||++.... ...|+.++|||||||++|+|+|
T Consensus 135 ~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~t 193 (299)
T 3m2w_A 135 SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLC 193 (299)
T ss_dssp HTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHH
T ss_pred hCC--cccCCCCHHHEEEecCCCCCcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHH
Confidence 999 9999999999999732 6899999999885432 2447889999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCC--CCC----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPA--SLS----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~--~~~----~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|..||....... ....+....... .++ ...++++++||.+||. +|.+||++.|+|+||||+..
T Consensus 194 g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 194 GYPPFYSNHGLA-ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SSCSCCC--------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred CCCCCCCCcchh-hhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 999997633221 111111111111 111 3568899999999996 69999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=316.29 Aligned_cols=218 Identities=28% Similarity=0.405 Sum_probs=174.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc----CCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVD----DTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQIL 75 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~----~~~~~l~lV~Ey~~gGsL~~~i~k~~---~l~e~~i~~i~~QIl 75 (568)
++...+++.+|+++|+.++||||+++++++.. ......++|||||.+|+|.+++...+ .+++..++.++.||+
T Consensus 52 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl 131 (676)
T 3qa8_A 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131 (676)
T ss_dssp CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHH
Confidence 45677889999999999999999999997654 12456889999999999999998765 599999999999999
Q ss_pred HHHHhhhhCCCCeEeeeccCCcEEEeCCCC---cEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehh
Q 008378 76 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYS 150 (568)
Q Consensus 76 ~gL~yLHs~g~~IiHRDLKp~NILl~~~~g---~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWS 150 (568)
.||.|||++| |+||||||+||+++ .+| .+||+|||++...... ......||+.|+|||++. ..|+.++||||
T Consensus 132 ~aL~yLHs~g--IVHrDLKP~NILl~-~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwS 208 (676)
T 3qa8_A 132 SALRYLHENR--IIHRDLKPENIVLQ-PGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWS 208 (676)
T ss_dssp HHHHHHHHTT--BCCCCCCSTTEEEE-CCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHH
T ss_pred HHHHHHHHCC--CccCCCCHHHeEee-cCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHH
Confidence 9999999999 99999999999998 334 4999999999876543 334568999999999884 56899999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCHHHHHHHHH-------------cC--------CCCCCCCCCCcHHHHHHHHHhcC-CCCC
Q 008378 151 FGMCILEMVTCEYPYNECKNPAQIYKKVT-------------SG--------IKPASLSKVTDPQVKQFIEKCIV-PASL 208 (568)
Q Consensus 151 LGiilyEmltG~~Pf~~~~~~~~i~~~i~-------------~~--------~~p~~~~~~~s~el~~lI~kcL~-~p~~ 208 (568)
||+++|+|++|..||.....+..+...+. .+ ..|..+....++.+.+||.+||. +|.+
T Consensus 209 LGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~k 288 (676)
T 3qa8_A 209 FGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ 288 (676)
T ss_dssp HHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC-
T ss_pred HHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhh
Confidence 99999999999999976433332211110 00 01122333457899999999996 7999
Q ss_pred CCCHHHHhcCCCCCC
Q 008378 209 RLPALELLKDPFLVT 223 (568)
Q Consensus 209 Rpsa~ElL~hpff~~ 223 (568)
||++.+++.||||+.
T Consensus 289 RPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 289 RGTDPQNPNVGCFQA 303 (676)
T ss_dssp --CCTTCCCCTTHHH
T ss_pred CcCHHHHhcCHHHHH
Confidence 999999999999976
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-33 Score=290.81 Aligned_cols=206 Identities=17% Similarity=0.196 Sum_probs=159.8
Q ss_pred HHHHHHHHHHHHHhCC---------CCCeeeeeeEEEcC----------------------------CCCeEEEEEecCC
Q 008378 6 QLERLYSEVHLLKSLK---------HENIIKFYNSWVDD----------------------------TNRTINMITELFT 48 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~---------HpNIV~l~~~~~~~----------------------------~~~~l~lV~Ey~~ 48 (568)
..+.+.+|+.+|+.|+ |||||++++.+... ....+|+|||||.
T Consensus 66 ~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~ 145 (336)
T 2vuw_A 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145 (336)
T ss_dssp CHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEEC
T ss_pred hHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecC
Confidence 3478899999999996 66666666654311 1457999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh-hCCCCeEeeeccCCcEEEeCCCC--------------------cE
Q 008378 49 SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG--------------------EV 107 (568)
Q Consensus 49 gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH-s~g~~IiHRDLKp~NILl~~~~g--------------------~v 107 (568)
+|++.+.+.+ +.+++..++.++.||+.||.||| ++| |+||||||+|||++ .+| .+
T Consensus 146 ~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~v 221 (336)
T 2vuw_A 146 GGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQV 221 (336)
T ss_dssp CCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEE
T ss_pred CCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceE
Confidence 9976665544 67899999999999999999999 899 99999999999998 455 89
Q ss_pred EEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHH-HHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CC
Q 008378 108 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC-ILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA 185 (568)
Q Consensus 108 KI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGii-lyEmltG~~Pf~~~~~~~~i~~~i~~~~~-p~ 185 (568)
||+|||+++..... ..+||+.|||||++.+..+.++||||||++ .+++++|..||........+...+..... +.
T Consensus 222 kL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
T 2vuw_A 222 SIIDYTLSRLERDG---IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT 298 (336)
T ss_dssp EECCCTTCBEEETT---EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS
T ss_pred EEeeccccEecCCC---cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc
Confidence 99999999876532 458999999999997777999999998777 77899999999542111223334332211 11
Q ss_pred C----CCCCCcHHHHHHHHHhcCCCCCCCCHHHHh-cCCCCC
Q 008378 186 S----LSKVTDPQVKQFIEKCIVPASLRLPALELL-KDPFLV 222 (568)
Q Consensus 186 ~----~~~~~s~el~~lI~kcL~~p~~Rpsa~ElL-~hpff~ 222 (568)
. .....++++++||.+||+.+ |+.|+| +||||+
T Consensus 299 ~~~~~~~~~~s~~~~dli~~~L~~d----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 KCNTPAMKQIKRKIQEFHRTMLNFS----SATDLLCQHSLFK 336 (336)
T ss_dssp CCCSHHHHHHHHHHHHHHHHGGGSS----SHHHHHHHCGGGC
T ss_pred ccchhhhhhcCHHHHHHHHHHhccC----CHHHHHhcCCCcC
Confidence 1 12235789999999999844 999999 999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=288.91 Aligned_cols=206 Identities=18% Similarity=0.268 Sum_probs=161.9
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
+++.+|+++++.|+|++++..+..+.. .....++||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++|
T Consensus 47 ~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g- 123 (483)
T 3sv0_A 47 PQLLYESKIYRILQGGTGIPNVRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123 (483)
T ss_dssp CCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 357889999999988555544443332 234789999999 8999999985 467999999999999999999999999
Q ss_pred CeEeeeccCCcEEEe--CCCCcEEEeecChhhhccCCC---------cccccCCCCccCcccc-ccCCCccceehhhHHH
Q 008378 87 PIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMC 154 (568)
Q Consensus 87 ~IiHRDLKp~NILl~--~~~g~vKI~DFGla~~~~~~~---------~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGii 154 (568)
|+||||||+|||++ ...+.+||+|||+++...... .....||+.|+|||++ ...|+.++|||||||+
T Consensus 124 -IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvi 202 (483)
T 3sv0_A 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYV 202 (483)
T ss_dssp -EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred -EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHH
Confidence 99999999999993 267899999999997664322 2256899999999987 4568999999999999
Q ss_pred HHHHhhcCCCCCCCCC--HHHHHHHHHcCCC---CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 155 ILEMVTCEYPYNECKN--PAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~--~~~i~~~i~~~~~---p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
+|+|++|..||.+... ..+.+..+..... ...+...+++++.+||..||. +|.+||++.+++.
T Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999976433 3333333322111 111224567899999999996 7999999887554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=308.37 Aligned_cols=203 Identities=20% Similarity=0.277 Sum_probs=165.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~---~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
+++..+.+.+|+++|++++|||||+++++|..... ...|+||||+.|++|.+++.. .+++..++.|+.||+.||.
T Consensus 119 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~ 196 (681)
T 2pzi_A 119 DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALS 196 (681)
T ss_dssp CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHH
Confidence 35667789999999999999999999999876543 127999999999999988765 7999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHHHHHHh
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEml 159 (568)
|||++| |+||||||+|||++ . +.+||+|||+++..... ...+||+.|+|||++...++.++|||||||++|+|+
T Consensus 197 ~lH~~g--iiHrDlkp~NIll~-~-~~~kl~DFG~a~~~~~~--~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~ 270 (681)
T 2pzi_A 197 YLHSIG--LVYNDLKPENIMLT-E-EQLKLIDLGAVSRINSF--GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALT 270 (681)
T ss_dssp HHHHTT--EECCCCSGGGEEEC-S-SCEEECCCTTCEETTCC--SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHH
T ss_pred HHHHCC--CeecccChHHeEEe-C-CcEEEEecccchhcccC--CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHH
Confidence 999999 99999999999997 3 58999999999766443 456799999999999877899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
+|..||.+... .+..........++.+.++|.+||. +|.+||++.+.+.|+|+.
T Consensus 271 ~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 271 LDLPTRNGRYV---------DGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp SCCCEETTEEC---------SSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hCCCCCccccc---------ccccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99988864210 0111000001124789999999996 699999999999998875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=284.37 Aligned_cols=206 Identities=19% Similarity=0.235 Sum_probs=155.6
Q ss_pred HHHHHHHHHHHHHhCCC-CCeee---------------------eeeEEEcCC---CCeEEEEEecCCCCCHHHHHHh--
Q 008378 6 QLERLYSEVHLLKSLKH-ENIIK---------------------FYNSWVDDT---NRTINMITELFTSGSLRQYRKK-- 58 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~H-pNIV~---------------------l~~~~~~~~---~~~l~lV~Ey~~gGsL~~~i~k-- 58 (568)
..+.+.+|+.+++.++| +|+.. ++.++.... ...++++|+++ +++|.++++.
T Consensus 121 ~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~ 199 (413)
T 3dzo_A 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL 199 (413)
T ss_dssp CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhh
Confidence 36789999999999987 32211 111111111 22466777766 5899998852
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCcc
Q 008378 59 -----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 133 (568)
Q Consensus 59 -----~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~Ym 133 (568)
.+.+++..+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++..... ....+| +.|+
T Consensus 200 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~-~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~ 274 (413)
T 3dzo_A 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGAS-AVSPIG-RGFA 274 (413)
T ss_dssp HHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCGGGCEETTEE-ECCCCC-TTTC
T ss_pred cccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEe-cCCeEEEEeccceeecCCc-cccCCC-Ccee
Confidence 234778899999999999999999999 99999999999997 7889999999998765433 445678 9999
Q ss_pred Cccccc----------c-CCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 008378 134 APELYE----------E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 202 (568)
Q Consensus 134 APEvl~----------~-~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kc 202 (568)
|||++. . .|+.++|||||||++|+|+||+.||..... ......+... ....++.+++||.+|
T Consensus 275 aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~~~~~~~~~------~~~~~~~~~~li~~~ 347 (413)
T 3dzo_A 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA-LGGSEWIFRS------CKNIPQPVRALLEGF 347 (413)
T ss_dssp CHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGG-GSCSGGGGSS------CCCCCHHHHHHHHHH
T ss_pred CchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcch-hhhHHHHHhh------cccCCHHHHHHHHHH
Confidence 999872 1 378899999999999999999999976432 2222222111 124578999999999
Q ss_pred cC-CCCCCCCHHHHhcCCCCCCC
Q 008378 203 IV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 203 L~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
|. +|.+||++.++++||||+..
T Consensus 348 l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 348 LRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp TCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccCChhhCcCHHHHHhCHHHHHH
Confidence 96 79999999999999999763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=261.06 Aligned_cols=183 Identities=14% Similarity=0.157 Sum_probs=147.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
++..+++.+|++++++++||||+++++++.+. ..+|+||||++|++|.+++++ + .....+..++.||+.||.|||+
T Consensus 72 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~ 147 (286)
T 3uqc_A 72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHR 147 (286)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999999999999998765 479999999999999999864 3 4666788999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHHHHHHhhcCC
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG~~ 163 (568)
+| |+||||||+|||++ .+|.+||+++ .|++| ++.++|||||||++|+|+||+.
T Consensus 148 ~g--ivH~Dikp~NIll~-~~g~~kl~~~------------------~~~~~------~~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 148 AG--VALSIDHPSRVRVS-IDGDVVLAYP------------------ATMPD------ANPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp TT--CCCCCCSGGGEEEE-TTSCEEECSC------------------CCCTT------CCHHHHHHHHHHHHHHHHHSEE
T ss_pred CC--CccCCCCcccEEEc-CCCCEEEEec------------------cccCC------CCchhHHHHHHHHHHHHHHCCC
Confidence 99 99999999999998 7889999743 34544 7899999999999999999999
Q ss_pred CCCCCCCHHHH---HHHHHcCCC-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 164 PYNECKNPAQI---YKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 164 Pf~~~~~~~~i---~~~i~~~~~-p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
||.+......+ .+.+..... +.......+++++++|.+||. +|.+| |+.|+++.
T Consensus 201 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 201 PLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 99874432211 011111111 112334578899999999996 69999 99998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=288.03 Aligned_cols=153 Identities=14% Similarity=0.096 Sum_probs=118.7
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+...++|.+|+++|+++ .|+||+++++++.++ ..+||||||++|++|.+++++.+.+++. .+++||+.||+|+|
T Consensus 282 ~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH 356 (569)
T 4azs_A 282 QRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALE 356 (569)
T ss_dssp HHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHH
Confidence 45667899999999999 799999999998765 4799999999999999999999999875 47899999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccccCCCccceehhhHHHHHHHhh
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmlt 160 (568)
++| ||||||||+|||++ .+|.+||+|||+|+..... ...+.+||+.|||||++.+.+...+|+||+|+++++|.+
T Consensus 357 ~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 357 KQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp HTT--CEESCCCGGGEEEC-TTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-----------------CCCCT
T ss_pred HCC--ceeccCchHhEEEC-CCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhcc
Confidence 999 99999999999997 7899999999999876433 345678999999999998888899999999999888766
Q ss_pred cCCC
Q 008378 161 CEYP 164 (568)
Q Consensus 161 G~~P 164 (568)
+..|
T Consensus 434 ~~~~ 437 (569)
T 4azs_A 434 PWSN 437 (569)
T ss_dssp THHH
T ss_pred ccch
Confidence 5433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.9e-23 Score=226.39 Aligned_cols=146 Identities=21% Similarity=0.238 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+++|++++||||+++..++.... ..|+||||+++++|.+++.+ +..++.||+.||.|||++|
T Consensus 382 ~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g 451 (540)
T 3en9_A 382 RKSRTAREARYLALVKDFGIPAPYIFDVDLD--NKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND 451 (540)
T ss_dssp HHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--ccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc
Confidence 3567899999999999999995554445444 35899999999999999876 6689999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---------cccccCCCCccCccccc---cCCCccceehhhHH
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFMAPELYE---EEYNELVDIYSFGM 153 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---------~~s~~GTp~YmAPEvl~---~~ys~ksDIWSLGi 153 (568)
|+||||||+|||++ . .+||+|||+++...... ..+.+||+.|||||++. ..|+..+|+|+..+
T Consensus 452 --IiHrDiKp~NILl~-~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl 526 (540)
T 3en9_A 452 --VIHNDLTTSNFIFD-K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL 526 (540)
T ss_dssp --EECTTCCTTSEEES-S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred --CccCCCCHHHEEEC-C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence 99999999999997 3 99999999998765432 23668999999999985 56889999999999
Q ss_pred HHHHHhhcCCCCC
Q 008378 154 CILEMVTCEYPYN 166 (568)
Q Consensus 154 ilyEmltG~~Pf~ 166 (568)
-.++.+.++.+|.
T Consensus 527 ~~l~~v~~r~rY~ 539 (540)
T 3en9_A 527 ELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHTCSCCC
T ss_pred HHHHHHHhccccC
Confidence 9999988887774
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.5e-17 Score=136.07 Aligned_cols=59 Identities=24% Similarity=0.416 Sum_probs=58.2
Q ss_pred ceEEEEEecCCCCCcceeeeecccCCCCHhHHHHHHHHccCCCCcCHHHHHHHHHHHHH
Q 008378 302 TVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIM 360 (568)
Q Consensus 302 ~i~L~Lri~d~~g~~r~I~F~F~~~~Dta~~vA~EmV~~~~~~~~d~~~iA~~i~~~i~ 360 (568)
+|+|+||+||++++++||+|+|.+++|||++||+|||++|+|++.|+++||++|+++|.
T Consensus 2 pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 2 PISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 69999999999999999999999999999999999999999999999999999999997
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=3.8e-17 Score=166.09 Aligned_cols=106 Identities=18% Similarity=0.198 Sum_probs=86.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
...++.+|+.+|+.++| +++++.+.. ...|+||||++||+|.+ +. ......++.||+.||.|||++|
T Consensus 147 ~~~~~~~E~~~l~~l~~---~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g 213 (282)
T 1zar_A 147 AIRSARNEFRALQKLQG---LAVPKVYAW---EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG 213 (282)
T ss_dssp HHHHHHHHHHHHHHTTT---SSSCCEEEE---ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhccC---CCcCeEEec---cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC
Confidence 46779999999999994 555554422 24689999999999987 31 2345579999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE 139 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~ 139 (568)
|+||||||+|||++ +|.+||+|||+++ .+..++|||++.
T Consensus 214 --iiHrDlkp~NILl~--~~~vkl~DFG~a~-----------~~~~~~a~e~l~ 252 (282)
T 1zar_A 214 --IVHGDLSQYNVLVS--EEGIWIIDFPQSV-----------EVGEEGWREILE 252 (282)
T ss_dssp --EECSCCSTTSEEEE--TTEEEECCCTTCE-----------ETTSTTHHHHHH
T ss_pred --CEeCCCCHHHEEEE--CCcEEEEECCCCe-----------ECCCCCHHHHHH
Confidence 99999999999997 7899999999985 345678999874
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.19 E-value=4.9e-15 Score=124.69 Aligned_cols=64 Identities=30% Similarity=0.378 Sum_probs=59.3
Q ss_pred CCceEEEEEecCC---CCCcc---eeeeecccCCCCHhHHHHHHHHccCCCCcCHHHHHHHHHHHHHHhC
Q 008378 300 DDTVSLTLRIGDK---SGHVS---NIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLV 363 (568)
Q Consensus 300 ~~~i~L~Lri~d~---~g~~r---~I~F~F~~~~Dta~~vA~EmV~~~~~~~~d~~~iA~~i~~~i~~l~ 363 (568)
.++|+|+|||.|+ .|+.| +|+|+|++++|||++||+|||++|++.++|+..||++|+.-|..+-
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~~ 92 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIK 92 (98)
Confidence 4679999999999 48899 9999999999999999999999999999999999999999876553
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=2.5e-13 Score=135.72 Aligned_cols=97 Identities=16% Similarity=0.230 Sum_probs=77.5
Q ss_pred HHHHHHHHHHHhCCCCCe--eeeeeEEEcCCCCeEEEEEecCCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 8 ERLYSEVHLLKSLKHENI--IKFYNSWVDDTNRTINMITELFTS-G----SLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNI--V~l~~~~~~~~~~~l~lV~Ey~~g-G----sL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
..+.+|+++|+.|.|++| +..+. .. ..++||||+.+ | +|.++... .++..+..++.||+.||.|
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~--~~----~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~ 185 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYT--YM----KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKR 185 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEE--EE----TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEE--cC----CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHH
Confidence 468899999999998864 33443 21 35789999942 3 78776433 3356788999999999999
Q ss_pred hh-hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhc
Q 008378 81 LH-SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118 (568)
Q Consensus 81 LH-s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~ 118 (568)
|| ++| |+||||||+|||++ . .++|+|||++...
T Consensus 186 lH~~~g--ivHrDlkp~NILl~-~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 186 LYQEAE--LVHADLSEYNIMYI-D--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHTSC--EECSSCSTTSEEES-S--SEEECCCTTCEET
T ss_pred HHHHCC--EEeCCCCHHHEEEc-C--cEEEEECcccccC
Confidence 99 999 99999999999997 3 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.88 E-value=5.3e-10 Score=118.85 Aligned_cols=94 Identities=16% Similarity=0.150 Sum_probs=68.5
Q ss_pred HHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCeEe
Q 008378 11 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 90 (568)
Q Consensus 11 ~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~IiH 90 (568)
.+|...|.+|.+.++.-..-+.... .++||||+.|++|.++. .......++.||+.+|.|||.+| |||
T Consensus 161 ~kE~~nL~rL~~~gv~vp~p~~~~~----~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVH 228 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFPVPEPIAQSR----HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIH 228 (397)
T ss_dssp HHHHHHHHHHHHTTCSCCCEEEEET----TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred HHHHHHHHHHHhcCCCCCeeeeccC----ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcC
Confidence 4678888888655543222111221 26899999998886532 22345678999999999999999 999
Q ss_pred eeccCCcEEEeCCCC----------cEEEeecChhhh
Q 008378 91 RDLKCDNIFVNGNNG----------EVKIGDLGLAIV 117 (568)
Q Consensus 91 RDLKp~NILl~~~~g----------~vKI~DFGla~~ 117 (568)
|||||.|||++ .+| .+.|+||+-+..
T Consensus 229 rDLKp~NILl~-~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 229 GDFNEFNILIR-EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCCSTTSEEEE-EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCHHHEEEe-CCCCcccccccccceEEEEeCCccc
Confidence 99999999997 444 388999996644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=1.1e-07 Score=93.84 Aligned_cols=100 Identities=18% Similarity=0.116 Sum_probs=77.1
Q ss_pred HHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC-
Q 008378 8 ERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN- 85 (568)
Q Consensus 8 e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g- 85 (568)
.++.+|+.+|+.|. |.++.++++++.+. ...|+||||++|.+|.+... +......++.++..+|..||+..
T Consensus 54 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~ 126 (263)
T 3tm0_A 54 YDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDI 126 (263)
T ss_dssp TCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCc
Confidence 45889999999994 67788888877543 47899999999999986521 22334577889999999999810
Q ss_pred --------------------------------------------------------CCeEeeeccCCcEEEeCCCCcEEE
Q 008378 86 --------------------------------------------------------PPIIHRDLKCDNIFVNGNNGEVKI 109 (568)
Q Consensus 86 --------------------------------------------------------~~IiHRDLKp~NILl~~~~g~vKI 109 (568)
+.++|+|++|.||+++ .++.+.|
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~l 205 (263)
T 3tm0_A 127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGF 205 (263)
T ss_dssp TTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEE
T ss_pred ccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEE
Confidence 2289999999999997 4445579
Q ss_pred eecChh
Q 008378 110 GDLGLA 115 (568)
Q Consensus 110 ~DFGla 115 (568)
+||+.+
T Consensus 206 IDwe~a 211 (263)
T 3tm0_A 206 IDLGRS 211 (263)
T ss_dssp CCCTTC
T ss_pred EEchhc
Confidence 999866
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.40 E-value=3.1e-07 Score=95.20 Aligned_cols=109 Identities=16% Similarity=0.215 Sum_probs=81.8
Q ss_pred HHHHHHHHHHHHhCC--CCCeeeeeeEEEcCCC-CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 7 LERLYSEVHLLKSLK--HENIIKFYNSWVDDTN-RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~--HpNIV~l~~~~~~~~~-~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
...+.+|+.+|+.|. +..+++++.++.+... ...|+||||++|..+.+. ....++......++.++...|..||+
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 457889999999997 4567888886644321 347899999998877431 22347788888999999999999997
Q ss_pred C--------------------------------------------------------CCCeEeeeccCCcEEEeCCCCc-
Q 008378 84 H--------------------------------------------------------NPPIIHRDLKCDNIFVNGNNGE- 106 (568)
Q Consensus 84 ~--------------------------------------------------------g~~IiHRDLKp~NILl~~~~g~- 106 (568)
. .+.++|+|++|+||+++.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v 237 (359)
T 3dxp_A 158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRV 237 (359)
T ss_dssp SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCE
T ss_pred CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcE
Confidence 3 1348999999999999743333
Q ss_pred EEEeecChhhh
Q 008378 107 VKIGDLGLAIV 117 (568)
Q Consensus 107 vKI~DFGla~~ 117 (568)
+.|+||+.+..
T Consensus 238 ~~viDwe~a~~ 248 (359)
T 3dxp_A 238 LAVLDWELSTL 248 (359)
T ss_dssp EEECCCTTCEE
T ss_pred EEEECcccccc
Confidence 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.34 E-value=3.4e-07 Score=92.73 Aligned_cols=157 Identities=21% Similarity=0.203 Sum_probs=99.7
Q ss_pred HHHHHHHHHHHHHHhCC-CCC--eeeeeeEEEcCCC-CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 5 DQLERLYSEVHLLKSLK-HEN--IIKFYNSWVDDTN-RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~-HpN--IV~l~~~~~~~~~-~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
....++.+|+.+|+.+. +.. +.+++........ ..-|+||++++|.+|..... ..++......++.|+...|..
T Consensus 52 ~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~ 129 (304)
T 3sg8_A 52 RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSE 129 (304)
T ss_dssp HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHH
Confidence 34678999999999983 433 3344432211111 23478999999988765332 346777778888888888888
Q ss_pred hhhCC--------------------------------------------------------CCeEeeeccCCcEEEeCC-
Q 008378 81 LHSHN--------------------------------------------------------PPIIHRDLKCDNIFVNGN- 103 (568)
Q Consensus 81 LHs~g--------------------------------------------------------~~IiHRDLKp~NILl~~~- 103 (568)
||+.. +.++|+|++|.||+++..
T Consensus 130 LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~ 209 (304)
T 3sg8_A 130 LHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK 209 (304)
T ss_dssp HHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT
T ss_pred HHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC
Confidence 88621 237999999999999843
Q ss_pred CCcEEEeecChhhhccCCCcccccCCCCc---cCccccc---cCC------------CccceehhhHHHHHHHhhcCCCC
Q 008378 104 NGEVKIGDLGLAIVMQQPTARSVIGTPEF---MAPELYE---EEY------------NELVDIYSFGMCILEMVTCEYPY 165 (568)
Q Consensus 104 ~g~vKI~DFGla~~~~~~~~~s~~GTp~Y---mAPEvl~---~~y------------s~ksDIWSLGiilyEmltG~~Pf 165 (568)
.+.+.|+||+.+..-.... .......+ ..|+... ..| ....+.|++|.++|.+.+|..+|
T Consensus 210 ~~~~~~iD~~~~~~~~~~~--Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 210 NTICGIIDFGDAAISDPDN--DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TEEEEECCCTTCEEECTTH--HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCEEEEEeCCCCccCChHH--HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 4567899999875432110 00000011 2232211 111 12257899999999999998777
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.33 E-value=7.9e-07 Score=86.44 Aligned_cols=98 Identities=15% Similarity=0.081 Sum_probs=69.9
Q ss_pred HHHHHHHHHHHhCCCCC--eeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 8 ERLYSEVHLLKSLKHEN--IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpN--IV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+|+.+|+.+.+.+ +.+++.+.... ...++||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSC
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCC
Confidence 45788999999996544 45577766543 3588999999998884 1 1122 2356677777777777643
Q ss_pred --------------------------------------------------------CCeEeeeccCCcEEEeCCCCcEEE
Q 008378 86 --------------------------------------------------------PPIIHRDLKCDNIFVNGNNGEVKI 109 (568)
Q Consensus 86 --------------------------------------------------------~~IiHRDLKp~NILl~~~~g~vKI 109 (568)
..++|+|++|.||+++ .++.+.|
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~l 206 (264)
T 1nd4_A 128 PATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGF 206 (264)
T ss_dssp GGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEE
T ss_pred CCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEE
Confidence 1189999999999997 4455679
Q ss_pred eecChhh
Q 008378 110 GDLGLAI 116 (568)
Q Consensus 110 ~DFGla~ 116 (568)
+|||.+.
T Consensus 207 iD~~~a~ 213 (264)
T 1nd4_A 207 IDCGRLG 213 (264)
T ss_dssp CCCTTCE
T ss_pred Ecchhcc
Confidence 9999763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00024 Score=72.08 Aligned_cols=111 Identities=21% Similarity=0.158 Sum_probs=71.4
Q ss_pred HHHHHHHHHHHHHHHhCCCC---CeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 4 PDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~Hp---NIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+....++.+|+++|+.|.+. .|.+.+.+... .....++||||++|..|....- ..++......++.|+...|..
T Consensus 50 ~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~ 126 (306)
T 3tdw_A 50 QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNE 126 (306)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHH
Confidence 44567899999999999753 34555554432 2345679999999988765311 223444444444444444444
Q ss_pred hhhC----------------------------------------------------------CCCeEeeeccCCcEEEeC
Q 008378 81 LHSH----------------------------------------------------------NPPIIHRDLKCDNIFVNG 102 (568)
Q Consensus 81 LHs~----------------------------------------------------------g~~IiHRDLKp~NILl~~ 102 (568)
||+. .+.++|+|++|.||+++.
T Consensus 127 LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~ 206 (306)
T 3tdw_A 127 LSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNL 206 (306)
T ss_dssp HHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECT
T ss_pred HhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEec
Confidence 4432 123699999999999974
Q ss_pred --CCCc-EEEeecChhhh
Q 008378 103 --NNGE-VKIGDLGLAIV 117 (568)
Q Consensus 103 --~~g~-vKI~DFGla~~ 117 (568)
.++. +.|+||+.+..
T Consensus 207 ~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 207 NSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp TCSSCCEEEECCCTTCEE
T ss_pred CCCCCceEEEEehhhcCC
Confidence 1355 48999997753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00068 Score=66.55 Aligned_cols=105 Identities=15% Similarity=0.081 Sum_probs=71.4
Q ss_pred HHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 5 DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.....+.+|...|+.|. +--|.+++.++.+. ..-|+|||+++|.++.+..... ......+..++...|.-||.
T Consensus 61 ~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~ 134 (272)
T 4gkh_A 61 SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHS 134 (272)
T ss_dssp HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHT
T ss_pred CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcC
Confidence 34567889999999984 33466777766554 3678999999998887765432 12223445555555555553
Q ss_pred CC--------------------------------------------------------CCeEeeeccCCcEEEeCCCCcE
Q 008378 84 HN--------------------------------------------------------PPIIHRDLKCDNIFVNGNNGEV 107 (568)
Q Consensus 84 ~g--------------------------------------------------------~~IiHRDLKp~NILl~~~~g~v 107 (568)
.. +.++|+|+.+.||+++ ..+.+
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~ 213 (272)
T 4gkh_A 135 IPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLI 213 (272)
T ss_dssp SCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEE
T ss_pred CCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEE
Confidence 21 0178999999999998 45556
Q ss_pred EEeecChhh
Q 008378 108 KIGDLGLAI 116 (568)
Q Consensus 108 KI~DFGla~ 116 (568)
-|+||+.+.
T Consensus 214 ~viDwe~a~ 222 (272)
T 4gkh_A 214 GCIDVGRVG 222 (272)
T ss_dssp EECCCTTCE
T ss_pred EEEECcccc
Confidence 699999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0013 Score=67.46 Aligned_cols=29 Identities=14% Similarity=0.243 Sum_probs=24.2
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
.++|+|++|+||+++ ..+.+.|+||+.+.
T Consensus 223 ~l~HgDl~~~Nil~~-~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 223 VLLWGDARVGNVLYR-DFQPVAVLDWEMVA 251 (357)
T ss_dssp EEECSSCSGGGEEEE-TTEEEEECCGGGCE
T ss_pred eEEeCCCCCCeEEEe-CCcEEEEEcccccc
Confidence 489999999999998 44457899999774
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.29 E-value=0.023 Score=55.46 Aligned_cols=122 Identities=19% Similarity=0.145 Sum_probs=80.1
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh-hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCccccc
Q 008378 50 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 127 (568)
Q Consensus 50 GsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL-Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~ 127 (568)
-+|.++++.. .+++++++|.++.|.+.+|.-+ +.+. -..+=+.|..|++. .+|.|-..+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVW-RDGAVTLAP-AADD----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEE-TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEe-cCCceeccc-cccc----------c
Confidence 4789988754 5899999999999999998765 2222 12334456899997 788887653 2110 1
Q ss_pred CCCCccCccccccCCCccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcCC
Q 008378 128 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 205 (568)
Q Consensus 128 GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~~ 205 (568)
....|.|||+.....+.+.=|||||+++|.-+--..|-. .....++.+..||..|...
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e~--------------------eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKEN--------------------EERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCTT--------------------EEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCcc--------------------cchhhCHHHHHHHHHHHhc
Confidence 233466888775555678889999999999886443332 2345678899999888743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.0083 Score=60.33 Aligned_cols=29 Identities=24% Similarity=0.437 Sum_probs=24.9
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla 115 (568)
+.++|+|+++.||+++ .++.+.|+||+.+
T Consensus 222 ~~l~HgD~~~~Nil~~-~~~~~~lIDfe~a 250 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG-ENEQIWVIDLDTV 250 (346)
T ss_dssp CCEECSSCSTTSEEEC-GGGCEEECCCTTC
T ss_pred CceecCCCCcccEEEe-CCCcEEEEehhhc
Confidence 3499999999999996 4578999999966
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=94.51 E-value=0.052 Score=56.43 Aligned_cols=27 Identities=37% Similarity=0.551 Sum_probs=22.8
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChh
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla 115 (568)
.++|+|+.|+||+++ . +.++|+||..+
T Consensus 228 ~L~HGDl~~~Nil~~-~-~~~~lID~e~a 254 (397)
T 2olc_A 228 TLIHGDLHTGSIFAS-E-HETKVIDPEFA 254 (397)
T ss_dssp EEECSCCSGGGEEEC-S-SCEEECCCTTC
T ss_pred ceeeCCCCcCcEEEe-C-CCeEEEeCccc
Confidence 489999999999996 3 35899999766
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.34 E-value=0.099 Score=52.83 Aligned_cols=31 Identities=23% Similarity=0.288 Sum_probs=25.3
Q ss_pred CeEeeeccCCcEEEeCC---CCcEEEeecChhhh
Q 008378 87 PIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIV 117 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~---~g~vKI~DFGla~~ 117 (568)
.++|+|+.+.||++++. .+.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 38999999999999732 26799999997753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=93.55 E-value=0.14 Score=51.12 Aligned_cols=27 Identities=22% Similarity=0.241 Sum_probs=23.3
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
++|+|+.|.||+. .++.+.|+||..+.
T Consensus 175 l~HgDl~~~Nil~--~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 175 ACHCDPLCENFLD--TGERMWIVDWEYSG 201 (301)
T ss_dssp EECSCCCGGGEEE--CSSCEEECCCTTCE
T ss_pred eeccCCCcCCEEE--CCCCEEEEeccccc
Confidence 7999999999995 46788999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=91.62 E-value=0.13 Score=54.03 Aligned_cols=104 Identities=16% Similarity=0.257 Sum_probs=62.7
Q ss_pred HHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHH-----------HH---HHh-C-------CCCC
Q 008378 7 LERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLR-----------QY---RKK-H-------KNVD 63 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~-----------~~---i~k-~-------~~l~ 63 (568)
...+.+|.++|+.|. +.-..+++..+ .+ .+||||++|..|. .+ +.+ | +...
T Consensus 97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~ 170 (379)
T 3feg_A 97 VDSLVLESVMFAILAERSLGPQLYGVF--PE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPH 170 (379)
T ss_dssp HHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCC
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 345668999999884 33335566644 22 2789999985442 11 111 1 1111
Q ss_pred --HHHHHHHHHHHHH-------------------HHHhh----hhCC--CCeEeeeccCCcEEEeCC---CCcEEEeecC
Q 008378 64 --MKAIKNWARQILR-------------------GLHYL----HSHN--PPIIHRDLKCDNIFVNGN---NGEVKIGDLG 113 (568)
Q Consensus 64 --e~~i~~i~~QIl~-------------------gL~yL----Hs~g--~~IiHRDLKp~NILl~~~---~g~vKI~DFG 113 (568)
...+.+|+.++-. .+..| ...+ ..++|+|+.++||+++.. .+.+.++||.
T Consensus 171 ~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE 250 (379)
T 3feg_A 171 WLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFE 250 (379)
T ss_dssp HHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCT
T ss_pred cHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecc
Confidence 3567777766532 12222 2222 237999999999999843 3689999998
Q ss_pred hhh
Q 008378 114 LAI 116 (568)
Q Consensus 114 la~ 116 (568)
.+.
T Consensus 251 ~a~ 253 (379)
T 3feg_A 251 YSS 253 (379)
T ss_dssp TCE
T ss_pred cCC
Confidence 763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=91.48 E-value=0.35 Score=49.26 Aligned_cols=44 Identities=14% Similarity=0.054 Sum_probs=33.2
Q ss_pred HHHHHHHHHHHHhCC---CCCeeeeeeEEEcCCCCeEEEEEecCCCCCH
Q 008378 7 LERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMITELFTSGSL 52 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~---HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL 52 (568)
...+.+|...|+.|. ...+++.+.+.... ...++||||++|..+
T Consensus 72 ~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 72 RSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEALNKSKN 118 (312)
T ss_dssp HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECCCCCCC
T ss_pred HHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEeccCCCC
Confidence 467889999999984 35677787765443 468999999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=89.80 E-value=0.24 Score=51.98 Aligned_cols=28 Identities=21% Similarity=0.472 Sum_probs=23.8
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhh
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~ 116 (568)
.++|+|++|.||+++ .++ ++|+||+.+.
T Consensus 233 ~liHGDl~~~Nil~~-~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVT-QDS-TQVIDPEFSF 260 (420)
T ss_dssp EEECSCCSGGGEEEC-SSC-EEECCCTTCE
T ss_pred eEEecCCCCCcEEEe-CCC-CEEEeCcccc
Confidence 389999999999997 344 9999998774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 568 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-48 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-13 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 2e-70
Identities = 118/222 (53%), Positives = 159/222 (71%), Gaps = 3/222 (1%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHK 60
+ + +R E +LK L+H NI++FY+SW + I ++TEL TSG+L+ Y K+ K
Sbjct: 48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK 107
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ +K +++W RQIL+GL +LH+ PPIIHRDLKCDNIF+ G G VKIGDLGLA + +
Sbjct: 108 VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167
Query: 121 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 180
A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTS
Sbjct: 168 SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
Query: 181 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
G+KPAS KV P+VK+ IE CI R +LL F
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 2e-53
Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 14/231 (6%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----RK 57
+ + + L SEV+LL+ LKH NI+++Y+ +D TN T+ ++ E G L K
Sbjct: 42 MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK 101
Query: 58 KHKNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGL 114
+ + +D + + Q+ L H + ++HRDLK N+F++G VK+GD GL
Sbjct: 102 ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGL 160
Query: 115 AIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP 171
A ++ T A++ +GTP +M+PE YNE DI+S G + E+ P+ +
Sbjct: 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQ 219
Query: 172 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
++ K+ G K + ++ + I + + R E+L++P +
Sbjct: 220 KELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (456), Expect = 1e-52
Identities = 71/256 (27%), Positives = 120/256 (46%), Gaps = 14/256 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
QS ++ + + EV L+ L+H N I++ ++ + ++ E + K
Sbjct: 53 KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKK 110
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ I L+GL YLHSHN +IHRD+K NI ++ G VK+GD G A +M
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP 167
Query: 121 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N
Sbjct: 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALY 224
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL- 234
+ PA S + F++ C+ R + LLK F++ + P ++ D +
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284
Query: 235 RLPNLVPEVMNLAHSE 250
R + V E+ NL + +
Sbjct: 285 RTKDAVRELDNLQYRK 300
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-51
Identities = 51/227 (22%), Positives = 106/227 (46%), Gaps = 10/227 (4%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
++ +L EV + L+H NI++ Y + D T + +I E G++ + +K
Sbjct: 44 LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLS 101
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
D + + ++ L Y HS +IHRD+K +N+ + + GE+KI D G ++
Sbjct: 102 KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPS 158
Query: 121 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
++ GT +++ PE + ++E VD++S G+ E + + P+ E + YK+++
Sbjct: 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 217
Query: 180 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 225
+ + I + + S R E+L+ P++ ++
Sbjct: 218 RV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 3e-50
Identities = 65/239 (27%), Positives = 115/239 (48%), Gaps = 15/239 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKH 59
+S ++LE E+ +L S H NI+K +++ + N + ++ E G++ +
Sbjct: 47 TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELE 104
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+ + I+ +Q L L+YLH + IIHRDLK NI +G++K+ D G++
Sbjct: 105 RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNT 161
Query: 120 QPTAR--SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 171
+ R S IGTP +MAPE+ + Y+ D++S G+ ++EM E P++E
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 172 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 229
+ K S + K F++KC+ R +LL+ PF+ D+ K +
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-49
Identities = 68/248 (27%), Positives = 116/248 (46%), Gaps = 19/248 (7%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+Q + E + +E+ +++ K+ NI+ + +S++ + ++ E GSL +
Sbjct: 55 LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETC 112
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVM 118
D I R+ L+ L +LHS+ +IHRD+K DNI + +G VK+ D G I
Sbjct: 113 M-DEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITP 168
Query: 119 QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
+Q +++GTP +MAPE + + Y VDI+S G+ +EM+ E PY +Y
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
Query: 178 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 236
T+G + + F+ +C+ R A ELL+ FL P L
Sbjct: 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP---------L 279
Query: 237 PNLVPEVM 244
+L P +
Sbjct: 280 SSLTPLIA 287
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-48
Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 12/233 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
++ D E + E+ + K L HEN++KFY + + E + G L +
Sbjct: 42 RAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIG 99
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--- 118
+ + + Q++ G+ YLH I HRD+K +N+ ++ +KI D GLA V
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN 156
Query: 119 -QQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
++ + GT ++APEL + + E VD++S G+ + M+ E P+++ + Q Y
Sbjct: 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
+ K D + K +V S R+ ++ KD + K
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-48
Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 19/229 (8%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 60
+P QL+ +EV +L+ +H NI+ F + ++T+ SL +
Sbjct: 43 PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIET 99
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+M + + ARQ +G+ YLH+ + IIHRDLK +NIF++ + VKIGD GLA V +
Sbjct: 100 KFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSR 156
Query: 121 PTA----RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPA 172
+ + G+ +MAPE+ + Y+ D+Y+FG+ + E++T + PY+ N
Sbjct: 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216
Query: 173 QIYKKVTSGIKPASLSKVTD---PQVKQFIEKCIVP-ASLRLPALELLK 217
QI V G LSKV +K+ + +C+ R ++L
Sbjct: 217 QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 5e-48
Identities = 59/269 (21%), Positives = 108/269 (40%), Gaps = 47/269 (17%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 62
P ++ E+ +L I+ FY ++ D I++ E GSL Q KK +
Sbjct: 44 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRI 101
Query: 63 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 122
+ + + +++GL YL + I+HRD+K NI VN + GE+K+ D G++ +
Sbjct: 102 PEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM 159
Query: 123 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY---------------- 165
A S +GT +M+PE L Y+ DI+S G+ ++EM YP
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
Query: 166 -------------------------NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 200
++ + + P S V + + F+
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279
Query: 201 KCIVP-ASLRLPALELLKDPFLVTDNPKD 228
KC++ + R +L+ F+ + ++
Sbjct: 280 KCLIKNPAERADLKQLMVHAFIKRSDAEE 308
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 158 bits (400), Expect = 3e-44
Identities = 58/262 (22%), Positives = 112/262 (42%), Gaps = 14/262 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 60
E + E+ + L+H ++ ++++ DD + MI E + G L + +H
Sbjct: 62 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHN 119
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQ 119
+ + RQ+ +GL ++H +N +H DLK +NI + E+K+ D GL +
Sbjct: 120 KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177
Query: 120 -QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
+ + + GT EF APE+ E + D++S G+ +++ P+ +N + +
Sbjct: 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRN 236
Query: 178 VTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP--KDLVCD 232
V S S K FI K ++ + R+ + L+ P+L N +D
Sbjct: 237 VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296
Query: 233 PLRLPNLVPEVMNLAHSEPHPM 254
R + + + P P+
Sbjct: 297 SSRYTKIRDSIKTKYDAWPEPL 318
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-43
Identities = 58/227 (25%), Positives = 107/227 (47%), Gaps = 14/227 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ +++ + E ++ L H +K Y ++ DD + +G L +Y +K
Sbjct: 46 IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIG 103
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-- 118
+ D + + +I+ L YLH IIHRDLK +NI +N + ++I D G A V+
Sbjct: 104 SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSP 160
Query: 119 --QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
+Q A S +GT ++++PE L E+ + D+++ G I ++V P+ N I+
Sbjct: 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIF 219
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
+K+ + P+ + +EK +V A+ RL E+ L
Sbjct: 220 QKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (394), Expect = 2e-43
Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 10/232 (4%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 60
P + +E+ ++ L H +I ++++ D + +I E + G L +
Sbjct: 65 PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDY 122
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQ 119
+ + N+ RQ GL ++H H+ I+H D+K +NI VKI D GLA +
Sbjct: 123 KMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180
Query: 120 QP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
+ T EF APE+ + E D+++ G+ +++ P+ + +
Sbjct: 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 240
Query: 178 VTSGIK-PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 227
+ P+ K FI+ + RL + L+ P+L D+
Sbjct: 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 4e-43
Identities = 48/243 (19%), Positives = 102/243 (41%), Gaps = 12/243 (4%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 63
+ + +E+ +L +KH NI+ + + + + +I +L + G L +
Sbjct: 48 EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYT 105
Query: 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQP 121
+ Q+L + YLH I+HRDLK +N+ + ++ I D GL+ +
Sbjct: 106 ERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163
Query: 122 T-ARSVIGTPEFMAP-ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
+ + GTP ++AP L ++ Y++ VD +S G+ ++ P+ + +N A++++++
Sbjct: 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQIL 222
Query: 180 SGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 236
+ K FI + R + L+ P++ D D
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVS 282
Query: 237 PNL 239
+
Sbjct: 283 EQI 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 4e-43
Identities = 45/221 (20%), Positives = 97/221 (43%), Gaps = 10/221 (4%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKK 58
+++ + +E ++ L+H N+++ V++ + ++TE GSL Y +
Sbjct: 38 IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRG 96
Query: 59 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
+ + ++ + + YL +N +HRDL N+ V+ + K+ D GL
Sbjct: 97 RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEA 153
Query: 119 QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
T + ++ APE L E++++ D++SFG+ + E+ + + +
Sbjct: 154 S-STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212
Query: 178 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
V G K + P V + ++ C A++R L+L +
Sbjct: 213 VEKGYKMDAPDGC-PPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-41
Identities = 47/226 (20%), Positives = 99/226 (43%), Gaps = 12/226 (5%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
+ E+ +L +H NI+ + S+ + MI E + + +
Sbjct: 41 KGTDQVLVKKEISILNIARHRNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFE 98
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQ 120
++ + I ++ Q+ L +LHSHN I H D++ +NI + +KI + G A ++
Sbjct: 99 LNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156
Query: 121 P-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
R + PE+ APE+++ + + D++S G + +++ P+ + QI + +
Sbjct: 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENI 215
Query: 179 TSG--IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
+ K + F+++ +V R+ A E L+ P+L
Sbjct: 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (373), Expect = 4e-41
Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 18/232 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ + E EV +L+ + H NII+ +++ +T ++ +L G L Y +
Sbjct: 48 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKV 105
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ K + R +L + LH N I+HRDLK +NI ++ ++ +K+ D G + +
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDP 162
Query: 121 -PTARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPA 172
R V GTP ++APE+ E Y + VD++S G+ + ++ P+ +
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQM 221
Query: 173 QIYKKVTSGIKPASLSKVTD--PQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
+ + + SG + D VK + + +V R A E L PF
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (373), Expect = 9e-41
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 17/252 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ Q+E E +L + H II+ + ++ D I MI + G L +K +
Sbjct: 42 VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQ 99
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
K +A ++ L YLHS + II+RDLK +NI ++ NG +KI D G A +
Sbjct: 100 RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD 156
Query: 121 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
T ++ GTP+++APE + + YN+ +D +SFG+ I EM+ P+ + N + Y+K+
Sbjct: 157 VT-YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKIL 214
Query: 180 SGIKPASLSKVTDPQVKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDP 233
+ + VK + + I +L+ ++ P+ + L+
Sbjct: 215 NA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN 272
Query: 234 LRLPNLVPEVMN 245
+ P P +
Sbjct: 273 IETP-YEPPIQQ 283
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-40
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 17/233 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
Q + +E +L+K L+H+ +++ Y + I +ITE +GSL + K
Sbjct: 47 QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSG 103
Query: 62 V--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM- 118
+ + + + A QI G+ ++ N IHRDL+ NI V+ + KI D GLA ++
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIE 160
Query: 119 --QQPTARSVIGTPEFMAP-ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
+ ++ AP + + D++SFG+ + E+VT ++
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA---LELLKDPFLVTD 224
+ + G + ++ Q + C R +L+D F T+
Sbjct: 221 QNLERGYRMVRPDNC-PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-40
Identities = 59/246 (23%), Positives = 108/246 (43%), Gaps = 13/246 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+ E + EV +LK ++H N+I + + + T+ + +I EL G L + + ++
Sbjct: 52 RRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKES 109
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVM 118
+ + + +QIL G++YLHS I H DLK +NI + N +KI D GLA +
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
Query: 119 QQPTARS-VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
+ GTPEF+APE+ E D++S G+ +++ P+ +
Sbjct: 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLA 226
Query: 177 KVTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDP 233
V++ T K FI + +V R+ + L+ P++ + + +
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSA 286
Query: 234 LRLPNL 239
P
Sbjct: 287 WSHPQF 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-40
Identities = 41/222 (18%), Positives = 85/222 (38%), Gaps = 12/222 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 60
+ E E ++ L H +++ Y ++ I ++ E G L Y R +
Sbjct: 39 EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRG 96
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ + + G+ YL +IHRDL N V N +K+ D G+ +
Sbjct: 97 LFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLD 153
Query: 121 PTAR---SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
++ +PE Y+ D++SFG+ + E+ + E ++ +++ +
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
+++G + ++ V Q + C R LL+
Sbjct: 214 DISTGFRL-YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-40
Identities = 39/230 (16%), Positives = 90/230 (39%), Gaps = 17/230 (7%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
P + L +E ++++ L + I++ ++ ++ E+ G L +Y ++++
Sbjct: 46 ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYLQQNR 102
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+V K I Q+ G+ YL N +HRDL N+ + KI D GL+ ++
Sbjct: 103 HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRA 159
Query: 121 P-----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 174
++ APE + +++ D++SFG+ + E + +++
Sbjct: 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219
Query: 175 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA---LELLKDPF 220
+ G + + ++ + C R L++ +
Sbjct: 220 TAMLEKGERMGCPAGC-PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 51/252 (20%), Positives = 115/252 (45%), Gaps = 18/252 (7%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ + D++ +E +L++ +H + ++ + + E G L + + +
Sbjct: 43 IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHLSRER 100
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVM 118
+ + + +I+ L YLHS + +++RD+K +N+ ++ +G +KI D GL +
Sbjct: 101 VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGIS 157
Query: 119 QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
T ++ GTPE++APE+ E +Y VD + G+ + EM+ P+ ++ ++++
Sbjct: 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFEL 216
Query: 178 VTSGIKPASLSKVTDPQVKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVC 231
+ + P+ K + + A E+++ F ++ N +D+V
Sbjct: 217 ILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274
Query: 232 DPLRLPNLVPEV 243
L P P+V
Sbjct: 275 KKLLPP-FKPQV 285
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (360), Expect = 4e-39
Identities = 44/225 (19%), Positives = 84/225 (37%), Gaps = 16/225 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
+ Q SE ++ H N+I T + +ITE +GSL + R+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQNDGQ 124
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+ + R I G+ YL N +HRDL NI VN +N K+ D GL+ ++
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDD 181
Query: 122 TARSV-------IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 173
T+ + APE + ++ D++S+G+ + E+++
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 174 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
+ + + + Q + C + R +++
Sbjct: 242 VINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (358), Expect = 5e-39
Identities = 48/231 (20%), Positives = 89/231 (38%), Gaps = 13/231 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR--TINMITELFTSGSLRQYRKK 58
+ P R E +L H I+ Y++ +T ++ E +LR
Sbjct: 45 ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT 104
Query: 59 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
+ K + L++ H + IIHRD+K NI ++ N VK+ D G+A +
Sbjct: 105 EGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATN-AVKVMDFGIARAI 161
Query: 119 QQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 172
+VIGT ++++PE + + D+YS G + E++T E P+ +
Sbjct: 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 173 QIYKKVTSGIKPAS-LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
Y+ V P S + + + K + R ++ +
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-39
Identities = 57/246 (23%), Positives = 109/246 (44%), Gaps = 15/246 (6%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK- 60
SP + + E +++ S+ + ++ + + T + +IT+L G L Y ++HK
Sbjct: 50 TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKD 106
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-- 118
N+ + + NW QI +G++YL ++HRDL N+ V VKI D GLA ++
Sbjct: 107 NIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGA 163
Query: 119 --QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
++ A ++MA E + Y D++S+G+ + E++T + ++I
Sbjct: 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDP-FLVTDNPKDLVCDP 233
+ G + + V + KC + A R EL+ + + D + LV
Sbjct: 224 SILEKGERL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282
Query: 234 LRLPNL 239
+L
Sbjct: 283 DERMHL 288
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-38
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 13/224 (5%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYR-KKH 59
S E+ E ++ H +I+K ++ + +I EL T G LR + +
Sbjct: 46 CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRK 102
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
++D+ ++ +A Q+ L YL S +HRD+ N+ V+ N VK+GD GL+ M+
Sbjct: 103 YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 159
Query: 120 QPTAR---SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
T ++MAPE + + D++ FG+C+ E++ + +
Sbjct: 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 218
++ +G + + P + + KC S R EL
Sbjct: 220 GRIENGERL-PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-38
Identities = 35/229 (15%), Positives = 85/229 (37%), Gaps = 18/229 (7%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 61
E + E ++ L + I++ + ++ E+ G L ++ K +
Sbjct: 49 EKADTEEMMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREE 105
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--- 118
+ + + Q+ G+ YL N +HRDL N+ + N KI D GL+ +
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGAD 162
Query: 119 --QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
+ ++ APE + +++ D++S+G+ + E ++ + ++
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP----ALELLKDPF 220
+ G + P++ + C + P + ++ +
Sbjct: 223 AFIEQGKRM-ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-38
Identities = 60/249 (24%), Positives = 113/249 (45%), Gaps = 15/249 (6%)
Query: 1 MQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 59
+ D +E E +L + +H + + ++ N M E G L + +
Sbjct: 40 VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM--EYLNGGDLMYHIQSC 97
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
D+ +A +I+ GL +LHS I++RDLK DNI ++ +G +KI D G+
Sbjct: 98 HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENM 154
Query: 120 QPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
A+ + GTP+++APE L ++YN VD +SFG+ + EM+ + P+ ++ +++
Sbjct: 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFH 213
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPAL-ELLKDPFLVTDNPKDLVCDPL 234
+ + + + K + K V RL ++ + P N ++L +
Sbjct: 214 SIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 271
Query: 235 RLPNLVPEV 243
P P+V
Sbjct: 272 D-PPFRPKV 279
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-38
Identities = 38/226 (16%), Positives = 87/226 (38%), Gaps = 17/226 (7%)
Query: 1 MQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK 58
R+ EV LLK + +I+ + + + + + L + +
Sbjct: 45 WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL-ERPEPVQDLFDFITE 103
Query: 59 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
+ + +++ Q+L + + H+ ++HRD+K +NI ++ N GE+K+ D G ++
Sbjct: 104 RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL 161
Query: 119 QQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
+ GT + PE + ++S G+ + +MV + P+ + +
Sbjct: 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 221
Query: 177 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 221
+ + + I C+ S R E+ P++
Sbjct: 222 FFRQRV---------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-38
Identities = 45/217 (20%), Positives = 86/217 (39%), Gaps = 12/217 (5%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA 66
+ E ++ +L HE +++ Y I +ITE +G L Y R+ +
Sbjct: 44 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQ 101
Query: 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS- 125
+ + + + YL S +HRDL N VN + G VK+ D GL+ + S
Sbjct: 102 LLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSS 158
Query: 126 --VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 182
+ PE+ +++ DI++FG+ + E+ + E ++ + + G+
Sbjct: 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 218
Query: 183 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 218
+ + +V + C A R LL +
Sbjct: 219 RL-YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-37
Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 14/225 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ P+ ++ EV+ + SL H N+I+ Y + + M+TEL GSL +KH+
Sbjct: 49 LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQ 105
Query: 61 N-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+ + +A Q+ G+ YL S IHRDL N+ + VKIGD GL +
Sbjct: 106 GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALP 162
Query: 120 QP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 173
Q + APE L ++ D + FG+ + EM T N +Q
Sbjct: 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222
Query: 174 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
I K+ + + + + +C R + L
Sbjct: 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-37
Identities = 48/229 (20%), Positives = 93/229 (40%), Gaps = 16/229 (6%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMK 65
E E ++K L+HE +++ Y + I ++TE + GSL + + K + +
Sbjct: 57 EAFLQEAQVMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP 113
Query: 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---T 122
+ + A QI G+ Y+ N +HRDL+ NI V N K+ D GLA +++
Sbjct: 114 QLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTA 170
Query: 123 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 181
+ ++ APE + D++SFG+ + E+ T ++ +V G
Sbjct: 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 230
Query: 182 IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK--DPFLVTDNPK 227
+ + + + +C R L + + + P+
Sbjct: 231 YRMPCPPEC-PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (347), Expect = 1e-36
Identities = 50/248 (20%), Positives = 102/248 (41%), Gaps = 18/248 (7%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
Q + L+ + I+ ++ ++ I +L G L + +H
Sbjct: 46 QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGV 103
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
++ +A +I+ GL ++H+ +++RDLK NI ++ +G V+I DLGLA +
Sbjct: 104 FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKK 160
Query: 122 TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
+ +GT +MAPE+ ++ Y+ D +S G + +++ P+ + K +
Sbjct: 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
Query: 180 SGIKPASLSKVTDPQVKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDP 233
+ L P+++ +E + L A E+ + PF + L
Sbjct: 221 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF-----RSLDWQM 275
Query: 234 LRLPNLVP 241
+ L P
Sbjct: 276 VFLQKYPP 283
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 57/260 (21%), Positives = 99/260 (38%), Gaps = 38/260 (14%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
E+ LL+ L H NII +++ +N I+++ + + + + I
Sbjct: 45 RTALREIKLLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHI 102
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARS 125
K + L+GL YLH H I+HRDLK +N+ ++ NG +K+ D GLA P
Sbjct: 103 KAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTH 159
Query: 126 VIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY------------------ 165
+ T + APEL Y VD+++ G + E++
Sbjct: 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 219
Query: 166 -------NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
+ C P + K GI + + I+ + R+ A + LK
Sbjct: 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
Query: 218 DPFLVTDNPKDLVCDPLRLP 237
+ ++ P +LP
Sbjct: 280 MKYF-SNRPGP--TPGCQLP 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 3e-36
Identities = 50/223 (22%), Positives = 90/223 (40%), Gaps = 13/223 (5%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKH 59
+ ++E E ++K +KH N+++ + I E T G+L Y
Sbjct: 52 EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT--EFMTYGNLLDYLRECNR 109
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+ V + A QI + YL N IHRDL N V N VK+ D GL+ +M
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMT 166
Query: 120 QPTARSVIGT---PEFMAP-ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
T + G ++ AP L +++ D+++FG+ + E+ T + +Q+Y
Sbjct: 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
Query: 176 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
+ + + +V + + C S R E+ +
Sbjct: 227 ELLEKDYRMERPEGCP-EKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-36
Identities = 47/226 (20%), Positives = 92/226 (40%), Gaps = 14/226 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KH 59
+ ++ + +E ++K H N++ + + ++ G LR + + +
Sbjct: 66 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNET 124
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
N +K + + Q+ +G+ + +HRDL N ++ VK+ D GLA M
Sbjct: 125 HNPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMY 181
Query: 120 QPTARS------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 172
S ++MA E L +++ D++SFG+ + E++T P N
Sbjct: 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241
Query: 173 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
I + G + DP + + + KC P A +R EL+
Sbjct: 242 DITVYLLQGRRLLQPEYCPDP-LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-36
Identities = 49/224 (21%), Positives = 91/224 (40%), Gaps = 14/224 (6%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 60
+ Q E ++ H NII+ I ITE +G+L ++ R+K
Sbjct: 48 YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI--ITEYMENGALDKFLREKDG 105
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ + R I G+ YL + N +HRDL NI VN +N K+ D GL+ V++
Sbjct: 106 EFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLED 162
Query: 121 P-----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 174
T + APE + ++ D++SFG+ + E++T + ++
Sbjct: 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222
Query: 175 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
K + G + + + Q + +C + R +++
Sbjct: 223 MKAINDGFRLPTPMDC-PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (338), Expect = 2e-35
Identities = 57/252 (22%), Positives = 113/252 (44%), Gaps = 17/252 (6%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ Q+E +E +L+++ ++K S+ D N + M+ E G + + ++
Sbjct: 79 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIG 136
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ +A QI+ YLHS + +I+RDLK +N+ ++ G +++ D G A ++
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG 193
Query: 121 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 179
T ++ GTPE +APE + + YN+ VD ++ G+ I EM P+ P QIY+K+
Sbjct: 194 RT-WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIV 251
Query: 180 SGIKPASLSKVTDPQVKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDP 233
SG +K + + +L+ ++ + T + +
Sbjct: 252 SGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRK 309
Query: 234 LRLPNLVPEVMN 245
+ P +P+
Sbjct: 310 VEAP-FIPKFKG 320
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-35
Identities = 54/246 (21%), Positives = 94/246 (38%), Gaps = 37/246 (15%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
+ E L SE+ ++ L HENI+ + I +I E G L Y + +
Sbjct: 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKRE 137
Query: 62 -----------------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 98
+ + + +A Q+ +G+ +L + +HRDL N+
Sbjct: 138 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNV 195
Query: 99 FVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 153
V + VKI D GLA + + ++MAPE L+E Y D++S+G+
Sbjct: 196 LVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 254
Query: 154 CILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 211
+ E+ + PY A YK + +G K T ++ ++ C + R
Sbjct: 255 LLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYAT-EEIYIIMQSCWAFDSRKRPS 313
Query: 212 ALELLK 217
L
Sbjct: 314 FPNLTS 319
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 4e-35
Identities = 43/238 (18%), Positives = 94/238 (39%), Gaps = 19/238 (7%)
Query: 5 DQLERLYSEVH-LLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQY--RKKH 59
+ EV ++ + +I++ + + + + + ++ E G L +
Sbjct: 46 QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 105
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA-I 116
+ + + I + YLHS N I HRD+K +N+ N +K+ D G A
Sbjct: 106 QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163
Query: 117 VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
+ + TP ++APE+ E+Y++ D++S G+ + ++ P+ + I
Sbjct: 164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAIS 222
Query: 176 KKVTSGIK------PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 226
+ + I+ P +VK I + + R+ E + P+++
Sbjct: 223 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 6e-35
Identities = 58/282 (20%), Positives = 109/282 (38%), Gaps = 46/282 (16%)
Query: 8 ERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSG---SLRQYRKKHK 60
E+ +++ L H NI++ FY+S +N++ + R Y + +
Sbjct: 58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
+ + +K + Q+ R L Y+HS I HRD+K N+ ++ + +K+ D G A + +
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 121 PTA-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
S I + + APEL +Y +D++S G + E++ + + Q+ +
Sbjct: 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 178 VT----------------------SGIKPASLSKV----TDPQVKQFIEKCIVP-ASLRL 210
+ IK +KV T P+ + + + RL
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 211 PALELLKDPFLVTDNPKDLVCDPLRLPNL--VPEVMNLAHSE 250
LE F +L ++LPN P + N E
Sbjct: 296 TPLEACAHSFF-----DELRDPNVKLPNGRDTPALFNFTTQE 332
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 9e-35
Identities = 51/235 (21%), Positives = 89/235 (37%), Gaps = 26/235 (11%)
Query: 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 59
S D E+ +L L H NII + + + E G+L + +K
Sbjct: 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRV 107
Query: 60 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 105
+ + + ++A + RG+ YL IHRDL NI V N
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENY 164
Query: 106 EVKIGDLGLAIVMQQPTARSVI-GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY 163
KI D GL+ + +++ +MA E L Y D++S+G+ + E+V+
Sbjct: 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
A++Y+K+ G + D +V + +C R ++L
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNC-DDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 129 bits (324), Expect = 3e-34
Identities = 54/252 (21%), Positives = 92/252 (36%), Gaps = 36/252 (14%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ E+ +LK LKH NI+K Y+ + ++ E +
Sbjct: 38 KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEG 95
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 120
++ K++ Q+L G+ Y H ++HRDLK N+ +N GE+KI D GLA
Sbjct: 96 GLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGI 152
Query: 121 PTAR--SVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
P + I T + AP++ Y+ +DI+S G EMV + Q+ +
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 177 --------------------------KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLR 209
V + S K D + K + + R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 210 LPALELLKDPFL 221
+ A + L+ +
Sbjct: 273 ITAKQALEHAYF 284
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 6e-34
Identities = 54/273 (19%), Positives = 95/273 (34%), Gaps = 48/273 (17%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT------NRTINMITELFTSGSLRQY 55
+ E+ +L+ LKHEN++ +I ++ +
Sbjct: 48 EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL 107
Query: 56 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 115
+ IK + +L GL+Y+H + I+HRD+K N+ + +G +K+ D GLA
Sbjct: 108 SNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLA 164
Query: 116 IVMQQPTA------RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 167
+ + T + PE L E +Y +D++ G + EM T
Sbjct: 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224
Query: 168 CKNPAQIY-----------------------------KKVTSGIKPASLSKVTDPQVKQF 198
Q+ K +K + V DP
Sbjct: 225 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
Query: 199 IEKCIVP-ASLRLPALELLKDPFLVTD-NPKDL 229
I+K +V + R+ + + L F +D P DL
Sbjct: 285 IDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (320), Expect = 3e-33
Identities = 49/266 (18%), Positives = 104/266 (39%), Gaps = 46/266 (17%)
Query: 3 SPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
P + +++ E+ +L++L+ NII + D +RT ++ E + +Q ++
Sbjct: 69 KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQT 125
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 120
+ I+ + +IL+ L Y HS I+HRD+K N+ ++ + ++++ D GLA
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183
Query: 121 PTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 178
+ + F PEL + Y+ +D++S G + M+ + P+ + ++
Sbjct: 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
Query: 179 T-----------------------------------SGIKPASLSKVTDPQVKQFIEKCI 203
+ + P+ F++K +
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 204 VP-ASLRLPALELLKDPFLVTDNPKD 228
RL A E ++ P+ KD
Sbjct: 304 RYDHQSRLTAREAMEHPYF-YTVVKD 328
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 52/259 (20%), Positives = 112/259 (43%), Gaps = 24/259 (9%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 59
+Q E +E +L+ ++ ++ + ++ +T + + + G L + +
Sbjct: 66 VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL--DYINGGELFTHLSQR 123
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-- 117
+ ++ + +I+ L +LH II+RD+K +NI ++ +NG V + D GL+
Sbjct: 124 ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFV 180
Query: 118 -MQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEMVTCEYPY---NECKN 170
+ A GT E+MAP++ + +++ VD +S G+ + E++T P+ E +
Sbjct: 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240
Query: 171 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV------PASLRLPALELLKDPFLVTD 224
A+I +++ P + K I++ ++ A E+ + F
Sbjct: 241 QAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298
Query: 225 NPKDLVCDPLRLPNLVPEV 243
N DL + P P +
Sbjct: 299 NWDDLAAKKVPAP-FKPVI 316
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (316), Expect = 5e-33
Identities = 40/245 (16%), Positives = 77/245 (31%), Gaps = 36/245 (14%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 61
S D E L+ + NI+K + ++ E G L ++ +
Sbjct: 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPH 113
Query: 62 -----------------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 98
+ ARQ+ G+ YL +HRDL N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNC 171
Query: 99 FVNGNNGEVKIGDLGLAIVMQQPTAR----SVIGTPEFMAPE-LYEEEYNELVDIYSFGM 153
V N VKI D GL+ + + +M PE ++ Y D++++G+
Sbjct: 172 LVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230
Query: 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 212
+ E+ + ++ V G + + ++ + C + R
Sbjct: 231 VLWEIFSYGLQPYYGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSF 289
Query: 213 LELLK 217
+ +
Sbjct: 290 CSIHR 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (316), Expect = 5e-33
Identities = 42/241 (17%), Positives = 82/241 (34%), Gaps = 24/241 (9%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ +L+ E + K ++ I W M+ EL + +
Sbjct: 40 ECVKTKHPQLHIESKIYKMMQGGVGIPTIR-WCGAEGDYNVMVMELLGPSLEDLFNFCSR 98
Query: 61 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVM 118
+K + A Q++ + Y+HS N IHRD+K DN + V I D GLA
Sbjct: 99 KFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
Query: 119 QQP---------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE--YPYN 166
+ +++ GT + + + E + D+ S G ++ +
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216
Query: 167 ECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVPASLRLP----ALELLKDP 219
+ Q Y++++ L K + ++ C P +L ++
Sbjct: 217 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
Query: 220 F 220
F
Sbjct: 277 F 277
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 6e-33
Identities = 58/246 (23%), Positives = 92/246 (37%), Gaps = 43/246 (17%)
Query: 13 EVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNW 70
E++ L+HENI+ F + D + +++ GSL Y ++ V ++ +
Sbjct: 47 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKL 105
Query: 71 ARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 122
A GL +LH P I HRDLK NI V NG I DLGLA+ T
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDT 164
Query: 123 ----ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNP 171
+GT +MAPE+ ++ E + DIY+ G+ E+ ++
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 172 AQIYKKVTSG-------------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 211
Y + I S + + + +C + RL
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 212 ALELLK 217
AL + K
Sbjct: 285 ALRIKK 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-33
Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 29/240 (12%)
Query: 2 QSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ L L SE+ ++K + KH+NII + D + +I E + G+LR+Y + +
Sbjct: 57 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARR 114
Query: 61 ----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 104
+ K + + A Q+ RG+ YL S IHRDL N+ V +
Sbjct: 115 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED- 171
Query: 105 GEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 159
+KI D GLA + + ++MAPE L++ Y D++SFG+ + E+
Sbjct: 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231
Query: 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 218
T +++K + G + S T ++ + C S R +L++D
Sbjct: 232 TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT-NELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-32
Identities = 55/253 (21%), Positives = 97/253 (38%), Gaps = 37/253 (14%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH- 59
++ E+ LLK L H NI+K + + + ++ E +
Sbjct: 39 TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASAL 96
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 119
+ + IK++ Q+L+GL + HSH ++HRDLK N+ +N G +K+ D GLA
Sbjct: 97 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFG 153
Query: 120 QPTAR--SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 175
P + T + APE+ + Y+ VDI+S G EMVT + Q++
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213
Query: 176 KKVTSGIKP--------------------------ASLSKVTDPQVKQFIEKCIVP-ASL 208
+ + P + + D + + + + +
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273
Query: 209 RLPALELLKDPFL 221
R+ A L PF
Sbjct: 274 RISAKAALAHPFF 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-32
Identities = 60/249 (24%), Positives = 100/249 (40%), Gaps = 34/249 (13%)
Query: 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVD---DTNRTINMITELFTSGSLRQY-RKKH 59
P R + + L++ +H N+++ ++ D + ++ E +
Sbjct: 51 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE 110
Query: 60 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVM 118
V + IK+ Q+LRGL +LHSH ++HRDLK NI V ++G++K+ D GLA I
Sbjct: 111 PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYS 167
Query: 119 QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
Q SV+ T + APE L + Y VD++S G EM + + + Q+ K
Sbjct: 168 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227
Query: 178 VTSGIKPAS------------------------LSKVTDPQVKQFIEKCIVP-ASLRLPA 212
+ P D K + KC+ + R+ A
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
Query: 213 LELLKDPFL 221
L P+
Sbjct: 288 YSALSHPYF 296
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-32
Identities = 46/241 (19%), Positives = 95/241 (39%), Gaps = 30/241 (12%)
Query: 2 QSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 60
+ E L SE+ +L L H NI+ + +ITE G L + ++ +
Sbjct: 65 AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKR 122
Query: 61 N------------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 102
+ +D++ + +++ Q+ +G+ +L S N IHRDL NI +
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT- 179
Query: 103 NNGEVKIGDLGLAIVMQQPTARSV----IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 157
+ KI D GLA ++ + V ++MAPE ++ Y D++S+G+ + E
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 158 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELL 216
+ + + K+ + ++ ++ C R +++
Sbjct: 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 217 K 217
+
Sbjct: 300 Q 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-32
Identities = 50/252 (19%), Positives = 100/252 (39%), Gaps = 37/252 (14%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
E+ LLK LKH+NI++ ++ D T+ E + + + +
Sbjct: 40 DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF--EFCDQDLKKYFDSCNGD 97
Query: 62 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 121
+D + +K++ Q+L+GL + HS N ++HRDLK N+ +N NGE+K+ + GLA P
Sbjct: 98 LDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIP 154
Query: 122 TARS--VIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 177
+ T + P++ + Y+ +D++S G E+ P + K+
Sbjct: 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
Query: 178 VTSGI---------------------------KPASLSKVTDPQVKQFIEKCIVP-ASLR 209
+ + ++ + + ++ + R
Sbjct: 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274
Query: 210 LPALELLKDPFL 221
+ A E L+ P+
Sbjct: 275 ISAEEALQHPYF 286
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 5e-32
Identities = 56/259 (21%), Positives = 93/259 (35%), Gaps = 42/259 (16%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN--MITELFTSGSLRQYRKK 58
+ +R E+ +L +HENII + T + + L + K
Sbjct: 44 FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT 103
Query: 59 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
+ I + QILRGL Y+HS N ++HRDLK N+ +N ++KI D GLA V
Sbjct: 104 QH-LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVA 159
Query: 119 -----QQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNP 171
+ T + APE+ Y + +DI+S G + EM++ +
Sbjct: 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219
Query: 172 AQIYKKVTSGIKP----------------------------ASLSKVTDPQVKQFIEKCI 203
Q+ + P L D + ++K +
Sbjct: 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279
Query: 204 VP-ASLRLPALELLKDPFL 221
R+ + L P+L
Sbjct: 280 TFNPHKRIEVEQALAHPYL 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 44/232 (18%), Positives = 88/232 (37%), Gaps = 22/232 (9%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 61
S + +E ++K ++++ +I EL T G L+ Y + +
Sbjct: 62 ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRP 119
Query: 62 V----------DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 111
+ + A +I G+ YL+++ +HRDL N V + VKIGD
Sbjct: 120 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGD 176
Query: 112 LGLAIVMQQP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN 166
G+ + + + +M+PE L + + D++SFG+ + E+ T
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 236
Query: 167 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
+ + Q+ + V G + + + C +R LE++
Sbjct: 237 QGLSNEQVLRFVMEGGLLDKPDNC-PDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 66/254 (25%), Positives = 102/254 (40%), Gaps = 37/254 (14%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS--GSLRQYRKK 58
QS +R Y E+ LLK ++HEN+I + + D L G+ K
Sbjct: 55 FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK 114
Query: 59 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
H+ + I+ Q+L+GL Y+H+ HRDLK N+ VN + E+KI D GLA
Sbjct: 115 HEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVN-EDCELKILDFGLARQA 171
Query: 119 QQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
+ T + APE+ Y + VDI+S G + EM+T + + + Q+ +
Sbjct: 172 DSEM-TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230
Query: 177 KVTSGIKP----------------------------ASLSKVTDPQVKQFIEKCIVP-AS 207
+ P AS+ P +EK +V A
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 208 LRLPALELLKDPFL 221
R+ A E L P+
Sbjct: 291 QRVTAGEALAHPYF 304
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 49/238 (20%), Positives = 95/238 (39%), Gaps = 27/238 (11%)
Query: 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 61
+ + L SE+ +L + H + + +I E G+L Y + +N
Sbjct: 56 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 115
Query: 62 ---------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 106
+ ++ + ++ Q+ +G+ +L S IHRDL NI ++
Sbjct: 116 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNV 172
Query: 107 VKIGDLGLAIVMQQP----TARSVIGTPEFMA-PELYEEEYNELVDIYSFGMCILEMVT- 160
VKI D GLA + + ++MA +++ Y D++SFG+ + E+ +
Sbjct: 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 232
Query: 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 217
PY K + +++ G + T P++ Q + C S R EL++
Sbjct: 233 GASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (290), Expect = 2e-29
Identities = 29/214 (13%), Positives = 76/214 (35%), Gaps = 22/214 (10%)
Query: 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 67
+L E K L I + + + ++ +L + +K +
Sbjct: 45 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV-LVIDLLGPSLEDLLDLCGRKFSVKTV 103
Query: 68 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQP-- 121
A+Q+L + +H + +++RD+K DN + N + + D G+ + P
Sbjct: 104 AMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161
Query: 122 -------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPYNECKNP 171
+++ GT +M+ + E + D+ + G + + + +
Sbjct: 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
Query: 172 AQIYKKVTSGIKPASLSKVTD---PQVKQFIEKC 202
Q Y+++ + L ++ + +++
Sbjct: 222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYA 255
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 7e-27
Identities = 69/269 (25%), Positives = 110/269 (40%), Gaps = 39/269 (14%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI--NMITELFTSGSLRQYRKK 58
QS +R Y E+ LLK +KHEN+I + + + ++ G+ K
Sbjct: 55 FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 59 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 118
+ + ++ QILRGL Y+HS + IIHRDLK N+ VN + E+KI D GLA
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHT 171
Query: 119 QQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 176
+ T + APE+ YN+ VDI+S G + E++T + + Q+
Sbjct: 172 DDEM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 177 KVTSGIKP----------------------------ASLSKVTDPQVKQFIEKCIVP-AS 207
+ P A++ +P +EK +V +
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290
Query: 208 LRLPALELLKDPFLVT-DNPKDL-VCDPL 234
R+ A + L + +P D V DP
Sbjct: 291 KRITAAQALAHAYFAQYHDPDDEPVADPY 319
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 5e-26
Identities = 62/291 (21%), Positives = 112/291 (38%), Gaps = 58/291 (19%)
Query: 1 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----TNRTINMITELFTSGSLRQYR 56
Q+ +R Y E+ L+K + H+NII N + + + ++ EL + + +
Sbjct: 54 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 113
Query: 57 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 116
+ D + + Q+L G+ +LHS IHRDLK NI V ++ +KI D GLA
Sbjct: 114 MEL---DHERMSYLLYQMLCGIKHLHSAGI--IHRDLKPSNIVVK-SDCTLKILDFGLAR 167
Query: 117 VMQQPTARS-VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 174
+ + T + APE + Y E VDI+S G + EMV + + Q
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
Query: 175 YKKVTSGIKP---------------------------------------ASLSKVTDPQV 195
K + P + +K+ Q
Sbjct: 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 287
Query: 196 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 245
+ + K +V + R+ + L+ P++ ++ DP + P++ +
Sbjct: 288 RDLLSKMLVIDPAKRISVDDALQHPYI------NVWYDPAEVEAPPPQIYD 332
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.7 bits (208), Expect = 2e-18
Identities = 50/303 (16%), Positives = 103/303 (33%), Gaps = 72/303 (23%)
Query: 2 QSPDQLERLYSEVHLLKSLKHENIIK--------------FYNSWVDDTNRTINMITELF 47
E E+ LL+ + + K +N + + + L
Sbjct: 48 GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLG 107
Query: 48 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 107
+ + +H+ + + +K ++Q+L GL Y+H IIH D+K +N+ + +
Sbjct: 108 ENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPE 166
Query: 108 KIGDLGLAIVMQ----QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCE 162
+ + +A + + I T E+ +PE L + DI+S I E++T +
Sbjct: 167 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
Query: 163 YPY------NECKNPAQIYKKVTSGIKPAS------------------------------ 186
+ + + K+ I + + + S
Sbjct: 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 286
Query: 187 ---------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD-LVCDPLR 235
SK ++ F+ + R A L+ P+L KD L + +R
Sbjct: 287 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL-----KDTLGMEEIR 341
Query: 236 LPN 238
+P+
Sbjct: 342 VPD 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.3 bits (161), Expect = 3e-13
Identities = 25/144 (17%), Positives = 47/144 (32%), Gaps = 17/144 (11%)
Query: 14 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 73
L+ L+ + K Y ++ EL K+ V ++
Sbjct: 65 FRALQKLQGLAVPKVY-----AWEGNA-VLMELI-------DAKELYRVRVENPDEVLDM 111
Query: 74 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 133
IL + + I+H DL N+ V+ + I D ++ + + R ++
Sbjct: 112 ILEEVAKFYHRG--IVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRN 167
Query: 134 APELYEEEYNELVDIYSFGMCILE 157
+ Y DI S IL+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 568 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.61 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 90.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 84.09 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=414.04 Aligned_cols=220 Identities=54% Similarity=1.003 Sum_probs=203.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcC--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~--~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~y 80 (568)
+....+++.+|+++|++|+|||||++|++|.+. ....+|+|||||++|+|.+++.+.+.+++..++.|+.||+.||+|
T Consensus 48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~y 127 (270)
T d1t4ha_ 48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127 (270)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHH
Confidence 456678899999999999999999999998753 345789999999999999999999999999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccccCCCccceehhhHHHHHHHhh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~~ys~ksDIWSLGiilyEmlt 160 (568)
||+++++|+||||||+|||+++.+|.+||+|||+++........+.+|||.|||||++.+.|+.++|||||||++|||+|
T Consensus 128 LH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~ 207 (270)
T d1t4ha_ 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMAT 207 (270)
T ss_dssp HHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHH
T ss_pred HHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHH
Confidence 99998889999999999999766899999999999887666677889999999999998899999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 222 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~ 222 (568)
|+.||.+..+..++++.+..+..|..++...++++++||.+||. +|.+|||+.|+|+||||+
T Consensus 208 g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 208 SEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp SSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999988889999999999888888888889999999999996 699999999999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=392.26 Aligned_cols=215 Identities=27% Similarity=0.436 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+..+++.+|+++|++|+|||||++|++|.+.. .+|+|||||++|+|.+++.+.+.+++..++.+++||+.||.|||++
T Consensus 45 ~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~--~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~ 122 (271)
T d1nvra_ 45 DCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122 (271)
T ss_dssp ----CHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 44567899999999999999999999997654 7999999999999999998888999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccc-cCC-CccceehhhHHHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEY-NELVDIYSFGMCILEM 158 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~-~~y-s~ksDIWSLGiilyEm 158 (568)
| |+||||||+|||++ .+|.+||+|||+|+..... ...+.+||+.|||||++. ..| +.++|||||||++|||
T Consensus 123 ~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyem 199 (271)
T d1nvra_ 123 G--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199 (271)
T ss_dssp T--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHH
T ss_pred C--CccCcccHHHEEEC-CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHH
Confidence 9 99999999999997 7789999999999876422 245678999999999884 444 6789999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+||+.||....+....+..+.............++++++||.+||. +|.+|||+.|+|+||||++.
T Consensus 200 l~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 200 LAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999876666666666665544444455678999999999996 69999999999999999754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=387.56 Aligned_cols=210 Identities=24% Similarity=0.458 Sum_probs=189.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+++|++++|||||+++++|.+. ..+|+|||||++|+|.+++.+.+.+++..++.|+.||+.||+|||++|
T Consensus 49 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ 126 (263)
T d2j4za1 49 VEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126 (263)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356789999999999999999999998765 479999999999999999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCCC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~P 164 (568)
|+||||||+|||++ .+|.+||+|||+++..........+||+.|||||++. ..|+.++|||||||++|+|+||+.|
T Consensus 127 --ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~P 203 (263)
T d2j4za1 127 --VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203 (263)
T ss_dssp --CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred --eeeeeeccccceec-CCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCC
Confidence 99999999999997 7899999999999887766667788999999999885 4589999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 165 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 165 f~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
|.+ .+..+++..+..+.. .++...++++++||.+||+ +|.+|||+.|+|+||||..
T Consensus 204 f~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 204 FEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred CCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 976 567777777776543 3566789999999999997 6999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=387.93 Aligned_cols=214 Identities=29% Similarity=0.514 Sum_probs=188.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+++|++++|||||+++++|.+.+ .+|+|||||+||+|.+++.+ +.+++..++.|++||+.||.|||++|
T Consensus 60 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ 136 (293)
T d1yhwa1 60 KKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 136 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--EEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3567899999999999999999999998654 79999999999999998876 46999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||+++.+... .....+||+.|||||++. ..|+.++|||||||++|+|+||+
T Consensus 137 --iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~ 213 (293)
T d1yhwa1 137 --VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (293)
T ss_dssp --EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --CcccCCcHHHeEEC-CCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCC
Confidence 99999999999997 7899999999999876433 345668999999999885 45899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.||.+......+...+..+.++...+...++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 214 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 214 PPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp CTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 999886666666666666655555566788999999999996 699999999999999998543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=383.47 Aligned_cols=216 Identities=28% Similarity=0.498 Sum_probs=176.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k----~~~l~e~~i~~i~~QIl~gL 78 (568)
++...+.+.+|+++|++++|||||++|++|.+.....+|+|||||++|+|.+++.+ .+.+++..++.|+.||+.||
T Consensus 43 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al 122 (269)
T d2java1 43 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122 (269)
T ss_dssp CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHH
Confidence 45677889999999999999999999999988776789999999999999999864 46799999999999999999
Q ss_pred HhhhhCC---CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc-cCCCccceehhhH
Q 008378 79 HYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFG 152 (568)
Q Consensus 79 ~yLHs~g---~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLG 152 (568)
.|||+++ .+|+||||||+|||++ .+|.+||+|||+++..... ...+.+|||.|||||++. ..|+.++||||||
T Consensus 123 ~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlG 201 (269)
T d2java1 123 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLG 201 (269)
T ss_dssp HHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHH
T ss_pred HHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhC
Confidence 9999865 2499999999999997 7899999999999887543 345678999999999884 5699999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 008378 153 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 221 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff 221 (568)
|++|||+||+.||.+ .+..++...+..+..+ .++...++++++||.+||+ +|.+|||+.|+|+|||+
T Consensus 202 vilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 202 CLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999976 5667777777776544 3556788999999999996 79999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=396.34 Aligned_cols=218 Identities=27% Similarity=0.499 Sum_probs=183.1
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+...+++.+|+.+|++|+|||||+++++|.+.. .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+
T Consensus 45 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~ 122 (322)
T d1s9ja_ 45 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122 (322)
T ss_dssp TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--EEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 445678999999999999999999999997654 799999999999999999999999999999999999999999997
Q ss_pred -CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 84 -HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 84 -~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
+| |+||||||+|||++ .+|.+||+|||+|+........+.+||+.|||||++. ..|+.++|||||||++|||+||
T Consensus 123 ~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G 199 (322)
T d1s9ja_ 123 KHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199 (322)
T ss_dssp HHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred hCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 58 99999999999997 7899999999999987666667889999999999884 5699999999999999999999
Q ss_pred CCCCCCCCCHHH-----------------------------------------HHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 008378 162 EYPYNECKNPAQ-----------------------------------------IYKKVTSGIKPASLSKVTDPQVKQFIE 200 (568)
Q Consensus 162 ~~Pf~~~~~~~~-----------------------------------------i~~~i~~~~~p~~~~~~~s~el~~lI~ 200 (568)
+.||........ ....+....+|.......++++++||.
T Consensus 200 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 279 (322)
T d1s9ja_ 200 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279 (322)
T ss_dssp SCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHH
Confidence 999976432211 111222222233333456889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 201 KCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 201 kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
+||+ +|.+|||+.|+|+||||+..++
T Consensus 280 ~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 280 KCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp HHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred HHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 9997 7999999999999999986543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=388.07 Aligned_cols=218 Identities=28% Similarity=0.512 Sum_probs=184.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+.+..+++.+|+++|++|+|||||+++++|.+.. .+|+|||||++|+|.+++.+ .+.+++..++.++.||+.||.||
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~yl 126 (288)
T d2jfla1 49 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126 (288)
T ss_dssp SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456678999999999999999999999997654 79999999999999998765 46799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCcccc------ccCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY------EEEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl------~~~ys~ksDIWSLGi 153 (568)
|++| |+||||||+|||++ .+|.+||+|||+|+..... ...+.+||+.|||||++ ...|+.++|||||||
T Consensus 127 H~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGv 203 (288)
T d2jfla1 127 HDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 203 (288)
T ss_dssp HHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHH
T ss_pred HHCC--EEEeecChhheeEC-CCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHH
Confidence 9999 99999999999997 7899999999999765332 23467899999999987 234899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
++|||+||+.||.+....+.+.+......+....+...++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 204 ilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 204 TLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp HHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999875544444444433333334455678999999999997 699999999999999997644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-46 Score=386.14 Aligned_cols=215 Identities=29% Similarity=0.492 Sum_probs=187.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+.+..+++.+|+++|++|+|||||+++++|.+.. .+|+|||||.+|+|..++...+++++..++.+++||+.||.|||
T Consensus 55 ~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH 132 (309)
T d1u5ra_ 55 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132 (309)
T ss_dssp HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4566788999999999999999999999997654 79999999999999988888889999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc----cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGiilyEm 158 (568)
++| |+||||||+|||++ .+|.+||+|||++..... ....+||+.|||||++. ..|+.++|||||||++|||
T Consensus 133 ~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~--~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel 207 (309)
T d1u5ra_ 133 SHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (309)
T ss_dssp HTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS--BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHH
T ss_pred hCC--EeccCCCcceEEEC-CCCCEEEeecccccccCC--CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHH
Confidence 999 99999999999998 789999999999976543 34678999999999873 3589999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
++|..||.+.. ..+....+..+..+...+...++++++||.+||+ +|.+|||+.|+|+||||....
T Consensus 208 ~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 208 AERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHSSCTTTTSC-HHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHCCCCCCCCC-HHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 99999998754 4444455555555555566788999999999996 699999999999999997643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=381.51 Aligned_cols=217 Identities=28% Similarity=0.462 Sum_probs=189.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+++|++|+|||||++|++|.+. ..+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++|
T Consensus 51 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ 128 (288)
T d1uu3a_ 51 KVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128 (288)
T ss_dssp CHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc
Confidence 457799999999999999999999998765 479999999999999999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
|+||||||+|||++ .+|.+||+|||+|+.+... ...+.+||+.|||||++ ...|+.++|||||||++|+|+|
T Consensus 129 --iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~ 205 (288)
T d1uu3a_ 129 --IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205 (288)
T ss_dssp --EECSCCSGGGEEEC-TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred --EEcCcCCccccccC-CCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh
Confidence 99999999999997 7899999999999876432 23456899999999988 4569999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHH------HhcCCCCCCCCCCCcc
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLV 230 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~E------lL~hpff~~~~~~~l~ 230 (568)
|+.||.+ .+...++..+..+.. .++...++++++||.+||+ +|.+|||+.| +++||||+..++..+.
T Consensus 206 g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 206 GLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp SSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred CCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence 9999986 567777777776532 3556789999999999996 6999999987 5899999998887754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=387.39 Aligned_cols=222 Identities=22% Similarity=0.445 Sum_probs=195.7
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+.+|++++|||||+++++|.+. ..+|+|||||+||+|.+++.+.+.+++..++.+++||+.||+|||++|
T Consensus 48 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ 125 (337)
T d1o6la_ 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC
Confidence 467889999999999999999999999765 479999999999999999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhhcC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||+|+.... ....+.+|||.|||||++ ...|+.++|||||||++|||+||+
T Consensus 126 --iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~ 202 (337)
T d1o6la_ 126 --VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp --CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred --ccccccCHHHeEec-CCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCC
Confidence 99999999999997 789999999999986543 344567999999999988 456999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCCCC
Q 008378 163 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLR 235 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~l~ 235 (568)
.||.+ .+...+++.+..+. ..++...++++++||.+||+ +|.+|++ +.|+++||||+..++..+....+.
T Consensus 203 ~pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~ 278 (337)
T d1o6la_ 203 LPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278 (337)
T ss_dssp CSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCC-cCHHHHHHHHhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCC
Confidence 99987 56777777777664 34567789999999999996 6999994 899999999998877665544443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=378.65 Aligned_cols=214 Identities=22% Similarity=0.409 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+.+|++|+|||||+++++|.+. ..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|
T Consensus 50 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~ 127 (307)
T d1a06a_ 50 KEGSMENEIAVLHKIKHPNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127 (307)
T ss_dssp -----CHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce
Confidence 346688999999999999999999998755 479999999999999999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 86 PPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
|+||||||+||++.. .+|.+||+|||+++..... ...+.+||+.|||||++. ..|+.++|||||||++|+|+||
T Consensus 128 --iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g 205 (307)
T d1a06a_ 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205 (307)
T ss_dssp --CCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred --eeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhC
Confidence 999999999999952 4789999999999876433 345678999999999884 5599999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+.||.+ .....+...+..+..+ .......++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 206 ~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 206 YPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp SCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999987 4556666666665432 23445678999999999997 69999999999999999754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-45 Score=378.00 Aligned_cols=223 Identities=29% Similarity=0.494 Sum_probs=194.5
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+.+|++++|||||+++++|.+. ..+|+|||||.||+|..++...+.+++..++.++.||+.||.|||++|
T Consensus 47 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 124 (316)
T d1fota_ 47 QVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124 (316)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHhccCcChhheeeeEeeC--CeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc
Confidence 457889999999999999999999998765 479999999999999999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccccc-CCCccceehhhHHHHHHHhhcCCC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~~-~ys~ksDIWSLGiilyEmltG~~P 164 (568)
|+||||||+|||++ .+|.+||+|||+|+..... ..+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.|
T Consensus 125 --iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~P 200 (316)
T d1fota_ 125 --IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200 (316)
T ss_dssp --EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred --EEccccCchheeEc-CCCCEEEecCccceEeccc-cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCC
Confidence 99999999999997 7899999999999876443 456789999999998854 599999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcccCCCCCC
Q 008378 165 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 237 (568)
Q Consensus 165 f~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~~~~l~~p 237 (568)
|.+ .+..++...+..+.. .++...+++++++|.+||. +|.+|+ +++++|+||||+..++..+....+..|
T Consensus 201 f~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p 276 (316)
T d1fota_ 201 FYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 276 (316)
T ss_dssp TCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred CCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcC
Confidence 986 466677777766533 3456678999999999996 688885 899999999999988776655444433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=374.95 Aligned_cols=218 Identities=26% Similarity=0.440 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+.+.+|+++|++|+|||||+++++|.+. ..+|+|||||++|+|.+++.+.+.+++..++.++.||+.||+|||+++
T Consensus 56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ 133 (293)
T d1jksa_ 56 SREDIEREVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc
Confidence 357899999999999999999999999765 479999999999999999999889999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCC----cEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 86 PPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g----~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
|+||||||+||+++ .+| .+||+|||++...... ...+..||+.|||||++. ..|+.++|||||||++|||+
T Consensus 134 --ivHrDiKp~Nill~-~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 134 --IAHFDLKPENIMLL-DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp --EECCCCSGGGEEES-CSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred --eeecccccceEEEe-cCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHH
Confidence 99999999999997 334 5999999999876543 345678999999999885 45999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCCCc
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 229 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~~~l 229 (568)
||+.||.+ .+..+....+..+... ...+...++++++||.+||. +|.+|||+.|+|+||||+..++...
T Consensus 211 ~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 211 SGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp HSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred cCCCCCCC-CCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence 99999986 4566666666665332 22335678999999999997 6999999999999999987665543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.3e-45 Score=384.54 Aligned_cols=219 Identities=22% Similarity=0.383 Sum_probs=186.8
Q ss_pred HHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCCe
Q 008378 9 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 88 (568)
Q Consensus 9 ~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~I 88 (568)
+..+|+.+|+.++|||||+++++|.+. ..+|+|||||+||+|.+++.+++.+++..++.|+.||+.||.|||++| |
T Consensus 53 ~e~~~~~~l~~~~hpnIv~l~~~~~~~--~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--i 128 (364)
T d1omwa3 53 NERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--V 128 (364)
T ss_dssp HHHHHHHHHSSSCCTTBCCEEEEEECS--SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred HHHHHHHHHhcCCCCcEEEEEEEEEEC--CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 334557788888999999999998765 479999999999999999999999999999999999999999999999 9
Q ss_pred EeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcCCCCC
Q 008378 89 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYN 166 (568)
Q Consensus 89 iHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~~Pf~ 166 (568)
+||||||+|||++ .+|.+||+|||+|+..........+||+.|||||++. ..|+.++|||||||++|||+||+.||.
T Consensus 129 iHrDlKP~NILl~-~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 207 (364)
T d1omwa3 129 VYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207 (364)
T ss_dssp ECCCCSGGGEEEC-SSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cceeeccceeEEc-CCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence 9999999999997 7899999999999887766677789999999999884 358999999999999999999999997
Q ss_pred CCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCCCcccCCC
Q 008378 167 ECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPL 234 (568)
Q Consensus 167 ~~~~--~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps-----a~ElL~hpff~~~~~~~l~~~~l 234 (568)
+... ...+.+.+. ..+..++...++++++||.+||+ +|.+||+ |+|+++||||+..++..+.....
T Consensus 208 ~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~ 281 (364)
T d1omwa3 208 QHKTKDKHEIDRMTL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY 281 (364)
T ss_dssp SSCSSCHHHHHHHSS--SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CCCHHHHHHHHHhcc--cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCC
Confidence 6433 233333322 23444566789999999999996 7999999 79999999999888766544333
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-45 Score=380.62 Aligned_cols=223 Identities=24% Similarity=0.423 Sum_probs=194.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
..+++.+|+++|+.++|||||+++++|.+. ..+++||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||++|
T Consensus 84 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~ 161 (350)
T d1rdqe_ 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161 (350)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHcCCCcEeecccccccc--cccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 457789999999999999999999998765 479999999999999999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhcCCC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYP 164 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG~~P 164 (568)
||||||||+|||++ .+|.+||+|||+|+..... ..+.+||+.|||||++. ..|+.++|||||||++|+|+||+.|
T Consensus 162 --iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~P 237 (350)
T d1rdqe_ 162 --LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp --EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred --EecCcCCHHHcccC-CCCCEEeeeceeeeecccc-cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCC
Confidence 99999999999997 7899999999999876543 44678999999999884 5699999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCC-----CCHHHHhcCCCCCCCCCCCcccCCCCCC
Q 008378 165 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR-----LPALELLKDPFLVTDNPKDLVCDPLRLP 237 (568)
Q Consensus 165 f~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~R-----psa~ElL~hpff~~~~~~~l~~~~l~~p 237 (568)
|.+ .+...++..+..+.. .++...++++++||.+||. +|.+| |++.++++||||+..++..+....+..|
T Consensus 238 f~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p 313 (350)
T d1rdqe_ 238 FFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313 (350)
T ss_dssp SCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred CCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcC
Confidence 976 467777777776643 2455678999999999996 68888 4899999999999988766655554444
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-44 Score=378.17 Aligned_cols=218 Identities=25% Similarity=0.413 Sum_probs=186.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~-k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+.+.+|+.+|++|+|||||+++++|.+. ..+|+|||||+||+|.+++. +.+.+++..++.|+.||+.||.|||
T Consensus 64 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH 141 (350)
T d1koaa2 64 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141 (350)
T ss_dssp HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45668899999999999999999999998765 47999999999999999985 4567999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeC-CCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~-~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++. .+|.+||+|||+++.+... ...+..||+.|||||++. ..|+.++|||||||++|+|+
T Consensus 142 ~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell 219 (350)
T d1koaa2 142 ENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219 (350)
T ss_dssp HTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH
T ss_pred hcC--CeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH
Confidence 999 999999999999963 3689999999999876543 344678999999999885 56899999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~~ 226 (568)
||+.||.+. +..++...+..+.. +.......++++++||.+||+ +|.+|||+.|+|+||||+..+.
T Consensus 220 ~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 220 SGLSPFGGE-NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HSSCSSCCS-SHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred hCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999764 55666666655432 222334578999999999996 6999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-44 Score=376.51 Aligned_cols=217 Identities=24% Similarity=0.397 Sum_probs=186.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLH 82 (568)
....+.+.+|+.+|++|+|||||+++++|.++ ..+|+|||||+||+|.+++.+.+ ++++..++.|+.||+.||.|||
T Consensus 67 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH 144 (352)
T d1koba_ 67 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144 (352)
T ss_dssp HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999999755 47999999999999998876554 6999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeC-CCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 83 SHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~-~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++| |+||||||+|||++. .+|.+||+|||+|+..... ...+..||+.|||||++. ..|+.++|||||||++|+|+
T Consensus 145 ~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 222 (352)
T d1koba_ 145 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 222 (352)
T ss_dssp HTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred HCC--eeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHH
Confidence 999 999999999999963 5689999999999877543 345678999999999885 55999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
||..||.+. +...+...+..+.. +.......++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 223 tG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 223 SGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred hCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 999999874 44555555555432 334456688999999999997 699999999999999998643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.2e-44 Score=360.40 Aligned_cols=212 Identities=26% Similarity=0.455 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+++.+|+.+|++|+ |||||+++++|.+. ..+|||||||++|+|.++++..+.+++..++.|+.||+.||+|||++
T Consensus 52 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~ 129 (277)
T d1phka_ 52 LREATLKEVDILRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129 (277)
T ss_dssp HHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEeecccC--cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 4567899999999997 99999999998754 47999999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-------cCCCccceehhhHHHHH
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-------~~ys~ksDIWSLGiily 156 (568)
| |+||||||+||+++ .+|.+||+|||+++..... .....+||+.|+|||++. ..|+.++||||+||++|
T Consensus 130 ~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvily 206 (277)
T d1phka_ 130 N--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206 (277)
T ss_dssp T--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred C--CcccccccceEEEc-CCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhh
Confidence 9 99999999999997 7899999999999876533 345578999999999873 23788999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
+|+||+.||.+. +...+.+.+..+.. +.......++++++||.+||+ +|.+||++.|+|+||||++
T Consensus 207 eml~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 207 TLLAGSPPFWHR-KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred hhccCCCCCCCC-CHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 999999999874 55556666665533 222334678999999999996 6999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=365.01 Aligned_cols=213 Identities=23% Similarity=0.360 Sum_probs=178.7
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+++.+|+++|++++|||||+++++|.+.+ .+|+|||||.++++..++...+.+++..++.|++||+.||+|||++|
T Consensus 44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~- 120 (299)
T d1ua2a_ 44 NRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120 (299)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc-
Confidence 356889999999999999999999987654 68999999999888888777788999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||+++..... ...+.+||+.|||||++. ..|+.++|||||||++|||+||.
T Consensus 121 -iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~ 198 (299)
T d1ua2a_ 121 -ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198 (299)
T ss_dssp -CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred -eecccCCcceEEec-CCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCc
Confidence 99999999999997 7899999999999876543 344668999999999873 45899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCC--CC-----------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 008378 163 YPYNECKNPAQIYKKVTSGIKP--AS-----------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELL 216 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~~~~p--~~-----------------------~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL 216 (568)
.||.+..+.+++.+.......| .. .....++++++||.+||+ +|.+||||.|+|
T Consensus 199 ~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 9998765555544433210000 00 012457899999999997 799999999999
Q ss_pred cCCCCCCC
Q 008378 217 KDPFLVTD 224 (568)
Q Consensus 217 ~hpff~~~ 224 (568)
+||||++.
T Consensus 279 ~Hp~f~~~ 286 (299)
T d1ua2a_ 279 KMKYFSNR 286 (299)
T ss_dssp TSGGGTSS
T ss_pred CCHhhCCC
Confidence 99999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=367.45 Aligned_cols=217 Identities=24% Similarity=0.465 Sum_probs=188.4
Q ss_pred HHHHHHHHHHHHH-hCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLK-SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk-~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+.+|. .++|||||+++++|.+.. .+|+|||||++|+|.+++...+.+++..++.++.||+.||+|||++
T Consensus 45 ~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~--~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~ 122 (320)
T d1xjda_ 45 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122 (320)
T ss_dssp CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC--ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3566778887765 689999999999987654 7999999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC--CCcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~--~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
+ |+||||||+|||++ .+|.+||+|||+++.... ......+||+.|+|||++. ..|+.++|||||||++|+|+||
T Consensus 123 ~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG 199 (320)
T d1xjda_ 123 G--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199 (320)
T ss_dssp T--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred C--eeeccCcccceeec-CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhC
Confidence 9 99999999999997 789999999999986543 2344568999999999884 5699999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH-HHhcCCCCCCCCCCCcc
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL-ELLKDPFLVTDNPKDLV 230 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~-ElL~hpff~~~~~~~l~ 230 (568)
+.||.+ .+..++...+..+.. .+++..++++++||.+||. +|.+||++. ++++||||+..++..+.
T Consensus 200 ~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~ 267 (320)
T d1xjda_ 200 QSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELE 267 (320)
T ss_dssp SCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred CCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHHHH
Confidence 999976 467777777776533 4567789999999999996 699999996 89999999987655443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=358.66 Aligned_cols=210 Identities=30% Similarity=0.493 Sum_probs=179.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+++..+++.+|+.+|++++|||||++++++.. ..+++|||||++|+|.+++... ..+++..+..++.||+.||+||
T Consensus 44 ~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yL 120 (276)
T d1uwha_ 44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120 (276)
T ss_dssp CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999997643 3578999999999999999765 5699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCccccc----cCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl~----~~ys~ksDIWSLGi 153 (568)
|+++ |+||||||+|||++ .++.+||+|||+|+..... ...+..||+.|||||++. ..|+.++|||||||
T Consensus 121 H~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv 197 (276)
T d1uwha_ 121 HAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGI 197 (276)
T ss_dssp HHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHH
T ss_pred hcCC--EeccccCHHHEEEc-CCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHH
Confidence 9999 99999999999998 7899999999999766432 234568999999999873 34899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++|||+||+.||.+.....++...+..+..++ ..+...++++++||.+||. +|.+|||+.|++++
T Consensus 198 ~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 198 VLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999998888888888887775543 3455678999999999996 69999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=356.63 Aligned_cols=212 Identities=19% Similarity=0.357 Sum_probs=181.7
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++...+++.+|+++|++|+|||||+++++|.++ ..++|||||++|+|.+++.+.+.+++..+..|+.||+.||.|||
T Consensus 48 ~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH 124 (277)
T d1xbba_ 48 DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 124 (277)
T ss_dssp -CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH
Confidence 345678899999999999999999999988543 47899999999999999999999999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
+++ |+||||||+|||++ .+|.+||+|||+++...... .....||+.|||||++ ...|+.++|||||||++|
T Consensus 125 ~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ 201 (277)
T d1xbba_ 125 ESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 201 (277)
T ss_dssp HTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred hCC--cccCCCcchhhccc-ccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhh
Confidence 999 99999999999998 78999999999998664322 2345799999999987 556899999999999999
Q ss_pred HHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHH---hcCCCCC
Q 008378 157 EMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL---LKDPFLV 222 (568)
Q Consensus 157 Emlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~El---L~hpff~ 222 (568)
||+| |+.||.+ .+..++...+..+..+. .+...++++++||.+||. +|.+|||+.++ |+|+|+.
T Consensus 202 ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 202 EAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHhhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9998 8999987 45677888888776553 456778999999999996 79999999987 5666653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=363.87 Aligned_cols=214 Identities=22% Similarity=0.377 Sum_probs=183.4
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
+.+.+.+|+++|++++|||||+++++|.+.. .+|+|||||+||+|.+++.+.+ .+++..++.|+.||+.||+|||++
T Consensus 44 ~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~ 121 (321)
T d1tkia_ 44 DQVLVKKEISILNIARHRNILHLHESFESME--ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121 (321)
T ss_dssp HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 4456889999999999999999999997654 7999999999999999998765 799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeC-CCCcEEEeecChhhhccCC-CcccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~-~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
| |+||||||+|||++. ..+.+||+|||+++..... ...+..||+.|+|||++. ..|+.++|||||||++|+|++|
T Consensus 122 ~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 122 N--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp T--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred C--CCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhC
Confidence 9 999999999999963 3458999999999876443 345568999999999874 5689999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
..||.. .+...++..+..+... .......++++++||.+||+ +|.+|||+.|+|+||||++.
T Consensus 200 ~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 200 INPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999976 4566667766665332 22234578999999999997 69999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=349.86 Aligned_cols=203 Identities=20% Similarity=0.373 Sum_probs=176.2
Q ss_pred HHHHHHHHHHhCC--CCCeeeeeeEEEcCCCCeEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 9 RLYSEVHLLKSLK--HENIIKFYNSWVDDTNRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 9 ~l~~Ei~iLk~L~--HpNIV~l~~~~~~~~~~~l~lV~Ey~~g-GsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
++.+|+.+|++++ |||||+++++|.+. ..+|+||||+.+ +++.+++.+.+.+++..++.|+.||+.||.|||++|
T Consensus 53 ~~~~E~~il~~l~~~h~nIv~~~~~~~~~--~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~ 130 (273)
T d1xwsa_ 53 RVPMEVVLLKKVSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130 (273)
T ss_dssp EEEHHHHHHHHHCSSSCSBCCEEEEEECS--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhccCCCCccEEEEEEeeC--CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4678999999997 89999999998765 479999999976 689999998899999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-cC-CCccceehhhHHHHHHHhhcCC
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EE-YNELVDIYSFGMCILEMVTCEY 163 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~~-ys~ksDIWSLGiilyEmltG~~ 163 (568)
|+||||||+|||++.+.+.+||+|||+++........+.+||+.|||||++. .. ++.++|||||||++|+|+||+.
T Consensus 131 --iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (273)
T d1xwsa_ 131 --VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208 (273)
T ss_dssp --EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred --CccccCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCC
Confidence 9999999999999866789999999999877666667789999999999884 33 4678999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 164 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 164 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
||... . .+..+. ..++...++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 209 Pf~~~---~----~i~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 209 PFEHD---E----EIIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SCCSH---H----HHHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCc---h----HHhhcc--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99752 2 222222 23556678999999999996 79999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=362.95 Aligned_cols=215 Identities=20% Similarity=0.362 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHh-CCCCCeeeeeeEEEc--CCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 8 ERLYSEVHLLKS-LKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 8 e~l~~Ei~iLk~-L~HpNIV~l~~~~~~--~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
+.+.+|+.++.+ ++|||||+++++|.+ .....+|+|||||+||+|.+++.+. ..+++..++.|+.||+.||+|||
T Consensus 49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH 128 (335)
T d2ozaa1 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128 (335)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 457789998755 589999999999865 3345799999999999999999875 46999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeC--CCCcEEEeecChhhhccC-CCcccccCCCCccCccccc-cCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEm 158 (568)
++| |+||||||+|||++. ..+.+||+|||+++.... ......+||+.|||||++. ..|+.++|||||||++|+|
T Consensus 129 ~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~l 206 (335)
T d2ozaa1 129 SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 206 (335)
T ss_dssp HTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHH
T ss_pred HcC--CccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHH
Confidence 999 999999999999973 356899999999987643 3445678999999999885 4599999999999999999
Q ss_pred hhcCCCCCCCCCHHH---HHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 008378 159 VTCEYPYNECKNPAQ---IYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~---i~~~i~~~~~--p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~ 224 (568)
+||+.||.+...... +...+..+.. |.......++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 207 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp TTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred hhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 999999976443322 2222222211 111112467899999999996 69999999999999999754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=358.95 Aligned_cols=209 Identities=25% Similarity=0.397 Sum_probs=179.4
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------------
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------------------- 60 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~---------------------- 60 (568)
....+.+.+|+.+|+++ +|||||++|++|.+.. .+|+|||||++|+|.+++++.+
T Consensus 81 ~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (325)
T d1rjba_ 81 SSEREALMSELKMMTQLGSHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158 (325)
T ss_dssp ---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC-------------------
T ss_pred HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhcccccccccccc
Confidence 34557889999999998 8999999999987654 6899999999999999997643
Q ss_pred -CCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCc
Q 008378 61 -NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAP 135 (568)
Q Consensus 61 -~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAP 135 (568)
.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+...... ..+..||+.||||
T Consensus 159 ~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 235 (325)
T d1rjba_ 159 NVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235 (325)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence 4899999999999999999999999 99999999999998 78999999999998764432 2345789999999
Q ss_pred ccc-ccCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 008378 136 ELY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA 212 (568)
Q Consensus 136 Evl-~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa 212 (568)
|++ .+.|+.++|||||||++|||+| |..||.+......+.+.+..+..+ ..+...++++++||.+||+ +|.+|||+
T Consensus 236 E~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 236 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 977 5679999999999999999998 899998877777777777776554 3556778999999999996 69999999
Q ss_pred HHHhcC
Q 008378 213 LELLKD 218 (568)
Q Consensus 213 ~ElL~h 218 (568)
.|+++|
T Consensus 315 ~ei~~~ 320 (325)
T d1rjba_ 315 PNLTSF 320 (325)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=351.81 Aligned_cols=212 Identities=18% Similarity=0.377 Sum_probs=182.6
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
++...+++.+|+++|++|+|||||++++++.++ .+|+|||||++|+|.+++... +.+++..+..++.||+.||.||
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yl 125 (285)
T d1u59a_ 49 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125 (285)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999988643 489999999999999997654 5799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
|+++ |+||||||+|||++ .++.+||+|||+++.+.... .....||+.|||||++ .+.|+.++|||||||++
T Consensus 126 H~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l 202 (285)
T d1u59a_ 126 EEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 202 (285)
T ss_dssp HHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HhCC--eecCcCchhheeec-cCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHH
Confidence 9999 99999999999998 78999999999998764322 2345789999999987 46699999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHH---hcCCCCC
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL---LKDPFLV 222 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~El---L~hpff~ 222 (568)
|||+| |+.||.+.. ..++...+..+..+. .+...++++.+||.+||. +|.+||++.++ |+|+|+.
T Consensus 203 ~E~lt~G~~Pf~~~~-~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 203 WEALSYGQKPYKKMK-GPEVMAFIEQGKRME-CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTSCCTTTTCC-THHHHHHHHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCC-HHHHHHHHHcCCCCC-CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99998 999998754 556777787776554 456788999999999996 69999998876 6778764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-42 Score=351.36 Aligned_cols=209 Identities=22% Similarity=0.384 Sum_probs=171.3
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+++..+++.+|+++|++|+|||||++++++.... .+++|||||++|+|.+++.+. +.+++..+..|+.||+.||.||
T Consensus 67 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 144 (299)
T d1jpaa_ 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144 (299)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4667789999999999999999999999986554 689999999999999988875 5699999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-------cccccCCCCccCcccc-ccCCCccceehhhHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGM 153 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-------~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGi 153 (568)
|+++ |+||||||+|||++ .++.+||+|||+++.+.... .....||+.|||||++ .+.|+.++|||||||
T Consensus 145 H~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gv 221 (299)
T d1jpaa_ 145 ADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGI 221 (299)
T ss_dssp HHTT--CCCSCCCGGGEEEC-TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred hhCC--CccCccccceEEEC-CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchH
Confidence 9999 99999999999997 78999999999998764321 1124579999999988 466999999999999
Q ss_pred HHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 154 CILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 154 ilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++|||+| |+.||.+. ...++...+..+..+. .+...++++++||.+||. +|.+|||+.|++++
T Consensus 222 vl~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 222 VMWEVMSYGERPYWDM-TNQDVINAIEQDYRLP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHTTSCCTTTTC-CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999998 89999874 5667777777765544 445678999999999996 79999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=349.62 Aligned_cols=215 Identities=26% Similarity=0.416 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+++.+|+++|++++|||||+++++|.+.. .+|+|||||.++.+...... .+.+++..++.++.||+.||.|||++
T Consensus 44 ~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~--~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~ 121 (298)
T d1gz8a_ 44 VPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121 (298)
T ss_dssp CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCcEEEecccccccc--ceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC
Confidence 3578899999999999999999999998754 79999999976545444333 45799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC--CcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~--~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmlt 160 (568)
| ||||||||+|||++ .++.+||+|||+++..... .....+||+.|+|||++. ..++.++|||||||++|+|++
T Consensus 122 ~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~ 198 (298)
T d1gz8a_ 122 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198 (298)
T ss_dssp T--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred C--EEccccCchheeec-ccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhh
Confidence 9 99999999999997 7889999999999877543 344568999999999763 336889999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCC--------------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPAS--------------------------LSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~--------------------------~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
|+.||.+......+.+.+.....+.. .....++++++||.+||+ +|.+|||+.
T Consensus 199 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ 278 (298)
T d1gz8a_ 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278 (298)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999876666666555432111110 012346889999999997 699999999
Q ss_pred HHhcCCCCCCCC
Q 008378 214 ELLKDPFLVTDN 225 (568)
Q Consensus 214 ElL~hpff~~~~ 225 (568)
|+|+||||++..
T Consensus 279 ell~H~ff~~~~ 290 (298)
T d1gz8a_ 279 AALAHPFFQDVT 290 (298)
T ss_dssp HHHTSGGGTTCC
T ss_pred HHhCCHhhccCC
Confidence 999999998643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-42 Score=349.11 Aligned_cols=207 Identities=24% Similarity=0.378 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 5 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
...+++.+|+++|++|+|||||++|++|.+.. .+++|||||++|+|.+++.+. ..+++..+..++.||+.||+|||
T Consensus 55 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH 132 (287)
T d1opja_ 55 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132 (287)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHhCCCCCEecCCccEeeCC--eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH
Confidence 34578999999999999999999999987554 688999999999999998764 56899999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCc---ccccCCCCccCcccc-ccCCCccceehhhHHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEM 158 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~---~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEm 158 (568)
++| |+||||||+|||++ .+|.+||+|||+++....... ....||+.|||||++ .+.|+.++|||||||++|||
T Consensus 133 ~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~el 209 (287)
T d1opja_ 133 KKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209 (287)
T ss_dssp HTT--CCCSCCSGGGEEEC-GGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred HCC--cccCccccCeEEEC-CCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHH
Confidence 999 99999999999997 789999999999987754332 234588999999977 56799999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 159 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 159 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
++|..||....+..++++.+..+..+. .+...++++++||.+||. +|.+|||+.|+++
T Consensus 210 l~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 210 ATYGMSPYPGIDLSQVYELLEKDYRME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCcchHHHHHHHHhcCCCCC-CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 998888877788888888888776554 456678999999999996 7999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-42 Score=342.66 Aligned_cols=206 Identities=19% Similarity=0.405 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+++|++++|||||++++++.... .+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++
T Consensus 44 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~ 121 (263)
T d1sm2a_ 44 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121 (263)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCcccccceeccCC--ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc
Confidence 467999999999999999999999987654 588999999999999998765 56899999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHHHhhc
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEmltG 161 (568)
|+||||||+|||++ .++.+||+|||+++...... .....||+.|||||++. ..|+.++|||||||++|||+|+
T Consensus 122 --iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~ 198 (263)
T d1sm2a_ 122 --VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 198 (263)
T ss_dssp --CCCTTCSGGGEEEC-GGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eeecccchhheeec-CCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHC
Confidence 99999999999997 78899999999998764432 23457999999999884 5699999999999999999996
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 162 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
..|+....+..++...+..+..+. .+...++++.+||.+||+ +|.+|||+.|+++|
T Consensus 199 ~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 199 GKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp SCCTTCSCCHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCC-CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 555555567788888888776543 456778999999999996 69999999999886
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=347.23 Aligned_cols=210 Identities=23% Similarity=0.394 Sum_probs=180.7
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~--~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
..+.+.+|+.+|++++|||||++++++.+. .+++|||||++|+|.+++... .++++..+..++.||+.||.|||+
T Consensus 51 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~ 127 (272)
T d1qpca_ 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127 (272)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHhCCCCCEeEEEeeeccC---CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346799999999999999999999977432 478999999999999976543 369999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCccccc-cCCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGiilyEml 159 (568)
++ |+||||||+|||++ .++.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+
T Consensus 128 ~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ell 204 (272)
T d1qpca_ 128 RN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204 (272)
T ss_dssp TT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred CC--cccCccchhheeee-cccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHH
Confidence 99 99999999999997 78999999999998765432 33457999999999884 56999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc--CCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK--DPFLV 222 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~--hpff~ 222 (568)
||..|+.......++...+..+..+. .+...++++++||.+||+ +|.+|||+.++++ |+||.
T Consensus 205 t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 205 THGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 97777666677888888888776554 455678999999999996 6999999999987 77875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=344.84 Aligned_cols=214 Identities=27% Similarity=0.415 Sum_probs=174.0
Q ss_pred HHHHHHHHHHhC---CCCCeeeeeeEEEcC---CCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 9 RLYSEVHLLKSL---KHENIIKFYNSWVDD---TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 9 ~l~~Ei~iLk~L---~HpNIV~l~~~~~~~---~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
.+.+|+.+|+.| +|||||+++++|... ....++++|||+.+|.+...... ...+++..++.++.||+.||+||
T Consensus 53 ~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL 132 (305)
T d1blxa_ 53 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132 (305)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 456788877766 899999999988642 33578999999998877655543 35799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-CCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
|++| |+||||||+|||++ ..|.+||+|||+++.... ......+||+.|||||++ ...|+.++|||||||++|||+
T Consensus 133 H~~~--ivHrDiKp~NILi~-~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell 209 (305)
T d1blxa_ 133 HSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 209 (305)
T ss_dssp HHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred HhCC--EEecCCCccEEEEc-CCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHH
Confidence 9999 99999999999997 789999999999876543 334567899999999987 566999999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCCC------------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGIK------------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALE 214 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~~------------------------p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~E 214 (568)
||+.||.+....+.+.+.+..... ...+....++.+++||.+||+ +|.+||||.|
T Consensus 210 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e 289 (305)
T d1blxa_ 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289 (305)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 999999876544444443321000 011234567899999999996 7999999999
Q ss_pred HhcCCCCCCCC
Q 008378 215 LLKDPFLVTDN 225 (568)
Q Consensus 215 lL~hpff~~~~ 225 (568)
+|+||||++..
T Consensus 290 ~L~Hpff~~i~ 300 (305)
T d1blxa_ 290 ALSHPYFQDLE 300 (305)
T ss_dssp HHTSGGGTTCC
T ss_pred HhcChhhcCch
Confidence 99999998653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-41 Score=343.98 Aligned_cols=212 Identities=25% Similarity=0.398 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
.+++.+|+.+|++++|||||+++++|.+.. .++++|||+.++.+..+.+..+.+++..++.+++||+.||+|||++|
T Consensus 44 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~- 120 (286)
T d1ob3a_ 44 PSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR- 120 (286)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHhCCCCcEEeeeeecccCC--ceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc-
Confidence 578999999999999999999999998665 68899999998888888887889999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhcC
Q 008378 87 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCE 162 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG~ 162 (568)
|+||||||+|||++ .+|.+||+|||++....... .....|++.|+|||++. ..++.++|||||||++|||++|+
T Consensus 121 -IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~ 198 (286)
T d1ob3a_ 121 -VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (286)
T ss_dssp -CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred -EEecCCCCceeeEc-CCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCC
Confidence 99999999999997 78999999999998765432 34557999999999874 34799999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHc-CCC-------------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 008378 163 YPYNECKNPAQIYKKVTS-GIK-------------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALEL 215 (568)
Q Consensus 163 ~Pf~~~~~~~~i~~~i~~-~~~-------------------------p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~El 215 (568)
.||.+....+++.+.... +.+ ........++.+++||.+||+ +|.+|||+.|+
T Consensus 199 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el 278 (286)
T d1ob3a_ 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278 (286)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999875555544443321 000 011234457899999999997 69999999999
Q ss_pred hcCCCCCC
Q 008378 216 LKDPFLVT 223 (568)
Q Consensus 216 L~hpff~~ 223 (568)
|+||||++
T Consensus 279 l~Hp~f~~ 286 (286)
T d1ob3a_ 279 LEHAYFKE 286 (286)
T ss_dssp HTSGGGGC
T ss_pred hcCcccCc
Confidence 99999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.7e-42 Score=344.64 Aligned_cols=216 Identities=22% Similarity=0.369 Sum_probs=175.6
Q ss_pred CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~--~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
++++..+++.+|+++|+.++|||||++++++..... ..+|+|||||+||+|.+++...+.+++..++.++.||+.||+
T Consensus 46 ~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~ 125 (277)
T d1o6ya_ 46 RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125 (277)
T ss_dssp TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHH
Confidence 356778899999999999999999999999876543 468999999999999999999999999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----CcccccCCCCccCccccc-cCCCccceehhhHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 153 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGi 153 (568)
|||++| |+||||||+|||++ .++.++|+|||++...... ...+.+||+.|||||++. ..|+.++|||||||
T Consensus 126 ~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGv 202 (277)
T d1o6ya_ 126 FSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 202 (277)
T ss_dssp HHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred HHHhCC--ccCccccCcccccC-ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchH
Confidence 999999 99999999999998 7889999999998655322 234568999999999885 45999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHHHHHhcC-CCCCCCC-HHHHhcCCCC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLP-ALELLKDPFL 221 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~el~~lI~kcL~-~p~~Rps-a~ElL~hpff 221 (568)
++|+|+||+.||.+....+.+.+.+.....+ .......++++++||.+||+ +|.+||+ ++++ .|+|.
T Consensus 203 ilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 203 VLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred HHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence 9999999999998755455555555554433 34456688999999999996 6999994 5554 45554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-41 Score=337.94 Aligned_cols=209 Identities=22% Similarity=0.351 Sum_probs=176.0
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+++..+++.+|+++|++|+|||||++++++.+.. .+++|||||.+|+|.+++... +.+++..+..++.||+.||+||
T Consensus 49 ~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~l 126 (283)
T d1mqba_ 49 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126 (283)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC--ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhc
Confidence 4566778999999999999999999999886544 689999999999999987755 6799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
|+++ |+||||||+|||++ .++.+||+|||+++.+.... .....||+.|||||++ .+.|+.++|||||||++
T Consensus 127 H~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil 203 (283)
T d1mqba_ 127 ANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 203 (283)
T ss_dssp HHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred cccc--cccCccccceEEEC-CCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHH
Confidence 9999 99999999999997 78999999999998764322 2234689999999987 55699999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||+||..||....+..++.+.+..+..+. .+...+++++++|.+||. +|.+||++.|+++
T Consensus 204 ~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 204 WEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHhCCCCccccCCHHHHHHHHhccCCCC-CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999998777766678888999988886654 455678999999999996 6999999999876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-41 Score=337.38 Aligned_cols=208 Identities=25% Similarity=0.445 Sum_probs=169.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+....+++.+|+++|++++|||||++|+++.+ ..+|+|||||.+|+|.+++.+ .+.+++..++.++.||+.||.||
T Consensus 48 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl 124 (273)
T d1mp8a_ 48 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124 (273)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhh
Confidence 45667889999999999999999999998843 358999999999999998765 45799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
|+++ |+||||||+||+++ .++.+||+|||+++.+... ......||+.|+|||++ ...|+.++|||||||++||
T Consensus 125 H~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e 201 (273)
T d1mp8a_ 125 ESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 201 (273)
T ss_dssp HHTT--CCCSCCSGGGEEEE-ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHH
T ss_pred cccC--eeccccchhheeec-CCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHH
Confidence 9999 99999999999998 7889999999999876432 23345789999999988 4679999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+| |..||.. .+..++...+..+..+. .+...++++++||.+||. +|.+|||+.|+++|
T Consensus 202 ~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 202 ILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 998 8888876 45666777777776543 566788999999999996 69999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=342.57 Aligned_cols=216 Identities=22% Similarity=0.389 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+++.+|+++|++++ ||||++++++|.......+++|||||.+|+|..+ .+.+++..++.+++||+.||.|||++
T Consensus 72 ~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~ 148 (328)
T d3bqca1 72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSM 148 (328)
T ss_dssp CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 3567899999999995 9999999999987776789999999999999765 35699999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-CCcccccCCCCccCccccc--cCCCccceehhhHHHHHHHhhc
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTC 161 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiilyEmltG 161 (568)
| |+||||||+|||++..++.+||+|||+++.... ......+||+.|+|||++. ..|+.++|||||||++|+|++|
T Consensus 149 g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g 226 (328)
T d3bqca1 149 G--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226 (328)
T ss_dssp T--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred c--cccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccC
Confidence 9 999999999999986666799999999987654 3455678999999999873 3589999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHc--------------CC---------------------CCCCCCCCCcHHHHHHHHHhcC-C
Q 008378 162 EYPYNECKNPAQIYKKVTS--------------GI---------------------KPASLSKVTDPQVKQFIEKCIV-P 205 (568)
Q Consensus 162 ~~Pf~~~~~~~~i~~~i~~--------------~~---------------------~p~~~~~~~s~el~~lI~kcL~-~ 205 (568)
..||....+.......+.. .. .+.......++++++||.+||+ +
T Consensus 227 ~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 306 (328)
T d3bqca1 227 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306 (328)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSS
T ss_pred CCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCC
Confidence 9999776554332222110 00 0011123357899999999996 7
Q ss_pred CCCCCCHHHHhcCCCCCCCCC
Q 008378 206 ASLRLPALELLKDPFLVTDNP 226 (568)
Q Consensus 206 p~~Rpsa~ElL~hpff~~~~~ 226 (568)
|.+|||++|+|+||||+...+
T Consensus 307 P~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 307 HQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGSCCHHHHHTSGGGTTSCC
T ss_pred hhHCcCHHHHhcCcccCCCCC
Confidence 999999999999999987643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=345.42 Aligned_cols=212 Identities=22% Similarity=0.380 Sum_probs=172.3
Q ss_pred HHHHHHHHhCCCCCeeeeeeEEEcC----CCCeEEEEEecCCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 11 YSEVHLLKSLKHENIIKFYNSWVDD----TNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 11 ~~Ei~iLk~L~HpNIV~l~~~~~~~----~~~~l~lV~Ey~~gGsL~~---~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
.+|+++|++|+|||||+++++|... +..++|+|||||.+|.+.. +......+++..++.|++||+.||+|||+
T Consensus 61 ~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~ 140 (350)
T d1q5ka_ 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140 (350)
T ss_dssp CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4799999999999999999998643 3457899999998764333 33455679999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC-CCcccccCCCCccCcccc--ccCCCccceehhhHHHHHHHhh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~-~~~~s~~GTp~YmAPEvl--~~~ys~ksDIWSLGiilyEmlt 160 (568)
+| |+||||||+|||++.+...+||+|||+++.... ....+.+||+.|+|||++ ...|+.++|||||||++|||++
T Consensus 141 ~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 141 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp TT--EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred cC--CcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhh
Confidence 99 999999999999985555899999999987643 345567899999999976 3468999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHc-C-----------------CCCC--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 008378 161 CEYPYNECKNPAQIYKKVTS-G-----------------IKPA--------SLSKVTDPQVKQFIEKCIV-PASLRLPAL 213 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~-~-----------------~~p~--------~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ 213 (568)
|+.||......+++.+.+.. + ..+. ......++++++||.+||. +|.+||||.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999876655555443321 0 0000 1123468899999999997 799999999
Q ss_pred HHhcCCCCCCC
Q 008378 214 ELLKDPFLVTD 224 (568)
Q Consensus 214 ElL~hpff~~~ 224 (568)
|+|+||||+..
T Consensus 299 e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 299 EACAHSFFDEL 309 (350)
T ss_dssp HHHTSGGGGGG
T ss_pred HHhcCHhhccc
Confidence 99999999764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=342.83 Aligned_cols=217 Identities=29% Similarity=0.441 Sum_probs=178.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~----~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
++...+++.+|+++|++|+|||||+++++|...+. ..+|+||||| +++|..+.+. +++++..++.+++||+.||
T Consensus 57 ~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL 134 (346)
T d1cm8a_ 57 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGL 134 (346)
T ss_dssp SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHH
Confidence 55677899999999999999999999999876542 3579999999 5678777654 6799999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc--cCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLGiily 156 (568)
.|||++| |+||||||+|||++ .++.+||+|||+++..... ....+||+.|+|||++. ..++.++|||||||++|
T Consensus 135 ~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 210 (346)
T d1cm8a_ 135 RYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210 (346)
T ss_dssp HHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HHHHhCC--CcccccCcchhhcc-cccccccccccceeccCCc-cccccccccccCHHHHcCCCCCCccchhhcchHHHH
Confidence 9999999 99999999999997 7899999999999876443 45678999999999874 34789999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcC-------------------------CC---CCCCCCCCcHHHHHHHHHhcC-CCC
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVTSG-------------------------IK---PASLSKVTDPQVKQFIEKCIV-PAS 207 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~~~-------------------------~~---p~~~~~~~s~el~~lI~kcL~-~p~ 207 (568)
+|++|+.||.+......+....... .. ........++++++||.+||. +|.
T Consensus 211 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 290 (346)
T d1cm8a_ 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290 (346)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChh
Confidence 9999999998765444433222110 00 111234568999999999996 799
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 008378 208 LRLPALELLKDPFLVTDN 225 (568)
Q Consensus 208 ~Rpsa~ElL~hpff~~~~ 225 (568)
+|||+.|+|+||||+...
T Consensus 291 ~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 291 QRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TSCCHHHHHHSGGGTTTC
T ss_pred HCcCHHHHhcChhhCcCC
Confidence 999999999999998643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=333.21 Aligned_cols=206 Identities=22% Similarity=0.434 Sum_probs=179.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k-~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
..+.+.+|+.+|++++|||||++|++|.+. ..+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++
T Consensus 42 ~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~ 119 (258)
T d1k2pa_ 42 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119 (258)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc
Confidence 346789999999999999999999988654 469999999999999998664 45799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC---cccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~---~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
| |+||||||+||+++ .++.+||+|||+++...... .....||+.|+|||++ ...|+.++|||||||++|||+|
T Consensus 120 ~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 120 Q--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp T--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred C--cccccccceeEEEc-CCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHh
Confidence 9 99999999999997 78999999999997664332 2235789999999987 4679999999999999999998
Q ss_pred -cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 161 -CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 161 -G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+.||.+. +..++...+..+..+. .+...++++++||.+||+ +|.+|||+.++++|
T Consensus 197 ~g~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 197 LGKMPYERF-TNSETAEHIAQGLRLY-RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp TSCCTTTTS-CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCC-CHHHHHHHHHhCCCCC-CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 89999875 4667778888776543 566788999999999997 69999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=334.76 Aligned_cols=211 Identities=23% Similarity=0.378 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHhhhhC
Q 008378 7 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSH 84 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k--~~~l~e~~i~~i~~QIl~gL~yLHs~ 84 (568)
.+.+.+|+.+|++++|||||++|+++.+. .+++|||||.+|+|..++.. .+.+++..+..++.||+.||+|||++
T Consensus 56 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~ 132 (285)
T d1fmka3 56 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132 (285)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcccCCEeEEEEEEecC---CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh
Confidence 46799999999999999999999987432 47899999999999988753 45799999999999999999999999
Q ss_pred CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHhh
Q 008378 85 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT 160 (568)
Q Consensus 85 g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEmlt 160 (568)
| |+||||||+|||++ .+|.+||+|||+++..... ......||+.|+|||++ .+.|+.++|||||||++|||+|
T Consensus 133 ~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t 209 (285)
T d1fmka3 133 N--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 209 (285)
T ss_dssp T--CCCSCCSGGGEEEC-GGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred h--eecccccceEEEEC-CCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHh
Confidence 9 99999999999997 7899999999999866432 22345799999999987 5679999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc--CCCCCCC
Q 008378 161 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK--DPFLVTD 224 (568)
Q Consensus 161 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~--hpff~~~ 224 (568)
|..||.......++...+..+..+. .+...++++++||.+||. +|.+||++.+++. ++||...
T Consensus 210 ~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 210 KGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 8777777677888888888776544 556778999999999996 7999999999987 8888654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=335.84 Aligned_cols=210 Identities=24% Similarity=0.416 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHH
Q 008378 4 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKA 66 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~~ 66 (568)
....+++.+|+.++.++ +|+|||.+++++.... ..+++|||||++|+|.+++...+ .+++..
T Consensus 57 ~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 135 (299)
T d1ywna1 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135 (299)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHH
T ss_pred cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHH
Confidence 45667888898888887 6899999999876543 47899999999999999997542 489999
Q ss_pred HHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-ccC
Q 008378 67 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EEE 141 (568)
Q Consensus 67 i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~~ 141 (568)
+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+..... ......||+.|||||++ .+.
T Consensus 136 ~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 212 (299)
T d1ywna1 136 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 212 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCC--CcCCcCCccceeEC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC
Confidence 9999999999999999999 99999999999997 7899999999999866432 23356899999999987 556
Q ss_pred CCccceehhhHHHHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 142 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 142 ys~ksDIWSLGiilyEmltG-~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
|+.++|||||||++|||+|| ..||.+......+...+..+..+. .+...+++++++|.+||. +|.+|||+.|+++|
T Consensus 213 ~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999986 567877777777888888776654 456678999999999996 69999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=328.44 Aligned_cols=215 Identities=23% Similarity=0.404 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 83 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs 83 (568)
+...+++.+|+.+|+.++|||||+++++|.+.. .+++|++++.+++|..++..++.+++..++.++.|++.||+|||+
T Consensus 42 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~ 119 (292)
T d1unla_ 42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119 (292)
T ss_dssp TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCcCCEEeecccccccc--ceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhc
Confidence 345788999999999999999999999997654 789999999999999999999999999999999999999999999
Q ss_pred CCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC--cccccCCCCccCcccccc--CCCccceehhhHHHHHHHh
Q 008378 84 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 84 ~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~--~~s~~GTp~YmAPEvl~~--~ys~ksDIWSLGiilyEml 159 (568)
+| |+||||||+|||++ ..+.+||+|||.++...... .....+++.|+|||++.. .++.++|||||||++|||+
T Consensus 120 ~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell 196 (292)
T d1unla_ 120 RN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp TT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred CC--EeeecccCcccccc-cCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHh
Confidence 99 99999999999997 67899999999998765432 334567889999998743 3789999999999999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHcCC---------------------------CCCCCCCCCcHHHHHHHHHhcC-CCCCCCC
Q 008378 160 TCEYPYNECKNPAQIYKKVTSGI---------------------------KPASLSKVTDPQVKQFIEKCIV-PASLRLP 211 (568)
Q Consensus 160 tG~~Pf~~~~~~~~i~~~i~~~~---------------------------~p~~~~~~~s~el~~lI~kcL~-~p~~Rps 211 (568)
+|..||....+..+....+.... .........++.+++||.+||+ +|.+|||
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s 276 (292)
T d1unla_ 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp TTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred hCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC
Confidence 99999877777776665553210 0111223457899999999997 6999999
Q ss_pred HHHHhcCCCCCC
Q 008378 212 ALELLKDPFLVT 223 (568)
Q Consensus 212 a~ElL~hpff~~ 223 (568)
|+|+|+||||++
T Consensus 277 a~e~L~Hp~f~~ 288 (292)
T d1unla_ 277 AEEALQHPYFSD 288 (292)
T ss_dssp HHHHTTSGGGSS
T ss_pred HHHHhcChhhcC
Confidence 999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-40 Score=337.99 Aligned_cols=208 Identities=25% Similarity=0.452 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhhh
Q 008378 4 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLH 82 (568)
Q Consensus 4 ~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yLH 82 (568)
++..+++.+|+.+|++++|||||+++++|.+. ..++++||+.+|+|.+++... ..+++..+..|+.||+.||.|||
T Consensus 52 ~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH 128 (317)
T d1xkka_ 52 PKANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128 (317)
T ss_dssp -CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999998764 467889999999999877764 57999999999999999999999
Q ss_pred hCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-ccCCCccceehhhHHHHHH
Q 008378 83 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILE 157 (568)
Q Consensus 83 s~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyE 157 (568)
+++ |+||||||+|||++ .++.+||+|||+++...... .....||+.|||||++ .+.|+.++|||||||++||
T Consensus 129 ~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~e 205 (317)
T d1xkka_ 129 DRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 205 (317)
T ss_dssp HTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HcC--cccCcchhhcceeC-CCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHH
Confidence 999 99999999999998 78899999999998764322 2334689999999977 5679999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 008378 158 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 219 (568)
Q Consensus 158 mlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hp 219 (568)
|+| |..||.+ .+..++...+..+..+. .+...+++++++|.+||. +|.+|||+.|++.|.
T Consensus 206 l~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 206 LMTFGSKPYDG-IPASEISSILEKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 998 7888876 45666777887776553 445678999999999996 699999999999883
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-40 Score=335.90 Aligned_cols=214 Identities=23% Similarity=0.380 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC------CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 6 QLERLYSEVHLLKSLKHENIIKFYNSWVDDT------NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 6 ~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~------~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
..+++.+|+++|++++||||+++++++.... ...+|+|||||.++.+..+......+++..++.+++||+.||.
T Consensus 52 ~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~ 131 (318)
T d3blha1 52 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131 (318)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999886532 3468999999998888777677778999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccC------CCcccccCCCCccCccccc--cCCCccceehhh
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ------PTARSVIGTPEFMAPELYE--EEYNELVDIYSF 151 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~------~~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSL 151 (568)
|||++| |+||||||+|||++ .+|.+||+|||+++.... ....+.+||+.|+|||++. ..|+.++|||||
T Consensus 132 ~lH~~~--ivHrDlKp~NILl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSl 208 (318)
T d3blha1 132 YIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208 (318)
T ss_dssp HHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred HhccCC--EEecCcCchheeec-CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccC
Confidence 999999 99999999999997 789999999999975532 2234568999999999873 468999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHH---cCCCCCCCCC---------------------------CCcHHHHHHHHH
Q 008378 152 GMCILEMVTCEYPYNECKNPAQIYKKVT---SGIKPASLSK---------------------------VTDPQVKQFIEK 201 (568)
Q Consensus 152 GiilyEmltG~~Pf~~~~~~~~i~~~i~---~~~~p~~~~~---------------------------~~s~el~~lI~k 201 (568)
||++|||++|+.||.+...... ...+. ....+..... ..++++++||.+
T Consensus 209 Gvil~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~ 287 (318)
T d3blha1 209 GCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 287 (318)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHH
T ss_pred CceeeeHhhCCCCCCCCCHHHH-HHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHH
Confidence 9999999999999976443332 22222 1111111110 126788999999
Q ss_pred hcC-CCCCCCCHHHHhcCCCCCC
Q 008378 202 CIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 202 cL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
||+ +|.+|||+.|+|+||||+.
T Consensus 288 mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 288 LLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp HSCSSTTTSCCHHHHHHSGGGSS
T ss_pred HCcCChhHCcCHHHHHcChhhcc
Confidence 997 7999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=340.59 Aligned_cols=222 Identities=23% Similarity=0.379 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHhCCC-CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 7 LERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 7 ~e~l~~Ei~iLk~L~H-pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
.+++.+|+++|++++| |||+++++++.+.. .+++||||+.+|+|.+++...+.+++..++.+++||+.||.|||++|
T Consensus 72 ~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~--~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ 149 (322)
T d1vzoa_ 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTET--KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 149 (322)
T ss_dssp GGGCCCHHHHHHHHHTCTTBCCEEEEEEETT--EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhccCCCeEEEeeeeeccCC--ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC
Confidence 4567899999999977 89999999887654 79999999999999999999999999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC---CcccccCCCCccCcccccc---CCCccceehhhHHHHHHHh
Q 008378 86 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~---~~~s~~GTp~YmAPEvl~~---~ys~ksDIWSLGiilyEml 159 (568)
|+||||||+||+++ .+|.+||+|||+++.+... ...+..||+.|+|||++.. .|+.++|||||||++|+|+
T Consensus 150 --ivHrDiKp~Nill~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyell 226 (322)
T d1vzoa_ 150 --IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 226 (322)
T ss_dssp --CCCCCCCGGGEEEC-TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH
T ss_pred --EEeccCCccceeec-CCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHH
Confidence 99999999999998 6799999999999765332 2345689999999998743 4788999999999999999
Q ss_pred hcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCCCcc
Q 008378 160 TCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLV 230 (568)
Q Consensus 160 tG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rp-----sa~ElL~hpff~~~~~~~l~ 230 (568)
||+.||.... ....+.+....... .++...++++++||.+||. +|.+|| +++|+|+||||+..++..+.
T Consensus 227 tG~~PF~~~~~~~~~~~i~~~~~~~~~--~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~ 304 (322)
T d1vzoa_ 227 TGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLA 304 (322)
T ss_dssp HSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhcccCCC--CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHH
Confidence 9999996643 33445554444422 3456789999999999997 699999 58999999999987766555
Q ss_pred cCCCC
Q 008378 231 CDPLR 235 (568)
Q Consensus 231 ~~~l~ 235 (568)
...+.
T Consensus 305 ~~~~~ 309 (322)
T d1vzoa_ 305 AKKVP 309 (322)
T ss_dssp TTCSC
T ss_pred hCCCC
Confidence 44433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=337.86 Aligned_cols=217 Identities=26% Similarity=0.381 Sum_probs=174.3
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCC---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~---~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
.+...+++.+|+.+|++|+|||||++++++..... ..+++ ++|+.+|+|.++++.. ++++..++.++.||+.||+
T Consensus 46 ~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l-~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~ 123 (345)
T d1pmea_ 46 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL-VTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLK 123 (345)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE-EEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE-EEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHH
Confidence 35567789999999999999999999998865432 23454 4566689999999764 6999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-----CcccccCCCCccCccccc--cCCCccceehhhH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFG 152 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-----~~~s~~GTp~YmAPEvl~--~~ys~ksDIWSLG 152 (568)
|||++| ||||||||+|||++ .+|.+||+|||++...... .....+||+.|+|||++. ..|+.++||||+|
T Consensus 124 yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG 200 (345)
T d1pmea_ 124 YIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 200 (345)
T ss_dssp HHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHH
T ss_pred HHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccC
Confidence 999999 99999999999997 7899999999999765332 234568999999999873 3578999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-------------------------C---CCCCCCcHHHHHHHHHhcC
Q 008378 153 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------------------A---SLSKVTDPQVKQFIEKCIV 204 (568)
Q Consensus 153 iilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p-------------------------~---~~~~~~s~el~~lI~kcL~ 204 (568)
|++|+|++|..||.......+....+.....+ . ......++++++||.+||+
T Consensus 201 ~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 280 (345)
T d1pmea_ 201 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280 (345)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSC
T ss_pred ceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHcc
Confidence 99999999999997754443333322110000 0 1123457899999999996
Q ss_pred -CCCCCCCHHHHhcCCCCCCC
Q 008378 205 -PASLRLPALELLKDPFLVTD 224 (568)
Q Consensus 205 -~p~~Rpsa~ElL~hpff~~~ 224 (568)
+|.+|||+.|+|+||||+..
T Consensus 281 ~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 281 FNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp SSTTTSCCHHHHHTSGGGTTT
T ss_pred CChhHCcCHHHHhcCHhhccC
Confidence 79999999999999999854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-40 Score=335.90 Aligned_cols=210 Identities=24% Similarity=0.336 Sum_probs=177.0
Q ss_pred CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHH
Q 008378 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMK 65 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------------~~l~e~ 65 (568)
+.+..+.+.+|+++|+++ +|||||++|++|.+.+ .+++|||||++|+|.+++.+. ..+++.
T Consensus 50 ~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~ 127 (309)
T d1fvra_ 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127 (309)
T ss_dssp -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHH
Confidence 345677899999999999 7999999999998654 799999999999999999754 579999
Q ss_pred HHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-cccccCCCCccCcccc-ccCCC
Q 008378 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEYN 143 (568)
Q Consensus 66 ~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-~~s~~GTp~YmAPEvl-~~~ys 143 (568)
.+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||.+ ...|+
T Consensus 128 ~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~-~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 204 (309)
T d1fvra_ 128 QLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT 204 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc-CCCceEEccccccccccccccccceecCCcccchHHhccCCCC
Confidence 99999999999999999999 99999999999997 77899999999997654332 3355799999999987 56699
Q ss_pred ccceehhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 144 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 144 ~ksDIWSLGiilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
.++|||||||++|||++|..|+....+..+++..+..+..+. .+...++++++||.+||. +|.+|||+.|++++
T Consensus 205 ~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999997654434567888888888876654 455678999999999996 79999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=328.87 Aligned_cols=208 Identities=26% Similarity=0.428 Sum_probs=171.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHhh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL 81 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~yL 81 (568)
+++..+++.+|+.+|++++|||||++|+++.+. .+++|||||++|+|.+++..+ +.+++..+..++.||+.||.||
T Consensus 51 ~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl 127 (273)
T d1u46a_ 51 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127 (273)
T ss_dssp -CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHh
Confidence 355678899999999999999999999988543 478999999999999876654 5799999999999999999999
Q ss_pred hhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC-----cccccCCCCccCcccc-ccCCCccceehhhHHHH
Q 008378 82 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 155 (568)
Q Consensus 82 Hs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~-----~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiil 155 (568)
|++| |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||++ ...|+.++|||||||++
T Consensus 128 H~~~--iiHrDikp~NIll~-~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil 204 (273)
T d1u46a_ 128 ESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204 (273)
T ss_dssp HHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred hhCC--EeeeeecHHHhccc-cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHH
Confidence 9999 99999999999998 67899999999998764332 2334678899999988 45589999999999999
Q ss_pred HHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 156 LEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 156 yEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||+| |..||.+. +..++...+.........+...++.+++||.+||. +|.+|||+.+++.
T Consensus 205 ~emlt~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 205 WEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHTTSCCTTTTC-CHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCc-CHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99998 89999874 45555555554433334556678999999999996 7999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=331.92 Aligned_cols=212 Identities=21% Similarity=0.343 Sum_probs=179.8
Q ss_pred CCHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHh
Q 008378 2 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 2 qs~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~-~~l~e~~i~~i~~QIl~gL~y 80 (568)
.+.+..+++.+|+++|++|+|||||++++++.... ..+++|||||++|+|.+++... ..+++..+..++.||+.||.|
T Consensus 67 ~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~ 145 (311)
T d1r0pa_ 67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145 (311)
T ss_dssp CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhh
Confidence 36778899999999999999999999999987644 4789999999999999988854 468888999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------CcccccCCCCccCcccc-ccCCCccceehhhHH
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGM 153 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGi 153 (568)
||+.+ |+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++ .+.|+.++|||||||
T Consensus 146 lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGi 222 (311)
T d1r0pa_ 146 LASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 222 (311)
T ss_dssp HHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred hcccC--cccCCccHHhEeEC-CCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHH
Confidence 99999 99999999999997 7899999999999865432 12235789999999977 567999999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 154 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 154 ilyEmltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
++|||+||..||....+..++...+..+..+. .+...++++.+||.+||+ +|.+||++.|+++|
T Consensus 223 vl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 223 LLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999998888877667777788888876654 456678999999999996 69999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=329.63 Aligned_cols=209 Identities=22% Similarity=0.428 Sum_probs=171.5
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHh
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHY 80 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~--~l~e~~i~~i~~QIl~gL~y 80 (568)
+....+.+.+|+++|++|+|||||++++++.+.. ..+|+||||+++|+|.+++.+.+ .+++..+..|+.||+.||.|
T Consensus 40 ~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~y 118 (262)
T d1byga_ 40 NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118 (262)
T ss_dssp CCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccc
Confidence 3445678999999999999999999999886543 35799999999999999987643 58999999999999999999
Q ss_pred hhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCCccceehhhHHHHHHHh
Q 008378 81 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMV 159 (568)
Q Consensus 81 LHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiilyEml 159 (568)
||+++ |+||||||+|||++ .+|.+||+|||+++..... .....+|+.|+|||++ ...|+.++|||||||++|||+
T Consensus 119 lH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~ 194 (262)
T d1byga_ 119 LEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 194 (262)
T ss_dssp HHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccCc--eeccccchHhheec-CCCCEeecccccceecCCC-CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHH
Confidence 99998 99999999999997 7899999999999875433 3445789999999977 567999999999999999999
Q ss_pred h-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 008378 160 T-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 218 (568)
Q Consensus 160 t-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~h 218 (568)
| |..||.. .+..++...+..+..+. .+...++++++||.+||. +|.+|||+.+++++
T Consensus 195 t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 195 SFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 8 6777765 56777888888776665 456678999999999996 69999999998774
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-39 Score=327.19 Aligned_cols=208 Identities=21% Similarity=0.330 Sum_probs=176.9
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------------
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------------------- 60 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~---------------------- 60 (568)
+.+..+++.+|+++|++++||||++++++|... ..+++||||+.+|+|.+++....
T Consensus 56 ~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (301)
T d1lufa_ 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133 (301)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHHTCC---------------------
T ss_pred ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccC
Confidence 455678899999999999999999999998754 36889999999999999987532
Q ss_pred --CCCHHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccC
Q 008378 61 --NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMA 134 (568)
Q Consensus 61 --~l~e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmA 134 (568)
.+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+... ...+..||+.|||
T Consensus 134 ~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~a 210 (301)
T d1lufa_ 134 PPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP 210 (301)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCC
Confidence 4889999999999999999999999 99999999999998 6789999999999876433 2234578999999
Q ss_pred cccc-ccCCCccceehhhHHHHHHHhhcCC-CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC
Q 008378 135 PELY-EEEYNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP 211 (568)
Q Consensus 135 PEvl-~~~ys~ksDIWSLGiilyEmltG~~-Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rps 211 (568)
||++ ...|+.++|||||||++|||++|.. ||.+ .+..++...+..+..+. .+...++++.+||.+||. +|.+|||
T Consensus 211 PE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 211 PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHccCCCChhhhhccchhhHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcC
Confidence 9987 4579999999999999999999965 5654 67777888888876543 456678999999999996 6999999
Q ss_pred HHHHhc
Q 008378 212 ALELLK 217 (568)
Q Consensus 212 a~ElL~ 217 (568)
+.|+++
T Consensus 289 ~~ev~~ 294 (301)
T d1lufa_ 289 FCSIHR 294 (301)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=323.70 Aligned_cols=208 Identities=27% Similarity=0.465 Sum_probs=180.3
Q ss_pred CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHH
Q 008378 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMK 65 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~----------------~l~e~ 65 (568)
+......+.+|+..++++ +|||||+++++|.++ ..+++|||||++|+|.+++...+ .+++.
T Consensus 58 ~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~ 135 (299)
T d1fgka_ 58 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135 (299)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHH
T ss_pred ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHH
Confidence 345678899999999998 899999999998764 46899999999999999997553 58999
Q ss_pred HHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-cc
Q 008378 66 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE 140 (568)
Q Consensus 66 ~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl-~~ 140 (568)
.+..|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+++...... .....||+.|+|||++ .+
T Consensus 136 ~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~ 212 (299)
T d1fgka_ 136 DLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHhhhCC--EEeeeecccceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC
Confidence 99999999999999999999 99999999999997 78999999999998664332 3346799999999977 56
Q ss_pred CCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 141 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 141 ~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
.|+.++||||||+++|||+| |..||.+ .+..+++..+..+..+. .+...++++++||.+||+ +|.+|||+.|+++
T Consensus 213 ~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCchhhhHHhHHHHHHhccCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 79999999999999999998 6777765 66778888888776554 456778999999999996 6999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-39 Score=332.31 Aligned_cols=217 Identities=29% Similarity=0.393 Sum_probs=171.1
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 79 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~---~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~ 79 (568)
+....+++.+|+++|++|+|||||+++++|.... ....++|++|+.+|+|.+++.. +++++..++.+++||+.||+
T Consensus 57 ~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~ 135 (348)
T d2gfsa1 57 SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 135 (348)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHH
Confidence 4567788999999999999999999999886432 2234556778889999998865 57999999999999999999
Q ss_pred hhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccCCCCccCccccc-c-CCCccceehhhHHHHHH
Q 008378 80 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILE 157 (568)
Q Consensus 80 yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl~-~-~ys~ksDIWSLGiilyE 157 (568)
|||++| |+||||||+|||++ .+|.+|++|||++..... ...+..||+.|+|||++. . .++.++|||||||++|+
T Consensus 136 ~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~~~~-~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ 211 (348)
T d2gfsa1 136 YIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211 (348)
T ss_dssp HHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----CCTG-GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHH
T ss_pred HHHhCC--CcccccCCcccccc-ccccccccccchhcccCc-ccccccccccccCchhhcCCccCCcccchhhhhHHHHH
Confidence 999999 99999999999997 789999999999976533 234567999999999763 3 46899999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCC--------------------C--------CCCCCcHHHHHHHHHhcC-CCCC
Q 008378 158 MVTCEYPYNECKNPAQIYKKVTSGIKPA--------------------S--------LSKVTDPQVKQFIEKCIV-PASL 208 (568)
Q Consensus 158 mltG~~Pf~~~~~~~~i~~~i~~~~~p~--------------------~--------~~~~~s~el~~lI~kcL~-~p~~ 208 (568)
|++|+.||.+................+. . .....++++++||.+||. +|.+
T Consensus 212 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 291 (348)
T d2gfsa1 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291 (348)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhh
Confidence 9999999987543333222211110000 0 113467899999999996 7999
Q ss_pred CCCHHHHhcCCCCCCC
Q 008378 209 RLPALELLKDPFLVTD 224 (568)
Q Consensus 209 Rpsa~ElL~hpff~~~ 224 (568)
||||.|+|+||||++.
T Consensus 292 R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 292 RITAAQALAHAYFAQY 307 (348)
T ss_dssp SCCHHHHHTSGGGTTT
T ss_pred CcCHHHHhcCHhhCCC
Confidence 9999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-39 Score=333.15 Aligned_cols=215 Identities=27% Similarity=0.403 Sum_probs=165.3
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 78 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~----~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL 78 (568)
++...+++.+|+.+|++++|||||+++++|.... ...+|+|||||.++.+.. + .+.+++..++.+++||+.||
T Consensus 56 ~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~-~--~~~~~~~~i~~~~~qil~gl 132 (355)
T d2b1pa1 56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-I--QMELDHERMSYLLYQMLCGI 132 (355)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHH-H--TSCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHh-h--hcCCCHHHHHHHHHHHHHHH
Confidence 4667788999999999999999999999987542 368999999998665543 3 45699999999999999999
Q ss_pred HhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC-CcccccCCCCccCcccc-ccCCCccceehhhHHHHH
Q 008378 79 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCIL 156 (568)
Q Consensus 79 ~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~-~~~s~~GTp~YmAPEvl-~~~ys~ksDIWSLGiily 156 (568)
+|||++| |+||||||+|||++ .++.+|++|||+++..... .....+||+.|+|||++ ...|++++||||+||++|
T Consensus 133 ~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ 209 (355)
T d2b1pa1 133 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209 (355)
T ss_dssp HHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHhhhcc--cccccCCccccccc-cccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHH
Confidence 9999999 99999999999997 6889999999998766543 34556899999999987 456899999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHH---------------------cCCCCCC-C-----------------CCCCcHHHHH
Q 008378 157 EMVTCEYPYNECKNPAQIYKKVT---------------------SGIKPAS-L-----------------SKVTDPQVKQ 197 (568)
Q Consensus 157 EmltG~~Pf~~~~~~~~i~~~i~---------------------~~~~p~~-~-----------------~~~~s~el~~ 197 (568)
+|++|+.||.+........+.+. ....+.. . ....++++++
T Consensus 210 ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 289 (355)
T d2b1pa1 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289 (355)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHH
Confidence 99999999987543333322211 1100000 0 0113568899
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 008378 198 FIEKCIV-PASLRLPALELLKDPFLVT 223 (568)
Q Consensus 198 lI~kcL~-~p~~Rpsa~ElL~hpff~~ 223 (568)
||.+||. +|.+||||+|+|+||||+.
T Consensus 290 ll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 290 LLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999996 7999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-38 Score=322.04 Aligned_cols=209 Identities=23% Similarity=0.399 Sum_probs=177.7
Q ss_pred CHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC------------------CCC
Q 008378 3 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK------------------NVD 63 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L-~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~------------------~l~ 63 (568)
......++.+|+.+++++ +|||||++|+++.+.. .+++|||||++|+|.+++.+.. .++
T Consensus 66 ~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~ 143 (311)
T d1t46a_ 66 HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143 (311)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCC
T ss_pred CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC--EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCC
Confidence 356677899999999999 7999999999986554 5899999999999999997654 589
Q ss_pred HHHHHHHHHHHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCCC----cccccCCCCccCcccc-
Q 008378 64 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY- 138 (568)
Q Consensus 64 e~~i~~i~~QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~----~~s~~GTp~YmAPEvl- 138 (568)
+..+..++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||+++...... .....||+.|+|||++
T Consensus 144 ~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 220 (311)
T d1t46a_ 144 LEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCC--eeeccccccccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc
Confidence 9999999999999999999999 99999999999998 78999999999998764322 2345789999999987
Q ss_pred ccCCCccceehhhHHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 008378 139 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 216 (568)
Q Consensus 139 ~~~ys~ksDIWSLGiilyEmlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL 216 (568)
...|+.++|||||||++|||+| |..||........+.+.+..+..+. .+...++.+++||.+||. +|.+|||+.+++
T Consensus 221 ~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il 299 (311)
T d1t46a_ 221 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (311)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 4668999999999999999999 5666666555566677776665554 455678999999999996 699999999988
Q ss_pred c
Q 008378 217 K 217 (568)
Q Consensus 217 ~ 217 (568)
+
T Consensus 300 ~ 300 (311)
T d1t46a_ 300 Q 300 (311)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-38 Score=321.30 Aligned_cols=208 Identities=22% Similarity=0.384 Sum_probs=177.4
Q ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHH
Q 008378 3 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWAR 72 (568)
Q Consensus 3 s~~~~e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~----------~~l~e~~i~~i~~ 72 (568)
+.+..+.+.+|+++|++++|||||++++++.... .+++|||||.+|+|.+++... ..+++..+..++.
T Consensus 63 ~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 140 (308)
T d1p4oa_ 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140 (308)
T ss_dssp CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHH
Confidence 4566678999999999999999999999886544 689999999999999998643 2478899999999
Q ss_pred HHHHHHHhhhhCCCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC----CcccccCCCCccCcccc-ccCCCccce
Q 008378 73 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EEEYNELVD 147 (568)
Q Consensus 73 QIl~gL~yLHs~g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~----~~~s~~GTp~YmAPEvl-~~~ys~ksD 147 (568)
||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+... ......||+.|+|||.+ .+.|+.++|
T Consensus 141 ~ia~gl~~LH~~~--ivHrDlk~~NiLld-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~D 217 (308)
T d1p4oa_ 141 EIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD 217 (308)
T ss_dssp HHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHhhCC--eeeceEcCCceeec-CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccc
Confidence 9999999999999 99999999999998 7889999999999866432 23345789999999987 456899999
Q ss_pred ehhhHHHHHHHhhcC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 008378 148 IYSFGMCILEMVTCE-YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 217 (568)
Q Consensus 148 IWSLGiilyEmltG~-~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~ 217 (568)
|||||+++|||+||. .||.+ .+..++...+..+..+. .+...++.++++|.+||+ +|.+|||+.++++
T Consensus 218 v~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 218 VWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999985 56654 67777788887776543 455678999999999996 6999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=311.00 Aligned_cols=206 Identities=27% Similarity=0.402 Sum_probs=159.9
Q ss_pred HHHHHHHHhCCCCCeeeeeeEEEcCCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhC----
Q 008378 11 YSEVHLLKSLKHENIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH---- 84 (568)
Q Consensus 11 ~~Ei~iLk~L~HpNIV~l~~~~~~~~~--~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~---- 84 (568)
.+|+..+++++|||||++|+++.+... ..+|+|||||++|+|.+++++. .+++..+..++.|++.||.|||+.
T Consensus 45 e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~ 123 (303)
T d1vjya_ 45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGT 123 (303)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred HHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 345556678899999999999986543 3689999999999999999875 599999999999999999999974
Q ss_pred --CCCeEeeeccCCcEEEeCCCCcEEEeecChhhhccCC------CcccccCCCCccCccccccC-------CCccceeh
Q 008378 85 --NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYEEE-------YNELVDIY 149 (568)
Q Consensus 85 --g~~IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~------~~~s~~GTp~YmAPEvl~~~-------ys~ksDIW 149 (568)
.++|+||||||+|||++ .+|.+||+|||+++..... .....+||+.|||||++... |+.++|||
T Consensus 124 ~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~ 202 (303)
T d1vjya_ 124 QGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 202 (303)
T ss_dssp TCBCEEECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred ccCCCeeccccCccceEEc-CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhh
Confidence 12399999999999997 7899999999999866432 23356899999999988543 57789999
Q ss_pred hhHHHHHHHhhcCCCCCCC--------------CCHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHhcC-CCCCC
Q 008378 150 SFGMCILEMVTCEYPYNEC--------------KNPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLR 209 (568)
Q Consensus 150 SLGiilyEmltG~~Pf~~~--------------~~~~~i~~~i~~~~~p~~~~~~-----~s~el~~lI~kcL~-~p~~R 209 (568)
||||++|||+||..||... .....+...+..+...+.++.. ....+.+++.+||+ +|.+|
T Consensus 203 S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 282 (303)
T d1vjya_ 203 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282 (303)
T ss_dssp HHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGS
T ss_pred hhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHC
Confidence 9999999999998776321 1234445554443332222222 12458899999996 69999
Q ss_pred CCHHHHhcC
Q 008378 210 LPALELLKD 218 (568)
Q Consensus 210 psa~ElL~h 218 (568)
||+.|++.+
T Consensus 283 ps~~ei~~~ 291 (303)
T d1vjya_ 283 LTALRIKKT 291 (303)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999998763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-35 Score=297.22 Aligned_cols=211 Identities=20% Similarity=0.266 Sum_probs=161.4
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHhhhhCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNP 86 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~-k~~~l~e~~i~~i~~QIl~gL~yLHs~g~ 86 (568)
+++.+|+++|+.++|+|+|.++..+... ....++||||+. |+|.+++. ..+.+++..+..++.||+.||+|||++|
T Consensus 47 ~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~- 123 (299)
T d1ckia_ 47 PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 123 (299)
T ss_dssp CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578899999999888777665554433 347889999995 56655554 4568999999999999999999999999
Q ss_pred CeEeeeccCCcEEEeC--CCCcEEEeecChhhhccCC---------CcccccCCCCccCccccc-cCCCccceehhhHHH
Q 008378 87 PIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 154 (568)
Q Consensus 87 ~IiHRDLKp~NILl~~--~~g~vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSLGii 154 (568)
|+||||||+|||++. .+..+||+|||+|+.+... ...+.+||+.|||||++. ..|+.++|||||||+
T Consensus 124 -iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~ 202 (299)
T d1ckia_ 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 202 (299)
T ss_dssp -EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHH
T ss_pred -eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHH
Confidence 999999999999852 3457999999999876432 234568999999999875 459999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHH--HHHHHc---CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH---HHhcCCCCC
Q 008378 155 ILEMVTCEYPYNECKNPAQI--YKKVTS---GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLV 222 (568)
Q Consensus 155 lyEmltG~~Pf~~~~~~~~i--~~~i~~---~~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~---ElL~hpff~ 222 (568)
+|||+||..||......... +..... ..++.......++++.+||.+||. +|.+||++. ++|+|+|.+
T Consensus 203 l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 203 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999765433221 111111 112222345678999999999995 799999987 557777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-33 Score=287.23 Aligned_cols=204 Identities=17% Similarity=0.235 Sum_probs=164.3
Q ss_pred HHHHHHHHHHHhCCC-CCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHhhhhCC
Q 008378 8 ERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 85 (568)
Q Consensus 8 e~l~~Ei~iLk~L~H-pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~-~l~e~~i~~i~~QIl~gL~yLHs~g 85 (568)
+.+.+|++.++.|+| +||+.+++++... ...++||||+ +++|.++++..+ .+++..+..++.|++.||+|||++|
T Consensus 45 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g 121 (293)
T d1csna_ 45 PQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121 (293)
T ss_dssp CCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHhcCCCCCCEEEEEeecC--CccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC
Confidence 357789999999976 8999999988654 4789999999 689999887654 6999999999999999999999999
Q ss_pred CCeEeeeccCCcEEEeC----CCCcEEEeecChhhhccCC---------CcccccCCCCccCccccc-cCCCccceehhh
Q 008378 86 PPIIHRDLKCDNIFVNG----NNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE-EEYNELVDIYSF 151 (568)
Q Consensus 86 ~~IiHRDLKp~NILl~~----~~g~vKI~DFGla~~~~~~---------~~~s~~GTp~YmAPEvl~-~~ys~ksDIWSL 151 (568)
|+||||||+|||++. ..+.+||+|||+|+.+... ...+.+||+.|||||++. ..|+.++|||||
T Consensus 122 --iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSl 199 (293)
T d1csna_ 122 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 199 (293)
T ss_dssp --EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred --ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHh
Confidence 999999999999962 3578999999999865322 234568999999999874 559999999999
Q ss_pred HHHHHHHhhcCCCCCCCC--CHHHHHHHHHcC---CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 008378 152 GMCILEMVTCEYPYNECK--NPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 216 (568)
Q Consensus 152 GiilyEmltG~~Pf~~~~--~~~~i~~~i~~~---~~p~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL 216 (568)
||++|||+||..||.+.. .....+..+... ..+..+.+..++++.+++..|+. +|.+||+...+.
T Consensus 200 G~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 200 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred hHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 999999999999997533 333333333221 12223345577899999999994 799999977653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-33 Score=288.58 Aligned_cols=218 Identities=22% Similarity=0.351 Sum_probs=161.8
Q ss_pred HHHHHHHHHHHHHHhCC-----------CCCeeeeeeEEEcCCCCeEEEEEecCCCCC-HHHHH--HhCCCCCHHHHHHH
Q 008378 5 DQLERLYSEVHLLKSLK-----------HENIIKFYNSWVDDTNRTINMITELFTSGS-LRQYR--KKHKNVDMKAIKNW 70 (568)
Q Consensus 5 ~~~e~l~~Ei~iLk~L~-----------HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGs-L~~~i--~k~~~l~e~~i~~i 70 (568)
...+.+.+|+++|+.++ |+|||++++++........+++++++..+. ...+. .....+++..++.+
T Consensus 51 ~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i 130 (362)
T d1q8ya_ 51 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHH
Confidence 34567888999999886 478999999987665556777777765554 33322 23457999999999
Q ss_pred HHHHHHHHHhhhh-CCCCeEeeeccCCcEEEeCCC-----CcEEEeecChhhhccCCCcccccCCCCccCcccc-ccCCC
Q 008378 71 ARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNN-----GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN 143 (568)
Q Consensus 71 ~~QIl~gL~yLHs-~g~~IiHRDLKp~NILl~~~~-----g~vKI~DFGla~~~~~~~~~s~~GTp~YmAPEvl-~~~ys 143 (568)
+.||+.||.|||+ +| |+||||||+|||++..+ ..+|++|||.+..... .....+||+.|+|||++ ...|+
T Consensus 131 ~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 131 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp HHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCC
T ss_pred HHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccceeeEeeccccccccc-ccccccccccccChhhccccCCC
Confidence 9999999999997 77 99999999999997322 1499999999876543 34567899999999977 56699
Q ss_pred ccceehhhHHHHHHHhhcCCCCCCCCCH------HHHHHHHHc-CC--------------------CC------------
Q 008378 144 ELVDIYSFGMCILEMVTCEYPYNECKNP------AQIYKKVTS-GI--------------------KP------------ 184 (568)
Q Consensus 144 ~ksDIWSLGiilyEmltG~~Pf~~~~~~------~~i~~~i~~-~~--------------------~p------------ 184 (568)
.++||||+||++++|++|+.||...... ..+...+.. +. .+
T Consensus 208 ~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (362)
T d1q8ya_ 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 287 (362)
T ss_dssp THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchh
Confidence 9999999999999999999999653221 111111100 00 00
Q ss_pred ------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 008378 185 ------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 225 (568)
Q Consensus 185 ------~~~~~~~s~el~~lI~kcL~-~p~~Rpsa~ElL~hpff~~~~ 225 (568)
.......++++++||.+||. +|.+||||.|+|+||||+...
T Consensus 288 ~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 288 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 00112235789999999996 799999999999999998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.61 E-value=4.4e-17 Score=153.40 Aligned_cols=128 Identities=19% Similarity=0.187 Sum_probs=95.2
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 008378 8 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 87 (568)
Q Consensus 8 e~l~~Ei~iLk~L~HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~i~k~~~l~e~~i~~i~~QIl~gL~yLHs~g~~ 87 (568)
....+|...|.++.|++++..+++. . -+++|||++++.+. .++...+..++.||+.||.|||++|
T Consensus 59 ~~~~~e~~~l~~l~~~~v~~~~~~~--~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g-- 123 (191)
T d1zara2 59 RSARNEFRALQKLQGLAVPKVYAWE--G----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG-- 123 (191)
T ss_dssp HHHHHHHHHHHHTTTSSSCCEEEEE--T----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHHHccCCCcceEEEec--C----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC--
Confidence 4456799999999999999988742 2 25899999986553 3566777889999999999999999
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChhhhccCCCcccccC-CCCccCccccccCCCccceehhhHH
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG-TPEFMAPELYEEEYNELVDIYSFGM 153 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla~~~~~~~~~s~~G-Tp~YmAPEvl~~~ys~ksDIWSLGi 153 (568)
|+||||||+|||++ + +.++|+|||+|.....+....+.. .... -.+.+.+.|+.++|+||+.-
T Consensus 124 iiHrDiKP~NILv~-~-~~~~liDFG~a~~~~~~~~~~~l~rd~~~-~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 124 IVHGDLSQYNVLVS-E-EGIWIIDFPQSVEVGEEGWREILERDVRN-IITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp EECSCCSTTSEEEE-T-TEEEECCCTTCEETTSTTHHHHHHHHHHH-HHHHHHHHHCCCCCHHHHHH
T ss_pred EEEccCChhheeee-C-CCEEEEECCCcccCCCCCcHHHHHHHHHH-HHHHHcCCCCCcccHHHHHH
Confidence 99999999999997 3 459999999997664433222110 0000 01234567899999999653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.80 E-value=0.0015 Score=61.22 Aligned_cols=45 Identities=11% Similarity=-0.041 Sum_probs=31.6
Q ss_pred HHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCHHHH
Q 008378 9 RLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 55 (568)
Q Consensus 9 ~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL~~~ 55 (568)
.+.+|+..|+.|. +--+.+++.+..+. ...++||++++|.++...
T Consensus 55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 55 DVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCSSEEHHHH
T ss_pred hHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEEEeccccccccc
Confidence 4678999988874 33356666654433 468899999999887543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.93 E-value=0.0041 Score=57.92 Aligned_cols=42 Identities=12% Similarity=0.004 Sum_probs=29.1
Q ss_pred HHHHHHHHHHhCCC--CCeeeeeeEEEcCCCCeEEEEEecCCCCCH
Q 008378 9 RLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSL 52 (568)
Q Consensus 9 ~l~~Ei~iLk~L~H--pNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL 52 (568)
.+.+|+..|+.|.. -.+.+++.+..+. ...++||++++|.++
T Consensus 50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 50 ELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDL 93 (255)
T ss_dssp CHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEET
T ss_pred HHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeeecccc
Confidence 46788888888843 3355667655443 467899999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.53 E-value=0.01 Score=59.84 Aligned_cols=26 Identities=38% Similarity=0.571 Sum_probs=22.6
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLA 115 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla 115 (568)
++|+|+.|.|||++ .+.++|+||..+
T Consensus 225 LiHGDl~~gNIlv~--~~~~~vID~E~a 250 (392)
T d2pula1 225 LIHGDLHTGSIFAS--EHETKVIDPEFA 250 (392)
T ss_dssp EECSCCCGGGEEEC--SSCEEECCCTTC
T ss_pred eeccCCcCCceeEc--CCceEEechhhc
Confidence 89999999999997 345899999866
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=90.09 E-value=0.091 Score=52.37 Aligned_cols=38 Identities=21% Similarity=0.259 Sum_probs=25.7
Q ss_pred HHHHHHHHHHhCC-CCCeeeeeeEEEcCCCCeEEEEEecCCCCCH
Q 008378 9 RLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSL 52 (568)
Q Consensus 9 ~l~~Ei~iLk~L~-HpNIV~l~~~~~~~~~~~l~lV~Ey~~gGsL 52 (568)
...+|..+++.+. +.-..+++.++ ++ ++|+||++|..|
T Consensus 90 dr~~E~~i~~~ls~~gl~Pkll~~~--~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 90 HLVAESVIFTLLSERHLGPKLYGIF--SG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEE--TT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEc--CC----ceEEEEeccccC
Confidence 4568999999984 43345677755 22 468899987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=84.09 E-value=0.41 Score=45.36 Aligned_cols=27 Identities=33% Similarity=0.415 Sum_probs=23.0
Q ss_pred eEeeeccCCcEEEeCCCCcEEEeecChh
Q 008378 88 IIHRDLKCDNIFVNGNNGEVKIGDLGLA 115 (568)
Q Consensus 88 IiHRDLKp~NILl~~~~g~vKI~DFGla 115 (568)
+||+|+.++||+++ .++..-|.||+.+
T Consensus 185 iIHgDl~~dNvl~~-~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 185 VIHADLFQDNVFFL-GDELSGLIDFYFA 211 (316)
T ss_dssp EECSCCCGGGEEEE-TTEEEEECCCTTC
T ss_pred cccCCcchhhhhcc-cccceeEeccccc
Confidence 89999999999998 4445579999976
|